data_1tof_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1tof _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -78.6 35.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.114 1.765 . . . . 0.0 112.968 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.14 171.05 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.415 1.086 . . . . 0.0 112.017 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -94.96 143.69 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.101 1.36 . . . . 0.0 107.415 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tp -147.56 155.09 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 111.013 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -136.23 32.58 2.86 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.32 1.448 . . . . 0.0 112.0 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -152.57 139.04 18.59 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.961 0.886 . . . . 0.0 111.805 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -42.53 80.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 111.115 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.43 86.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.537 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.68 76.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.383 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -49.96 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.17 -50.14 74.84 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.782 0.801 . . . . 0.0 110.58 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.52 -56.65 13.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.801 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.16 -50.84 70.01 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.9 -47.85 11.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.502 0.721 . . . . 0.0 109.59 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.82 0.83 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -59.93 -21.94 61.79 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 111.786 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.96 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.179 . . . . 0.0 111.231 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm 62.41 50.72 3.59 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.323 1.449 . . . . 0.0 107.398 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -50.53 -31.91 16.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.192 2.197 . . . . 0.0 115.005 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -59.79 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 128.888 2.875 . . . . 0.0 114.061 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -136.85 84.22 2.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -178.16 155.84 1.01 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.952 0.901 . . . . 0.0 110.085 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.47 117.13 3.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.387 3.391 . . . . 0.0 114.179 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.8 mt -88.7 96.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -93.1 104.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.88 131.73 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -104.66 98.76 8.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.3 98.14 8.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -124.66 174.92 7.54 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.835 1.254 . . . . 0.0 108.644 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.5 169.92 16.93 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.031 0.832 . . . . 0.0 109.696 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 p -71.25 -70.11 0.33 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -50.55 -30.17 12.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 115.358 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.6 p -76.04 61.58 1.55 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.902 1.228 . . . . 0.0 112.728 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 10.26 -84.6 0.0 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 128.83 3.11 . . . . 0.0 115.601 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -39.81 -39.44 2.15 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.875 3.716 . . . . 0.0 114.203 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -44.11 -44.22 7.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.92 1.688 . . . . 0.0 111.286 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -61.86 -26.17 67.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 112.11 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -91.02 -40.84 11.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.179 1.392 . . . . 0.0 109.756 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.52 -39.71 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.431 0.692 . . . . 0.0 109.617 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -61.54 6.13 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.832 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.62 -29.78 89.17 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.919 2.412 . . . . 0.0 112.284 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.83 -58.2 9.58 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.23 -32.36 66.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.93 0.892 . . . . 0.0 110.556 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.23 -33.86 63.47 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -59.02 -53.53 57.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.9 mt -59.6 -39.6 84.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 m -56.25 -51.49 67.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.477 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -56.06 -48.6 75.75 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.697 0.799 . . . . 0.0 110.269 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -64.1 -61.32 2.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.269 0.556 . . . . 0.0 111.295 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.24 57.49 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.647 1.179 . . . . 0.0 110.125 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.95 173.35 11.33 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.521 -0.737 . . . . 0.0 111.15 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -65.98 1.31 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.466 1.031 . . . . 0.0 114.686 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -82.63 -59.06 2.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.628 0.714 . . . . 0.0 111.04 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -78.67 129.43 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.68 104.08 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -91.54 88.2 6.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.1 mt -83.91 99.67 10.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -81.82 94.0 6.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.19 124.31 43.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.04 0.536 . . . . 0.0 110.018 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -81.22 92.47 6.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.36 -36.51 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.683 1.993 . . . . 0.0 110.288 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -50.95 -37.84 46.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.372 0.669 . . . . 0.0 109.91 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.8 -62.31 1.41 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.2 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.99 58.28 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.496 -0.753 . . . . 0.0 111.069 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.67 87.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.308 0.643 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.59 -58.07 9.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.871 0.869 . . . . 0.0 111.894 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.6 -42.59 92.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.92 27.52 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -65.05 -39.56 93.48 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.063 -1.023 . . . . 0.0 110.315 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.04 93.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.412 0.551 . . . . 0.0 110.512 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.94 -32.09 73.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.096 0.958 . . . . 0.0 109.887 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.22 40.51 1.93 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.683 1.135 . . . . 0.0 111.952 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.32 137.98 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 p -136.0 -83.72 0.38 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.12 78.05 2.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.392 0.677 . . . . 0.0 109.802 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 143.14 93.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.99 143.81 76.69 Favored 'Cis proline' 0 N--CA 1.447 -1.258 0 CA-C-N 119.651 0.911 . . . . 0.0 110.453 -0.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.2 m -126.68 119.54 27.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -100.08 129.28 46.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.393 1.077 . . . . 0.0 109.433 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -124.09 147.23 48.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -114.69 91.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -84.43 64.73 8.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -61.03 138.52 58.19 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 72.98 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.807 2.043 . . . . 0.0 110.268 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.85 25.15 0.02 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.497 1.523 . . . . 0.0 111.686 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -156.12 138.57 6.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.236 1.518 . . . . 0.0 109.231 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -46.73 91.07 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.207 2.203 . . . . 0.0 110.88 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.35 21.5 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.95 164.22 39.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -147.29 164.02 34.55 Favored 'General case' 0 N--CA 1.46 0.05 0 C-N-CA 124.364 1.066 . . . . 0.0 109.243 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -162.11 114.83 1.75 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.198 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.56 157.43 3.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.804 0.811 . . . . 0.0 110.261 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.38 -174.65 53.47 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.897 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.29 -60.33 3.91 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 m 35.11 50.41 0.49 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.093 2.157 . . . . 0.0 112.874 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -47.01 -51.16 17.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.475 1.51 . . . . 0.0 113.353 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.87 -47.25 86.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.797 -0.565 . . . . 0.0 111.269 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.27 -41.23 97.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.2 tp -56.99 -54.84 42.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -50.93 -51.71 49.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.82 0.848 . . . . 0.0 109.945 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.905 0.482 . . . . 0.0 110.811 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.26 -48.04 81.71 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.307 0.503 . . . . 0.0 110.891 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.81 -52.66 33.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.42 27.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.477 0.311 . . . . 0.0 110.815 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -50.29 -57.44 7.87 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.543 1.137 . . . . 0.0 111.225 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -74.42 -25.26 59.34 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.13 40.02 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.796 0.726 . . . . 0.0 109.644 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.797 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.0 t -83.38 97.09 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.42 169.58 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.393 1.092 . . . . 0.0 112.699 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.33 138.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tp -151.11 152.14 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.918 0.781 . . . . 0.0 111.226 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -131.89 24.75 4.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.944 1.698 . . . . 0.0 112.415 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -149.33 142.45 24.96 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.158 0.89 . . . . 0.0 111.171 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -70.43 -36.55 74.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.563 1.545 . . . . 0.0 109.614 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.46 75.42 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.85 91.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.2 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -48.86 -58.16 5.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.32 -47.83 83.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.321 0.648 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.9 -47.32 71.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.614 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -64.11 -49.7 71.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp -46.1 -47.99 17.21 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.696 0.798 . . . . 0.0 110.285 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -64.74 0.82 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.492 0.317 . . . . 0.0 111.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -61.09 -24.74 66.46 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.719 -0.613 . . . . 0.0 112.634 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.76 -20.46 64.14 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.462 -1.188 . . . . 0.0 112.322 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 62.92 63.1 0.98 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.308 1.443 . . . . 0.0 108.751 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -75.25 62.32 1.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.892 1.277 . . . . 0.0 110.305 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.58 -55.44 13.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -154.16 19.23 0.5 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 109.554 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -78.59 133.81 62.48 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.16 119.28 6.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.576 1.517 . . . . 0.0 112.498 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mt -99.12 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.43 116.43 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.14 128.8 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.06 96.17 7.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.465 1.506 . . . . 0.0 107.224 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.15 94.01 9.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.8 m -131.69 117.42 18.62 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.06 58.83 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.895 0.316 . . . . 0.0 111.471 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.11 -49.15 52.66 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.112 0.965 . . . . 0.0 110.924 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -68.98 -6.56 28.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 113.29 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.53 64.81 4.51 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.55 -79.88 0.01 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.388 2.899 . . . . 0.0 115.748 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.33 -36.91 53.28 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.436 2.091 . . . . 0.0 111.188 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -38.06 70.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.644 0.778 . . . . 0.0 109.248 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -53.42 -26.64 20.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.634 0.773 . . . . 0.0 111.889 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.2 mtt -62.42 -16.21 53.65 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.11 0.868 . . . . 0.0 111.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.77 -26.18 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.371 0.668 . . . . 0.0 109.812 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.15 16.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.304 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -56.42 -38.92 94.37 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.024 1.816 . . . . 0.0 112.018 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.6 mt -56.6 -57.34 12.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.558 0.694 . . . . 0.0 109.602 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.96 -41.72 75.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.048 0.539 . . . . 0.0 110.067 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -62.61 -34.46 77.08 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.36 -0.838 . . . . 0.0 110.539 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.1 m -62.28 -47.46 84.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.58 -40.63 92.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.454 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 19.5 m -53.58 -52.39 59.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.63 -46.33 89.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.367 0.667 . . . . 0.0 110.429 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -51.16 -54.05 28.93 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.55 -55.52 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.739 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 36.05 -125.44 0.14 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.206 1.402 . . . . 0.0 110.391 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 45.05 -84.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.159 2.314 . . . . 0.0 115.188 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -91.19 -39.43 12.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.372 1.469 . . . . 0.0 112.916 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.63 132.14 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 113.235 -167.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.4 129.53 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 78.8 m-85 -122.14 113.47 19.54 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.15 101.58 10.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.844 1.258 . . . . 0.0 110.985 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.6 119.41 22.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.38 138.67 53.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.849 0.833 . . . . 0.0 111.88 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -97.88 104.92 16.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.949 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 m -55.65 -28.63 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.19 0.596 . . . . 0.0 110.985 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.01 -36.5 77.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.76 -66.38 0.9 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.936 0.495 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.07 53.88 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 121.497 -0.752 . . . . 0.0 111.267 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.62 -43.58 25.98 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.042 0.937 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.01 73.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.965 0.906 . . . . 0.0 111.138 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.34 -43.49 87.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.45 27.48 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.667 0.387 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.16 -42.54 88.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.685 -0.634 . . . . 0.0 110.748 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.22 93.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.679 0.672 . . . . 0.0 110.886 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.54 91.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.767 1.227 . . . . 0.0 109.785 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 43.23 1.18 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.456 1.027 . . . . 0.0 112.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.45 131.08 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 p -113.51 -74.92 0.61 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.57 14.76 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.692 1.197 . . . . 0.0 108.899 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -137.96 139.87 27.48 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -62.73 155.63 67.04 Favored 'Cis proline' 0 N--CA 1.457 -0.667 0 CA-C-N 120.758 1.307 . . . . 0.0 114.899 -0.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -144.45 135.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.09 121.25 38.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -119.81 153.85 35.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.02 122.91 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.042 0.937 . . . . 0.0 108.698 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -113.59 118.85 35.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -90.69 -57.52 2.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.461 0.573 . . . . 0.0 112.107 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -93.16 -42.46 9.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.198 1.399 . . . . 0.0 110.545 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.02 -24.18 0.11 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.673 2.082 . . . . 0.0 110.138 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.84 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.16 1.384 . . . . 0.0 108.864 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.0 103.01 0.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.59 -33.66 41.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.835 0.854 . . . . 0.0 110.319 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -158.98 166.94 30.64 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.44 29.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.694 0.797 . . . . 0.0 111.569 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -160.3 149.34 17.25 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.067 1.747 . . . . 0.0 108.14 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.14 156.0 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.97 1.308 . . . . 0.0 110.631 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.33 177.43 46.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.816 0.722 . . . . 0.0 112.124 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.89 46.16 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.736 1.214 . . . . 0.0 111.138 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -80.04 67.08 5.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.33 -0.856 . . . . 0.0 109.985 -175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -49.53 -45.15 47.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.594 1.158 . . . . 0.0 111.963 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -56.76 -48.91 76.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.03 0.932 . . . . 0.0 110.147 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -67.65 -38.93 84.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -56.46 -55.43 33.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -51.58 -53.77 34.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.798 0.439 . . . . 0.0 110.462 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.91 -44.46 74.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.706 0.402 . . . . 0.0 111.209 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.9 mt -61.3 -49.76 75.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.955 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.26 -46.97 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.06 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.98 -52.26 58.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.143 0.177 . . . . 0.0 110.817 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -56.31 -62.7 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.897 0.879 . . . . 0.0 110.499 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -70.28 -14.95 62.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.16 16.78 25.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.035 0.834 . . . . 0.0 110.671 174.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 111.959 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.88 101.65 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 108.734 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 pt -145.76 129.47 10.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 122.73 1.252 . . . . 0.0 111.397 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.14 57.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.03 -179.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.209 1.004 . . . . 0.0 111.152 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -134.32 -38.33 0.85 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -174.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -80.48 156.39 26.59 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -165.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.74 -46.2 91.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.837 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.72 -51.92 52.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.98 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.8 81.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.169 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -46.85 -58.96 3.4 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.89 -54.68 43.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 111.646 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.39 -63.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.234 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -55.68 -47.42 76.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.581 -0.724 . . . . 0.0 110.901 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.61 -19.44 0.91 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.837 0.711 . . . . 0.0 112.016 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.32 -56.86 2.14 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.266 0.939 . . . . 0.0 111.092 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.42 63.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.96 -8.38 57.86 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 119.883 1.22 . . . . 0.0 112.569 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.42 56.28 0.78 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.795 2.038 . . . . 0.0 109.547 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -67.91 64.15 0.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.62 3.168 . . . . 0.0 111.202 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.36 93.71 4.03 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.766 2.026 . . . . 0.0 107.226 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 68.04 72.81 0.31 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 128.864 2.865 . . . . 0.0 110.217 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -172.53 155.27 3.24 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 122.731 0.412 . . . . 0.0 111.858 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.96 135.05 6.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.225 2.616 . . . . 0.0 113.883 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.89 99.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -91.45 109.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.12 123.66 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.904 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -88.68 101.66 14.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.86 1.264 . . . . 0.0 110.232 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.42 115.53 20.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -140.85 162.03 36.42 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 108.212 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.62 163.81 15.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.0 1.32 . . . . 0.0 109.307 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.2 p -77.96 -57.92 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.505 0.722 . . . . 0.0 109.608 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -50.74 -31.59 17.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.648 1.579 . . . . 0.0 113.272 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -77.44 55.37 1.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.616 1.098 . . . . 0.0 110.778 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.86 -68.12 0.01 OUTLIER Glycine 0 CA--C 1.536 1.369 0 C-N-CA 127.938 2.685 . . . . 0.0 115.477 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -42.5 -39.22 6.61 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.577 3.518 . . . . 0.0 114.232 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.6 m -42.78 -44.06 4.24 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.474 1.51 . . . . 0.0 110.88 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.0 -29.16 59.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.03 0.932 . . . . 0.0 112.26 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.49 -19.87 64.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.902 0.774 . . . . 0.0 111.861 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.6 -28.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.51 27.3 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.993 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.2 -42.06 38.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.057 1.838 . . . . 0.0 111.736 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.78 -54.48 45.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.75 0.786 . . . . 0.0 109.565 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -55.86 -45.41 78.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.223 1.009 . . . . 0.0 109.311 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.68 -41.84 95.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.808 0.843 . . . . 0.0 110.836 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 m -58.36 -49.84 75.79 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.1 tp -60.43 -37.64 81.55 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.116 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 37.8 m -58.94 -44.71 91.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 122.073 -0.392 . . . . 0.0 110.549 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -58.85 -48.33 81.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -46.7 -52.89 12.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 112.736 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -103.99 36.26 2.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.623 0.647 . . . . 0.0 111.471 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.06 71.11 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.234 0.925 . . . . 0.0 112.038 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.37 -75.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.18 -49.2 17.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.45 124.61 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.382 -167.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mm -90.99 114.53 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 96.8 m-85 -105.98 101.75 11.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.82 163.48 14.14 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.15 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -138.02 150.84 47.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.76 136.43 26.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -87.78 113.03 23.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.15 -30.48 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.274 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -62.34 -52.86 61.94 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.06 -60.81 2.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.198 0.599 . . . . 0.0 110.393 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.86 58.57 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.716 0.769 . . . . 0.0 110.338 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.07 -47.14 72.01 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.922 0.889 . . . . 0.0 111.04 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.1 -55.52 23.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.998 0.919 . . . . 0.0 111.978 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.25 -43.99 95.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.97 68.89 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.49 -42.39 74.84 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.83 -0.544 . . . . 0.0 109.761 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.65 78.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.679 0.672 . . . . 0.0 110.535 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 2.7 22.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.258 1.023 . . . . 0.0 111.757 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.75 42.86 94.64 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.569 1.08 . . . . 0.0 112.604 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.81 139.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 117.537 0.668 . . . . 0.0 109.632 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.1 p -139.84 -78.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 110.151 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.8 74.12 1.58 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.336 1.054 . . . . 0.0 111.311 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.31 138.67 91.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -63.7 135.25 19.54 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.443 1.551 . . . . 0.0 112.498 -1.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -125.52 107.37 10.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.86 121.1 33.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.943 0.897 . . . . 0.0 108.604 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.03 141.96 43.81 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.71 96.33 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.3 105.42 17.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -82.44 116.57 21.95 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.0 -59.81 0.37 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.784 2.834 . . . . 0.0 110.346 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.04 23.02 0.09 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.266 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.65 135.16 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.256 1.528 . . . . 0.0 108.406 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -62.96 98.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.393 0.677 . . . . 0.0 109.386 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -33.07 40.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.483 0.713 . . . . 0.0 110.182 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -161.91 174.67 12.78 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -160.61 172.24 17.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.16 1.384 . . . . 0.0 108.165 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.08 150.52 9.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.555 1.142 . . . . 0.0 108.666 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -126.95 158.56 37.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 175.04 46.23 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.573 1.082 . . . . 0.0 111.863 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.62 42.79 0.45 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.904 0.882 . . . . 0.0 110.548 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -78.71 55.4 1.68 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.081 1.752 . . . . 0.0 110.842 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.27 21.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.329 1.052 . . . . 0.0 113.104 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.49 -52.26 65.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.116 0.871 . . . . 0.0 110.245 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.77 -37.94 89.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.76 -57.94 9.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -53.47 -49.9 66.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.016 0.527 . . . . 0.0 110.754 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.93 76.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.14 0.176 . . . . 0.0 111.129 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.02 -47.09 81.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.935 -0.478 . . . . 0.0 110.466 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 65.6 t -56.42 -48.17 80.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.69 -56.6 15.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -47.11 -63.95 0.91 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.905 1.282 . . . . 0.0 111.065 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -70.39 -23.88 62.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.051 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.12 54.51 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.277 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.93 26.65 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.121 1.368 . . . . 0.0 107.857 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 pt -145.67 177.27 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 126.424 1.89 . . . . 0.0 107.431 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.76 73.9 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 122.007 0.908 . . . . 0.0 110.496 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.26 127.9 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 107.952 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -105.12 -42.48 5.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.636 1.974 . . . . 0.0 110.675 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 m -14.13 110.81 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.301 3.041 . . . . 0.0 115.035 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -40.29 -47.1 2.44 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.477 1.511 . . . . 0.0 111.326 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.53 -49.54 74.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.932 0.493 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.19 85.63 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -58.59 5.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.588 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -59.54 -47.28 86.16 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.115 0.966 . . . . 0.0 110.346 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -48.47 64.61 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.954 0.902 . . . . 0.0 110.857 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -51.68 -25.92 8.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.866 0.866 . . . . 0.0 112.133 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.19 -60.23 1.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.195 0.907 . . . . 0.0 111.296 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -22.22 63.84 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.814 -0.554 . . . . 0.0 112.081 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.93 -29.71 71.35 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.896 -0.947 . . . . 0.0 110.95 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 45.89 55.04 7.37 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.866 1.266 . . . . 0.0 107.801 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 pm0 -73.55 43.36 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -47.83 -51.05 24.18 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 0.0 109.032 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -135.09 58.48 1.77 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.649 0.78 . . . . 0.0 108.905 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -138.32 126.76 14.16 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.91 105.23 1.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 120.823 1.015 . . . . 0.0 112.212 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.98 118.4 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -118.06 122.11 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.6 110.79 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 123.385 0.674 . . . . 0.0 109.877 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -88.44 93.1 9.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -79.5 94.54 5.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -116.14 -165.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.338 1.455 . . . . 0.0 108.832 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -154.23 147.17 24.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.73 -0.606 . . . . 0.0 110.572 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -64.33 -46.01 85.36 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 112.512 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -68.26 -47.69 67.07 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -77.94 64.43 3.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.065 0.848 . . . . 0.0 112.276 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 11.04 -83.29 0.0 OUTLIER Glycine 0 CA--C 1.536 1.377 0 C-N-CA 128.987 3.184 . . . . 0.0 115.398 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -40.45 -46.37 4.43 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.375 3.383 . . . . 0.0 113.251 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.3 m -46.11 -51.62 13.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.409 1.484 . . . . 0.0 109.695 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -72.46 -41.37 66.15 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 mmt -60.82 -25.39 66.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.532 0.605 . . . . 0.0 112.217 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mt -70.75 -27.11 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.688 -0.632 . . . . 0.0 110.001 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.05 -51.78 79.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 116.994 -1.479 . . . . 0.0 110.653 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.99 -44.23 23.29 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.441 2.76 . . . . 0.0 113.565 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -59.98 -54.93 40.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.47 -34.62 69.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.142 0.577 . . . . 0.0 110.362 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.7 -34.15 75.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.531 1.132 . . . . 0.0 109.926 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -62.66 -47.65 82.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.1 -39.5 86.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.857 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -53.63 -52.1 60.98 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.879 0.471 . . . . 0.0 109.87 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -55.18 -47.13 75.64 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.555 . . . . 0.0 110.344 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.64 -64.95 0.76 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.294 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -80.06 60.39 3.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.187 0.995 . . . . 0.0 108.923 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.19 69.03 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.43 -136.68 0.01 OUTLIER Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.171 1.843 . . . . 0.0 116.229 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -71.81 38.45 0.07 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.072 1.349 . . . . 0.0 114.462 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -121.85 137.32 55.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.25 108.22 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.39 110.0 22.64 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 105.46 14.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.655 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -88.26 90.44 8.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.24 103.57 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.184 0.516 . . . . 0.0 109.775 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -76.99 100.33 5.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.85 -33.11 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.544 0.738 . . . . 0.0 112.14 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.83 -27.92 67.04 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.541 0.61 . . . . 0.0 111.035 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.0 -61.42 1.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 77.2 t -83.42 57.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 122.686 1.231 . . . . 0.0 109.314 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.69 40.06 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.864 1.266 . . . . 0.0 112.788 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.87 -50.84 32.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.724 0.81 . . . . 0.0 111.56 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -63.81 -47.86 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.47 69.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.359 0.264 . . . . 0.0 111.704 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -66.16 -43.49 86.83 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.63 77.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 0.0 110.971 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.56 -9.21 58.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 111.882 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.73 36.03 38.56 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.197 0.904 . . . . 0.0 112.342 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -78.96 141.37 15.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.221 1.01 . . . . 0.0 109.025 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -136.75 -82.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.73 72.59 2.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.375 1.07 . . . . 0.0 111.1 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.65 146.27 86.15 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.793 0.437 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.49 159.83 96.96 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 119.684 0.923 . . . . 0.0 110.185 -1.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.4 m -147.8 118.41 7.49 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.13 120.75 34.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 109.593 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -114.68 153.39 30.31 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.33 124.82 67.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -110.64 105.59 14.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.927 0.891 . . . . 0.0 110.33 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -92.45 147.78 22.62 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.46 -64.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 129.096 2.959 . . . . 0.0 112.153 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.68 33.67 0.05 OUTLIER Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.955 2.217 . . . . 0.0 110.486 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.28 145.17 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 118.357 1.078 . . . . 0.0 109.901 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -57.51 106.08 0.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.291 1.436 . . . . 0.0 108.174 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.45 -37.56 12.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.477 1.111 . . . . 0.0 112.554 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -155.54 167.56 29.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -160.68 175.69 12.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.724 0.773 . . . . 0.0 111.939 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -156.87 110.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.513 2.325 . . . . 0.0 106.533 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.53 145.68 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.96 -158.79 29.63 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.37 122.4 44.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.762 1.225 . . . . 0.0 109.955 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -157.59 80.27 0.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -32.75 65.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.987 0.515 . . . . 0.0 111.704 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -60.93 -50.39 73.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.32 -37.43 87.23 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.49 -55.4 35.34 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.629 0.771 . . . . 0.0 109.812 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -51.97 -50.63 60.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.87 86.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.475 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.28 -51.97 67.29 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.816 0.846 . . . . 0.0 109.477 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.47 -50.36 73.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.35 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.55 -58.07 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.877 0.37 . . . . 0.0 110.582 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -45.91 -58.16 3.77 Favored 'General case' 0 C--O 1.228 -0.059 0 C-N-CA 125.57 1.548 . . . . 0.0 110.433 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -83.19 9.79 9.8 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.31 -46.27 5.08 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.177 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.793 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 121.784 0.802 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.01 120.72 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.405 1.082 . . . . 0.0 109.904 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -144.38 171.81 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.172 0.987 . . . . 0.0 111.728 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.04 136.03 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -153.29 152.42 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 118.696 0.68 . . . . 0.0 110.787 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -115.81 -62.56 1.58 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.233 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 m -37.12 105.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.203 3.001 . . . . 0.0 113.483 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -44.53 -49.0 10.23 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.007 1.323 . . . . 0.0 110.346 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.78 -49.77 57.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.106 0.562 . . . . 0.0 111.074 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 -44.36 83.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.823 0.449 . . . . 0.0 109.966 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -61.34 2.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.876 0.87 . . . . 0.0 108.906 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -58.69 -48.66 80.35 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.463 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.24 -63.42 1.15 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.399 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -58.63 -48.2 81.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -46.49 -49.88 17.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 110.758 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -49.18 8.64 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -28.65 61.93 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.698 1.136 . . . . 0.0 111.261 -176.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.72 -37.57 61.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.061 -0.855 . . . . 0.0 111.824 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? 44.98 51.53 8.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.811 1.245 . . . . 0.0 109.281 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.44 56.72 1.81 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.679 1.191 . . . . 0.0 113.02 -171.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -22.57 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 128.321 2.648 . . . . 0.0 112.172 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -132.55 59.23 1.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -135.15 142.3 41.28 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.35 111.17 3.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.478 2.119 . . . . 0.0 114.52 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.79 97.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.51 114.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.6 t -106.42 115.79 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -100.13 103.65 15.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.46 90.39 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -114.94 139.7 49.61 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.749 1.219 . . . . 0.0 109.036 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.71 72.28 2.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.669 0.788 . . . . 0.0 110.037 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -25.67 -47.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.632 2.373 . . . . 0.0 113.428 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -38.74 65.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.4 p -77.18 66.54 2.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.487 1.04 . . . . 0.0 112.898 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.28 -88.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 128.849 3.119 . . . . 0.0 114.769 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.73 -45.05 4.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.872 3.048 . . . . 0.0 113.723 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.0 m -45.03 -39.13 5.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.042 1.737 . . . . 0.0 111.634 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -49.27 -33.29 12.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.939 0.896 . . . . 0.0 111.858 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -53.94 -24.75 17.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.9 -37.78 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.78 -57.33 26.31 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -58.51 -27.76 83.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 111.234 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mt -75.15 -44.67 45.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.502 0.592 . . . . 0.0 110.714 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -55.72 -39.09 70.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.21 -34.5 72.99 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.317 0.647 . . . . 0.0 111.456 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.7 m -55.35 -44.73 76.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.076 1.307 . . . . 0.0 107.875 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.4 -18.09 48.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.778 -0.629 . . . . 0.0 112.428 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 p -59.16 -38.03 78.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 120.293 1.406 . . . . 0.0 109.226 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -62.61 -49.16 76.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.373 1.046 . . . . 0.0 108.196 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.29 -59.82 4.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.923 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -88.05 65.18 8.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.784 0.802 . . . . 0.0 109.625 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.79 67.6 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.337 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.32 -166.12 19.45 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 121.417 0.454 . . . . 0.0 111.998 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.642 . . . . 0.0 110.892 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.69 131.66 69.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.32 96.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.673 1.124 . . . . 0.0 108.583 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.61 115.04 27.72 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.87 98.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.072 1.349 . . . . 0.0 110.107 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.91 113.81 18.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -90.47 122.18 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -69.9 86.2 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.13 -50.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.629 1.971 . . . . 0.0 110.779 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -56.68 -31.31 64.32 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.482 1.113 . . . . 0.0 112.192 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.78 -70.8 0.55 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.31 61.56 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.906 0.86 . . . . 0.0 111.036 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.5 60.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.795 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.51 86.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.592 0.757 . . . . 0.0 111.71 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.19 -47.19 82.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.14 69.06 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.53 -55.81 25.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.137 0.975 . . . . 0.0 110.457 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.91 -41.8 75.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.047 0.539 . . . . 0.0 111.048 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -8.62 55.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.391 0.677 . . . . 0.0 111.761 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.43 30.19 31.01 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.231 0.919 . . . . 0.0 112.881 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.68 117.09 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 p -101.34 -71.41 0.71 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.23 156.14 18.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.707 1.203 . . . . 0.0 107.876 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -150.1 161.18 31.78 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.38 141.43 53.45 Favored 'Cis proline' 0 N--CA 1.453 -0.902 0 CA-C-N 120.726 1.295 . . . . 0.0 111.922 1.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.3 m -133.6 122.55 23.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.29 119.33 38.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.325 1.45 . . . . 0.0 108.419 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -107.86 153.52 22.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.67 117.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -107.08 126.64 52.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.978 0.911 . . . . 0.0 109.41 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -92.03 123.78 35.65 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 67.26 -63.12 0.3 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 128.617 2.767 . . . . 0.0 110.585 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.09 23.86 0.05 OUTLIER Glycine 0 CA--C 1.533 1.174 0 C-N-CA 127.151 2.31 . . . . 0.0 110.938 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.13 128.05 74.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.69 111.3 1.79 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.355 0.662 . . . . 0.0 109.881 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.08 -33.9 14.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.627 1.171 . . . . 0.0 110.938 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -155.4 166.01 34.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.768 0.258 . . . . 0.0 111.099 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -143.23 162.36 35.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.738 1.615 . . . . 0.0 109.759 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 tt -159.9 143.44 14.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.595 1.958 . . . . 0.0 106.424 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.25 152.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.07 -158.84 29.55 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.92 139.99 20.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 m -163.85 108.13 1.0 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -51.6 -49.2 62.62 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.912 1.285 . . . . 0.0 111.876 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -58.1 -43.87 87.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.889 0.476 . . . . 0.0 110.034 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -38.39 86.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.06 -46.86 85.49 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -54.6 -49.3 70.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -46.54 85.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.681 0.792 . . . . 0.0 111.005 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.35 -52.64 63.82 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.852 0.751 . . . . 0.0 109.523 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.44 -50.97 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.39 -54.98 28.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.708 0.403 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.58 -63.74 1.02 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 125.254 1.422 . . . . 0.0 110.198 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -68.04 -22.31 64.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.452 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -44.73 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 108.987 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.867 0.867 . . . . 0.0 109.44 178.952 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.72 108.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.91 149.89 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.079 0.942 . . . . 0.0 112.425 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -96.52 123.28 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 tp -148.61 146.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.312 0.96 . . . . 0.0 111.153 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -145.01 56.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.974 0.91 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -157.64 117.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -48.52 -38.85 21.4 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.458 1.103 . . . . 0.0 112.794 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.69 86.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.101 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.71 -35.89 65.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.72 0.408 . . . . 0.0 110.126 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -52.23 -53.01 48.93 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.56 -51.29 70.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.355 0.662 . . . . 0.0 110.68 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.14 -48.45 64.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.231 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.14 -51.19 70.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.3 tp -49.22 -50.02 40.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.97 0.508 . . . . 0.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.99 -61.16 2.64 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 111.236 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -63.57 -15.59 58.49 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.457 -0.777 . . . . 0.0 111.877 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.14 60.87 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.079 1.323 . . . . 0.0 111.986 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 mttm 66.08 73.75 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.752 1.263 . . . . 0.0 108.554 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.06 49.44 0.13 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.047 2.139 . . . . 0.0 113.797 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.6 -58.61 3.17 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -152.96 24.61 0.56 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.621 1.168 . . . . 0.0 110.313 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.34 148.88 35.35 Favored Pre-proline 0 C--O 1.234 0.239 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.62 129.98 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.294 3.329 . . . . 0.0 113.31 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.57 95.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.71 130.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.36 133.24 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -104.49 101.62 11.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.566 1.947 . . . . 0.0 106.599 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.4 95.99 8.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.6 m -122.49 162.81 21.04 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.845 1.258 . . . . 0.0 107.808 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.24 172.44 6.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.124 0.969 . . . . 0.0 110.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.6 p -83.05 -62.52 1.57 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.712 0.805 . . . . 0.0 109.382 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.4 -26.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.716 2.007 . . . . 0.0 113.742 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.7 p -76.69 9.87 2.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.447 1.021 . . . . 0.0 112.703 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 28.82 -89.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 128.635 3.017 . . . . 0.0 114.757 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.58 -37.82 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.089 3.193 . . . . 0.0 114.38 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 p -48.1 -35.1 10.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.024 0.93 . . . . 0.0 111.97 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -52.67 -28.44 21.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.396 1.078 . . . . 0.0 112.172 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.76 -19.8 52.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.158 0.89 . . . . 0.0 112.039 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -71.83 -30.37 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.684 -0.635 . . . . 0.0 109.916 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.98 -58.23 12.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.558 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.78 -37.37 94.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.42 2.08 . . . . 0.0 112.452 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -54.54 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.56 -36.86 79.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.907 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.25 -37.46 83.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 0.0 109.764 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 m -59.17 -52.41 65.84 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.63 -41.11 76.54 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 m -56.12 -49.99 72.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.782 0.325 . . . . 0.0 110.276 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -41.42 95.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.107 0.563 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -63.61 -63.37 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.64 0.733 . . . . 0.0 109.806 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.05 57.32 4.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.24 1.416 . . . . 0.0 109.955 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.47 153.08 40.5 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.758 0.79 . . . . 0.0 112.332 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.24 -72.44 1.15 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.616 1.103 . . . . 0.0 114.978 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -71.95 -30.93 65.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.668 0.734 . . . . 0.0 112.818 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.08 136.75 26.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.82 129.91 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -117.33 107.13 14.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.161 0.984 . . . . 0.0 108.541 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.4 mt -100.85 101.21 11.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.84 1.256 . . . . 0.0 110.272 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -86.4 120.88 28.22 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.5 141.12 47.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.949 0.899 . . . . 0.0 110.432 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -94.62 109.47 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.788 1.235 . . . . 0.0 107.668 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.0 t -53.2 -34.35 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.836 1.254 . . . . 0.0 110.732 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -68.43 -23.07 64.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.11 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.18 -75.32 0.47 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 0.0 110.9 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.28 63.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.324 0.966 . . . . 0.0 110.169 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.08 54.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.989 0.916 . . . . 0.0 109.739 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.49 -52.83 63.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.131 0.973 . . . . 0.0 111.228 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.35 -46.69 94.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.54 -53.57 52.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.068 0.547 . . . . 0.0 111.539 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.57 -39.81 80.83 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.268 -0.895 . . . . 0.0 110.4 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 86.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.485 0.584 . . . . 0.0 110.203 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.74 -33.75 75.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.392 0.677 . . . . 0.0 110.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.15 48.66 1.69 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.757 1.17 . . . . 0.0 111.767 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.87 98.54 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.3 p -93.21 -75.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.12 72.71 5.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.895 0.878 . . . . 0.0 111.012 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.51 142.71 97.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.73 134.35 34.28 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.306 1.145 . . . . 0.0 111.102 0.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.3 m -122.67 141.01 52.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.903 1.681 . . . . 0.0 108.506 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.11 116.83 23.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 108.628 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -112.6 147.84 35.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.2 t -115.13 98.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -87.44 107.45 18.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.47 115.01 21.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 68.18 -58.92 0.45 Allowed 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 128.177 2.591 . . . . 0.0 111.448 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.68 19.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.355 0.979 . . . . 0.0 112.686 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.24 134.98 57.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.981 1.39 . . . . 0.0 108.336 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -60.87 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.484 1.114 . . . . 0.0 108.853 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.76 -28.08 40.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.871 0.869 . . . . 0.0 110.12 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -156.05 167.12 31.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.534 0.152 . . . . 0.0 111.026 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.61 -175.21 4.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.472 1.909 . . . . 0.0 108.306 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 tp 167.01 142.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.277 2.631 . . . . 0.0 107.595 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.15 149.21 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.088 1.355 . . . . 0.0 108.295 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.13 168.69 44.33 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.749 0.639 . . . . 0.0 111.89 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.48 43.61 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 113.38 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 t -80.03 72.63 6.82 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.16 -0.963 . . . . 0.0 108.655 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.67 -41.6 55.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.538 0.735 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.14 -50.44 72.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.251 0.62 . . . . 0.0 110.054 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -65.15 -38.93 92.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -52.93 58.2 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.94 -52.29 66.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.933 0.893 . . . . 0.0 110.171 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.82 76.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.706 0.402 . . . . 0.0 111.173 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.6 mt -57.6 -57.17 13.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.737 0.815 . . . . 0.0 109.379 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.09 -47.24 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.987 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.75 -50.52 72.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.416 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.12 -50.16 56.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.783 0.719 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -71.53 -13.5 61.82 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.21 -39.61 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.399 1.48 . . . . 0.0 112.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 124.95 1.3 . . . . 0.0 108.894 -177.701 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.48 0.657 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.7 t -83.49 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 126.059 1.744 . . . . 0.0 108.575 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -76.89 137.58 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 122.431 1.11 . . . . 0.0 109.651 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.43 64.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.9 tt -160.06 167.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.129 -170.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -162.61 -44.22 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.598 1.559 . . . . 0.0 108.268 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.6 m -112.92 157.21 21.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.148 1.379 . . . . 0.0 113.58 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -43.78 -37.97 2.99 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 127.814 2.446 . . . . 0.0 112.895 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.18 -28.67 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.78 3.22 15.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.274 0.943 . . . . 0.0 112.232 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.04 -57.11 13.52 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.91 1.284 . . . . 0.0 108.721 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -57.81 -47.04 83.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.078 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.34 -59.0 5.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.627 0.771 . . . . 0.0 110.856 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.3 -49.18 76.91 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.8 mt -52.04 -57.09 10.55 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.94 -59.55 4.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.104 0.962 . . . . 0.0 111.43 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -60.27 -26.85 66.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.14 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.66 -24.4 69.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.32 -1.267 . . . . 0.0 113.669 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.53 56.42 6.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.606 1.703 . . . . 0.0 108.897 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -31.76 -34.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 131.404 3.882 . . . . 0.0 117.564 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -12.65 -70.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 129.348 3.059 . . . . 0.0 113.147 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -139.16 53.16 1.75 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -117.59 131.1 24.25 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.13 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.7 91.6 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.538 1.492 . . . . 0.0 109.593 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mt -86.16 92.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.84 125.45 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 113.37 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -83.4 88.58 6.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.97 98.35 9.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -124.81 171.99 9.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.781 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.65 105.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.993 1.317 . . . . 0.0 108.231 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -43.28 -53.34 5.25 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.057 1.743 . . . . 0.0 112.807 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -58.92 -33.36 70.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.175 0.59 . . . . 0.0 111.867 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.2 t -75.82 85.42 2.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.93 -59.64 0.9 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.664 1.126 . . . . 0.0 112.638 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.22 -39.54 71.51 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.21 2.606 . . . . 0.0 113.214 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.5 m -71.16 -37.85 72.19 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.43 0.692 . . . . 0.0 109.179 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -67.26 -40.99 86.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.199 0.6 . . . . 0.0 110.442 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 83.3 mmm -53.61 -30.75 44.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.246 1.019 . . . . 0.0 112.672 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.64 -30.01 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.145 -0.347 . . . . 0.0 111.071 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.37 -55.4 37.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.704 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.1 -34.34 94.58 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 122.397 1.892 . . . . 0.0 112.067 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.24 -53.26 59.78 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -53.9 -43.76 69.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.79 -44.39 90.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -58.99 -49.48 77.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.27 -33.56 74.85 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 121.93 -0.481 . . . . 0.0 110.516 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.457 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 7.0 m -57.02 -45.48 83.06 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.763 -0.585 . . . . 0.0 109.65 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -63.91 -48.28 77.24 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.38 -45.17 55.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.855 0.462 . . . . 0.0 111.257 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -102.69 44.68 1.0 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.184 0.994 . . . . 0.0 110.116 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.81 43.29 0.33 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.986 -1.071 . . . . 0.0 111.158 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.27 -135.22 8.21 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.848 1.69 . . . . 0.0 109.668 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -80.44 45.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.827 0.814 . . . . 0.0 110.007 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.46 148.77 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 107.801 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.82 130.69 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 26.0 m-85 -113.38 137.19 51.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.27 124.72 11.65 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.882 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -89.14 143.35 26.91 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.81 130.95 62.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.48 99.68 10.27 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -53.89 -43.37 57.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.38 1.072 . . . . 0.0 111.244 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.4 -49.63 73.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.718 0.407 . . . . 0.0 110.482 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 -59.17 2.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.506 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.08 54.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.635 -0.666 . . . . 0.0 110.716 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.95 70.75 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.768 0.827 . . . . 0.0 110.974 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.82 -56.32 20.64 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.917 0.887 . . . . 0.0 111.926 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.76 -43.58 98.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.8 -41.88 91.36 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.194 -0.941 . . . . 0.0 110.636 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.15 94.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.252 0.478 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.97 76.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.397 1.079 . . . . 0.0 110.312 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.0 70.95 0.47 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.87 145.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -136.39 -88.67 0.3 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 110.89 21.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -76.67 140.88 68.2 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -72.92 141.29 71.2 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 119.687 0.924 . . . . 0.0 111.02 -2.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -114.97 129.64 56.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.17 122.05 46.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -116.8 144.55 44.35 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.62 103.84 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -95.36 93.72 7.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.199 0.454 . . . . 0.0 111.079 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -90.86 140.12 30.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.28 -58.87 0.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.156 2.583 . . . . 0.0 110.646 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.12 28.7 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 127.26 2.362 . . . . 0.0 110.095 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.72 136.27 39.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 96.7 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.23 40.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.736 0.415 . . . . 0.0 110.713 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -160.23 167.46 27.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.79 175.51 13.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.668 0.787 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.9 tp -164.68 158.75 18.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.893 1.677 . . . . 0.0 108.255 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.58 160.88 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 110.377 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.32 176.42 41.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.471 1.034 . . . . 0.0 111.554 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.42 41.77 0.26 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.145 0.978 . . . . 0.0 111.352 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -78.26 58.83 2.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.126 1.77 . . . . 0.0 110.047 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.71 -35.59 66.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 112.192 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -58.49 -53.15 61.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.262 0.625 . . . . 0.0 109.578 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -66.6 -34.9 78.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.7 tp -59.75 -50.48 73.67 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.165 0.586 . . . . 0.0 110.081 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -55.46 -44.78 76.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.13 95.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.508 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.2 mt -54.37 -55.88 24.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.74 -49.53 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.15 -52.71 50.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.36 0.264 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -56.63 -68.62 0.2 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.164 0.585 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -62.61 -22.69 66.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.841 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.76 80.66 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 123.56 0.744 . . . . 0.0 110.878 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.27 31.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.169 1.787 . . . . 0.0 108.805 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.74 152.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 122.56 1.171 . . . . 0.0 113.085 -171.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.75 128.7 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.541 1.536 . . . . 0.0 110.566 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . 0.404 ' CG1' ' H ' ' A' ' 8' ' ' ASP . 2.4 tt -160.82 -160.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . 0.404 ' H ' ' CG1' ' A' ' 7' ' ' ILE . 6.8 t70 -157.19 -56.9 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.616 0.766 . . . . 0.0 109.955 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -31.06 118.38 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.36 2.264 . . . . 0.0 113.018 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -40.51 -54.62 2.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.683 1.193 . . . . 0.0 112.869 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -43.24 67.41 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.475 -0.765 . . . . 0.0 111.029 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -35.74 73.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.399 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -55.13 38.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.67 -51.17 69.76 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.271 0.628 . . . . 0.0 110.069 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.22 79.45 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.64 -42.68 93.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -56.22 -58.41 8.08 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.572 1.078 . . . . 0.0 109.212 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 -57.83 9.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.233 0.613 . . . . 0.0 112.318 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.88 -10.11 35.39 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.001 -0.437 . . . . 0.0 111.44 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.43 91.6 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 58.76 76.63 0.34 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.026 1.331 . . . . 0.0 107.883 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 66.54 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.236 1.415 . . . . 0.0 109.591 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.27 -46.67 54.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -170.39 65.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.759 1.624 . . . . 0.0 107.724 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -139.99 132.67 14.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.416 1.486 . . . . 0.0 107.436 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.65 137.27 32.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.658 1.572 . . . . 0.0 109.096 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.61 120.3 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 t -120.81 126.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 125.353 1.461 . . . . 0.0 107.988 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.19 134.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 118.395 0.543 . . . . 0.0 110.327 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -101.41 96.49 7.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.098 1.359 . . . . 0.0 107.525 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -87.8 90.54 8.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -111.47 -178.48 3.46 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.664 1.186 . . . . 0.0 110.387 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.86 112.33 8.74 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.313 1.045 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -36.99 -57.18 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.568 1.947 . . . . 0.0 113.283 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -64.31 -28.33 69.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 t -76.9 91.41 3.57 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -26.8 -65.97 0.07 OUTLIER Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.151 1.834 . . . . 0.0 115.211 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.44 -37.71 47.21 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.153 1.902 . . . . 0.0 112.102 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.4 m -62.14 -40.36 95.68 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -62.43 -50.72 70.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.1 tpp -56.93 -32.55 66.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.775 0.83 . . . . 0.0 112.057 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -66.85 -27.43 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.471 -0.768 . . . . 0.0 110.746 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.25 45.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.98 -1.075 . . . . 0.0 113.601 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.1 -31.08 83.29 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.861 1.707 . . . . 0.0 111.435 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 -48.37 74.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -54.58 -45.7 73.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -58.02 -43.27 86.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.704 0.402 . . . . 0.0 110.394 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.3 m -58.8 -45.61 89.5 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.51 -39.65 94.18 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.257 0.48 . . . . 0.0 110.132 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 m -51.53 -53.15 40.76 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -61.14 -48.72 80.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.013 0.525 . . . . 0.0 110.998 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -48.5 -56.38 8.46 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.045 1.338 . . . . 0.0 111.744 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -79.61 -33.26 41.66 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.78 -173.34 0.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.736 1.614 . . . . 0.0 112.082 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -41.43 -26.05 0.2 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.893 2.187 . . . . 0.0 117.142 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -66.2 -19.01 65.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.677 1.739 . . . . 0.0 111.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.98 139.29 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.76 121.42 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.09 124.23 41.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.321 -0.862 . . . . 0.0 109.127 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -115.68 107.55 15.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.535 1.134 . . . . 0.0 111.111 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -79.87 131.17 35.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.65 134.32 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 119.203 0.911 . . . . 0.0 109.798 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.71 100.09 11.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.065 0.946 . . . . 0.0 109.046 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.7 t -44.56 -46.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 128.165 2.586 . . . . 0.0 110.708 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.64 -53.32 58.01 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.455 0.472 . . . . 0.0 110.491 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.55 -62.59 1.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.822 0.449 . . . . 0.0 111.098 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.07 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.288 -0.883 . . . . 0.0 111.69 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.48 30.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.133 0.973 . . . . 0.0 111.27 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -48.55 79.0 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.761 0.825 . . . . 0.0 111.13 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.82 -42.42 89.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.83 63.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.466 0.307 . . . . 0.0 111.216 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.77 -39.93 91.49 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.617 -0.677 . . . . 0.0 110.104 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.93 87.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.539 0.609 . . . . 0.0 110.662 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.45 77.85 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 0.0 110.325 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.12 46.56 2.81 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.888 1.232 . . . . 0.0 110.77 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -78.92 150.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.6 p -124.51 -84.94 0.64 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.14 177.71 6.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -138.44 152.26 70.84 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.52 141.96 57.98 Favored 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.216 -1.109 . . . . 0.0 109.216 -3.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 m -110.58 135.04 51.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -119.61 112.79 19.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 110.397 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -110.17 154.04 23.9 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.79 139.03 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -136.17 73.88 1.48 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.399 0.545 . . . . 0.0 112.453 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.67 152.66 43.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 69.18 -64.11 0.35 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 128.426 2.69 . . . . 0.0 109.116 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.04 34.88 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.664 2.078 . . . . 0.0 110.339 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.08 145.1 26.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.99 101.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -41.75 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.347 1.459 . . . . 0.0 111.195 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -159.02 160.06 35.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -175.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -160.9 164.24 31.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 pp -166.27 158.17 13.81 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.137 2.175 . . . . 0.0 108.947 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.52 132.42 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.86 1.264 . . . . 0.0 107.948 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.83 160.56 10.18 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.67 38.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.822 1.249 . . . . 0.0 111.441 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 m -79.55 70.63 6.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.374 1.07 . . . . 0.0 110.63 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -48.81 -41.15 31.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.837 1.255 . . . . 0.0 111.936 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.5 -47.82 84.47 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.863 0.865 . . . . 0.0 110.152 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.96 -40.03 87.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.14 -58.76 5.92 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -49.16 -50.71 36.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.14 -40.42 77.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.603 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.0 -50.05 75.28 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.984 1.266 . . . . 0.0 108.682 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.8 -50.15 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.45 11.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.235 0.214 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -46.4 -62.16 1.48 Allowed 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.971 1.708 . . . . 0.0 111.117 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.28 -22.28 59.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.967 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.77 -47.78 61.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 123.469 0.708 . . . . 0.0 109.837 177.949 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.959 0.885 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.26 31.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 127.662 2.385 . . . . 0.0 107.57 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.12 -171.48 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 126.922 2.089 . . . . 0.0 108.785 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.42 73.43 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tp -79.08 145.8 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.755 1.222 . . . . 0.0 109.202 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -80.12 63.47 4.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.323 0.649 . . . . 0.0 112.492 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.1 t 29.73 -119.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.534 1.934 . . . . 0.0 113.532 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.2 -47.89 1.22 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.111 2.964 . . . . 0.0 115.304 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.99 79.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.928 0.491 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.55 -40.15 14.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.955 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -32.41 -64.75 0.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 128.566 2.746 . . . . 0.0 113.181 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.99 -55.91 29.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.858 0.837 . . . . 0.0 111.833 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.86 -52.45 49.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.653 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -53.75 54.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.799 1.24 . . . . 0.0 110.155 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.44 -49.21 18.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.976 1.311 . . . . 0.0 109.834 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.41 -61.84 1.88 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -56.81 -26.7 58.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.395 0.678 . . . . 0.0 111.665 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.89 63.18 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 117.56 -1.689 . . . . 0.0 112.103 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm 49.19 60.38 3.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.288 1.544 . . . . 0.0 108.054 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -63.39 24.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.392 2.677 . . . . 0.0 116.342 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -80.92 -59.74 2.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 120.867 -1.146 . . . . 0.0 108.378 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -112.45 36.36 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.544 1.137 . . . . 0.0 108.1 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -145.22 123.35 6.49 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.39 118.64 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.712 2.941 . . . . 0.0 110.454 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -107.08 112.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -119.84 148.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 107.085 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.62 137.05 53.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -105.71 98.06 7.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.415 2.286 . . . . 0.0 106.217 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.74 93.85 8.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -113.36 -167.71 1.23 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.34 0.656 . . . . 0.0 109.654 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.64 11.3 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.288 1.435 . . . . 0.0 110.11 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -99.28 -65.06 0.98 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.442 1.497 . . . . 0.0 109.376 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -49.37 -24.62 2.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.317 1.847 . . . . 0.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.6 p -58.41 -16.64 15.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.134 0.574 . . . . 0.0 111.881 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.64 -112.64 5.1 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.128 -1.373 . . . . 0.0 110.552 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -38.62 -46.61 2.56 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.126 3.217 . . . . 0.0 115.026 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -32.28 39.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -56.13 -28.59 58.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.618 0.767 . . . . 0.0 110.559 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -54.35 -25.45 24.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.802 0.841 . . . . 0.0 112.501 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.86 -30.12 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 122.009 -0.432 . . . . 0.0 110.654 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.9 -59.07 10.72 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.258 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.5 -35.95 94.55 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.817 1.678 . . . . 0.0 112.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.67 -50.74 69.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -55.38 -44.12 75.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -61.15 -37.56 83.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 110.536 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.5 m -61.46 -47.29 86.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.39 -43.48 98.8 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.4 m -50.27 -51.01 48.46 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -35.98 81.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.881 0.872 . . . . 0.0 110.71 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.69 -47.91 82.92 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 123.107 0.563 . . . . 0.0 110.345 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -79.17 -50.95 10.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.7 -63.72 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.737 2.415 . . . . 0.0 116.048 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.89 -104.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.955 2.217 . . . . 0.0 115.755 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -76.61 48.7 0.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.143 0.977 . . . . 0.0 113.215 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.36 159.81 13.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 110.505 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -134.19 121.63 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -123.31 95.08 4.46 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.051 1.34 . . . . 0.0 107.746 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.79 102.62 10.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.468 1.107 . . . . 0.0 111.349 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -79.58 118.83 21.78 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.52 148.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.907 0.86 . . . . 0.0 111.173 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -111.43 112.89 24.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.443 1.497 . . . . 0.0 109.178 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.18 -31.2 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 122.527 0.331 . . . . 0.0 110.954 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.32 -34.39 76.53 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.55 -66.46 0.89 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -85.69 62.96 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 121.605 -0.684 . . . . 0.0 111.766 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.38 -43.19 44.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.351 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -56.31 23.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.215 1.006 . . . . 0.0 111.711 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.12 -43.35 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.13 35.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.867 0.467 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.2 -40.01 90.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.668 0.667 . . . . 0.0 110.08 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.03 82.28 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.639 0.654 . . . . 0.0 110.352 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.51 3.44 21.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.958 0.903 . . . . 0.0 111.715 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.45 32.74 85.19 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.013 0.816 . . . . 0.0 112.644 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.12 134.88 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 p -136.58 -70.11 0.47 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.872 1.269 . . . . 0.0 108.323 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.82 62.28 1.53 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.769 0.828 . . . . 0.0 111.376 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 143.27 98.2 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.46 136.56 44.19 Favored 'Cis proline' 0 N--CA 1.448 -1.151 0 CA-C-N 120.063 1.058 . . . . 0.0 110.606 0.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -126.56 129.57 48.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.44 1.096 . . . . 0.0 108.34 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.97 128.33 54.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.23 1.812 . . . . 0.0 106.902 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -127.94 150.98 49.65 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.699 1.199 . . . . 0.0 108.889 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.08 138.06 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.842 1.257 . . . . 0.0 107.639 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -129.75 50.81 2.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.851 0.75 . . . . 0.0 111.108 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.02 154.38 34.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 74.51 -58.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.626 1.97 . . . . 0.0 109.227 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.35 -48.6 0.3 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.54 157.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.93 0.492 . . . . 0.0 109.924 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -56.42 106.15 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.06 -42.5 17.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.103 0.961 . . . . 0.0 112.367 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -159.98 155.84 26.1 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -142.29 163.64 32.29 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 124.469 1.108 . . . . 0.0 110.076 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -157.52 115.86 3.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.146 1.378 . . . . 0.0 107.959 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.62 160.77 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.708 0.803 . . . . 0.0 112.274 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 177.17 40.42 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.196 0.903 . . . . 0.0 112.185 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.44 40.99 0.24 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.361 1.064 . . . . 0.0 111.298 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.1 m -80.73 58.98 3.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.31 1.444 . . . . 0.0 110.271 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -43.95 -51.97 7.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.59 1.556 . . . . 0.0 112.555 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -52.77 -51.03 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.419 0.687 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -69.48 -32.37 71.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.093 0.557 . . . . 0.0 109.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -57.76 11.08 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -55.78 -46.24 78.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.755 0.422 . . . . 0.0 109.869 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.76 -47.73 73.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.684 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mt -63.09 -45.64 91.15 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.661 0.664 . . . . 0.0 110.473 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.45 -50.9 70.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.16 74.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.618 0.367 . . . . 0.0 111.031 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -60.13 -58.64 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.006 0.922 . . . . 0.0 111.501 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -70.66 -53.13 16.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.14 57.58 4.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.712 0.805 . . . . 0.0 109.059 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.154 0 C-N-CA 122.785 0.434 . . . . 0.0 109.951 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.08 20.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 124.894 1.278 . . . . 0.0 111.972 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -157.71 176.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 126.849 2.059 . . . . 0.0 106.908 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.44 -158.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -156.39 164.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -68.85 -34.6 75.75 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.422 1.089 . . . . 0.0 112.652 -174.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.8 m -62.71 105.12 0.61 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.879 0.472 . . . . 0.0 109.976 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -39.62 -51.66 2.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.811 1.645 . . . . 0.0 113.158 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.7 45.72 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.465 0.65 . . . . 0.0 111.597 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.92 66.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.188 0.595 . . . . 0.0 111.246 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -49.41 76.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -59.98 -47.08 87.27 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.69 68.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -50.81 68.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.527 0.731 . . . . 0.0 109.525 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.81 -50.74 43.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.279 0.491 . . . . 0.0 109.804 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -55.7 27.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -64.27 -22.0 66.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.776 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.18 25.39 0.2 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.728 1.156 . . . . 0.0 115.399 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp 51.44 70.82 0.5 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.276 1.43 . . . . 0.0 111.461 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.9 70.84 0.51 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.496 1.918 . . . . 0.0 109.728 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -109.18 -66.38 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -161.4 17.85 0.11 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.08 1.752 . . . . 0.0 109.872 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -75.29 142.16 74.76 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.93 115.08 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.762 2.975 . . . . 0.0 110.931 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.7 mt -101.16 101.04 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.32 109.61 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.72 121.22 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 109.846 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -85.59 100.01 11.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.723 1.609 . . . . 0.0 106.958 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.02 99.22 11.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.2 m -131.71 153.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.43 158.43 17.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.316 0.579 . . . . 0.0 110.678 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -66.4 -29.52 69.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.365 1.066 . . . . 0.0 108.235 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -60.97 179.5 0.18 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.257 2.223 . . . . 0.0 112.996 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t 69.39 -62.25 0.41 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.518 2.327 . . . . 0.0 111.733 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.38 -83.05 0.36 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.665 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -47.32 -41.98 27.91 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.494 2.796 . . . . 0.0 112.276 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.0 m -46.47 -39.24 10.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.703 1.601 . . . . 0.0 111.285 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -80.79 -12.45 59.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.339 1.056 . . . . 0.0 113.067 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.3 mmm -58.63 -27.23 64.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.876 1.216 . . . . 0.0 111.362 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.63 -27.69 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.395 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.17 10.19 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.47 -35.62 89.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.153 1.902 . . . . 0.0 112.614 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.4 -53.11 60.89 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.8 -41.46 70.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 108.963 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -62.66 -35.51 79.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.608 1.163 . . . . 0.0 110.794 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -62.8 -50.92 69.1 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.92 -41.46 82.72 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -50.97 -55.76 15.71 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -58.64 -38.0 77.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.273 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -60.61 -48.13 83.14 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.589 0.631 . . . . 0.0 111.263 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -79.62 -29.98 41.24 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.794 -0.566 . . . . 0.0 112.033 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.11 -70.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 128.434 2.694 . . . . 0.0 114.342 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.72 -15.51 2.39 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.334 1.445 . . . . 0.0 112.654 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.49 -34.65 77.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.467 1.134 . . . . 0.0 110.388 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.73 139.44 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.0 mm -93.61 99.53 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -94.46 115.63 27.84 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.4 mt -109.9 140.59 43.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.517 1.127 . . . . 0.0 108.95 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -121.65 89.95 3.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.196 0.999 . . . . 0.0 110.448 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -97.19 120.23 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 102.42 5.59 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -44.84 -43.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.867 1.267 . . . . 0.0 111.446 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.93 -41.42 11.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.094 1.758 . . . . 0.0 111.611 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.37 -70.21 0.46 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.019 0.527 . . . . 0.0 111.354 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.64 59.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.743 -0.598 . . . . 0.0 111.191 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.41 -43.1 23.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.024 0.93 . . . . 0.0 111.137 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.12 -49.68 76.11 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.941 0.896 . . . . 0.0 111.307 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 -44.52 91.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.8 -55.14 33.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.893 0.477 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.21 -43.47 94.91 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.384 0.538 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.95 76.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.716 0.689 . . . . 0.0 110.844 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.58 6.28 18.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.607 1.163 . . . . 0.0 111.695 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.09 28.3 66.26 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.243 -0.91 . . . . 0.0 112.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.78 119.75 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -137.3 -70.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.883 1.273 . . . . 0.0 108.74 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.92 65.75 1.45 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.456 0.702 . . . . 0.0 110.996 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.25 142.0 89.31 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.05 133.4 10.84 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.253 1.483 . . . . 0.0 112.894 -2.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -127.05 109.87 12.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -96.62 123.49 40.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -115.74 139.99 49.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.596 1.159 . . . . 0.0 109.68 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.48 121.77 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.13 107.06 14.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.84 1.338 . . . . 0.0 107.418 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -86.63 130.5 34.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 t70 70.46 -68.69 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.847 2.059 . . . . 0.0 107.753 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.94 27.14 0.05 OUTLIER Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.148 2.309 . . . . 0.0 110.245 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.0 130.07 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -61.07 109.4 1.08 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.87 -40.84 9.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.197 0.599 . . . . 0.0 111.682 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -160.38 170.81 20.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.04 170.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -163.01 122.67 2.21 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.9 m -105.9 164.63 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.765 1.226 . . . . 0.0 112.289 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.48 179.23 49.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.676 1.132 . . . . 0.0 111.692 176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.34 39.18 0.25 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.819 0.848 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.3 m -80.87 57.94 3.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.63 1.572 . . . . 0.0 110.164 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -51.12 -48.93 61.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.401 1.08 . . . . 0.0 112.559 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.53 -47.13 80.03 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -61.54 -44.18 97.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.34 -54.49 44.84 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -54.81 -47.64 73.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.75 80.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.51 -46.15 91.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.572 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.99 -51.68 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 119.292 0.951 . . . . 0.0 108.683 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.19 69.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.472 0.309 . . . . 0.0 111.077 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -58.17 -58.69 7.34 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.394 1.078 . . . . 0.0 111.273 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -75.05 -15.68 60.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.746 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -37.48 -48.81 1.0 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.12 1.768 . . . . 0.0 112.67 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 0.0 109.739 -178.545 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.72 128.32 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -145.01 143.64 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 124.476 1.111 . . . . 0.0 110.705 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.28 120.95 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 171.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.71 160.39 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 122.669 1.223 . . . . 0.0 111.639 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -133.69 35.36 3.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.076 2.15 . . . . 0.0 108.544 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 134.3 8.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.925 1.29 . . . . 0.0 108.232 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -51.69 -37.19 49.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.417 1.087 . . . . 0.0 112.46 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -34.01 -62.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.432 1.893 . . . . 0.0 112.573 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.13 77.16 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.935 -0.478 . . . . 0.0 111.363 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -51.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.57 -47.51 69.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.213 0.53 . . . . 0.0 110.297 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.84 60.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.02 -46.14 68.72 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.53 -52.2 6.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.932 0.787 . . . . 0.0 109.443 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.46 -70.0 0.21 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.228 0.611 . . . . 0.0 112.179 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -59.91 -28.42 67.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.895 0.77 . . . . 0.0 112.072 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.82 -24.28 69.79 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.542 1.544 . . . . 0.0 111.842 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 60.68 67.33 0.84 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.623 1.212 . . . . 0.0 110.485 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.02 -22.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.837 2.055 . . . . 0.0 113.459 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -34.14 -54.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.318 2.247 . . . . 0.0 110.572 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -130.66 -13.28 3.76 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -79.85 115.14 51.82 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.35 129.05 24.18 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.095 1.196 . . . . 0.0 109.734 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.4 mm -102.72 87.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.47 118.07 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.38 116.39 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 123.274 0.63 . . . . 0.0 109.468 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -92.47 89.19 6.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -79.71 94.49 5.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -115.84 -174.19 2.49 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.166 1.386 . . . . 0.0 108.38 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.72 139.56 40.22 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 123.191 0.596 . . . . 0.0 110.971 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -41.86 -58.91 1.87 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.293 1.437 . . . . 0.0 110.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -72.47 7.85 1.65 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.076 1.351 . . . . 0.0 113.94 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -74.43 -7.65 53.68 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.449 1.477 . . . . 0.0 111.747 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.11 -110.36 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.153 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.53 -41.6 10.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.0 3.133 . . . . 0.0 114.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -25.9 60.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.239 -0.288 . . . . 0.0 111.455 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -54.01 -27.92 34.85 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.8 -0.562 . . . . 0.0 111.135 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.0 mtm -57.71 -21.7 42.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.734 0.697 . . . . 0.0 112.457 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.04 -32.14 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.654 -0.654 . . . . 0.0 109.704 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.72 22.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.56 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -59.47 -34.72 97.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.26 1.974 . . . . 0.0 112.357 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.55 -54.41 43.48 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.71 -39.16 73.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.99 -42.33 99.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.339 1.056 . . . . 0.0 109.572 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.1 m -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 tp -59.61 -36.54 76.49 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 12.5 m -58.35 -48.83 79.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.477 0.711 . . . . 0.0 110.135 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.94 -54.04 51.14 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -54.33 -44.31 71.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.347 0.659 . . . . 0.0 111.844 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -105.83 32.39 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.968 0.907 . . . . 0.0 111.308 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.94 144.42 33.87 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.519 -0.738 . . . . 0.0 110.899 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 -60.7 3.53 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.12 -30.82 71.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.21 143.09 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 mm -100.48 118.02 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 63.2 m-85 -107.51 105.6 15.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.105 0.962 . . . . 0.0 108.827 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.81 89.36 2.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.607 1.163 . . . . 0.0 110.692 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -79.9 111.04 15.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.78 128.56 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.008 0.923 . . . . 0.0 109.952 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.25 106.31 14.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -62.37 -33.79 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.204 0.601 . . . . 0.0 111.059 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.42 -48.2 62.73 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.45 -59.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.663 0.785 . . . . 0.0 110.846 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.74 60.36 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.498 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.27 -43.96 79.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.021 0.928 . . . . 0.0 110.675 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.27 -57.11 11.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 111.907 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.66 -44.07 96.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.04 -52.83 57.23 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.19 -42.43 79.95 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.79 -0.569 . . . . 0.0 109.974 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.28 77.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.684 0.674 . . . . 0.0 110.813 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.21 3.38 27.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.782 1.233 . . . . 0.0 111.636 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.41 38.59 91.12 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.19 0.9 . . . . 0.0 112.632 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mm -76.26 134.66 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.7 p -136.25 -74.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.605 1.162 . . . . 0.0 108.749 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.23 68.41 1.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.503 1.121 . . . . 0.0 110.683 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.83 149.47 96.58 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.79 131.28 22.9 Favored 'Cis proline' 0 N--CA 1.448 -1.192 0 CA-C-N 119.948 1.017 . . . . 0.0 109.917 -1.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -115.42 128.84 56.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.747 1.219 . . . . 0.0 108.407 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -104.24 102.02 11.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.689 1.595 . . . . 0.0 109.913 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -98.94 156.11 17.07 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -127.5 103.73 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.7 66.36 4.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.368 0.531 . . . . 0.0 111.704 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -69.96 154.91 41.34 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 69.59 -63.62 0.37 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.829 2.452 . . . . 0.0 110.157 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.44 35.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.911 2.196 . . . . 0.0 110.419 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.0 152.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -60.01 94.7 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.175 0.59 . . . . 0.0 109.463 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.46 41.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.391 0.676 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -152.43 164.05 38.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.718 0.235 . . . . 0.0 110.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.36 -177.45 4.85 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.21 2.204 . . . . 0.0 107.237 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp 165.82 147.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 128.557 2.743 . . . . 0.0 106.828 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -132.53 150.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.473 1.109 . . . . 0.0 108.965 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.2 173.88 49.38 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 122.088 0.827 . . . . 0.0 113.4 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.1 35.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.416 1.487 . . . . 0.0 113.908 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m -78.1 67.15 3.88 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.479 -0.763 . . . . 0.0 110.216 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -49.43 -42.63 43.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.936 1.694 . . . . 0.0 111.504 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -56.58 -49.32 75.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.899 0.88 . . . . 0.0 110.003 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -70.26 -31.12 68.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -53.98 52.18 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.72 -47.3 80.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.92 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.77 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.0 mt -55.15 -55.36 32.07 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.263 0.625 . . . . 0.0 109.726 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.14 -54.11 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.22 -55.59 23.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.663 0.385 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -52.5 -58.62 6.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.288 1.435 . . . . 0.0 111.108 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -72.19 -26.52 62.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.764 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.53 -58.74 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 126.124 1.769 . . . . 0.0 111.629 -179.134 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.2 29.55 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.231 1.412 . . . . 0.0 112.233 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.15 162.02 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.206 1.003 . . . . 0.0 113.211 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.32 135.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.616 1.966 . . . . 0.0 107.181 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 tt -160.04 169.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.949 0.881 . . . . 0.0 110.63 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -132.16 45.8 2.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 110.442 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -154.41 127.05 8.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.072 -1.018 . . . . 0.0 111.35 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -48.88 -50.07 36.69 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.528 1.131 . . . . 0.0 110.254 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.63 -48.35 19.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.721 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.95 81.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -52.2 48.57 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.69 -47.27 81.85 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.94 57.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.463 0.305 . . . . 0.0 110.275 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -51.47 69.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.085 0.954 . . . . 0.0 109.447 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tt -48.17 -50.07 30.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -62.24 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -63.47 -15.04 56.63 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.599 -0.688 . . . . 0.0 112.285 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.87 -16.74 57.28 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.112 -0.827 . . . . 0.0 111.455 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mttp 76.53 84.49 0.09 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.931 1.692 . . . . 0.0 108.296 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.49 66.16 0.31 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.622 1.969 . . . . 0.0 110.204 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.62 -61.25 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -168.1 8.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.9 153.03 57.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -170.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -65.91 116.1 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.308 2.672 . . . . 0.0 111.304 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.7 mt -97.64 91.96 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.03 109.69 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 p -111.61 126.24 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -95.72 105.66 17.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 107.615 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -86.25 97.39 10.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -117.6 142.51 47.12 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.1 56.58 1.22 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.9 p 6.89 -74.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.486 3.115 . . . . 0.0 114.645 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -43.64 -28.81 0.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.318 1.847 . . . . 0.0 115.094 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.41 69.18 1.15 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.9 1.682 . . . . 0.0 112.167 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 32.35 -95.99 0.01 OUTLIER Glycine 0 CA--C 1.532 1.151 0 C-N-CA 128.279 2.847 . . . . 0.0 113.576 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -39.59 -45.83 3.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.221 3.281 . . . . 0.0 112.555 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m -46.4 -37.85 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.821 1.648 . . . . 0.0 112.215 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -74.21 -62.15 1.61 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.2 ptp -58.88 -26.33 64.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 113.012 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.96 -29.76 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.653 -0.654 . . . . 0.0 110.047 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.73 -55.12 46.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.527 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -46.16 -43.84 20.3 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.757 2.971 . . . . 0.0 114.707 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.31 -55.13 35.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.07 -37.79 75.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.54 -34.35 74.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.504 1.121 . . . . 0.0 109.844 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 m -61.21 -53.66 54.11 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.6 -43.52 76.14 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 17.9 m -52.83 -56.46 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.577 0.751 . . . . 0.0 109.853 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.79 -50.61 60.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.703 0.401 . . . . 0.0 110.477 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.8 -60.17 4.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.887 1.367 . . . . 0.0 112.558 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -88.27 23.68 2.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.91 1.232 . . . . 0.0 111.754 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.17 151.92 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.868 -1.145 . . . . 0.0 111.769 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 -60.53 4.53 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.822 0.449 . . . . 0.0 109.969 175.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.26 138.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 107.373 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 mp -98.53 131.14 46.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 97.1 m-85 -122.66 139.94 53.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.408 0.549 . . . . 0.0 110.68 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.89 125.43 29.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.338 1.055 . . . . 0.0 109.949 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -107.96 102.36 11.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.18 122.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.669 . . . . 0.0 110.82 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.47 104.54 5.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 t -56.62 -40.09 66.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.96 1.304 . . . . 0.0 110.781 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.81 -51.04 62.39 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.52 -60.05 2.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.256 0.622 . . . . 0.0 110.882 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.83 57.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.175 0.988 . . . . 0.0 109.576 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.16 98.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.811 0.844 . . . . 0.0 110.271 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.18 -57.22 10.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 111.993 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.07 -47.46 93.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.39 -47.14 63.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.634 0.254 . . . . 0.0 110.529 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.05 -58.35 8.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.882 0.873 . . . . 0.0 110.197 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -41.27 72.6 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.54 0.336 . . . . 0.0 111.78 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 -2.84 41.78 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.739 1.216 . . . . 0.0 111.754 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.36 47.49 78.89 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.028 -1.045 . . . . 0.0 113.019 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.38 117.85 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -98.37 -84.54 0.39 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.486 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.094 0.957 . . . . 0.0 110.245 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.52 141.47 79.88 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -71.24 140.36 64.18 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.246 1.123 . . . . 0.0 111.713 -1.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.3 m -121.01 109.42 15.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.31 131.09 34.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -126.58 135.51 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 107.979 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -113.15 91.31 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.925 0.784 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.21 69.22 9.88 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.7 133.46 55.36 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 70.84 -66.99 0.27 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 127.447 2.299 . . . . 0.0 107.061 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.86 26.86 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.427 1.965 . . . . 0.0 110.299 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.0 122.34 31.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 118.152 0.976 . . . . 0.0 108.542 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -45.61 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.593 1.957 . . . . 0.0 110.772 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.91 -33.68 19.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.039 0.936 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.89 159.11 37.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -143.79 166.0 26.12 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.807 1.243 . . . . 0.0 109.078 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.7 tp -162.52 115.46 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.862 0.865 . . . . 0.0 109.881 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.98 158.7 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.017 -0.427 . . . . 0.0 110.768 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 172.07 48.67 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.472 1.034 . . . . 0.0 112.662 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.85 74.0 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.083 0.953 . . . . 0.0 110.523 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.4 m 23.16 57.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.153 2.981 . . . . 0.0 115.055 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -57.97 -59.64 4.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 113.424 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.58 -45.84 73.62 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.894 0.854 . . . . 0.0 110.105 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.45 -43.86 96.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.03 0.932 . . . . 0.0 109.583 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -56.17 21.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.355 1.062 . . . . 0.0 108.185 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -53.36 -50.75 64.41 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.22 76.17 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.426 0.29 . . . . 0.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.64 -53.91 51.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 t -55.23 -47.43 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.406 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.73 -57.08 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.159 0.583 . . . . 0.0 111.746 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -64.7 -48.92 72.93 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.028 0.831 . . . . 0.0 112.098 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -64.44 -33.56 76.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.677 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.0 47.97 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.084 0.856 . . . . 0.0 110.837 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 123.484 0.714 . . . . 0.0 111.824 179.592 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.72 91.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.46 149.57 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.083 0.553 . . . . 0.0 109.865 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.89 55.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.253 1.421 . . . . 0.0 108.865 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.33 82.8 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 123.002 1.382 . . . . 0.0 110.179 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -76.09 70.0 2.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.64 1.576 . . . . 0.0 108.972 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -146.65 123.12 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.142 0.577 . . . . 0.0 110.302 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -49.32 -45.06 44.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.813 0.845 . . . . 0.0 110.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.71 78.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.303 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.23 74.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.876 0.47 . . . . 0.0 109.833 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -54.75 17.08 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.38 -57.21 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.666 0.786 . . . . 0.0 111.792 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -50.88 67.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.275 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.84 -49.08 74.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 109.351 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.66 -52.77 28.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.887 0.875 . . . . 0.0 109.636 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -60.28 4.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.456 0.702 . . . . 0.0 111.759 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -60.55 -24.16 65.18 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.668 -0.645 . . . . 0.0 111.428 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.09 -22.38 57.89 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.654 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mttp 54.8 60.3 3.57 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.05 1.425 . . . . 0.0 107.915 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -62.4 37.18 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 130.348 3.459 . . . . 0.0 116.221 -173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.1 -76.37 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -114.82 11.26 16.67 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 123.821 0.849 . . . . 0.0 110.883 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -76.55 139.83 67.65 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.66 94.7 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.644 2.229 . . . . 0.0 111.665 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.25 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.39 120.34 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.0 116.57 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.591 0.756 . . . . 0.0 110.834 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -91.03 104.28 16.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.488 1.115 . . . . 0.0 108.565 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -96.54 129.2 43.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 t -157.59 -172.74 4.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 120.4 16.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.989 0.813 . . . . 0.0 111.589 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -36.85 -63.8 0.39 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.056 2.142 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -54.81 -33.04 61.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 112.369 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.87 82.09 6.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.01 -62.68 0.56 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.004 1.288 . . . . 0.0 113.461 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.41 -30.96 93.99 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 119.828 1.814 . . . . 0.0 112.734 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.25 -29.43 67.34 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -81.32 -30.37 33.9 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.059 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.5 mmt -57.24 -22.06 38.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.04 0.836 . . . . 0.0 111.769 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -68.81 -30.44 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.759 . . . . 0.0 110.377 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.64 15.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 112.604 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -57.25 -39.72 87.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 CA-C-N 121.594 1.605 . . . . 0.0 111.495 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.74 -54.55 45.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -51.81 -48.65 63.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.916 1.286 . . . . 0.0 109.258 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.97 -30.36 70.91 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.688 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.4 m -56.56 -39.57 73.68 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 0.0 107.96 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.79 -25.82 63.47 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.099 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -50.65 -38.69 47.86 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.306 1.412 . . . . 0.0 110.294 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -55.94 -43.05 77.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.226 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.62 -53.4 9.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.67 0.788 . . . . 0.0 110.318 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.46 66.6 9.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.43 72.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.965 1.306 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.31 -166.14 3.73 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.466 1.031 . . . . 0.0 113.69 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.72 36.62 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.66 1.984 . . . . 0.0 114.805 -175.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.5 122.84 39.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.64 104.47 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -92.59 90.22 7.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.72 145.09 31.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.98 121.2 41.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.31 72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.69 121.91 14.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.94 -29.14 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.897 0.879 . . . . 0.0 111.754 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.59 -29.86 70.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.6 -71.86 0.68 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.949 0.9 . . . . 0.0 110.342 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.04 61.8 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 122.649 1.214 . . . . 0.0 108.861 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.46 -42.15 77.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.006 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 -53.26 43.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.9 0.88 . . . . 0.0 111.613 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.61 -43.49 90.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -50.69 64.74 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.4 -43.98 76.07 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.733 -0.604 . . . . 0.0 109.711 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.84 -40.8 76.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.794 0.725 . . . . 0.0 111.169 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.25 45.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.143 1.377 . . . . 0.0 111.434 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.76 41.55 95.68 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 123.925 0.774 . . . . 0.0 112.405 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.7 mm -73.69 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.107 0.954 . . . . 0.0 108.874 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.8 p -131.03 -78.67 0.53 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.484 1.114 . . . . 0.0 108.86 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.57 63.21 1.5 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.626 1.171 . . . . 0.0 111.014 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 151.16 95.91 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.14 158.43 94.98 Favored 'Cis proline' 0 N--CA 1.448 -1.16 0 CA-C-N 119.721 0.936 . . . . 0.0 109.979 0.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 m -150.13 136.32 18.76 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.62 121.3 43.74 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.196 1.398 . . . . 0.0 108.211 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -115.95 150.36 37.27 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.051 0.94 . . . . 0.0 108.906 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.33 107.05 19.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -93.42 89.0 6.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.934 0.493 . . . . 0.0 111.884 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -90.47 156.46 18.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 69.67 -60.19 0.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.325 2.65 . . . . 0.0 109.485 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.31 28.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.058 2.742 . . . . 0.0 110.198 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.4 p -160.54 143.47 4.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.821 1.31 . . . . 0.0 109.902 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -39.83 97.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.749 2.019 . . . . 0.0 111.312 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.59 -37.55 21.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.404 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -139.15 163.16 33.15 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -160.39 169.45 23.05 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.649 0.78 . . . . 0.0 110.12 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -163.19 150.31 12.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.407 1.483 . . . . 0.0 107.921 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.95 162.87 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.495 1.118 . . . . 0.0 110.729 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.99 176.41 40.73 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.934 0.778 . . . . 0.0 112.565 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.72 40.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.354 1.062 . . . . 0.0 111.576 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -77.27 57.93 1.55 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.618 1.967 . . . . 0.0 110.729 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -50.51 -42.02 54.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.111 1.764 . . . . 0.0 112.217 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -57.66 -48.62 78.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 109.969 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -73.08 -26.8 61.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -54.5 45.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -53.33 -47.88 68.94 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.43 75.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.683 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -56.71 -54.61 44.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.612 0.642 . . . . 0.0 109.685 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.51 -46.36 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.771 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.24 -54.36 46.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.612 0.365 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -54.89 -56.04 23.93 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.519 1.128 . . . . 0.0 111.383 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -74.43 -27.93 60.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.156 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.83 41.86 0.82 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.597 1.09 . . . . 0.0 110.853 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 C-N-CA 123.121 0.568 . . . . 0.0 112.085 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.89 0.376 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.23 90.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.63 2.372 . . . . 0.0 105.902 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 pt -145.08 149.56 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.315 0.646 . . . . 0.0 109.761 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.03 55.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.176 1.39 . . . . 0.0 109.022 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.19 -173.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.936 1.294 . . . . 0.0 110.475 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -165.34 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 125.653 1.581 . . . . 0.0 109.156 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -35.57 114.99 0.29 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.56 2.344 . . . . 0.0 113.753 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -42.74 -52.28 5.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.727 1.611 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.17 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.821 -0.549 . . . . 0.0 111.678 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.93 -32.73 67.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.829 -0.545 . . . . 0.0 109.95 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.94 79.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.89 -45.71 91.66 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.05 -53.92 46.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -50.54 38.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.488 1.115 . . . . 0.0 109.416 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.64 -14.38 3.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.897 1.279 . . . . 0.0 113.862 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.33 -63.12 1.39 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.761 1.224 . . . . 0.0 110.695 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -20.86 58.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.43 0.692 . . . . 0.0 112.46 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.09 -19.87 62.0 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.603 -1.109 . . . . 0.0 111.926 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? 67.81 64.88 0.38 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.594 1.558 . . . . 0.0 108.539 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -70.1 56.95 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.806 2.842 . . . . 0.0 111.762 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.65 -52.03 6.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.151 1.38 . . . . 0.0 108.064 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -160.53 75.25 0.56 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.245 1.418 . . . . 0.0 108.106 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -147.17 145.51 22.3 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 121.971 -0.456 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.81 126.7 7.41 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.999 2.466 . . . . 0.0 112.168 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mt -96.15 120.89 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 t -112.36 118.65 58.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.02 118.03 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 122.658 0.383 . . . . 0.0 111.79 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.78 87.08 7.26 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -84.76 93.94 8.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 t -117.89 -177.85 3.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.2 112.92 15.68 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.802 1.241 . . . . 0.0 109.08 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -43.56 -56.97 3.37 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.808 1.243 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -57.73 -31.19 66.19 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 112.496 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.6 t -77.39 85.81 3.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -36.23 -59.21 0.99 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.758 1.17 . . . . 0.0 113.07 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.19 -41.23 73.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.017 2.478 . . . . 0.0 112.986 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 m -68.74 -36.59 78.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.74 -47.58 77.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.284 0.634 . . . . 0.0 109.417 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.4 mtm -58.67 -20.3 46.96 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.4 mt -78.36 -24.85 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.88 -51.48 80.09 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.534 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.9 -36.63 89.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.283 1.851 . . . . 0.0 111.529 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.37 -50.81 72.13 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -56.32 -45.96 80.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.662 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.78 -43.4 90.43 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.445 1.02 . . . . 0.0 110.239 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.3 m -55.43 -48.66 74.09 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.65 -43.93 97.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.195 0.521 . . . . 0.0 109.972 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . 41.1 m -54.95 -47.23 74.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 111.537 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -67.53 -12.77 61.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.525 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -74.99 -64.53 1.03 Allowed 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.924 1.238 . . . . 0.0 108.773 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.11 38.31 0.47 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.339 -0.85 . . . . 0.0 110.61 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.914 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.6 -64.2 2.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -60.29 -49.05 79.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.854 0.827 . . . . 0.0 110.285 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -96.76 134.25 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.28 98.78 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 50' ' ' SER . 96.5 m-85 -91.21 143.19 26.92 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.544 -0.723 . . . . 0.0 110.621 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.42 109.69 5.89 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.257 -170.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -79.67 136.78 36.89 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.6 134.79 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -100.93 104.65 15.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.52 -30.16 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 122.607 0.363 . . . . 0.0 110.611 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.9 -36.4 76.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.506 0.323 . . . . 0.0 110.514 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.65 -69.5 0.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.91 58.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.432 -0.792 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.96 35.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.315 1.046 . . . . 0.0 110.678 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.4 72.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.806 0.842 . . . . 0.0 111.13 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.87 -45.41 91.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.98 -53.8 51.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.409 0.283 . . . . 0.0 111.501 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.46 -42.35 83.18 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.595 -0.691 . . . . 0.0 110.544 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.15 -46.2 90.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.539 0.609 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.64 90.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.938 0.895 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.84 52.44 0.75 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.325 0.964 . . . . 0.0 111.946 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.68 147.92 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.9 p -127.24 -81.42 0.6 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.22 177.89 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.819 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -140.55 139.23 19.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -63.36 153.67 70.99 Favored 'Cis proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.518 1.221 . . . . 0.0 113.987 -3.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.3 m -128.61 126.42 40.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.52 101.0 8.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.529 1.132 . . . . 0.0 109.447 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -97.35 145.39 26.18 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.36 111.53 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.17 104.3 14.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -75.98 105.28 6.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 70.58 -56.11 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.879 2.471 . . . . 0.0 110.673 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.47 -13.11 0.03 OUTLIER Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.484 1.992 . . . . 0.0 111.77 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.67 122.63 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 118.8 1.3 . . . . 0.0 108.204 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.29 94.93 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.2 -35.84 35.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.645 1.178 . . . . 0.0 111.145 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.49 168.28 27.77 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -148.24 167.33 25.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.412 2.285 . . . . 0.0 107.509 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 tp -178.09 138.55 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.205 2.202 . . . . 0.0 106.125 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.13 144.91 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.3 63.69 0.98 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 49.62 -108.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.72 1.208 . . . . 0.0 111.56 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 m 56.84 60.84 2.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.615 1.166 . . . . 0.0 111.003 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -52.01 -36.65 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.583 1.153 . . . . 0.0 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.25 -46.8 88.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.368 0.667 . . . . 0.0 109.72 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -69.02 -35.7 76.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -56.5 -53.68 54.64 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -53.31 -47.42 69.27 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.08 79.88 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.91 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.05 -55.75 29.09 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.497 0.589 . . . . 0.0 109.607 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.59 -47.28 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.84 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.68 -56.44 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.672 0.272 . . . . 0.0 110.295 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -49.37 -62.77 1.36 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.914 1.286 . . . . 0.0 110.773 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -69.79 -22.55 63.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.84 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.21 -44.81 62.39 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 123.075 0.55 . . . . 0.0 109.802 177.664 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 119.56 -0.257 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.38 107.06 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.01 146.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 CA-C-N 119.315 0.962 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.84 22.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.317 1.847 . . . . 0.0 108.608 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.27 162.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -78.72 77.94 5.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -59.42 72.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 127.943 2.497 . . . . 0.0 115.45 -170.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -92.94 -66.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.121 1.369 . . . . 0.0 108.444 167.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.9 17.14 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.027 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.8 65.1 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.667 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -53.13 18.15 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 109.361 175.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.73 -48.52 68.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.828 0.451 . . . . 0.0 110.895 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.95 -60.92 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.598 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -57.09 -47.37 81.22 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.258 1.023 . . . . 0.0 109.689 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -49.66 -48.92 49.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.034 0.379 . . . . 0.0 110.61 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -63.63 1.08 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.638 0.375 . . . . 0.0 111.011 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.37 -25.87 67.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.822 -0.549 . . . . 0.0 111.951 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 -24.55 71.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.721 -1.044 . . . . 0.0 111.801 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 51.31 67.1 1.0 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.224 1.012 . . . . 0.0 109.752 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 46.12 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.395 1.878 . . . . 0.0 114.489 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -139.89 7.23 2.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.468 0.707 . . . . 0.0 112.803 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.03 129.3 61.87 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.14 122.86 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.608 1.538 . . . . 0.0 112.188 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.34 99.79 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.62 111.31 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.79 125.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.35 98.8 11.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.959 1.304 . . . . 0.0 109.463 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.77 96.83 9.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 t -127.21 -150.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -167.97 161.17 12.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 110.912 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -66.56 -59.67 3.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.749 1.22 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -51.01 -33.69 26.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.471 1.508 . . . . 0.0 114.594 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 p -78.37 57.81 2.0 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.605 1.093 . . . . 0.0 112.051 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.46 -87.65 0.0 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 129.129 3.252 . . . . 0.0 115.398 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -41.2 -37.16 2.77 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.717 3.611 . . . . 0.0 113.979 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -45.05 -45.87 11.11 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.405 1.482 . . . . 0.0 111.335 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -65.23 -21.97 66.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.865 0.866 . . . . 0.0 111.593 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.2 mtt -90.0 -37.51 14.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.999 1.32 . . . . 0.0 109.403 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mt -64.16 -42.52 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 109.382 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.98 -53.75 29.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.201 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -46.57 -46.9 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.167 3.245 . . . . 0.0 114.186 172.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.08 -49.51 77.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.746 0.784 . . . . 0.0 108.891 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -58.53 -42.33 87.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.152 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.12 -40.63 96.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.026 0.83 . . . . 0.0 109.574 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -58.52 -49.98 75.41 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.75 -36.47 76.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.044 0.449 . . . . 0.0 109.995 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . 0.456 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 41.9 m -60.17 -46.28 90.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.973 -0.454 . . . . 0.0 109.78 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -64.72 -43.8 92.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -47.55 -51.62 20.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.951 0.5 . . . . 0.0 111.675 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -101.54 33.7 2.86 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.377 0.535 . . . . 0.0 111.659 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.58 151.5 10.54 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.565 -0.709 . . . . 0.0 111.681 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 -62.99 3.2 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -55.66 -52.86 62.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.509 0.724 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.75 140.55 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 mm -96.31 131.77 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 93.8 m-85 -121.79 118.21 28.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.861 0.755 . . . . 0.0 110.778 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -112.44 148.66 33.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.612 1.565 . . . . 0.0 110.072 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -123.22 132.71 54.14 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.42 1.488 . . . . 0.0 107.849 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.23 130.46 39.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 119.171 0.896 . . . . 0.0 109.765 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.54 109.71 21.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.59 -27.38 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.958 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.03 -40.9 97.35 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.608 0.64 . . . . 0.0 109.476 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.51 -63.64 1.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.124 0.57 . . . . 0.0 110.073 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.57 58.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.666 0.746 . . . . 0.0 110.001 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.39 68.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.034 0.934 . . . . 0.0 110.963 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.5 -56.11 22.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.878 0.871 . . . . 0.0 112.16 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.16 -42.62 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.86 63.44 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.7 -38.64 80.43 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.454 -0.779 . . . . 0.0 110.189 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.82 -46.28 89.73 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.564 0.62 . . . . 0.0 109.943 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.92 73.06 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.453 0.701 . . . . 0.0 110.015 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 43.73 4.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.712 1.149 . . . . 0.0 111.208 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.8 mm -79.17 140.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -134.15 -80.35 0.46 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.376 1.07 . . . . 0.0 109.226 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.29 67.21 2.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.261 1.024 . . . . 0.0 111.033 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -63.77 144.77 97.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.168 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.45 148.22 64.43 Favored 'Cis proline' 0 N--CA 1.455 -0.745 0 CA-C-N 120.847 1.338 . . . . 0.0 112.783 -0.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -146.32 122.98 11.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.84 118.9 37.78 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.606 1.162 . . . . 0.0 109.395 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -109.52 150.12 28.62 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.77 107.75 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -99.77 114.31 27.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.648 0.779 . . . . 0.0 111.285 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.57 -170.5 2.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 166.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' VAL . 25.7 p-10 -67.61 -34.22 76.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.123 -0.985 . . . . 0.0 108.474 165.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 41.39 0.97 Allowed Glycine 0 CA--C 1.541 1.709 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.31 20.1 m 24.45 -139.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.64 1 C-N-CA 133.701 4.8 . . . . 0.0 113.458 -179.178 . . . . . . . . 4 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -54.12 85.14 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.873 1.269 . . . . 0.0 109.616 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.87 40.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.491 0.716 . . . . 0.0 109.856 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.68 161.85 41.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.888 0.475 . . . . 0.0 110.345 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -140.58 165.48 27.34 Favored 'General case' 0 C--N 1.335 -0.048 0 C-N-CA 127.14 2.176 . . . . 0.0 107.731 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.1 tp -172.39 103.9 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.893 1.277 . . . . 0.0 109.785 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.82 162.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.548 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 170.42 27.77 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.423 1.011 . . . . 0.0 112.743 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.45 45.34 0.56 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.465 1.106 . . . . 0.0 110.312 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -77.99 60.11 2.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.051 1.34 . . . . 0.0 111.688 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.39 -46.37 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.56 1.544 . . . . 0.0 113.982 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.63 -48.31 75.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.283 -0.886 . . . . 0.0 110.372 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.6 -38.96 86.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.16 -57.43 13.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -45.38 -53.52 8.52 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.621 0.768 . . . . 0.0 110.213 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.55 -50.81 70.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.321 1.013 . . . . 0.0 111.511 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.98 -46.02 90.82 Favored 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.583 -0.698 . . . . 0.0 110.34 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.33 -46.34 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.9 -52.68 59.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.83 -61.0 2.57 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.104 0.962 . . . . 0.0 111.144 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -64.59 -31.79 73.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.885 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.58 42.67 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.946 0.898 . . . . 0.0 111.154 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.347 0.659 . . . . 0.0 112.342 179.65 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.26 31.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.83 2.052 . . . . 0.0 108.087 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 pt -131.79 -173.1 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.392 1.477 . . . . 0.0 110.677 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.95 115.45 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -155.64 99.54 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 122.343 1.068 . . . . 0.0 109.244 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -91.58 -42.49 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.866 1.266 . . . . 0.0 109.705 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 m -32.86 113.17 0.13 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 115.016 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -40.92 66.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 110.527 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -25.12 64.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.938 0.495 . . . . 0.0 111.885 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.44 -31.63 12.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.123 0.969 . . . . 0.0 110.898 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -45.94 -58.25 3.71 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.48 1.512 . . . . 0.0 112.147 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.95 -44.72 84.2 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.655 -0.653 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.77 -42.85 62.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -56.15 25.58 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.94 1.696 . . . . 0.0 109.085 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.6 mt -49.67 -45.79 49.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 110.481 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.85 -63.46 1.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.135 0.574 . . . . 0.0 111.589 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -57.4 -32.08 66.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.373 0.533 . . . . 0.0 111.082 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.97 55.31 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.113 -1.382 . . . . 0.0 113.031 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? 59.0 69.92 0.69 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -68.64 62.51 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.441 2.696 . . . . 0.0 112.767 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -116.92 -93.16 0.51 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.67 73.48 0.82 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.922 0.889 . . . . 0.0 109.052 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -140.29 150.31 60.9 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.13 86.39 0.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 N-CA-C 106.609 -2.112 . . . . 0.0 106.609 168.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.24 79.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.36 137.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 147.23 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -117.6 113.53 22.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.63 112.1 22.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -142.79 179.0 7.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.23 170.62 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.585 1.554 . . . . 0.0 110.812 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.9 p -96.8 -66.49 0.9 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.943 1.697 . . . . 0.0 110.708 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -43.07 -32.38 0.68 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.51 2.324 . . . . 0.0 113.164 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -58.46 -19.55 37.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.482 1.113 . . . . 0.0 113.093 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 -113.44 3.77 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.359 -1.245 . . . . 0.0 110.065 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.89 -42.84 6.78 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.282 3.321 . . . . 0.0 115.207 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -23.09 55.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -71.17 -31.67 67.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.428 -0.795 . . . . 0.0 110.364 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 mmt -61.22 -18.25 57.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.14 0.976 . . . . 0.0 112.467 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 mt -62.98 -33.43 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.6 6.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.114 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -57.11 -35.99 99.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.801 1.679 . . . . 0.0 112.019 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.34 -55.14 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.399 0.618 . . . . 0.0 109.733 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -56.5 -41.26 76.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.67 0.788 . . . . 0.0 109.522 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.68 -40.61 97.64 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.881 -0.512 . . . . 0.0 110.119 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -60.21 -48.84 80.03 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.51 -39.17 75.94 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.257 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -54.88 -54.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.05 -45.79 79.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.989 0.915 . . . . 0.0 110.771 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.24 -43.14 95.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.759 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -79.42 -45.41 19.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.97 -64.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.76 -119.47 0.01 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.575 2.512 . . . . 0.0 116.92 -170.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 55.37 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.091 -1.24 . . . . 0.0 111.12 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.89 149.46 25.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.042 1.337 . . . . 0.0 110.552 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.72 105.44 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.92 94.39 5.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.604 1.162 . . . . 0.0 108.434 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.9 92.45 5.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.911 1.284 . . . . 0.0 109.824 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -85.25 107.42 17.28 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.233 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.67 149.75 17.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 125.292 1.437 . . . . 0.0 110.255 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.99 115.77 30.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.0 0.92 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.66 -45.8 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 124.867 1.267 . . . . 0.0 110.991 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -58.45 -41.66 85.64 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.03 -70.91 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -87.88 63.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 O-C-N 121.332 -0.855 . . . . 0.0 110.955 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.93 48.3 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.48 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.5 69.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.008 0.923 . . . . 0.0 111.295 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.07 -44.96 97.83 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -55.59 29.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.648 0.379 . . . . 0.0 111.169 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.92 -41.71 97.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.707 0.685 . . . . 0.0 109.831 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.66 77.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.641 0.655 . . . . 0.0 110.528 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 7.76 12.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.12 0.968 . . . . 0.0 111.792 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.38 27.06 70.16 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.211 0.91 . . . . 0.0 113.093 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.88 81.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 122.558 1.171 . . . . 0.0 108.707 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -92.1 -72.58 0.58 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.842 2.057 . . . . 0.0 108.099 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.46 59.94 1.53 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.831 0.852 . . . . 0.0 111.389 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.86 152.18 96.89 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -60.17 147.96 44.01 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 121.016 1.398 . . . . 0.0 112.491 -2.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.8 m -147.35 141.79 26.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -134.34 130.49 37.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.666 1.587 . . . . 0.0 107.917 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -125.3 158.49 34.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.551 1.14 . . . . 0.0 107.925 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.4 122.02 63.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -110.81 76.36 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.107 0.563 . . . . 0.0 111.966 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -90.43 -168.08 2.01 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.349 -0.845 . . . . 0.0 110.285 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 89' ' ' VAL . 3.3 m-20 -51.23 -43.07 61.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.08 17.86 0.14 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.612 2.053 . . . . 0.0 112.507 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.277 40.5 t 67.18 -154.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.42 1.488 . . . . 0.0 107.34 170.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . 0.409 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 22.5 ttpp -64.29 79.53 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.29 -32.45 43.58 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.622 -166.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -147.19 151.07 36.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -142.97 166.27 25.1 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.081 1.352 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -161.83 140.98 9.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.762 1.225 . . . . 0.0 108.263 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 m -127.26 162.68 31.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.485 1.114 . . . . 0.0 110.793 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 179.16 36.76 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.841 -0.799 . . . . 0.0 111.09 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.2 m -80.08 58.86 3.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -48.92 -46.57 43.27 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.374 . . . . 0.0 111.864 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.36 -48.51 74.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.103 0.561 . . . . 0.0 110.128 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -68.8 -35.62 77.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -58.69 -48.71 80.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 109.132 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.98 -47.76 80.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.93 77.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.23 -55.72 31.34 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.0 t -51.08 -53.34 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.24 -52.11 62.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.94 0.496 . . . . 0.0 111.562 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -68.28 0.23 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.471 0.653 . . . . 0.0 110.034 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -61.01 -24.04 65.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.091 -170.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.42 94.45 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.728 0.695 . . . . 0.0 109.696 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.477 0.711 . . . . 0.0 109.47 178.991 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.71 32.41 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.481 1.512 . . . . 0.0 112.784 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -107.99 154.09 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.35 -0.844 . . . . 0.0 112.392 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.89 135.95 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -160.58 -41.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 122.7 1.238 . . . . 0.0 111.295 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.38 49.36 6.05 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 128.044 2.538 . . . . 0.0 112.241 168.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -131.82 134.73 46.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.578 1.151 . . . . 0.0 107.988 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -49.57 -46.81 49.35 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.754 0.822 . . . . 0.0 111.113 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.92 -11.34 37.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.871 1.268 . . . . 0.0 113.143 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 -33.28 6.91 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.499 1.12 . . . . 0.0 110.075 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -46.79 19.75 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.171 1.388 . . . . 0.0 110.274 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -69.47 -53.39 19.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.012 0.525 . . . . 0.0 109.954 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.68 27.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.608 1.163 . . . . 0.0 111.26 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -44.72 41.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.499 1.52 . . . . 0.0 111.286 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.54 -39.1 93.14 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.704 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.57 -54.13 15.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.039 0.536 . . . . 0.0 109.869 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.5 -28.63 69.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.43 -54.53 33.54 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.767 1.175 . . . . 0.0 111.312 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 103.64 81.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 1 C-N-CA 132.063 4.145 . . . . 0.0 107.665 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -72.83 60.89 0.53 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.641 1.977 . . . . 0.0 110.189 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -119.33 -60.1 1.77 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.947 1.299 . . . . 0.0 108.207 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -152.32 90.9 1.54 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -157.77 152.77 21.36 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -76.36 106.71 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.912 3.075 . . . . 0.0 108.793 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.24 81.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -84.18 120.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -120.62 118.42 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -88.72 96.75 10.79 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.567 1.147 . . . . 0.0 108.958 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -82.25 113.2 19.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 m -141.46 149.47 40.99 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 122.987 0.515 . . . . 0.0 110.041 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 133.21 34.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -50.83 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.63 100.74 5.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.2 133.13 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.479 -0.763 . . . . 0.0 109.003 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.48 150.97 40.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER 50.91 -29.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.445 3.43 . . . . 0.0 118.59 -170.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.2 m -50.73 -45.86 58.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 122.573 2.442 . . . . 0.0 108.354 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -56.06 -26.48 49.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.876 1.67 . . . . 0.0 112.438 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 60.6 mtt -91.15 -43.67 9.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.27 1.428 . . . . 0.0 110.371 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.65 -42.5 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.38 1.472 . . . . 0.0 110.31 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.32 -60.09 9.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.769 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.14 -46.9 18.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.643 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.96 -55.44 34.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.429 0.633 . . . . 0.0 110.466 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -57.42 -37.91 73.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.023 0.529 . . . . 0.0 109.718 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.62 -38.35 89.2 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.704 -0.623 . . . . 0.0 110.146 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 m -60.9 -46.02 92.3 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.11 -40.49 93.94 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 p -58.7 -41.93 87.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.117 -0.99 . . . . 0.0 109.599 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -39.83 94.96 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.76 -47.91 81.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.773 0.429 . . . . 0.0 110.965 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -79.25 -47.74 15.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.874 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 18.77 73.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.585 2.754 . . . . 0.0 115.238 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.0 -96.76 0.11 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -76.46 46.29 0.42 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.09 1.356 . . . . 0.0 110.686 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.6 m -156.76 161.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.047 -1.033 . . . . 0.0 109.62 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.98 121.35 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 169.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.36 91.48 3.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.624 1.169 . . . . 0.0 107.92 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.96 127.24 34.09 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.273 1.029 . . . . 0.0 110.923 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.34 128.76 44.44 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.0 101.06 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 122.138 0.97 . . . . 0.0 111.388 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.07 104.07 0.84 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.22 -36.18 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.982 1.313 . . . . 0.0 110.018 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -63.16 -28.23 69.91 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.618 0.367 . . . . 0.0 111.104 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.46 -65.8 0.97 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.7 56.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 110.134 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.13 77.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.023 0.929 . . . . 0.0 111.529 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.32 -53.12 48.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.907 0.883 . . . . 0.0 111.657 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.41 -46.57 94.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.26 -57.25 11.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.722 0.237 . . . . 0.0 111.437 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.02 -41.3 97.94 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.415 -0.803 . . . . 0.0 110.703 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.35 98.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.384 0.538 . . . . 0.0 111.367 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.32 81.24 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 0.0 111.151 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.67 82.4 1.35 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.76 139.3 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 126.279 1.832 . . . . 0.0 106.401 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -131.92 -96.11 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.76 71.64 5.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.725 0.81 . . . . 0.0 109.446 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -53.98 143.66 41.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.052 0.941 . . . . 0.0 109.855 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -57.55 154.98 32.59 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-N 121.131 1.44 . . . . 0.0 113.642 -1.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.9 108.7 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.76 89.94 5.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.635 1.574 . . . . 0.0 110.104 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -80.26 146.15 31.81 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.42 104.58 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -92.68 52.83 1.94 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -50.69 132.14 25.92 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 74.85 -62.19 0.46 Allowed 'General case' 0 CA--C 1.526 0.043 0 C-N-CA 126.835 2.054 . . . . 0.0 108.726 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.71 39.06 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.912 1.244 . . . . 0.0 111.533 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.88 142.22 8.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -60.54 91.23 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 109.945 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.44 -31.56 29.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.224 1.41 . . . . 0.0 110.741 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -150.27 170.87 17.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.609 0.242 . . . . 0.0 111.163 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -150.12 165.07 33.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.448 1.899 . . . . 0.0 107.43 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.9 tp -172.39 108.08 0.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.264 1.426 . . . . 0.0 108.842 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.6 168.04 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.345 0.658 . . . . 0.0 110.446 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.12 -177.76 27.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.38 -65.77 0.63 Allowed 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m 45.45 43.91 9.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 113.046 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -48.59 -44.14 36.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 112.695 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -59.71 -52.32 65.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.21 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.85 -31.55 71.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.21 -59.22 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -53.54 -49.85 66.74 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.258 0.623 . . . . 0.0 110.464 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.84 71.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.067 0.147 . . . . 0.0 110.87 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.37 -46.27 84.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.454 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.77 -48.81 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.794 1.179 . . . . 0.0 108.916 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.72 47.7 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.75 0.42 . . . . 0.0 110.485 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -52.37 -63.23 1.21 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.057 0.943 . . . . 0.0 110.661 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.24 -19.1 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.351 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.29 9.12 37.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.277 0.944 . . . . 0.0 111.385 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.23 0 CA-C-N 119.295 0.952 . . . . 0.0 111.703 -179.079 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.8 m -142.57 31.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.048 2.139 . . . . 0.0 107.179 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.11 147.48 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 125.248 1.419 . . . . 0.0 111.672 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.1 71.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.352 1.061 . . . . 0.0 110.816 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.34 122.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -98.75 -25.15 14.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.336 2.254 . . . . 0.0 113.569 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -38.06 130.11 1.2 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.663 1.585 . . . . 0.0 111.627 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -49.89 -40.39 42.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.049 0.84 . . . . 0.0 112.537 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 -42.6 81.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.749 0.785 . . . . 0.0 110.034 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.18 -33.64 67.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.189 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -57.95 -52.23 66.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -56.2 -50.05 72.32 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.404 0.682 . . . . 0.0 109.939 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.1 61.97 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.869 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.6 -39.14 73.05 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.562 1.145 . . . . 0.0 111.058 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -62.34 -10.5 11.36 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.222 0.609 . . . . 0.0 111.454 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.69 -58.97 1.94 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.645 1.178 . . . . 0.0 109.908 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -9.57 23.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.522 -0.736 . . . . 0.0 112.184 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.53 -26.7 71.02 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt 55.07 51.73 12.93 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.738 1.215 . . . . 0.0 109.475 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -77.18 62.63 2.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.702 1.601 . . . . 0.0 110.218 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.95 -49.77 70.53 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 109.154 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.37 22.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.676 1.99 . . . . 0.0 108.865 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -87.56 160.71 47.14 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.498 1.119 . . . . 0.0 110.723 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.91 120.62 5.85 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.437 2.091 . . . . 0.0 112.255 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.36 92.88 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.64 111.29 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.64 128.96 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -99.84 102.74 14.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.591 2.356 . . . . 0.0 108.461 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.45 96.75 8.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 m -136.75 -177.34 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -169.46 -177.83 2.91 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 120.878 1.672 . . . . 0.0 110.147 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 p -56.53 -50.17 72.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.931 1.693 . . . . 0.0 109.001 172.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -59.43 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.214 2.605 . . . . 0.0 113.704 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.0 p 170.72 -21.58 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.839 2.456 . . . . 0.0 110.491 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.95 -114.52 5.61 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.088 -1.396 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -41.04 -41.45 4.28 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.502 3.468 . . . . 0.0 115.853 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -27.23 58.02 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.473 0.579 . . . . 0.0 111.57 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -57.99 -23.7 55.07 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.544 -0.723 . . . . 0.0 111.125 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.8 mtm -60.83 -13.72 17.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.778 0.717 . . . . 0.0 111.965 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.84 -30.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.632 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.04 -56.48 25.37 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.629 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.24 -33.46 97.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 122.11 1.789 . . . . 0.0 111.962 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.99 -46.94 76.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.94 -42.72 97.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.579 0.752 . . . . 0.0 110.005 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.4 m -57.62 -47.07 83.22 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.64 -42.25 98.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -52.34 -50.25 62.68 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -41.76 95.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.952 0.501 . . . . 0.0 110.651 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.12 -49.8 75.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.728 0.811 . . . . 0.0 111.315 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.17 -48.18 14.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.176 0.19 . . . . 0.0 110.635 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.91 -73.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.313 1.845 . . . . 0.0 114.133 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.24 -68.7 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.388 0.994 . . . . 0.0 114.23 -172.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -69.88 19.43 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -152.13 154.93 7.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 119.886 1.221 . . . . 0.0 109.43 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.52 102.87 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.25 98.03 10.65 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.086 0.954 . . . . 0.0 109.278 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.94 121.77 32.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.857 0.463 . . . . 0.0 109.787 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -99.52 115.77 30.12 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.81 119.45 58.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 118.484 0.584 . . . . 0.0 110.868 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.68 100.2 10.07 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 172.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -44.22 -58.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.854 1.662 . . . . 0.0 111.51 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.26 -42.59 86.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.9 0.88 . . . . 0.0 111.574 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.38 -67.9 0.42 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.124 0.42 . . . . 0.0 110.063 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -86.44 63.79 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.926 0.87 . . . . 0.0 109.869 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.2 -40.74 34.64 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.674 1.189 . . . . 0.0 110.615 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.39 77.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.692 0.797 . . . . 0.0 111.048 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.52 -45.07 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.12 35.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.552 0.341 . . . . 0.0 111.435 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.81 -41.12 96.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.26 0.482 . . . . 0.0 109.758 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.31 -41.82 76.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.741 0.7 . . . . 0.0 110.235 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.1 6.9 14.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.48 0.712 . . . . 0.0 112.295 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.94 97.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.023 0.821 . . . . 0.0 112.731 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.0 mm -94.3 153.65 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.5 m -153.64 -57.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.12 159.5 18.18 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.81 158.99 29.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.414 -1.279 . . . . 0.0 107.855 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.34 126.44 3.64 Favored 'Cis proline' 0 C--N 1.35 0.612 0 CA-C-N 121.338 1.514 . . . . 0.0 112.975 -1.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 m -126.87 122.07 33.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.44 129.01 56.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.146 . . . . 0.0 108.521 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -121.3 152.4 38.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.13 94.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -88.65 104.75 17.15 Favored 'General case' 0 C--O 1.227 -0.103 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -77.1 127.65 33.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.28 -64.78 0.32 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.792 2.037 . . . . 0.0 109.136 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 22.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.032 1.777 . . . . 0.0 112.242 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.34 125.63 43.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 119.324 1.562 . . . . 0.0 109.576 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -50.28 97.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.135 1.774 . . . . 0.0 110.782 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.97 -31.07 27.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.294 1.038 . . . . 0.0 110.101 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -160.35 172.89 16.49 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.737 0.815 . . . . 0.0 108.9 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.48 -179.28 7.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.115 0.966 . . . . 0.0 109.284 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -164.96 106.18 0.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 106.951 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.56 32.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.0 1.32 . . . . 0.0 113.075 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 168.73 37.19 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.187 -0.946 . . . . 0.0 112.661 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.92 38.55 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.298 1.439 . . . . 0.0 112.942 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.3 m -81.4 70.92 8.37 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 120.649 -1.282 . . . . 0.0 109.717 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -39.62 -52.06 2.23 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.826 1.651 . . . . 0.0 113.757 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.57 -44.19 93.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.81 -0.556 . . . . 0.0 110.959 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -65.32 -41.57 93.85 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -51.81 -58.01 7.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.938 1.295 . . . . 0.0 108.187 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.49 -52.68 58.78 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.92 0.888 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.25 71.24 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.8 mt -58.66 -51.37 70.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.18 -48.88 81.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.489 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.9 61.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.599 0.36 . . . . 0.0 110.864 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -56.21 -65.09 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.122 0.969 . . . . 0.0 110.417 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -64.42 -24.44 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.455 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.5 2.84 23.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.951 0.796 . . . . 0.0 112.033 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 120.031 1.287 . . . . 0.0 111.462 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.404 0.621 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.66 92.38 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -136.96 176.06 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.247 0.546 . . . . 0.0 112.406 -171.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.08 22.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.516 1.526 . . . . 0.0 110.939 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -82.03 78.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.99 64.24 0.33 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.413 1.885 . . . . 0.0 109.631 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.6 m -153.12 167.82 27.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.19 1.396 . . . . 0.0 109.469 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -39.77 -42.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.695 1.998 . . . . 0.0 112.339 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.5 -41.12 9.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 112.037 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.01 62.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.578 -0.701 . . . . 0.0 109.944 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -53.96 -40.25 66.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.98 0.912 . . . . 0.0 112.198 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.06 -72.62 0.71 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.49 -55.68 23.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.257 0.623 . . . . 0.0 111.899 -173.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.96 -50.18 73.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -47.19 -50.13 21.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.891 0.476 . . . . 0.0 110.762 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.37 -58.35 8.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.118 0.567 . . . . 0.0 111.147 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.47 -19.4 63.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.561 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.18 49.2 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.751 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 57.56 65.76 1.28 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.026 1.413 . . . . 0.0 109.837 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 68.13 1.86 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 109.839 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.01 -51.79 35.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -163.48 22.59 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.38 1.872 . . . . 0.0 109.487 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -69.31 144.47 94.83 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 121.865 -0.522 . . . . 0.0 111.674 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.81 92.39 0.52 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.539 1.493 . . . . 0.0 108.844 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.5 111.65 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.52 123.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.3 104.22 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.832 0.853 . . . . 0.0 110.282 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.97 90.55 5.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.274 1.03 . . . . 0.0 109.395 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.11 113.35 18.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -139.55 146.89 40.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.58 107.48 10.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.8 m -58.44 -36.65 73.98 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.795 0.725 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -60.91 -32.39 71.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.466 0.706 . . . . 0.0 110.572 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -78.89 77.08 5.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.58 -54.09 2.84 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.524 1.059 . . . . 0.0 112.184 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.49 -45.49 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.094 2.529 . . . . 0.0 112.75 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.16 -45.56 90.67 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -61.49 -13.01 17.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.753 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.92 -12.87 60.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 121.556 1.98 . . . . 0.0 111.128 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.79 -23.83 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 118.714 0.688 . . . . 0.0 109.306 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.55 -47.04 97.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.71 -1.244 . . . . 0.0 112.644 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.35 -35.43 73.07 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.347 1.874 . . . . 0.0 110.795 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.27 -46.26 89.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.75 -46.4 81.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.01 -41.97 88.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.567 0.747 . . . . 0.0 109.974 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -60.17 -44.83 94.72 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.51 -38.02 88.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.081 -0.387 . . . . 0.0 110.036 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 m -60.08 -48.67 80.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.401 0.68 . . . . 0.0 109.757 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -59.4 -45.19 92.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.944 0.497 . . . . 0.0 109.667 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.11 -56.77 17.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.734 0.414 . . . . 0.0 110.501 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -86.19 58.02 4.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.23 -20.73 66.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.649 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -149.44 0.05 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.591 1.567 . . . . 0.0 113.959 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 53.53 0.84 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 113.012 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.91 140.01 49.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.323 1.849 . . . . 0.0 106.183 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.1 mm -112.91 134.64 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -126.41 111.81 14.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.673 0.67 . . . . 0.0 110.04 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.59 147.21 37.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.307 1.443 . . . . 0.0 108.949 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -118.23 144.14 46.0 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.93 126.29 37.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -83.88 117.76 23.53 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.8 72.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 177.69 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.543 2.737 . . . . 0.0 105.759 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.02 65.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.457 0.303 . . . . 0.0 110.414 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.16 39.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.57 -49.59 26.12 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.224 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.21 -47.43 62.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.462 0.705 . . . . 0.0 112.252 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.49 -46.7 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.46 78.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.061 0.458 . . . . 0.0 110.271 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -57.46 -58.92 6.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.25 1.02 . . . . 0.0 109.519 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.9 73.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.814 0.446 . . . . 0.0 111.23 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.04 -17.89 63.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.707 0.803 . . . . 0.0 111.578 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 44.27 13.69 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.71 0.671 . . . . 0.0 111.436 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.0 mm -74.37 139.72 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.4 p -124.52 -85.08 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.509 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.67 86.3 6.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.434 1.094 . . . . 0.0 111.402 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -62.64 145.01 95.78 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.462 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.91 153.05 72.97 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.62 1.257 . . . . 0.0 111.634 -2.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -145.38 114.69 7.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.52 119.74 35.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.593 1.157 . . . . 0.0 109.382 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -111.2 134.9 52.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.99 109.44 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.76 97.64 7.44 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.658 0.383 . . . . 0.0 111.788 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -90.3 -165.22 1.3 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 89' ' ' VAL . 19.3 p-10 -69.63 -36.68 76.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 169.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.5 41.37 1.16 Allowed Glycine 0 CA--C 1.543 1.808 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 166.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.333 25.3 m 20.89 -134.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.448 1 C-N-CA 133.008 4.523 . . . . 0.0 113.482 -178.105 . . . . . . . . 4 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -58.18 79.06 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.338 1.455 . . . . 0.0 109.032 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -29.21 39.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.41 1.084 . . . . 0.0 111.589 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -158.34 157.4 32.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -147.05 158.87 44.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.0 tp -155.52 109.58 2.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 109.882 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.68 168.54 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 110.562 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.66 178.43 40.4 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.388 0.518 . . . . 0.0 112.208 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.74 -59.04 4.98 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 110.196 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 33.49 21.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.0 3.32 . . . . 0.0 119.237 171.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -51.51 -40.59 59.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.279 1.4 . . . . 0.0 111.846 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.69 -36.42 69.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.848 -0.533 . . . . 0.0 111.203 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.66 -38.23 26.23 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.2 tp -45.81 -51.33 13.01 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.36 0.664 . . . . 0.0 109.508 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -41.5 -52.87 3.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 0.0 111.759 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.68 79.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.45 1.1 . . . . 0.0 110.725 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -49.12 79.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.6 t -57.83 -46.99 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.29 -53.26 46.4 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -54.98 -62.33 1.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.221 1.008 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -62.65 -22.21 66.28 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.72 -5.15 54.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.79 0.723 . . . . 0.0 112.126 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 119.831 1.196 . . . . 0.0 111.328 179.457 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 120.3 0.095 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.7 26.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.335 1.854 . . . . 0.0 108.719 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 pp -97.94 175.31 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.66 122.69 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.24 2.216 . . . . 0.0 108.051 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 tt -160.63 151.32 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.772 0.714 . . . . 0.0 109.666 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -74.75 72.61 2.02 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -55.56 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 129.233 3.013 . . . . 0.0 115.556 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -93.78 -94.86 0.16 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.906 1.282 . . . . 0.0 109.596 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.73 77.06 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.453 -1.404 . . . . 0.0 109.314 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.9 69.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.14 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -50.29 71.83 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.48 1.037 . . . . 0.0 108.402 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -48.75 79.67 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.66 -49.39 75.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.386 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.57 64.68 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.554 0.742 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -49.42 -54.54 16.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 -62.36 1.74 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.924 0.489 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -59.61 -29.03 67.71 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.423 0.556 . . . . 0.0 111.103 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.41 67.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.091 -1.394 . . . . 0.0 112.916 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.33 55.01 10.13 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.995 1.398 . . . . 0.0 108.754 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -38.75 -31.57 0.06 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.56 3.144 . . . . 0.0 116.377 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -9.06 -74.09 0.0 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 129.464 3.106 . . . . 0.0 111.208 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -138.83 74.07 1.46 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -165.51 121.98 1.03 Allowed Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 133.98 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.057 1.838 . . . . 0.0 113.76 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.35 102.21 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 101.203 -3.628 . . . . 0.0 101.203 169.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 t -99.95 120.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.68 104.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 124.935 1.294 . . . . 0.0 110.636 -173.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -83.46 95.73 8.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.301 1.44 . . . . 0.0 107.925 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -80.19 122.81 27.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -146.51 168.24 21.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.66 114.85 23.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.895 0.77 . . . . 0.0 108.95 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -43.36 -57.0 3.24 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.193 1.397 . . . . 0.0 113.128 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -59.19 -30.67 68.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.076 0.551 . . . . 0.0 112.192 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.9 t -76.06 84.71 2.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.24 -59.73 0.76 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.95 1.262 . . . . 0.0 112.942 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.7 -40.6 79.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.163 2.575 . . . . 0.0 113.025 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -67.1 -43.95 81.23 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -62.77 -43.3 99.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.998 0.519 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.6 mmm -58.99 -17.49 25.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt -79.14 -24.45 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 119.193 0.906 . . . . 0.0 109.79 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.36 -55.05 41.4 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 117.453 -1.26 . . . . 0.0 112.272 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.73 94.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.205 1.937 . . . . 0.0 111.686 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.98 -52.9 63.76 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -60.54 -37.47 81.31 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.717 -0.615 . . . . 0.0 109.898 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.35 -35.52 75.85 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.297 -0.877 . . . . 0.0 109.861 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -61.23 -47.49 85.81 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.89 -39.63 90.02 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -55.89 -51.98 65.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.868 0.467 . . . . 0.0 109.857 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -39.9 94.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.159 0.584 . . . . 0.0 109.888 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.02 -46.54 85.12 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.031 0.532 . . . . 0.0 111.35 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -79.65 -53.17 7.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 -56.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.161 2.184 . . . . 0.0 115.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.49 -116.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.823 2.154 . . . . 0.0 115.688 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -40.4 -45.37 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.14 136.97 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 O-C-N 122.209 -0.307 . . . . 0.0 110.189 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.22 125.81 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -112.72 143.86 43.23 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.64 118.67 7.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.593 -167.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -106.28 118.2 36.02 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.85 134.4 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.389 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -85.39 106.66 16.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.424 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.41 -38.99 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 126.473 1.909 . . . . 0.0 109.791 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.96 -34.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.076 0.151 . . . . 0.0 111.29 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.65 -72.25 0.44 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.17 61.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 121.502 -0.749 . . . . 0.0 110.495 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.49 -41.25 53.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.501 0.72 . . . . 0.0 109.9 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.46 68.66 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.13 0.972 . . . . 0.0 111.112 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.11 -45.98 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -54.81 38.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.859 0.464 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.12 -40.09 82.61 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 110.646 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.07 89.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.521 0.601 . . . . 0.0 110.215 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.02 95.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.288 0.635 . . . . 0.0 109.833 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.01 47.09 0.73 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.58 1.086 . . . . 0.0 112.583 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.07 132.22 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.7 p -112.31 -76.79 0.59 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.31 149.39 22.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.512 1.125 . . . . 0.0 108.89 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.69 143.37 33.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -72.26 170.6 66.89 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 C-N-CA 125.144 -0.773 . . . . 0.0 112.588 -1.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 129.68 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -106.1 118.09 35.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.962 1.305 . . . . 0.0 110.58 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -112.38 144.21 42.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 118.824 0.738 . . . . 0.0 110.195 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.39 124.16 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.21 60.78 0.69 Allowed 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 124.763 1.289 . . . . 0.0 110.803 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -71.11 149.15 46.74 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.72 -52.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.248 1.819 . . . . 0.0 112.265 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.37 -57.93 0.22 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.76 164.04 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.106 0.563 . . . . 0.0 109.569 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -56.64 104.01 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.98 -39.65 29.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.097 0.959 . . . . 0.0 110.711 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -161.0 168.01 25.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.06 177.49 10.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.37 0.532 . . . . 0.0 109.914 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 tp -162.54 110.85 1.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.079 1.352 . . . . 0.0 109.404 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.1 161.61 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 0.0 110.989 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.6 -177.91 54.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.605 0.622 . . . . 0.0 112.601 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.18 34.99 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 109.307 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 m 30.82 46.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 115.124 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -59.15 -44.23 92.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 112.246 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -54.52 -53.6 52.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.45 0.7 . . . . 0.0 110.388 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.73 -37.1 76.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.1 tp -53.85 -51.96 61.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -52.39 -48.58 65.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.02 0.373 . . . . 0.0 110.18 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.24 86.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.232 0.213 . . . . 0.0 110.699 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.46 -50.49 67.27 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.66 -0.65 . . . . 0.0 110.37 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.57 -47.35 48.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.34 78.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.302 0.376 . . . . 0.0 111.207 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -49.14 -54.58 15.63 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.328 1.051 . . . . 0.0 110.77 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -75.93 -46.97 27.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.625 0.25 . . . . 0.0 111.454 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.31 -32.79 73.17 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.606 1.162 . . . . 0.0 113.179 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 124.877 1.271 . . . . 0.0 108.881 -173.935 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.66 94.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 pt -152.75 169.12 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.874 0.845 . . . . 0.0 110.861 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.27 149.02 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -150.42 155.4 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 119.329 0.968 . . . . 0.0 110.471 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -137.7 36.3 2.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.958 1.303 . . . . 0.0 111.455 -175.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 m -157.28 127.01 6.14 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.164 -0.96 . . . . 0.0 111.162 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -51.85 -45.67 64.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.353 1.061 . . . . 0.0 110.428 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.15 59.6 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.212 0.53 . . . . 0.0 110.481 -178.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.32 90.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -52.19 65.73 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -64.49 -45.41 87.46 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.103 -178.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.47 65.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.969 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.87 -50.09 75.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.566 0.746 . . . . 0.0 110.256 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -46.94 -49.76 20.06 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.703 0.401 . . . . 0.0 109.927 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -65.97 0.61 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -58.77 -31.04 68.02 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.605 -0.685 . . . . 0.0 111.848 -174.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.5 -24.67 39.59 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.35 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 45.98 8.38 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.125 1.37 . . . . 0.0 109.911 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.64 40.0 0.36 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -174.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -15.2 -63.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.727 2.811 . . . . 0.0 113.399 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -142.74 23.14 1.94 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.885 1.674 . . . . 0.0 109.112 177.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.87 153.15 37.9 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.589 0.756 . . . . 0.0 111.192 -171.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -71.76 133.14 21.4 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.845 1.697 . . . . 0.0 114.124 -177.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.21 116.65 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 100.964 -3.717 . . . . 0.0 100.964 167.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.4 t -102.64 111.44 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -174.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.56 136.77 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.15 89.84 3.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 168.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.44 99.0 7.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 m -136.13 151.74 50.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.789 1.636 . . . . 0.0 107.1 178.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.44 -178.82 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.988 0.915 . . . . 0.0 111.114 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 p -77.2 -63.33 1.39 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.678 1.591 . . . . 0.0 106.84 174.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -61.28 147.47 44.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.744 174.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.7 t 136.24 -59.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 129.212 3.005 . . . . 0.0 107.766 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.28 -92.87 1.02 Allowed Glycine 0 CA--C 1.53 1.025 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.07 -40.73 15.83 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.971 3.114 . . . . 0.0 113.523 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -44.64 -43.52 8.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.577 1.151 . . . . 0.0 110.905 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -58.59 -33.75 70.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.596 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.35 -18.93 65.7 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -177.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.99 -27.33 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.96 -57.04 13.72 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.474 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.37 -41.2 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.904 1.716 . . . . 0.0 112.016 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.4 -51.6 69.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.752 0.787 . . . . 0.0 109.493 178.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.6 -49.15 75.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.236 1.014 . . . . 0.0 109.835 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.79 -41.22 90.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.828 0.851 . . . . 0.0 110.792 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -57.41 -50.6 72.48 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.39 -44.77 89.11 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 121.051 0.453 . . . . 0.0 110.227 176.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -50.98 -46.23 61.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.231 0.612 . . . . 0.0 111.162 -177.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -54.14 -30.47 49.17 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.85 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.09 -52.34 36.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.77 0.714 . . . . 0.0 111.221 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -90.95 -13.37 33.58 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -19.37 -61.85 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 129.192 2.997 . . . . 0.0 115.69 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -50.51 -47.77 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.415 0.531 . . . . 0.0 111.831 -177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -86.16 -60.3 2.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.238 0.615 . . . . 0.0 110.498 -178.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -88.02 146.48 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.431 2.292 . . . . 0.0 112.825 -169.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.49 146.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -135.42 113.61 11.36 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.69 101.28 7.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.51 1.124 . . . . 0.0 111.189 -175.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -79.85 94.63 5.85 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.1 t -79.39 117.91 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -67.93 102.22 1.23 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.28 -34.23 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.499 1.12 . . . . 0.0 110.477 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.76 -28.0 69.68 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.337 0.255 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 -65.87 0.94 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.569 0.748 . . . . 0.0 110.856 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.01 60.71 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.879 0.847 . . . . 0.0 110.172 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.5 76.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.906 0.882 . . . . 0.0 110.526 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.64 -55.85 22.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 111.867 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -44.78 98.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.73 38.15 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.653 0.263 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.71 -41.17 88.39 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.217 -0.927 . . . . 0.0 110.491 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.49 92.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.548 0.613 . . . . 0.0 110.531 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.02 77.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.003 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.52 48.61 1.28 Allowed Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.661 1.124 . . . . 0.0 111.508 175.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.8 136.35 23.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.2 p -140.18 -76.65 0.33 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.0 0.92 . . . . 0.0 108.656 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.44 73.6 1.39 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.547 1.139 . . . . 0.0 110.577 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.08 138.75 96.29 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -64.78 130.52 10.66 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 CA-C-N 121.068 1.417 . . . . 0.0 112.731 -0.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.5 m -120.62 105.0 10.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.07 132.08 34.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -124.25 150.06 45.75 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.78 113.09 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.77 125.54 54.11 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.36 112.57 20.04 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 176.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 69.71 -64.03 0.36 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.984 2.514 . . . . 0.0 109.161 -173.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.95 7.21 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.975 1.75 . . . . 0.0 112.468 177.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.18 117.09 44.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-N 118.996 1.398 . . . . 0.0 107.526 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -56.48 111.2 0.93 Allowed 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.81 -32.21 10.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.341 1.057 . . . . 0.0 111.154 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.55 172.36 17.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.833 0.288 . . . . 0.0 110.53 -177.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -160.46 168.39 25.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.813 1.245 . . . . 0.0 108.856 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 tp -167.87 120.36 0.88 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.804 0.842 . . . . 0.0 109.603 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.4 163.28 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.239 0.616 . . . . 0.0 111.312 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.5 174.85 46.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.716 1.15 . . . . 0.0 111.951 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.32 43.35 0.37 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 110.72 178.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 m -79.35 54.12 1.64 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.926 1.69 . . . . 0.0 110.287 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -36.51 63.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.019 0.927 . . . . 0.0 112.445 -175.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -61.44 -51.58 68.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.533 0.733 . . . . 0.0 109.861 177.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -68.43 -32.97 73.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.09 -56.22 24.54 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -50.61 -50.61 53.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.111 0.564 . . . . 0.0 110.403 177.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.55 71.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.42 -48.17 82.42 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.787 -0.571 . . . . 0.0 110.378 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.7 t -54.92 -51.05 57.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.78 -51.19 61.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.436 0.295 . . . . 0.0 110.926 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -53.87 -66.66 0.36 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.041 0.924 . . . . 0.0 110.507 178.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -59.33 -31.71 69.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.409 -174.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.09 -2.64 28.46 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.489 0 CA-C-N 119.965 1.257 . . . . 0.0 111.277 179.733 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 121.609 0.719 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.38 85.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -144.91 167.29 10.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.541 0.686 . . . . 0.0 111.287 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.85 134.7 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 174.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -153.61 162.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.913 0.863 . . . . 0.0 110.475 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -126.95 11.73 7.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.134 1.774 . . . . 0.0 112.648 -173.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -124.28 114.45 19.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.786 0.435 . . . . 0.0 111.65 -174.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -47.82 -40.59 21.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.006 1.322 . . . . 0.0 111.775 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.1 70.23 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.089 0.955 . . . . 0.0 111.058 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.31 74.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.936 -0.478 . . . . 0.0 109.802 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -50.86 68.09 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.09 -49.79 76.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.99 0.916 . . . . 0.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.41 -57.02 11.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.001 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -54.51 -44.8 73.04 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.539 0.736 . . . . 0.0 110.221 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -23.2 2.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.012 0.925 . . . . 0.0 112.046 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.47 -68.38 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 110.636 175.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -61.91 -23.0 66.05 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -171.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.57 -12.53 64.21 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.986 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 59.9 69.1 0.73 Allowed 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.53 2.13 23.27 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.176 -172.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -10.24 -65.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 129.742 3.217 . . . . 0.0 113.602 -176.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -146.39 57.27 1.18 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -118.48 136.61 24.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.021 . . . . 0.0 109.274 -177.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.25 114.87 4.14 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.146 1.898 . . . . 0.0 110.743 177.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.38 98.33 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 171.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.42 116.72 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.07 114.92 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 117.964 0.347 . . . . 0.0 110.296 -176.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -92.65 85.7 5.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 172.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.69 105.83 11.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -166.12 -159.79 0.4 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.754 0.706 . . . . 0.0 112.22 -171.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 64.1 -135.27 0.32 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 112.563 172.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p 54.61 -107.43 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.083 1.753 . . . . 0.0 109.537 -175.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -72.8 -26.63 61.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.919 0.487 . . . . 0.0 111.451 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.16 82.78 1.81 Allowed 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.53 -0.731 . . . . 0.0 111.056 -175.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 -56.63 8.27 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.976 0.798 . . . . 0.0 111.972 176.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.74 -37.07 64.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.977 2.451 . . . . 0.0 113.447 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.7 m -59.24 -26.0 64.52 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.609 0.364 . . . . 0.0 111.032 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -58.8 -20.63 51.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.498 0.59 . . . . 0.0 110.932 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.6 mmt -82.73 -31.3 28.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.812 0.733 . . . . 0.0 110.697 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.69 -33.5 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.83 -59.41 4.71 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.256 1.022 . . . . 0.0 113.168 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -59.76 -38.57 79.74 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.182 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.75 -54.16 45.65 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -57.91 -41.12 81.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -57.19 -37.41 72.13 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.728 -0.653 . . . . 0.0 112.381 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -59.87 -51.92 67.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.447 1.476 . . . . 0.0 110.002 178.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -57.87 -41.42 82.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 m -52.72 -54.95 26.58 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -41.17 86.16 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.325 0.65 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.14 -53.92 52.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.128 0.571 . . . . 0.0 111.429 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -81.05 -21.42 40.11 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -21.45 110.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.504 2.322 . . . . 0.0 115.713 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.01 -71.08 0.39 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 174.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.35 24.84 2.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.945 0.898 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.42 161.12 4.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.801 1.64 . . . . 0.0 107.951 -174.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 93.79 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.99 94.97 10.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.257 0.623 . . . . 0.0 109.801 -178.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 111.93 23.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.009 1.323 . . . . 0.0 110.754 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -91.65 109.34 20.65 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.62 122.49 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.08 81.13 3.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.8 m -39.92 -47.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 126.988 2.115 . . . . 0.0 114.176 -176.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.23 -40.57 67.82 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.039 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.57 -48.59 14.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.1 t -80.95 51.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.241 1.02 . . . . 0.0 108.849 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.69 -58.13 9.4 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.841 1.656 . . . . 0.0 112.857 -173.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.12 -52.0 54.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -176.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.91 -48.38 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.25 69.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.412 0.285 . . . . 0.0 110.283 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.63 -56.62 19.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.219 1.008 . . . . 0.0 110.007 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.8 -41.26 73.89 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.444 0.298 . . . . 0.0 111.118 -178.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 3.29 19.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.332 1.053 . . . . 0.0 111.905 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.1 41.8 94.8 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.011 -1.056 . . . . 0.0 113.412 176.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.7 137.62 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 p -148.9 -80.24 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.57 78.3 1.47 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.15 0.98 . . . . 0.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.73 139.43 88.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.73 132.38 22.06 Favored 'Cis proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.479 1.207 . . . . 0.0 110.595 -1.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 m -109.27 111.89 23.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -99.61 108.27 20.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.21 1.004 . . . . 0.0 109.197 -177.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -107.87 160.82 15.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.98 0.809 . . . . 0.0 109.891 177.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.02 110.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.42 108.4 19.72 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 175.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -83.97 109.56 17.72 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 71.4 -60.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.811 2.044 . . . . 0.0 110.807 -176.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.41 -41.0 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.219 1.39 . . . . 0.0 111.344 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.59 134.53 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.131 0.966 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -66.55 101.9 0.83 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.51 -32.43 25.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.111 0.964 . . . . 0.0 111.336 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.82 169.08 25.42 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -144.11 161.14 39.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.728 2.011 . . . . 0.0 107.285 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 tp -174.05 152.93 1.98 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.85 165.18 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 110.138 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 -179.08 39.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.184 0.897 . . . . 0.0 111.833 177.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.73 44.24 0.36 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.862 0.865 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m -81.22 61.37 4.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 109.688 -176.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.09 -42.73 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.922 0.889 . . . . 0.0 112.034 -175.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -57.82 -50.33 73.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.06 177.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -66.19 -40.32 90.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.27 -55.25 30.04 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.8 -51.28 61.42 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.442 0.297 . . . . 0.0 110.2 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.26 74.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.339 0.256 . . . . 0.0 111.298 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.82 -49.04 74.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.262 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.22 -54.33 18.26 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.6 -55.0 21.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.579 0.351 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.93 -64.78 0.71 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.463 0.705 . . . . 0.0 110.988 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -66.51 -19.98 65.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.086 0.954 . . . . 0.0 112.601 -173.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.02 -40.09 22.59 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.602 -0.686 . . . . 0.0 109.246 174.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.217 0 C-N-CA 123.383 0.673 . . . . 0.0 112.147 -178.302 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.32 29.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.777 2.031 . . . . 0.0 108.202 174.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.02 170.94 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -169.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.71 13.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.333 1.853 . . . . 0.0 111.404 178.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.06 73.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.69 -17.8 64.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.834 -174.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -38.13 117.59 0.62 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.413 1.485 . . . . 0.0 110.601 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -39.42 -44.04 1.3 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -51.07 71.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.467 0.651 . . . . 0.0 110.328 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.224 1.01 . . . . 0.0 109.697 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -61.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.268 1.427 . . . . 0.0 108.483 175.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -55.82 -50.23 71.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.703 0.401 . . . . 0.0 110.286 -178.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.19 77.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.424 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -63.55 -47.34 81.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.294 1.038 . . . . 0.0 109.369 -177.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -56.96 -55.47 34.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.63 -58.82 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.989 0.516 . . . . 0.0 112.067 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -65.89 -14.2 61.06 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.646 -0.658 . . . . 0.0 111.457 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.52 -24.1 70.77 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.395 -1.225 . . . . 0.0 111.917 177.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 57.55 73.02 0.48 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.607 1.163 . . . . 0.0 109.319 -179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.39 52.14 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.631 2.372 . . . . 0.0 113.35 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.57 -59.77 3.33 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.519 -0.738 . . . . 0.0 109.158 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.14 95.42 1.61 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -167.43 139.17 2.59 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 126.02 8.51 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.8 1.667 . . . . 0.0 111.525 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.4 mp -88.98 94.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 102.197 -3.261 . . . . 0.0 102.197 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.8 110.37 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -176.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.73 130.23 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.552 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -92.83 95.92 9.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.952 2.501 . . . . 0.0 106.985 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -88.86 100.53 13.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -127.47 -162.39 1.16 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.22 1.008 . . . . 0.0 108.369 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.24 117.71 2.87 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 120.155 1.343 . . . . 0.0 113.341 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -36.66 -46.79 0.61 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.498 1.519 . . . . 0.0 110.423 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -48.29 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.315 1.446 . . . . 0.0 113.685 177.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.24 35.34 1.62 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.221 0.464 . . . . 0.0 111.808 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 25.24 -88.35 0.01 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 128.411 2.91 . . . . 0.0 115.234 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -42.05 -40.77 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.869 3.046 . . . . 0.0 113.837 177.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.62 -36.97 79.93 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.711 0.404 . . . . 0.0 110.571 178.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -77.08 -31.16 55.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.845 0.858 . . . . 0.0 109.309 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -63.85 -4.1 2.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.061 0.544 . . . . 0.0 112.366 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.24 -23.87 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.222 0.919 . . . . 0.0 108.79 171.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.02 -53.84 43.89 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 120.89 -1.131 . . . . 0.0 112.339 177.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.15 -30.45 91.39 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.944 1.763 . . . . 0.0 111.982 176.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.58 -48.44 66.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.16 -35.07 69.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.404 1.081 . . . . 0.0 110.404 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -50.26 -34.01 21.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 110.418 176.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -57.67 -54.93 41.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 -41.61 99.18 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -49.14 -54.64 15.33 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -56.15 -57.72 10.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.734 0.814 . . . . 0.0 109.73 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -49.7 -44.21 47.96 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.267 1.027 . . . . 0.0 112.474 -174.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -95.39 -1.76 50.39 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.23 136.09 25.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.33 0.968 . . . . 0.0 111.461 -177.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.02 -67.01 0.53 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -81.43 -50.93 8.86 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 122.124 -0.633 . . . . 0.0 110.544 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.93 174.34 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.386 1.074 . . . . 0.0 112.75 -169.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 mm -129.92 94.7 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 174.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.94 138.87 31.1 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.93 126.24 23.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.74 0.816 . . . . 0.0 110.932 -174.131 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -100.65 119.93 39.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.74 134.98 64.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 123.014 0.526 . . . . 0.0 111.377 -176.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.23 95.61 7.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.117 1.367 . . . . 0.0 107.352 177.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -49.1 -41.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.978 2.511 . . . . 0.0 110.892 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.19 -22.34 66.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.8 0.84 . . . . 0.0 111.421 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.96 -72.4 0.65 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.936 0.894 . . . . 0.0 108.997 175.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 63.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.956 1.36 . . . . 0.0 109.392 -177.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.55 81.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.869 177.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.92 -43.38 18.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.568 1.547 . . . . 0.0 112.037 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.9 t -75.29 -57.39 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -43.66 -52.08 6.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.347 1.059 . . . . 0.0 113.293 -175.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.54 -35.01 69.76 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.81 20.93 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.81 -45.93 90.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.497 1.119 . . . . 0.0 111.741 -178.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.38 79.96 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.54 151.88 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.726 1.21 . . . . 0.0 108.37 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.9 p -119.89 -109.39 0.35 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 132.37 35.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -76.13 131.95 74.61 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -78.6 138.08 48.42 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.034 1.048 . . . . 0.0 112.789 -1.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.5 m -111.71 115.51 29.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 167.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -95.88 130.2 42.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 108.545 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -122.62 150.37 42.74 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.08 113.33 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.022 1.329 . . . . 0.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -107.39 137.46 45.39 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -90.82 -100.2 0.11 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.863 1.21 . . . . 0.0 110.279 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.25 -42.55 66.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.862 1.315 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.0 -27.33 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.07 2.271 . . . . 0.0 109.726 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.11 135.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.529 1.165 . . . . 0.0 110.893 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -52.18 112.43 0.8 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.225 1.81 . . . . 0.0 107.759 172.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.72 -41.02 7.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.135 1.374 . . . . 0.0 112.64 -174.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -151.14 161.29 42.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -150.77 169.01 22.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.175 0.99 . . . . 0.0 109.484 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -159.9 158.42 30.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 106.981 177.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.66 157.27 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.89 -164.69 51.85 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 -80.0 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.245 0.618 . . . . 0.0 110.717 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m 36.11 57.9 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.975 2.11 . . . . 0.0 113.59 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -46.86 -42.41 17.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.14 1.376 . . . . 0.0 111.862 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -57.91 -53.81 53.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.946 0.898 . . . . 0.0 110.44 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -64.09 -40.97 97.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.13 -53.97 36.32 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.262 1.025 . . . . 0.0 108.484 177.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.72 -50.14 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.583 0.353 . . . . 0.0 110.083 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.89 64.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.889 0.476 . . . . 0.0 110.666 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.31 -58.62 6.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.5 -51.67 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 123.215 0.606 . . . . 0.0 110.685 -177.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.71 -38.35 6.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.383 1.073 . . . . 0.0 112.424 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 109' ' ' HIS . 6.2 ptmt -64.3 -37.91 89.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.44 0.564 . . . . 0.0 111.358 -178.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 108' ' ' LYS . 80.7 m-70 -84.45 -49.15 8.92 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.95 0.9 . . . . 0.0 110.221 -178.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.07 96.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.454 2.301 . . . . 0.0 111.939 -177.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 125.733 1.613 . . . . 0.0 109.31 -175.119 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.8 77.04 0.07 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.699 1.142 . . . . 0.0 113.853 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 m -71.96 72.99 0.86 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.987 0.894 . . . . 0.0 108.797 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -78.6 35.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.114 1.765 . . . . 0.0 112.968 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.14 171.05 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.415 1.086 . . . . 0.0 112.017 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -94.96 143.69 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.101 1.36 . . . . 0.0 107.415 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.9 tp -147.56 155.09 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 111.013 -177.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -136.23 32.58 2.86 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.32 1.448 . . . . 0.0 112.0 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -152.57 139.04 18.59 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.961 0.886 . . . . 0.0 111.805 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -42.53 80.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 111.115 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.43 86.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.537 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.68 76.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.383 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -49.96 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.17 -50.14 74.84 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.782 0.801 . . . . 0.0 110.58 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.52 -56.65 13.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.801 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.16 -50.84 70.01 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.9 -47.85 11.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.502 0.721 . . . . 0.0 109.59 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.82 0.83 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -59.93 -21.94 61.79 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 111.786 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.96 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.179 . . . . 0.0 111.231 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm 62.41 50.72 3.59 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.323 1.449 . . . . 0.0 107.398 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -50.53 -31.91 16.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.192 2.197 . . . . 0.0 115.005 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -59.79 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 128.888 2.875 . . . . 0.0 114.061 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -136.85 84.22 2.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -178.16 155.84 1.01 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.952 0.901 . . . . 0.0 110.085 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.47 117.13 3.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.387 3.391 . . . . 0.0 114.179 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 56.8 mt -88.7 96.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -93.1 104.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.88 131.73 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -104.66 98.76 8.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.3 98.14 8.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -124.66 174.92 7.54 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.835 1.254 . . . . 0.0 108.644 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.5 169.92 16.93 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.031 0.832 . . . . 0.0 109.696 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 p -71.25 -70.11 0.33 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -50.55 -30.17 12.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 115.358 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.6 p -76.04 61.58 1.55 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.902 1.228 . . . . 0.0 112.728 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 10.26 -84.6 0.0 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 128.83 3.11 . . . . 0.0 115.601 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -39.81 -39.44 2.15 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.875 3.716 . . . . 0.0 114.203 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -44.11 -44.22 7.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.92 1.688 . . . . 0.0 111.286 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -61.86 -26.17 67.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 112.11 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -91.02 -40.84 11.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.179 1.392 . . . . 0.0 109.756 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.52 -39.71 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.431 0.692 . . . . 0.0 109.617 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -61.54 6.13 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.832 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.62 -29.78 89.17 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.919 2.412 . . . . 0.0 112.284 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.83 -58.2 9.58 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.23 -32.36 66.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.93 0.892 . . . . 0.0 110.556 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.23 -33.86 63.47 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -59.02 -53.53 57.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.9 mt -59.6 -39.6 84.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 8.5 m -56.25 -51.49 67.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.477 178.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -56.06 -48.6 75.75 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.697 0.799 . . . . 0.0 110.269 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -64.1 -61.32 2.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.269 0.556 . . . . 0.0 111.295 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.24 57.49 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.647 1.179 . . . . 0.0 110.125 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.95 173.35 11.33 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.521 -0.737 . . . . 0.0 111.15 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -65.98 1.31 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.466 1.031 . . . . 0.0 114.686 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -82.63 -59.06 2.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.628 0.714 . . . . 0.0 111.04 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 58.0 t -78.67 129.43 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -171.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.68 104.08 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 33.8 m-85 -91.54 88.2 6.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.1 mt -83.91 99.67 10.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -81.82 94.0 6.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.19 124.31 43.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.04 0.536 . . . . 0.0 110.018 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -81.22 92.47 6.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.36 -36.51 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.683 1.993 . . . . 0.0 110.288 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -50.95 -37.84 46.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.372 0.669 . . . . 0.0 109.91 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.8 -62.31 1.41 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.2 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.99 58.28 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.496 -0.753 . . . . 0.0 111.069 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.67 87.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.308 0.643 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.59 -58.07 9.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.871 0.869 . . . . 0.0 111.894 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.6 -42.59 92.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.92 27.52 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -65.05 -39.56 93.48 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.063 -1.023 . . . . 0.0 110.315 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.04 93.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.412 0.551 . . . . 0.0 110.512 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.94 -32.09 73.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.096 0.958 . . . . 0.0 109.887 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.22 40.51 1.93 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.683 1.135 . . . . 0.0 111.952 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.32 137.98 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 p -136.0 -83.72 0.38 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.12 78.05 2.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.392 0.677 . . . . 0.0 109.802 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 143.14 93.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.99 143.81 76.69 Favored 'Cis proline' 0 N--CA 1.447 -1.258 0 CA-C-N 119.651 0.911 . . . . 0.0 110.453 -0.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.2 m -126.68 119.54 27.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -100.08 129.28 46.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.393 1.077 . . . . 0.0 109.433 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -124.09 147.23 48.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -114.69 91.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -84.43 64.73 8.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -61.03 138.52 58.19 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 72.98 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.807 2.043 . . . . 0.0 110.268 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.85 25.15 0.02 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.497 1.523 . . . . 0.0 111.686 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -156.12 138.57 6.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.236 1.518 . . . . 0.0 109.231 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -46.73 91.07 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.207 2.203 . . . . 0.0 110.88 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.35 21.5 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.95 164.22 39.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -147.29 164.02 34.55 Favored 'General case' 0 N--CA 1.46 0.05 0 C-N-CA 124.364 1.066 . . . . 0.0 109.243 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -162.11 114.83 1.75 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.198 -177.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.56 157.43 3.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.804 0.811 . . . . 0.0 110.261 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.38 -174.65 53.47 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.897 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.29 -60.33 3.91 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.7 m 35.11 50.41 0.49 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.093 2.157 . . . . 0.0 112.874 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -47.01 -51.16 17.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.475 1.51 . . . . 0.0 113.353 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.87 -47.25 86.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.797 -0.565 . . . . 0.0 111.269 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.27 -41.23 97.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.2 tp -56.99 -54.84 42.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -50.93 -51.71 49.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.82 0.848 . . . . 0.0 109.945 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.905 0.482 . . . . 0.0 110.811 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.26 -48.04 81.71 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.307 0.503 . . . . 0.0 110.891 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.81 -52.66 33.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.42 27.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.477 0.311 . . . . 0.0 110.815 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -50.29 -57.44 7.87 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.543 1.137 . . . . 0.0 111.225 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -74.42 -25.26 59.34 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.13 40.02 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.796 0.726 . . . . 0.0 109.644 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.75 56.64 2.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.239 1.416 . . . . 0.0 107.279 -178.193 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.12 50.93 0.75 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.917 1.723 . . . . 0.0 113.6 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -80.61 85.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.911 0.884 . . . . 0.0 109.431 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.0 t -83.38 97.09 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.42 169.58 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.393 1.092 . . . . 0.0 112.699 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.33 138.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tp -151.11 152.14 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.918 0.781 . . . . 0.0 111.226 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -131.89 24.75 4.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.944 1.698 . . . . 0.0 112.415 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -149.33 142.45 24.96 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.158 0.89 . . . . 0.0 111.171 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -70.43 -36.55 74.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.563 1.545 . . . . 0.0 109.614 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.46 75.42 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.85 91.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.2 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 20.6 t-105 -48.86 -58.16 5.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.32 -47.83 83.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.321 0.648 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.9 -47.32 71.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.614 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -64.11 -49.7 71.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp -46.1 -47.99 17.21 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.696 0.798 . . . . 0.0 110.285 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -64.74 0.82 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.492 0.317 . . . . 0.0 111.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -61.09 -24.74 66.46 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.719 -0.613 . . . . 0.0 112.634 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.76 -20.46 64.14 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.462 -1.188 . . . . 0.0 112.322 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 62.92 63.1 0.98 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.308 1.443 . . . . 0.0 108.751 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -75.25 62.32 1.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.892 1.277 . . . . 0.0 110.305 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.58 -55.44 13.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -154.16 19.23 0.5 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 109.554 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -78.59 133.81 62.48 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.16 119.28 6.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.576 1.517 . . . . 0.0 112.498 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mt -99.12 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.43 116.43 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.14 128.8 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.06 96.17 7.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.465 1.506 . . . . 0.0 107.224 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.15 94.01 9.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.8 m -131.69 117.42 18.62 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.06 58.83 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.895 0.316 . . . . 0.0 111.471 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.11 -49.15 52.66 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.112 0.965 . . . . 0.0 110.924 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -68.98 -6.56 28.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 113.29 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.53 64.81 4.51 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.55 -79.88 0.01 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.388 2.899 . . . . 0.0 115.748 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.33 -36.91 53.28 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.436 2.091 . . . . 0.0 111.188 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -38.06 70.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.644 0.778 . . . . 0.0 109.248 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -53.42 -26.64 20.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.634 0.773 . . . . 0.0 111.889 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.2 mtt -62.42 -16.21 53.65 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.11 0.868 . . . . 0.0 111.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.77 -26.18 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.371 0.668 . . . . 0.0 109.812 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.15 16.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.304 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -56.42 -38.92 94.37 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.024 1.816 . . . . 0.0 112.018 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.6 mt -56.6 -57.34 12.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.558 0.694 . . . . 0.0 109.602 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.96 -41.72 75.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.048 0.539 . . . . 0.0 110.067 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -62.61 -34.46 77.08 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.36 -0.838 . . . . 0.0 110.539 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.1 m -62.28 -47.46 84.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.58 -40.63 92.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.454 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 19.5 m -53.58 -52.39 59.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.63 -46.33 89.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.367 0.667 . . . . 0.0 110.429 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -51.16 -54.05 28.93 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.55 -55.52 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.739 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 36.05 -125.44 0.14 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.206 1.402 . . . . 0.0 110.391 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 45.05 -84.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.159 2.314 . . . . 0.0 115.188 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -91.19 -39.43 12.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.372 1.469 . . . . 0.0 112.916 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.63 132.14 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 113.235 -167.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.4 129.53 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.454 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 78.8 m-85 -122.14 113.47 19.54 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.15 101.58 10.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.844 1.258 . . . . 0.0 110.985 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.6 119.41 22.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.38 138.67 53.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.849 0.833 . . . . 0.0 111.88 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -97.88 104.92 16.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.949 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 m -55.65 -28.63 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.19 0.596 . . . . 0.0 110.985 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.01 -36.5 77.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.76 -66.38 0.9 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.936 0.495 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.07 53.88 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 121.497 -0.752 . . . . 0.0 111.267 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.62 -43.58 25.98 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.042 0.937 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.01 73.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.965 0.906 . . . . 0.0 111.138 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.0 t -67.34 -43.49 87.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.474 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.45 27.48 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.667 0.387 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.16 -42.54 88.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.685 -0.634 . . . . 0.0 110.748 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.22 93.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.679 0.672 . . . . 0.0 110.886 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.54 91.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.767 1.227 . . . . 0.0 109.785 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 43.23 1.18 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.456 1.027 . . . . 0.0 112.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.45 131.08 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 p -113.51 -74.92 0.61 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.57 14.76 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.692 1.197 . . . . 0.0 108.899 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -137.96 139.87 27.48 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -62.73 155.63 67.04 Favored 'Cis proline' 0 N--CA 1.457 -0.667 0 CA-C-N 120.758 1.307 . . . . 0.0 114.899 -0.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -144.45 135.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.09 121.25 38.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -119.81 153.85 35.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.02 122.91 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.042 0.937 . . . . 0.0 108.698 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -113.59 118.85 35.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -90.69 -57.52 2.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.461 0.573 . . . . 0.0 112.107 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -93.16 -42.46 9.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.198 1.399 . . . . 0.0 110.545 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.02 -24.18 0.11 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.673 2.082 . . . . 0.0 110.138 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.84 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.16 1.384 . . . . 0.0 108.864 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.0 103.01 0.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.59 -33.66 41.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.835 0.854 . . . . 0.0 110.319 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -158.98 166.94 30.64 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.44 29.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.694 0.797 . . . . 0.0 111.569 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -160.3 149.34 17.25 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.067 1.747 . . . . 0.0 108.14 -175.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.14 156.0 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.97 1.308 . . . . 0.0 110.631 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.33 177.43 46.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.816 0.722 . . . . 0.0 112.124 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.89 46.16 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.736 1.214 . . . . 0.0 111.138 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -80.04 67.08 5.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.33 -0.856 . . . . 0.0 109.985 -175.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -49.53 -45.15 47.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.594 1.158 . . . . 0.0 111.963 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -56.76 -48.91 76.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.03 0.932 . . . . 0.0 110.147 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.5 tppt? -67.65 -38.93 84.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -56.46 -55.43 33.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -51.58 -53.77 34.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.798 0.439 . . . . 0.0 110.462 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.91 -44.46 74.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.706 0.402 . . . . 0.0 111.209 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.9 mt -61.3 -49.76 75.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.955 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.26 -46.97 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.06 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.98 -52.26 58.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.143 0.177 . . . . 0.0 110.817 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -56.31 -62.7 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.897 0.879 . . . . 0.0 110.499 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -70.28 -14.95 62.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.16 16.78 25.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.035 0.834 . . . . 0.0 110.671 174.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.46 72.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 111.959 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.909 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.26 50.37 2.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.927 1.864 . . . . 0.0 111.271 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -77.86 75.8 4.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.639 1.575 . . . . 0.0 109.217 -177.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 77.0 t -105.88 101.65 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 108.734 179.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 pt -145.76 129.47 10.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 122.73 1.252 . . . . 0.0 111.397 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.14 57.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 6.6 tp -89.03 -179.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.209 1.004 . . . . 0.0 111.152 -174.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 16.7 p-10 -134.32 -38.33 0.85 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -174.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -80.48 156.39 26.59 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -165.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.74 -46.2 91.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.837 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.72 -51.92 52.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.98 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -62.77 -47.8 81.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.169 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -46.85 -58.96 3.4 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.89 -54.68 43.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 111.646 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.39 -63.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.234 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -55.68 -47.42 76.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.581 -0.724 . . . . 0.0 110.901 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.61 -19.44 0.91 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.837 0.711 . . . . 0.0 112.016 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.32 -56.86 2.14 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.266 0.939 . . . . 0.0 111.092 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.42 63.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.96 -8.38 57.86 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 119.883 1.22 . . . . 0.0 112.569 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.42 56.28 0.78 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.795 2.038 . . . . 0.0 109.547 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -67.91 64.15 0.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.62 3.168 . . . . 0.0 111.202 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.36 93.71 4.03 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.766 2.026 . . . . 0.0 107.226 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 68.04 72.81 0.31 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 128.864 2.865 . . . . 0.0 110.217 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -172.53 155.27 3.24 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 122.731 0.412 . . . . 0.0 111.858 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.96 135.05 6.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.225 2.616 . . . . 0.0 113.883 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 5.3 mp -104.89 99.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -91.45 109.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.12 123.66 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.904 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -88.68 101.66 14.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.86 1.264 . . . . 0.0 110.232 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.42 115.53 20.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -140.85 162.03 36.42 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 108.212 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.62 163.81 15.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.0 1.32 . . . . 0.0 109.307 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.2 p -77.96 -57.92 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.505 0.722 . . . . 0.0 109.608 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -50.74 -31.59 17.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.648 1.579 . . . . 0.0 113.272 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -77.44 55.37 1.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.616 1.098 . . . . 0.0 110.778 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.86 -68.12 0.01 OUTLIER Glycine 0 CA--C 1.536 1.369 0 C-N-CA 127.938 2.685 . . . . 0.0 115.477 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -42.5 -39.22 6.61 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.577 3.518 . . . . 0.0 114.232 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.6 m -42.78 -44.06 4.24 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.474 1.51 . . . . 0.0 110.88 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.0 -29.16 59.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.03 0.932 . . . . 0.0 112.26 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.49 -19.87 64.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.902 0.774 . . . . 0.0 111.861 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.6 -28.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.51 27.3 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.993 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.2 -42.06 38.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.057 1.838 . . . . 0.0 111.736 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.78 -54.48 45.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.75 0.786 . . . . 0.0 109.565 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -55.86 -45.41 78.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.223 1.009 . . . . 0.0 109.311 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.68 -41.84 95.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.808 0.843 . . . . 0.0 110.836 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 m -58.36 -49.84 75.79 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.1 tp -60.43 -37.64 81.55 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.116 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.463 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 37.8 m -58.94 -44.71 91.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 122.073 -0.392 . . . . 0.0 110.549 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -58.85 -48.33 81.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -46.7 -52.89 12.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 112.736 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -103.99 36.26 2.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.623 0.647 . . . . 0.0 111.471 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.06 71.11 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.234 0.925 . . . . 0.0 112.038 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.37 -75.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.18 -49.2 17.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.45 124.61 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.382 -167.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 17.1 mm -90.99 114.53 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.463 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 96.8 m-85 -105.98 101.75 11.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.82 163.48 14.14 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.15 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -138.02 150.84 47.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.76 136.43 26.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -87.78 113.03 23.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.15 -30.48 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.274 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -62.34 -52.86 61.94 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.06 -60.81 2.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.198 0.599 . . . . 0.0 110.393 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.86 58.57 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.716 0.769 . . . . 0.0 110.338 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.07 -47.14 72.01 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.922 0.889 . . . . 0.0 111.04 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.1 -55.52 23.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.998 0.919 . . . . 0.0 111.978 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.25 -43.99 95.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.97 68.89 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.49 -42.39 74.84 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.83 -0.544 . . . . 0.0 109.761 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.65 78.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.679 0.672 . . . . 0.0 110.535 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 2.7 22.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.258 1.023 . . . . 0.0 111.757 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.75 42.86 94.64 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.569 1.08 . . . . 0.0 112.604 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.81 139.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 117.537 0.668 . . . . 0.0 109.632 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.1 p -139.84 -78.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 110.151 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.8 74.12 1.58 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.336 1.054 . . . . 0.0 111.311 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.31 138.67 91.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -63.7 135.25 19.54 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.443 1.551 . . . . 0.0 112.498 -1.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -125.52 107.37 10.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.86 121.1 33.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.943 0.897 . . . . 0.0 108.604 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.03 141.96 43.81 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.71 96.33 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.3 105.42 17.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -82.44 116.57 21.95 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.0 -59.81 0.37 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.784 2.834 . . . . 0.0 110.346 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.04 23.02 0.09 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.266 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.65 135.16 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.256 1.528 . . . . 0.0 108.406 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -62.96 98.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.393 0.677 . . . . 0.0 109.386 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -33.07 40.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.483 0.713 . . . . 0.0 110.182 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -161.91 174.67 12.78 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -160.61 172.24 17.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.16 1.384 . . . . 0.0 108.165 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.08 150.52 9.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.555 1.142 . . . . 0.0 108.666 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -126.95 158.56 37.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 175.04 46.23 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.573 1.082 . . . . 0.0 111.863 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.62 42.79 0.45 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.904 0.882 . . . . 0.0 110.548 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -78.71 55.4 1.68 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.081 1.752 . . . . 0.0 110.842 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.27 21.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.329 1.052 . . . . 0.0 113.104 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.49 -52.26 65.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.116 0.871 . . . . 0.0 110.245 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.77 -37.94 89.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.76 -57.94 9.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -53.47 -49.9 66.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.016 0.527 . . . . 0.0 110.754 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.93 76.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.14 0.176 . . . . 0.0 111.129 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.02 -47.09 81.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.935 -0.478 . . . . 0.0 110.466 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 65.6 t -56.42 -48.17 80.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.69 -56.6 15.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -47.11 -63.95 0.91 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.905 1.282 . . . . 0.0 111.065 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -70.39 -23.88 62.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.051 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.12 54.51 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.46 55.14 2.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.558 -179.354 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 CA-C-O 118.361 -1.244 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.69 -125.82 15.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 m -65.65 102.44 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.93 26.65 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.121 1.368 . . . . 0.0 107.857 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 pt -145.67 177.27 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 126.424 1.89 . . . . 0.0 107.431 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.76 73.9 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 122.007 0.908 . . . . 0.0 110.496 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.26 127.9 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 107.952 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -105.12 -42.48 5.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.636 1.974 . . . . 0.0 110.675 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 m -14.13 110.81 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.301 3.041 . . . . 0.0 115.035 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -40.29 -47.1 2.44 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.477 1.511 . . . . 0.0 111.326 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.53 -49.54 74.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.932 0.493 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.19 85.63 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -58.59 5.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.588 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -59.54 -47.28 86.16 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.115 0.966 . . . . 0.0 110.346 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -48.47 64.61 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.954 0.902 . . . . 0.0 110.857 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -51.68 -25.92 8.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.866 0.866 . . . . 0.0 112.133 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.19 -60.23 1.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.195 0.907 . . . . 0.0 111.296 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -22.22 63.84 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.814 -0.554 . . . . 0.0 112.081 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.93 -29.71 71.35 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.896 -0.947 . . . . 0.0 110.95 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 45.89 55.04 7.37 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.866 1.266 . . . . 0.0 107.801 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 pm0 -73.55 43.36 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -47.83 -51.05 24.18 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 0.0 109.032 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -135.09 58.48 1.77 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.649 0.78 . . . . 0.0 108.905 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -138.32 126.76 14.16 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.91 105.23 1.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 120.823 1.015 . . . . 0.0 112.212 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.98 118.4 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -118.06 122.11 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.6 110.79 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 123.385 0.674 . . . . 0.0 109.877 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -88.44 93.1 9.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -79.5 94.54 5.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -116.14 -165.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.338 1.455 . . . . 0.0 108.832 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -154.23 147.17 24.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.73 -0.606 . . . . 0.0 110.572 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -64.33 -46.01 85.36 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 112.512 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -68.26 -47.69 67.07 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -77.94 64.43 3.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.065 0.848 . . . . 0.0 112.276 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 11.04 -83.29 0.0 OUTLIER Glycine 0 CA--C 1.536 1.377 0 C-N-CA 128.987 3.184 . . . . 0.0 115.398 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -40.45 -46.37 4.43 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.375 3.383 . . . . 0.0 113.251 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.3 m -46.11 -51.62 13.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.409 1.484 . . . . 0.0 109.695 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -72.46 -41.37 66.15 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 mmt -60.82 -25.39 66.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.532 0.605 . . . . 0.0 112.217 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mt -70.75 -27.11 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.688 -0.632 . . . . 0.0 110.001 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.05 -51.78 79.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 116.994 -1.479 . . . . 0.0 110.653 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.99 -44.23 23.29 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.441 2.76 . . . . 0.0 113.565 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -59.98 -54.93 40.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.47 -34.62 69.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.142 0.577 . . . . 0.0 110.362 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.7 -34.15 75.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.531 1.132 . . . . 0.0 109.926 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -62.66 -47.65 82.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.1 -39.5 86.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.857 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -53.63 -52.1 60.98 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.879 0.471 . . . . 0.0 109.87 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -55.18 -47.13 75.64 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.555 . . . . 0.0 110.344 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.64 -64.95 0.76 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.294 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -80.06 60.39 3.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.187 0.995 . . . . 0.0 108.923 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.19 69.03 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.43 -136.68 0.01 OUTLIER Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.171 1.843 . . . . 0.0 116.229 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -71.81 38.45 0.07 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.072 1.349 . . . . 0.0 114.462 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -121.85 137.32 55.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.25 108.22 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.39 110.0 22.64 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 105.46 14.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.655 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -88.26 90.44 8.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.24 103.57 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.184 0.516 . . . . 0.0 109.775 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -76.99 100.33 5.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.85 -33.11 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.544 0.738 . . . . 0.0 112.14 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.83 -27.92 67.04 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.541 0.61 . . . . 0.0 111.035 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.0 -61.42 1.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 77.2 t -83.42 57.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 122.686 1.231 . . . . 0.0 109.314 -177.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.69 40.06 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.864 1.266 . . . . 0.0 112.788 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.87 -50.84 32.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.724 0.81 . . . . 0.0 111.56 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 67.5 t -63.81 -47.86 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.47 69.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.359 0.264 . . . . 0.0 111.704 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -66.16 -43.49 86.83 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.63 77.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 0.0 110.971 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.56 -9.21 58.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 111.882 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.73 36.03 38.56 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.197 0.904 . . . . 0.0 112.342 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -78.96 141.37 15.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.221 1.01 . . . . 0.0 109.025 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -136.75 -82.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.73 72.59 2.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.375 1.07 . . . . 0.0 111.1 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.65 146.27 86.15 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.793 0.437 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.49 159.83 96.96 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 119.684 0.923 . . . . 0.0 110.185 -1.099 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.4 m -147.8 118.41 7.49 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.13 120.75 34.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 109.593 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -114.68 153.39 30.31 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.33 124.82 67.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -110.64 105.59 14.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.927 0.891 . . . . 0.0 110.33 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -92.45 147.78 22.62 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.46 -64.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 129.096 2.959 . . . . 0.0 112.153 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.68 33.67 0.05 OUTLIER Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.955 2.217 . . . . 0.0 110.486 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.28 145.17 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 118.357 1.078 . . . . 0.0 109.901 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -57.51 106.08 0.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.291 1.436 . . . . 0.0 108.174 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.45 -37.56 12.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.477 1.111 . . . . 0.0 112.554 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -155.54 167.56 29.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -160.68 175.69 12.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.724 0.773 . . . . 0.0 111.939 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -156.87 110.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.513 2.325 . . . . 0.0 106.533 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.53 145.68 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.96 -158.79 29.63 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.37 122.4 44.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.762 1.225 . . . . 0.0 109.955 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -157.59 80.27 0.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -32.75 65.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.987 0.515 . . . . 0.0 111.704 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -60.93 -50.39 73.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.32 -37.43 87.23 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.49 -55.4 35.34 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.629 0.771 . . . . 0.0 109.812 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -51.97 -50.63 60.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.87 86.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.475 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.28 -51.97 67.29 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.816 0.846 . . . . 0.0 109.477 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.47 -50.36 73.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.35 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.55 -58.07 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.877 0.37 . . . . 0.0 110.582 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -45.91 -58.16 3.77 Favored 'General case' 0 C--O 1.228 -0.059 0 C-N-CA 125.57 1.548 . . . . 0.0 110.433 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -83.19 9.79 9.8 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.31 -46.27 5.08 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.35 -58.09 7.5 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.24 0 CA-C-O 116.495 -1.717 . . . . 0.0 107.15 172.34 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.987 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.69 -176.35 16.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.732 1.266 . . . . 0.0 111.424 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.06 78.47 0.23 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.761 1.224 . . . . 0.0 109.281 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 75.4 t -123.01 120.72 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.405 1.082 . . . . 0.0 109.904 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -144.38 171.81 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.172 0.987 . . . . 0.0 111.728 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.04 136.03 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -153.29 152.42 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 118.696 0.68 . . . . 0.0 110.787 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -115.81 -62.56 1.58 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.233 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 m -37.12 105.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.203 3.001 . . . . 0.0 113.483 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -44.53 -49.0 10.23 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.007 1.323 . . . . 0.0 110.346 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.78 -49.77 57.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.106 0.562 . . . . 0.0 111.074 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 -44.36 83.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.823 0.449 . . . . 0.0 109.966 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -61.34 2.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.876 0.87 . . . . 0.0 108.906 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -58.69 -48.66 80.35 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.463 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.24 -63.42 1.15 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.399 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -58.63 -48.2 81.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -46.49 -49.88 17.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 110.758 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -49.18 8.64 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -28.65 61.93 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.698 1.136 . . . . 0.0 111.261 -176.157 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.72 -37.57 61.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.061 -0.855 . . . . 0.0 111.824 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? 44.98 51.53 8.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.811 1.245 . . . . 0.0 109.281 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.44 56.72 1.81 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.679 1.191 . . . . 0.0 113.02 -171.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -22.57 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 128.321 2.648 . . . . 0.0 112.172 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -132.55 59.23 1.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -135.15 142.3 41.28 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.35 111.17 3.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.478 2.119 . . . . 0.0 114.52 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.79 97.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.51 114.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.6 t -106.42 115.79 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -100.13 103.65 15.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.46 90.39 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -114.94 139.7 49.61 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.749 1.219 . . . . 0.0 109.036 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.71 72.28 2.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.669 0.788 . . . . 0.0 110.037 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -25.67 -47.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.632 2.373 . . . . 0.0 113.428 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -38.74 65.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.4 p -77.18 66.54 2.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.487 1.04 . . . . 0.0 112.898 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.28 -88.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 128.849 3.119 . . . . 0.0 114.769 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.73 -45.05 4.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.872 3.048 . . . . 0.0 113.723 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.0 m -45.03 -39.13 5.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.042 1.737 . . . . 0.0 111.634 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -49.27 -33.29 12.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.939 0.896 . . . . 0.0 111.858 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -53.94 -24.75 17.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.9 -37.78 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.78 -57.33 26.31 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -58.51 -27.76 83.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 111.234 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mt -75.15 -44.67 45.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.502 0.592 . . . . 0.0 110.714 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -55.72 -39.09 70.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.21 -34.5 72.99 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.317 0.647 . . . . 0.0 111.456 174.276 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.7 m -55.35 -44.73 76.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.076 1.307 . . . . 0.0 107.875 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.4 -18.09 48.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.778 -0.629 . . . . 0.0 112.428 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 25.9 p -59.16 -38.03 78.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 120.293 1.406 . . . . 0.0 109.226 173.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -62.61 -49.16 76.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.373 1.046 . . . . 0.0 108.196 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.29 -59.82 4.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.923 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -88.05 65.18 8.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.784 0.802 . . . . 0.0 109.625 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.79 67.6 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.337 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.32 -166.12 19.45 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 121.417 0.454 . . . . 0.0 111.998 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.642 . . . . 0.0 110.892 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.69 131.66 69.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.32 96.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.673 1.124 . . . . 0.0 108.583 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -91.61 115.04 27.72 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.87 98.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.072 1.349 . . . . 0.0 110.107 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.91 113.81 18.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -90.47 122.18 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -69.9 86.2 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.13 -50.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.629 1.971 . . . . 0.0 110.779 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -56.68 -31.31 64.32 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.482 1.113 . . . . 0.0 112.192 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.78 -70.8 0.55 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.31 61.56 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.906 0.86 . . . . 0.0 111.036 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.5 60.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.795 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.51 86.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.592 0.757 . . . . 0.0 111.71 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.19 -47.19 82.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.14 69.06 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.53 -55.81 25.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.137 0.975 . . . . 0.0 110.457 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.91 -41.8 75.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.047 0.539 . . . . 0.0 111.048 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -8.62 55.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.391 0.677 . . . . 0.0 111.761 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.43 30.19 31.01 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.231 0.919 . . . . 0.0 112.881 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.68 117.09 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 p -101.34 -71.41 0.71 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.23 156.14 18.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.707 1.203 . . . . 0.0 107.876 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -150.1 161.18 31.78 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.38 141.43 53.45 Favored 'Cis proline' 0 N--CA 1.453 -0.902 0 CA-C-N 120.726 1.295 . . . . 0.0 111.922 1.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.3 m -133.6 122.55 23.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.29 119.33 38.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.325 1.45 . . . . 0.0 108.419 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -107.86 153.52 22.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.67 117.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -107.08 126.64 52.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.978 0.911 . . . . 0.0 109.41 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -92.03 123.78 35.65 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 67.26 -63.12 0.3 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 128.617 2.767 . . . . 0.0 110.585 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.09 23.86 0.05 OUTLIER Glycine 0 CA--C 1.533 1.174 0 C-N-CA 127.151 2.31 . . . . 0.0 110.938 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.13 128.05 74.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.69 111.3 1.79 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.355 0.662 . . . . 0.0 109.881 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.08 -33.9 14.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.627 1.171 . . . . 0.0 110.938 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -155.4 166.01 34.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.768 0.258 . . . . 0.0 111.099 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -143.23 162.36 35.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.738 1.615 . . . . 0.0 109.759 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 tt -159.9 143.44 14.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.595 1.958 . . . . 0.0 106.424 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.25 152.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.07 -158.84 29.55 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.92 139.99 20.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 m -163.85 108.13 1.0 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -51.6 -49.2 62.62 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.912 1.285 . . . . 0.0 111.876 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -58.1 -43.87 87.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.889 0.476 . . . . 0.0 110.034 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -38.39 86.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.06 -46.86 85.49 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -54.6 -49.3 70.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -46.54 85.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.681 0.792 . . . . 0.0 111.005 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.35 -52.64 63.82 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.852 0.751 . . . . 0.0 109.523 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.44 -50.97 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.39 -54.98 28.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.708 0.403 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.58 -63.74 1.02 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 125.254 1.422 . . . . 0.0 110.198 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -68.04 -22.31 64.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.452 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -44.73 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 108.987 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.31 -105.32 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.867 0.867 . . . . 0.0 109.44 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.418 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.456 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.898 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.29 -115.4 6.57 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p -75.04 -17.41 60.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.435 0.694 . . . . 0.0 112.084 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.72 108.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.91 149.89 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.079 0.942 . . . . 0.0 112.425 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -96.52 123.28 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 tp -148.61 146.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.312 0.96 . . . . 0.0 111.153 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -145.01 56.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.974 0.91 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -157.64 117.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -48.52 -38.85 21.4 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.458 1.103 . . . . 0.0 112.794 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.69 86.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.101 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.71 -35.89 65.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.72 0.408 . . . . 0.0 110.126 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -52.23 -53.01 48.93 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.56 -51.29 70.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.355 0.662 . . . . 0.0 110.68 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.14 -48.45 64.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.231 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.14 -51.19 70.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.3 tp -49.22 -50.02 40.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.97 0.508 . . . . 0.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.99 -61.16 2.64 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 111.236 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -63.57 -15.59 58.49 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.457 -0.777 . . . . 0.0 111.877 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.14 60.87 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.079 1.323 . . . . 0.0 111.986 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 mttm 66.08 73.75 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.752 1.263 . . . . 0.0 108.554 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.06 49.44 0.13 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.047 2.139 . . . . 0.0 113.797 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.6 -58.61 3.17 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -152.96 24.61 0.56 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.621 1.168 . . . . 0.0 110.313 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.34 148.88 35.35 Favored Pre-proline 0 C--O 1.234 0.239 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_endo -79.62 129.98 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.294 3.329 . . . . 0.0 113.31 174.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.57 95.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.71 130.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.36 133.24 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -104.49 101.62 11.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.566 1.947 . . . . 0.0 106.599 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.4 95.99 8.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.6 m -122.49 162.81 21.04 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.845 1.258 . . . . 0.0 107.808 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.24 172.44 6.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.124 0.969 . . . . 0.0 110.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.6 p -83.05 -62.52 1.57 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.712 0.805 . . . . 0.0 109.382 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.4 -26.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.716 2.007 . . . . 0.0 113.742 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.7 p -76.69 9.87 2.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.447 1.021 . . . . 0.0 112.703 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 28.82 -89.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 128.635 3.017 . . . . 0.0 114.757 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.58 -37.82 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.089 3.193 . . . . 0.0 114.38 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 p -48.1 -35.1 10.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.024 0.93 . . . . 0.0 111.97 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -52.67 -28.44 21.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.396 1.078 . . . . 0.0 112.172 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.76 -19.8 52.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.158 0.89 . . . . 0.0 112.039 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 35.9 mt -71.83 -30.37 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.684 -0.635 . . . . 0.0 109.916 176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.98 -58.23 12.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.558 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.78 -37.37 94.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.42 2.08 . . . . 0.0 112.452 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -54.54 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.56 -36.86 79.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.907 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.25 -37.46 83.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 0.0 109.764 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 m -59.17 -52.41 65.84 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.63 -41.11 76.54 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 m -56.12 -49.99 72.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.782 0.325 . . . . 0.0 110.276 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -41.42 95.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.107 0.563 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -63.61 -63.37 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.64 0.733 . . . . 0.0 109.806 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.05 57.32 4.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.24 1.416 . . . . 0.0 109.955 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.47 153.08 40.5 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.758 0.79 . . . . 0.0 112.332 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.24 -72.44 1.15 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.616 1.103 . . . . 0.0 114.978 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -71.95 -30.93 65.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.668 0.734 . . . . 0.0 112.818 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 90.3 t -97.08 136.75 26.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 mp -100.82 129.91 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -117.33 107.13 14.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.161 0.984 . . . . 0.0 108.541 179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.4 mt -100.85 101.21 11.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.84 1.256 . . . . 0.0 110.272 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -86.4 120.88 28.22 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.5 141.12 47.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.949 0.899 . . . . 0.0 110.432 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -94.62 109.47 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.788 1.235 . . . . 0.0 107.668 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.0 t -53.2 -34.35 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.836 1.254 . . . . 0.0 110.732 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -68.43 -23.07 64.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.11 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.18 -75.32 0.47 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 0.0 110.9 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.28 63.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.324 0.966 . . . . 0.0 110.169 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.08 54.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.989 0.916 . . . . 0.0 109.739 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.49 -52.83 63.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.131 0.973 . . . . 0.0 111.228 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.35 -46.69 94.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.54 -53.57 52.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.068 0.547 . . . . 0.0 111.539 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.57 -39.81 80.83 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.268 -0.895 . . . . 0.0 110.4 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 86.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.485 0.584 . . . . 0.0 110.203 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.74 -33.75 75.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.392 0.677 . . . . 0.0 110.431 178.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.15 48.66 1.69 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.757 1.17 . . . . 0.0 111.767 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -85.87 98.54 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.3 p -93.21 -75.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.12 72.71 5.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.895 0.878 . . . . 0.0 111.012 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.51 142.71 97.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.73 134.35 34.28 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.306 1.145 . . . . 0.0 111.102 0.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.3 m -122.67 141.01 52.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.903 1.681 . . . . 0.0 108.506 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 84.1 m-85 -124.11 116.83 23.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 108.628 -178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -112.6 147.84 35.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.2 t -115.13 98.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -87.44 107.45 18.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.47 115.01 21.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 68.18 -58.92 0.45 Allowed 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 128.177 2.591 . . . . 0.0 111.448 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.68 19.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.355 0.979 . . . . 0.0 112.686 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.24 134.98 57.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.981 1.39 . . . . 0.0 108.336 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -60.87 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.484 1.114 . . . . 0.0 108.853 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.76 -28.08 40.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.871 0.869 . . . . 0.0 110.12 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -156.05 167.12 31.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.534 0.152 . . . . 0.0 111.026 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.61 -175.21 4.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.472 1.909 . . . . 0.0 108.306 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.5 tp 167.01 142.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.277 2.631 . . . . 0.0 107.595 179.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.15 149.21 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.088 1.355 . . . . 0.0 108.295 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.13 168.69 44.33 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.749 0.639 . . . . 0.0 111.89 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.48 43.61 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 113.38 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.3 t -80.03 72.63 6.82 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.16 -0.963 . . . . 0.0 108.655 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.67 -41.6 55.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.538 0.735 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.14 -50.44 72.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.251 0.62 . . . . 0.0 110.054 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -65.15 -38.93 92.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -52.93 58.2 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.94 -52.29 66.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.933 0.893 . . . . 0.0 110.171 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.82 76.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.706 0.402 . . . . 0.0 111.173 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.6 mt -57.6 -57.17 13.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.737 0.815 . . . . 0.0 109.379 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.09 -47.24 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.987 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.75 -50.52 72.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.416 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.12 -50.16 56.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.783 0.719 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -71.53 -13.5 61.82 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.21 -39.61 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.399 1.48 . . . . 0.0 112.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 63.15 -126.47 0.57 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.95 1.3 . . . . 0.0 108.894 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 179.807 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.88 50.66 3.02 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 118.471 1.136 . . . . 0.0 111.78 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -80.03 58.86 3.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.627 1.171 . . . . 0.0 109.447 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.7 t -83.49 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 126.059 1.744 . . . . 0.0 108.575 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -76.89 137.58 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 122.431 1.11 . . . . 0.0 109.651 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.43 64.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.9 tt -160.06 167.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.129 -170.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -162.61 -44.22 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.598 1.559 . . . . 0.0 108.268 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.6 m -112.92 157.21 21.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.148 1.379 . . . . 0.0 113.58 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -43.78 -37.97 2.99 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 127.814 2.446 . . . . 0.0 112.895 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.18 -28.67 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.78 3.22 15.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.274 0.943 . . . . 0.0 112.232 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.04 -57.11 13.52 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.91 1.284 . . . . 0.0 108.721 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -57.81 -47.04 83.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.078 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.34 -59.0 5.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.627 0.771 . . . . 0.0 110.856 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.3 -49.18 76.91 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.8 mt -52.04 -57.09 10.55 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.94 -59.55 4.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.104 0.962 . . . . 0.0 111.43 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -60.27 -26.85 66.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.14 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.66 -24.4 69.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.32 -1.267 . . . . 0.0 113.669 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.53 56.42 6.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.606 1.703 . . . . 0.0 108.897 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -31.76 -34.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 131.404 3.882 . . . . 0.0 117.564 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -12.65 -70.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 129.348 3.059 . . . . 0.0 113.147 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -139.16 53.16 1.75 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -117.59 131.1 24.25 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.13 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.7 91.6 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.538 1.492 . . . . 0.0 109.593 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mt -86.16 92.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.84 125.45 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 113.37 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -83.4 88.58 6.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.97 98.35 9.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -124.81 171.99 9.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.781 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.65 105.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.993 1.317 . . . . 0.0 108.231 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -43.28 -53.34 5.25 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.057 1.743 . . . . 0.0 112.807 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -58.92 -33.36 70.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.175 0.59 . . . . 0.0 111.867 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.2 t -75.82 85.42 2.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.93 -59.64 0.9 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.664 1.126 . . . . 0.0 112.638 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.22 -39.54 71.51 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.21 2.606 . . . . 0.0 113.214 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.5 m -71.16 -37.85 72.19 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.43 0.692 . . . . 0.0 109.179 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -67.26 -40.99 86.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.199 0.6 . . . . 0.0 110.442 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 83.3 mmm -53.61 -30.75 44.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.246 1.019 . . . . 0.0 112.672 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.64 -30.01 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.145 -0.347 . . . . 0.0 111.071 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.37 -55.4 37.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.704 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.1 -34.34 94.58 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 122.397 1.892 . . . . 0.0 112.067 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.24 -53.26 59.78 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 93.0 t80 -53.9 -43.76 69.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 177.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.79 -44.39 90.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -58.99 -49.48 77.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.27 -33.56 74.85 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 121.93 -0.481 . . . . 0.0 110.516 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.457 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 7.0 m -57.02 -45.48 83.06 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.763 -0.585 . . . . 0.0 109.65 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -63.91 -48.28 77.24 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.38 -45.17 55.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.855 0.462 . . . . 0.0 111.257 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -102.69 44.68 1.0 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.184 0.994 . . . . 0.0 110.116 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.81 43.29 0.33 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.986 -1.071 . . . . 0.0 111.158 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.27 -135.22 8.21 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.848 1.69 . . . . 0.0 109.668 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -80.44 45.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.827 0.814 . . . . 0.0 110.007 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.46 148.77 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 107.801 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.82 130.69 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.457 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 26.0 m-85 -113.38 137.19 51.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.27 124.72 11.65 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.882 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -89.14 143.35 26.91 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.81 130.95 62.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.48 99.68 10.27 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -53.89 -43.37 57.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.38 1.072 . . . . 0.0 111.244 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.4 -49.63 73.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.718 0.407 . . . . 0.0 110.482 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 -59.17 2.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.506 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.08 54.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.635 -0.666 . . . . 0.0 110.716 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.95 70.75 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.768 0.827 . . . . 0.0 110.974 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.82 -56.32 20.64 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.917 0.887 . . . . 0.0 111.926 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.76 -43.58 98.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.8 -41.88 91.36 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.194 -0.941 . . . . 0.0 110.636 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.15 94.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.252 0.478 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.97 76.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.397 1.079 . . . . 0.0 110.312 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.0 70.95 0.47 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.87 145.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -136.39 -88.67 0.3 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 110.89 21.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -76.67 140.88 68.2 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -72.92 141.29 71.2 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 119.687 0.924 . . . . 0.0 111.02 -2.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -114.97 129.64 56.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -111.17 122.05 46.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -116.8 144.55 44.35 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.62 103.84 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -95.36 93.72 7.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.199 0.454 . . . . 0.0 111.079 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -90.86 140.12 30.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.28 -58.87 0.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.156 2.583 . . . . 0.0 110.646 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.12 28.7 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 127.26 2.362 . . . . 0.0 110.095 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.72 136.27 39.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 96.7 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.23 40.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.736 0.415 . . . . 0.0 110.713 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -160.23 167.46 27.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.79 175.51 13.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.668 0.787 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.9 tp -164.68 158.75 18.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.893 1.677 . . . . 0.0 108.255 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.58 160.88 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 110.377 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.32 176.42 41.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.471 1.034 . . . . 0.0 111.554 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.42 41.77 0.26 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.145 0.978 . . . . 0.0 111.352 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -78.26 58.83 2.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.126 1.77 . . . . 0.0 110.047 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.71 -35.59 66.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 112.192 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -58.49 -53.15 61.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.262 0.625 . . . . 0.0 109.578 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -66.6 -34.9 78.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.7 tp -59.75 -50.48 73.67 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.165 0.586 . . . . 0.0 110.081 178.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -55.46 -44.78 76.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.13 95.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.508 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.2 mt -54.37 -55.88 24.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.74 -49.53 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.15 -52.71 50.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.36 0.264 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -56.63 -68.62 0.2 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.164 0.585 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -62.61 -22.69 66.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.841 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.76 80.66 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -87.06 -51.05 6.23 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.56 0.744 . . . . 0.0 110.878 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.168 1.387 . . . . 0.0 108.351 -179.105 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.981 0 CA-C-O 118.879 -0.956 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.47 62.42 1.13 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.4 1.0 . . . . 0.0 114.212 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -80.95 65.48 6.11 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 8.5 p -130.27 31.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.169 1.787 . . . . 0.0 108.805 -175.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.74 152.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 122.56 1.171 . . . . 0.0 113.085 -171.292 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.75 128.7 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.541 1.536 . . . . 0.0 110.566 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . 0.404 ' CG1' ' H ' ' A' ' 8' ' ' ASP . 2.4 tt -160.82 -160.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 174.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.404 ' H ' ' CG1' ' A' ' 7' ' ' ILE . 6.8 t70 -157.19 -56.9 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.616 0.766 . . . . 0.0 109.955 177.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -31.06 118.38 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.36 2.264 . . . . 0.0 113.018 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -40.51 -54.62 2.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.683 1.193 . . . . 0.0 112.869 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -43.24 67.41 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.475 -0.765 . . . . 0.0 111.029 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -35.74 73.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.399 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -55.13 38.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.67 -51.17 69.76 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.271 0.628 . . . . 0.0 110.069 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.22 79.45 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.64 -42.68 93.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -56.22 -58.41 8.08 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.572 1.078 . . . . 0.0 109.212 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 -57.83 9.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.233 0.613 . . . . 0.0 112.318 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.88 -10.11 35.39 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.001 -0.437 . . . . 0.0 111.44 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.43 91.6 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 58.76 76.63 0.34 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.026 1.331 . . . . 0.0 107.883 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 66.54 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.236 1.415 . . . . 0.0 109.591 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.27 -46.67 54.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -170.39 65.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.759 1.624 . . . . 0.0 107.724 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -139.99 132.67 14.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.416 1.486 . . . . 0.0 107.436 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.65 137.27 32.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.658 1.572 . . . . 0.0 109.096 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.61 120.3 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 t -120.81 126.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 125.353 1.461 . . . . 0.0 107.988 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.19 134.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 118.395 0.543 . . . . 0.0 110.327 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -101.41 96.49 7.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.098 1.359 . . . . 0.0 107.525 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -87.8 90.54 8.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -111.47 -178.48 3.46 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.664 1.186 . . . . 0.0 110.387 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.86 112.33 8.74 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.313 1.045 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -36.99 -57.18 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.568 1.947 . . . . 0.0 113.283 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -64.31 -28.33 69.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 t -76.9 91.41 3.57 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -26.8 -65.97 0.07 OUTLIER Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.151 1.834 . . . . 0.0 115.211 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.44 -37.71 47.21 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.153 1.902 . . . . 0.0 112.102 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.4 m -62.14 -40.36 95.68 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -62.43 -50.72 70.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.1 tpp -56.93 -32.55 66.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.775 0.83 . . . . 0.0 112.057 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -66.85 -27.43 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.471 -0.768 . . . . 0.0 110.746 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.25 45.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.98 -1.075 . . . . 0.0 113.601 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.1 -31.08 83.29 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.861 1.707 . . . . 0.0 111.435 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 -48.37 74.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -54.58 -45.7 73.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -58.02 -43.27 86.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.704 0.402 . . . . 0.0 110.394 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.3 m -58.8 -45.61 89.5 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.51 -39.65 94.18 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.257 0.48 . . . . 0.0 110.132 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.3 m -51.53 -53.15 40.76 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -61.14 -48.72 80.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.013 0.525 . . . . 0.0 110.998 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -48.5 -56.38 8.46 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.045 1.338 . . . . 0.0 111.744 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -79.61 -33.26 41.66 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.78 -173.34 0.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.736 1.614 . . . . 0.0 112.082 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -41.43 -26.05 0.2 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.893 2.187 . . . . 0.0 117.142 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -66.2 -19.01 65.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.677 1.739 . . . . 0.0 111.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.98 139.29 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.76 121.42 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.09 124.23 41.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.321 -0.862 . . . . 0.0 109.127 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -115.68 107.55 15.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.535 1.134 . . . . 0.0 111.111 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -79.87 131.17 35.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 57.7 t -139.65 134.32 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 119.203 0.911 . . . . 0.0 109.798 177.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.71 100.09 11.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.065 0.946 . . . . 0.0 109.046 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.7 t -44.56 -46.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 128.165 2.586 . . . . 0.0 110.708 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.64 -53.32 58.01 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.455 0.472 . . . . 0.0 110.491 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.55 -62.59 1.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.822 0.449 . . . . 0.0 111.098 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 28.0 m -83.07 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.288 -0.883 . . . . 0.0 111.69 -175.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.48 30.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.133 0.973 . . . . 0.0 111.27 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -48.55 79.0 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.761 0.825 . . . . 0.0 111.13 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.82 -42.42 89.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.83 63.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.466 0.307 . . . . 0.0 111.216 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.77 -39.93 91.49 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.617 -0.677 . . . . 0.0 110.104 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.93 87.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.539 0.609 . . . . 0.0 110.662 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.45 77.85 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 0.0 110.325 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.12 46.56 2.81 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.888 1.232 . . . . 0.0 110.77 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -78.92 150.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.6 p -124.51 -84.94 0.64 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.14 177.71 6.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -138.44 152.26 70.84 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.52 141.96 57.98 Favored 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.216 -1.109 . . . . 0.0 109.216 -3.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 m -110.58 135.04 51.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -119.61 112.79 19.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 110.397 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -110.17 154.04 23.9 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -119.79 139.03 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -136.17 73.88 1.48 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.399 0.545 . . . . 0.0 112.453 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.67 152.66 43.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 69.18 -64.11 0.35 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 128.426 2.69 . . . . 0.0 109.116 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.04 34.88 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.664 2.078 . . . . 0.0 110.339 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.08 145.1 26.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.99 101.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -41.75 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.347 1.459 . . . . 0.0 111.195 -175.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -159.02 160.06 35.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -175.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -160.9 164.24 31.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 pp -166.27 158.17 13.81 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.137 2.175 . . . . 0.0 108.947 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.52 132.42 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.86 1.264 . . . . 0.0 107.948 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.83 160.56 10.18 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.67 38.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.822 1.249 . . . . 0.0 111.441 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 m -79.55 70.63 6.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.374 1.07 . . . . 0.0 110.63 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -48.81 -41.15 31.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.837 1.255 . . . . 0.0 111.936 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.5 -47.82 84.47 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.863 0.865 . . . . 0.0 110.152 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.96 -40.03 87.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.14 -58.76 5.92 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -49.16 -50.71 36.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.14 -40.42 77.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.603 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.0 -50.05 75.28 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.984 1.266 . . . . 0.0 108.682 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.8 -50.15 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.45 11.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.235 0.214 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -46.4 -62.16 1.48 Allowed 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.971 1.708 . . . . 0.0 111.117 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.28 -22.28 59.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.967 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.77 -47.78 61.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.13 56.64 2.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.469 0.708 . . . . 0.0 109.837 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -179.798 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.925 0 CA-C-O 119.682 -0.51 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.43 -60.08 3.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -74.79 65.41 1.36 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.684 1.594 . . . . 0.0 110.891 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.26 31.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 127.662 2.385 . . . . 0.0 107.57 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.12 -171.48 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 126.922 2.089 . . . . 0.0 108.785 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.42 73.43 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tp -79.08 145.8 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.755 1.222 . . . . 0.0 109.202 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -80.12 63.47 4.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.323 0.649 . . . . 0.0 112.492 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.1 t 29.73 -119.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.534 1.934 . . . . 0.0 113.532 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.2 -47.89 1.22 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.111 2.964 . . . . 0.0 115.304 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.99 79.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.928 0.491 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.55 -40.15 14.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.955 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -32.41 -64.75 0.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 128.566 2.746 . . . . 0.0 113.181 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.99 -55.91 29.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.858 0.837 . . . . 0.0 111.833 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.86 -52.45 49.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.653 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -53.75 54.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.799 1.24 . . . . 0.0 110.155 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.44 -49.21 18.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.976 1.311 . . . . 0.0 109.834 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.41 -61.84 1.88 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -56.81 -26.7 58.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.395 0.678 . . . . 0.0 111.665 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.89 63.18 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 117.56 -1.689 . . . . 0.0 112.103 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm 49.19 60.38 3.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.288 1.544 . . . . 0.0 108.054 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -63.39 24.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.392 2.677 . . . . 0.0 116.342 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -80.92 -59.74 2.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 120.867 -1.146 . . . . 0.0 108.378 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -112.45 36.36 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.544 1.137 . . . . 0.0 108.1 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -145.22 123.35 6.49 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.39 118.64 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.712 2.941 . . . . 0.0 110.454 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -107.08 112.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -119.84 148.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 107.085 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.7 p -133.62 137.05 53.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -105.71 98.06 7.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.415 2.286 . . . . 0.0 106.217 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.74 93.85 8.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -113.36 -167.71 1.23 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.34 0.656 . . . . 0.0 109.654 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.64 11.3 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.288 1.435 . . . . 0.0 110.11 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -99.28 -65.06 0.98 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.442 1.497 . . . . 0.0 109.376 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -49.37 -24.62 2.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.317 1.847 . . . . 0.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.6 p -58.41 -16.64 15.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.134 0.574 . . . . 0.0 111.881 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.64 -112.64 5.1 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.128 -1.373 . . . . 0.0 110.552 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -38.62 -46.61 2.56 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.126 3.217 . . . . 0.0 115.026 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -32.28 39.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -56.13 -28.59 58.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.618 0.767 . . . . 0.0 110.559 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -54.35 -25.45 24.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.802 0.841 . . . . 0.0 112.501 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.86 -30.12 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 122.009 -0.432 . . . . 0.0 110.654 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.9 -59.07 10.72 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.258 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.5 -35.95 94.55 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.817 1.678 . . . . 0.0 112.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.67 -50.74 69.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -55.38 -44.12 75.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -61.15 -37.56 83.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 110.536 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.5 m -61.46 -47.29 86.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.39 -43.48 98.8 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.4 m -50.27 -51.01 48.46 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -35.98 81.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.881 0.872 . . . . 0.0 110.71 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.69 -47.91 82.92 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 123.107 0.563 . . . . 0.0 110.345 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -79.17 -50.95 10.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.7 -63.72 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.737 2.415 . . . . 0.0 116.048 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.89 -104.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.955 2.217 . . . . 0.0 115.755 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -76.61 48.7 0.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.143 0.977 . . . . 0.0 113.215 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.36 159.81 13.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 110.505 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -134.19 121.63 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -123.31 95.08 4.46 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.051 1.34 . . . . 0.0 107.746 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.79 102.62 10.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.468 1.107 . . . . 0.0 111.349 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -79.58 118.83 21.78 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.52 148.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.907 0.86 . . . . 0.0 111.173 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -111.43 112.89 24.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.443 1.497 . . . . 0.0 109.178 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.18 -31.2 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 122.527 0.331 . . . . 0.0 110.954 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.32 -34.39 76.53 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.55 -66.46 0.89 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -85.69 62.96 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 121.605 -0.684 . . . . 0.0 111.766 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.38 -43.19 44.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.351 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -56.31 23.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.215 1.006 . . . . 0.0 111.711 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.12 -43.35 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.13 35.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.867 0.467 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.2 -40.01 90.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.668 0.667 . . . . 0.0 110.08 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.03 82.28 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.639 0.654 . . . . 0.0 110.352 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.51 3.44 21.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.958 0.903 . . . . 0.0 111.715 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.45 32.74 85.19 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.013 0.816 . . . . 0.0 112.644 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.12 134.88 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 p -136.58 -70.11 0.47 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.872 1.269 . . . . 0.0 108.323 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.82 62.28 1.53 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.769 0.828 . . . . 0.0 111.376 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 143.27 98.2 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.46 136.56 44.19 Favored 'Cis proline' 0 N--CA 1.448 -1.151 0 CA-C-N 120.063 1.058 . . . . 0.0 110.606 0.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -126.56 129.57 48.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.44 1.096 . . . . 0.0 108.34 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.97 128.33 54.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.23 1.812 . . . . 0.0 106.902 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -127.94 150.98 49.65 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.699 1.199 . . . . 0.0 108.889 -177.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.08 138.06 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.842 1.257 . . . . 0.0 107.639 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -129.75 50.81 2.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.851 0.75 . . . . 0.0 111.108 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.02 154.38 34.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 74.51 -58.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.626 1.97 . . . . 0.0 109.227 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.35 -48.6 0.3 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.54 157.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.93 0.492 . . . . 0.0 109.924 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -56.42 106.15 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.06 -42.5 17.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.103 0.961 . . . . 0.0 112.367 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -159.98 155.84 26.1 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -142.29 163.64 32.29 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 124.469 1.108 . . . . 0.0 110.076 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -157.52 115.86 3.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.146 1.378 . . . . 0.0 107.959 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.62 160.77 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.708 0.803 . . . . 0.0 112.274 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 177.17 40.42 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.196 0.903 . . . . 0.0 112.185 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.44 40.99 0.24 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.361 1.064 . . . . 0.0 111.298 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.1 m -80.73 58.98 3.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.31 1.444 . . . . 0.0 110.271 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -43.95 -51.97 7.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.59 1.556 . . . . 0.0 112.555 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -52.77 -51.03 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.419 0.687 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -69.48 -32.37 71.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.093 0.557 . . . . 0.0 109.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -57.76 11.08 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -55.78 -46.24 78.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.755 0.422 . . . . 0.0 109.869 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.76 -47.73 73.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.684 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mt -63.09 -45.64 91.15 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.661 0.664 . . . . 0.0 110.473 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.45 -50.9 70.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.16 74.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.618 0.367 . . . . 0.0 111.031 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -60.13 -58.64 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.006 0.922 . . . . 0.0 111.501 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -70.66 -53.13 16.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.14 57.58 4.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.712 0.805 . . . . 0.0 109.059 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.33 -46.8 38.51 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.785 0.434 . . . . 0.0 109.951 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.458 2.303 . . . . 0.0 105.588 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.034 0 CA-C-O 117.354 -1.803 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.19 -158.32 14.36 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p -82.42 67.55 8.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.08 20.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 124.894 1.278 . . . . 0.0 111.972 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -157.71 176.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 126.849 2.059 . . . . 0.0 106.908 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.2 p -150.44 -158.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 172.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -156.39 164.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -68.85 -34.6 75.75 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.422 1.089 . . . . 0.0 112.652 -174.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.8 m -62.71 105.12 0.61 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.879 0.472 . . . . 0.0 109.976 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -39.62 -51.66 2.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.811 1.645 . . . . 0.0 113.158 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.7 45.72 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.465 0.65 . . . . 0.0 111.597 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.92 66.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.188 0.595 . . . . 0.0 111.246 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -49.41 76.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -59.98 -47.08 87.27 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.69 68.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -50.81 68.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.527 0.731 . . . . 0.0 109.525 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.81 -50.74 43.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.279 0.491 . . . . 0.0 109.804 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -55.7 27.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -64.27 -22.0 66.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.776 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.18 25.39 0.2 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.728 1.156 . . . . 0.0 115.399 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp 51.44 70.82 0.5 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.276 1.43 . . . . 0.0 111.461 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.9 70.84 0.51 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.496 1.918 . . . . 0.0 109.728 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -109.18 -66.38 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -161.4 17.85 0.11 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.08 1.752 . . . . 0.0 109.872 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -75.29 142.16 74.76 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.93 115.08 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.762 2.975 . . . . 0.0 110.931 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.7 mt -101.16 101.04 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.32 109.61 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.72 121.22 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 109.846 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -85.59 100.01 11.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.723 1.609 . . . . 0.0 106.958 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.02 99.22 11.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.2 m -131.71 153.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.43 158.43 17.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.316 0.579 . . . . 0.0 110.678 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -66.4 -29.52 69.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.365 1.066 . . . . 0.0 108.235 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -60.97 179.5 0.18 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.257 2.223 . . . . 0.0 112.996 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t 69.39 -62.25 0.41 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.518 2.327 . . . . 0.0 111.733 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.38 -83.05 0.36 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.665 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -47.32 -41.98 27.91 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.494 2.796 . . . . 0.0 112.276 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.0 m -46.47 -39.24 10.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.703 1.601 . . . . 0.0 111.285 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -80.79 -12.45 59.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.339 1.056 . . . . 0.0 113.067 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.3 mmm -58.63 -27.23 64.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.876 1.216 . . . . 0.0 111.362 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.63 -27.69 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.395 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.17 10.19 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.47 -35.62 89.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.153 1.902 . . . . 0.0 112.614 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.4 -53.11 60.89 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.8 -41.46 70.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 108.963 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -62.66 -35.51 79.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.608 1.163 . . . . 0.0 110.794 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -62.8 -50.92 69.1 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.92 -41.46 82.72 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -50.97 -55.76 15.71 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -58.64 -38.0 77.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.273 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -60.61 -48.13 83.14 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.589 0.631 . . . . 0.0 111.263 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -79.62 -29.98 41.24 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.794 -0.566 . . . . 0.0 112.033 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.11 -70.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 128.434 2.694 . . . . 0.0 114.342 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.72 -15.51 2.39 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.334 1.445 . . . . 0.0 112.654 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.49 -34.65 77.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.467 1.134 . . . . 0.0 110.388 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.73 139.44 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.0 mm -93.61 99.53 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -94.46 115.63 27.84 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.4 mt -109.9 140.59 43.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.517 1.127 . . . . 0.0 108.95 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 8.9 mtpm? -121.65 89.95 3.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.196 0.999 . . . . 0.0 110.448 -177.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -97.19 120.23 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 102.42 5.59 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -44.84 -43.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.867 1.267 . . . . 0.0 111.446 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.93 -41.42 11.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.094 1.758 . . . . 0.0 111.611 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.37 -70.21 0.46 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.019 0.527 . . . . 0.0 111.354 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.64 59.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.743 -0.598 . . . . 0.0 111.191 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.41 -43.1 23.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.024 0.93 . . . . 0.0 111.137 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.12 -49.68 76.11 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.941 0.896 . . . . 0.0 111.307 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 -44.52 91.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.8 -55.14 33.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.893 0.477 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.21 -43.47 94.91 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.384 0.538 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.95 76.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.716 0.689 . . . . 0.0 110.844 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.58 6.28 18.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.607 1.163 . . . . 0.0 111.695 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.09 28.3 66.26 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.243 -0.91 . . . . 0.0 112.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.78 119.75 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -137.3 -70.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.883 1.273 . . . . 0.0 108.74 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.92 65.75 1.45 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.456 0.702 . . . . 0.0 110.996 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.25 142.0 89.31 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.05 133.4 10.84 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.253 1.483 . . . . 0.0 112.894 -2.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -127.05 109.87 12.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -96.62 123.49 40.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -115.74 139.99 49.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.596 1.159 . . . . 0.0 109.68 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.48 121.77 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.13 107.06 14.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.84 1.338 . . . . 0.0 107.418 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -86.63 130.5 34.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 t70 70.46 -68.69 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.847 2.059 . . . . 0.0 107.753 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.94 27.14 0.05 OUTLIER Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.148 2.309 . . . . 0.0 110.245 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.0 130.07 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -61.07 109.4 1.08 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.87 -40.84 9.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.197 0.599 . . . . 0.0 111.682 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -160.38 170.81 20.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.04 170.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -163.01 122.67 2.21 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.472 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.9 m -105.9 164.63 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.765 1.226 . . . . 0.0 112.289 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.48 179.23 49.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.676 1.132 . . . . 0.0 111.692 176.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.34 39.18 0.25 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.819 0.848 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.3 m -80.87 57.94 3.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.63 1.572 . . . . 0.0 110.164 -175.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -51.12 -48.93 61.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.401 1.08 . . . . 0.0 112.559 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.53 -47.13 80.03 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -61.54 -44.18 97.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.34 -54.49 44.84 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -54.81 -47.64 73.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.75 80.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.51 -46.15 91.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.572 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.99 -51.68 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 119.292 0.951 . . . . 0.0 108.683 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.19 69.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.472 0.309 . . . . 0.0 111.077 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -58.17 -58.69 7.34 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.394 1.078 . . . . 0.0 111.273 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -75.05 -15.68 60.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.746 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -37.48 -48.81 1.0 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.12 1.768 . . . . 0.0 112.67 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.1 -119.56 1.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 0.0 109.739 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.895 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.55 -120.39 22.62 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 p -74.12 -24.46 59.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.735 0.767 . . . . 0.0 112.424 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.72 128.32 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -145.01 143.64 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 124.476 1.111 . . . . 0.0 110.705 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.28 120.95 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 171.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.71 160.39 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 122.669 1.223 . . . . 0.0 111.639 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -133.69 35.36 3.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.076 2.15 . . . . 0.0 108.544 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 134.3 8.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.925 1.29 . . . . 0.0 108.232 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -51.69 -37.19 49.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.417 1.087 . . . . 0.0 112.46 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -34.01 -62.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.432 1.893 . . . . 0.0 112.573 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.13 77.16 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.935 -0.478 . . . . 0.0 111.363 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -51.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.57 -47.51 69.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.213 0.53 . . . . 0.0 110.297 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.84 60.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.02 -46.14 68.72 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.53 -52.2 6.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.932 0.787 . . . . 0.0 109.443 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.46 -70.0 0.21 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.228 0.611 . . . . 0.0 112.179 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -59.91 -28.42 67.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.895 0.77 . . . . 0.0 112.072 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.82 -24.28 69.79 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.542 1.544 . . . . 0.0 111.842 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 60.68 67.33 0.84 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.623 1.212 . . . . 0.0 110.485 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.02 -22.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.837 2.055 . . . . 0.0 113.459 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -34.14 -54.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.318 2.247 . . . . 0.0 110.572 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -130.66 -13.28 3.76 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -79.85 115.14 51.82 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -63.35 129.05 24.18 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.095 1.196 . . . . 0.0 109.734 178.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.4 mm -102.72 87.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.47 118.07 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.38 116.39 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 123.274 0.63 . . . . 0.0 109.468 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -92.47 89.19 6.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -79.71 94.49 5.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -115.84 -174.19 2.49 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.166 1.386 . . . . 0.0 108.38 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.72 139.56 40.22 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 123.191 0.596 . . . . 0.0 110.971 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -41.86 -58.91 1.87 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.293 1.437 . . . . 0.0 110.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -72.47 7.85 1.65 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.076 1.351 . . . . 0.0 113.94 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -74.43 -7.65 53.68 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.449 1.477 . . . . 0.0 111.747 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.11 -110.36 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.153 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.53 -41.6 10.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.0 3.133 . . . . 0.0 114.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -25.9 60.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.239 -0.288 . . . . 0.0 111.455 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -54.01 -27.92 34.85 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.8 -0.562 . . . . 0.0 111.135 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.0 mtm -57.71 -21.7 42.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.734 0.697 . . . . 0.0 112.457 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.1 mt -69.04 -32.14 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.654 -0.654 . . . . 0.0 109.704 176.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.72 22.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.56 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -59.47 -34.72 97.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.26 1.974 . . . . 0.0 112.357 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.55 -54.41 43.48 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.71 -39.16 73.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.99 -42.33 99.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.339 1.056 . . . . 0.0 109.572 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.1 m -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 tp -59.61 -36.54 76.49 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.494 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 12.5 m -58.35 -48.83 79.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.477 0.711 . . . . 0.0 110.135 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.94 -54.04 51.14 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -54.33 -44.31 71.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.347 0.659 . . . . 0.0 111.844 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -105.83 32.39 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.968 0.907 . . . . 0.0 111.308 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.94 144.42 33.87 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.519 -0.738 . . . . 0.0 110.899 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 -60.7 3.53 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.12 -30.82 71.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 78.4 t -126.21 143.09 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 mm -100.48 118.02 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.494 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 63.2 m-85 -107.51 105.6 15.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.105 0.962 . . . . 0.0 108.827 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.81 89.36 2.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.607 1.163 . . . . 0.0 110.692 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -79.9 111.04 15.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.78 128.56 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.008 0.923 . . . . 0.0 109.952 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.25 106.31 14.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -62.37 -33.79 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.204 0.601 . . . . 0.0 111.059 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.42 -48.2 62.73 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.45 -59.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.663 0.785 . . . . 0.0 110.846 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.74 60.36 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.498 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.27 -43.96 79.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.021 0.928 . . . . 0.0 110.675 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.27 -57.11 11.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 111.907 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.66 -44.07 96.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.04 -52.83 57.23 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.19 -42.43 79.95 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.79 -0.569 . . . . 0.0 109.974 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.28 77.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.684 0.674 . . . . 0.0 110.813 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.21 3.38 27.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.782 1.233 . . . . 0.0 111.636 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.41 38.59 91.12 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.19 0.9 . . . . 0.0 112.632 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mm -76.26 134.66 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.7 p -136.25 -74.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.605 1.162 . . . . 0.0 108.749 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.23 68.41 1.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.503 1.121 . . . . 0.0 110.683 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.83 149.47 96.58 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.79 131.28 22.9 Favored 'Cis proline' 0 N--CA 1.448 -1.192 0 CA-C-N 119.948 1.017 . . . . 0.0 109.917 -1.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -115.42 128.84 56.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.747 1.219 . . . . 0.0 108.407 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -104.24 102.02 11.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.689 1.595 . . . . 0.0 109.913 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -98.94 156.11 17.07 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -127.5 103.73 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.7 66.36 4.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.368 0.531 . . . . 0.0 111.704 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -69.96 154.91 41.34 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 69.59 -63.62 0.37 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.829 2.452 . . . . 0.0 110.157 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.44 35.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.911 2.196 . . . . 0.0 110.419 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.0 152.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -60.01 94.7 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.175 0.59 . . . . 0.0 109.463 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.46 41.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.391 0.676 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -152.43 164.05 38.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.718 0.235 . . . . 0.0 110.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.36 -177.45 4.85 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.21 2.204 . . . . 0.0 107.237 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp 165.82 147.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 128.557 2.743 . . . . 0.0 106.828 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -132.53 150.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.473 1.109 . . . . 0.0 108.965 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.2 173.88 49.38 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 122.088 0.827 . . . . 0.0 113.4 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.1 35.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.416 1.487 . . . . 0.0 113.908 -175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m -78.1 67.15 3.88 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.479 -0.763 . . . . 0.0 110.216 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -49.43 -42.63 43.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.936 1.694 . . . . 0.0 111.504 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -56.58 -49.32 75.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.899 0.88 . . . . 0.0 110.003 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -70.26 -31.12 68.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -53.98 52.18 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.72 -47.3 80.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.92 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.77 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.0 mt -55.15 -55.36 32.07 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.263 0.625 . . . . 0.0 109.726 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.14 -54.11 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.22 -55.59 23.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.663 0.385 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -52.5 -58.62 6.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.288 1.435 . . . . 0.0 111.108 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -72.19 -26.52 62.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.764 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.53 -58.74 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 70.14 -59.31 0.52 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.124 1.769 . . . . 0.0 111.629 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 C-N-CA 126.065 1.746 . . . . 0.0 107.571 179.052 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.212 0 CA-C-O 118.101 -1.388 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.56 -130.68 2.76 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -72.21 73.8 0.95 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.312 1.056 . . . . 0.0 110.129 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.2 29.55 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.231 1.412 . . . . 0.0 112.233 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.15 162.02 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.206 1.003 . . . . 0.0 113.211 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.32 135.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.616 1.966 . . . . 0.0 107.181 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 tt -160.04 169.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.949 0.881 . . . . 0.0 110.63 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -132.16 45.8 2.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 110.442 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -154.41 127.05 8.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.072 -1.018 . . . . 0.0 111.35 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -48.88 -50.07 36.69 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.528 1.131 . . . . 0.0 110.254 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.63 -48.35 19.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.721 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.95 81.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -52.2 48.57 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.69 -47.27 81.85 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.94 57.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.463 0.305 . . . . 0.0 110.275 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -51.47 69.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.085 0.954 . . . . 0.0 109.447 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tt -48.17 -50.07 30.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -62.24 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -63.47 -15.04 56.63 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.599 -0.688 . . . . 0.0 112.285 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.87 -16.74 57.28 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.112 -0.827 . . . . 0.0 111.455 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mttp 76.53 84.49 0.09 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.931 1.692 . . . . 0.0 108.296 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.49 66.16 0.31 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.622 1.969 . . . . 0.0 110.204 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.62 -61.25 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -168.1 8.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.9 153.03 57.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -170.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -65.91 116.1 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.308 2.672 . . . . 0.0 111.304 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.7 mt -97.64 91.96 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.03 109.69 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.9 p -111.61 126.24 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -95.72 105.66 17.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 107.615 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -86.25 97.39 10.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -117.6 142.51 47.12 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.1 56.58 1.22 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.9 p 6.89 -74.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.486 3.115 . . . . 0.0 114.645 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -43.64 -28.81 0.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.318 1.847 . . . . 0.0 115.094 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.41 69.18 1.15 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.9 1.682 . . . . 0.0 112.167 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 32.35 -95.99 0.01 OUTLIER Glycine 0 CA--C 1.532 1.151 0 C-N-CA 128.279 2.847 . . . . 0.0 113.576 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -39.59 -45.83 3.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.221 3.281 . . . . 0.0 112.555 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m -46.4 -37.85 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.821 1.648 . . . . 0.0 112.215 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -74.21 -62.15 1.61 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.2 ptp -58.88 -26.33 64.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 113.012 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.96 -29.76 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.653 -0.654 . . . . 0.0 110.047 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.73 -55.12 46.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.527 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -46.16 -43.84 20.3 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.757 2.971 . . . . 0.0 114.707 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.31 -55.13 35.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.07 -37.79 75.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.54 -34.35 74.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.504 1.121 . . . . 0.0 109.844 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 m -61.21 -53.66 54.11 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.6 -43.52 76.14 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.447 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 17.9 m -52.83 -56.46 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.577 0.751 . . . . 0.0 109.853 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.79 -50.61 60.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.703 0.401 . . . . 0.0 110.477 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.8 -60.17 4.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.887 1.367 . . . . 0.0 112.558 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -88.27 23.68 2.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.91 1.232 . . . . 0.0 111.754 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.17 151.92 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.868 -1.145 . . . . 0.0 111.769 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 -60.53 4.53 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.822 0.449 . . . . 0.0 109.969 175.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.26 138.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 107.373 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.3 mp -98.53 131.14 46.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 97.1 m-85 -122.66 139.94 53.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.408 0.549 . . . . 0.0 110.68 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -132.89 125.43 29.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.338 1.055 . . . . 0.0 109.949 -177.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -107.96 102.36 11.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.18 122.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.669 . . . . 0.0 110.82 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.47 104.54 5.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 t -56.62 -40.09 66.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.96 1.304 . . . . 0.0 110.781 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.81 -51.04 62.39 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.52 -60.05 2.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.256 0.622 . . . . 0.0 110.882 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.83 57.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.175 0.988 . . . . 0.0 109.576 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.16 98.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.811 0.844 . . . . 0.0 110.271 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.18 -57.22 10.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 111.993 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.07 -47.46 93.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.39 -47.14 63.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.634 0.254 . . . . 0.0 110.529 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.05 -58.35 8.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.882 0.873 . . . . 0.0 110.197 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -41.27 72.6 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.54 0.336 . . . . 0.0 111.78 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 -2.84 41.78 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.739 1.216 . . . . 0.0 111.754 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.36 47.49 78.89 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.028 -1.045 . . . . 0.0 113.019 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.38 117.85 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -98.37 -84.54 0.39 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.486 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.094 0.957 . . . . 0.0 110.245 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.52 141.47 79.88 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -71.24 140.36 64.18 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.246 1.123 . . . . 0.0 111.713 -1.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.3 m -121.01 109.42 15.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.31 131.09 34.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -126.58 135.51 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 107.979 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -113.15 91.31 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.925 0.784 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.21 69.22 9.88 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.7 133.46 55.36 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 70.84 -66.99 0.27 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 127.447 2.299 . . . . 0.0 107.061 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.86 26.86 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.427 1.965 . . . . 0.0 110.299 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.0 122.34 31.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 118.152 0.976 . . . . 0.0 108.542 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -45.61 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.593 1.957 . . . . 0.0 110.772 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.91 -33.68 19.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.039 0.936 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.89 159.11 37.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -143.79 166.0 26.12 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.807 1.243 . . . . 0.0 109.078 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.7 tp -162.52 115.46 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.862 0.865 . . . . 0.0 109.881 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.98 158.7 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.017 -0.427 . . . . 0.0 110.768 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 172.07 48.67 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.472 1.034 . . . . 0.0 112.662 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.85 74.0 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.083 0.953 . . . . 0.0 110.523 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.4 m 23.16 57.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.153 2.981 . . . . 0.0 115.055 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -57.97 -59.64 4.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 113.424 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.58 -45.84 73.62 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.894 0.854 . . . . 0.0 110.105 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.45 -43.86 96.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.03 0.932 . . . . 0.0 109.583 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -56.17 21.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.355 1.062 . . . . 0.0 108.185 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -53.36 -50.75 64.41 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.22 76.17 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.426 0.29 . . . . 0.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.64 -53.91 51.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 t -55.23 -47.43 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.406 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.73 -57.08 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.159 0.583 . . . . 0.0 111.746 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -64.7 -48.92 72.93 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.028 0.831 . . . . 0.0 112.098 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -64.44 -33.56 76.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.677 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.0 47.97 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.084 0.856 . . . . 0.0 110.837 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.87 -30.48 71.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.484 0.714 . . . . 0.0 111.824 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.766 2.027 . . . . 0.0 105.634 179.3 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.86 95.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 118.21 1.005 . . . . 0.0 111.234 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -71.62 48.56 0.15 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.59 1.556 . . . . 0.0 113.831 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -141.72 91.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.46 149.57 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.083 0.553 . . . . 0.0 109.865 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.89 55.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.253 1.421 . . . . 0.0 108.865 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.33 82.8 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 123.002 1.382 . . . . 0.0 110.179 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -76.09 70.0 2.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.64 1.576 . . . . 0.0 108.972 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -146.65 123.12 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.142 0.577 . . . . 0.0 110.302 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -49.32 -45.06 44.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.813 0.845 . . . . 0.0 110.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.71 78.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.303 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.23 74.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.876 0.47 . . . . 0.0 109.833 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -54.75 17.08 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.38 -57.21 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.666 0.786 . . . . 0.0 111.792 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -50.88 67.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.275 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.84 -49.08 74.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 109.351 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.66 -52.77 28.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.887 0.875 . . . . 0.0 109.636 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -60.28 4.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.456 0.702 . . . . 0.0 111.759 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -60.55 -24.16 65.18 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.668 -0.645 . . . . 0.0 111.428 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.09 -22.38 57.89 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.654 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mttp 54.8 60.3 3.57 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.05 1.425 . . . . 0.0 107.915 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -62.4 37.18 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 130.348 3.459 . . . . 0.0 116.221 -173.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.1 -76.37 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -114.82 11.26 16.67 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 123.821 0.849 . . . . 0.0 110.883 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -76.55 139.83 67.65 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.66 94.7 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.644 2.229 . . . . 0.0 111.665 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.25 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.39 120.34 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.0 116.57 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.591 0.756 . . . . 0.0 110.834 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -91.03 104.28 16.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.488 1.115 . . . . 0.0 108.565 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -96.54 129.2 43.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 t -157.59 -172.74 4.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 120.4 16.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.989 0.813 . . . . 0.0 111.589 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -36.85 -63.8 0.39 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.056 2.142 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -54.81 -33.04 61.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 112.369 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.87 82.09 6.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.01 -62.68 0.56 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.004 1.288 . . . . 0.0 113.461 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.41 -30.96 93.99 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 119.828 1.814 . . . . 0.0 112.734 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.25 -29.43 67.34 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -81.32 -30.37 33.9 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.059 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.5 mmt -57.24 -22.06 38.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.04 0.836 . . . . 0.0 111.769 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -68.81 -30.44 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.759 . . . . 0.0 110.377 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.64 15.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 112.604 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -57.25 -39.72 87.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 CA-C-N 121.594 1.605 . . . . 0.0 111.495 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.74 -54.55 45.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -51.81 -48.65 63.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.916 1.286 . . . . 0.0 109.258 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.97 -30.36 70.91 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.688 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.4 m -56.56 -39.57 73.68 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 0.0 107.96 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.79 -25.82 63.47 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.099 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -50.65 -38.69 47.86 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.306 1.412 . . . . 0.0 110.294 175.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -55.94 -43.05 77.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.226 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.62 -53.4 9.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.67 0.788 . . . . 0.0 110.318 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.46 66.6 9.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.43 72.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.965 1.306 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.31 -166.14 3.73 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.466 1.031 . . . . 0.0 113.69 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.72 36.62 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.66 1.984 . . . . 0.0 114.805 -175.468 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.5 122.84 39.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.64 104.47 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 13.1 m-85 -92.59 90.22 7.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.72 145.09 31.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.98 121.2 41.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.31 72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.69 121.91 14.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.94 -29.14 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.897 0.879 . . . . 0.0 111.754 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.59 -29.86 70.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.6 -71.86 0.68 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.949 0.9 . . . . 0.0 110.342 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.04 61.8 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 122.649 1.214 . . . . 0.0 108.861 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.46 -42.15 77.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.006 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 -53.26 43.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.9 0.88 . . . . 0.0 111.613 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.61 -43.49 90.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -50.69 64.74 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.4 -43.98 76.07 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.733 -0.604 . . . . 0.0 109.711 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.84 -40.8 76.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.794 0.725 . . . . 0.0 111.169 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.25 45.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.143 1.377 . . . . 0.0 111.434 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.76 41.55 95.68 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 123.925 0.774 . . . . 0.0 112.405 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.7 mm -73.69 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.107 0.954 . . . . 0.0 108.874 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.8 p -131.03 -78.67 0.53 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.484 1.114 . . . . 0.0 108.86 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.57 63.21 1.5 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.626 1.171 . . . . 0.0 111.014 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 151.16 95.91 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.14 158.43 94.98 Favored 'Cis proline' 0 N--CA 1.448 -1.16 0 CA-C-N 119.721 0.936 . . . . 0.0 109.979 0.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 m -150.13 136.32 18.76 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.62 121.3 43.74 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.196 1.398 . . . . 0.0 108.211 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -115.95 150.36 37.27 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.051 0.94 . . . . 0.0 108.906 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.33 107.05 19.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -93.42 89.0 6.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.934 0.493 . . . . 0.0 111.884 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -90.47 156.46 18.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 69.67 -60.19 0.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.325 2.65 . . . . 0.0 109.485 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.31 28.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.058 2.742 . . . . 0.0 110.198 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.4 p -160.54 143.47 4.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.821 1.31 . . . . 0.0 109.902 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -39.83 97.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.749 2.019 . . . . 0.0 111.312 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.59 -37.55 21.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.404 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -139.15 163.16 33.15 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -160.39 169.45 23.05 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.649 0.78 . . . . 0.0 110.12 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -163.19 150.31 12.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.407 1.483 . . . . 0.0 107.921 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.95 162.87 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.495 1.118 . . . . 0.0 110.729 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.99 176.41 40.73 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.934 0.778 . . . . 0.0 112.565 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.72 40.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.354 1.062 . . . . 0.0 111.576 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -77.27 57.93 1.55 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.618 1.967 . . . . 0.0 110.729 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -50.51 -42.02 54.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.111 1.764 . . . . 0.0 112.217 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -57.66 -48.62 78.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 109.969 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -73.08 -26.8 61.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -54.5 45.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -53.33 -47.88 68.94 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.43 75.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.683 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -56.71 -54.61 44.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.612 0.642 . . . . 0.0 109.685 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.51 -46.36 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.771 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.24 -54.36 46.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.612 0.365 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -54.89 -56.04 23.93 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.519 1.128 . . . . 0.0 111.383 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -74.43 -27.93 60.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.156 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.83 41.86 0.82 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.597 1.09 . . . . 0.0 110.853 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.05 75.0 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.121 0.568 . . . . 0.0 112.085 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.456 1.902 . . . . 0.0 106.186 -179.737 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 CA-C-O 118.209 -1.328 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.39 -86.77 0.25 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -78.48 46.39 0.63 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.715 -0.874 . . . . 0.0 110.418 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 78.5 t -154.23 90.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.63 2.372 . . . . 0.0 105.902 -175.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 pt -145.08 149.56 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.315 0.646 . . . . 0.0 109.761 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.03 55.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.176 1.39 . . . . 0.0 109.022 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.19 -173.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.936 1.294 . . . . 0.0 110.475 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -165.34 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 125.653 1.581 . . . . 0.0 109.156 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -35.57 114.99 0.29 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.56 2.344 . . . . 0.0 113.753 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -42.74 -52.28 5.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.727 1.611 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.17 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.821 -0.549 . . . . 0.0 111.678 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.93 -32.73 67.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.829 -0.545 . . . . 0.0 109.95 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.94 79.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.89 -45.71 91.66 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.05 -53.92 46.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -50.54 38.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.488 1.115 . . . . 0.0 109.416 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.64 -14.38 3.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.897 1.279 . . . . 0.0 113.862 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.33 -63.12 1.39 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.761 1.224 . . . . 0.0 110.695 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -20.86 58.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.43 0.692 . . . . 0.0 112.46 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.09 -19.87 62.0 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.603 -1.109 . . . . 0.0 111.926 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? 67.81 64.88 0.38 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.594 1.558 . . . . 0.0 108.539 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -70.1 56.95 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.806 2.842 . . . . 0.0 111.762 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.65 -52.03 6.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.151 1.38 . . . . 0.0 108.064 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -160.53 75.25 0.56 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.245 1.418 . . . . 0.0 108.106 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -147.17 145.51 22.3 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 121.971 -0.456 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.81 126.7 7.41 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.999 2.466 . . . . 0.0 112.168 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mt -96.15 120.89 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 t -112.36 118.65 58.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.02 118.03 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 122.658 0.383 . . . . 0.0 111.79 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.78 87.08 7.26 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -84.76 93.94 8.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 t -117.89 -177.85 3.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.2 112.92 15.68 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.802 1.241 . . . . 0.0 109.08 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -43.56 -56.97 3.37 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.808 1.243 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -57.73 -31.19 66.19 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 112.496 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.6 t -77.39 85.81 3.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -36.23 -59.21 0.99 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.758 1.17 . . . . 0.0 113.07 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.19 -41.23 73.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.017 2.478 . . . . 0.0 112.986 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 m -68.74 -36.59 78.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.74 -47.58 77.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.284 0.634 . . . . 0.0 109.417 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.4 mtm -58.67 -20.3 46.96 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.4 mt -78.36 -24.85 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.88 -51.48 80.09 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.534 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.9 -36.63 89.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.283 1.851 . . . . 0.0 111.529 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.37 -50.81 72.13 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -56.32 -45.96 80.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.662 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.78 -43.4 90.43 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.445 1.02 . . . . 0.0 110.239 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.3 m -55.43 -48.66 74.09 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.65 -43.93 97.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.195 0.521 . . . . 0.0 109.972 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.451 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . 41.1 m -54.95 -47.23 74.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 111.537 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -67.53 -12.77 61.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.525 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -74.99 -64.53 1.03 Allowed 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.924 1.238 . . . . 0.0 108.773 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.11 38.31 0.47 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.339 -0.85 . . . . 0.0 110.61 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.914 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.6 -64.2 2.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -60.29 -49.05 79.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.854 0.827 . . . . 0.0 110.285 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.5 t -96.76 134.25 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.28 98.78 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.451 ' CZ ' ' HA ' ' A' ' 50' ' ' SER . 96.5 m-85 -91.21 143.19 26.92 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.544 -0.723 . . . . 0.0 110.621 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.42 109.69 5.89 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.257 -170.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -79.67 136.78 36.89 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.6 134.79 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -100.93 104.65 15.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.52 -30.16 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 122.607 0.363 . . . . 0.0 110.611 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.9 -36.4 76.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.506 0.323 . . . . 0.0 110.514 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.65 -69.5 0.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.91 58.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.432 -0.792 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.96 35.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.315 1.046 . . . . 0.0 110.678 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.4 72.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.806 0.842 . . . . 0.0 111.13 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.87 -45.41 91.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.98 -53.8 51.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.409 0.283 . . . . 0.0 111.501 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.46 -42.35 83.18 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.595 -0.691 . . . . 0.0 110.544 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.15 -46.2 90.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.539 0.609 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.64 90.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.938 0.895 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.84 52.44 0.75 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.325 0.964 . . . . 0.0 111.946 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.68 147.92 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.9 p -127.24 -81.42 0.6 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.22 177.89 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.819 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -140.55 139.23 19.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -63.36 153.67 70.99 Favored 'Cis proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.518 1.221 . . . . 0.0 113.987 -3.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.3 m -128.61 126.42 40.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.52 101.0 8.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.529 1.132 . . . . 0.0 109.447 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -97.35 145.39 26.18 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.36 111.53 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.17 104.3 14.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -75.98 105.28 6.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 70.58 -56.11 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.879 2.471 . . . . 0.0 110.673 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -163.47 -13.11 0.03 OUTLIER Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.484 1.992 . . . . 0.0 111.77 177.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 24.6 t -85.67 122.63 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 118.8 1.3 . . . . 0.0 108.204 -177.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.29 94.93 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.2 -35.84 35.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.645 1.178 . . . . 0.0 111.145 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.49 168.28 27.77 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -148.24 167.33 25.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.412 2.285 . . . . 0.0 107.509 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 tp -178.09 138.55 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.205 2.202 . . . . 0.0 106.125 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.13 144.91 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.3 63.69 0.98 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 49.62 -108.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.72 1.208 . . . . 0.0 111.56 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 m 56.84 60.84 2.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.615 1.166 . . . . 0.0 111.003 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -52.01 -36.65 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.583 1.153 . . . . 0.0 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.25 -46.8 88.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.368 0.667 . . . . 0.0 109.72 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -69.02 -35.7 76.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -56.5 -53.68 54.64 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -53.31 -47.42 69.27 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.08 79.88 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.91 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.05 -55.75 29.09 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.497 0.589 . . . . 0.0 109.607 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.59 -47.28 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.84 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.68 -56.44 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.672 0.272 . . . . 0.0 110.295 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -49.37 -62.77 1.36 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.914 1.286 . . . . 0.0 110.773 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -69.79 -22.55 63.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.84 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.21 -44.81 62.39 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.73 53.55 2.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.075 0.55 . . . . 0.0 109.802 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.593 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.17 -107.78 1.08 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.119 0.96 . . . . 0.0 111.37 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -71.85 -20.65 61.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.6 t -102.38 107.06 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.01 146.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 CA-C-N 119.315 0.962 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.84 22.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.317 1.847 . . . . 0.0 108.608 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.27 162.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -78.72 77.94 5.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -59.42 72.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 127.943 2.497 . . . . 0.0 115.45 -170.791 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -92.94 -66.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.121 1.369 . . . . 0.0 108.444 167.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.9 17.14 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.027 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.8 65.1 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.667 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -53.13 18.15 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 109.361 175.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.73 -48.52 68.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.828 0.451 . . . . 0.0 110.895 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.95 -60.92 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.598 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -57.09 -47.37 81.22 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.258 1.023 . . . . 0.0 109.689 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -49.66 -48.92 49.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.034 0.379 . . . . 0.0 110.61 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -63.63 1.08 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.638 0.375 . . . . 0.0 111.011 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.37 -25.87 67.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.822 -0.549 . . . . 0.0 111.951 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 -24.55 71.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.721 -1.044 . . . . 0.0 111.801 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 51.31 67.1 1.0 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.224 1.012 . . . . 0.0 109.752 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 46.12 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.395 1.878 . . . . 0.0 114.489 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -139.89 7.23 2.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.468 0.707 . . . . 0.0 112.803 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.03 129.3 61.87 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.14 122.86 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.608 1.538 . . . . 0.0 112.188 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.34 99.79 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.62 111.31 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.79 125.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.35 98.8 11.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.959 1.304 . . . . 0.0 109.463 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.77 96.83 9.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 t -127.21 -150.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -167.97 161.17 12.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 110.912 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -66.56 -59.67 3.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.749 1.22 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -51.01 -33.69 26.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.471 1.508 . . . . 0.0 114.594 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 p -78.37 57.81 2.0 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.605 1.093 . . . . 0.0 112.051 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.46 -87.65 0.0 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 129.129 3.252 . . . . 0.0 115.398 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -41.2 -37.16 2.77 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.717 3.611 . . . . 0.0 113.979 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -45.05 -45.87 11.11 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.405 1.482 . . . . 0.0 111.335 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -65.23 -21.97 66.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.865 0.866 . . . . 0.0 111.593 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.2 mtt -90.0 -37.51 14.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.999 1.32 . . . . 0.0 109.403 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mt -64.16 -42.52 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 109.382 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -47.98 -53.75 29.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.201 179.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_exo -46.57 -46.9 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.167 3.245 . . . . 0.0 114.186 172.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.08 -49.51 77.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.746 0.784 . . . . 0.0 108.891 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -58.53 -42.33 87.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.152 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.12 -40.63 96.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.026 0.83 . . . . 0.0 109.574 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -58.52 -49.98 75.41 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.75 -36.47 76.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.044 0.449 . . . . 0.0 109.995 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . 0.456 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 41.9 m -60.17 -46.28 90.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.973 -0.454 . . . . 0.0 109.78 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -64.72 -43.8 92.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -47.55 -51.62 20.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.951 0.5 . . . . 0.0 111.675 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -101.54 33.7 2.86 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.377 0.535 . . . . 0.0 111.659 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.58 151.5 10.54 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.565 -0.709 . . . . 0.0 111.681 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 -62.99 3.2 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -55.66 -52.86 62.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.509 0.724 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.8 t -106.75 140.55 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 mm -96.31 131.77 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.456 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 93.8 m-85 -121.79 118.21 28.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.861 0.755 . . . . 0.0 110.778 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -112.44 148.66 33.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.612 1.565 . . . . 0.0 110.072 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -123.22 132.71 54.14 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.42 1.488 . . . . 0.0 107.849 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.23 130.46 39.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 119.171 0.896 . . . . 0.0 109.765 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.54 109.71 21.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.59 -27.38 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.958 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.03 -40.9 97.35 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.608 0.64 . . . . 0.0 109.476 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.51 -63.64 1.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.124 0.57 . . . . 0.0 110.073 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.57 58.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.666 0.746 . . . . 0.0 110.001 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.39 68.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.034 0.934 . . . . 0.0 110.963 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.5 -56.11 22.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.878 0.871 . . . . 0.0 112.16 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.16 -42.62 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.86 63.44 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.7 -38.64 80.43 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.454 -0.779 . . . . 0.0 110.189 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.82 -46.28 89.73 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.564 0.62 . . . . 0.0 109.943 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.92 73.06 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.453 0.701 . . . . 0.0 110.015 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 43.73 4.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.712 1.149 . . . . 0.0 111.208 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.8 mm -79.17 140.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -134.15 -80.35 0.46 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.376 1.07 . . . . 0.0 109.226 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.29 67.21 2.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.261 1.024 . . . . 0.0 111.033 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -63.77 144.77 97.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.168 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.45 148.22 64.43 Favored 'Cis proline' 0 N--CA 1.455 -0.745 0 CA-C-N 120.847 1.338 . . . . 0.0 112.783 -0.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -146.32 122.98 11.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.84 118.9 37.78 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.606 1.162 . . . . 0.0 109.395 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -109.52 150.12 28.62 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.77 107.75 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -99.77 114.31 27.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.648 0.779 . . . . 0.0 111.285 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.57 -170.5 2.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 166.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.481 ' C ' ' H ' ' A' ' 89' ' ' VAL . 25.7 p-10 -67.61 -34.22 76.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.123 -0.985 . . . . 0.0 108.474 165.054 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 41.39 0.97 Allowed Glycine 0 CA--C 1.541 1.709 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.481 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.31 20.1 m 24.45 -139.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.64 1 C-N-CA 133.701 4.8 . . . . 0.0 113.458 -179.178 . . . . . . . . 4 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -54.12 85.14 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.873 1.269 . . . . 0.0 109.616 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.87 40.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.491 0.716 . . . . 0.0 109.856 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.68 161.85 41.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.888 0.475 . . . . 0.0 110.345 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -140.58 165.48 27.34 Favored 'General case' 0 C--N 1.335 -0.048 0 C-N-CA 127.14 2.176 . . . . 0.0 107.731 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.1 tp -172.39 103.9 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.893 1.277 . . . . 0.0 109.785 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.82 162.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.548 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 170.42 27.77 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.423 1.011 . . . . 0.0 112.743 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.45 45.34 0.56 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.465 1.106 . . . . 0.0 110.312 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -77.99 60.11 2.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.051 1.34 . . . . 0.0 111.688 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.39 -46.37 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.56 1.544 . . . . 0.0 113.982 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.63 -48.31 75.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.283 -0.886 . . . . 0.0 110.372 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.6 -38.96 86.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.16 -57.43 13.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -45.38 -53.52 8.52 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.621 0.768 . . . . 0.0 110.213 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.55 -50.81 70.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.321 1.013 . . . . 0.0 111.511 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.98 -46.02 90.82 Favored 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.583 -0.698 . . . . 0.0 110.34 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.33 -46.34 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.9 -52.68 59.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.83 -61.0 2.57 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.104 0.962 . . . . 0.0 111.144 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -64.59 -31.79 73.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.885 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.58 42.67 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.946 0.898 . . . . 0.0 111.154 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.92 -23.0 66.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.347 0.659 . . . . 0.0 112.342 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.538 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.106 0 CA-C-O 119.074 -0.848 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.69 -71.98 0.86 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m -75.83 61.07 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.822 1.649 . . . . 0.0 110.583 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.26 31.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.83 2.052 . . . . 0.0 108.087 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 pt -131.79 -173.1 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.392 1.477 . . . . 0.0 110.677 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.95 115.45 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -155.64 99.54 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 122.343 1.068 . . . . 0.0 109.244 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -91.58 -42.49 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.866 1.266 . . . . 0.0 109.705 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 m -32.86 113.17 0.13 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 115.016 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -40.92 66.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 110.527 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -25.12 64.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.938 0.495 . . . . 0.0 111.885 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.44 -31.63 12.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.123 0.969 . . . . 0.0 110.898 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -45.94 -58.25 3.71 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.48 1.512 . . . . 0.0 112.147 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.95 -44.72 84.2 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.655 -0.653 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.77 -42.85 62.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -56.15 25.58 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.94 1.696 . . . . 0.0 109.085 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.6 mt -49.67 -45.79 49.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 110.481 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.85 -63.46 1.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.135 0.574 . . . . 0.0 111.589 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -57.4 -32.08 66.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.373 0.533 . . . . 0.0 111.082 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.97 55.31 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.113 -1.382 . . . . 0.0 113.031 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? 59.0 69.92 0.69 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -68.64 62.51 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.441 2.696 . . . . 0.0 112.767 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -116.92 -93.16 0.51 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.67 73.48 0.82 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.922 0.889 . . . . 0.0 109.052 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.4 mmtm -140.29 150.31 60.9 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 172.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.13 86.39 0.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 N-CA-C 106.609 -2.112 . . . . 0.0 106.609 168.409 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 3.4 mp -82.24 79.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 173.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.36 137.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 147.23 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -117.6 113.53 22.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.63 112.1 22.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -142.79 179.0 7.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.23 170.62 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.585 1.554 . . . . 0.0 110.812 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.9 p -96.8 -66.49 0.9 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.943 1.697 . . . . 0.0 110.708 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -43.07 -32.38 0.68 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.51 2.324 . . . . 0.0 113.164 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -58.46 -19.55 37.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.482 1.113 . . . . 0.0 113.093 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 -113.44 3.77 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.359 -1.245 . . . . 0.0 110.065 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.89 -42.84 6.78 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.282 3.321 . . . . 0.0 115.207 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -23.09 55.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -71.17 -31.67 67.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.428 -0.795 . . . . 0.0 110.364 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 mmt -61.22 -18.25 57.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.14 0.976 . . . . 0.0 112.467 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 43.6 mt -62.98 -33.43 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.6 6.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.114 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -57.11 -35.99 99.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.801 1.679 . . . . 0.0 112.019 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.34 -55.14 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.399 0.618 . . . . 0.0 109.733 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -56.5 -41.26 76.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.67 0.788 . . . . 0.0 109.522 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.68 -40.61 97.64 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.881 -0.512 . . . . 0.0 110.119 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -60.21 -48.84 80.03 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.51 -39.17 75.94 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.257 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -54.88 -54.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.05 -45.79 79.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.989 0.915 . . . . 0.0 110.771 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.24 -43.14 95.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.759 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -79.42 -45.41 19.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.97 -64.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.76 -119.47 0.01 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.575 2.512 . . . . 0.0 116.92 -170.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 55.37 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.091 -1.24 . . . . 0.0 111.12 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.89 149.46 25.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.042 1.337 . . . . 0.0 110.552 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.72 105.44 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.92 94.39 5.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.604 1.162 . . . . 0.0 108.434 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.9 92.45 5.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.911 1.284 . . . . 0.0 109.824 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -85.25 107.42 17.28 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.233 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.67 149.75 17.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 125.292 1.437 . . . . 0.0 110.255 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.99 115.77 30.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.0 0.92 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.66 -45.8 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 124.867 1.267 . . . . 0.0 110.991 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -58.45 -41.66 85.64 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.03 -70.91 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -87.88 63.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 O-C-N 121.332 -0.855 . . . . 0.0 110.955 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.93 48.3 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.48 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.5 69.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.008 0.923 . . . . 0.0 111.295 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.07 -44.96 97.83 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -55.59 29.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.648 0.379 . . . . 0.0 111.169 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.92 -41.71 97.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.707 0.685 . . . . 0.0 109.831 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.66 77.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.641 0.655 . . . . 0.0 110.528 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 7.76 12.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.12 0.968 . . . . 0.0 111.792 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.38 27.06 70.16 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.211 0.91 . . . . 0.0 113.093 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.88 81.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 122.558 1.171 . . . . 0.0 108.707 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -92.1 -72.58 0.58 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.842 2.057 . . . . 0.0 108.099 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.46 59.94 1.53 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.831 0.852 . . . . 0.0 111.389 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.86 152.18 96.89 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -60.17 147.96 44.01 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 121.016 1.398 . . . . 0.0 112.491 -2.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.8 m -147.35 141.79 26.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 51.8 m-85 -134.34 130.49 37.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.666 1.587 . . . . 0.0 107.917 -176.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -125.3 158.49 34.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.551 1.14 . . . . 0.0 107.925 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.4 122.02 63.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -110.81 76.36 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.107 0.563 . . . . 0.0 111.966 -173.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -90.43 -168.08 2.01 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.349 -0.845 . . . . 0.0 110.285 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.426 ' C ' ' H ' ' A' ' 89' ' ' VAL . 3.3 m-20 -51.23 -43.07 61.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.08 17.86 0.14 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.612 2.053 . . . . 0.0 112.507 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.426 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.277 40.5 t 67.18 -154.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.42 1.488 . . . . 0.0 107.34 170.592 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . 0.409 ' H ' ' CG1' ' A' ' 89' ' ' VAL . 22.5 ttpp -64.29 79.53 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.29 -32.45 43.58 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.622 -166.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -147.19 151.07 36.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -142.97 166.27 25.1 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.081 1.352 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -161.83 140.98 9.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.762 1.225 . . . . 0.0 108.263 -177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 m -127.26 162.68 31.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.485 1.114 . . . . 0.0 110.793 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 179.16 36.76 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.841 -0.799 . . . . 0.0 111.09 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.2 m -80.08 58.86 3.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 -176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -48.92 -46.57 43.27 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.374 . . . . 0.0 111.864 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.36 -48.51 74.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.103 0.561 . . . . 0.0 110.128 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 50.7 tttm -68.8 -35.62 77.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -58.69 -48.71 80.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 109.132 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.98 -47.76 80.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.93 77.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.23 -55.72 31.34 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.0 t -51.08 -53.34 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.24 -52.11 62.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.94 0.496 . . . . 0.0 111.562 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -68.28 0.23 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.471 0.653 . . . . 0.0 110.034 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -61.01 -24.04 65.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.091 -170.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.42 94.45 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.728 0.695 . . . . 0.0 109.696 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.26 -62.94 1.44 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.477 0.711 . . . . 0.0 109.47 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.591 1.556 . . . . 0.0 108.173 -179.845 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.25 80.3 0.5 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.351 0.575 . . . . 0.0 112.028 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -72.48 79.11 1.04 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.132 0.966 . . . . 0.0 109.139 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.71 32.41 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.481 1.512 . . . . 0.0 112.784 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -107.99 154.09 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.35 -0.844 . . . . 0.0 112.392 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.89 135.95 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -160.58 -41.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 122.7 1.238 . . . . 0.0 111.295 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.38 49.36 6.05 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 128.044 2.538 . . . . 0.0 112.241 168.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -131.82 134.73 46.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.578 1.151 . . . . 0.0 107.988 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -49.57 -46.81 49.35 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.754 0.822 . . . . 0.0 111.113 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.92 -11.34 37.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.871 1.268 . . . . 0.0 113.143 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 -33.28 6.91 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.499 1.12 . . . . 0.0 110.075 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -46.79 19.75 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.171 1.388 . . . . 0.0 110.274 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -69.47 -53.39 19.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.012 0.525 . . . . 0.0 109.954 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.68 27.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.608 1.163 . . . . 0.0 111.26 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -44.72 41.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.499 1.52 . . . . 0.0 111.286 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.54 -39.1 93.14 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.704 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.57 -54.13 15.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.039 0.536 . . . . 0.0 109.869 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.5 -28.63 69.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.43 -54.53 33.54 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.767 1.175 . . . . 0.0 111.312 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 103.64 81.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 1 C-N-CA 132.063 4.145 . . . . 0.0 107.665 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -72.83 60.89 0.53 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.641 1.977 . . . . 0.0 110.189 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -119.33 -60.1 1.77 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.947 1.299 . . . . 0.0 108.207 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -152.32 90.9 1.54 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -157.77 152.77 21.36 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -76.36 106.71 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.912 3.075 . . . . 0.0 108.793 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.24 81.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -84.18 120.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 4.0 p -120.62 118.42 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -88.72 96.75 10.79 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.567 1.147 . . . . 0.0 108.958 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -82.25 113.2 19.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 m -141.46 149.47 40.99 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 122.987 0.515 . . . . 0.0 110.041 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 133.21 34.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -50.83 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.63 100.74 5.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.2 133.13 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.479 -0.763 . . . . 0.0 109.003 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.48 150.97 40.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER 50.91 -29.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.445 3.43 . . . . 0.0 118.59 -170.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.2 m -50.73 -45.86 58.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 122.573 2.442 . . . . 0.0 108.354 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -56.06 -26.48 49.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.876 1.67 . . . . 0.0 112.438 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 60.6 mtt -91.15 -43.67 9.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.27 1.428 . . . . 0.0 110.371 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.65 -42.5 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.38 1.472 . . . . 0.0 110.31 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.32 -60.09 9.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.769 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_exo -47.14 -46.9 18.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.643 173.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.96 -55.44 34.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.429 0.633 . . . . 0.0 110.466 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -57.42 -37.91 73.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.023 0.529 . . . . 0.0 109.718 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.62 -38.35 89.2 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.704 -0.623 . . . . 0.0 110.146 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 m -60.9 -46.02 92.3 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.11 -40.49 93.94 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 p -58.7 -41.93 87.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.117 -0.99 . . . . 0.0 109.599 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -39.83 94.96 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.76 -47.91 81.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.773 0.429 . . . . 0.0 110.965 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -79.25 -47.74 15.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.874 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 18.77 73.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.585 2.754 . . . . 0.0 115.238 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.0 -96.76 0.11 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -76.46 46.29 0.42 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.09 1.356 . . . . 0.0 110.686 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.6 m -156.76 161.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.047 -1.033 . . . . 0.0 109.62 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.98 121.35 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 169.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.36 91.48 3.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.624 1.169 . . . . 0.0 107.92 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.96 127.24 34.09 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.273 1.029 . . . . 0.0 110.923 -178.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.34 128.76 44.44 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.0 101.06 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 122.138 0.97 . . . . 0.0 111.388 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.07 104.07 0.84 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.22 -36.18 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.982 1.313 . . . . 0.0 110.018 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -63.16 -28.23 69.91 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.618 0.367 . . . . 0.0 111.104 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.46 -65.8 0.97 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.7 56.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 110.134 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.13 77.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.023 0.929 . . . . 0.0 111.529 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.32 -53.12 48.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.907 0.883 . . . . 0.0 111.657 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.41 -46.57 94.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.26 -57.25 11.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.722 0.237 . . . . 0.0 111.437 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.02 -41.3 97.94 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.415 -0.803 . . . . 0.0 110.703 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.35 98.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.384 0.538 . . . . 0.0 111.367 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.32 81.24 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 0.0 111.151 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.67 82.4 1.35 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.76 139.3 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 126.279 1.832 . . . . 0.0 106.401 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -131.92 -96.11 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.76 71.64 5.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.725 0.81 . . . . 0.0 109.446 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -53.98 143.66 41.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.052 0.941 . . . . 0.0 109.855 178.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 99.9 Cg_exo -57.55 154.98 32.59 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-N 121.131 1.44 . . . . 0.0 113.642 -1.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.9 108.7 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.76 89.94 5.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.635 1.574 . . . . 0.0 110.104 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -80.26 146.15 31.81 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.42 104.58 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -92.68 52.83 1.94 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -50.69 132.14 25.92 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 74.85 -62.19 0.46 Allowed 'General case' 0 CA--C 1.526 0.043 0 C-N-CA 126.835 2.054 . . . . 0.0 108.726 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.71 39.06 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.912 1.244 . . . . 0.0 111.533 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.88 142.22 8.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -60.54 91.23 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 109.945 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.44 -31.56 29.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.224 1.41 . . . . 0.0 110.741 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -150.27 170.87 17.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.609 0.242 . . . . 0.0 111.163 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -150.12 165.07 33.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.448 1.899 . . . . 0.0 107.43 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.9 tp -172.39 108.08 0.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.264 1.426 . . . . 0.0 108.842 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.6 168.04 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.345 0.658 . . . . 0.0 110.446 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.12 -177.76 27.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.38 -65.77 0.63 Allowed 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m 45.45 43.91 9.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 113.046 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -48.59 -44.14 36.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 112.695 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -59.71 -52.32 65.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.21 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.85 -31.55 71.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.21 -59.22 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -53.54 -49.85 66.74 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.258 0.623 . . . . 0.0 110.464 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.84 71.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.067 0.147 . . . . 0.0 110.87 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.37 -46.27 84.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.454 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.77 -48.81 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.794 1.179 . . . . 0.0 108.916 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.72 47.7 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.75 0.42 . . . . 0.0 110.485 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -52.37 -63.23 1.21 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.057 0.943 . . . . 0.0 110.661 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.24 -19.1 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.351 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.29 9.12 37.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.277 0.944 . . . . 0.0 111.385 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.58 76.77 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.295 0.952 . . . . 0.0 111.703 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.502 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 CA-C-O 118.208 -1.329 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.44 -30.85 72.53 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.756 1.278 . . . . 0.0 110.591 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 4.3 m -66.49 71.99 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.098 2.159 . . . . 0.0 113.192 179.55 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.8 m -142.57 31.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.048 2.139 . . . . 0.0 107.179 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.11 147.48 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 125.248 1.419 . . . . 0.0 111.672 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.1 71.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.352 1.061 . . . . 0.0 110.816 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.34 122.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -98.75 -25.15 14.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.336 2.254 . . . . 0.0 113.569 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -38.06 130.11 1.2 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.663 1.585 . . . . 0.0 111.627 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -49.89 -40.39 42.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.049 0.84 . . . . 0.0 112.537 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 -42.6 81.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.749 0.785 . . . . 0.0 110.034 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.18 -33.64 67.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.189 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -57.95 -52.23 66.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -56.2 -50.05 72.32 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.404 0.682 . . . . 0.0 109.939 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.1 61.97 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.869 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.6 -39.14 73.05 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.562 1.145 . . . . 0.0 111.058 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -62.34 -10.5 11.36 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.222 0.609 . . . . 0.0 111.454 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.69 -58.97 1.94 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.645 1.178 . . . . 0.0 109.908 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -9.57 23.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.522 -0.736 . . . . 0.0 112.184 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.53 -26.7 71.02 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt 55.07 51.73 12.93 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.738 1.215 . . . . 0.0 109.475 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -77.18 62.63 2.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.702 1.601 . . . . 0.0 110.218 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.95 -49.77 70.53 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 109.154 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.37 22.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.676 1.99 . . . . 0.0 108.865 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -87.56 160.71 47.14 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.498 1.119 . . . . 0.0 110.723 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.91 120.62 5.85 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.437 2.091 . . . . 0.0 112.255 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.36 92.88 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.64 111.29 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.64 128.96 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -99.84 102.74 14.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.591 2.356 . . . . 0.0 108.461 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.45 96.75 8.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.9 m -136.75 -177.34 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -169.46 -177.83 2.91 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 120.878 1.672 . . . . 0.0 110.147 178.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 p -56.53 -50.17 72.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.931 1.693 . . . . 0.0 109.001 172.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -59.43 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.214 2.605 . . . . 0.0 113.704 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.0 p 170.72 -21.58 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.839 2.456 . . . . 0.0 110.491 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.95 -114.52 5.61 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.088 -1.396 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -41.04 -41.45 4.28 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.502 3.468 . . . . 0.0 115.853 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -27.23 58.02 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.473 0.579 . . . . 0.0 111.57 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -57.99 -23.7 55.07 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.544 -0.723 . . . . 0.0 111.125 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.8 mtm -60.83 -13.72 17.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.778 0.717 . . . . 0.0 111.965 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.84 -30.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.632 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.04 -56.48 25.37 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.629 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.24 -33.46 97.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 122.11 1.789 . . . . 0.0 111.962 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.99 -46.94 76.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.94 -42.72 97.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.579 0.752 . . . . 0.0 110.005 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.4 m -57.62 -47.07 83.22 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.64 -42.25 98.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -52.34 -50.25 62.68 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -41.76 95.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.952 0.501 . . . . 0.0 110.651 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.12 -49.8 75.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.728 0.811 . . . . 0.0 111.315 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.17 -48.18 14.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.176 0.19 . . . . 0.0 110.635 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.91 -73.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.313 1.845 . . . . 0.0 114.133 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.24 -68.7 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.388 0.994 . . . . 0.0 114.23 -172.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -69.88 19.43 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 41.0 t -152.13 154.93 7.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 119.886 1.221 . . . . 0.0 109.43 -178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -116.52 102.87 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.0 m-85 -94.25 98.03 10.65 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.086 0.954 . . . . 0.0 109.278 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.94 121.77 32.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.857 0.463 . . . . 0.0 109.787 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -99.52 115.77 30.12 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.81 119.45 58.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 118.484 0.584 . . . . 0.0 110.868 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.68 100.2 10.07 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 172.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -44.22 -58.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.854 1.662 . . . . 0.0 111.51 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.26 -42.59 86.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.9 0.88 . . . . 0.0 111.574 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.38 -67.9 0.42 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.124 0.42 . . . . 0.0 110.063 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -86.44 63.79 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.926 0.87 . . . . 0.0 109.869 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.2 -40.74 34.64 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.674 1.189 . . . . 0.0 110.615 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.39 77.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.692 0.797 . . . . 0.0 111.048 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.52 -45.07 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.12 35.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.552 0.341 . . . . 0.0 111.435 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.81 -41.12 96.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.26 0.482 . . . . 0.0 109.758 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.31 -41.82 76.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.741 0.7 . . . . 0.0 110.235 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.1 6.9 14.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.48 0.712 . . . . 0.0 112.295 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.94 97.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.023 0.821 . . . . 0.0 112.731 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.0 mm -94.3 153.65 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.5 m -153.64 -57.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.12 159.5 18.18 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.81 158.99 29.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.414 -1.279 . . . . 0.0 107.855 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.34 126.44 3.64 Favored 'Cis proline' 0 C--N 1.35 0.612 0 CA-C-N 121.338 1.514 . . . . 0.0 112.975 -1.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 m -126.87 122.07 33.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.44 129.01 56.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.146 . . . . 0.0 108.521 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -121.3 152.4 38.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.13 94.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -88.65 104.75 17.15 Favored 'General case' 0 C--O 1.227 -0.103 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -77.1 127.65 33.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.28 -64.78 0.32 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.792 2.037 . . . . 0.0 109.136 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 22.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.032 1.777 . . . . 0.0 112.242 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.34 125.63 43.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 119.324 1.562 . . . . 0.0 109.576 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -50.28 97.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.135 1.774 . . . . 0.0 110.782 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.97 -31.07 27.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.294 1.038 . . . . 0.0 110.101 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -160.35 172.89 16.49 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.737 0.815 . . . . 0.0 108.9 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.48 -179.28 7.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.115 0.966 . . . . 0.0 109.284 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -164.96 106.18 0.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 106.951 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.56 32.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.0 1.32 . . . . 0.0 113.075 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 168.73 37.19 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.187 -0.946 . . . . 0.0 112.661 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.92 38.55 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.298 1.439 . . . . 0.0 112.942 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.3 m -81.4 70.92 8.37 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 120.649 -1.282 . . . . 0.0 109.717 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -39.62 -52.06 2.23 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.826 1.651 . . . . 0.0 113.757 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.57 -44.19 93.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.81 -0.556 . . . . 0.0 110.959 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -65.32 -41.57 93.85 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -51.81 -58.01 7.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.938 1.295 . . . . 0.0 108.187 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.49 -52.68 58.78 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.92 0.888 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.25 71.24 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.8 mt -58.66 -51.37 70.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.18 -48.88 81.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.489 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.9 61.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.599 0.36 . . . . 0.0 110.864 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -56.21 -65.09 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.122 0.969 . . . . 0.0 110.417 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -64.42 -24.44 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.455 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.5 2.84 23.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.951 0.796 . . . . 0.0 112.033 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.95 48.72 0.73 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.031 1.287 . . . . 0.0 111.462 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 116.65 -1.643 . . . . 0.0 107.465 179.098 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.6 92.72 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 m -68.55 69.56 0.16 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.49 1.916 . . . . 0.0 112.429 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.3 t -131.66 92.38 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 174.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -136.96 176.06 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.247 0.546 . . . . 0.0 112.406 -171.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.08 22.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.516 1.526 . . . . 0.0 110.939 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -82.03 78.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.99 64.24 0.33 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.413 1.885 . . . . 0.0 109.631 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.6 m -153.12 167.82 27.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.19 1.396 . . . . 0.0 109.469 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -39.77 -42.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.695 1.998 . . . . 0.0 112.339 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.5 -41.12 9.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 112.037 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.01 62.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.578 -0.701 . . . . 0.0 109.944 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -53.96 -40.25 66.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.98 0.912 . . . . 0.0 112.198 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.06 -72.62 0.71 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.49 -55.68 23.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.257 0.623 . . . . 0.0 111.899 -173.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.96 -50.18 73.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -47.19 -50.13 21.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.891 0.476 . . . . 0.0 110.762 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.37 -58.35 8.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.118 0.567 . . . . 0.0 111.147 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.47 -19.4 63.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.561 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.18 49.2 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.751 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 57.56 65.76 1.28 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.026 1.413 . . . . 0.0 109.837 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 68.13 1.86 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 109.839 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.01 -51.79 35.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -163.48 22.59 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.38 1.872 . . . . 0.0 109.487 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -69.31 144.47 94.83 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 121.865 -0.522 . . . . 0.0 111.674 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.81 92.39 0.52 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.539 1.493 . . . . 0.0 108.844 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.5 111.65 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.52 123.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.3 104.22 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.832 0.853 . . . . 0.0 110.282 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.97 90.55 5.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.274 1.03 . . . . 0.0 109.395 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.11 113.35 18.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -139.55 146.89 40.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -77.58 107.48 10.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.8 m -58.44 -36.65 73.98 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.795 0.725 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 37.1 p-90 -60.91 -32.39 71.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.466 0.706 . . . . 0.0 110.572 175.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -78.89 77.08 5.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.58 -54.09 2.84 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.524 1.059 . . . . 0.0 112.184 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.49 -45.49 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.094 2.529 . . . . 0.0 112.75 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.16 -45.56 90.67 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -61.49 -13.01 17.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.753 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.92 -12.87 60.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 121.556 1.98 . . . . 0.0 111.128 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.79 -23.83 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 118.714 0.688 . . . . 0.0 109.306 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.55 -47.04 97.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.71 -1.244 . . . . 0.0 112.644 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.35 -35.43 73.07 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.347 1.874 . . . . 0.0 110.795 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.27 -46.26 89.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.75 -46.4 81.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.01 -41.97 88.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.567 0.747 . . . . 0.0 109.974 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -60.17 -44.83 94.72 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.0 tp -62.51 -38.02 88.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.081 -0.387 . . . . 0.0 110.036 177.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.5 m -60.08 -48.67 80.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.401 0.68 . . . . 0.0 109.757 176.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -59.4 -45.19 92.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.944 0.497 . . . . 0.0 109.667 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.11 -56.77 17.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.734 0.414 . . . . 0.0 110.501 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -86.19 58.02 4.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.23 -20.73 66.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.649 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -149.44 0.05 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.591 1.567 . . . . 0.0 113.959 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 53.53 0.84 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 113.012 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.91 140.01 49.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.323 1.849 . . . . 0.0 106.183 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.1 mm -112.91 134.64 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -126.41 111.81 14.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.673 0.67 . . . . 0.0 110.04 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.59 147.21 37.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.307 1.443 . . . . 0.0 108.949 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -118.23 144.14 46.0 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.93 126.29 37.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -83.88 117.76 23.53 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.8 72.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 177.69 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.543 2.737 . . . . 0.0 105.759 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.02 65.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.457 0.303 . . . . 0.0 110.414 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.16 39.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.57 -49.59 26.12 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.224 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.21 -47.43 62.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.462 0.705 . . . . 0.0 112.252 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.49 -46.7 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.46 78.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.061 0.458 . . . . 0.0 110.271 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -57.46 -58.92 6.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.25 1.02 . . . . 0.0 109.519 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.9 73.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.814 0.446 . . . . 0.0 111.23 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.04 -17.89 63.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.707 0.803 . . . . 0.0 111.578 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 44.27 13.69 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.71 0.671 . . . . 0.0 111.436 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.0 mm -74.37 139.72 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.4 p -124.52 -85.08 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.509 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.67 86.3 6.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.434 1.094 . . . . 0.0 111.402 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -62.64 145.01 95.78 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.462 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.91 153.05 72.97 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.62 1.257 . . . . 0.0 111.634 -2.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -145.38 114.69 7.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.52 119.74 35.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.593 1.157 . . . . 0.0 109.382 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -111.2 134.9 52.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.99 109.44 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.76 97.64 7.44 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.658 0.383 . . . . 0.0 111.788 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -90.3 -165.22 1.3 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.479 ' C ' ' H ' ' A' ' 89' ' ' VAL . 19.3 p-10 -69.63 -36.68 76.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 169.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.5 41.37 1.16 Allowed Glycine 0 CA--C 1.543 1.808 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 166.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . 0.479 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.333 25.3 m 20.89 -134.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.448 1 C-N-CA 133.008 4.523 . . . . 0.0 113.482 -178.105 . . . . . . . . 4 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -58.18 79.06 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.338 1.455 . . . . 0.0 109.032 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -29.21 39.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.41 1.084 . . . . 0.0 111.589 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -158.34 157.4 32.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -147.05 158.87 44.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.0 tp -155.52 109.58 2.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 109.882 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.68 168.54 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 110.562 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.66 178.43 40.4 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.388 0.518 . . . . 0.0 112.208 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.74 -59.04 4.98 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 110.196 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 33.49 21.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.0 3.32 . . . . 0.0 119.237 171.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.0 pm0 -51.51 -40.59 59.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.279 1.4 . . . . 0.0 111.846 -179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.69 -36.42 69.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.848 -0.533 . . . . 0.0 111.203 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.66 -38.23 26.23 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.2 tp -45.81 -51.33 13.01 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.36 0.664 . . . . 0.0 109.508 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -41.5 -52.87 3.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 0.0 111.759 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.68 79.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.45 1.1 . . . . 0.0 110.725 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -49.12 79.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.6 t -57.83 -46.99 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.29 -53.26 46.4 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -54.98 -62.33 1.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.221 1.008 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -62.65 -22.21 66.28 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.72 -5.15 54.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.79 0.723 . . . . 0.0 112.126 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.91 49.56 0.93 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.831 1.196 . . . . 0.0 111.328 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.763 1.625 . . . . 0.0 107.426 179.566 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.0 -58.6 3.55 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 m -64.46 96.31 0.16 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.663 1.185 . . . . 0.0 110.983 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.7 26.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.335 1.854 . . . . 0.0 108.719 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 pp -97.94 175.31 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.66 122.69 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.24 2.216 . . . . 0.0 108.051 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 tt -160.63 151.32 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.772 0.714 . . . . 0.0 109.666 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -74.75 72.61 2.02 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -55.56 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 129.233 3.013 . . . . 0.0 115.556 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -93.78 -94.86 0.16 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.906 1.282 . . . . 0.0 109.596 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.73 77.06 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.453 -1.404 . . . . 0.0 109.314 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.9 69.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.14 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -50.29 71.83 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.48 1.037 . . . . 0.0 108.402 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -48.75 79.67 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.66 -49.39 75.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.386 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.57 64.68 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.554 0.742 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -49.42 -54.54 16.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 -62.36 1.74 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.924 0.489 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -59.61 -29.03 67.71 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.423 0.556 . . . . 0.0 111.103 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.41 67.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.091 -1.394 . . . . 0.0 112.916 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.33 55.01 10.13 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.995 1.398 . . . . 0.0 108.754 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -38.75 -31.57 0.06 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.56 3.144 . . . . 0.0 116.377 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -9.06 -74.09 0.0 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 129.464 3.106 . . . . 0.0 111.208 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -138.83 74.07 1.46 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -165.51 121.98 1.03 Allowed Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 133.98 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.057 1.838 . . . . 0.0 113.76 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.35 102.21 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 101.203 -3.628 . . . . 0.0 101.203 169.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 t -99.95 120.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -173.496 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.68 104.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 124.935 1.294 . . . . 0.0 110.636 -173.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -83.46 95.73 8.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.301 1.44 . . . . 0.0 107.925 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -80.19 122.81 27.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -146.51 168.24 21.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.66 114.85 23.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.895 0.77 . . . . 0.0 108.95 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -43.36 -57.0 3.24 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.193 1.397 . . . . 0.0 113.128 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -59.19 -30.67 68.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.076 0.551 . . . . 0.0 112.192 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.9 t -76.06 84.71 2.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.24 -59.73 0.76 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.95 1.262 . . . . 0.0 112.942 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.7 -40.6 79.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.163 2.575 . . . . 0.0 113.025 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -67.1 -43.95 81.23 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -62.77 -43.3 99.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.998 0.519 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.6 mmm -58.99 -17.49 25.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt -79.14 -24.45 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 119.193 0.906 . . . . 0.0 109.79 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.36 -55.05 41.4 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 117.453 -1.26 . . . . 0.0 112.272 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.73 94.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.205 1.937 . . . . 0.0 111.686 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.98 -52.9 63.76 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -60.54 -37.47 81.31 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.717 -0.615 . . . . 0.0 109.898 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.35 -35.52 75.85 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.297 -0.877 . . . . 0.0 109.861 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -61.23 -47.49 85.81 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.89 -39.63 90.02 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -55.89 -51.98 65.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.868 0.467 . . . . 0.0 109.857 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -39.9 94.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.159 0.584 . . . . 0.0 109.888 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.02 -46.54 85.12 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.031 0.532 . . . . 0.0 111.35 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -79.65 -53.17 7.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 -56.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.161 2.184 . . . . 0.0 115.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.49 -116.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.823 2.154 . . . . 0.0 115.688 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -40.4 -45.37 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.14 136.97 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 O-C-N 122.209 -0.307 . . . . 0.0 110.189 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.22 125.81 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 175.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -112.72 143.86 43.23 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.64 118.67 7.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.593 -167.794 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -106.28 118.2 36.02 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.85 134.4 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.389 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -85.39 106.66 16.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.424 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.41 -38.99 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 126.473 1.909 . . . . 0.0 109.791 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.96 -34.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.076 0.151 . . . . 0.0 111.29 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.65 -72.25 0.44 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.17 61.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 121.502 -0.749 . . . . 0.0 110.495 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.49 -41.25 53.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.501 0.72 . . . . 0.0 109.9 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.46 68.66 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.13 0.972 . . . . 0.0 111.112 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.11 -45.98 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -54.81 38.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.859 0.464 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.12 -40.09 82.61 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 110.646 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.07 89.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.521 0.601 . . . . 0.0 110.215 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.02 95.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.288 0.635 . . . . 0.0 109.833 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.01 47.09 0.73 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.58 1.086 . . . . 0.0 112.583 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.07 132.22 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.7 p -112.31 -76.79 0.59 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.31 149.39 22.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.512 1.125 . . . . 0.0 108.89 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.69 143.37 33.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -72.26 170.6 66.89 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 C-N-CA 125.144 -0.773 . . . . 0.0 112.588 -1.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 129.68 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -106.1 118.09 35.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.962 1.305 . . . . 0.0 110.58 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -112.38 144.21 42.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 118.824 0.738 . . . . 0.0 110.195 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.39 124.16 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.21 60.78 0.69 Allowed 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 124.763 1.289 . . . . 0.0 110.803 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -71.11 149.15 46.74 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.72 -52.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.248 1.819 . . . . 0.0 112.265 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.37 -57.93 0.22 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.76 164.04 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.106 0.563 . . . . 0.0 109.569 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -56.64 104.01 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.98 -39.65 29.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.097 0.959 . . . . 0.0 110.711 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -161.0 168.01 25.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.06 177.49 10.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.37 0.532 . . . . 0.0 109.914 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 tp -162.54 110.85 1.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.079 1.352 . . . . 0.0 109.404 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.1 161.61 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 0.0 110.989 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.6 -177.91 54.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.605 0.622 . . . . 0.0 112.601 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.18 34.99 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 109.307 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 m 30.82 46.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 115.124 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -59.15 -44.23 92.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 112.246 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -54.52 -53.6 52.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.45 0.7 . . . . 0.0 110.388 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.73 -37.1 76.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.1 tp -53.85 -51.96 61.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -52.39 -48.58 65.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.02 0.373 . . . . 0.0 110.18 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.24 86.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.232 0.213 . . . . 0.0 110.699 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.46 -50.49 67.27 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.66 -0.65 . . . . 0.0 110.37 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.57 -47.35 48.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.34 78.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.302 0.376 . . . . 0.0 111.207 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -49.14 -54.58 15.63 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.328 1.051 . . . . 0.0 110.77 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -75.93 -46.97 27.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.625 0.25 . . . . 0.0 111.454 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.31 -32.79 73.17 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.606 1.162 . . . . 0.0 113.179 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.88 45.76 14.8 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.877 1.271 . . . . 0.0 108.881 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.712 2.005 . . . . 0.0 106.449 -179.354 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 CA-C-O 119.228 -0.762 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.29 -56.21 0.61 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.282 1.42 . . . . 0.0 110.632 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -68.47 78.26 0.27 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.66 94.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 pt -152.75 169.12 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.874 0.845 . . . . 0.0 110.861 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.27 149.02 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -150.42 155.4 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 119.329 0.968 . . . . 0.0 110.471 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -137.7 36.3 2.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.958 1.303 . . . . 0.0 111.455 -175.39 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 m -157.28 127.01 6.14 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.164 -0.96 . . . . 0.0 111.162 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -51.85 -45.67 64.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.353 1.061 . . . . 0.0 110.428 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.15 59.6 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.212 0.53 . . . . 0.0 110.481 -178.105 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.32 90.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -52.19 65.73 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -64.49 -45.41 87.46 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.103 -178.567 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.47 65.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.969 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.87 -50.09 75.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.566 0.746 . . . . 0.0 110.256 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -46.94 -49.76 20.06 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.703 0.401 . . . . 0.0 109.927 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -65.97 0.61 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -58.77 -31.04 68.02 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.605 -0.685 . . . . 0.0 111.848 -174.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.5 -24.67 39.59 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.35 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 45.98 8.38 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.125 1.37 . . . . 0.0 109.911 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.64 40.0 0.36 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -174.354 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -15.2 -63.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.727 2.811 . . . . 0.0 113.399 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -142.74 23.14 1.94 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.885 1.674 . . . . 0.0 109.112 177.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.87 153.15 37.9 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.589 0.756 . . . . 0.0 111.192 -171.486 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -71.76 133.14 21.4 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.845 1.697 . . . . 0.0 114.124 -177.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.21 116.65 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 100.964 -3.717 . . . . 0.0 100.964 167.32 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.4 t -102.64 111.44 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -174.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.56 136.77 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.15 89.84 3.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 168.997 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.44 99.0 7.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.598 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 m -136.13 151.74 50.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.789 1.636 . . . . 0.0 107.1 178.861 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.44 -178.82 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.988 0.915 . . . . 0.0 111.114 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 p -77.2 -63.33 1.39 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.678 1.591 . . . . 0.0 106.84 174.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -61.28 147.47 44.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.744 174.342 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.7 t 136.24 -59.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 129.212 3.005 . . . . 0.0 107.766 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.28 -92.87 1.02 Allowed Glycine 0 CA--C 1.53 1.025 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.07 -40.73 15.83 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.971 3.114 . . . . 0.0 113.523 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -44.64 -43.52 8.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.577 1.151 . . . . 0.0 110.905 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -58.59 -33.75 70.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.596 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.35 -18.93 65.7 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -177.514 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 2.1 mp -76.99 -27.33 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.125 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.96 -57.04 13.72 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.474 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.37 -41.2 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.904 1.716 . . . . 0.0 112.016 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.4 -51.6 69.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.752 0.787 . . . . 0.0 109.493 178.313 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.6 -49.15 75.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.236 1.014 . . . . 0.0 109.835 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.79 -41.22 90.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.828 0.851 . . . . 0.0 110.792 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -57.41 -50.6 72.48 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.39 -44.77 89.11 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 121.051 0.453 . . . . 0.0 110.227 176.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -50.98 -46.23 61.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.231 0.612 . . . . 0.0 111.162 -177.394 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -54.14 -30.47 49.17 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.85 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.09 -52.34 36.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.77 0.714 . . . . 0.0 111.221 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -90.95 -13.37 33.58 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -19.37 -61.85 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 129.192 2.997 . . . . 0.0 115.69 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -50.51 -47.77 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.415 0.531 . . . . 0.0 111.831 -177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -86.16 -60.3 2.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.238 0.615 . . . . 0.0 110.498 -178.117 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -88.02 146.48 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.431 2.292 . . . . 0.0 112.825 -169.589 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.49 146.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -135.42 113.61 11.36 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.69 101.28 7.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.51 1.124 . . . . 0.0 111.189 -175.67 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -79.85 94.63 5.85 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.1 t -79.39 117.91 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -67.93 102.22 1.23 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.28 -34.23 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.499 1.12 . . . . 0.0 110.477 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.76 -28.0 69.68 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.337 0.255 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 -65.87 0.94 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.569 0.748 . . . . 0.0 110.856 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.01 60.71 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.879 0.847 . . . . 0.0 110.172 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.5 76.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.906 0.882 . . . . 0.0 110.526 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.64 -55.85 22.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 111.867 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -44.78 98.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.73 38.15 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.653 0.263 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.71 -41.17 88.39 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.217 -0.927 . . . . 0.0 110.491 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.49 92.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.548 0.613 . . . . 0.0 110.531 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.02 77.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.003 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.52 48.61 1.28 Allowed Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.661 1.124 . . . . 0.0 111.508 175.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.8 136.35 23.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.2 p -140.18 -76.65 0.33 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.0 0.92 . . . . 0.0 108.656 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.44 73.6 1.39 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.547 1.139 . . . . 0.0 110.577 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.08 138.75 96.29 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.337 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -64.78 130.52 10.66 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 CA-C-N 121.068 1.417 . . . . 0.0 112.731 -0.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.5 m -120.62 105.0 10.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.131 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.07 132.08 34.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.216 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -124.25 150.06 45.75 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.849 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.78 113.09 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.77 125.54 54.11 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.437 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.36 112.57 20.04 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 176.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 69.71 -64.03 0.36 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.984 2.514 . . . . 0.0 109.161 -173.4 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.95 7.21 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.975 1.75 . . . . 0.0 112.468 177.871 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.18 117.09 44.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-N 118.996 1.398 . . . . 0.0 107.526 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -56.48 111.2 0.93 Allowed 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.81 -32.21 10.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.341 1.057 . . . . 0.0 111.154 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.55 172.36 17.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.833 0.288 . . . . 0.0 110.53 -177.845 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -160.46 168.39 25.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.813 1.245 . . . . 0.0 108.856 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 tp -167.87 120.36 0.88 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.804 0.842 . . . . 0.0 109.603 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.4 163.28 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.239 0.616 . . . . 0.0 111.312 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.5 174.85 46.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.716 1.15 . . . . 0.0 111.951 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.32 43.35 0.37 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 110.72 178.555 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 m -79.35 54.12 1.64 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.926 1.69 . . . . 0.0 110.287 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -36.51 63.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.019 0.927 . . . . 0.0 112.445 -175.365 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -61.44 -51.58 68.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.533 0.733 . . . . 0.0 109.861 177.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -68.43 -32.97 73.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.09 -56.22 24.54 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.438 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -50.61 -50.61 53.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.111 0.564 . . . . 0.0 110.403 177.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.55 71.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.42 -48.17 82.42 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.787 -0.571 . . . . 0.0 110.378 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.7 t -54.92 -51.05 57.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.78 -51.19 61.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.436 0.295 . . . . 0.0 110.926 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -53.87 -66.66 0.36 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.041 0.924 . . . . 0.0 110.507 178.017 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -59.33 -31.71 69.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.409 -174.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.09 -2.64 28.46 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.81 52.4 1.03 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.965 1.257 . . . . 0.0 111.277 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.573 1.549 . . . . 0.0 107.765 179.611 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.632 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.17 57.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 118.642 1.221 . . . . 0.0 112.081 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 63.71 1.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.421 1.088 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 76.3 t -79.38 85.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.005 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -144.91 167.29 10.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.541 0.686 . . . . 0.0 111.287 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.8 p -111.85 134.7 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 174.05 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -153.61 162.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.913 0.863 . . . . 0.0 110.475 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -126.95 11.73 7.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.134 1.774 . . . . 0.0 112.648 -173.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -124.28 114.45 19.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.786 0.435 . . . . 0.0 111.65 -174.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -47.82 -40.59 21.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.006 1.322 . . . . 0.0 111.775 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.1 70.23 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.089 0.955 . . . . 0.0 111.058 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.31 74.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.936 -0.478 . . . . 0.0 109.802 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -50.86 68.09 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.413 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.09 -49.79 76.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.99 0.916 . . . . 0.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.41 -57.02 11.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.001 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -54.51 -44.8 73.04 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.539 0.736 . . . . 0.0 110.221 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -23.2 2.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.012 0.925 . . . . 0.0 112.046 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.47 -68.38 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 110.636 175.163 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -61.91 -23.0 66.05 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -171.487 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.57 -12.53 64.21 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.986 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 59.9 69.1 0.73 Allowed 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.53 2.13 23.27 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.176 -172.27 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -10.24 -65.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 129.742 3.217 . . . . 0.0 113.602 -176.115 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -146.39 57.27 1.18 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -118.48 136.61 24.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.021 . . . . 0.0 109.274 -177.083 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.25 114.87 4.14 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.146 1.898 . . . . 0.0 110.743 177.187 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.38 98.33 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 171.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.42 116.72 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.07 114.92 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 117.964 0.347 . . . . 0.0 110.296 -176.856 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -92.65 85.7 5.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 172.309 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.69 105.83 11.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -166.12 -159.79 0.4 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.754 0.706 . . . . 0.0 112.22 -171.562 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 64.1 -135.27 0.32 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 112.563 172.839 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p 54.61 -107.43 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.083 1.753 . . . . 0.0 109.537 -175.463 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -72.8 -26.63 61.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.919 0.487 . . . . 0.0 111.451 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.16 82.78 1.81 Allowed 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.53 -0.731 . . . . 0.0 111.056 -175.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 -56.63 8.27 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.976 0.798 . . . . 0.0 111.972 176.328 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.74 -37.07 64.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.977 2.451 . . . . 0.0 113.447 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.7 m -59.24 -26.0 64.52 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.609 0.364 . . . . 0.0 111.032 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -58.8 -20.63 51.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.498 0.59 . . . . 0.0 110.932 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.6 mmt -82.73 -31.3 28.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.812 0.733 . . . . 0.0 110.697 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.69 -33.5 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.83 -59.41 4.71 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.256 1.022 . . . . 0.0 113.168 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -59.76 -38.57 79.74 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.182 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.75 -54.16 45.65 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -57.91 -41.12 81.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -57.19 -37.41 72.13 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.728 -0.653 . . . . 0.0 112.381 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -59.87 -51.92 67.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.447 1.476 . . . . 0.0 110.002 178.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -57.87 -41.42 82.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.69 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.6 m -52.72 -54.95 26.58 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -41.17 86.16 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.325 0.65 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.14 -53.92 52.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.128 0.571 . . . . 0.0 111.429 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -81.05 -21.42 40.11 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -21.45 110.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.504 2.322 . . . . 0.0 115.713 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.01 -71.08 0.39 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 174.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.35 24.84 2.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.945 0.898 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.42 161.12 4.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.801 1.64 . . . . 0.0 107.951 -174.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 93.79 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.99 94.97 10.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.257 0.623 . . . . 0.0 109.801 -178.884 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 111.93 23.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.009 1.323 . . . . 0.0 110.754 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.9 mtpp -91.65 109.34 20.65 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 174.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.62 122.49 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.08 81.13 3.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.848 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.8 m -39.92 -47.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 126.988 2.115 . . . . 0.0 114.176 -176.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.23 -40.57 67.82 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.039 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.57 -48.59 14.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 95.1 t -80.95 51.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.241 1.02 . . . . 0.0 108.849 179.3 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.69 -58.13 9.4 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.841 1.656 . . . . 0.0 112.857 -173.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.12 -52.0 54.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -176.418 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 84.0 t -62.91 -48.38 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.518 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.25 69.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.412 0.285 . . . . 0.0 110.283 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.63 -56.62 19.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.219 1.008 . . . . 0.0 110.007 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.8 -41.26 73.89 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.444 0.298 . . . . 0.0 111.118 -178.356 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 3.29 19.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.332 1.053 . . . . 0.0 111.905 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.1 41.8 94.8 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.011 -1.056 . . . . 0.0 113.412 176.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.7 137.62 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 p -148.9 -80.24 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.57 78.3 1.47 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.15 0.98 . . . . 0.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.73 139.43 88.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.73 132.38 22.06 Favored 'Cis proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.479 1.207 . . . . 0.0 110.595 -1.659 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 m -109.27 111.89 23.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -99.61 108.27 20.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.21 1.004 . . . . 0.0 109.197 -177.063 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -107.87 160.82 15.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.98 0.809 . . . . 0.0 109.891 177.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.02 110.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.42 108.4 19.72 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 175.776 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -83.97 109.56 17.72 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 71.4 -60.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.811 2.044 . . . . 0.0 110.807 -176.761 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.41 -41.0 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.219 1.39 . . . . 0.0 111.344 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.59 134.53 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.131 0.966 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -66.55 101.9 0.83 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.371 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.51 -32.43 25.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.111 0.964 . . . . 0.0 111.336 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.82 169.08 25.42 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -144.11 161.14 39.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.728 2.011 . . . . 0.0 107.285 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 tp -174.05 152.93 1.98 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.85 165.18 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 110.138 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 -179.08 39.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.184 0.897 . . . . 0.0 111.833 177.193 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.73 44.24 0.36 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.862 0.865 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m -81.22 61.37 4.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 109.688 -176.576 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.09 -42.73 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.922 0.889 . . . . 0.0 112.034 -175.619 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -57.82 -50.33 73.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.06 177.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -66.19 -40.32 90.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.27 -55.25 30.04 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.8 -51.28 61.42 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.442 0.297 . . . . 0.0 110.2 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.26 74.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.339 0.256 . . . . 0.0 111.298 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.82 -49.04 74.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.262 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.22 -54.33 18.26 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.504 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.6 -55.0 21.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.579 0.351 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.93 -64.78 0.71 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.463 0.705 . . . . 0.0 110.988 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -66.51 -19.98 65.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.086 0.954 . . . . 0.0 112.601 -173.62 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.02 -40.09 22.59 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.602 -0.686 . . . . 0.0 109.246 174.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.28 70.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.383 0.673 . . . . 0.0 112.147 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.456 -1.259 . . . . 0.0 109.52 -178.685 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.87 -7.2 88.71 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 174.994 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -51.69 105.81 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.76 2.424 . . . . 0.0 114.018 -178.035 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.32 29.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.777 2.031 . . . . 0.0 108.202 174.634 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.02 170.94 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -169.915 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.71 13.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.333 1.853 . . . . 0.0 111.404 178.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.06 73.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.69 -17.8 64.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.834 -174.464 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -38.13 117.59 0.62 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.413 1.485 . . . . 0.0 110.601 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 20.3 ptmt -39.42 -44.04 1.3 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -173.815 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -51.07 71.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.467 0.651 . . . . 0.0 110.328 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.224 1.01 . . . . 0.0 109.697 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -48.16 -61.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.268 1.427 . . . . 0.0 108.483 175.291 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -55.82 -50.23 71.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.703 0.401 . . . . 0.0 110.286 -178.291 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.19 77.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.424 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -63.55 -47.34 81.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.294 1.038 . . . . 0.0 109.369 -177.774 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -56.96 -55.47 34.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.272 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.63 -58.82 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.989 0.516 . . . . 0.0 112.067 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -65.89 -14.2 61.06 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.646 -0.658 . . . . 0.0 111.457 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.52 -24.1 70.77 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.395 -1.225 . . . . 0.0 111.917 177.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 57.55 73.02 0.48 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.607 1.163 . . . . 0.0 109.319 -179.179 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.39 52.14 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.631 2.372 . . . . 0.0 113.35 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.57 -59.77 3.33 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.519 -0.738 . . . . 0.0 109.158 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.14 95.42 1.61 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -167.43 139.17 2.59 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.388 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 126.02 8.51 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.8 1.667 . . . . 0.0 111.525 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.4 mp -88.98 94.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 102.197 -3.261 . . . . 0.0 102.197 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.8 110.37 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -176.941 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.73 130.23 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.552 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -92.83 95.92 9.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.952 2.501 . . . . 0.0 106.985 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -88.86 100.53 13.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.943 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -127.47 -162.39 1.16 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.22 1.008 . . . . 0.0 108.369 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.24 117.71 2.87 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 120.155 1.343 . . . . 0.0 113.341 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -36.66 -46.79 0.61 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.498 1.519 . . . . 0.0 110.423 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -48.29 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.315 1.446 . . . . 0.0 113.685 177.68 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.24 35.34 1.62 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.221 0.464 . . . . 0.0 111.808 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 25.24 -88.35 0.01 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 128.411 2.91 . . . . 0.0 115.234 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -42.05 -40.77 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.869 3.046 . . . . 0.0 113.837 177.049 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.62 -36.97 79.93 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.711 0.404 . . . . 0.0 110.571 178.134 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -77.08 -31.16 55.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.845 0.858 . . . . 0.0 109.309 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -63.85 -4.1 2.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.061 0.544 . . . . 0.0 112.366 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.24 -23.87 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.222 0.919 . . . . 0.0 108.79 171.439 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.02 -53.84 43.89 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 120.89 -1.131 . . . . 0.0 112.339 177.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.15 -30.45 91.39 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.944 1.763 . . . . 0.0 111.982 176.627 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.58 -48.44 66.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.16 -35.07 69.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.404 1.081 . . . . 0.0 110.404 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -50.26 -34.01 21.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 110.418 176.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -57.67 -54.93 41.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 -41.61 99.18 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -49.14 -54.64 15.33 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -56.15 -57.72 10.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.734 0.814 . . . . 0.0 109.73 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -49.7 -44.21 47.96 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.267 1.027 . . . . 0.0 112.474 -174.623 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -95.39 -1.76 50.39 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.23 136.09 25.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.33 0.968 . . . . 0.0 111.461 -177.286 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.02 -67.01 0.53 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -81.43 -50.93 8.86 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 122.124 -0.633 . . . . 0.0 110.544 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.93 174.34 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.386 1.074 . . . . 0.0 112.75 -169.473 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 mm -129.92 94.7 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 174.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.94 138.87 31.1 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.93 126.24 23.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.74 0.816 . . . . 0.0 110.932 -174.131 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -100.65 119.93 39.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.74 134.98 64.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 123.014 0.526 . . . . 0.0 111.377 -176.993 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.23 95.61 7.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.117 1.367 . . . . 0.0 107.352 177.557 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -49.1 -41.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.978 2.511 . . . . 0.0 110.892 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.19 -22.34 66.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.8 0.84 . . . . 0.0 111.421 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.96 -72.4 0.65 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.936 0.894 . . . . 0.0 108.997 175.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 63.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.956 1.36 . . . . 0.0 109.392 -177.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.55 81.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.869 177.005 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.92 -43.38 18.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.568 1.547 . . . . 0.0 112.037 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.9 t -75.29 -57.39 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -43.66 -52.08 6.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.347 1.059 . . . . 0.0 113.293 -175.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.54 -35.01 69.76 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.783 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.81 20.93 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.81 -45.93 90.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.497 1.119 . . . . 0.0 111.741 -178.303 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.38 79.96 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.54 151.88 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.726 1.21 . . . . 0.0 108.37 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.9 p -119.89 -109.39 0.35 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 132.37 35.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.709 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -76.13 131.95 74.61 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -78.6 138.08 48.42 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.034 1.048 . . . . 0.0 112.789 -1.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.5 m -111.71 115.51 29.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 167.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -95.88 130.2 42.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 108.545 -179.89 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -122.62 150.37 42.74 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.08 113.33 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.022 1.329 . . . . 0.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -107.39 137.46 45.39 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -90.82 -100.2 0.11 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.863 1.21 . . . . 0.0 110.279 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.25 -42.55 66.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.862 1.315 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.0 -27.33 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.07 2.271 . . . . 0.0 109.726 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.11 135.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.529 1.165 . . . . 0.0 110.893 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -52.18 112.43 0.8 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.225 1.81 . . . . 0.0 107.759 172.462 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.72 -41.02 7.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.135 1.374 . . . . 0.0 112.64 -174.966 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -151.14 161.29 42.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.572 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -150.77 169.01 22.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.175 0.99 . . . . 0.0 109.484 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -159.9 158.42 30.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 106.981 177.565 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.66 157.27 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.89 -164.69 51.85 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 -80.0 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.245 0.618 . . . . 0.0 110.717 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m 36.11 57.9 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.975 2.11 . . . . 0.0 113.59 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -46.86 -42.41 17.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.14 1.376 . . . . 0.0 111.862 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -57.91 -53.81 53.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.946 0.898 . . . . 0.0 110.44 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -64.09 -40.97 97.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.6 tt -52.13 -53.97 36.32 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.262 1.025 . . . . 0.0 108.484 177.216 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.72 -50.14 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.583 0.353 . . . . 0.0 110.083 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.89 64.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.889 0.476 . . . . 0.0 110.666 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.31 -58.62 6.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.852 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.5 -51.67 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 123.215 0.606 . . . . 0.0 110.685 -177.19 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.71 -38.35 6.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.383 1.073 . . . . 0.0 112.424 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . 0.491 ' HG2' ' CD2' ' A' ' 109' ' ' HIS . 6.2 ptmt -64.3 -37.91 89.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.44 0.564 . . . . 0.0 111.358 -178.546 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.491 ' CD2' ' HG2' ' A' ' 108' ' ' LYS . 80.7 m-70 -84.45 -49.15 8.92 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.95 0.9 . . . . 0.0 110.221 -178.809 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.07 96.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.454 2.301 . . . . 0.0 111.939 -177.121 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 64.66 49.35 2.33 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.733 1.613 . . . . 0.0 109.31 -175.119 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 C-N-CA 126.211 1.804 . . . . 0.0 106.865 179.728 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -78.6 35.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.114 1.765 . . . . 0.0 112.968 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.14 171.05 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.415 1.086 . . . . 0.0 112.017 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -94.96 143.69 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.101 1.36 . . . . 0.0 107.415 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -147.56 155.09 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 111.013 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -136.23 32.58 2.86 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.32 1.448 . . . . 0.0 112.0 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -152.57 139.04 18.59 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.961 0.886 . . . . 0.0 111.805 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -42.53 80.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 111.115 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.43 86.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.537 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.68 76.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.383 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -49.96 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.17 -50.14 74.84 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.782 0.801 . . . . 0.0 110.58 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.52 -56.65 13.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.801 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.16 -50.84 70.01 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.9 -47.85 11.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.502 0.721 . . . . 0.0 109.59 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.82 0.83 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -59.93 -21.94 61.79 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 111.786 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.96 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.179 . . . . 0.0 111.231 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm 62.41 50.72 3.59 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.323 1.449 . . . . 0.0 107.398 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -50.53 -31.91 16.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.192 2.197 . . . . 0.0 115.005 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -59.79 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 128.888 2.875 . . . . 0.0 114.061 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -136.85 84.22 2.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -178.16 155.84 1.01 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.952 0.901 . . . . 0.0 110.085 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.47 117.13 3.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.387 3.391 . . . . 0.0 114.179 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 27' ' ' ILE . 56.8 mt -88.7 96.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.176 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -93.1 104.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.88 131.73 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -104.66 98.76 8.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.3 98.14 8.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -124.66 174.92 7.54 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.835 1.254 . . . . 0.0 108.644 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.5 169.92 16.93 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.031 0.832 . . . . 0.0 109.696 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 p -71.25 -70.11 0.33 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -50.55 -30.17 12.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 115.358 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.6 p -76.04 61.58 1.55 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.902 1.228 . . . . 0.0 112.728 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 10.26 -84.6 0.0 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 128.83 3.11 . . . . 0.0 115.601 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -39.81 -39.44 2.15 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.875 3.716 . . . . 0.0 114.203 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -44.11 -44.22 7.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.92 1.688 . . . . 0.0 111.286 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -61.86 -26.17 67.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 112.11 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -91.02 -40.84 11.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.179 1.392 . . . . 0.0 109.756 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.52 -39.71 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.431 0.692 . . . . 0.0 109.617 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -61.54 6.13 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.832 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.62 -29.78 89.17 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.919 2.412 . . . . 0.0 112.284 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.83 -58.2 9.58 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.23 -32.36 66.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.93 0.892 . . . . 0.0 110.556 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.23 -33.86 63.47 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -59.02 -53.53 57.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.9 mt -59.6 -39.6 84.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 8.5 m -56.25 -51.49 67.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.477 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -56.06 -48.6 75.75 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.697 0.799 . . . . 0.0 110.269 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -64.1 -61.32 2.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.269 0.556 . . . . 0.0 111.295 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.24 57.49 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.647 1.179 . . . . 0.0 110.125 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.95 173.35 11.33 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.521 -0.737 . . . . 0.0 111.15 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -65.98 1.31 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.466 1.031 . . . . 0.0 114.686 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -82.63 -59.06 2.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.628 0.714 . . . . 0.0 111.04 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 59' ' ' PHE . 58.0 t -78.67 129.43 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -171.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.68 104.08 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 57' ' ' VAL . 33.8 m-85 -91.54 88.2 6.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.1 mt -83.91 99.67 10.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -81.82 94.0 6.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.19 124.31 43.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.04 0.536 . . . . 0.0 110.018 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -81.22 92.47 6.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.36 -36.51 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.683 1.993 . . . . 0.0 110.288 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -50.95 -37.84 46.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.372 0.669 . . . . 0.0 109.91 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.8 -62.31 1.41 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.2 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.99 58.28 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.496 -0.753 . . . . 0.0 111.069 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.67 87.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.308 0.643 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.59 -58.07 9.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.871 0.869 . . . . 0.0 111.894 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.6 -42.59 92.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.92 27.52 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -65.05 -39.56 93.48 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.063 -1.023 . . . . 0.0 110.315 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.04 93.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.412 0.551 . . . . 0.0 110.512 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.94 -32.09 73.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.096 0.958 . . . . 0.0 109.887 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.22 40.51 1.93 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.683 1.135 . . . . 0.0 111.952 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.32 137.98 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 p -136.0 -83.72 0.38 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.12 78.05 2.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.392 0.677 . . . . 0.0 109.802 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 143.14 93.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.99 143.81 76.69 Favored 'Cis proline' 0 N--CA 1.447 -1.258 0 CA-C-N 119.651 0.911 . . . . 0.0 110.453 -0.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.2 m -126.68 119.54 27.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -100.08 129.28 46.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.393 1.077 . . . . 0.0 109.433 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -124.09 147.23 48.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -114.69 91.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -84.43 64.73 8.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -61.03 138.52 58.19 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 72.98 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.807 2.043 . . . . 0.0 110.268 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.85 25.15 0.02 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.497 1.523 . . . . 0.0 111.686 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -156.12 138.57 6.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.236 1.518 . . . . 0.0 109.231 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -46.73 91.07 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.207 2.203 . . . . 0.0 110.88 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.35 21.5 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.95 164.22 39.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -147.29 164.02 34.55 Favored 'General case' 0 N--CA 1.46 0.05 0 C-N-CA 124.364 1.066 . . . . 0.0 109.243 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.6 tm? -162.11 114.83 1.75 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.198 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.56 157.43 3.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.804 0.811 . . . . 0.0 110.261 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.38 -174.65 53.47 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.897 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.29 -60.33 3.91 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.7 m 35.11 50.41 0.49 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.093 2.157 . . . . 0.0 112.874 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -47.01 -51.16 17.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.475 1.51 . . . . 0.0 113.353 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.87 -47.25 86.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.797 -0.565 . . . . 0.0 111.269 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.27 -41.23 97.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.2 tp -56.99 -54.84 42.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -50.93 -51.71 49.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.82 0.848 . . . . 0.0 109.945 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.905 0.482 . . . . 0.0 110.811 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.26 -48.04 81.71 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.307 0.503 . . . . 0.0 110.891 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.81 -52.66 33.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.42 27.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.477 0.311 . . . . 0.0 110.815 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -50.29 -57.44 7.87 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.543 1.137 . . . . 0.0 111.225 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -74.42 -25.26 59.34 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.13 40.02 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.796 0.726 . . . . 0.0 109.644 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.797 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.0 t -83.38 97.09 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.42 169.58 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.393 1.092 . . . . 0.0 112.699 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.33 138.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tp -151.11 152.14 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.918 0.781 . . . . 0.0 111.226 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -131.89 24.75 4.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.944 1.698 . . . . 0.0 112.415 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -149.33 142.45 24.96 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.158 0.89 . . . . 0.0 111.171 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -70.43 -36.55 74.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.563 1.545 . . . . 0.0 109.614 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.46 75.42 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.85 91.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.2 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.426 ' CZ3' HG11 ' A' ' 70' ' ' VAL . 20.6 t-105 -48.86 -58.16 5.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.32 -47.83 83.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.321 0.648 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.9 -47.32 71.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.614 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -64.11 -49.7 71.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp -46.1 -47.99 17.21 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.696 0.798 . . . . 0.0 110.285 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -64.74 0.82 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.492 0.317 . . . . 0.0 111.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -61.09 -24.74 66.46 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.719 -0.613 . . . . 0.0 112.634 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.76 -20.46 64.14 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.462 -1.188 . . . . 0.0 112.322 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 62.92 63.1 0.98 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.308 1.443 . . . . 0.0 108.751 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -75.25 62.32 1.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.892 1.277 . . . . 0.0 110.305 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.58 -55.44 13.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -154.16 19.23 0.5 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 109.554 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -78.59 133.81 62.48 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.16 119.28 6.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.576 1.517 . . . . 0.0 112.498 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mt -99.12 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.43 116.43 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.14 128.8 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.06 96.17 7.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.465 1.506 . . . . 0.0 107.224 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.15 94.01 9.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.8 m -131.69 117.42 18.62 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.06 58.83 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.895 0.316 . . . . 0.0 111.471 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.11 -49.15 52.66 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.112 0.965 . . . . 0.0 110.924 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -68.98 -6.56 28.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 113.29 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.53 64.81 4.51 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.55 -79.88 0.01 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.388 2.899 . . . . 0.0 115.748 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.33 -36.91 53.28 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.436 2.091 . . . . 0.0 111.188 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -38.06 70.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.644 0.778 . . . . 0.0 109.248 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -53.42 -26.64 20.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.634 0.773 . . . . 0.0 111.889 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.2 mtt -62.42 -16.21 53.65 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.11 0.868 . . . . 0.0 111.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.77 -26.18 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.371 0.668 . . . . 0.0 109.812 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.15 16.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.304 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -56.42 -38.92 94.37 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.024 1.816 . . . . 0.0 112.018 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.6 mt -56.6 -57.34 12.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.558 0.694 . . . . 0.0 109.602 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.96 -41.72 75.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.048 0.539 . . . . 0.0 110.067 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -62.61 -34.46 77.08 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.36 -0.838 . . . . 0.0 110.539 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.1 m -62.28 -47.46 84.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.58 -40.63 92.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 19.5 m -53.58 -52.39 59.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.63 -46.33 89.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.367 0.667 . . . . 0.0 110.429 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -51.16 -54.05 28.93 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.55 -55.52 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.739 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 36.05 -125.44 0.14 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.206 1.402 . . . . 0.0 110.391 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 45.05 -84.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.159 2.314 . . . . 0.0 115.188 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -91.19 -39.43 12.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.372 1.469 . . . . 0.0 112.916 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.63 132.14 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 113.235 -167.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.4 129.53 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 78.8 m-85 -122.14 113.47 19.54 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.15 101.58 10.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.844 1.258 . . . . 0.0 110.985 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.6 119.41 22.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.38 138.67 53.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.849 0.833 . . . . 0.0 111.88 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -97.88 104.92 16.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.949 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 m -55.65 -28.63 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.19 0.596 . . . . 0.0 110.985 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.01 -36.5 77.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.76 -66.38 0.9 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.936 0.495 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.07 53.88 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 121.497 -0.752 . . . . 0.0 111.267 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.62 -43.58 25.98 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.042 0.937 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.01 73.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.965 0.906 . . . . 0.0 111.138 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.426 HG11 ' CZ3' ' A' ' 13' ' ' TRP . 40.0 t -67.34 -43.49 87.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.45 27.48 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.667 0.387 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.16 -42.54 88.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.685 -0.634 . . . . 0.0 110.748 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.22 93.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.679 0.672 . . . . 0.0 110.886 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.54 91.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.767 1.227 . . . . 0.0 109.785 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 43.23 1.18 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.456 1.027 . . . . 0.0 112.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.45 131.08 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 p -113.51 -74.92 0.61 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.57 14.76 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.692 1.197 . . . . 0.0 108.899 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -137.96 139.87 27.48 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -62.73 155.63 67.04 Favored 'Cis proline' 0 N--CA 1.457 -0.667 0 CA-C-N 120.758 1.307 . . . . 0.0 114.899 -0.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -144.45 135.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.09 121.25 38.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -119.81 153.85 35.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.02 122.91 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.042 0.937 . . . . 0.0 108.698 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -113.59 118.85 35.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -90.69 -57.52 2.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.461 0.573 . . . . 0.0 112.107 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -93.16 -42.46 9.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.198 1.399 . . . . 0.0 110.545 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.02 -24.18 0.11 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.673 2.082 . . . . 0.0 110.138 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.84 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.16 1.384 . . . . 0.0 108.864 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.0 103.01 0.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.59 -33.66 41.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.835 0.854 . . . . 0.0 110.319 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -158.98 166.94 30.64 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.44 29.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.694 0.797 . . . . 0.0 111.569 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.3 tm? -160.3 149.34 17.25 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.067 1.747 . . . . 0.0 108.14 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.14 156.0 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.97 1.308 . . . . 0.0 110.631 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.33 177.43 46.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.816 0.722 . . . . 0.0 112.124 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.89 46.16 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.736 1.214 . . . . 0.0 111.138 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.658 ' HB2' HD11 ' A' ' 94' ' ' LEU . 8.4 m -80.04 67.08 5.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.33 -0.856 . . . . 0.0 109.985 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -49.53 -45.15 47.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.594 1.158 . . . . 0.0 111.963 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -56.76 -48.91 76.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.03 0.932 . . . . 0.0 110.147 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HG2' HD23 ' A' ' 94' ' ' LEU . 14.5 tppt? -67.65 -38.93 84.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -56.46 -55.43 33.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -51.58 -53.77 34.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.798 0.439 . . . . 0.0 110.462 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.91 -44.46 74.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.706 0.402 . . . . 0.0 111.209 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.9 mt -61.3 -49.76 75.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.955 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.26 -46.97 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.06 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.98 -52.26 58.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.143 0.177 . . . . 0.0 110.817 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -56.31 -62.7 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.897 0.879 . . . . 0.0 110.499 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -70.28 -14.95 62.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.16 16.78 25.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.035 0.834 . . . . 0.0 110.671 174.354 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 111.959 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.667 ' HB2' HG23 ' A' ' 58' ' ' ILE . 15.0 m . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' A' ' 50' ' ' SER . 77.0 t -105.88 101.65 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 108.734 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 pt -145.76 129.47 10.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 122.73 1.252 . . . . 0.0 111.397 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.14 57.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 8' ' ' ASP . 6.6 tp -89.03 -179.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.209 1.004 . . . . 0.0 111.152 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 7' ' ' ILE . 16.7 p-10 -134.32 -38.33 0.85 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -80.48 156.39 26.59 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -165.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.74 -46.2 91.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.837 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.72 -51.92 52.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.98 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' CB ' HG12 ' A' ' 7' ' ' ILE . . . -62.77 -47.8 81.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.169 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -46.85 -58.96 3.4 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.89 -54.68 43.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 111.646 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.39 -63.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.234 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -55.68 -47.42 76.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.581 -0.724 . . . . 0.0 110.901 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.61 -19.44 0.91 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.837 0.711 . . . . 0.0 112.016 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.32 -56.86 2.14 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.266 0.939 . . . . 0.0 111.092 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.42 63.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.96 -8.38 57.86 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 119.883 1.22 . . . . 0.0 112.569 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.42 56.28 0.78 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.795 2.038 . . . . 0.0 109.547 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -67.91 64.15 0.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.62 3.168 . . . . 0.0 111.202 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.36 93.71 4.03 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.766 2.026 . . . . 0.0 107.226 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 68.04 72.81 0.31 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 128.864 2.865 . . . . 0.0 110.217 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -172.53 155.27 3.24 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 122.731 0.412 . . . . 0.0 111.858 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.96 135.05 6.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.225 2.616 . . . . 0.0 113.883 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 5.3 mp -104.89 99.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -91.45 109.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.12 123.66 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.904 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -88.68 101.66 14.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.86 1.264 . . . . 0.0 110.232 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.42 115.53 20.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -140.85 162.03 36.42 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 108.212 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.62 163.81 15.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.0 1.32 . . . . 0.0 109.307 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.2 p -77.96 -57.92 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.505 0.722 . . . . 0.0 109.608 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -50.74 -31.59 17.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.648 1.579 . . . . 0.0 113.272 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -77.44 55.37 1.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.616 1.098 . . . . 0.0 110.778 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.86 -68.12 0.01 OUTLIER Glycine 0 CA--C 1.536 1.369 0 C-N-CA 127.938 2.685 . . . . 0.0 115.477 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -42.5 -39.22 6.61 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.577 3.518 . . . . 0.0 114.232 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.6 m -42.78 -44.06 4.24 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.474 1.51 . . . . 0.0 110.88 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.0 -29.16 59.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.03 0.932 . . . . 0.0 112.26 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.49 -19.87 64.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.902 0.774 . . . . 0.0 111.861 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.6 -28.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.51 27.3 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.993 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.2 -42.06 38.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.057 1.838 . . . . 0.0 111.736 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.78 -54.48 45.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.75 0.786 . . . . 0.0 109.565 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -55.86 -45.41 78.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.223 1.009 . . . . 0.0 109.311 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.68 -41.84 95.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.808 0.843 . . . . 0.0 110.836 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 m -58.36 -49.84 75.79 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.1 tp -60.43 -37.64 81.55 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.116 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.476 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 37.8 m -58.94 -44.71 91.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 122.073 -0.392 . . . . 0.0 110.549 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -58.85 -48.33 81.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -46.7 -52.89 12.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 112.736 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -103.99 36.26 2.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.623 0.647 . . . . 0.0 111.471 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.06 71.11 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.234 0.925 . . . . 0.0 112.038 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.37 -75.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.18 -49.2 17.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.45 124.61 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.382 -167.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 3' ' ' SER . 17.1 mm -90.99 114.53 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 96.8 m-85 -105.98 101.75 11.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.82 163.48 14.14 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.15 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -138.02 150.84 47.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.76 136.43 26.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -87.78 113.03 23.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.15 -30.48 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.274 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -62.34 -52.86 61.94 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.06 -60.81 2.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.198 0.599 . . . . 0.0 110.393 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.86 58.57 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.716 0.769 . . . . 0.0 110.338 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.07 -47.14 72.01 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.922 0.889 . . . . 0.0 111.04 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.1 -55.52 23.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.998 0.919 . . . . 0.0 111.978 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.25 -43.99 95.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.97 68.89 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.49 -42.39 74.84 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.83 -0.544 . . . . 0.0 109.761 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.65 78.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.679 0.672 . . . . 0.0 110.535 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 2.7 22.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.258 1.023 . . . . 0.0 111.757 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.75 42.86 94.64 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.569 1.08 . . . . 0.0 112.604 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.81 139.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 117.537 0.668 . . . . 0.0 109.632 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.1 p -139.84 -78.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 110.151 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.8 74.12 1.58 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.336 1.054 . . . . 0.0 111.311 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.31 138.67 91.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -63.7 135.25 19.54 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.443 1.551 . . . . 0.0 112.498 -1.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -125.52 107.37 10.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.86 121.1 33.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.943 0.897 . . . . 0.0 108.604 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.03 141.96 43.81 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.71 96.33 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.3 105.42 17.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -82.44 116.57 21.95 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.0 -59.81 0.37 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.784 2.834 . . . . 0.0 110.346 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.04 23.02 0.09 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.266 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.65 135.16 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.256 1.528 . . . . 0.0 108.406 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -62.96 98.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.393 0.677 . . . . 0.0 109.386 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -33.07 40.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.483 0.713 . . . . 0.0 110.182 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -161.91 174.67 12.78 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -160.61 172.24 17.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.16 1.384 . . . . 0.0 108.165 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.08 150.52 9.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.555 1.142 . . . . 0.0 108.666 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -126.95 158.56 37.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 175.04 46.23 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.573 1.082 . . . . 0.0 111.863 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.62 42.79 0.45 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.904 0.882 . . . . 0.0 110.548 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -78.71 55.4 1.68 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.081 1.752 . . . . 0.0 110.842 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.27 21.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.329 1.052 . . . . 0.0 113.104 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.49 -52.26 65.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.116 0.871 . . . . 0.0 110.245 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.77 -37.94 89.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.76 -57.94 9.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -53.47 -49.9 66.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.016 0.527 . . . . 0.0 110.754 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.93 76.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.14 0.176 . . . . 0.0 111.129 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.02 -47.09 81.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.935 -0.478 . . . . 0.0 110.466 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 65.6 t -56.42 -48.17 80.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.69 -56.6 15.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -47.11 -63.95 0.91 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.905 1.282 . . . . 0.0 111.065 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -70.39 -23.88 62.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.051 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.12 54.51 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.277 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.93 26.65 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.121 1.368 . . . . 0.0 107.857 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 pt -145.67 177.27 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 126.424 1.89 . . . . 0.0 107.431 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.76 73.9 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 122.007 0.908 . . . . 0.0 110.496 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.26 127.9 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 107.952 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -105.12 -42.48 5.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.636 1.974 . . . . 0.0 110.675 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 m -14.13 110.81 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.301 3.041 . . . . 0.0 115.035 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -40.29 -47.1 2.44 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.477 1.511 . . . . 0.0 111.326 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.53 -49.54 74.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.932 0.493 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.19 85.63 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -58.59 5.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.588 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -59.54 -47.28 86.16 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.115 0.966 . . . . 0.0 110.346 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -48.47 64.61 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.954 0.902 . . . . 0.0 110.857 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -51.68 -25.92 8.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.866 0.866 . . . . 0.0 112.133 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.19 -60.23 1.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.195 0.907 . . . . 0.0 111.296 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -22.22 63.84 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.814 -0.554 . . . . 0.0 112.081 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.93 -29.71 71.35 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.896 -0.947 . . . . 0.0 110.95 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 45.89 55.04 7.37 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.866 1.266 . . . . 0.0 107.801 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 pm0 -73.55 43.36 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -47.83 -51.05 24.18 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 0.0 109.032 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -135.09 58.48 1.77 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.649 0.78 . . . . 0.0 108.905 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -138.32 126.76 14.16 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.91 105.23 1.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 120.823 1.015 . . . . 0.0 112.212 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.98 118.4 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -118.06 122.11 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.6 110.79 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 123.385 0.674 . . . . 0.0 109.877 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -88.44 93.1 9.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -79.5 94.54 5.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -116.14 -165.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.338 1.455 . . . . 0.0 108.832 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -154.23 147.17 24.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.73 -0.606 . . . . 0.0 110.572 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -64.33 -46.01 85.36 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 112.512 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -68.26 -47.69 67.07 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -77.94 64.43 3.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.065 0.848 . . . . 0.0 112.276 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 11.04 -83.29 0.0 OUTLIER Glycine 0 CA--C 1.536 1.377 0 C-N-CA 128.987 3.184 . . . . 0.0 115.398 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -40.45 -46.37 4.43 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.375 3.383 . . . . 0.0 113.251 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.3 m -46.11 -51.62 13.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.409 1.484 . . . . 0.0 109.695 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -72.46 -41.37 66.15 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 mmt -60.82 -25.39 66.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.532 0.605 . . . . 0.0 112.217 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mt -70.75 -27.11 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.688 -0.632 . . . . 0.0 110.001 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.05 -51.78 79.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 116.994 -1.479 . . . . 0.0 110.653 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.99 -44.23 23.29 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.441 2.76 . . . . 0.0 113.565 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -59.98 -54.93 40.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.47 -34.62 69.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.142 0.577 . . . . 0.0 110.362 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.7 -34.15 75.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.531 1.132 . . . . 0.0 109.926 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -62.66 -47.65 82.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.1 -39.5 86.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.857 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -53.63 -52.1 60.98 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.879 0.471 . . . . 0.0 109.87 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -55.18 -47.13 75.64 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.555 . . . . 0.0 110.344 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.64 -64.95 0.76 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.294 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -80.06 60.39 3.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.187 0.995 . . . . 0.0 108.923 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.19 69.03 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.43 -136.68 0.01 OUTLIER Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.171 1.843 . . . . 0.0 116.229 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -71.81 38.45 0.07 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.072 1.349 . . . . 0.0 114.462 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -121.85 137.32 55.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.25 108.22 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.39 110.0 22.64 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 105.46 14.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.655 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -88.26 90.44 8.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.24 103.57 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.184 0.516 . . . . 0.0 109.775 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -76.99 100.33 5.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.85 -33.11 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.544 0.738 . . . . 0.0 112.14 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.83 -27.92 67.04 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.541 0.61 . . . . 0.0 111.035 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.0 -61.42 1.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 70' ' ' VAL . 77.2 t -83.42 57.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 122.686 1.231 . . . . 0.0 109.314 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.69 40.06 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.864 1.266 . . . . 0.0 112.788 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.87 -50.84 32.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.724 0.81 . . . . 0.0 111.56 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 67' ' ' VAL . 67.5 t -63.81 -47.86 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.47 69.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.359 0.264 . . . . 0.0 111.704 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -66.16 -43.49 86.83 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.63 77.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 0.0 110.971 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.56 -9.21 58.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 111.882 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.73 36.03 38.56 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.197 0.904 . . . . 0.0 112.342 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -78.96 141.37 15.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.221 1.01 . . . . 0.0 109.025 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -136.75 -82.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.73 72.59 2.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.375 1.07 . . . . 0.0 111.1 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.65 146.27 86.15 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.793 0.437 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.49 159.83 96.96 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 119.684 0.923 . . . . 0.0 110.185 -1.099 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.4 m -147.8 118.41 7.49 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.13 120.75 34.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 109.593 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -114.68 153.39 30.31 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.33 124.82 67.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -110.64 105.59 14.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.927 0.891 . . . . 0.0 110.33 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -92.45 147.78 22.62 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.46 -64.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 129.096 2.959 . . . . 0.0 112.153 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.68 33.67 0.05 OUTLIER Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.955 2.217 . . . . 0.0 110.486 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.28 145.17 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 118.357 1.078 . . . . 0.0 109.901 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -57.51 106.08 0.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.291 1.436 . . . . 0.0 108.174 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.45 -37.56 12.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.477 1.111 . . . . 0.0 112.554 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -155.54 167.56 29.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -160.68 175.69 12.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.724 0.773 . . . . 0.0 111.939 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -156.87 110.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.513 2.325 . . . . 0.0 106.533 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.53 145.68 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.96 -158.79 29.63 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.37 122.4 44.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.762 1.225 . . . . 0.0 109.955 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -157.59 80.27 0.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -32.75 65.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.987 0.515 . . . . 0.0 111.704 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -60.93 -50.39 73.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.32 -37.43 87.23 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.49 -55.4 35.34 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.629 0.771 . . . . 0.0 109.812 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -51.97 -50.63 60.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.87 86.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.475 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.28 -51.97 67.29 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.816 0.846 . . . . 0.0 109.477 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.47 -50.36 73.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.35 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.55 -58.07 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.877 0.37 . . . . 0.0 110.582 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -45.91 -58.16 3.77 Favored 'General case' 0 C--O 1.228 -0.059 0 C-N-CA 125.57 1.548 . . . . 0.0 110.433 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -83.19 9.79 9.8 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.31 -46.27 5.08 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.177 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.793 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 121.784 0.802 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 59' ' ' PHE . 75.4 t -123.01 120.72 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.405 1.082 . . . . 0.0 109.904 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -144.38 171.81 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.172 0.987 . . . . 0.0 111.728 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.04 136.03 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -153.29 152.42 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 118.696 0.68 . . . . 0.0 110.787 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -115.81 -62.56 1.58 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.233 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 m -37.12 105.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.203 3.001 . . . . 0.0 113.483 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -44.53 -49.0 10.23 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.007 1.323 . . . . 0.0 110.346 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.78 -49.77 57.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.106 0.562 . . . . 0.0 111.074 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 -44.36 83.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.823 0.449 . . . . 0.0 109.966 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -61.34 2.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.876 0.87 . . . . 0.0 108.906 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -58.69 -48.66 80.35 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.463 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.24 -63.42 1.15 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.399 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.63 -48.2 81.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -46.49 -49.88 17.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 110.758 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -49.18 8.64 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -28.65 61.93 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.698 1.136 . . . . 0.0 111.261 -176.157 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.72 -37.57 61.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.061 -0.855 . . . . 0.0 111.824 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? 44.98 51.53 8.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.811 1.245 . . . . 0.0 109.281 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.44 56.72 1.81 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.679 1.191 . . . . 0.0 113.02 -171.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -22.57 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 128.321 2.648 . . . . 0.0 112.172 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -132.55 59.23 1.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -135.15 142.3 41.28 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.35 111.17 3.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.478 2.119 . . . . 0.0 114.52 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.79 97.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.51 114.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.6 t -106.42 115.79 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -100.13 103.65 15.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.46 90.39 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -114.94 139.7 49.61 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.749 1.219 . . . . 0.0 109.036 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.71 72.28 2.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.669 0.788 . . . . 0.0 110.037 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -25.67 -47.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.632 2.373 . . . . 0.0 113.428 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -38.74 65.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.4 p -77.18 66.54 2.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.487 1.04 . . . . 0.0 112.898 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.28 -88.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 128.849 3.119 . . . . 0.0 114.769 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.73 -45.05 4.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.872 3.048 . . . . 0.0 113.723 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.0 m -45.03 -39.13 5.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.042 1.737 . . . . 0.0 111.634 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -49.27 -33.29 12.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.939 0.896 . . . . 0.0 111.858 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -53.94 -24.75 17.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.9 -37.78 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.78 -57.33 26.31 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -58.51 -27.76 83.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 111.234 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mt -75.15 -44.67 45.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.502 0.592 . . . . 0.0 110.714 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -55.72 -39.09 70.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' HG11 ' A' ' 4' ' ' VAL . 32.6 mt-10 -70.21 -34.5 72.99 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.317 0.647 . . . . 0.0 111.456 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.7 m -55.35 -44.73 76.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.076 1.307 . . . . 0.0 107.875 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.4 -18.09 48.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.778 -0.629 . . . . 0.0 112.428 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.425 ' CB ' HG21 ' A' ' 4' ' ' VAL . 25.9 p -59.16 -38.03 78.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 120.293 1.406 . . . . 0.0 109.226 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -62.61 -49.16 76.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.373 1.046 . . . . 0.0 108.196 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.29 -59.82 4.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.923 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -88.05 65.18 8.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.784 0.802 . . . . 0.0 109.625 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.79 67.6 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.337 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.32 -166.12 19.45 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 121.417 0.454 . . . . 0.0 111.998 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.642 . . . . 0.0 110.892 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.69 131.66 69.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.32 96.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.673 1.124 . . . . 0.0 108.583 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.505 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 m-30 -91.61 115.04 27.72 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.87 98.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.072 1.349 . . . . 0.0 110.107 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.91 113.81 18.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -90.47 122.18 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -69.9 86.2 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.13 -50.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.629 1.971 . . . . 0.0 110.779 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -56.68 -31.31 64.32 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.482 1.113 . . . . 0.0 112.192 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.78 -70.8 0.55 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.31 61.56 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.906 0.86 . . . . 0.0 111.036 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.5 60.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.795 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.51 86.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.592 0.757 . . . . 0.0 111.71 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.19 -47.19 82.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.14 69.06 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.53 -55.81 25.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.137 0.975 . . . . 0.0 110.457 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.91 -41.8 75.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.047 0.539 . . . . 0.0 111.048 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -8.62 55.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.391 0.677 . . . . 0.0 111.761 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.43 30.19 31.01 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.231 0.919 . . . . 0.0 112.881 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.68 117.09 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 p -101.34 -71.41 0.71 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.23 156.14 18.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.707 1.203 . . . . 0.0 107.876 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -150.1 161.18 31.78 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.38 141.43 53.45 Favored 'Cis proline' 0 N--CA 1.453 -0.902 0 CA-C-N 120.726 1.295 . . . . 0.0 111.922 1.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.3 m -133.6 122.55 23.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.29 119.33 38.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.325 1.45 . . . . 0.0 108.419 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -107.86 153.52 22.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.67 117.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -107.08 126.64 52.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.978 0.911 . . . . 0.0 109.41 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -92.03 123.78 35.65 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 67.26 -63.12 0.3 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 128.617 2.767 . . . . 0.0 110.585 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.09 23.86 0.05 OUTLIER Glycine 0 CA--C 1.533 1.174 0 C-N-CA 127.151 2.31 . . . . 0.0 110.938 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.13 128.05 74.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.69 111.3 1.79 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.355 0.662 . . . . 0.0 109.881 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.08 -33.9 14.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.627 1.171 . . . . 0.0 110.938 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -155.4 166.01 34.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.768 0.258 . . . . 0.0 111.099 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -143.23 162.36 35.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.738 1.615 . . . . 0.0 109.759 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 tt -159.9 143.44 14.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.595 1.958 . . . . 0.0 106.424 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.25 152.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.07 -158.84 29.55 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.92 139.99 20.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 m -163.85 108.13 1.0 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -51.6 -49.2 62.62 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.912 1.285 . . . . 0.0 111.876 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -58.1 -43.87 87.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.889 0.476 . . . . 0.0 110.034 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -38.39 86.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.06 -46.86 85.49 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -54.6 -49.3 70.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -46.54 85.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.681 0.792 . . . . 0.0 111.005 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.35 -52.64 63.82 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.852 0.751 . . . . 0.0 109.523 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.44 -50.97 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.39 -54.98 28.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.708 0.403 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.58 -63.74 1.02 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 125.254 1.422 . . . . 0.0 110.198 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -68.04 -22.31 64.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.452 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -44.73 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 108.987 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.867 0.867 . . . . 0.0 109.44 178.952 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.72 108.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.91 149.89 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.079 0.942 . . . . 0.0 112.425 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -96.52 123.28 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 tp -148.61 146.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.312 0.96 . . . . 0.0 111.153 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -145.01 56.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.974 0.91 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -157.64 117.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -48.52 -38.85 21.4 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.458 1.103 . . . . 0.0 112.794 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.69 86.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.101 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.71 -35.89 65.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.72 0.408 . . . . 0.0 110.126 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -52.23 -53.01 48.93 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.56 -51.29 70.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.355 0.662 . . . . 0.0 110.68 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.14 -48.45 64.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.231 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.14 -51.19 70.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.3 tp -49.22 -50.02 40.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.97 0.508 . . . . 0.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.99 -61.16 2.64 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 111.236 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -63.57 -15.59 58.49 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.457 -0.777 . . . . 0.0 111.877 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.14 60.87 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.079 1.323 . . . . 0.0 111.986 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 mttm 66.08 73.75 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.752 1.263 . . . . 0.0 108.554 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.06 49.44 0.13 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.047 2.139 . . . . 0.0 113.797 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.6 -58.61 3.17 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -152.96 24.61 0.56 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.621 1.168 . . . . 0.0 110.313 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.34 148.88 35.35 Favored Pre-proline 0 C--O 1.234 0.239 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HG2' HG13 ' A' ' 57' ' ' VAL . 84.4 Cg_endo -79.62 129.98 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.294 3.329 . . . . 0.0 113.31 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.57 95.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.71 130.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.36 133.24 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -104.49 101.62 11.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.566 1.947 . . . . 0.0 106.599 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.4 95.99 8.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.6 m -122.49 162.81 21.04 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.845 1.258 . . . . 0.0 107.808 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.24 172.44 6.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.124 0.969 . . . . 0.0 110.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.6 p -83.05 -62.52 1.57 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.712 0.805 . . . . 0.0 109.382 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.4 -26.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.716 2.007 . . . . 0.0 113.742 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.7 p -76.69 9.87 2.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.447 1.021 . . . . 0.0 112.703 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 28.82 -89.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 128.635 3.017 . . . . 0.0 114.757 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.58 -37.82 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.089 3.193 . . . . 0.0 114.38 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 p -48.1 -35.1 10.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.024 0.93 . . . . 0.0 111.97 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -52.67 -28.44 21.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.396 1.078 . . . . 0.0 112.172 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.76 -19.8 52.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.158 0.89 . . . . 0.0 112.039 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 35.9 mt -71.83 -30.37 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.684 -0.635 . . . . 0.0 109.916 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.98 -58.23 12.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.558 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.78 -37.37 94.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.42 2.08 . . . . 0.0 112.452 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -54.54 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.56 -36.86 79.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.907 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.25 -37.46 83.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 0.0 109.764 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 m -59.17 -52.41 65.84 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.63 -41.11 76.54 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 m -56.12 -49.99 72.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.782 0.325 . . . . 0.0 110.276 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -41.42 95.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.107 0.563 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -63.61 -63.37 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.64 0.733 . . . . 0.0 109.806 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.05 57.32 4.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.24 1.416 . . . . 0.0 109.955 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.47 153.08 40.5 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.758 0.79 . . . . 0.0 112.332 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.24 -72.44 1.15 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.616 1.103 . . . . 0.0 114.978 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -71.95 -30.93 65.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.668 0.734 . . . . 0.0 112.818 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HG2' ' A' ' 26' ' ' PRO . 90.3 t -97.08 136.75 26.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -100.82 129.91 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 57' ' ' VAL . 47.4 m-85 -117.33 107.13 14.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.161 0.984 . . . . 0.0 108.541 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.4 mt -100.85 101.21 11.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.84 1.256 . . . . 0.0 110.272 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -86.4 120.88 28.22 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.5 141.12 47.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.949 0.899 . . . . 0.0 110.432 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -94.62 109.47 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.788 1.235 . . . . 0.0 107.668 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.0 t -53.2 -34.35 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.836 1.254 . . . . 0.0 110.732 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -68.43 -23.07 64.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.11 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.18 -75.32 0.47 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 0.0 110.9 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.28 63.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.324 0.966 . . . . 0.0 110.169 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.08 54.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.989 0.916 . . . . 0.0 109.739 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.49 -52.83 63.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.131 0.973 . . . . 0.0 111.228 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.35 -46.69 94.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.54 -53.57 52.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.068 0.547 . . . . 0.0 111.539 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.57 -39.81 80.83 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.268 -0.895 . . . . 0.0 110.4 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 86.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.485 0.584 . . . . 0.0 110.203 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' A' ' 76' ' ' ILE . . . -67.74 -33.75 75.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.392 0.677 . . . . 0.0 110.431 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.15 48.66 1.69 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.757 1.17 . . . . 0.0 111.767 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -85.87 98.54 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.3 p -93.21 -75.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.12 72.71 5.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.895 0.878 . . . . 0.0 111.012 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.51 142.71 97.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.73 134.35 34.28 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.306 1.145 . . . . 0.0 111.102 0.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.3 m -122.67 141.01 52.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.903 1.681 . . . . 0.0 108.506 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 84.1 m-85 -124.11 116.83 23.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 108.628 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -112.6 147.84 35.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.2 t -115.13 98.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -87.44 107.45 18.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.47 115.01 21.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 68.18 -58.92 0.45 Allowed 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 128.177 2.591 . . . . 0.0 111.448 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.68 19.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.355 0.979 . . . . 0.0 112.686 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.24 134.98 57.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.981 1.39 . . . . 0.0 108.336 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -60.87 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.484 1.114 . . . . 0.0 108.853 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.76 -28.08 40.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.871 0.869 . . . . 0.0 110.12 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -156.05 167.12 31.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.534 0.152 . . . . 0.0 111.026 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.61 -175.21 4.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.472 1.909 . . . . 0.0 108.306 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 98' ' ' SER . 13.5 tp 167.01 142.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.277 2.631 . . . . 0.0 107.595 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.15 149.21 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.088 1.355 . . . . 0.0 108.295 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.13 168.69 44.33 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.749 0.639 . . . . 0.0 111.89 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.48 43.61 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 113.38 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' HD11 ' A' ' 94' ' ' LEU . 8.3 t -80.03 72.63 6.82 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.16 -0.963 . . . . 0.0 108.655 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.67 -41.6 55.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.538 0.735 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.14 -50.44 72.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.251 0.62 . . . . 0.0 110.054 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -65.15 -38.93 92.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -52.93 58.2 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.94 -52.29 66.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.933 0.893 . . . . 0.0 110.171 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.82 76.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.706 0.402 . . . . 0.0 111.173 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.6 mt -57.6 -57.17 13.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.737 0.815 . . . . 0.0 109.379 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.09 -47.24 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.987 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.75 -50.52 72.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.416 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.12 -50.16 56.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.783 0.719 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -71.53 -13.5 61.82 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.21 -39.61 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.399 1.48 . . . . 0.0 112.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 124.95 1.3 . . . . 0.0 108.894 -177.701 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.48 0.657 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.7 t -83.49 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 126.059 1.744 . . . . 0.0 108.575 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -76.89 137.58 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 122.431 1.11 . . . . 0.0 109.651 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.43 64.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 61' ' ' LYS . 11.9 tt -160.06 167.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.129 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -162.61 -44.22 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.598 1.559 . . . . 0.0 108.268 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.6 m -112.92 157.21 21.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.148 1.379 . . . . 0.0 113.58 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -43.78 -37.97 2.99 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 127.814 2.446 . . . . 0.0 112.895 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.18 -28.67 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.78 3.22 15.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.274 0.943 . . . . 0.0 112.232 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.04 -57.11 13.52 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.91 1.284 . . . . 0.0 108.721 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -57.81 -47.04 83.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.078 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.34 -59.0 5.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.627 0.771 . . . . 0.0 110.856 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.3 -49.18 76.91 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.8 mt -52.04 -57.09 10.55 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.94 -59.55 4.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.104 0.962 . . . . 0.0 111.43 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -60.27 -26.85 66.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.14 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.66 -24.4 69.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.32 -1.267 . . . . 0.0 113.669 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.53 56.42 6.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.606 1.703 . . . . 0.0 108.897 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -31.76 -34.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 131.404 3.882 . . . . 0.0 117.564 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -12.65 -70.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 129.348 3.059 . . . . 0.0 113.147 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -139.16 53.16 1.75 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -117.59 131.1 24.25 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.13 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.7 91.6 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.538 1.492 . . . . 0.0 109.593 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mt -86.16 92.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.84 125.45 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 113.37 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' HB2' ' CE2' ' A' ' 46' ' ' PHE . 8.7 t0 -83.4 88.58 6.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.97 98.35 9.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -124.81 171.99 9.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.781 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.65 105.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.993 1.317 . . . . 0.0 108.231 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -43.28 -53.34 5.25 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.057 1.743 . . . . 0.0 112.807 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -58.92 -33.36 70.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.175 0.59 . . . . 0.0 111.867 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.2 t -75.82 85.42 2.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.93 -59.64 0.9 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.664 1.126 . . . . 0.0 112.638 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.22 -39.54 71.51 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.21 2.606 . . . . 0.0 113.214 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.5 m -71.16 -37.85 72.19 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.43 0.692 . . . . 0.0 109.179 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -67.26 -40.99 86.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.199 0.6 . . . . 0.0 110.442 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 83.3 mmm -53.61 -30.75 44.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.246 1.019 . . . . 0.0 112.672 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.64 -30.01 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.145 -0.347 . . . . 0.0 111.071 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.37 -55.4 37.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.704 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.1 -34.34 94.58 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 122.397 1.892 . . . . 0.0 112.067 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.24 -53.26 59.78 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 30' ' ' ASP . 93.0 t80 -53.9 -43.76 69.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.79 -44.39 90.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -58.99 -49.48 77.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.27 -33.56 74.85 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 121.93 -0.481 . . . . 0.0 110.516 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 7.0 m -57.02 -45.48 83.06 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.763 -0.585 . . . . 0.0 109.65 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -63.91 -48.28 77.24 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.38 -45.17 55.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.855 0.462 . . . . 0.0 111.257 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -102.69 44.68 1.0 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.184 0.994 . . . . 0.0 110.116 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.81 43.29 0.33 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.986 -1.071 . . . . 0.0 111.158 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.27 -135.22 8.21 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.848 1.69 . . . . 0.0 109.668 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -80.44 45.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.827 0.814 . . . . 0.0 110.007 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.46 148.77 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 107.801 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.82 130.69 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 26.0 m-85 -113.38 137.19 51.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.27 124.72 11.65 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.882 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 7' ' ' ILE . 39.4 ttpt -89.14 143.35 26.91 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.81 130.95 62.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.48 99.68 10.27 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -53.89 -43.37 57.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.38 1.072 . . . . 0.0 111.244 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.4 -49.63 73.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.718 0.407 . . . . 0.0 110.482 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 -59.17 2.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.506 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.08 54.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.635 -0.666 . . . . 0.0 110.716 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.95 70.75 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.768 0.827 . . . . 0.0 110.974 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.82 -56.32 20.64 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.917 0.887 . . . . 0.0 111.926 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.76 -43.58 98.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.8 -41.88 91.36 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.194 -0.941 . . . . 0.0 110.636 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.15 94.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.252 0.478 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.97 76.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.397 1.079 . . . . 0.0 110.312 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.0 70.95 0.47 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.87 145.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -136.39 -88.67 0.3 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 110.89 21.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -76.67 140.88 68.2 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -72.92 141.29 71.2 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 119.687 0.924 . . . . 0.0 111.02 -2.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -114.97 129.64 56.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' HD13 ' A' ' 102' ' ' LEU . 89.9 m-85 -111.17 122.05 46.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -116.8 144.55 44.35 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.62 103.84 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -95.36 93.72 7.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.199 0.454 . . . . 0.0 111.079 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -90.86 140.12 30.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.28 -58.87 0.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.156 2.583 . . . . 0.0 110.646 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.12 28.7 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 127.26 2.362 . . . . 0.0 110.095 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.72 136.27 39.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 96.7 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.23 40.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.736 0.415 . . . . 0.0 110.713 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -160.23 167.46 27.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.79 175.51 13.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.668 0.787 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.9 tp -164.68 158.75 18.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.893 1.677 . . . . 0.0 108.255 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.58 160.88 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 110.377 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.32 176.42 41.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.471 1.034 . . . . 0.0 111.554 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.42 41.77 0.26 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.145 0.978 . . . . 0.0 111.352 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -78.26 58.83 2.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.126 1.77 . . . . 0.0 110.047 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.71 -35.59 66.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 112.192 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -58.49 -53.15 61.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.262 0.625 . . . . 0.0 109.578 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -66.6 -34.9 78.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' A' ' 82' ' ' PHE . 23.7 tp -59.75 -50.48 73.67 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.165 0.586 . . . . 0.0 110.081 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -55.46 -44.78 76.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.13 95.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.508 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.2 mt -54.37 -55.88 24.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.74 -49.53 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.15 -52.71 50.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.36 0.264 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -56.63 -68.62 0.2 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.164 0.585 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -62.61 -22.69 66.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.841 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.76 80.66 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 123.56 0.744 . . . . 0.0 110.878 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 50' ' ' SER . 8.5 p -130.27 31.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.169 1.787 . . . . 0.0 108.805 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.74 152.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 122.56 1.171 . . . . 0.0 113.085 -171.292 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.75 128.7 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.541 1.536 . . . . 0.0 110.566 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tt -160.82 -160.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -157.19 -56.9 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.616 0.766 . . . . 0.0 109.955 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -31.06 118.38 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.36 2.264 . . . . 0.0 113.018 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -40.51 -54.62 2.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.683 1.193 . . . . 0.0 112.869 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -43.24 67.41 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.475 -0.765 . . . . 0.0 111.029 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -35.74 73.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.399 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -55.13 38.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.67 -51.17 69.76 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.271 0.628 . . . . 0.0 110.069 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.22 79.45 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.64 -42.68 93.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -56.22 -58.41 8.08 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.572 1.078 . . . . 0.0 109.212 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 -57.83 9.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.233 0.613 . . . . 0.0 112.318 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.88 -10.11 35.39 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.001 -0.437 . . . . 0.0 111.44 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.43 91.6 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 58.76 76.63 0.34 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.026 1.331 . . . . 0.0 107.883 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 66.54 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.236 1.415 . . . . 0.0 109.591 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.27 -46.67 54.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -170.39 65.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.759 1.624 . . . . 0.0 107.724 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -139.99 132.67 14.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.416 1.486 . . . . 0.0 107.436 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.65 137.27 32.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.658 1.572 . . . . 0.0 109.096 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.61 120.3 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 t -120.81 126.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 125.353 1.461 . . . . 0.0 107.988 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.19 134.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 118.395 0.543 . . . . 0.0 110.327 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -101.41 96.49 7.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.098 1.359 . . . . 0.0 107.525 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -87.8 90.54 8.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -111.47 -178.48 3.46 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.664 1.186 . . . . 0.0 110.387 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.86 112.33 8.74 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.313 1.045 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -36.99 -57.18 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.568 1.947 . . . . 0.0 113.283 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -64.31 -28.33 69.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 t -76.9 91.41 3.57 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -26.8 -65.97 0.07 OUTLIER Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.151 1.834 . . . . 0.0 115.211 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.44 -37.71 47.21 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.153 1.902 . . . . 0.0 112.102 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.4 m -62.14 -40.36 95.68 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -62.43 -50.72 70.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.1 tpp -56.93 -32.55 66.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.775 0.83 . . . . 0.0 112.057 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -66.85 -27.43 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.471 -0.768 . . . . 0.0 110.746 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.25 45.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.98 -1.075 . . . . 0.0 113.601 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.1 -31.08 83.29 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.861 1.707 . . . . 0.0 111.435 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 -48.37 74.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -54.58 -45.7 73.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -58.02 -43.27 86.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.704 0.402 . . . . 0.0 110.394 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.3 m -58.8 -45.61 89.5 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.51 -39.65 94.18 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.257 0.48 . . . . 0.0 110.132 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 4' ' ' VAL . 10.3 m -51.53 -53.15 40.76 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -61.14 -48.72 80.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.013 0.525 . . . . 0.0 110.998 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -48.5 -56.38 8.46 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.045 1.338 . . . . 0.0 111.744 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -79.61 -33.26 41.66 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.78 -173.34 0.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.736 1.614 . . . . 0.0 112.082 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -41.43 -26.05 0.2 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.893 2.187 . . . . 0.0 117.142 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -66.2 -19.01 65.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.677 1.739 . . . . 0.0 111.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.98 139.29 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.76 121.42 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.09 124.23 41.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.321 -0.862 . . . . 0.0 109.127 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -115.68 107.55 15.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.535 1.134 . . . . 0.0 111.111 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -79.87 131.17 35.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' VAL . . . . . 0.473 ' CG1' HG21 ' A' ' 67' ' ' VAL . 57.7 t -139.65 134.32 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 119.203 0.911 . . . . 0.0 109.798 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.71 100.09 11.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.065 0.946 . . . . 0.0 109.046 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.7 t -44.56 -46.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 128.165 2.586 . . . . 0.0 110.708 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.64 -53.32 58.01 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.455 0.472 . . . . 0.0 110.491 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.55 -62.59 1.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.822 0.449 . . . . 0.0 111.098 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 62' ' ' VAL . 28.0 m -83.07 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.288 -0.883 . . . . 0.0 111.69 -175.485 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.48 30.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.133 0.973 . . . . 0.0 111.27 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -48.55 79.0 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.761 0.825 . . . . 0.0 111.13 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.82 -42.42 89.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.83 63.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.466 0.307 . . . . 0.0 111.216 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.77 -39.93 91.49 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.617 -0.677 . . . . 0.0 110.104 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.93 87.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.539 0.609 . . . . 0.0 110.662 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.45 77.85 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 0.0 110.325 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.12 46.56 2.81 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.888 1.232 . . . . 0.0 110.77 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -78.92 150.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.6 p -124.51 -84.94 0.64 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.14 177.71 6.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -138.44 152.26 70.84 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.52 141.96 57.98 Favored 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.216 -1.109 . . . . 0.0 109.216 -3.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 m -110.58 135.04 51.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -119.61 112.79 19.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 110.397 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -110.17 154.04 23.9 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.947 HG12 ' HB3' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -119.79 139.03 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.734 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -136.17 73.88 1.48 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.399 0.545 . . . . 0.0 112.453 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.67 152.66 43.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 69.18 -64.11 0.35 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 128.426 2.69 . . . . 0.0 109.116 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.04 34.88 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.664 2.078 . . . . 0.0 110.339 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.08 145.1 26.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.99 101.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.947 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -79.86 -41.75 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.347 1.459 . . . . 0.0 111.195 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -159.02 160.06 35.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -175.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -160.9 164.24 31.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 pp -166.27 158.17 13.81 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.137 2.175 . . . . 0.0 108.947 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.52 132.42 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.86 1.264 . . . . 0.0 107.948 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.83 160.56 10.18 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.67 38.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.822 1.249 . . . . 0.0 111.441 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 m -79.55 70.63 6.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.374 1.07 . . . . 0.0 110.63 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -48.81 -41.15 31.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.837 1.255 . . . . 0.0 111.936 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.5 -47.82 84.47 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.863 0.865 . . . . 0.0 110.152 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.96 -40.03 87.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.14 -58.76 5.92 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -49.16 -50.71 36.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.14 -40.42 77.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.603 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.0 -50.05 75.28 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.984 1.266 . . . . 0.0 108.682 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.8 -50.15 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.45 11.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.235 0.214 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -46.4 -62.16 1.48 Allowed 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.971 1.708 . . . . 0.0 111.117 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.28 -22.28 59.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.967 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.77 -47.78 61.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 123.469 0.708 . . . . 0.0 109.837 177.949 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.959 0.885 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.26 31.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 127.662 2.385 . . . . 0.0 107.57 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.12 -171.48 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 126.922 2.089 . . . . 0.0 108.785 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.42 73.43 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tp -79.08 145.8 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.755 1.222 . . . . 0.0 109.202 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -80.12 63.47 4.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.323 0.649 . . . . 0.0 112.492 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.1 t 29.73 -119.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.534 1.934 . . . . 0.0 113.532 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.2 -47.89 1.22 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.111 2.964 . . . . 0.0 115.304 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.99 79.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.928 0.491 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.55 -40.15 14.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.955 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -32.41 -64.75 0.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 128.566 2.746 . . . . 0.0 113.181 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.99 -55.91 29.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.858 0.837 . . . . 0.0 111.833 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.86 -52.45 49.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.653 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -53.75 54.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.799 1.24 . . . . 0.0 110.155 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.44 -49.21 18.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.976 1.311 . . . . 0.0 109.834 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.41 -61.84 1.88 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -56.81 -26.7 58.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.395 0.678 . . . . 0.0 111.665 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.89 63.18 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 117.56 -1.689 . . . . 0.0 112.103 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm 49.19 60.38 3.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.288 1.544 . . . . 0.0 108.054 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -63.39 24.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.392 2.677 . . . . 0.0 116.342 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -80.92 -59.74 2.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 120.867 -1.146 . . . . 0.0 108.378 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -112.45 36.36 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.544 1.137 . . . . 0.0 108.1 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -145.22 123.35 6.49 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.39 118.64 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.712 2.941 . . . . 0.0 110.454 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -107.08 112.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -119.84 148.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 107.085 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 83' ' ' HIS . 7.7 p -133.62 137.05 53.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -105.71 98.06 7.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.415 2.286 . . . . 0.0 106.217 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.74 93.85 8.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -113.36 -167.71 1.23 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.34 0.656 . . . . 0.0 109.654 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.64 11.3 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.288 1.435 . . . . 0.0 110.11 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -99.28 -65.06 0.98 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.442 1.497 . . . . 0.0 109.376 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -49.37 -24.62 2.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.317 1.847 . . . . 0.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.6 p -58.41 -16.64 15.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.134 0.574 . . . . 0.0 111.881 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.64 -112.64 5.1 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.128 -1.373 . . . . 0.0 110.552 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -38.62 -46.61 2.56 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.126 3.217 . . . . 0.0 115.026 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -32.28 39.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -56.13 -28.59 58.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.618 0.767 . . . . 0.0 110.559 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -54.35 -25.45 24.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.802 0.841 . . . . 0.0 112.501 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.86 -30.12 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 122.009 -0.432 . . . . 0.0 110.654 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.9 -59.07 10.72 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.258 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.5 -35.95 94.55 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.817 1.678 . . . . 0.0 112.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.67 -50.74 69.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -55.38 -44.12 75.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -61.15 -37.56 83.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 110.536 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.5 m -61.46 -47.29 86.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.39 -43.48 98.8 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.4 m -50.27 -51.01 48.46 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -35.98 81.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.881 0.872 . . . . 0.0 110.71 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.69 -47.91 82.92 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 123.107 0.563 . . . . 0.0 110.345 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -79.17 -50.95 10.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.7 -63.72 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.737 2.415 . . . . 0.0 116.048 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.89 -104.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.955 2.217 . . . . 0.0 115.755 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -76.61 48.7 0.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.143 0.977 . . . . 0.0 113.215 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.36 159.81 13.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 110.505 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -134.19 121.63 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -123.31 95.08 4.46 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.051 1.34 . . . . 0.0 107.746 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.79 102.62 10.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.468 1.107 . . . . 0.0 111.349 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -79.58 118.83 21.78 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.52 148.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.907 0.86 . . . . 0.0 111.173 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -111.43 112.89 24.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.443 1.497 . . . . 0.0 109.178 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.18 -31.2 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 122.527 0.331 . . . . 0.0 110.954 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.32 -34.39 76.53 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.55 -66.46 0.89 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -85.69 62.96 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 121.605 -0.684 . . . . 0.0 111.766 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.38 -43.19 44.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.351 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -56.31 23.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.215 1.006 . . . . 0.0 111.711 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.12 -43.35 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.13 35.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.867 0.467 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.2 -40.01 90.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.668 0.667 . . . . 0.0 110.08 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.03 82.28 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.639 0.654 . . . . 0.0 110.352 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.51 3.44 21.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.958 0.903 . . . . 0.0 111.715 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.45 32.74 85.19 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.013 0.816 . . . . 0.0 112.644 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.12 134.88 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 p -136.58 -70.11 0.47 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.872 1.269 . . . . 0.0 108.323 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.82 62.28 1.53 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.769 0.828 . . . . 0.0 111.376 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 143.27 98.2 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.46 136.56 44.19 Favored 'Cis proline' 0 N--CA 1.448 -1.151 0 CA-C-N 120.063 1.058 . . . . 0.0 110.606 0.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -126.56 129.57 48.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.44 1.096 . . . . 0.0 108.34 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.97 128.33 54.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.23 1.812 . . . . 0.0 106.902 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.2 m170 -127.94 150.98 49.65 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.699 1.199 . . . . 0.0 108.889 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.08 138.06 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.842 1.257 . . . . 0.0 107.639 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -129.75 50.81 2.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.851 0.75 . . . . 0.0 111.108 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.02 154.38 34.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 74.51 -58.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.626 1.97 . . . . 0.0 109.227 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.35 -48.6 0.3 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.54 157.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.93 0.492 . . . . 0.0 109.924 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -56.42 106.15 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.06 -42.5 17.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.103 0.961 . . . . 0.0 112.367 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -159.98 155.84 26.1 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -142.29 163.64 32.29 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 124.469 1.108 . . . . 0.0 110.076 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -157.52 115.86 3.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.146 1.378 . . . . 0.0 107.959 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.62 160.77 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.708 0.803 . . . . 0.0 112.274 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 177.17 40.42 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.196 0.903 . . . . 0.0 112.185 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.44 40.99 0.24 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.361 1.064 . . . . 0.0 111.298 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.1 m -80.73 58.98 3.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.31 1.444 . . . . 0.0 110.271 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -43.95 -51.97 7.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.59 1.556 . . . . 0.0 112.555 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -52.77 -51.03 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.419 0.687 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -69.48 -32.37 71.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.093 0.557 . . . . 0.0 109.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -57.76 11.08 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -55.78 -46.24 78.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.755 0.422 . . . . 0.0 109.869 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.76 -47.73 73.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.684 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mt -63.09 -45.64 91.15 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.661 0.664 . . . . 0.0 110.473 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.45 -50.9 70.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.16 74.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.618 0.367 . . . . 0.0 111.031 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -60.13 -58.64 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.006 0.922 . . . . 0.0 111.501 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -70.66 -53.13 16.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.14 57.58 4.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.712 0.805 . . . . 0.0 109.059 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.154 0 C-N-CA 122.785 0.434 . . . . 0.0 109.951 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.08 20.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 124.894 1.278 . . . . 0.0 111.972 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -157.71 176.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 126.849 2.059 . . . . 0.0 106.908 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 61' ' ' LYS . 6.2 p -150.44 -158.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 6' ' ' VAL . 21.1 tt -156.39 164.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -68.85 -34.6 75.75 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.422 1.089 . . . . 0.0 112.652 -174.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.8 m -62.71 105.12 0.61 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.879 0.472 . . . . 0.0 109.976 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -39.62 -51.66 2.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.811 1.645 . . . . 0.0 113.158 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.7 45.72 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.465 0.65 . . . . 0.0 111.597 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.92 66.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.188 0.595 . . . . 0.0 111.246 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -49.41 76.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -59.98 -47.08 87.27 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.69 68.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -50.81 68.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.527 0.731 . . . . 0.0 109.525 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.81 -50.74 43.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.279 0.491 . . . . 0.0 109.804 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -55.7 27.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -64.27 -22.0 66.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.776 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.18 25.39 0.2 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.728 1.156 . . . . 0.0 115.399 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp 51.44 70.82 0.5 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.276 1.43 . . . . 0.0 111.461 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.9 70.84 0.51 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.496 1.918 . . . . 0.0 109.728 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -109.18 -66.38 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -161.4 17.85 0.11 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.08 1.752 . . . . 0.0 109.872 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -75.29 142.16 74.76 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.93 115.08 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.762 2.975 . . . . 0.0 110.931 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.7 mt -101.16 101.04 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.32 109.61 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.72 121.22 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 109.846 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -85.59 100.01 11.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.723 1.609 . . . . 0.0 106.958 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.02 99.22 11.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.2 m -131.71 153.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.43 158.43 17.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.316 0.579 . . . . 0.0 110.678 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -66.4 -29.52 69.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.365 1.066 . . . . 0.0 108.235 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -60.97 179.5 0.18 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.257 2.223 . . . . 0.0 112.996 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t 69.39 -62.25 0.41 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.518 2.327 . . . . 0.0 111.733 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.38 -83.05 0.36 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.665 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -47.32 -41.98 27.91 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.494 2.796 . . . . 0.0 112.276 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.0 m -46.47 -39.24 10.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.703 1.601 . . . . 0.0 111.285 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -80.79 -12.45 59.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.339 1.056 . . . . 0.0 113.067 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.3 mmm -58.63 -27.23 64.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.876 1.216 . . . . 0.0 111.362 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.63 -27.69 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.395 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.17 10.19 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.47 -35.62 89.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.153 1.902 . . . . 0.0 112.614 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.4 -53.11 60.89 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.8 -41.46 70.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 108.963 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -62.66 -35.51 79.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.608 1.163 . . . . 0.0 110.794 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -62.8 -50.92 69.1 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.92 -41.46 82.72 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -50.97 -55.76 15.71 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -58.64 -38.0 77.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.273 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -60.61 -48.13 83.14 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.589 0.631 . . . . 0.0 111.263 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -79.62 -29.98 41.24 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.794 -0.566 . . . . 0.0 112.033 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.11 -70.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 128.434 2.694 . . . . 0.0 114.342 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.72 -15.51 2.39 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.334 1.445 . . . . 0.0 112.654 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.49 -34.65 77.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.467 1.134 . . . . 0.0 110.388 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.73 139.44 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.0 mm -93.61 99.53 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -94.46 115.63 27.84 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.4 mt -109.9 140.59 43.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.517 1.127 . . . . 0.0 108.95 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.9 mtpm? -121.65 89.95 3.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.196 0.999 . . . . 0.0 110.448 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -97.19 120.23 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 102.42 5.59 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -44.84 -43.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.867 1.267 . . . . 0.0 111.446 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.93 -41.42 11.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.094 1.758 . . . . 0.0 111.611 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.37 -70.21 0.46 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.019 0.527 . . . . 0.0 111.354 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.64 59.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.743 -0.598 . . . . 0.0 111.191 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.41 -43.1 23.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.024 0.93 . . . . 0.0 111.137 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.12 -49.68 76.11 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.941 0.896 . . . . 0.0 111.307 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 -44.52 91.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.8 -55.14 33.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.893 0.477 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.21 -43.47 94.91 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.384 0.538 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.95 76.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.716 0.689 . . . . 0.0 110.844 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.58 6.28 18.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.607 1.163 . . . . 0.0 111.695 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.09 28.3 66.26 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.243 -0.91 . . . . 0.0 112.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.78 119.75 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -137.3 -70.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.883 1.273 . . . . 0.0 108.74 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.92 65.75 1.45 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.456 0.702 . . . . 0.0 110.996 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.25 142.0 89.31 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.05 133.4 10.84 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.253 1.483 . . . . 0.0 112.894 -2.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -127.05 109.87 12.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -96.62 123.49 40.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -115.74 139.99 49.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.596 1.159 . . . . 0.0 109.68 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.48 121.77 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.13 107.06 14.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.84 1.338 . . . . 0.0 107.418 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -86.63 130.5 34.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 t70 70.46 -68.69 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.847 2.059 . . . . 0.0 107.753 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.94 27.14 0.05 OUTLIER Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.148 2.309 . . . . 0.0 110.245 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.0 130.07 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -61.07 109.4 1.08 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.87 -40.84 9.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.197 0.599 . . . . 0.0 111.682 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -160.38 170.81 20.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.04 170.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.1 tm? -163.01 122.67 2.21 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.9 m -105.9 164.63 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.765 1.226 . . . . 0.0 112.289 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.48 179.23 49.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.676 1.132 . . . . 0.0 111.692 176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.34 39.18 0.25 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.819 0.848 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.3 m -80.87 57.94 3.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.63 1.572 . . . . 0.0 110.164 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -51.12 -48.93 61.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.401 1.08 . . . . 0.0 112.559 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.53 -47.13 80.03 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -61.54 -44.18 97.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.34 -54.49 44.84 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -54.81 -47.64 73.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.75 80.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.51 -46.15 91.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.572 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.99 -51.68 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 119.292 0.951 . . . . 0.0 108.683 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.19 69.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.472 0.309 . . . . 0.0 111.077 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -58.17 -58.69 7.34 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.394 1.078 . . . . 0.0 111.273 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -75.05 -15.68 60.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.746 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -37.48 -48.81 1.0 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.12 1.768 . . . . 0.0 112.67 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 0.0 109.739 -178.545 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.72 128.32 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -145.01 143.64 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 124.476 1.111 . . . . 0.0 110.705 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.28 120.95 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 171.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.71 160.39 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 122.669 1.223 . . . . 0.0 111.639 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -133.69 35.36 3.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.076 2.15 . . . . 0.0 108.544 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 134.3 8.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.925 1.29 . . . . 0.0 108.232 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -51.69 -37.19 49.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.417 1.087 . . . . 0.0 112.46 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -34.01 -62.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.432 1.893 . . . . 0.0 112.573 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.13 77.16 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.935 -0.478 . . . . 0.0 111.363 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -51.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.57 -47.51 69.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.213 0.53 . . . . 0.0 110.297 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.84 60.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.02 -46.14 68.72 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.53 -52.2 6.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.932 0.787 . . . . 0.0 109.443 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.46 -70.0 0.21 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.228 0.611 . . . . 0.0 112.179 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -59.91 -28.42 67.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.895 0.77 . . . . 0.0 112.072 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.82 -24.28 69.79 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.542 1.544 . . . . 0.0 111.842 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 60.68 67.33 0.84 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.623 1.212 . . . . 0.0 110.485 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.02 -22.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.837 2.055 . . . . 0.0 113.459 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -34.14 -54.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.318 2.247 . . . . 0.0 110.572 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -130.66 -13.28 3.76 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -79.85 115.14 51.82 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HG2' HG22 ' A' ' 57' ' ' VAL . 57.1 Cg_endo -63.35 129.05 24.18 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.095 1.196 . . . . 0.0 109.734 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.4 mm -102.72 87.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.47 118.07 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.38 116.39 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 123.274 0.63 . . . . 0.0 109.468 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -92.47 89.19 6.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -79.71 94.49 5.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -115.84 -174.19 2.49 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.166 1.386 . . . . 0.0 108.38 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.72 139.56 40.22 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 123.191 0.596 . . . . 0.0 110.971 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -41.86 -58.91 1.87 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.293 1.437 . . . . 0.0 110.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -72.47 7.85 1.65 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.076 1.351 . . . . 0.0 113.94 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -74.43 -7.65 53.68 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.449 1.477 . . . . 0.0 111.747 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.11 -110.36 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.153 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.53 -41.6 10.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.0 3.133 . . . . 0.0 114.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -25.9 60.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.239 -0.288 . . . . 0.0 111.455 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -54.01 -27.92 34.85 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.8 -0.562 . . . . 0.0 111.135 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.0 mtm -57.71 -21.7 42.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.734 0.697 . . . . 0.0 112.457 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 97' ' ' ALA . 43.1 mt -69.04 -32.14 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.654 -0.654 . . . . 0.0 109.704 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.72 22.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.56 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -59.47 -34.72 97.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.26 1.974 . . . . 0.0 112.357 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.55 -54.41 43.48 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.71 -39.16 73.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.99 -42.33 99.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.339 1.056 . . . . 0.0 109.572 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.1 m -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 tp -59.61 -36.54 76.49 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.51 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 12.5 m -58.35 -48.83 79.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.477 0.711 . . . . 0.0 110.135 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.94 -54.04 51.14 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -54.33 -44.31 71.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.347 0.659 . . . . 0.0 111.844 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -105.83 32.39 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.968 0.907 . . . . 0.0 111.308 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.94 144.42 33.87 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.519 -0.738 . . . . 0.0 110.899 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 -60.7 3.53 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.12 -30.82 71.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' A' ' 26' ' ' PRO . 78.4 t -126.21 143.09 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 mm -100.48 118.02 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 63.2 m-85 -107.51 105.6 15.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.105 0.962 . . . . 0.0 108.827 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.81 89.36 2.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.607 1.163 . . . . 0.0 110.692 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -79.9 111.04 15.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.78 128.56 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.008 0.923 . . . . 0.0 109.952 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.25 106.31 14.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -62.37 -33.79 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.204 0.601 . . . . 0.0 111.059 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.42 -48.2 62.73 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.45 -59.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.663 0.785 . . . . 0.0 110.846 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.74 60.36 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.498 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.27 -43.96 79.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.021 0.928 . . . . 0.0 110.675 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.27 -57.11 11.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 111.907 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.66 -44.07 96.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.04 -52.83 57.23 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.19 -42.43 79.95 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.79 -0.569 . . . . 0.0 109.974 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.28 77.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.684 0.674 . . . . 0.0 110.813 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.21 3.38 27.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.782 1.233 . . . . 0.0 111.636 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.41 38.59 91.12 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.19 0.9 . . . . 0.0 112.632 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mm -76.26 134.66 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.7 p -136.25 -74.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.605 1.162 . . . . 0.0 108.749 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.23 68.41 1.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.503 1.121 . . . . 0.0 110.683 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.83 149.47 96.58 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.79 131.28 22.9 Favored 'Cis proline' 0 N--CA 1.448 -1.192 0 CA-C-N 119.948 1.017 . . . . 0.0 109.917 -1.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -115.42 128.84 56.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.747 1.219 . . . . 0.0 108.407 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -104.24 102.02 11.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.689 1.595 . . . . 0.0 109.913 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -98.94 156.11 17.07 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -127.5 103.73 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.7 66.36 4.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.368 0.531 . . . . 0.0 111.704 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -69.96 154.91 41.34 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 69.59 -63.62 0.37 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.829 2.452 . . . . 0.0 110.157 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.44 35.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.911 2.196 . . . . 0.0 110.419 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.0 152.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -60.01 94.7 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.175 0.59 . . . . 0.0 109.463 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.46 41.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.391 0.676 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -152.43 164.05 38.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.718 0.235 . . . . 0.0 110.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.36 -177.45 4.85 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.21 2.204 . . . . 0.0 107.237 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp 165.82 147.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 128.557 2.743 . . . . 0.0 106.828 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -132.53 150.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.473 1.109 . . . . 0.0 108.965 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.2 173.88 49.38 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 122.088 0.827 . . . . 0.0 113.4 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -76.1 35.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.416 1.487 . . . . 0.0 113.908 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m -78.1 67.15 3.88 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.479 -0.763 . . . . 0.0 110.216 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -49.43 -42.63 43.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.936 1.694 . . . . 0.0 111.504 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -56.58 -49.32 75.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.899 0.88 . . . . 0.0 110.003 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -70.26 -31.12 68.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -53.98 52.18 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.72 -47.3 80.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.92 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.77 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.0 mt -55.15 -55.36 32.07 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.263 0.625 . . . . 0.0 109.726 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.14 -54.11 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.22 -55.59 23.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.663 0.385 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -52.5 -58.62 6.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.288 1.435 . . . . 0.0 111.108 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -72.19 -26.52 62.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.764 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.53 -58.74 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 126.124 1.769 . . . . 0.0 111.629 -179.134 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.2 29.55 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.231 1.412 . . . . 0.0 112.233 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.15 162.02 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.206 1.003 . . . . 0.0 113.211 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.32 135.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.616 1.966 . . . . 0.0 107.181 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 tt -160.04 169.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.949 0.881 . . . . 0.0 110.63 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -132.16 45.8 2.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 110.442 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -154.41 127.05 8.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.072 -1.018 . . . . 0.0 111.35 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -48.88 -50.07 36.69 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.528 1.131 . . . . 0.0 110.254 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.63 -48.35 19.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.721 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.95 81.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -52.2 48.57 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.69 -47.27 81.85 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.94 57.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.463 0.305 . . . . 0.0 110.275 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -51.47 69.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.085 0.954 . . . . 0.0 109.447 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tt -48.17 -50.07 30.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -62.24 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -63.47 -15.04 56.63 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.599 -0.688 . . . . 0.0 112.285 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.87 -16.74 57.28 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.112 -0.827 . . . . 0.0 111.455 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mttp 76.53 84.49 0.09 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.931 1.692 . . . . 0.0 108.296 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.49 66.16 0.31 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.622 1.969 . . . . 0.0 110.204 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.62 -61.25 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -168.1 8.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.9 153.03 57.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -170.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -65.91 116.1 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.308 2.672 . . . . 0.0 111.304 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.7 mt -97.64 91.96 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.03 109.69 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -111.61 126.24 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -95.72 105.66 17.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 107.615 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -86.25 97.39 10.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -117.6 142.51 47.12 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.1 56.58 1.22 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.9 p 6.89 -74.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.486 3.115 . . . . 0.0 114.645 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -43.64 -28.81 0.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.318 1.847 . . . . 0.0 115.094 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.41 69.18 1.15 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.9 1.682 . . . . 0.0 112.167 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 32.35 -95.99 0.01 OUTLIER Glycine 0 CA--C 1.532 1.151 0 C-N-CA 128.279 2.847 . . . . 0.0 113.576 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -39.59 -45.83 3.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.221 3.281 . . . . 0.0 112.555 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m -46.4 -37.85 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.821 1.648 . . . . 0.0 112.215 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -74.21 -62.15 1.61 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.2 ptp -58.88 -26.33 64.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 113.012 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.96 -29.76 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.653 -0.654 . . . . 0.0 110.047 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.73 -55.12 46.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.527 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -46.16 -43.84 20.3 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.757 2.971 . . . . 0.0 114.707 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.31 -55.13 35.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.07 -37.79 75.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.54 -34.35 74.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.504 1.121 . . . . 0.0 109.844 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 m -61.21 -53.66 54.11 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.6 -43.52 76.14 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 17.9 m -52.83 -56.46 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.577 0.751 . . . . 0.0 109.853 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.79 -50.61 60.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.703 0.401 . . . . 0.0 110.477 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.8 -60.17 4.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.887 1.367 . . . . 0.0 112.558 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -88.27 23.68 2.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.91 1.232 . . . . 0.0 111.754 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.17 151.92 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.868 -1.145 . . . . 0.0 111.769 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 -60.53 4.53 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.822 0.449 . . . . 0.0 109.969 175.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.26 138.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 107.373 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -98.53 131.14 46.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 97.1 m-85 -122.66 139.94 53.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.408 0.549 . . . . 0.0 110.68 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -132.89 125.43 29.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.338 1.055 . . . . 0.0 109.949 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -107.96 102.36 11.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.18 122.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.669 . . . . 0.0 110.82 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.47 104.54 5.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 t -56.62 -40.09 66.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.96 1.304 . . . . 0.0 110.781 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.81 -51.04 62.39 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.52 -60.05 2.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.256 0.622 . . . . 0.0 110.882 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.83 57.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.175 0.988 . . . . 0.0 109.576 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.16 98.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.811 0.844 . . . . 0.0 110.271 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.18 -57.22 10.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 111.993 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.07 -47.46 93.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.39 -47.14 63.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.634 0.254 . . . . 0.0 110.529 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.05 -58.35 8.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.882 0.873 . . . . 0.0 110.197 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -41.27 72.6 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.54 0.336 . . . . 0.0 111.78 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 -2.84 41.78 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.739 1.216 . . . . 0.0 111.754 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.36 47.49 78.89 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.028 -1.045 . . . . 0.0 113.019 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.38 117.85 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -98.37 -84.54 0.39 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.486 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.094 0.957 . . . . 0.0 110.245 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.52 141.47 79.88 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -71.24 140.36 64.18 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.246 1.123 . . . . 0.0 111.713 -1.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.3 m -121.01 109.42 15.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.31 131.09 34.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -126.58 135.51 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 107.979 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -113.15 91.31 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.925 0.784 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.21 69.22 9.88 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.7 133.46 55.36 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 70.84 -66.99 0.27 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 127.447 2.299 . . . . 0.0 107.061 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.86 26.86 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.427 1.965 . . . . 0.0 110.299 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.0 122.34 31.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 118.152 0.976 . . . . 0.0 108.542 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -45.61 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.593 1.957 . . . . 0.0 110.772 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.91 -33.68 19.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.039 0.936 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.89 159.11 37.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -143.79 166.0 26.12 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.807 1.243 . . . . 0.0 109.078 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.7 tp -162.52 115.46 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.862 0.865 . . . . 0.0 109.881 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.98 158.7 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.017 -0.427 . . . . 0.0 110.768 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 172.07 48.67 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.472 1.034 . . . . 0.0 112.662 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.85 74.0 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.083 0.953 . . . . 0.0 110.523 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.4 m 23.16 57.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.153 2.981 . . . . 0.0 115.055 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -57.97 -59.64 4.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 113.424 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.58 -45.84 73.62 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.894 0.854 . . . . 0.0 110.105 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.45 -43.86 96.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.03 0.932 . . . . 0.0 109.583 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -56.17 21.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.355 1.062 . . . . 0.0 108.185 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -53.36 -50.75 64.41 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.22 76.17 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.426 0.29 . . . . 0.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.64 -53.91 51.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 t -55.23 -47.43 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.406 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.73 -57.08 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.159 0.583 . . . . 0.0 111.746 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -64.7 -48.92 72.93 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.028 0.831 . . . . 0.0 112.098 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -64.44 -33.56 76.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.677 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.0 47.97 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.084 0.856 . . . . 0.0 110.837 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 123.484 0.714 . . . . 0.0 111.824 179.592 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 50' ' ' SER . 46.9 t -141.72 91.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.46 149.57 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.083 0.553 . . . . 0.0 109.865 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.89 55.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.253 1.421 . . . . 0.0 108.865 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.33 82.8 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 123.002 1.382 . . . . 0.0 110.179 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -76.09 70.0 2.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.64 1.576 . . . . 0.0 108.972 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -146.65 123.12 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.142 0.577 . . . . 0.0 110.302 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -49.32 -45.06 44.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.813 0.845 . . . . 0.0 110.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.71 78.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.303 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.23 74.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.876 0.47 . . . . 0.0 109.833 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -54.75 17.08 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.38 -57.21 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.666 0.786 . . . . 0.0 111.792 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -50.88 67.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.275 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.84 -49.08 74.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 109.351 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.66 -52.77 28.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.887 0.875 . . . . 0.0 109.636 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -60.28 4.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.456 0.702 . . . . 0.0 111.759 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -60.55 -24.16 65.18 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.668 -0.645 . . . . 0.0 111.428 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.09 -22.38 57.89 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.654 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mttp 54.8 60.3 3.57 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.05 1.425 . . . . 0.0 107.915 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -62.4 37.18 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 130.348 3.459 . . . . 0.0 116.221 -173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.1 -76.37 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -114.82 11.26 16.67 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 123.821 0.849 . . . . 0.0 110.883 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -76.55 139.83 67.65 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.66 94.7 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.644 2.229 . . . . 0.0 111.665 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.25 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.39 120.34 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.0 116.57 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.591 0.756 . . . . 0.0 110.834 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -91.03 104.28 16.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.488 1.115 . . . . 0.0 108.565 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -96.54 129.2 43.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 t -157.59 -172.74 4.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 120.4 16.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.989 0.813 . . . . 0.0 111.589 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -36.85 -63.8 0.39 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.056 2.142 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -54.81 -33.04 61.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 112.369 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.87 82.09 6.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.01 -62.68 0.56 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.004 1.288 . . . . 0.0 113.461 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.41 -30.96 93.99 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 119.828 1.814 . . . . 0.0 112.734 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.25 -29.43 67.34 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -81.32 -30.37 33.9 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.059 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.5 mmt -57.24 -22.06 38.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.04 0.836 . . . . 0.0 111.769 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -68.81 -30.44 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.759 . . . . 0.0 110.377 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.64 15.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 112.604 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -57.25 -39.72 87.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 CA-C-N 121.594 1.605 . . . . 0.0 111.495 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.74 -54.55 45.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -51.81 -48.65 63.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.916 1.286 . . . . 0.0 109.258 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.97 -30.36 70.91 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.688 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.4 m -56.56 -39.57 73.68 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 0.0 107.96 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.79 -25.82 63.47 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.099 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.608 ' HB2' HG11 ' A' ' 4' ' ' VAL . 22.9 t -50.65 -38.69 47.86 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.306 1.412 . . . . 0.0 110.294 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -55.94 -43.05 77.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.226 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.62 -53.4 9.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.67 0.788 . . . . 0.0 110.318 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.46 66.6 9.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.43 72.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.965 1.306 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.31 -166.14 3.73 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.466 1.031 . . . . 0.0 113.69 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.72 36.62 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.66 1.984 . . . . 0.0 114.805 -175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.5 122.84 39.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.64 104.47 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 4' ' ' VAL . 13.1 m-85 -92.59 90.22 7.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.72 145.09 31.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.98 121.2 41.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.31 72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.69 121.91 14.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.94 -29.14 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.897 0.879 . . . . 0.0 111.754 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.59 -29.86 70.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.6 -71.86 0.68 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.949 0.9 . . . . 0.0 110.342 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.04 61.8 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 122.649 1.214 . . . . 0.0 108.861 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.46 -42.15 77.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.006 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 -53.26 43.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.9 0.88 . . . . 0.0 111.613 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.61 -43.49 90.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -50.69 64.74 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.4 -43.98 76.07 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.733 -0.604 . . . . 0.0 109.711 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.84 -40.8 76.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.794 0.725 . . . . 0.0 111.169 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.25 45.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.143 1.377 . . . . 0.0 111.434 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.76 41.55 95.68 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 123.925 0.774 . . . . 0.0 112.405 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.7 mm -73.69 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.107 0.954 . . . . 0.0 108.874 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.8 p -131.03 -78.67 0.53 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.484 1.114 . . . . 0.0 108.86 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.57 63.21 1.5 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.626 1.171 . . . . 0.0 111.014 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 151.16 95.91 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.14 158.43 94.98 Favored 'Cis proline' 0 N--CA 1.448 -1.16 0 CA-C-N 119.721 0.936 . . . . 0.0 109.979 0.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 m -150.13 136.32 18.76 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.62 121.3 43.74 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.196 1.398 . . . . 0.0 108.211 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -115.95 150.36 37.27 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.051 0.94 . . . . 0.0 108.906 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.33 107.05 19.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -93.42 89.0 6.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.934 0.493 . . . . 0.0 111.884 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -90.47 156.46 18.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 69.67 -60.19 0.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.325 2.65 . . . . 0.0 109.485 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.31 28.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.058 2.742 . . . . 0.0 110.198 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.4 p -160.54 143.47 4.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.821 1.31 . . . . 0.0 109.902 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -39.83 97.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.749 2.019 . . . . 0.0 111.312 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.59 -37.55 21.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.404 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -139.15 163.16 33.15 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -160.39 169.45 23.05 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.649 0.78 . . . . 0.0 110.12 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -163.19 150.31 12.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.407 1.483 . . . . 0.0 107.921 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.95 162.87 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.495 1.118 . . . . 0.0 110.729 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.99 176.41 40.73 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.934 0.778 . . . . 0.0 112.565 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.72 40.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.354 1.062 . . . . 0.0 111.576 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -77.27 57.93 1.55 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.618 1.967 . . . . 0.0 110.729 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -50.51 -42.02 54.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.111 1.764 . . . . 0.0 112.217 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -57.66 -48.62 78.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 109.969 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -73.08 -26.8 61.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -54.5 45.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -53.33 -47.88 68.94 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.43 75.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.683 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -56.71 -54.61 44.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.612 0.642 . . . . 0.0 109.685 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.51 -46.36 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.771 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.24 -54.36 46.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.612 0.365 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -54.89 -56.04 23.93 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.519 1.128 . . . . 0.0 111.383 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -74.43 -27.93 60.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.156 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.83 41.86 0.82 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.597 1.09 . . . . 0.0 110.853 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 C-N-CA 123.121 0.568 . . . . 0.0 112.085 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.89 0.376 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 50' ' ' SER . 78.5 t -154.23 90.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.63 2.372 . . . . 0.0 105.902 -175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 pt -145.08 149.56 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.315 0.646 . . . . 0.0 109.761 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.03 55.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.176 1.39 . . . . 0.0 109.022 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.19 -173.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.936 1.294 . . . . 0.0 110.475 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -165.34 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 125.653 1.581 . . . . 0.0 109.156 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -35.57 114.99 0.29 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.56 2.344 . . . . 0.0 113.753 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -42.74 -52.28 5.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.727 1.611 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.17 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.821 -0.549 . . . . 0.0 111.678 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.93 -32.73 67.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.829 -0.545 . . . . 0.0 109.95 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.94 79.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.89 -45.71 91.66 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.05 -53.92 46.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -50.54 38.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.488 1.115 . . . . 0.0 109.416 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.64 -14.38 3.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.897 1.279 . . . . 0.0 113.862 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.33 -63.12 1.39 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.761 1.224 . . . . 0.0 110.695 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -20.86 58.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.43 0.692 . . . . 0.0 112.46 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.09 -19.87 62.0 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.603 -1.109 . . . . 0.0 111.926 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? 67.81 64.88 0.38 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.594 1.558 . . . . 0.0 108.539 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -70.1 56.95 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.806 2.842 . . . . 0.0 111.762 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.65 -52.03 6.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.151 1.38 . . . . 0.0 108.064 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -160.53 75.25 0.56 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.245 1.418 . . . . 0.0 108.106 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -147.17 145.51 22.3 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 121.971 -0.456 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.81 126.7 7.41 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.999 2.466 . . . . 0.0 112.168 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mt -96.15 120.89 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 t -112.36 118.65 58.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.02 118.03 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 122.658 0.383 . . . . 0.0 111.79 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.78 87.08 7.26 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -84.76 93.94 8.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 t -117.89 -177.85 3.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.2 112.92 15.68 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.802 1.241 . . . . 0.0 109.08 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -43.56 -56.97 3.37 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.808 1.243 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -57.73 -31.19 66.19 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 112.496 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.6 t -77.39 85.81 3.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -36.23 -59.21 0.99 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.758 1.17 . . . . 0.0 113.07 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.19 -41.23 73.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.017 2.478 . . . . 0.0 112.986 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 m -68.74 -36.59 78.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.74 -47.58 77.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.284 0.634 . . . . 0.0 109.417 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.4 mtm -58.67 -20.3 46.96 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.4 mt -78.36 -24.85 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.88 -51.48 80.09 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.534 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.9 -36.63 89.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.283 1.851 . . . . 0.0 111.529 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.37 -50.81 72.13 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -56.32 -45.96 80.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.662 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.78 -43.4 90.43 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.445 1.02 . . . . 0.0 110.239 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.3 m -55.43 -48.66 74.09 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.65 -43.93 97.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.195 0.521 . . . . 0.0 109.972 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . 41.1 m -54.95 -47.23 74.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 111.537 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -67.53 -12.77 61.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.525 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -74.99 -64.53 1.03 Allowed 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.924 1.238 . . . . 0.0 108.773 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.11 38.31 0.47 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.339 -0.85 . . . . 0.0 110.61 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.914 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.6 -64.2 2.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -60.29 -49.05 79.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.854 0.827 . . . . 0.0 110.285 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 94.5 t -96.76 134.25 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.28 98.78 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 50' ' ' SER . 96.5 m-85 -91.21 143.19 26.92 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.544 -0.723 . . . . 0.0 110.621 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.42 109.69 5.89 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.257 -170.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -79.67 136.78 36.89 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.6 134.79 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -100.93 104.65 15.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.52 -30.16 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 122.607 0.363 . . . . 0.0 110.611 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.9 -36.4 76.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.506 0.323 . . . . 0.0 110.514 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.65 -69.5 0.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.91 58.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.432 -0.792 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.96 35.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.315 1.046 . . . . 0.0 110.678 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.4 72.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.806 0.842 . . . . 0.0 111.13 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.87 -45.41 91.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.98 -53.8 51.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.409 0.283 . . . . 0.0 111.501 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.46 -42.35 83.18 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.595 -0.691 . . . . 0.0 110.544 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.15 -46.2 90.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.539 0.609 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.64 90.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.938 0.895 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.84 52.44 0.75 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.325 0.964 . . . . 0.0 111.946 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.68 147.92 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.9 p -127.24 -81.42 0.6 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.22 177.89 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.819 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -140.55 139.23 19.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -63.36 153.67 70.99 Favored 'Cis proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.518 1.221 . . . . 0.0 113.987 -3.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.3 m -128.61 126.42 40.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.52 101.0 8.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.529 1.132 . . . . 0.0 109.447 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -97.35 145.39 26.18 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.36 111.53 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.17 104.3 14.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -75.98 105.28 6.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 70.58 -56.11 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.879 2.471 . . . . 0.0 110.673 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 89' ' ' VAL . . . -163.47 -13.11 0.03 OUTLIER Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.484 1.992 . . . . 0.0 111.77 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.416 ' H ' ' H ' ' A' ' 88' ' ' GLY . 24.6 t -85.67 122.63 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 118.8 1.3 . . . . 0.0 108.204 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.29 94.93 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.2 -35.84 35.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.645 1.178 . . . . 0.0 111.145 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.49 168.28 27.77 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -148.24 167.33 25.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.412 2.285 . . . . 0.0 107.509 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 tp -178.09 138.55 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.205 2.202 . . . . 0.0 106.125 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.13 144.91 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.3 63.69 0.98 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 49.62 -108.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.72 1.208 . . . . 0.0 111.56 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 m 56.84 60.84 2.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.615 1.166 . . . . 0.0 111.003 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -52.01 -36.65 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.583 1.153 . . . . 0.0 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.25 -46.8 88.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.368 0.667 . . . . 0.0 109.72 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -69.02 -35.7 76.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -56.5 -53.68 54.64 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.314 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -53.31 -47.42 69.27 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.08 79.88 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.91 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.05 -55.75 29.09 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.497 0.589 . . . . 0.0 109.607 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.59 -47.28 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.84 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.68 -56.44 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.672 0.272 . . . . 0.0 110.295 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -49.37 -62.77 1.36 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.914 1.286 . . . . 0.0 110.773 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -69.79 -22.55 63.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.84 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.21 -44.81 62.39 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 123.075 0.55 . . . . 0.0 109.802 177.664 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 119.56 -0.257 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 50' ' ' SER . 46.6 t -102.38 107.06 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.01 146.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 CA-C-N 119.315 0.962 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.84 22.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.317 1.847 . . . . 0.0 108.608 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.27 162.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -78.72 77.94 5.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -59.42 72.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 127.943 2.497 . . . . 0.0 115.45 -170.791 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -92.94 -66.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.121 1.369 . . . . 0.0 108.444 167.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.9 17.14 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.027 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.8 65.1 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.667 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -53.13 18.15 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 109.361 175.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.73 -48.52 68.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.828 0.451 . . . . 0.0 110.895 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.95 -60.92 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.598 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -57.09 -47.37 81.22 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.258 1.023 . . . . 0.0 109.689 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -49.66 -48.92 49.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.034 0.379 . . . . 0.0 110.61 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -63.63 1.08 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.638 0.375 . . . . 0.0 111.011 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.37 -25.87 67.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.822 -0.549 . . . . 0.0 111.951 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 -24.55 71.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.721 -1.044 . . . . 0.0 111.801 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 51.31 67.1 1.0 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.224 1.012 . . . . 0.0 109.752 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 46.12 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.395 1.878 . . . . 0.0 114.489 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -139.89 7.23 2.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.468 0.707 . . . . 0.0 112.803 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.03 129.3 61.87 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.14 122.86 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.608 1.538 . . . . 0.0 112.188 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.34 99.79 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.62 111.31 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.79 125.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.35 98.8 11.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.959 1.304 . . . . 0.0 109.463 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.77 96.83 9.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 t -127.21 -150.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -167.97 161.17 12.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 110.912 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -66.56 -59.67 3.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.749 1.22 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -51.01 -33.69 26.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.471 1.508 . . . . 0.0 114.594 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 p -78.37 57.81 2.0 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.605 1.093 . . . . 0.0 112.051 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.46 -87.65 0.0 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 129.129 3.252 . . . . 0.0 115.398 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -41.2 -37.16 2.77 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.717 3.611 . . . . 0.0 113.979 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -45.05 -45.87 11.11 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.405 1.482 . . . . 0.0 111.335 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -65.23 -21.97 66.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.865 0.866 . . . . 0.0 111.593 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.2 mtt -90.0 -37.51 14.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.999 1.32 . . . . 0.0 109.403 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mt -64.16 -42.52 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 109.382 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -47.98 -53.75 29.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.201 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 75.1 Cg_exo -46.57 -46.9 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.167 3.245 . . . . 0.0 114.186 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.08 -49.51 77.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.746 0.784 . . . . 0.0 108.891 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -58.53 -42.33 87.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.152 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.12 -40.63 96.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.026 0.83 . . . . 0.0 109.574 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -58.52 -49.98 75.41 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.75 -36.47 76.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.044 0.449 . . . . 0.0 109.995 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 41.9 m -60.17 -46.28 90.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.973 -0.454 . . . . 0.0 109.78 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -64.72 -43.8 92.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -47.55 -51.62 20.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.951 0.5 . . . . 0.0 111.675 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -101.54 33.7 2.86 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.377 0.535 . . . . 0.0 111.659 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.58 151.5 10.54 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.565 -0.709 . . . . 0.0 111.681 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 -62.99 3.2 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -55.66 -52.86 62.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.509 0.724 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 94.8 t -106.75 140.55 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 mm -96.31 131.77 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 93.8 m-85 -121.79 118.21 28.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.861 0.755 . . . . 0.0 110.778 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -112.44 148.66 33.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.612 1.565 . . . . 0.0 110.072 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -123.22 132.71 54.14 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.42 1.488 . . . . 0.0 107.849 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.23 130.46 39.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 119.171 0.896 . . . . 0.0 109.765 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.54 109.71 21.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.59 -27.38 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.958 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.03 -40.9 97.35 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.608 0.64 . . . . 0.0 109.476 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.51 -63.64 1.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.124 0.57 . . . . 0.0 110.073 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.57 58.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.666 0.746 . . . . 0.0 110.001 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.39 68.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.034 0.934 . . . . 0.0 110.963 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.5 -56.11 22.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.878 0.871 . . . . 0.0 112.16 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.16 -42.62 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.86 63.44 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.7 -38.64 80.43 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.454 -0.779 . . . . 0.0 110.189 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.82 -46.28 89.73 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.564 0.62 . . . . 0.0 109.943 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.92 73.06 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.453 0.701 . . . . 0.0 110.015 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 43.73 4.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.712 1.149 . . . . 0.0 111.208 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.8 mm -79.17 140.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -134.15 -80.35 0.46 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.376 1.07 . . . . 0.0 109.226 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.29 67.21 2.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.261 1.024 . . . . 0.0 111.033 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -63.77 144.77 97.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.168 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.45 148.22 64.43 Favored 'Cis proline' 0 N--CA 1.455 -0.745 0 CA-C-N 120.847 1.338 . . . . 0.0 112.783 -0.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -146.32 122.98 11.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.84 118.9 37.78 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.606 1.162 . . . . 0.0 109.395 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -109.52 150.12 28.62 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.77 107.75 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -99.77 114.31 27.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.648 0.779 . . . . 0.0 111.285 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.57 -170.5 2.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 166.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 89' ' ' VAL . 25.7 p-10 -67.61 -34.22 76.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.123 -0.985 . . . . 0.0 108.474 165.054 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 41.39 0.97 Allowed Glycine 0 CA--C 1.541 1.709 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.31 20.1 m 24.45 -139.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.64 1 C-N-CA 133.701 4.8 . . . . 0.0 113.458 -179.178 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -54.12 85.14 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.873 1.269 . . . . 0.0 109.616 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.87 40.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.491 0.716 . . . . 0.0 109.856 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.68 161.85 41.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.888 0.475 . . . . 0.0 110.345 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -140.58 165.48 27.34 Favored 'General case' 0 C--N 1.335 -0.048 0 C-N-CA 127.14 2.176 . . . . 0.0 107.731 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.1 tp -172.39 103.9 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.893 1.277 . . . . 0.0 109.785 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.82 162.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.548 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 170.42 27.77 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.423 1.011 . . . . 0.0 112.743 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.45 45.34 0.56 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.465 1.106 . . . . 0.0 110.312 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -77.99 60.11 2.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.051 1.34 . . . . 0.0 111.688 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.39 -46.37 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.56 1.544 . . . . 0.0 113.982 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.63 -48.31 75.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.283 -0.886 . . . . 0.0 110.372 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.6 -38.96 86.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.16 -57.43 13.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -45.38 -53.52 8.52 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.621 0.768 . . . . 0.0 110.213 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.55 -50.81 70.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.321 1.013 . . . . 0.0 111.511 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.98 -46.02 90.82 Favored 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.583 -0.698 . . . . 0.0 110.34 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.33 -46.34 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.9 -52.68 59.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.83 -61.0 2.57 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.104 0.962 . . . . 0.0 111.144 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -64.59 -31.79 73.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.885 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.58 42.67 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.946 0.898 . . . . 0.0 111.154 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.347 0.659 . . . . 0.0 112.342 179.65 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.26 31.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.83 2.052 . . . . 0.0 108.087 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 pt -131.79 -173.1 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.392 1.477 . . . . 0.0 110.677 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.95 115.45 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -155.64 99.54 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 122.343 1.068 . . . . 0.0 109.244 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -91.58 -42.49 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.866 1.266 . . . . 0.0 109.705 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 m -32.86 113.17 0.13 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 115.016 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -40.92 66.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 110.527 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -25.12 64.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.938 0.495 . . . . 0.0 111.885 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.44 -31.63 12.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.123 0.969 . . . . 0.0 110.898 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -45.94 -58.25 3.71 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.48 1.512 . . . . 0.0 112.147 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.95 -44.72 84.2 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.655 -0.653 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.77 -42.85 62.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -56.15 25.58 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.94 1.696 . . . . 0.0 109.085 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.6 mt -49.67 -45.79 49.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 110.481 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.85 -63.46 1.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.135 0.574 . . . . 0.0 111.589 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -57.4 -32.08 66.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.373 0.533 . . . . 0.0 111.082 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.97 55.31 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.113 -1.382 . . . . 0.0 113.031 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? 59.0 69.92 0.69 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -68.64 62.51 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.441 2.696 . . . . 0.0 112.767 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -116.92 -93.16 0.51 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.67 73.48 0.82 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.922 0.889 . . . . 0.0 109.052 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 27' ' ' ILE . 29.4 mmtm -140.29 150.31 60.9 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.13 86.39 0.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 N-CA-C 106.609 -2.112 . . . . 0.0 106.609 168.409 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 25' ' ' LYS . 3.4 mp -82.24 79.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.36 137.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 147.23 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -117.6 113.53 22.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.63 112.1 22.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -142.79 179.0 7.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.23 170.62 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.585 1.554 . . . . 0.0 110.812 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.9 p -96.8 -66.49 0.9 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.943 1.697 . . . . 0.0 110.708 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -43.07 -32.38 0.68 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.51 2.324 . . . . 0.0 113.164 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -58.46 -19.55 37.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.482 1.113 . . . . 0.0 113.093 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 -113.44 3.77 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.359 -1.245 . . . . 0.0 110.065 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.89 -42.84 6.78 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.282 3.321 . . . . 0.0 115.207 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -23.09 55.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -71.17 -31.67 67.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.428 -0.795 . . . . 0.0 110.364 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 mmt -61.22 -18.25 57.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.14 0.976 . . . . 0.0 112.467 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.405 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 43.6 mt -62.98 -33.43 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.6 6.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.114 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -57.11 -35.99 99.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.801 1.679 . . . . 0.0 112.019 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.34 -55.14 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.399 0.618 . . . . 0.0 109.733 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -56.5 -41.26 76.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.67 0.788 . . . . 0.0 109.522 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.68 -40.61 97.64 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.881 -0.512 . . . . 0.0 110.119 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -60.21 -48.84 80.03 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.51 -39.17 75.94 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.257 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -54.88 -54.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.05 -45.79 79.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.989 0.915 . . . . 0.0 110.771 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.24 -43.14 95.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.759 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -79.42 -45.41 19.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.97 -64.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.76 -119.47 0.01 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.575 2.512 . . . . 0.0 116.92 -170.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 55.37 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.091 -1.24 . . . . 0.0 111.12 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.89 149.46 25.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.042 1.337 . . . . 0.0 110.552 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.72 105.44 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.92 94.39 5.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.604 1.162 . . . . 0.0 108.434 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.9 92.45 5.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.911 1.284 . . . . 0.0 109.824 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -85.25 107.42 17.28 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.233 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.67 149.75 17.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 125.292 1.437 . . . . 0.0 110.255 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.99 115.77 30.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.0 0.92 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.66 -45.8 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 124.867 1.267 . . . . 0.0 110.991 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -58.45 -41.66 85.64 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.03 -70.91 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -87.88 63.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 O-C-N 121.332 -0.855 . . . . 0.0 110.955 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.93 48.3 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.48 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.5 69.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.008 0.923 . . . . 0.0 111.295 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.07 -44.96 97.83 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -55.59 29.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.648 0.379 . . . . 0.0 111.169 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.92 -41.71 97.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.707 0.685 . . . . 0.0 109.831 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.66 77.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.641 0.655 . . . . 0.0 110.528 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 7.76 12.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.12 0.968 . . . . 0.0 111.792 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.38 27.06 70.16 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.211 0.91 . . . . 0.0 113.093 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.88 81.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 122.558 1.171 . . . . 0.0 108.707 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -92.1 -72.58 0.58 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.842 2.057 . . . . 0.0 108.099 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.46 59.94 1.53 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.831 0.852 . . . . 0.0 111.389 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.86 152.18 96.89 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -60.17 147.96 44.01 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 121.016 1.398 . . . . 0.0 112.491 -2.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.8 m -147.35 141.79 26.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 51.8 m-85 -134.34 130.49 37.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.666 1.587 . . . . 0.0 107.917 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -125.3 158.49 34.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.551 1.14 . . . . 0.0 107.925 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.4 122.02 63.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 27' ' ' ILE . 40.6 m-85 -110.81 76.36 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.107 0.563 . . . . 0.0 111.966 -173.796 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -90.43 -168.08 2.01 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.349 -0.845 . . . . 0.0 110.285 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 89' ' ' VAL . 3.3 m-20 -51.23 -43.07 61.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.08 17.86 0.14 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.612 2.053 . . . . 0.0 112.507 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 90' ' ' LYS 0.277 40.5 t 67.18 -154.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.42 1.488 . . . . 0.0 107.34 170.592 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LYS . . . . . 0.67 ' H ' HG12 ' A' ' 89' ' ' VAL . 22.5 ttpp -64.29 79.53 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.29 -32.45 43.58 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.622 -166.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -147.19 151.07 36.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -142.97 166.27 25.1 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.081 1.352 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 98' ' ' SER . 1.7 tm? -161.83 140.98 9.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.762 1.225 . . . . 0.0 108.263 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 m -127.26 162.68 31.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.485 1.114 . . . . 0.0 110.793 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 179.16 36.76 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.841 -0.799 . . . . 0.0 111.09 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 94' ' ' LEU . 14.2 m -80.08 58.86 3.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -48.92 -46.57 43.27 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.374 . . . . 0.0 111.864 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.36 -48.51 74.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.103 0.561 . . . . 0.0 110.128 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' HD3' HD23 ' A' ' 94' ' ' LEU . 50.7 tttm -68.8 -35.62 77.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -58.69 -48.71 80.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 109.132 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.98 -47.76 80.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.93 77.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.23 -55.72 31.34 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.0 t -51.08 -53.34 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.24 -52.11 62.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.94 0.496 . . . . 0.0 111.562 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -68.28 0.23 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.471 0.653 . . . . 0.0 110.034 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -61.01 -24.04 65.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.091 -170.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.42 94.45 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.728 0.695 . . . . 0.0 109.696 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.477 0.711 . . . . 0.0 109.47 178.991 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.71 32.41 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.481 1.512 . . . . 0.0 112.784 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -107.99 154.09 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.35 -0.844 . . . . 0.0 112.392 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.89 135.95 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -160.58 -41.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 122.7 1.238 . . . . 0.0 111.295 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.38 49.36 6.05 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 128.044 2.538 . . . . 0.0 112.241 168.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -131.82 134.73 46.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.578 1.151 . . . . 0.0 107.988 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -49.57 -46.81 49.35 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.754 0.822 . . . . 0.0 111.113 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.92 -11.34 37.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.871 1.268 . . . . 0.0 113.143 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 -33.28 6.91 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.499 1.12 . . . . 0.0 110.075 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -46.79 19.75 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.171 1.388 . . . . 0.0 110.274 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -69.47 -53.39 19.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.012 0.525 . . . . 0.0 109.954 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.68 27.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.608 1.163 . . . . 0.0 111.26 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -44.72 41.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.499 1.52 . . . . 0.0 111.286 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.54 -39.1 93.14 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.704 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.57 -54.13 15.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.039 0.536 . . . . 0.0 109.869 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.5 -28.63 69.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.43 -54.53 33.54 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.767 1.175 . . . . 0.0 111.312 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 103.64 81.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 1 C-N-CA 132.063 4.145 . . . . 0.0 107.665 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -72.83 60.89 0.53 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.641 1.977 . . . . 0.0 110.189 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -119.33 -60.1 1.77 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.947 1.299 . . . . 0.0 108.207 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -152.32 90.9 1.54 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -157.77 152.77 21.36 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -76.36 106.71 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.912 3.075 . . . . 0.0 108.793 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.24 81.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -84.18 120.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -120.62 118.42 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -88.72 96.75 10.79 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.567 1.147 . . . . 0.0 108.958 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -82.25 113.2 19.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 m -141.46 149.47 40.99 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 122.987 0.515 . . . . 0.0 110.041 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 133.21 34.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -50.83 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.63 100.74 5.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.2 133.13 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.479 -0.763 . . . . 0.0 109.003 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.48 150.97 40.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER 50.91 -29.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.445 3.43 . . . . 0.0 118.59 -170.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.2 m -50.73 -45.86 58.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 122.573 2.442 . . . . 0.0 108.354 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -56.06 -26.48 49.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.876 1.67 . . . . 0.0 112.438 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 60.6 mtt -91.15 -43.67 9.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.27 1.428 . . . . 0.0 110.371 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.65 -42.5 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.38 1.472 . . . . 0.0 110.31 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -55.32 -60.09 9.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.769 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 71.2 Cg_exo -47.14 -46.9 18.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.643 173.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.96 -55.44 34.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.429 0.633 . . . . 0.0 110.466 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -57.42 -37.91 73.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.023 0.529 . . . . 0.0 109.718 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.62 -38.35 89.2 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.704 -0.623 . . . . 0.0 110.146 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 m -60.9 -46.02 92.3 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.11 -40.49 93.94 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 p -58.7 -41.93 87.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.117 -0.99 . . . . 0.0 109.599 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -39.83 94.96 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.76 -47.91 81.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.773 0.429 . . . . 0.0 110.965 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -79.25 -47.74 15.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.874 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 18.77 73.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.585 2.754 . . . . 0.0 115.238 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.0 -96.76 0.11 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -76.46 46.29 0.42 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.09 1.356 . . . . 0.0 110.686 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.6 m -156.76 161.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.047 -1.033 . . . . 0.0 109.62 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.98 121.35 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 169.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.36 91.48 3.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.624 1.169 . . . . 0.0 107.92 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -84.96 127.24 34.09 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.273 1.029 . . . . 0.0 110.923 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.34 128.76 44.44 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.0 101.06 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 122.138 0.97 . . . . 0.0 111.388 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.07 104.07 0.84 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.22 -36.18 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.982 1.313 . . . . 0.0 110.018 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -63.16 -28.23 69.91 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.618 0.367 . . . . 0.0 111.104 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.46 -65.8 0.97 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.7 56.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 110.134 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.13 77.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.023 0.929 . . . . 0.0 111.529 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.32 -53.12 48.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.907 0.883 . . . . 0.0 111.657 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.41 -46.57 94.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.26 -57.25 11.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.722 0.237 . . . . 0.0 111.437 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.02 -41.3 97.94 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.415 -0.803 . . . . 0.0 110.703 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.35 98.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.384 0.538 . . . . 0.0 111.367 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.32 81.24 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 0.0 111.151 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.67 82.4 1.35 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.76 139.3 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 126.279 1.832 . . . . 0.0 106.401 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -131.92 -96.11 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.76 71.64 5.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.725 0.81 . . . . 0.0 109.446 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' MET . . . . . 0.409 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 1.7 pmm? -53.98 143.66 41.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.052 0.941 . . . . 0.0 109.855 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 79' ' ' MET . 99.9 Cg_exo -57.55 154.98 32.59 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-N 121.131 1.44 . . . . 0.0 113.642 -1.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.9 108.7 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.76 89.94 5.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.635 1.574 . . . . 0.0 110.104 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -80.26 146.15 31.81 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.42 104.58 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -92.68 52.83 1.94 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -50.69 132.14 25.92 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 74.85 -62.19 0.46 Allowed 'General case' 0 CA--C 1.526 0.043 0 C-N-CA 126.835 2.054 . . . . 0.0 108.726 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.71 39.06 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.912 1.244 . . . . 0.0 111.533 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.88 142.22 8.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -60.54 91.23 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 109.945 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.44 -31.56 29.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.224 1.41 . . . . 0.0 110.741 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -150.27 170.87 17.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.609 0.242 . . . . 0.0 111.163 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -150.12 165.07 33.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.448 1.899 . . . . 0.0 107.43 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.9 tp -172.39 108.08 0.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.264 1.426 . . . . 0.0 108.842 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.6 168.04 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.345 0.658 . . . . 0.0 110.446 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.12 -177.76 27.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.38 -65.77 0.63 Allowed 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m 45.45 43.91 9.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 113.046 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -48.59 -44.14 36.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 112.695 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -59.71 -52.32 65.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.21 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.85 -31.55 71.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.21 -59.22 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -53.54 -49.85 66.74 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.258 0.623 . . . . 0.0 110.464 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.84 71.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.067 0.147 . . . . 0.0 110.87 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.37 -46.27 84.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.454 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.77 -48.81 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.794 1.179 . . . . 0.0 108.916 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.72 47.7 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.75 0.42 . . . . 0.0 110.485 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -52.37 -63.23 1.21 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.057 0.943 . . . . 0.0 110.661 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.24 -19.1 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.351 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.29 9.12 37.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.277 0.944 . . . . 0.0 111.385 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.23 0 CA-C-N 119.295 0.952 . . . . 0.0 111.703 -179.079 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 58' ' ' ILE . 4.3 m . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.8 m -142.57 31.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.048 2.139 . . . . 0.0 107.179 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.11 147.48 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 125.248 1.419 . . . . 0.0 111.672 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.1 71.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.352 1.061 . . . . 0.0 110.816 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.34 122.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -98.75 -25.15 14.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.336 2.254 . . . . 0.0 113.569 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -38.06 130.11 1.2 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.663 1.585 . . . . 0.0 111.627 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -49.89 -40.39 42.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.049 0.84 . . . . 0.0 112.537 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 -42.6 81.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.749 0.785 . . . . 0.0 110.034 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.18 -33.64 67.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.189 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -57.95 -52.23 66.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -56.2 -50.05 72.32 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.404 0.682 . . . . 0.0 109.939 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.1 61.97 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.869 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.6 -39.14 73.05 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.562 1.145 . . . . 0.0 111.058 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -62.34 -10.5 11.36 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.222 0.609 . . . . 0.0 111.454 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.69 -58.97 1.94 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.645 1.178 . . . . 0.0 109.908 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -9.57 23.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.522 -0.736 . . . . 0.0 112.184 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.53 -26.7 71.02 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt 55.07 51.73 12.93 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.738 1.215 . . . . 0.0 109.475 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -77.18 62.63 2.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.702 1.601 . . . . 0.0 110.218 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.95 -49.77 70.53 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 109.154 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.37 22.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.676 1.99 . . . . 0.0 108.865 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -87.56 160.71 47.14 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.498 1.119 . . . . 0.0 110.723 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.91 120.62 5.85 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.437 2.091 . . . . 0.0 112.255 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.36 92.88 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.64 111.29 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.64 128.96 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -99.84 102.74 14.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.591 2.356 . . . . 0.0 108.461 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.45 96.75 8.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 33' ' ' ALA . 72.9 m -136.75 -177.34 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 32' ' ' THR . . . -169.46 -177.83 2.91 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 120.878 1.672 . . . . 0.0 110.147 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 p -56.53 -50.17 72.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.931 1.693 . . . . 0.0 109.001 172.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -59.43 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.214 2.605 . . . . 0.0 113.704 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.0 p 170.72 -21.58 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.839 2.456 . . . . 0.0 110.491 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.95 -114.52 5.61 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.088 -1.396 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -41.04 -41.45 4.28 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.502 3.468 . . . . 0.0 115.853 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -27.23 58.02 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.473 0.579 . . . . 0.0 111.57 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -57.99 -23.7 55.07 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.544 -0.723 . . . . 0.0 111.125 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.8 mtm -60.83 -13.72 17.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.778 0.717 . . . . 0.0 111.965 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.84 -30.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.632 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.04 -56.48 25.37 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.629 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.24 -33.46 97.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 122.11 1.789 . . . . 0.0 111.962 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.99 -46.94 76.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.94 -42.72 97.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.579 0.752 . . . . 0.0 110.005 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.4 m -57.62 -47.07 83.22 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.64 -42.25 98.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -52.34 -50.25 62.68 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -41.76 95.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.952 0.501 . . . . 0.0 110.651 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.12 -49.8 75.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.728 0.811 . . . . 0.0 111.315 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.17 -48.18 14.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.176 0.19 . . . . 0.0 110.635 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.91 -73.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.313 1.845 . . . . 0.0 114.133 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.24 -68.7 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.388 0.994 . . . . 0.0 114.23 -172.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -69.88 19.43 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CE1' ' A' ' 59' ' ' PHE . 41.0 t -152.13 154.93 7.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 119.886 1.221 . . . . 0.0 109.43 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 3' ' ' SER . 4.2 mp -116.52 102.87 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE1' HG11 ' A' ' 57' ' ' VAL . 24.0 m-85 -94.25 98.03 10.65 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.086 0.954 . . . . 0.0 109.278 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.94 121.77 32.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.857 0.463 . . . . 0.0 109.787 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -99.52 115.77 30.12 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.81 119.45 58.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 118.484 0.584 . . . . 0.0 110.868 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.68 100.2 10.07 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 172.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -44.22 -58.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.854 1.662 . . . . 0.0 111.51 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.26 -42.59 86.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.9 0.88 . . . . 0.0 111.574 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.38 -67.9 0.42 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.124 0.42 . . . . 0.0 110.063 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -86.44 63.79 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.926 0.87 . . . . 0.0 109.869 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.2 -40.74 34.64 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.674 1.189 . . . . 0.0 110.615 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.39 77.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.692 0.797 . . . . 0.0 111.048 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.52 -45.07 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.12 35.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.552 0.341 . . . . 0.0 111.435 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.81 -41.12 96.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.26 0.482 . . . . 0.0 109.758 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.31 -41.82 76.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.741 0.7 . . . . 0.0 110.235 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.1 6.9 14.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.48 0.712 . . . . 0.0 112.295 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.94 97.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.023 0.821 . . . . 0.0 112.731 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.0 mm -94.3 153.65 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.5 m -153.64 -57.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.12 159.5 18.18 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.81 158.99 29.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.414 -1.279 . . . . 0.0 107.855 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.34 126.44 3.64 Favored 'Cis proline' 0 C--N 1.35 0.612 0 CA-C-N 121.338 1.514 . . . . 0.0 112.975 -1.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 m -126.87 122.07 33.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.44 129.01 56.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.146 . . . . 0.0 108.521 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -121.3 152.4 38.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.13 94.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -88.65 104.75 17.15 Favored 'General case' 0 C--O 1.227 -0.103 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -77.1 127.65 33.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.28 -64.78 0.32 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.792 2.037 . . . . 0.0 109.136 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 22.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.032 1.777 . . . . 0.0 112.242 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.34 125.63 43.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 119.324 1.562 . . . . 0.0 109.576 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -50.28 97.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.135 1.774 . . . . 0.0 110.782 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.97 -31.07 27.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.294 1.038 . . . . 0.0 110.101 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -160.35 172.89 16.49 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.737 0.815 . . . . 0.0 108.9 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.48 -179.28 7.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.115 0.966 . . . . 0.0 109.284 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -164.96 106.18 0.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 106.951 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.56 32.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.0 1.32 . . . . 0.0 113.075 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 168.73 37.19 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.187 -0.946 . . . . 0.0 112.661 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.92 38.55 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.298 1.439 . . . . 0.0 112.942 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.3 m -81.4 70.92 8.37 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 120.649 -1.282 . . . . 0.0 109.717 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -39.62 -52.06 2.23 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.826 1.651 . . . . 0.0 113.757 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.57 -44.19 93.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.81 -0.556 . . . . 0.0 110.959 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -65.32 -41.57 93.85 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -51.81 -58.01 7.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.938 1.295 . . . . 0.0 108.187 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.49 -52.68 58.78 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.92 0.888 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.25 71.24 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.8 mt -58.66 -51.37 70.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.18 -48.88 81.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.489 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.9 61.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.599 0.36 . . . . 0.0 110.864 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -56.21 -65.09 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.122 0.969 . . . . 0.0 110.417 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -64.42 -24.44 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.455 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.5 2.84 23.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.951 0.796 . . . . 0.0 112.033 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 120.031 1.287 . . . . 0.0 111.462 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.404 0.621 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 50' ' ' SER . 11.3 t -131.66 92.38 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -136.96 176.06 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.247 0.546 . . . . 0.0 112.406 -171.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.08 22.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.516 1.526 . . . . 0.0 110.939 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -82.03 78.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.99 64.24 0.33 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.413 1.885 . . . . 0.0 109.631 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.6 m -153.12 167.82 27.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.19 1.396 . . . . 0.0 109.469 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -39.77 -42.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.695 1.998 . . . . 0.0 112.339 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.5 -41.12 9.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 112.037 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.01 62.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.578 -0.701 . . . . 0.0 109.944 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -53.96 -40.25 66.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.98 0.912 . . . . 0.0 112.198 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.06 -72.62 0.71 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.49 -55.68 23.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.257 0.623 . . . . 0.0 111.899 -173.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.96 -50.18 73.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -47.19 -50.13 21.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.891 0.476 . . . . 0.0 110.762 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.37 -58.35 8.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.118 0.567 . . . . 0.0 111.147 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.47 -19.4 63.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.561 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.18 49.2 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.751 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 57.56 65.76 1.28 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.026 1.413 . . . . 0.0 109.837 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 68.13 1.86 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 109.839 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.01 -51.79 35.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -163.48 22.59 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.38 1.872 . . . . 0.0 109.487 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -69.31 144.47 94.83 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 121.865 -0.522 . . . . 0.0 111.674 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.81 92.39 0.52 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.539 1.493 . . . . 0.0 108.844 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.5 111.65 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.52 123.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.3 104.22 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.832 0.853 . . . . 0.0 110.282 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.97 90.55 5.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.274 1.03 . . . . 0.0 109.395 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.11 113.35 18.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -139.55 146.89 40.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ALA . . . . . 0.602 ' HB1' ' CE2' ' A' ' 35' ' ' TRP . . . -77.58 107.48 10.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.8 m -58.44 -36.65 73.98 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.795 0.725 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TRP . . . . . 0.602 ' CE2' ' HB1' ' A' ' 33' ' ' ALA . 37.1 p-90 -60.91 -32.39 71.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.466 0.706 . . . . 0.0 110.572 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -78.89 77.08 5.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.58 -54.09 2.84 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.524 1.059 . . . . 0.0 112.184 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.49 -45.49 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.094 2.529 . . . . 0.0 112.75 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.16 -45.56 90.67 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -61.49 -13.01 17.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.753 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.92 -12.87 60.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 121.556 1.98 . . . . 0.0 111.128 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.79 -23.83 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 118.714 0.688 . . . . 0.0 109.306 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.55 -47.04 97.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.71 -1.244 . . . . 0.0 112.644 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.35 -35.43 73.07 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.347 1.874 . . . . 0.0 110.795 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.27 -46.26 89.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.75 -46.4 81.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.01 -41.97 88.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.567 0.747 . . . . 0.0 109.974 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -60.17 -44.83 94.72 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 49' ' ' LEU . 14.0 tp -62.51 -38.02 88.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.081 -0.387 . . . . 0.0 110.036 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.533 ' HB3' HG13 ' A' ' 4' ' ' VAL . 11.5 m -60.08 -48.67 80.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.401 0.68 . . . . 0.0 109.757 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -59.4 -45.19 92.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.944 0.497 . . . . 0.0 109.667 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.11 -56.77 17.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.734 0.414 . . . . 0.0 110.501 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -86.19 58.02 4.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.23 -20.73 66.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.649 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -149.44 0.05 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.591 1.567 . . . . 0.0 113.959 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 53.53 0.84 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 113.012 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.91 140.01 49.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.323 1.849 . . . . 0.0 106.183 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.1 mm -112.91 134.64 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -126.41 111.81 14.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.673 0.67 . . . . 0.0 110.04 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.59 147.21 37.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.307 1.443 . . . . 0.0 108.949 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -118.23 144.14 46.0 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.93 126.29 37.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -83.88 117.76 23.53 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.8 72.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 177.69 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.543 2.737 . . . . 0.0 105.759 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.02 65.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.457 0.303 . . . . 0.0 110.414 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.16 39.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.57 -49.59 26.12 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.224 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.21 -47.43 62.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.462 0.705 . . . . 0.0 112.252 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.49 -46.7 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.46 78.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.061 0.458 . . . . 0.0 110.271 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -57.46 -58.92 6.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.25 1.02 . . . . 0.0 109.519 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.9 73.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.814 0.446 . . . . 0.0 111.23 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.04 -17.89 63.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.707 0.803 . . . . 0.0 111.578 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 44.27 13.69 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.71 0.671 . . . . 0.0 111.436 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.0 mm -74.37 139.72 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.4 p -124.52 -85.08 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.509 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.67 86.3 6.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.434 1.094 . . . . 0.0 111.402 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -62.64 145.01 95.78 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.462 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.91 153.05 72.97 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.62 1.257 . . . . 0.0 111.634 -2.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -145.38 114.69 7.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.52 119.74 35.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.593 1.157 . . . . 0.0 109.382 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -111.2 134.9 52.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.99 109.44 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.76 97.64 7.44 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.658 0.383 . . . . 0.0 111.788 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -90.3 -165.22 1.3 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 89' ' ' VAL . 19.3 p-10 -69.63 -36.68 76.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 169.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.5 41.37 1.16 Allowed Glycine 0 CA--C 1.543 1.808 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 166.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.333 25.3 m 20.89 -134.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.448 1 C-N-CA 133.008 4.523 . . . . 0.0 113.482 -178.105 . . . . . . . . 4 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -58.18 79.06 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.338 1.455 . . . . 0.0 109.032 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -29.21 39.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.41 1.084 . . . . 0.0 111.589 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -158.34 157.4 32.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -147.05 158.87 44.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.0 tp -155.52 109.58 2.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 109.882 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.68 168.54 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 110.562 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.66 178.43 40.4 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.388 0.518 . . . . 0.0 112.208 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.74 -59.04 4.98 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 110.196 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 33.49 21.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.0 3.32 . . . . 0.0 119.237 171.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 4.0 pm0 -51.51 -40.59 59.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.279 1.4 . . . . 0.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.69 -36.42 69.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.848 -0.533 . . . . 0.0 111.203 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.66 -38.23 26.23 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.2 tp -45.81 -51.33 13.01 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.36 0.664 . . . . 0.0 109.508 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -41.5 -52.87 3.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 0.0 111.759 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.68 79.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.45 1.1 . . . . 0.0 110.725 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -49.12 79.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.6 t -57.83 -46.99 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.29 -53.26 46.4 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -54.98 -62.33 1.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.221 1.008 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -62.65 -22.21 66.28 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.72 -5.15 54.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.79 0.723 . . . . 0.0 112.126 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 119.831 1.196 . . . . 0.0 111.328 179.457 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 120.3 0.095 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.7 26.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.335 1.854 . . . . 0.0 108.719 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 pp -97.94 175.31 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.66 122.69 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.24 2.216 . . . . 0.0 108.051 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 tt -160.63 151.32 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.772 0.714 . . . . 0.0 109.666 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -74.75 72.61 2.02 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -55.56 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 129.233 3.013 . . . . 0.0 115.556 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -93.78 -94.86 0.16 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.906 1.282 . . . . 0.0 109.596 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.73 77.06 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.453 -1.404 . . . . 0.0 109.314 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.9 69.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.14 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -50.29 71.83 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.48 1.037 . . . . 0.0 108.402 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -48.75 79.67 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.66 -49.39 75.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.386 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.57 64.68 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.554 0.742 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -49.42 -54.54 16.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 -62.36 1.74 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.924 0.489 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -59.61 -29.03 67.71 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.423 0.556 . . . . 0.0 111.103 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.41 67.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.091 -1.394 . . . . 0.0 112.916 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.33 55.01 10.13 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.995 1.398 . . . . 0.0 108.754 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -38.75 -31.57 0.06 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.56 3.144 . . . . 0.0 116.377 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -9.06 -74.09 0.0 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 129.464 3.106 . . . . 0.0 111.208 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -138.83 74.07 1.46 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -165.51 121.98 1.03 Allowed Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 133.98 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.057 1.838 . . . . 0.0 113.76 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.35 102.21 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 101.203 -3.628 . . . . 0.0 101.203 169.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 t -99.95 120.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.68 104.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 124.935 1.294 . . . . 0.0 110.636 -173.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -83.46 95.73 8.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.301 1.44 . . . . 0.0 107.925 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -80.19 122.81 27.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -146.51 168.24 21.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.66 114.85 23.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.895 0.77 . . . . 0.0 108.95 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -43.36 -57.0 3.24 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.193 1.397 . . . . 0.0 113.128 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -59.19 -30.67 68.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.076 0.551 . . . . 0.0 112.192 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.9 t -76.06 84.71 2.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.24 -59.73 0.76 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.95 1.262 . . . . 0.0 112.942 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.7 -40.6 79.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.163 2.575 . . . . 0.0 113.025 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -67.1 -43.95 81.23 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -62.77 -43.3 99.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.998 0.519 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.6 mmm -58.99 -17.49 25.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt -79.14 -24.45 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 119.193 0.906 . . . . 0.0 109.79 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.36 -55.05 41.4 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 117.453 -1.26 . . . . 0.0 112.272 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.73 94.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.205 1.937 . . . . 0.0 111.686 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.98 -52.9 63.76 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -60.54 -37.47 81.31 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.717 -0.615 . . . . 0.0 109.898 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.35 -35.52 75.85 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.297 -0.877 . . . . 0.0 109.861 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -61.23 -47.49 85.81 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.89 -39.63 90.02 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -55.89 -51.98 65.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.868 0.467 . . . . 0.0 109.857 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -39.9 94.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.159 0.584 . . . . 0.0 109.888 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.02 -46.54 85.12 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.031 0.532 . . . . 0.0 111.35 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -79.65 -53.17 7.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 -56.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.161 2.184 . . . . 0.0 115.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.49 -116.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.823 2.154 . . . . 0.0 115.688 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -40.4 -45.37 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.14 136.97 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 O-C-N 122.209 -0.307 . . . . 0.0 110.189 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.22 125.81 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -112.72 143.86 43.23 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.64 118.67 7.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.593 -167.794 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -106.28 118.2 36.02 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.85 134.4 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.389 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -85.39 106.66 16.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.424 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.41 -38.99 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 126.473 1.909 . . . . 0.0 109.791 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.96 -34.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.076 0.151 . . . . 0.0 111.29 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.65 -72.25 0.44 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.17 61.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 121.502 -0.749 . . . . 0.0 110.495 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.49 -41.25 53.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.501 0.72 . . . . 0.0 109.9 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.46 68.66 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.13 0.972 . . . . 0.0 111.112 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.11 -45.98 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -54.81 38.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.859 0.464 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.12 -40.09 82.61 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 110.646 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.07 89.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.521 0.601 . . . . 0.0 110.215 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.02 95.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.288 0.635 . . . . 0.0 109.833 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.01 47.09 0.73 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.58 1.086 . . . . 0.0 112.583 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.07 132.22 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.7 p -112.31 -76.79 0.59 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.31 149.39 22.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.512 1.125 . . . . 0.0 108.89 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.69 143.37 33.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -72.26 170.6 66.89 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 C-N-CA 125.144 -0.773 . . . . 0.0 112.588 -1.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 129.68 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -106.1 118.09 35.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.962 1.305 . . . . 0.0 110.58 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -112.38 144.21 42.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 118.824 0.738 . . . . 0.0 110.195 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.39 124.16 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.21 60.78 0.69 Allowed 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 124.763 1.289 . . . . 0.0 110.803 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -71.11 149.15 46.74 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.72 -52.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.248 1.819 . . . . 0.0 112.265 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.37 -57.93 0.22 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.76 164.04 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.106 0.563 . . . . 0.0 109.569 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -56.64 104.01 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.98 -39.65 29.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.097 0.959 . . . . 0.0 110.711 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -161.0 168.01 25.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.06 177.49 10.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.37 0.532 . . . . 0.0 109.914 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 tp -162.54 110.85 1.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.079 1.352 . . . . 0.0 109.404 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.1 161.61 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 0.0 110.989 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.6 -177.91 54.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.605 0.622 . . . . 0.0 112.601 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.18 34.99 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 109.307 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 m 30.82 46.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 115.124 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -59.15 -44.23 92.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 112.246 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -54.52 -53.6 52.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.45 0.7 . . . . 0.0 110.388 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.73 -37.1 76.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.1 tp -53.85 -51.96 61.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -52.39 -48.58 65.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.02 0.373 . . . . 0.0 110.18 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.24 86.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.232 0.213 . . . . 0.0 110.699 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.46 -50.49 67.27 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.66 -0.65 . . . . 0.0 110.37 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.57 -47.35 48.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.34 78.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.302 0.376 . . . . 0.0 111.207 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -49.14 -54.58 15.63 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.328 1.051 . . . . 0.0 110.77 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -75.93 -46.97 27.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.625 0.25 . . . . 0.0 111.454 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.31 -32.79 73.17 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.606 1.162 . . . . 0.0 113.179 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 124.877 1.271 . . . . 0.0 108.881 -173.935 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.66 94.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.102 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 pt -152.75 169.12 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.874 0.845 . . . . 0.0 110.861 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.27 149.02 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -150.42 155.4 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 119.329 0.968 . . . . 0.0 110.471 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -137.7 36.3 2.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.958 1.303 . . . . 0.0 111.455 -175.39 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 m -157.28 127.01 6.14 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.164 -0.96 . . . . 0.0 111.162 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -51.85 -45.67 64.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.353 1.061 . . . . 0.0 110.428 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.15 59.6 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.212 0.53 . . . . 0.0 110.481 -178.105 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.32 90.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -52.19 65.73 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -64.49 -45.41 87.46 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.103 -178.567 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.47 65.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.969 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.87 -50.09 75.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.566 0.746 . . . . 0.0 110.256 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -46.94 -49.76 20.06 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.703 0.401 . . . . 0.0 109.927 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -65.97 0.61 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -58.77 -31.04 68.02 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.605 -0.685 . . . . 0.0 111.848 -174.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.5 -24.67 39.59 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.35 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 45.98 8.38 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.125 1.37 . . . . 0.0 109.911 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.64 40.0 0.36 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -174.354 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -15.2 -63.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.727 2.811 . . . . 0.0 113.399 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -142.74 23.14 1.94 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.885 1.674 . . . . 0.0 109.112 177.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.87 153.15 37.9 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.589 0.756 . . . . 0.0 111.192 -171.486 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -71.76 133.14 21.4 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.845 1.697 . . . . 0.0 114.124 -177.114 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.21 116.65 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 100.964 -3.717 . . . . 0.0 100.964 167.32 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.4 t -102.64 111.44 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -174.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.56 136.77 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.15 89.84 3.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 168.997 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.44 99.0 7.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 m -136.13 151.74 50.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.789 1.636 . . . . 0.0 107.1 178.861 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.44 -178.82 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.988 0.915 . . . . 0.0 111.114 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 p -77.2 -63.33 1.39 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.678 1.591 . . . . 0.0 106.84 174.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -61.28 147.47 44.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.744 174.342 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.7 t 136.24 -59.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 129.212 3.005 . . . . 0.0 107.766 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.28 -92.87 1.02 Allowed Glycine 0 CA--C 1.53 1.025 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.07 -40.73 15.83 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.971 3.114 . . . . 0.0 113.523 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -44.64 -43.52 8.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.577 1.151 . . . . 0.0 110.905 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -58.59 -33.75 70.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.596 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.35 -18.93 65.7 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -177.514 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.1 mp -76.99 -27.33 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.125 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.96 -57.04 13.72 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.474 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.37 -41.2 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.904 1.716 . . . . 0.0 112.016 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.4 -51.6 69.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.752 0.787 . . . . 0.0 109.493 178.313 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.6 -49.15 75.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.236 1.014 . . . . 0.0 109.835 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.79 -41.22 90.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.828 0.851 . . . . 0.0 110.792 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -57.41 -50.6 72.48 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.39 -44.77 89.11 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 121.051 0.453 . . . . 0.0 110.227 176.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -50.98 -46.23 61.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.231 0.612 . . . . 0.0 111.162 -177.394 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -54.14 -30.47 49.17 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.85 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.09 -52.34 36.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.77 0.714 . . . . 0.0 111.221 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -90.95 -13.37 33.58 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -19.37 -61.85 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 129.192 2.997 . . . . 0.0 115.69 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -50.51 -47.77 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.415 0.531 . . . . 0.0 111.831 -177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -86.16 -60.3 2.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.238 0.615 . . . . 0.0 110.498 -178.117 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -88.02 146.48 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.431 2.292 . . . . 0.0 112.825 -169.589 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.49 146.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -135.42 113.61 11.36 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.69 101.28 7.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.51 1.124 . . . . 0.0 111.189 -175.67 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -79.85 94.63 5.85 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.1 t -79.39 117.91 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -67.93 102.22 1.23 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.28 -34.23 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.499 1.12 . . . . 0.0 110.477 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.76 -28.0 69.68 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.337 0.255 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 -65.87 0.94 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.569 0.748 . . . . 0.0 110.856 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.01 60.71 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.879 0.847 . . . . 0.0 110.172 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.5 76.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.906 0.882 . . . . 0.0 110.526 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.64 -55.85 22.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 111.867 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -44.78 98.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.73 38.15 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.653 0.263 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.71 -41.17 88.39 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.217 -0.927 . . . . 0.0 110.491 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.49 92.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.548 0.613 . . . . 0.0 110.531 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.02 77.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.003 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.52 48.61 1.28 Allowed Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.661 1.124 . . . . 0.0 111.508 175.814 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.8 136.35 23.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.2 p -140.18 -76.65 0.33 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.0 0.92 . . . . 0.0 108.656 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.44 73.6 1.39 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.547 1.139 . . . . 0.0 110.577 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.08 138.75 96.29 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.337 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -64.78 130.52 10.66 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 CA-C-N 121.068 1.417 . . . . 0.0 112.731 -0.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.5 m -120.62 105.0 10.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.07 132.08 34.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.216 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -124.25 150.06 45.75 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.849 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.78 113.09 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.77 125.54 54.11 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.437 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.36 112.57 20.04 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 176.059 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 69.71 -64.03 0.36 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.984 2.514 . . . . 0.0 109.161 -173.4 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.95 7.21 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.975 1.75 . . . . 0.0 112.468 177.871 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.18 117.09 44.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-N 118.996 1.398 . . . . 0.0 107.526 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -56.48 111.2 0.93 Allowed 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.81 -32.21 10.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.341 1.057 . . . . 0.0 111.154 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.55 172.36 17.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.833 0.288 . . . . 0.0 110.53 -177.845 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -160.46 168.39 25.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.813 1.245 . . . . 0.0 108.856 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 tp -167.87 120.36 0.88 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.804 0.842 . . . . 0.0 109.603 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.4 163.28 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.239 0.616 . . . . 0.0 111.312 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.5 174.85 46.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.716 1.15 . . . . 0.0 111.951 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.32 43.35 0.37 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 110.72 178.555 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 m -79.35 54.12 1.64 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.926 1.69 . . . . 0.0 110.287 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -36.51 63.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.019 0.927 . . . . 0.0 112.445 -175.365 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -61.44 -51.58 68.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.533 0.733 . . . . 0.0 109.861 177.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -68.43 -32.97 73.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.09 -56.22 24.54 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.438 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -50.61 -50.61 53.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.111 0.564 . . . . 0.0 110.403 177.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.55 71.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.42 -48.17 82.42 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.787 -0.571 . . . . 0.0 110.378 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.7 t -54.92 -51.05 57.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.78 -51.19 61.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.436 0.295 . . . . 0.0 110.926 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -53.87 -66.66 0.36 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.041 0.924 . . . . 0.0 110.507 178.017 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -59.33 -31.71 69.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.409 -174.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.09 -2.64 28.46 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.489 0 CA-C-N 119.965 1.257 . . . . 0.0 111.277 179.733 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 121.609 0.719 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 50' ' ' SER . 76.3 t -79.38 85.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.005 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -144.91 167.29 10.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.541 0.686 . . . . 0.0 111.287 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 7.8 p -111.85 134.7 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 174.05 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -153.61 162.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.913 0.863 . . . . 0.0 110.475 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -126.95 11.73 7.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.134 1.774 . . . . 0.0 112.648 -173.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -124.28 114.45 19.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.786 0.435 . . . . 0.0 111.65 -174.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -47.82 -40.59 21.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.006 1.322 . . . . 0.0 111.775 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.1 70.23 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.089 0.955 . . . . 0.0 111.058 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.31 74.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.936 -0.478 . . . . 0.0 109.802 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -50.86 68.09 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.413 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.09 -49.79 76.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.99 0.916 . . . . 0.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.41 -57.02 11.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.001 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -54.51 -44.8 73.04 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.539 0.736 . . . . 0.0 110.221 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -23.2 2.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.012 0.925 . . . . 0.0 112.046 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.47 -68.38 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 110.636 175.163 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -61.91 -23.0 66.05 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -171.487 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.57 -12.53 64.21 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.986 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 59.9 69.1 0.73 Allowed 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.53 2.13 23.27 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.176 -172.27 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -10.24 -65.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 129.742 3.217 . . . . 0.0 113.602 -176.115 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -146.39 57.27 1.18 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.833 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -118.48 136.61 24.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.021 . . . . 0.0 109.274 -177.083 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.25 114.87 4.14 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.146 1.898 . . . . 0.0 110.743 177.187 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.38 98.33 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 171.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.42 116.72 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.07 114.92 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 117.964 0.347 . . . . 0.0 110.296 -176.856 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 8.8 t0 -92.65 85.7 5.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 172.309 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.69 105.83 11.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.169 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -166.12 -159.79 0.4 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.754 0.706 . . . . 0.0 112.22 -171.562 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 64.1 -135.27 0.32 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 112.563 172.839 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p 54.61 -107.43 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.083 1.753 . . . . 0.0 109.537 -175.463 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -72.8 -26.63 61.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.919 0.487 . . . . 0.0 111.451 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.16 82.78 1.81 Allowed 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.53 -0.731 . . . . 0.0 111.056 -175.959 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 -56.63 8.27 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.976 0.798 . . . . 0.0 111.972 176.328 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.74 -37.07 64.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.977 2.451 . . . . 0.0 113.447 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.7 m -59.24 -26.0 64.52 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.609 0.364 . . . . 0.0 111.032 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -58.8 -20.63 51.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.498 0.59 . . . . 0.0 110.932 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.6 mmt -82.73 -31.3 28.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.812 0.733 . . . . 0.0 110.697 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.69 -33.5 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.83 -59.41 4.71 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.256 1.022 . . . . 0.0 113.168 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -59.76 -38.57 79.74 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.182 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.75 -54.16 45.65 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 30' ' ' ASP . 49.9 t80 -57.91 -41.12 81.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.132 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -57.19 -37.41 72.13 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.728 -0.653 . . . . 0.0 112.381 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -59.87 -51.92 67.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.447 1.476 . . . . 0.0 110.002 178.985 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -57.87 -41.42 82.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.69 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.461 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.6 m -52.72 -54.95 26.58 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -41.17 86.16 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.325 0.65 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.14 -53.92 52.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.128 0.571 . . . . 0.0 111.429 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -81.05 -21.42 40.11 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.096 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -21.45 110.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.504 2.322 . . . . 0.0 115.713 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.01 -71.08 0.39 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 174.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.35 24.84 2.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.945 0.898 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.42 161.12 4.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.801 1.64 . . . . 0.0 107.951 -174.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 93.79 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.99 94.97 10.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.257 0.623 . . . . 0.0 109.801 -178.884 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 111.93 23.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.009 1.323 . . . . 0.0 110.754 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.9 mtpp -91.65 109.34 20.65 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 174.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.62 122.49 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.08 81.13 3.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.848 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.8 m -39.92 -47.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 126.988 2.115 . . . . 0.0 114.176 -176.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.23 -40.57 67.82 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.039 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.57 -48.59 14.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 70' ' ' VAL . 95.1 t -80.95 51.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.241 1.02 . . . . 0.0 108.849 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.69 -58.13 9.4 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.841 1.656 . . . . 0.0 112.857 -173.299 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.12 -52.0 54.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -176.418 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 67' ' ' VAL . 84.0 t -62.91 -48.38 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.25 69.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.412 0.285 . . . . 0.0 110.283 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.63 -56.62 19.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.219 1.008 . . . . 0.0 110.007 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.8 -41.26 73.89 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.444 0.298 . . . . 0.0 111.118 -178.356 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 3.29 19.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.332 1.053 . . . . 0.0 111.905 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.1 41.8 94.8 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.011 -1.056 . . . . 0.0 113.412 176.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.7 137.62 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 p -148.9 -80.24 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.57 78.3 1.47 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.15 0.98 . . . . 0.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.73 139.43 88.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.73 132.38 22.06 Favored 'Cis proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.479 1.207 . . . . 0.0 110.595 -1.659 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 m -109.27 111.89 23.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.821 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -99.61 108.27 20.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.21 1.004 . . . . 0.0 109.197 -177.063 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -107.87 160.82 15.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.98 0.809 . . . . 0.0 109.891 177.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.02 110.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.42 108.4 19.72 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 175.776 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -83.97 109.56 17.72 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 71.4 -60.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.811 2.044 . . . . 0.0 110.807 -176.761 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.41 -41.0 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.219 1.39 . . . . 0.0 111.344 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.59 134.53 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.131 0.966 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -66.55 101.9 0.83 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.371 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.51 -32.43 25.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.111 0.964 . . . . 0.0 111.336 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.82 169.08 25.42 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -144.11 161.14 39.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.728 2.011 . . . . 0.0 107.285 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 tp -174.05 152.93 1.98 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.85 165.18 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 110.138 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 -179.08 39.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.184 0.897 . . . . 0.0 111.833 177.193 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.73 44.24 0.36 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.862 0.865 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m -81.22 61.37 4.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 109.688 -176.576 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.09 -42.73 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.922 0.889 . . . . 0.0 112.034 -175.619 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -57.82 -50.33 73.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.06 177.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -66.19 -40.32 90.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.27 -55.25 30.04 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.238 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.8 -51.28 61.42 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.442 0.297 . . . . 0.0 110.2 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.26 74.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.339 0.256 . . . . 0.0 111.298 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.82 -49.04 74.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.262 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.22 -54.33 18.26 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.504 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.6 -55.0 21.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.579 0.351 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.93 -64.78 0.71 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.463 0.705 . . . . 0.0 110.988 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -66.51 -19.98 65.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.086 0.954 . . . . 0.0 112.601 -173.62 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.02 -40.09 22.59 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.602 -0.686 . . . . 0.0 109.246 174.421 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.217 0 C-N-CA 123.383 0.673 . . . . 0.0 112.147 -178.302 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.32 29.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.777 2.031 . . . . 0.0 108.202 174.634 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.02 170.94 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -169.915 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.71 13.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.333 1.853 . . . . 0.0 111.404 178.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.06 73.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.69 -17.8 64.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.834 -174.464 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -38.13 117.59 0.62 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.413 1.485 . . . . 0.0 110.601 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 13' ' ' TRP . 20.3 ptmt -39.42 -44.04 1.3 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -51.07 71.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.467 0.651 . . . . 0.0 110.328 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.224 1.01 . . . . 0.0 109.697 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -48.16 -61.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.268 1.427 . . . . 0.0 108.483 175.291 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -55.82 -50.23 71.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.703 0.401 . . . . 0.0 110.286 -178.291 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.19 77.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.424 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -63.55 -47.34 81.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.294 1.038 . . . . 0.0 109.369 -177.774 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -56.96 -55.47 34.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.272 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.63 -58.82 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.989 0.516 . . . . 0.0 112.067 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -65.89 -14.2 61.06 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.646 -0.658 . . . . 0.0 111.457 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.52 -24.1 70.77 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.395 -1.225 . . . . 0.0 111.917 177.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 57.55 73.02 0.48 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.607 1.163 . . . . 0.0 109.319 -179.179 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.39 52.14 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.631 2.372 . . . . 0.0 113.35 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.57 -59.77 3.33 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.519 -0.738 . . . . 0.0 109.158 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.14 95.42 1.61 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -167.43 139.17 2.59 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.388 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 126.02 8.51 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.8 1.667 . . . . 0.0 111.525 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.4 mp -88.98 94.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 102.197 -3.261 . . . . 0.0 102.197 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.8 110.37 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -176.941 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.73 130.23 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.552 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -92.83 95.92 9.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.952 2.501 . . . . 0.0 106.985 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -88.86 100.53 13.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.943 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -127.47 -162.39 1.16 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.22 1.008 . . . . 0.0 108.369 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.24 117.71 2.87 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 120.155 1.343 . . . . 0.0 113.341 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -36.66 -46.79 0.61 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.498 1.519 . . . . 0.0 110.423 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -48.29 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.315 1.446 . . . . 0.0 113.685 177.68 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.24 35.34 1.62 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.221 0.464 . . . . 0.0 111.808 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 25.24 -88.35 0.01 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 128.411 2.91 . . . . 0.0 115.234 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -42.05 -40.77 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.869 3.046 . . . . 0.0 113.837 177.049 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.62 -36.97 79.93 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.711 0.404 . . . . 0.0 110.571 178.134 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -77.08 -31.16 55.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.845 0.858 . . . . 0.0 109.309 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -63.85 -4.1 2.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.061 0.544 . . . . 0.0 112.366 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.24 -23.87 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.222 0.919 . . . . 0.0 108.79 171.439 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.02 -53.84 43.89 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 120.89 -1.131 . . . . 0.0 112.339 177.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.15 -30.45 91.39 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.944 1.763 . . . . 0.0 111.982 176.627 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.58 -48.44 66.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.16 -35.07 69.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.404 1.081 . . . . 0.0 110.404 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -50.26 -34.01 21.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 110.418 176.894 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -57.67 -54.93 41.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 -41.61 99.18 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -49.14 -54.64 15.33 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -56.15 -57.72 10.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.734 0.814 . . . . 0.0 109.73 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -49.7 -44.21 47.96 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.267 1.027 . . . . 0.0 112.474 -174.623 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -95.39 -1.76 50.39 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.23 136.09 25.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.33 0.968 . . . . 0.0 111.461 -177.286 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.02 -67.01 0.53 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -81.43 -50.93 8.86 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 122.124 -0.633 . . . . 0.0 110.544 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.93 174.34 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.386 1.074 . . . . 0.0 112.75 -169.473 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 mm -129.92 94.7 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 174.225 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.94 138.87 31.1 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.93 126.24 23.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.74 0.816 . . . . 0.0 110.932 -174.131 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -100.65 119.93 39.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.74 134.98 64.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 123.014 0.526 . . . . 0.0 111.377 -176.993 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.23 95.61 7.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.117 1.367 . . . . 0.0 107.352 177.557 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -49.1 -41.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.978 2.511 . . . . 0.0 110.892 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.19 -22.34 66.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.8 0.84 . . . . 0.0 111.421 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.96 -72.4 0.65 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.936 0.894 . . . . 0.0 108.997 175.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 63.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.956 1.36 . . . . 0.0 109.392 -177.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.55 81.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.869 177.005 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.92 -43.38 18.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.568 1.547 . . . . 0.0 112.037 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.9 t -75.29 -57.39 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.633 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -43.66 -52.08 6.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.347 1.059 . . . . 0.0 113.293 -175.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.54 -35.01 69.76 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.783 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.81 20.93 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.998 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.81 -45.93 90.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.497 1.119 . . . . 0.0 111.741 -178.303 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.38 79.96 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.54 151.88 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.726 1.21 . . . . 0.0 108.37 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.9 p -119.89 -109.39 0.35 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 132.37 35.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.709 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -76.13 131.95 74.61 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -78.6 138.08 48.42 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.034 1.048 . . . . 0.0 112.789 -1.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.5 m -111.71 115.51 29.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 167.511 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 102' ' ' LEU . 55.2 m-85 -95.88 130.2 42.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 108.545 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -122.62 150.37 42.74 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.08 113.33 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.022 1.329 . . . . 0.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -107.39 137.46 45.39 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.434 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -90.82 -100.2 0.11 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.863 1.21 . . . . 0.0 110.279 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.25 -42.55 66.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.862 1.315 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.0 -27.33 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.07 2.271 . . . . 0.0 109.726 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.11 135.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.529 1.165 . . . . 0.0 110.893 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -52.18 112.43 0.8 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.225 1.81 . . . . 0.0 107.759 172.462 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.72 -41.02 7.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.135 1.374 . . . . 0.0 112.64 -174.966 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -151.14 161.29 42.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.572 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -150.77 169.01 22.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.175 0.99 . . . . 0.0 109.484 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -159.9 158.42 30.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 106.981 177.565 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.66 157.27 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.89 -164.69 51.85 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 -80.0 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.245 0.618 . . . . 0.0 110.717 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m 36.11 57.9 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.975 2.11 . . . . 0.0 113.59 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -46.86 -42.41 17.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.14 1.376 . . . . 0.0 111.862 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -57.91 -53.81 53.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.946 0.898 . . . . 0.0 110.44 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -64.09 -40.97 97.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 82' ' ' PHE . 1.6 tt -52.13 -53.97 36.32 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.262 1.025 . . . . 0.0 108.484 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.72 -50.14 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.583 0.353 . . . . 0.0 110.083 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.89 64.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.889 0.476 . . . . 0.0 110.666 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.31 -58.62 6.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.852 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.5 -51.67 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 123.215 0.606 . . . . 0.0 110.685 -177.19 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.71 -38.35 6.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.383 1.073 . . . . 0.0 112.424 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 109' ' ' HIS . 6.2 ptmt -64.3 -37.91 89.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.44 0.564 . . . . 0.0 111.358 -178.546 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 108' ' ' LYS . 80.7 m-70 -84.45 -49.15 8.92 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.95 0.9 . . . . 0.0 110.221 -178.809 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.07 96.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.454 2.301 . . . . 0.0 111.939 -177.121 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 125.733 1.613 . . . . 0.0 109.31 -175.119 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.8 77.04 0.07 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.699 1.142 . . . . 0.0 113.853 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 m -71.96 72.99 0.86 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.987 0.894 . . . . 0.0 108.797 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -78.6 35.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.114 1.765 . . . . 0.0 112.968 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.14 171.05 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.415 1.086 . . . . 0.0 112.017 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -94.96 143.69 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.101 1.36 . . . . 0.0 107.415 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -147.56 155.09 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 111.013 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -136.23 32.58 2.86 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.32 1.448 . . . . 0.0 112.0 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -152.57 139.04 18.59 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.961 0.886 . . . . 0.0 111.805 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -42.53 80.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 111.115 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.43 86.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.537 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.68 76.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.383 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -49.96 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.17 -50.14 74.84 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.782 0.801 . . . . 0.0 110.58 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.52 -56.65 13.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.801 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.16 -50.84 70.01 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.9 -47.85 11.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.502 0.721 . . . . 0.0 109.59 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.82 0.83 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -59.93 -21.94 61.79 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 111.786 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.96 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.179 . . . . 0.0 111.231 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm 62.41 50.72 3.59 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.323 1.449 . . . . 0.0 107.398 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -50.53 -31.91 16.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.192 2.197 . . . . 0.0 115.005 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -59.79 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 128.888 2.875 . . . . 0.0 114.061 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -136.85 84.22 2.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -178.16 155.84 1.01 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.952 0.901 . . . . 0.0 110.085 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.47 117.13 3.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.387 3.391 . . . . 0.0 114.179 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 27' ' ' ILE . 56.8 mt -88.7 96.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.176 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -93.1 104.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.88 131.73 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -104.66 98.76 8.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.3 98.14 8.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -124.66 174.92 7.54 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.835 1.254 . . . . 0.0 108.644 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.5 169.92 16.93 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.031 0.832 . . . . 0.0 109.696 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 p -71.25 -70.11 0.33 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -50.55 -30.17 12.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 115.358 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.6 p -76.04 61.58 1.55 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.902 1.228 . . . . 0.0 112.728 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 10.26 -84.6 0.0 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 128.83 3.11 . . . . 0.0 115.601 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -39.81 -39.44 2.15 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.875 3.716 . . . . 0.0 114.203 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -44.11 -44.22 7.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.92 1.688 . . . . 0.0 111.286 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -61.86 -26.17 67.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 112.11 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -91.02 -40.84 11.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.179 1.392 . . . . 0.0 109.756 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.52 -39.71 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.431 0.692 . . . . 0.0 109.617 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -61.54 6.13 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.832 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.62 -29.78 89.17 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.919 2.412 . . . . 0.0 112.284 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.83 -58.2 9.58 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.23 -32.36 66.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.93 0.892 . . . . 0.0 110.556 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.23 -33.86 63.47 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -59.02 -53.53 57.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.9 mt -59.6 -39.6 84.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 8.5 m -56.25 -51.49 67.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.477 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -56.06 -48.6 75.75 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.697 0.799 . . . . 0.0 110.269 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -64.1 -61.32 2.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.269 0.556 . . . . 0.0 111.295 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.24 57.49 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.647 1.179 . . . . 0.0 110.125 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.95 173.35 11.33 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.521 -0.737 . . . . 0.0 111.15 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -65.98 1.31 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.466 1.031 . . . . 0.0 114.686 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -82.63 -59.06 2.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.628 0.714 . . . . 0.0 111.04 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 59' ' ' PHE . 58.0 t -78.67 129.43 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -171.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.68 104.08 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 57' ' ' VAL . 33.8 m-85 -91.54 88.2 6.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.1 mt -83.91 99.67 10.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -81.82 94.0 6.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.19 124.31 43.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.04 0.536 . . . . 0.0 110.018 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -81.22 92.47 6.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.36 -36.51 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.683 1.993 . . . . 0.0 110.288 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -50.95 -37.84 46.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.372 0.669 . . . . 0.0 109.91 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.8 -62.31 1.41 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.2 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.99 58.28 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.496 -0.753 . . . . 0.0 111.069 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.67 87.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.308 0.643 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.59 -58.07 9.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.871 0.869 . . . . 0.0 111.894 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.6 -42.59 92.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.92 27.52 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -65.05 -39.56 93.48 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.063 -1.023 . . . . 0.0 110.315 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.04 93.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.412 0.551 . . . . 0.0 110.512 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.94 -32.09 73.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.096 0.958 . . . . 0.0 109.887 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.22 40.51 1.93 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.683 1.135 . . . . 0.0 111.952 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.32 137.98 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 p -136.0 -83.72 0.38 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.12 78.05 2.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.392 0.677 . . . . 0.0 109.802 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 143.14 93.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.99 143.81 76.69 Favored 'Cis proline' 0 N--CA 1.447 -1.258 0 CA-C-N 119.651 0.911 . . . . 0.0 110.453 -0.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.2 m -126.68 119.54 27.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -100.08 129.28 46.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.393 1.077 . . . . 0.0 109.433 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -124.09 147.23 48.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -114.69 91.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -84.43 64.73 8.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -61.03 138.52 58.19 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 72.98 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.807 2.043 . . . . 0.0 110.268 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.85 25.15 0.02 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.497 1.523 . . . . 0.0 111.686 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -156.12 138.57 6.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.236 1.518 . . . . 0.0 109.231 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -46.73 91.07 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.207 2.203 . . . . 0.0 110.88 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.35 21.5 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.95 164.22 39.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -147.29 164.02 34.55 Favored 'General case' 0 N--CA 1.46 0.05 0 C-N-CA 124.364 1.066 . . . . 0.0 109.243 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.6 tm? -162.11 114.83 1.75 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.198 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.56 157.43 3.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.804 0.811 . . . . 0.0 110.261 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.38 -174.65 53.47 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.897 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.29 -60.33 3.91 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.7 m 35.11 50.41 0.49 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.093 2.157 . . . . 0.0 112.874 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -47.01 -51.16 17.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.475 1.51 . . . . 0.0 113.353 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.87 -47.25 86.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.797 -0.565 . . . . 0.0 111.269 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.27 -41.23 97.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.2 tp -56.99 -54.84 42.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -50.93 -51.71 49.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.82 0.848 . . . . 0.0 109.945 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.905 0.482 . . . . 0.0 110.811 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.26 -48.04 81.71 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.307 0.503 . . . . 0.0 110.891 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.81 -52.66 33.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.42 27.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.477 0.311 . . . . 0.0 110.815 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -50.29 -57.44 7.87 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.543 1.137 . . . . 0.0 111.225 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -74.42 -25.26 59.34 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.13 40.02 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.796 0.726 . . . . 0.0 109.644 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.75 56.64 2.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.239 1.416 . . . . 0.0 107.279 -178.193 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.12 50.93 0.75 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.917 1.723 . . . . 0.0 113.6 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -80.61 85.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.911 0.884 . . . . 0.0 109.431 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.0 t -83.38 97.09 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.42 169.58 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.393 1.092 . . . . 0.0 112.699 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.33 138.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tp -151.11 152.14 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.918 0.781 . . . . 0.0 111.226 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -131.89 24.75 4.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.944 1.698 . . . . 0.0 112.415 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -149.33 142.45 24.96 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.158 0.89 . . . . 0.0 111.171 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -70.43 -36.55 74.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.563 1.545 . . . . 0.0 109.614 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.46 75.42 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.85 91.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.2 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.426 ' CZ3' HG11 ' A' ' 70' ' ' VAL . 20.6 t-105 -48.86 -58.16 5.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.32 -47.83 83.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.321 0.648 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.9 -47.32 71.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.614 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -64.11 -49.7 71.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp -46.1 -47.99 17.21 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.696 0.798 . . . . 0.0 110.285 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -64.74 0.82 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.492 0.317 . . . . 0.0 111.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -61.09 -24.74 66.46 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.719 -0.613 . . . . 0.0 112.634 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.76 -20.46 64.14 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.462 -1.188 . . . . 0.0 112.322 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 62.92 63.1 0.98 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.308 1.443 . . . . 0.0 108.751 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -75.25 62.32 1.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.892 1.277 . . . . 0.0 110.305 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.58 -55.44 13.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -154.16 19.23 0.5 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 109.554 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -78.59 133.81 62.48 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.16 119.28 6.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.576 1.517 . . . . 0.0 112.498 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mt -99.12 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.43 116.43 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.14 128.8 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.06 96.17 7.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.465 1.506 . . . . 0.0 107.224 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.15 94.01 9.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.8 m -131.69 117.42 18.62 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.06 58.83 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.895 0.316 . . . . 0.0 111.471 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.11 -49.15 52.66 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.112 0.965 . . . . 0.0 110.924 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -68.98 -6.56 28.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 113.29 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.53 64.81 4.51 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.55 -79.88 0.01 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.388 2.899 . . . . 0.0 115.748 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.33 -36.91 53.28 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.436 2.091 . . . . 0.0 111.188 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -38.06 70.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.644 0.778 . . . . 0.0 109.248 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -53.42 -26.64 20.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.634 0.773 . . . . 0.0 111.889 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.2 mtt -62.42 -16.21 53.65 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.11 0.868 . . . . 0.0 111.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.77 -26.18 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.371 0.668 . . . . 0.0 109.812 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.15 16.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.304 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -56.42 -38.92 94.37 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.024 1.816 . . . . 0.0 112.018 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.6 mt -56.6 -57.34 12.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.558 0.694 . . . . 0.0 109.602 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.96 -41.72 75.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.048 0.539 . . . . 0.0 110.067 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -62.61 -34.46 77.08 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.36 -0.838 . . . . 0.0 110.539 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.1 m -62.28 -47.46 84.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.58 -40.63 92.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 19.5 m -53.58 -52.39 59.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.63 -46.33 89.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.367 0.667 . . . . 0.0 110.429 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -51.16 -54.05 28.93 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.55 -55.52 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.739 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 36.05 -125.44 0.14 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.206 1.402 . . . . 0.0 110.391 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 45.05 -84.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.159 2.314 . . . . 0.0 115.188 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -91.19 -39.43 12.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.372 1.469 . . . . 0.0 112.916 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.63 132.14 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 113.235 -167.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.4 129.53 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 78.8 m-85 -122.14 113.47 19.54 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.15 101.58 10.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.844 1.258 . . . . 0.0 110.985 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.6 119.41 22.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.38 138.67 53.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.849 0.833 . . . . 0.0 111.88 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -97.88 104.92 16.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.949 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 m -55.65 -28.63 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.19 0.596 . . . . 0.0 110.985 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.01 -36.5 77.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.76 -66.38 0.9 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.936 0.495 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.07 53.88 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 121.497 -0.752 . . . . 0.0 111.267 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.62 -43.58 25.98 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.042 0.937 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.01 73.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.965 0.906 . . . . 0.0 111.138 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.426 HG11 ' CZ3' ' A' ' 13' ' ' TRP . 40.0 t -67.34 -43.49 87.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.45 27.48 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.667 0.387 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.16 -42.54 88.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.685 -0.634 . . . . 0.0 110.748 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.22 93.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.679 0.672 . . . . 0.0 110.886 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.54 91.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.767 1.227 . . . . 0.0 109.785 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 43.23 1.18 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.456 1.027 . . . . 0.0 112.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.45 131.08 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 p -113.51 -74.92 0.61 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.57 14.76 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.692 1.197 . . . . 0.0 108.899 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -137.96 139.87 27.48 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -62.73 155.63 67.04 Favored 'Cis proline' 0 N--CA 1.457 -0.667 0 CA-C-N 120.758 1.307 . . . . 0.0 114.899 -0.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -144.45 135.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.09 121.25 38.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -119.81 153.85 35.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.02 122.91 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.042 0.937 . . . . 0.0 108.698 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -113.59 118.85 35.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -90.69 -57.52 2.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.461 0.573 . . . . 0.0 112.107 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -93.16 -42.46 9.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.198 1.399 . . . . 0.0 110.545 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.02 -24.18 0.11 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.673 2.082 . . . . 0.0 110.138 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.84 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.16 1.384 . . . . 0.0 108.864 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.0 103.01 0.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.59 -33.66 41.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.835 0.854 . . . . 0.0 110.319 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -158.98 166.94 30.64 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.44 29.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.694 0.797 . . . . 0.0 111.569 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.3 tm? -160.3 149.34 17.25 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.067 1.747 . . . . 0.0 108.14 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.14 156.0 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.97 1.308 . . . . 0.0 110.631 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.33 177.43 46.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.816 0.722 . . . . 0.0 112.124 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.89 46.16 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.736 1.214 . . . . 0.0 111.138 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.658 ' HB2' HD11 ' A' ' 94' ' ' LEU . 8.4 m -80.04 67.08 5.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.33 -0.856 . . . . 0.0 109.985 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -49.53 -45.15 47.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.594 1.158 . . . . 0.0 111.963 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -56.76 -48.91 76.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.03 0.932 . . . . 0.0 110.147 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HG2' HD23 ' A' ' 94' ' ' LEU . 14.5 tppt? -67.65 -38.93 84.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -56.46 -55.43 33.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -51.58 -53.77 34.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.798 0.439 . . . . 0.0 110.462 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.91 -44.46 74.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.706 0.402 . . . . 0.0 111.209 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.9 mt -61.3 -49.76 75.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.955 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.26 -46.97 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.06 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.98 -52.26 58.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.143 0.177 . . . . 0.0 110.817 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -56.31 -62.7 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.897 0.879 . . . . 0.0 110.499 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -70.28 -14.95 62.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.16 16.78 25.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.035 0.834 . . . . 0.0 110.671 174.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.46 72.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 111.959 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.909 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.26 50.37 2.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.927 1.864 . . . . 0.0 111.271 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.667 ' HB2' HG23 ' A' ' 58' ' ' ILE . 15.0 m -77.86 75.8 4.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.639 1.575 . . . . 0.0 109.217 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' A' ' 50' ' ' SER . 77.0 t -105.88 101.65 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 108.734 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 pt -145.76 129.47 10.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 122.73 1.252 . . . . 0.0 111.397 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.14 57.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 8' ' ' ASP . 6.6 tp -89.03 -179.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.209 1.004 . . . . 0.0 111.152 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 7' ' ' ILE . 16.7 p-10 -134.32 -38.33 0.85 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -80.48 156.39 26.59 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -165.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.74 -46.2 91.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.837 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.72 -51.92 52.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.98 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' CB ' HG12 ' A' ' 7' ' ' ILE . . . -62.77 -47.8 81.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.169 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -46.85 -58.96 3.4 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.89 -54.68 43.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 111.646 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.39 -63.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.234 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -55.68 -47.42 76.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.581 -0.724 . . . . 0.0 110.901 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.61 -19.44 0.91 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.837 0.711 . . . . 0.0 112.016 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.32 -56.86 2.14 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.266 0.939 . . . . 0.0 111.092 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.42 63.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.96 -8.38 57.86 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 119.883 1.22 . . . . 0.0 112.569 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.42 56.28 0.78 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.795 2.038 . . . . 0.0 109.547 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -67.91 64.15 0.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.62 3.168 . . . . 0.0 111.202 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.36 93.71 4.03 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.766 2.026 . . . . 0.0 107.226 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 68.04 72.81 0.31 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 128.864 2.865 . . . . 0.0 110.217 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -172.53 155.27 3.24 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 122.731 0.412 . . . . 0.0 111.858 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.96 135.05 6.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.225 2.616 . . . . 0.0 113.883 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 5.3 mp -104.89 99.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -91.45 109.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.12 123.66 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.904 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -88.68 101.66 14.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.86 1.264 . . . . 0.0 110.232 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.42 115.53 20.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -140.85 162.03 36.42 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 108.212 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.62 163.81 15.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.0 1.32 . . . . 0.0 109.307 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.2 p -77.96 -57.92 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.505 0.722 . . . . 0.0 109.608 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -50.74 -31.59 17.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.648 1.579 . . . . 0.0 113.272 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -77.44 55.37 1.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.616 1.098 . . . . 0.0 110.778 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.86 -68.12 0.01 OUTLIER Glycine 0 CA--C 1.536 1.369 0 C-N-CA 127.938 2.685 . . . . 0.0 115.477 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -42.5 -39.22 6.61 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.577 3.518 . . . . 0.0 114.232 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.6 m -42.78 -44.06 4.24 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.474 1.51 . . . . 0.0 110.88 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.0 -29.16 59.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.03 0.932 . . . . 0.0 112.26 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.49 -19.87 64.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.902 0.774 . . . . 0.0 111.861 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.6 -28.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.51 27.3 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.993 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.2 -42.06 38.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.057 1.838 . . . . 0.0 111.736 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.78 -54.48 45.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.75 0.786 . . . . 0.0 109.565 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -55.86 -45.41 78.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.223 1.009 . . . . 0.0 109.311 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.68 -41.84 95.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.808 0.843 . . . . 0.0 110.836 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 m -58.36 -49.84 75.79 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.1 tp -60.43 -37.64 81.55 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.116 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.476 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 37.8 m -58.94 -44.71 91.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 122.073 -0.392 . . . . 0.0 110.549 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -58.85 -48.33 81.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -46.7 -52.89 12.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 112.736 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -103.99 36.26 2.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.623 0.647 . . . . 0.0 111.471 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.06 71.11 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.234 0.925 . . . . 0.0 112.038 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.37 -75.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.18 -49.2 17.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.45 124.61 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.382 -167.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 3' ' ' SER . 17.1 mm -90.99 114.53 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 96.8 m-85 -105.98 101.75 11.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.82 163.48 14.14 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.15 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -138.02 150.84 47.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.76 136.43 26.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -87.78 113.03 23.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.15 -30.48 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.274 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -62.34 -52.86 61.94 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.06 -60.81 2.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.198 0.599 . . . . 0.0 110.393 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.86 58.57 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.716 0.769 . . . . 0.0 110.338 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.07 -47.14 72.01 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.922 0.889 . . . . 0.0 111.04 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.1 -55.52 23.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.998 0.919 . . . . 0.0 111.978 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.25 -43.99 95.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.97 68.89 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.49 -42.39 74.84 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.83 -0.544 . . . . 0.0 109.761 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.65 78.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.679 0.672 . . . . 0.0 110.535 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 2.7 22.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.258 1.023 . . . . 0.0 111.757 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.75 42.86 94.64 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.569 1.08 . . . . 0.0 112.604 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.81 139.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 117.537 0.668 . . . . 0.0 109.632 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.1 p -139.84 -78.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 110.151 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.8 74.12 1.58 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.336 1.054 . . . . 0.0 111.311 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.31 138.67 91.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -63.7 135.25 19.54 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.443 1.551 . . . . 0.0 112.498 -1.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -125.52 107.37 10.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.86 121.1 33.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.943 0.897 . . . . 0.0 108.604 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.03 141.96 43.81 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.71 96.33 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.3 105.42 17.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -82.44 116.57 21.95 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.0 -59.81 0.37 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.784 2.834 . . . . 0.0 110.346 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.04 23.02 0.09 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.266 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.65 135.16 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.256 1.528 . . . . 0.0 108.406 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -62.96 98.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.393 0.677 . . . . 0.0 109.386 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -33.07 40.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.483 0.713 . . . . 0.0 110.182 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -161.91 174.67 12.78 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -160.61 172.24 17.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.16 1.384 . . . . 0.0 108.165 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.08 150.52 9.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.555 1.142 . . . . 0.0 108.666 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -126.95 158.56 37.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 175.04 46.23 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.573 1.082 . . . . 0.0 111.863 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.62 42.79 0.45 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.904 0.882 . . . . 0.0 110.548 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -78.71 55.4 1.68 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.081 1.752 . . . . 0.0 110.842 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.27 21.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.329 1.052 . . . . 0.0 113.104 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.49 -52.26 65.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.116 0.871 . . . . 0.0 110.245 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.77 -37.94 89.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.76 -57.94 9.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -53.47 -49.9 66.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.016 0.527 . . . . 0.0 110.754 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.93 76.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.14 0.176 . . . . 0.0 111.129 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.02 -47.09 81.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.935 -0.478 . . . . 0.0 110.466 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 65.6 t -56.42 -48.17 80.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.69 -56.6 15.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -47.11 -63.95 0.91 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.905 1.282 . . . . 0.0 111.065 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -70.39 -23.88 62.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.051 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.12 54.51 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.46 55.14 2.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.558 -179.354 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 CA-C-O 118.361 -1.244 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.69 -125.82 15.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 m -65.65 102.44 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.93 26.65 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.121 1.368 . . . . 0.0 107.857 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 pt -145.67 177.27 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 126.424 1.89 . . . . 0.0 107.431 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.76 73.9 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 122.007 0.908 . . . . 0.0 110.496 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.26 127.9 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 107.952 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -105.12 -42.48 5.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.636 1.974 . . . . 0.0 110.675 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 m -14.13 110.81 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.301 3.041 . . . . 0.0 115.035 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -40.29 -47.1 2.44 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.477 1.511 . . . . 0.0 111.326 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.53 -49.54 74.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.932 0.493 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.19 85.63 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -58.59 5.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.588 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -59.54 -47.28 86.16 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.115 0.966 . . . . 0.0 110.346 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -48.47 64.61 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.954 0.902 . . . . 0.0 110.857 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -51.68 -25.92 8.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.866 0.866 . . . . 0.0 112.133 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.19 -60.23 1.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.195 0.907 . . . . 0.0 111.296 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -22.22 63.84 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.814 -0.554 . . . . 0.0 112.081 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.93 -29.71 71.35 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.896 -0.947 . . . . 0.0 110.95 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 45.89 55.04 7.37 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.866 1.266 . . . . 0.0 107.801 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 pm0 -73.55 43.36 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -47.83 -51.05 24.18 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 0.0 109.032 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -135.09 58.48 1.77 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.649 0.78 . . . . 0.0 108.905 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -138.32 126.76 14.16 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.91 105.23 1.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 120.823 1.015 . . . . 0.0 112.212 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.98 118.4 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -118.06 122.11 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.6 110.79 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 123.385 0.674 . . . . 0.0 109.877 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -88.44 93.1 9.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -79.5 94.54 5.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -116.14 -165.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.338 1.455 . . . . 0.0 108.832 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -154.23 147.17 24.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.73 -0.606 . . . . 0.0 110.572 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -64.33 -46.01 85.36 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 112.512 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -68.26 -47.69 67.07 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -77.94 64.43 3.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.065 0.848 . . . . 0.0 112.276 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 11.04 -83.29 0.0 OUTLIER Glycine 0 CA--C 1.536 1.377 0 C-N-CA 128.987 3.184 . . . . 0.0 115.398 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -40.45 -46.37 4.43 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.375 3.383 . . . . 0.0 113.251 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.3 m -46.11 -51.62 13.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.409 1.484 . . . . 0.0 109.695 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -72.46 -41.37 66.15 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 mmt -60.82 -25.39 66.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.532 0.605 . . . . 0.0 112.217 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mt -70.75 -27.11 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.688 -0.632 . . . . 0.0 110.001 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.05 -51.78 79.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 116.994 -1.479 . . . . 0.0 110.653 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.99 -44.23 23.29 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.441 2.76 . . . . 0.0 113.565 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -59.98 -54.93 40.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.47 -34.62 69.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.142 0.577 . . . . 0.0 110.362 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.7 -34.15 75.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.531 1.132 . . . . 0.0 109.926 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -62.66 -47.65 82.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.1 -39.5 86.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.857 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -53.63 -52.1 60.98 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.879 0.471 . . . . 0.0 109.87 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -55.18 -47.13 75.64 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.555 . . . . 0.0 110.344 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.64 -64.95 0.76 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.294 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -80.06 60.39 3.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.187 0.995 . . . . 0.0 108.923 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.19 69.03 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.43 -136.68 0.01 OUTLIER Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.171 1.843 . . . . 0.0 116.229 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -71.81 38.45 0.07 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.072 1.349 . . . . 0.0 114.462 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -121.85 137.32 55.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.25 108.22 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.39 110.0 22.64 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 105.46 14.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.655 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -88.26 90.44 8.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.24 103.57 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.184 0.516 . . . . 0.0 109.775 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -76.99 100.33 5.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.85 -33.11 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.544 0.738 . . . . 0.0 112.14 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.83 -27.92 67.04 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.541 0.61 . . . . 0.0 111.035 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.0 -61.42 1.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 70' ' ' VAL . 77.2 t -83.42 57.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 122.686 1.231 . . . . 0.0 109.314 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.69 40.06 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.864 1.266 . . . . 0.0 112.788 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.87 -50.84 32.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.724 0.81 . . . . 0.0 111.56 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 67' ' ' VAL . 67.5 t -63.81 -47.86 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.47 69.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.359 0.264 . . . . 0.0 111.704 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -66.16 -43.49 86.83 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.63 77.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 0.0 110.971 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.56 -9.21 58.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 111.882 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.73 36.03 38.56 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.197 0.904 . . . . 0.0 112.342 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -78.96 141.37 15.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.221 1.01 . . . . 0.0 109.025 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -136.75 -82.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.73 72.59 2.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.375 1.07 . . . . 0.0 111.1 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.65 146.27 86.15 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.793 0.437 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.49 159.83 96.96 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 119.684 0.923 . . . . 0.0 110.185 -1.099 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.4 m -147.8 118.41 7.49 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.13 120.75 34.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 109.593 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -114.68 153.39 30.31 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.33 124.82 67.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -110.64 105.59 14.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.927 0.891 . . . . 0.0 110.33 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -92.45 147.78 22.62 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.46 -64.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 129.096 2.959 . . . . 0.0 112.153 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.68 33.67 0.05 OUTLIER Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.955 2.217 . . . . 0.0 110.486 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.28 145.17 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 118.357 1.078 . . . . 0.0 109.901 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -57.51 106.08 0.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.291 1.436 . . . . 0.0 108.174 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.45 -37.56 12.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.477 1.111 . . . . 0.0 112.554 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -155.54 167.56 29.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -160.68 175.69 12.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.724 0.773 . . . . 0.0 111.939 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -156.87 110.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.513 2.325 . . . . 0.0 106.533 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.53 145.68 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.96 -158.79 29.63 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.37 122.4 44.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.762 1.225 . . . . 0.0 109.955 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -157.59 80.27 0.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -32.75 65.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.987 0.515 . . . . 0.0 111.704 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -60.93 -50.39 73.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.32 -37.43 87.23 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.49 -55.4 35.34 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.629 0.771 . . . . 0.0 109.812 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -51.97 -50.63 60.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.87 86.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.475 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.28 -51.97 67.29 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.816 0.846 . . . . 0.0 109.477 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.47 -50.36 73.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.35 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.55 -58.07 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.877 0.37 . . . . 0.0 110.582 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -45.91 -58.16 3.77 Favored 'General case' 0 C--O 1.228 -0.059 0 C-N-CA 125.57 1.548 . . . . 0.0 110.433 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -83.19 9.79 9.8 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.31 -46.27 5.08 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.35 -58.09 7.5 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.24 0 CA-C-O 116.495 -1.717 . . . . 0.0 107.15 172.34 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.987 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.69 -176.35 16.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.732 1.266 . . . . 0.0 111.424 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.06 78.47 0.23 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.761 1.224 . . . . 0.0 109.281 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 59' ' ' PHE . 75.4 t -123.01 120.72 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.405 1.082 . . . . 0.0 109.904 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -144.38 171.81 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.172 0.987 . . . . 0.0 111.728 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.04 136.03 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -153.29 152.42 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 118.696 0.68 . . . . 0.0 110.787 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -115.81 -62.56 1.58 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.233 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 m -37.12 105.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.203 3.001 . . . . 0.0 113.483 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -44.53 -49.0 10.23 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.007 1.323 . . . . 0.0 110.346 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.78 -49.77 57.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.106 0.562 . . . . 0.0 111.074 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 -44.36 83.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.823 0.449 . . . . 0.0 109.966 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -61.34 2.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.876 0.87 . . . . 0.0 108.906 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -58.69 -48.66 80.35 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.463 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.24 -63.42 1.15 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.399 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 45.4 tt0 -58.63 -48.2 81.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -46.49 -49.88 17.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 110.758 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -49.18 8.64 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -28.65 61.93 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.698 1.136 . . . . 0.0 111.261 -176.157 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.72 -37.57 61.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.061 -0.855 . . . . 0.0 111.824 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? 44.98 51.53 8.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.811 1.245 . . . . 0.0 109.281 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.44 56.72 1.81 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.679 1.191 . . . . 0.0 113.02 -171.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -22.57 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 128.321 2.648 . . . . 0.0 112.172 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -132.55 59.23 1.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -135.15 142.3 41.28 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.35 111.17 3.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.478 2.119 . . . . 0.0 114.52 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.79 97.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.51 114.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.6 t -106.42 115.79 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -100.13 103.65 15.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.46 90.39 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -114.94 139.7 49.61 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.749 1.219 . . . . 0.0 109.036 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.71 72.28 2.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.669 0.788 . . . . 0.0 110.037 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -25.67 -47.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.632 2.373 . . . . 0.0 113.428 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -38.74 65.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.4 p -77.18 66.54 2.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.487 1.04 . . . . 0.0 112.898 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.28 -88.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 128.849 3.119 . . . . 0.0 114.769 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.73 -45.05 4.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.872 3.048 . . . . 0.0 113.723 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.0 m -45.03 -39.13 5.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.042 1.737 . . . . 0.0 111.634 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -49.27 -33.29 12.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.939 0.896 . . . . 0.0 111.858 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -53.94 -24.75 17.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.9 -37.78 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.78 -57.33 26.31 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -58.51 -27.76 83.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 111.234 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mt -75.15 -44.67 45.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.502 0.592 . . . . 0.0 110.714 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -55.72 -39.09 70.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' HG11 ' A' ' 4' ' ' VAL . 32.6 mt-10 -70.21 -34.5 72.99 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.317 0.647 . . . . 0.0 111.456 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.7 m -55.35 -44.73 76.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.076 1.307 . . . . 0.0 107.875 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.4 -18.09 48.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.778 -0.629 . . . . 0.0 112.428 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.425 ' CB ' HG21 ' A' ' 4' ' ' VAL . 25.9 p -59.16 -38.03 78.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 120.293 1.406 . . . . 0.0 109.226 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -62.61 -49.16 76.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.373 1.046 . . . . 0.0 108.196 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.29 -59.82 4.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.923 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -88.05 65.18 8.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.784 0.802 . . . . 0.0 109.625 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.79 67.6 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.337 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.32 -166.12 19.45 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 121.417 0.454 . . . . 0.0 111.998 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.642 . . . . 0.0 110.892 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.69 131.66 69.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.32 96.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.673 1.124 . . . . 0.0 108.583 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 m-30 -91.61 115.04 27.72 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.87 98.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.072 1.349 . . . . 0.0 110.107 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.91 113.81 18.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -90.47 122.18 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -69.9 86.2 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.13 -50.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.629 1.971 . . . . 0.0 110.779 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -56.68 -31.31 64.32 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.482 1.113 . . . . 0.0 112.192 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.78 -70.8 0.55 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.31 61.56 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.906 0.86 . . . . 0.0 111.036 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.5 60.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.795 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.51 86.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.592 0.757 . . . . 0.0 111.71 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.19 -47.19 82.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.14 69.06 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.53 -55.81 25.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.137 0.975 . . . . 0.0 110.457 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.91 -41.8 75.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.047 0.539 . . . . 0.0 111.048 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -8.62 55.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.391 0.677 . . . . 0.0 111.761 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.43 30.19 31.01 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.231 0.919 . . . . 0.0 112.881 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.68 117.09 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 p -101.34 -71.41 0.71 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.23 156.14 18.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.707 1.203 . . . . 0.0 107.876 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -150.1 161.18 31.78 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.38 141.43 53.45 Favored 'Cis proline' 0 N--CA 1.453 -0.902 0 CA-C-N 120.726 1.295 . . . . 0.0 111.922 1.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.3 m -133.6 122.55 23.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.29 119.33 38.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.325 1.45 . . . . 0.0 108.419 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -107.86 153.52 22.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.67 117.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -107.08 126.64 52.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.978 0.911 . . . . 0.0 109.41 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -92.03 123.78 35.65 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 67.26 -63.12 0.3 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 128.617 2.767 . . . . 0.0 110.585 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.09 23.86 0.05 OUTLIER Glycine 0 CA--C 1.533 1.174 0 C-N-CA 127.151 2.31 . . . . 0.0 110.938 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.13 128.05 74.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.69 111.3 1.79 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.355 0.662 . . . . 0.0 109.881 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.08 -33.9 14.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.627 1.171 . . . . 0.0 110.938 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -155.4 166.01 34.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.768 0.258 . . . . 0.0 111.099 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -143.23 162.36 35.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.738 1.615 . . . . 0.0 109.759 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 tt -159.9 143.44 14.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.595 1.958 . . . . 0.0 106.424 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.25 152.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.07 -158.84 29.55 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.92 139.99 20.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 m -163.85 108.13 1.0 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -51.6 -49.2 62.62 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.912 1.285 . . . . 0.0 111.876 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -58.1 -43.87 87.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.889 0.476 . . . . 0.0 110.034 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -38.39 86.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.06 -46.86 85.49 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -54.6 -49.3 70.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -46.54 85.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.681 0.792 . . . . 0.0 111.005 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.35 -52.64 63.82 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.852 0.751 . . . . 0.0 109.523 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.44 -50.97 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.39 -54.98 28.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.708 0.403 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.58 -63.74 1.02 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 125.254 1.422 . . . . 0.0 110.198 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -68.04 -22.31 64.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.452 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -44.73 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 108.987 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.31 -105.32 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.867 0.867 . . . . 0.0 109.44 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.418 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.456 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.898 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.29 -115.4 6.57 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p -75.04 -17.41 60.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.435 0.694 . . . . 0.0 112.084 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.72 108.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.91 149.89 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.079 0.942 . . . . 0.0 112.425 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -96.52 123.28 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 tp -148.61 146.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.312 0.96 . . . . 0.0 111.153 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -145.01 56.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.974 0.91 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -157.64 117.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -48.52 -38.85 21.4 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.458 1.103 . . . . 0.0 112.794 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.69 86.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.101 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.71 -35.89 65.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.72 0.408 . . . . 0.0 110.126 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -52.23 -53.01 48.93 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.56 -51.29 70.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.355 0.662 . . . . 0.0 110.68 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.14 -48.45 64.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.231 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.14 -51.19 70.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.3 tp -49.22 -50.02 40.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.97 0.508 . . . . 0.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.99 -61.16 2.64 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 111.236 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -63.57 -15.59 58.49 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.457 -0.777 . . . . 0.0 111.877 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.14 60.87 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.079 1.323 . . . . 0.0 111.986 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 mttm 66.08 73.75 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.752 1.263 . . . . 0.0 108.554 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.06 49.44 0.13 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.047 2.139 . . . . 0.0 113.797 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.6 -58.61 3.17 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -152.96 24.61 0.56 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.621 1.168 . . . . 0.0 110.313 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.34 148.88 35.35 Favored Pre-proline 0 C--O 1.234 0.239 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HG2' HG13 ' A' ' 57' ' ' VAL . 84.4 Cg_endo -79.62 129.98 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.294 3.329 . . . . 0.0 113.31 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.57 95.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.71 130.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.36 133.24 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -104.49 101.62 11.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.566 1.947 . . . . 0.0 106.599 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.4 95.99 8.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.6 m -122.49 162.81 21.04 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.845 1.258 . . . . 0.0 107.808 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.24 172.44 6.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.124 0.969 . . . . 0.0 110.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.6 p -83.05 -62.52 1.57 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.712 0.805 . . . . 0.0 109.382 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.4 -26.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.716 2.007 . . . . 0.0 113.742 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.7 p -76.69 9.87 2.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.447 1.021 . . . . 0.0 112.703 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 28.82 -89.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 128.635 3.017 . . . . 0.0 114.757 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.58 -37.82 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.089 3.193 . . . . 0.0 114.38 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 p -48.1 -35.1 10.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.024 0.93 . . . . 0.0 111.97 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -52.67 -28.44 21.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.396 1.078 . . . . 0.0 112.172 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.76 -19.8 52.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.158 0.89 . . . . 0.0 112.039 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 35.9 mt -71.83 -30.37 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.684 -0.635 . . . . 0.0 109.916 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.98 -58.23 12.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.558 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.78 -37.37 94.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.42 2.08 . . . . 0.0 112.452 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -54.54 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.56 -36.86 79.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.907 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.25 -37.46 83.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 0.0 109.764 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 m -59.17 -52.41 65.84 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.63 -41.11 76.54 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 m -56.12 -49.99 72.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.782 0.325 . . . . 0.0 110.276 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -41.42 95.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.107 0.563 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -63.61 -63.37 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.64 0.733 . . . . 0.0 109.806 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.05 57.32 4.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.24 1.416 . . . . 0.0 109.955 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.47 153.08 40.5 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.758 0.79 . . . . 0.0 112.332 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.24 -72.44 1.15 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.616 1.103 . . . . 0.0 114.978 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -71.95 -30.93 65.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.668 0.734 . . . . 0.0 112.818 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HG2' ' A' ' 26' ' ' PRO . 90.3 t -97.08 136.75 26.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -100.82 129.91 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 57' ' ' VAL . 47.4 m-85 -117.33 107.13 14.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.161 0.984 . . . . 0.0 108.541 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.4 mt -100.85 101.21 11.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.84 1.256 . . . . 0.0 110.272 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -86.4 120.88 28.22 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.5 141.12 47.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.949 0.899 . . . . 0.0 110.432 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -94.62 109.47 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.788 1.235 . . . . 0.0 107.668 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.0 t -53.2 -34.35 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.836 1.254 . . . . 0.0 110.732 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -68.43 -23.07 64.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.11 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.18 -75.32 0.47 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 0.0 110.9 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.28 63.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.324 0.966 . . . . 0.0 110.169 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.08 54.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.989 0.916 . . . . 0.0 109.739 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.49 -52.83 63.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.131 0.973 . . . . 0.0 111.228 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.35 -46.69 94.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.54 -53.57 52.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.068 0.547 . . . . 0.0 111.539 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.57 -39.81 80.83 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.268 -0.895 . . . . 0.0 110.4 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 86.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.485 0.584 . . . . 0.0 110.203 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' A' ' 76' ' ' ILE . . . -67.74 -33.75 75.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.392 0.677 . . . . 0.0 110.431 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.15 48.66 1.69 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.757 1.17 . . . . 0.0 111.767 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -85.87 98.54 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.3 p -93.21 -75.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.12 72.71 5.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.895 0.878 . . . . 0.0 111.012 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.51 142.71 97.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.73 134.35 34.28 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.306 1.145 . . . . 0.0 111.102 0.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.3 m -122.67 141.01 52.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.903 1.681 . . . . 0.0 108.506 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 84.1 m-85 -124.11 116.83 23.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 108.628 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -112.6 147.84 35.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.2 t -115.13 98.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -87.44 107.45 18.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.47 115.01 21.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 68.18 -58.92 0.45 Allowed 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 128.177 2.591 . . . . 0.0 111.448 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.68 19.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.355 0.979 . . . . 0.0 112.686 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.24 134.98 57.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.981 1.39 . . . . 0.0 108.336 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -60.87 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.484 1.114 . . . . 0.0 108.853 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.76 -28.08 40.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.871 0.869 . . . . 0.0 110.12 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -156.05 167.12 31.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.534 0.152 . . . . 0.0 111.026 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.61 -175.21 4.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.472 1.909 . . . . 0.0 108.306 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 98' ' ' SER . 13.5 tp 167.01 142.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.277 2.631 . . . . 0.0 107.595 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.15 149.21 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.088 1.355 . . . . 0.0 108.295 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.13 168.69 44.33 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.749 0.639 . . . . 0.0 111.89 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.48 43.61 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 113.38 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' HD11 ' A' ' 94' ' ' LEU . 8.3 t -80.03 72.63 6.82 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.16 -0.963 . . . . 0.0 108.655 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.67 -41.6 55.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.538 0.735 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.14 -50.44 72.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.251 0.62 . . . . 0.0 110.054 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -65.15 -38.93 92.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -52.93 58.2 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.94 -52.29 66.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.933 0.893 . . . . 0.0 110.171 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.82 76.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.706 0.402 . . . . 0.0 111.173 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.6 mt -57.6 -57.17 13.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.737 0.815 . . . . 0.0 109.379 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.09 -47.24 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.987 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.75 -50.52 72.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.416 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.12 -50.16 56.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.783 0.719 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -71.53 -13.5 61.82 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.21 -39.61 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.399 1.48 . . . . 0.0 112.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 63.15 -126.47 0.57 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.95 1.3 . . . . 0.0 108.894 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 179.807 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.88 50.66 3.02 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 118.471 1.136 . . . . 0.0 111.78 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -80.03 58.86 3.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.627 1.171 . . . . 0.0 109.447 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.7 t -83.49 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 126.059 1.744 . . . . 0.0 108.575 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -76.89 137.58 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 122.431 1.11 . . . . 0.0 109.651 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.43 64.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 61' ' ' LYS . 11.9 tt -160.06 167.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.129 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -162.61 -44.22 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.598 1.559 . . . . 0.0 108.268 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.6 m -112.92 157.21 21.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.148 1.379 . . . . 0.0 113.58 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -43.78 -37.97 2.99 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 127.814 2.446 . . . . 0.0 112.895 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.18 -28.67 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.78 3.22 15.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.274 0.943 . . . . 0.0 112.232 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.04 -57.11 13.52 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.91 1.284 . . . . 0.0 108.721 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -57.81 -47.04 83.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.078 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.34 -59.0 5.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.627 0.771 . . . . 0.0 110.856 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.3 -49.18 76.91 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.8 mt -52.04 -57.09 10.55 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.94 -59.55 4.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.104 0.962 . . . . 0.0 111.43 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -60.27 -26.85 66.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.14 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.66 -24.4 69.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.32 -1.267 . . . . 0.0 113.669 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.53 56.42 6.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.606 1.703 . . . . 0.0 108.897 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -31.76 -34.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 131.404 3.882 . . . . 0.0 117.564 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -12.65 -70.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 129.348 3.059 . . . . 0.0 113.147 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -139.16 53.16 1.75 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -117.59 131.1 24.25 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.13 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.7 91.6 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.538 1.492 . . . . 0.0 109.593 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mt -86.16 92.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.84 125.45 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 113.37 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' HB2' ' CE2' ' A' ' 46' ' ' PHE . 8.7 t0 -83.4 88.58 6.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.97 98.35 9.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -124.81 171.99 9.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.781 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.65 105.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.993 1.317 . . . . 0.0 108.231 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -43.28 -53.34 5.25 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.057 1.743 . . . . 0.0 112.807 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -58.92 -33.36 70.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.175 0.59 . . . . 0.0 111.867 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.2 t -75.82 85.42 2.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.93 -59.64 0.9 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.664 1.126 . . . . 0.0 112.638 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.22 -39.54 71.51 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.21 2.606 . . . . 0.0 113.214 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.5 m -71.16 -37.85 72.19 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.43 0.692 . . . . 0.0 109.179 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -67.26 -40.99 86.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.199 0.6 . . . . 0.0 110.442 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 83.3 mmm -53.61 -30.75 44.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.246 1.019 . . . . 0.0 112.672 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.64 -30.01 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.145 -0.347 . . . . 0.0 111.071 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.37 -55.4 37.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.704 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.1 -34.34 94.58 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 122.397 1.892 . . . . 0.0 112.067 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.24 -53.26 59.78 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 30' ' ' ASP . 93.0 t80 -53.9 -43.76 69.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.79 -44.39 90.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -58.99 -49.48 77.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.27 -33.56 74.85 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 121.93 -0.481 . . . . 0.0 110.516 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 7.0 m -57.02 -45.48 83.06 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.763 -0.585 . . . . 0.0 109.65 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -63.91 -48.28 77.24 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.38 -45.17 55.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.855 0.462 . . . . 0.0 111.257 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -102.69 44.68 1.0 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.184 0.994 . . . . 0.0 110.116 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.81 43.29 0.33 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.986 -1.071 . . . . 0.0 111.158 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.27 -135.22 8.21 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.848 1.69 . . . . 0.0 109.668 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -80.44 45.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.827 0.814 . . . . 0.0 110.007 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.46 148.77 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 107.801 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.82 130.69 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 26.0 m-85 -113.38 137.19 51.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.27 124.72 11.65 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.882 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 7' ' ' ILE . 39.4 ttpt -89.14 143.35 26.91 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.81 130.95 62.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.48 99.68 10.27 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -53.89 -43.37 57.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.38 1.072 . . . . 0.0 111.244 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.4 -49.63 73.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.718 0.407 . . . . 0.0 110.482 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 -59.17 2.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.506 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.08 54.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.635 -0.666 . . . . 0.0 110.716 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.95 70.75 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.768 0.827 . . . . 0.0 110.974 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.82 -56.32 20.64 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.917 0.887 . . . . 0.0 111.926 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.76 -43.58 98.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.8 -41.88 91.36 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.194 -0.941 . . . . 0.0 110.636 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.15 94.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.252 0.478 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.97 76.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.397 1.079 . . . . 0.0 110.312 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.0 70.95 0.47 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.87 145.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -136.39 -88.67 0.3 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 110.89 21.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -76.67 140.88 68.2 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -72.92 141.29 71.2 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 119.687 0.924 . . . . 0.0 111.02 -2.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -114.97 129.64 56.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' HD13 ' A' ' 102' ' ' LEU . 89.9 m-85 -111.17 122.05 46.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -116.8 144.55 44.35 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.62 103.84 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -95.36 93.72 7.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.199 0.454 . . . . 0.0 111.079 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -90.86 140.12 30.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.28 -58.87 0.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.156 2.583 . . . . 0.0 110.646 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.12 28.7 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 127.26 2.362 . . . . 0.0 110.095 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.72 136.27 39.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 96.7 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.23 40.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.736 0.415 . . . . 0.0 110.713 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -160.23 167.46 27.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.79 175.51 13.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.668 0.787 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.9 tp -164.68 158.75 18.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.893 1.677 . . . . 0.0 108.255 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.58 160.88 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 110.377 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.32 176.42 41.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.471 1.034 . . . . 0.0 111.554 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.42 41.77 0.26 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.145 0.978 . . . . 0.0 111.352 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -78.26 58.83 2.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.126 1.77 . . . . 0.0 110.047 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.71 -35.59 66.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 112.192 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -58.49 -53.15 61.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.262 0.625 . . . . 0.0 109.578 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -66.6 -34.9 78.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' A' ' 82' ' ' PHE . 23.7 tp -59.75 -50.48 73.67 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.165 0.586 . . . . 0.0 110.081 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -55.46 -44.78 76.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.13 95.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.508 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.2 mt -54.37 -55.88 24.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.74 -49.53 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.15 -52.71 50.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.36 0.264 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -56.63 -68.62 0.2 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.164 0.585 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -62.61 -22.69 66.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.841 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.76 80.66 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -87.06 -51.05 6.23 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.56 0.744 . . . . 0.0 110.878 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.168 1.387 . . . . 0.0 108.351 -179.105 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.981 0 CA-C-O 118.879 -0.956 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.47 62.42 1.13 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.4 1.0 . . . . 0.0 114.212 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -80.95 65.48 6.11 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 50' ' ' SER . 8.5 p -130.27 31.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.169 1.787 . . . . 0.0 108.805 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.74 152.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 122.56 1.171 . . . . 0.0 113.085 -171.292 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.75 128.7 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.541 1.536 . . . . 0.0 110.566 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tt -160.82 -160.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -157.19 -56.9 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.616 0.766 . . . . 0.0 109.955 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -31.06 118.38 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.36 2.264 . . . . 0.0 113.018 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -40.51 -54.62 2.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.683 1.193 . . . . 0.0 112.869 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -43.24 67.41 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.475 -0.765 . . . . 0.0 111.029 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -35.74 73.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.399 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -55.13 38.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.67 -51.17 69.76 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.271 0.628 . . . . 0.0 110.069 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.22 79.45 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.64 -42.68 93.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -56.22 -58.41 8.08 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.572 1.078 . . . . 0.0 109.212 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 -57.83 9.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.233 0.613 . . . . 0.0 112.318 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.88 -10.11 35.39 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.001 -0.437 . . . . 0.0 111.44 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.43 91.6 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 58.76 76.63 0.34 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.026 1.331 . . . . 0.0 107.883 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 66.54 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.236 1.415 . . . . 0.0 109.591 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.27 -46.67 54.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -170.39 65.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.759 1.624 . . . . 0.0 107.724 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -139.99 132.67 14.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.416 1.486 . . . . 0.0 107.436 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.65 137.27 32.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.658 1.572 . . . . 0.0 109.096 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.61 120.3 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 t -120.81 126.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 125.353 1.461 . . . . 0.0 107.988 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.19 134.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 118.395 0.543 . . . . 0.0 110.327 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -101.41 96.49 7.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.098 1.359 . . . . 0.0 107.525 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -87.8 90.54 8.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -111.47 -178.48 3.46 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.664 1.186 . . . . 0.0 110.387 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.86 112.33 8.74 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.313 1.045 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -36.99 -57.18 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.568 1.947 . . . . 0.0 113.283 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -64.31 -28.33 69.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 t -76.9 91.41 3.57 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -26.8 -65.97 0.07 OUTLIER Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.151 1.834 . . . . 0.0 115.211 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.44 -37.71 47.21 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.153 1.902 . . . . 0.0 112.102 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.4 m -62.14 -40.36 95.68 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -62.43 -50.72 70.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.1 tpp -56.93 -32.55 66.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.775 0.83 . . . . 0.0 112.057 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -66.85 -27.43 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.471 -0.768 . . . . 0.0 110.746 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.25 45.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.98 -1.075 . . . . 0.0 113.601 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.1 -31.08 83.29 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.861 1.707 . . . . 0.0 111.435 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 -48.37 74.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -54.58 -45.7 73.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -58.02 -43.27 86.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.704 0.402 . . . . 0.0 110.394 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.3 m -58.8 -45.61 89.5 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.51 -39.65 94.18 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.257 0.48 . . . . 0.0 110.132 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 4' ' ' VAL . 10.3 m -51.53 -53.15 40.76 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -61.14 -48.72 80.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.013 0.525 . . . . 0.0 110.998 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -48.5 -56.38 8.46 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.045 1.338 . . . . 0.0 111.744 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -79.61 -33.26 41.66 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.78 -173.34 0.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.736 1.614 . . . . 0.0 112.082 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -41.43 -26.05 0.2 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.893 2.187 . . . . 0.0 117.142 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -66.2 -19.01 65.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.677 1.739 . . . . 0.0 111.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.98 139.29 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.76 121.42 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.09 124.23 41.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.321 -0.862 . . . . 0.0 109.127 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -115.68 107.55 15.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.535 1.134 . . . . 0.0 111.111 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -79.87 131.17 35.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' VAL . . . . . 0.473 ' CG1' HG21 ' A' ' 67' ' ' VAL . 57.7 t -139.65 134.32 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 119.203 0.911 . . . . 0.0 109.798 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.71 100.09 11.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.065 0.946 . . . . 0.0 109.046 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.7 t -44.56 -46.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 128.165 2.586 . . . . 0.0 110.708 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.64 -53.32 58.01 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.455 0.472 . . . . 0.0 110.491 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.55 -62.59 1.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.822 0.449 . . . . 0.0 111.098 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 62' ' ' VAL . 28.0 m -83.07 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.288 -0.883 . . . . 0.0 111.69 -175.485 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.48 30.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.133 0.973 . . . . 0.0 111.27 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -48.55 79.0 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.761 0.825 . . . . 0.0 111.13 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.82 -42.42 89.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.83 63.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.466 0.307 . . . . 0.0 111.216 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.77 -39.93 91.49 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.617 -0.677 . . . . 0.0 110.104 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.93 87.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.539 0.609 . . . . 0.0 110.662 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.45 77.85 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 0.0 110.325 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.12 46.56 2.81 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.888 1.232 . . . . 0.0 110.77 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -78.92 150.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.6 p -124.51 -84.94 0.64 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.14 177.71 6.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -138.44 152.26 70.84 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.52 141.96 57.98 Favored 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.216 -1.109 . . . . 0.0 109.216 -3.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 m -110.58 135.04 51.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -119.61 112.79 19.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 110.397 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -110.17 154.04 23.9 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.947 HG12 ' HB3' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -119.79 139.03 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -136.17 73.88 1.48 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.399 0.545 . . . . 0.0 112.453 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.67 152.66 43.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 69.18 -64.11 0.35 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 128.426 2.69 . . . . 0.0 109.116 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.04 34.88 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.664 2.078 . . . . 0.0 110.339 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.08 145.1 26.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.99 101.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.947 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -79.86 -41.75 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.347 1.459 . . . . 0.0 111.195 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -159.02 160.06 35.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -175.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -160.9 164.24 31.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 pp -166.27 158.17 13.81 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.137 2.175 . . . . 0.0 108.947 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.52 132.42 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.86 1.264 . . . . 0.0 107.948 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.83 160.56 10.18 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.67 38.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.822 1.249 . . . . 0.0 111.441 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 m -79.55 70.63 6.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.374 1.07 . . . . 0.0 110.63 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -48.81 -41.15 31.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.837 1.255 . . . . 0.0 111.936 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.5 -47.82 84.47 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.863 0.865 . . . . 0.0 110.152 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.96 -40.03 87.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.14 -58.76 5.92 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -49.16 -50.71 36.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.14 -40.42 77.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.603 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.0 -50.05 75.28 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.984 1.266 . . . . 0.0 108.682 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.8 -50.15 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.45 11.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.235 0.214 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -46.4 -62.16 1.48 Allowed 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.971 1.708 . . . . 0.0 111.117 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.28 -22.28 59.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.967 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.77 -47.78 61.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.13 56.64 2.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.469 0.708 . . . . 0.0 109.837 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -179.798 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.925 0 CA-C-O 119.682 -0.51 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.43 -60.08 3.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -74.79 65.41 1.36 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.684 1.594 . . . . 0.0 110.891 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.26 31.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 127.662 2.385 . . . . 0.0 107.57 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.12 -171.48 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 126.922 2.089 . . . . 0.0 108.785 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.42 73.43 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tp -79.08 145.8 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.755 1.222 . . . . 0.0 109.202 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -80.12 63.47 4.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.323 0.649 . . . . 0.0 112.492 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.1 t 29.73 -119.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.534 1.934 . . . . 0.0 113.532 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.2 -47.89 1.22 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.111 2.964 . . . . 0.0 115.304 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.99 79.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.928 0.491 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.55 -40.15 14.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.955 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -32.41 -64.75 0.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 128.566 2.746 . . . . 0.0 113.181 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.99 -55.91 29.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.858 0.837 . . . . 0.0 111.833 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.86 -52.45 49.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.653 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -53.75 54.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.799 1.24 . . . . 0.0 110.155 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.44 -49.21 18.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.976 1.311 . . . . 0.0 109.834 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.41 -61.84 1.88 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -56.81 -26.7 58.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.395 0.678 . . . . 0.0 111.665 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.89 63.18 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 117.56 -1.689 . . . . 0.0 112.103 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm 49.19 60.38 3.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.288 1.544 . . . . 0.0 108.054 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -63.39 24.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.392 2.677 . . . . 0.0 116.342 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -80.92 -59.74 2.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 120.867 -1.146 . . . . 0.0 108.378 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -112.45 36.36 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.544 1.137 . . . . 0.0 108.1 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -145.22 123.35 6.49 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.39 118.64 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.712 2.941 . . . . 0.0 110.454 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -107.08 112.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -119.84 148.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 107.085 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 83' ' ' HIS . 7.7 p -133.62 137.05 53.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -105.71 98.06 7.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.415 2.286 . . . . 0.0 106.217 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.74 93.85 8.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -113.36 -167.71 1.23 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.34 0.656 . . . . 0.0 109.654 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.64 11.3 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.288 1.435 . . . . 0.0 110.11 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -99.28 -65.06 0.98 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.442 1.497 . . . . 0.0 109.376 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -49.37 -24.62 2.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.317 1.847 . . . . 0.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.6 p -58.41 -16.64 15.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.134 0.574 . . . . 0.0 111.881 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.64 -112.64 5.1 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.128 -1.373 . . . . 0.0 110.552 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -38.62 -46.61 2.56 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.126 3.217 . . . . 0.0 115.026 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -32.28 39.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -56.13 -28.59 58.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.618 0.767 . . . . 0.0 110.559 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -54.35 -25.45 24.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.802 0.841 . . . . 0.0 112.501 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.86 -30.12 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 122.009 -0.432 . . . . 0.0 110.654 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.9 -59.07 10.72 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.258 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.5 -35.95 94.55 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.817 1.678 . . . . 0.0 112.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.67 -50.74 69.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -55.38 -44.12 75.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -61.15 -37.56 83.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 110.536 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.5 m -61.46 -47.29 86.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.39 -43.48 98.8 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.4 m -50.27 -51.01 48.46 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -35.98 81.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.881 0.872 . . . . 0.0 110.71 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.69 -47.91 82.92 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 123.107 0.563 . . . . 0.0 110.345 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -79.17 -50.95 10.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.7 -63.72 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.737 2.415 . . . . 0.0 116.048 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.89 -104.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.955 2.217 . . . . 0.0 115.755 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -76.61 48.7 0.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.143 0.977 . . . . 0.0 113.215 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.36 159.81 13.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 110.505 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -134.19 121.63 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -123.31 95.08 4.46 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.051 1.34 . . . . 0.0 107.746 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.79 102.62 10.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.468 1.107 . . . . 0.0 111.349 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -79.58 118.83 21.78 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.52 148.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.907 0.86 . . . . 0.0 111.173 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -111.43 112.89 24.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.443 1.497 . . . . 0.0 109.178 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.18 -31.2 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 122.527 0.331 . . . . 0.0 110.954 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.32 -34.39 76.53 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.55 -66.46 0.89 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -85.69 62.96 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 121.605 -0.684 . . . . 0.0 111.766 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.38 -43.19 44.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.351 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -56.31 23.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.215 1.006 . . . . 0.0 111.711 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.12 -43.35 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.13 35.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.867 0.467 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.2 -40.01 90.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.668 0.667 . . . . 0.0 110.08 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.03 82.28 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.639 0.654 . . . . 0.0 110.352 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.51 3.44 21.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.958 0.903 . . . . 0.0 111.715 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.45 32.74 85.19 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.013 0.816 . . . . 0.0 112.644 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.12 134.88 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 p -136.58 -70.11 0.47 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.872 1.269 . . . . 0.0 108.323 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.82 62.28 1.53 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.769 0.828 . . . . 0.0 111.376 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 143.27 98.2 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.46 136.56 44.19 Favored 'Cis proline' 0 N--CA 1.448 -1.151 0 CA-C-N 120.063 1.058 . . . . 0.0 110.606 0.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -126.56 129.57 48.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.44 1.096 . . . . 0.0 108.34 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.97 128.33 54.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.23 1.812 . . . . 0.0 106.902 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.2 m170 -127.94 150.98 49.65 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.699 1.199 . . . . 0.0 108.889 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.08 138.06 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.842 1.257 . . . . 0.0 107.639 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -129.75 50.81 2.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.851 0.75 . . . . 0.0 111.108 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.02 154.38 34.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 74.51 -58.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.626 1.97 . . . . 0.0 109.227 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.35 -48.6 0.3 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.54 157.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.93 0.492 . . . . 0.0 109.924 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -56.42 106.15 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.06 -42.5 17.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.103 0.961 . . . . 0.0 112.367 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -159.98 155.84 26.1 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -142.29 163.64 32.29 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 124.469 1.108 . . . . 0.0 110.076 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -157.52 115.86 3.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.146 1.378 . . . . 0.0 107.959 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.62 160.77 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.708 0.803 . . . . 0.0 112.274 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 177.17 40.42 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.196 0.903 . . . . 0.0 112.185 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.44 40.99 0.24 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.361 1.064 . . . . 0.0 111.298 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.1 m -80.73 58.98 3.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.31 1.444 . . . . 0.0 110.271 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -43.95 -51.97 7.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.59 1.556 . . . . 0.0 112.555 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -52.77 -51.03 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.419 0.687 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -69.48 -32.37 71.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.093 0.557 . . . . 0.0 109.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -57.76 11.08 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -55.78 -46.24 78.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.755 0.422 . . . . 0.0 109.869 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.76 -47.73 73.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.684 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mt -63.09 -45.64 91.15 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.661 0.664 . . . . 0.0 110.473 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.45 -50.9 70.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.16 74.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.618 0.367 . . . . 0.0 111.031 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -60.13 -58.64 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.006 0.922 . . . . 0.0 111.501 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -70.66 -53.13 16.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.14 57.58 4.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.712 0.805 . . . . 0.0 109.059 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.33 -46.8 38.51 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.785 0.434 . . . . 0.0 109.951 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.458 2.303 . . . . 0.0 105.588 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.034 0 CA-C-O 117.354 -1.803 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.19 -158.32 14.36 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p -82.42 67.55 8.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.08 20.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 124.894 1.278 . . . . 0.0 111.972 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -157.71 176.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 126.849 2.059 . . . . 0.0 106.908 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 61' ' ' LYS . 6.2 p -150.44 -158.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 6' ' ' VAL . 21.1 tt -156.39 164.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -68.85 -34.6 75.75 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.422 1.089 . . . . 0.0 112.652 -174.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.8 m -62.71 105.12 0.61 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.879 0.472 . . . . 0.0 109.976 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -39.62 -51.66 2.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.811 1.645 . . . . 0.0 113.158 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.7 45.72 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.465 0.65 . . . . 0.0 111.597 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.92 66.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.188 0.595 . . . . 0.0 111.246 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -49.41 76.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -59.98 -47.08 87.27 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.69 68.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -50.81 68.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.527 0.731 . . . . 0.0 109.525 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.81 -50.74 43.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.279 0.491 . . . . 0.0 109.804 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -55.7 27.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -64.27 -22.0 66.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.776 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.18 25.39 0.2 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.728 1.156 . . . . 0.0 115.399 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp 51.44 70.82 0.5 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.276 1.43 . . . . 0.0 111.461 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.9 70.84 0.51 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.496 1.918 . . . . 0.0 109.728 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -109.18 -66.38 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -161.4 17.85 0.11 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.08 1.752 . . . . 0.0 109.872 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -75.29 142.16 74.76 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.93 115.08 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.762 2.975 . . . . 0.0 110.931 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.7 mt -101.16 101.04 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.32 109.61 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.72 121.22 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 109.846 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -85.59 100.01 11.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.723 1.609 . . . . 0.0 106.958 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.02 99.22 11.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.2 m -131.71 153.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.43 158.43 17.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.316 0.579 . . . . 0.0 110.678 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -66.4 -29.52 69.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.365 1.066 . . . . 0.0 108.235 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -60.97 179.5 0.18 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.257 2.223 . . . . 0.0 112.996 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t 69.39 -62.25 0.41 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.518 2.327 . . . . 0.0 111.733 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.38 -83.05 0.36 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.665 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -47.32 -41.98 27.91 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.494 2.796 . . . . 0.0 112.276 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.0 m -46.47 -39.24 10.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.703 1.601 . . . . 0.0 111.285 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -80.79 -12.45 59.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.339 1.056 . . . . 0.0 113.067 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.3 mmm -58.63 -27.23 64.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.876 1.216 . . . . 0.0 111.362 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.63 -27.69 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.395 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.17 10.19 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.47 -35.62 89.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.153 1.902 . . . . 0.0 112.614 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.4 -53.11 60.89 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.8 -41.46 70.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 108.963 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -62.66 -35.51 79.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.608 1.163 . . . . 0.0 110.794 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -62.8 -50.92 69.1 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.92 -41.46 82.72 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -50.97 -55.76 15.71 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -58.64 -38.0 77.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.273 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -60.61 -48.13 83.14 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.589 0.631 . . . . 0.0 111.263 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -79.62 -29.98 41.24 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.794 -0.566 . . . . 0.0 112.033 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.11 -70.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 128.434 2.694 . . . . 0.0 114.342 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.72 -15.51 2.39 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.334 1.445 . . . . 0.0 112.654 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.49 -34.65 77.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.467 1.134 . . . . 0.0 110.388 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.73 139.44 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.0 mm -93.61 99.53 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -94.46 115.63 27.84 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.4 mt -109.9 140.59 43.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.517 1.127 . . . . 0.0 108.95 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.9 mtpm? -121.65 89.95 3.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.196 0.999 . . . . 0.0 110.448 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -97.19 120.23 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 102.42 5.59 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -44.84 -43.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.867 1.267 . . . . 0.0 111.446 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.93 -41.42 11.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.094 1.758 . . . . 0.0 111.611 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.37 -70.21 0.46 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.019 0.527 . . . . 0.0 111.354 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.64 59.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.743 -0.598 . . . . 0.0 111.191 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.41 -43.1 23.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.024 0.93 . . . . 0.0 111.137 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.12 -49.68 76.11 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.941 0.896 . . . . 0.0 111.307 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 -44.52 91.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.8 -55.14 33.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.893 0.477 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.21 -43.47 94.91 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.384 0.538 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.95 76.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.716 0.689 . . . . 0.0 110.844 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.58 6.28 18.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.607 1.163 . . . . 0.0 111.695 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.09 28.3 66.26 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.243 -0.91 . . . . 0.0 112.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.78 119.75 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -137.3 -70.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.883 1.273 . . . . 0.0 108.74 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.92 65.75 1.45 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.456 0.702 . . . . 0.0 110.996 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.25 142.0 89.31 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.05 133.4 10.84 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.253 1.483 . . . . 0.0 112.894 -2.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -127.05 109.87 12.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -96.62 123.49 40.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -115.74 139.99 49.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.596 1.159 . . . . 0.0 109.68 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.48 121.77 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.13 107.06 14.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.84 1.338 . . . . 0.0 107.418 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -86.63 130.5 34.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 t70 70.46 -68.69 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.847 2.059 . . . . 0.0 107.753 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.94 27.14 0.05 OUTLIER Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.148 2.309 . . . . 0.0 110.245 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.0 130.07 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -61.07 109.4 1.08 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.87 -40.84 9.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.197 0.599 . . . . 0.0 111.682 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -160.38 170.81 20.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.04 170.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.1 tm? -163.01 122.67 2.21 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.9 m -105.9 164.63 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.765 1.226 . . . . 0.0 112.289 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.48 179.23 49.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.676 1.132 . . . . 0.0 111.692 176.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.34 39.18 0.25 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.819 0.848 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.3 m -80.87 57.94 3.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.63 1.572 . . . . 0.0 110.164 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -51.12 -48.93 61.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.401 1.08 . . . . 0.0 112.559 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.53 -47.13 80.03 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -61.54 -44.18 97.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.34 -54.49 44.84 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -54.81 -47.64 73.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.75 80.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.51 -46.15 91.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.572 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.99 -51.68 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 119.292 0.951 . . . . 0.0 108.683 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.19 69.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.472 0.309 . . . . 0.0 111.077 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -58.17 -58.69 7.34 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.394 1.078 . . . . 0.0 111.273 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -75.05 -15.68 60.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.746 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -37.48 -48.81 1.0 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.12 1.768 . . . . 0.0 112.67 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.1 -119.56 1.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 0.0 109.739 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.895 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.55 -120.39 22.62 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 p -74.12 -24.46 59.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.735 0.767 . . . . 0.0 112.424 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.72 128.32 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -145.01 143.64 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 124.476 1.111 . . . . 0.0 110.705 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.28 120.95 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 171.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.71 160.39 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 122.669 1.223 . . . . 0.0 111.639 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -133.69 35.36 3.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.076 2.15 . . . . 0.0 108.544 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 134.3 8.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.925 1.29 . . . . 0.0 108.232 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -51.69 -37.19 49.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.417 1.087 . . . . 0.0 112.46 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -34.01 -62.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.432 1.893 . . . . 0.0 112.573 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.13 77.16 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.935 -0.478 . . . . 0.0 111.363 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -51.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.57 -47.51 69.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.213 0.53 . . . . 0.0 110.297 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.84 60.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.02 -46.14 68.72 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.53 -52.2 6.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.932 0.787 . . . . 0.0 109.443 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.46 -70.0 0.21 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.228 0.611 . . . . 0.0 112.179 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -59.91 -28.42 67.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.895 0.77 . . . . 0.0 112.072 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.82 -24.28 69.79 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.542 1.544 . . . . 0.0 111.842 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 60.68 67.33 0.84 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.623 1.212 . . . . 0.0 110.485 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.02 -22.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.837 2.055 . . . . 0.0 113.459 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -34.14 -54.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.318 2.247 . . . . 0.0 110.572 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -130.66 -13.28 3.76 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -79.85 115.14 51.82 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HG2' HG22 ' A' ' 57' ' ' VAL . 57.1 Cg_endo -63.35 129.05 24.18 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.095 1.196 . . . . 0.0 109.734 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.4 mm -102.72 87.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.47 118.07 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.38 116.39 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 123.274 0.63 . . . . 0.0 109.468 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -92.47 89.19 6.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -79.71 94.49 5.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -115.84 -174.19 2.49 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.166 1.386 . . . . 0.0 108.38 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.72 139.56 40.22 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 123.191 0.596 . . . . 0.0 110.971 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -41.86 -58.91 1.87 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.293 1.437 . . . . 0.0 110.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -72.47 7.85 1.65 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.076 1.351 . . . . 0.0 113.94 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -74.43 -7.65 53.68 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.449 1.477 . . . . 0.0 111.747 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.11 -110.36 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.153 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.53 -41.6 10.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.0 3.133 . . . . 0.0 114.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -25.9 60.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.239 -0.288 . . . . 0.0 111.455 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -54.01 -27.92 34.85 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.8 -0.562 . . . . 0.0 111.135 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.0 mtm -57.71 -21.7 42.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.734 0.697 . . . . 0.0 112.457 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 97' ' ' ALA . 43.1 mt -69.04 -32.14 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.654 -0.654 . . . . 0.0 109.704 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.72 22.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.56 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -59.47 -34.72 97.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.26 1.974 . . . . 0.0 112.357 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.55 -54.41 43.48 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.71 -39.16 73.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.99 -42.33 99.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.339 1.056 . . . . 0.0 109.572 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.1 m -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 tp -59.61 -36.54 76.49 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.51 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 12.5 m -58.35 -48.83 79.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.477 0.711 . . . . 0.0 110.135 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.94 -54.04 51.14 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -54.33 -44.31 71.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.347 0.659 . . . . 0.0 111.844 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -105.83 32.39 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.968 0.907 . . . . 0.0 111.308 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.94 144.42 33.87 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.519 -0.738 . . . . 0.0 110.899 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 -60.7 3.53 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.12 -30.82 71.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' A' ' 26' ' ' PRO . 78.4 t -126.21 143.09 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 mm -100.48 118.02 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 63.2 m-85 -107.51 105.6 15.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.105 0.962 . . . . 0.0 108.827 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.81 89.36 2.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.607 1.163 . . . . 0.0 110.692 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -79.9 111.04 15.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.78 128.56 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.008 0.923 . . . . 0.0 109.952 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.25 106.31 14.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -62.37 -33.79 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.204 0.601 . . . . 0.0 111.059 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.42 -48.2 62.73 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.45 -59.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.663 0.785 . . . . 0.0 110.846 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.74 60.36 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.498 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.27 -43.96 79.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.021 0.928 . . . . 0.0 110.675 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.27 -57.11 11.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 111.907 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.66 -44.07 96.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.04 -52.83 57.23 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.19 -42.43 79.95 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.79 -0.569 . . . . 0.0 109.974 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.28 77.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.684 0.674 . . . . 0.0 110.813 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.21 3.38 27.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.782 1.233 . . . . 0.0 111.636 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.41 38.59 91.12 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.19 0.9 . . . . 0.0 112.632 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mm -76.26 134.66 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.7 p -136.25 -74.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.605 1.162 . . . . 0.0 108.749 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.23 68.41 1.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.503 1.121 . . . . 0.0 110.683 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.83 149.47 96.58 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.79 131.28 22.9 Favored 'Cis proline' 0 N--CA 1.448 -1.192 0 CA-C-N 119.948 1.017 . . . . 0.0 109.917 -1.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -115.42 128.84 56.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.747 1.219 . . . . 0.0 108.407 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -104.24 102.02 11.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.689 1.595 . . . . 0.0 109.913 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -98.94 156.11 17.07 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -127.5 103.73 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.7 66.36 4.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.368 0.531 . . . . 0.0 111.704 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -69.96 154.91 41.34 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 69.59 -63.62 0.37 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.829 2.452 . . . . 0.0 110.157 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.44 35.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.911 2.196 . . . . 0.0 110.419 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.0 152.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -60.01 94.7 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.175 0.59 . . . . 0.0 109.463 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.46 41.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.391 0.676 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -152.43 164.05 38.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.718 0.235 . . . . 0.0 110.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.36 -177.45 4.85 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.21 2.204 . . . . 0.0 107.237 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp 165.82 147.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 128.557 2.743 . . . . 0.0 106.828 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -132.53 150.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.473 1.109 . . . . 0.0 108.965 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.2 173.88 49.38 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 122.088 0.827 . . . . 0.0 113.4 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -76.1 35.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.416 1.487 . . . . 0.0 113.908 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m -78.1 67.15 3.88 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.479 -0.763 . . . . 0.0 110.216 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -49.43 -42.63 43.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.936 1.694 . . . . 0.0 111.504 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -56.58 -49.32 75.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.899 0.88 . . . . 0.0 110.003 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -70.26 -31.12 68.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -53.98 52.18 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.72 -47.3 80.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.92 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.77 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.0 mt -55.15 -55.36 32.07 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.263 0.625 . . . . 0.0 109.726 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.14 -54.11 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.22 -55.59 23.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.663 0.385 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -52.5 -58.62 6.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.288 1.435 . . . . 0.0 111.108 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -72.19 -26.52 62.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.764 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.53 -58.74 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 70.14 -59.31 0.52 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.124 1.769 . . . . 0.0 111.629 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 C-N-CA 126.065 1.746 . . . . 0.0 107.571 179.052 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.212 0 CA-C-O 118.101 -1.388 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.56 -130.68 2.76 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -72.21 73.8 0.95 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.312 1.056 . . . . 0.0 110.129 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.2 29.55 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.231 1.412 . . . . 0.0 112.233 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.15 162.02 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.206 1.003 . . . . 0.0 113.211 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.32 135.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.616 1.966 . . . . 0.0 107.181 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 tt -160.04 169.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.949 0.881 . . . . 0.0 110.63 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -132.16 45.8 2.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 110.442 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -154.41 127.05 8.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.072 -1.018 . . . . 0.0 111.35 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -48.88 -50.07 36.69 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.528 1.131 . . . . 0.0 110.254 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.63 -48.35 19.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.721 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.95 81.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -52.2 48.57 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.69 -47.27 81.85 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.94 57.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.463 0.305 . . . . 0.0 110.275 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -51.47 69.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.085 0.954 . . . . 0.0 109.447 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tt -48.17 -50.07 30.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -62.24 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -63.47 -15.04 56.63 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.599 -0.688 . . . . 0.0 112.285 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.87 -16.74 57.28 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.112 -0.827 . . . . 0.0 111.455 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mttp 76.53 84.49 0.09 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.931 1.692 . . . . 0.0 108.296 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.49 66.16 0.31 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.622 1.969 . . . . 0.0 110.204 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.62 -61.25 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -168.1 8.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.9 153.03 57.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -170.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -65.91 116.1 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.308 2.672 . . . . 0.0 111.304 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.7 mt -97.64 91.96 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.03 109.69 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -111.61 126.24 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -95.72 105.66 17.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 107.615 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -86.25 97.39 10.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -117.6 142.51 47.12 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.1 56.58 1.22 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.9 p 6.89 -74.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.486 3.115 . . . . 0.0 114.645 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -43.64 -28.81 0.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.318 1.847 . . . . 0.0 115.094 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.41 69.18 1.15 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.9 1.682 . . . . 0.0 112.167 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 32.35 -95.99 0.01 OUTLIER Glycine 0 CA--C 1.532 1.151 0 C-N-CA 128.279 2.847 . . . . 0.0 113.576 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -39.59 -45.83 3.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.221 3.281 . . . . 0.0 112.555 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m -46.4 -37.85 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.821 1.648 . . . . 0.0 112.215 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -74.21 -62.15 1.61 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.2 ptp -58.88 -26.33 64.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 113.012 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.96 -29.76 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.653 -0.654 . . . . 0.0 110.047 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.73 -55.12 46.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.527 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -46.16 -43.84 20.3 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.757 2.971 . . . . 0.0 114.707 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.31 -55.13 35.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.07 -37.79 75.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.54 -34.35 74.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.504 1.121 . . . . 0.0 109.844 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 m -61.21 -53.66 54.11 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.6 -43.52 76.14 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 17.9 m -52.83 -56.46 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.577 0.751 . . . . 0.0 109.853 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.79 -50.61 60.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.703 0.401 . . . . 0.0 110.477 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.8 -60.17 4.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.887 1.367 . . . . 0.0 112.558 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -88.27 23.68 2.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.91 1.232 . . . . 0.0 111.754 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.17 151.92 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.868 -1.145 . . . . 0.0 111.769 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 -60.53 4.53 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.822 0.449 . . . . 0.0 109.969 175.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.26 138.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 107.373 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -98.53 131.14 46.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 97.1 m-85 -122.66 139.94 53.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.408 0.549 . . . . 0.0 110.68 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -132.89 125.43 29.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.338 1.055 . . . . 0.0 109.949 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -107.96 102.36 11.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.18 122.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.669 . . . . 0.0 110.82 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.47 104.54 5.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 t -56.62 -40.09 66.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.96 1.304 . . . . 0.0 110.781 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.81 -51.04 62.39 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.52 -60.05 2.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.256 0.622 . . . . 0.0 110.882 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.83 57.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.175 0.988 . . . . 0.0 109.576 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.16 98.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.811 0.844 . . . . 0.0 110.271 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.18 -57.22 10.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 111.993 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.07 -47.46 93.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.39 -47.14 63.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.634 0.254 . . . . 0.0 110.529 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.05 -58.35 8.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.882 0.873 . . . . 0.0 110.197 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -41.27 72.6 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.54 0.336 . . . . 0.0 111.78 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 -2.84 41.78 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.739 1.216 . . . . 0.0 111.754 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.36 47.49 78.89 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.028 -1.045 . . . . 0.0 113.019 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.38 117.85 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -98.37 -84.54 0.39 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.486 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.094 0.957 . . . . 0.0 110.245 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.52 141.47 79.88 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -71.24 140.36 64.18 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.246 1.123 . . . . 0.0 111.713 -1.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.3 m -121.01 109.42 15.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.31 131.09 34.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -126.58 135.51 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 107.979 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -113.15 91.31 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.925 0.784 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.21 69.22 9.88 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.7 133.46 55.36 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 70.84 -66.99 0.27 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 127.447 2.299 . . . . 0.0 107.061 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.86 26.86 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.427 1.965 . . . . 0.0 110.299 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.0 122.34 31.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 118.152 0.976 . . . . 0.0 108.542 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -45.61 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.593 1.957 . . . . 0.0 110.772 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.91 -33.68 19.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.039 0.936 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.89 159.11 37.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -143.79 166.0 26.12 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.807 1.243 . . . . 0.0 109.078 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.7 tp -162.52 115.46 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.862 0.865 . . . . 0.0 109.881 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.98 158.7 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.017 -0.427 . . . . 0.0 110.768 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 172.07 48.67 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.472 1.034 . . . . 0.0 112.662 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.85 74.0 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.083 0.953 . . . . 0.0 110.523 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.4 m 23.16 57.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.153 2.981 . . . . 0.0 115.055 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -57.97 -59.64 4.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 113.424 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.58 -45.84 73.62 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.894 0.854 . . . . 0.0 110.105 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.45 -43.86 96.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.03 0.932 . . . . 0.0 109.583 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -56.17 21.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.355 1.062 . . . . 0.0 108.185 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -53.36 -50.75 64.41 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.22 76.17 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.426 0.29 . . . . 0.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.64 -53.91 51.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 t -55.23 -47.43 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.406 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.73 -57.08 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.159 0.583 . . . . 0.0 111.746 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -64.7 -48.92 72.93 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.028 0.831 . . . . 0.0 112.098 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -64.44 -33.56 76.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.677 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.0 47.97 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.084 0.856 . . . . 0.0 110.837 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.87 -30.48 71.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.484 0.714 . . . . 0.0 111.824 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.766 2.027 . . . . 0.0 105.634 179.3 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.86 95.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 118.21 1.005 . . . . 0.0 111.234 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -71.62 48.56 0.15 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.59 1.556 . . . . 0.0 113.831 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 50' ' ' SER . 46.9 t -141.72 91.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.46 149.57 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.083 0.553 . . . . 0.0 109.865 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.89 55.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.253 1.421 . . . . 0.0 108.865 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.33 82.8 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 123.002 1.382 . . . . 0.0 110.179 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -76.09 70.0 2.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.64 1.576 . . . . 0.0 108.972 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -146.65 123.12 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.142 0.577 . . . . 0.0 110.302 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -49.32 -45.06 44.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.813 0.845 . . . . 0.0 110.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.71 78.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.303 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.23 74.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.876 0.47 . . . . 0.0 109.833 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -54.75 17.08 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.38 -57.21 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.666 0.786 . . . . 0.0 111.792 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -50.88 67.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.275 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.84 -49.08 74.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 109.351 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.66 -52.77 28.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.887 0.875 . . . . 0.0 109.636 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -60.28 4.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.456 0.702 . . . . 0.0 111.759 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -60.55 -24.16 65.18 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.668 -0.645 . . . . 0.0 111.428 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.09 -22.38 57.89 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.654 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mttp 54.8 60.3 3.57 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.05 1.425 . . . . 0.0 107.915 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -62.4 37.18 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 130.348 3.459 . . . . 0.0 116.221 -173.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.1 -76.37 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -114.82 11.26 16.67 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 123.821 0.849 . . . . 0.0 110.883 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -76.55 139.83 67.65 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.66 94.7 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.644 2.229 . . . . 0.0 111.665 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.25 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.39 120.34 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.0 116.57 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.591 0.756 . . . . 0.0 110.834 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -91.03 104.28 16.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.488 1.115 . . . . 0.0 108.565 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -96.54 129.2 43.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 t -157.59 -172.74 4.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 120.4 16.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.989 0.813 . . . . 0.0 111.589 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -36.85 -63.8 0.39 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.056 2.142 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -54.81 -33.04 61.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 112.369 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.87 82.09 6.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.01 -62.68 0.56 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.004 1.288 . . . . 0.0 113.461 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.41 -30.96 93.99 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 119.828 1.814 . . . . 0.0 112.734 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.25 -29.43 67.34 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -81.32 -30.37 33.9 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.059 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.5 mmt -57.24 -22.06 38.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.04 0.836 . . . . 0.0 111.769 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -68.81 -30.44 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.759 . . . . 0.0 110.377 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.64 15.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 112.604 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -57.25 -39.72 87.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 CA-C-N 121.594 1.605 . . . . 0.0 111.495 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.74 -54.55 45.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -51.81 -48.65 63.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.916 1.286 . . . . 0.0 109.258 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.97 -30.36 70.91 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.688 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.4 m -56.56 -39.57 73.68 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 0.0 107.96 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.79 -25.82 63.47 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.099 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.608 ' HB2' HG11 ' A' ' 4' ' ' VAL . 22.9 t -50.65 -38.69 47.86 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.306 1.412 . . . . 0.0 110.294 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -55.94 -43.05 77.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.226 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.62 -53.4 9.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.67 0.788 . . . . 0.0 110.318 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.46 66.6 9.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.43 72.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.965 1.306 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.31 -166.14 3.73 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.466 1.031 . . . . 0.0 113.69 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.72 36.62 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.66 1.984 . . . . 0.0 114.805 -175.468 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.5 122.84 39.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.64 104.47 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 4' ' ' VAL . 13.1 m-85 -92.59 90.22 7.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.72 145.09 31.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.98 121.2 41.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.31 72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.69 121.91 14.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.94 -29.14 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.897 0.879 . . . . 0.0 111.754 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.59 -29.86 70.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.6 -71.86 0.68 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.949 0.9 . . . . 0.0 110.342 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.04 61.8 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 122.649 1.214 . . . . 0.0 108.861 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.46 -42.15 77.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.006 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 -53.26 43.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.9 0.88 . . . . 0.0 111.613 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.61 -43.49 90.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -50.69 64.74 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.4 -43.98 76.07 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.733 -0.604 . . . . 0.0 109.711 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.84 -40.8 76.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.794 0.725 . . . . 0.0 111.169 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.25 45.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.143 1.377 . . . . 0.0 111.434 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.76 41.55 95.68 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 123.925 0.774 . . . . 0.0 112.405 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.7 mm -73.69 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.107 0.954 . . . . 0.0 108.874 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.8 p -131.03 -78.67 0.53 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.484 1.114 . . . . 0.0 108.86 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.57 63.21 1.5 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.626 1.171 . . . . 0.0 111.014 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 151.16 95.91 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.14 158.43 94.98 Favored 'Cis proline' 0 N--CA 1.448 -1.16 0 CA-C-N 119.721 0.936 . . . . 0.0 109.979 0.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 m -150.13 136.32 18.76 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.62 121.3 43.74 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.196 1.398 . . . . 0.0 108.211 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -115.95 150.36 37.27 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.051 0.94 . . . . 0.0 108.906 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.33 107.05 19.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -93.42 89.0 6.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.934 0.493 . . . . 0.0 111.884 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -90.47 156.46 18.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 69.67 -60.19 0.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.325 2.65 . . . . 0.0 109.485 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.31 28.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.058 2.742 . . . . 0.0 110.198 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.4 p -160.54 143.47 4.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.821 1.31 . . . . 0.0 109.902 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -39.83 97.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.749 2.019 . . . . 0.0 111.312 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.59 -37.55 21.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.404 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -139.15 163.16 33.15 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -160.39 169.45 23.05 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.649 0.78 . . . . 0.0 110.12 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -163.19 150.31 12.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.407 1.483 . . . . 0.0 107.921 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.95 162.87 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.495 1.118 . . . . 0.0 110.729 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.99 176.41 40.73 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.934 0.778 . . . . 0.0 112.565 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.72 40.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.354 1.062 . . . . 0.0 111.576 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -77.27 57.93 1.55 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.618 1.967 . . . . 0.0 110.729 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -50.51 -42.02 54.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.111 1.764 . . . . 0.0 112.217 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -57.66 -48.62 78.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 109.969 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -73.08 -26.8 61.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -54.5 45.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -53.33 -47.88 68.94 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.43 75.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.683 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -56.71 -54.61 44.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.612 0.642 . . . . 0.0 109.685 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.51 -46.36 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.771 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.24 -54.36 46.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.612 0.365 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -54.89 -56.04 23.93 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.519 1.128 . . . . 0.0 111.383 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -74.43 -27.93 60.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.156 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.83 41.86 0.82 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.597 1.09 . . . . 0.0 110.853 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.05 75.0 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.121 0.568 . . . . 0.0 112.085 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.456 1.902 . . . . 0.0 106.186 -179.737 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 CA-C-O 118.209 -1.328 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.39 -86.77 0.25 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -78.48 46.39 0.63 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.715 -0.874 . . . . 0.0 110.418 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 50' ' ' SER . 78.5 t -154.23 90.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.63 2.372 . . . . 0.0 105.902 -175.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 pt -145.08 149.56 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.315 0.646 . . . . 0.0 109.761 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.03 55.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.176 1.39 . . . . 0.0 109.022 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.19 -173.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.936 1.294 . . . . 0.0 110.475 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -165.34 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 125.653 1.581 . . . . 0.0 109.156 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -35.57 114.99 0.29 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.56 2.344 . . . . 0.0 113.753 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -42.74 -52.28 5.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.727 1.611 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.17 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.821 -0.549 . . . . 0.0 111.678 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.93 -32.73 67.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.829 -0.545 . . . . 0.0 109.95 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.94 79.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.89 -45.71 91.66 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.05 -53.92 46.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -50.54 38.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.488 1.115 . . . . 0.0 109.416 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.64 -14.38 3.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.897 1.279 . . . . 0.0 113.862 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.33 -63.12 1.39 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.761 1.224 . . . . 0.0 110.695 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -20.86 58.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.43 0.692 . . . . 0.0 112.46 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.09 -19.87 62.0 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.603 -1.109 . . . . 0.0 111.926 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? 67.81 64.88 0.38 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.594 1.558 . . . . 0.0 108.539 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -70.1 56.95 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.806 2.842 . . . . 0.0 111.762 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.65 -52.03 6.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.151 1.38 . . . . 0.0 108.064 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -160.53 75.25 0.56 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.245 1.418 . . . . 0.0 108.106 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -147.17 145.51 22.3 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 121.971 -0.456 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.81 126.7 7.41 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.999 2.466 . . . . 0.0 112.168 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mt -96.15 120.89 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 t -112.36 118.65 58.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.02 118.03 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 122.658 0.383 . . . . 0.0 111.79 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.78 87.08 7.26 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -84.76 93.94 8.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 t -117.89 -177.85 3.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.2 112.92 15.68 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.802 1.241 . . . . 0.0 109.08 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -43.56 -56.97 3.37 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.808 1.243 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -57.73 -31.19 66.19 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 112.496 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.6 t -77.39 85.81 3.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -36.23 -59.21 0.99 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.758 1.17 . . . . 0.0 113.07 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.19 -41.23 73.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.017 2.478 . . . . 0.0 112.986 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 m -68.74 -36.59 78.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.74 -47.58 77.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.284 0.634 . . . . 0.0 109.417 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.4 mtm -58.67 -20.3 46.96 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.4 mt -78.36 -24.85 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.88 -51.48 80.09 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.534 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.9 -36.63 89.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.283 1.851 . . . . 0.0 111.529 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.37 -50.81 72.13 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -56.32 -45.96 80.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.662 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.78 -43.4 90.43 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.445 1.02 . . . . 0.0 110.239 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.3 m -55.43 -48.66 74.09 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.65 -43.93 97.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.195 0.521 . . . . 0.0 109.972 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . 41.1 m -54.95 -47.23 74.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 111.537 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -67.53 -12.77 61.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.525 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -74.99 -64.53 1.03 Allowed 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.924 1.238 . . . . 0.0 108.773 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.11 38.31 0.47 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.339 -0.85 . . . . 0.0 110.61 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.914 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.6 -64.2 2.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -60.29 -49.05 79.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.854 0.827 . . . . 0.0 110.285 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 94.5 t -96.76 134.25 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.28 98.78 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 50' ' ' SER . 96.5 m-85 -91.21 143.19 26.92 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.544 -0.723 . . . . 0.0 110.621 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.42 109.69 5.89 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.257 -170.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -79.67 136.78 36.89 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.6 134.79 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -100.93 104.65 15.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.52 -30.16 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 122.607 0.363 . . . . 0.0 110.611 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.9 -36.4 76.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.506 0.323 . . . . 0.0 110.514 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.65 -69.5 0.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.91 58.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.432 -0.792 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.96 35.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.315 1.046 . . . . 0.0 110.678 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.4 72.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.806 0.842 . . . . 0.0 111.13 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.87 -45.41 91.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.98 -53.8 51.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.409 0.283 . . . . 0.0 111.501 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.46 -42.35 83.18 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.595 -0.691 . . . . 0.0 110.544 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.15 -46.2 90.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.539 0.609 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.64 90.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.938 0.895 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.84 52.44 0.75 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.325 0.964 . . . . 0.0 111.946 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.68 147.92 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.9 p -127.24 -81.42 0.6 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.22 177.89 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.819 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -140.55 139.23 19.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -63.36 153.67 70.99 Favored 'Cis proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.518 1.221 . . . . 0.0 113.987 -3.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.3 m -128.61 126.42 40.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.52 101.0 8.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.529 1.132 . . . . 0.0 109.447 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -97.35 145.39 26.18 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.36 111.53 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.17 104.3 14.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -75.98 105.28 6.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 70.58 -56.11 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.879 2.471 . . . . 0.0 110.673 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 89' ' ' VAL . . . -163.47 -13.11 0.03 OUTLIER Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.484 1.992 . . . . 0.0 111.77 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.416 ' H ' ' H ' ' A' ' 88' ' ' GLY . 24.6 t -85.67 122.63 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 118.8 1.3 . . . . 0.0 108.204 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.29 94.93 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.2 -35.84 35.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.645 1.178 . . . . 0.0 111.145 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.49 168.28 27.77 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -148.24 167.33 25.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.412 2.285 . . . . 0.0 107.509 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 tp -178.09 138.55 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.205 2.202 . . . . 0.0 106.125 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.13 144.91 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.3 63.69 0.98 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 49.62 -108.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.72 1.208 . . . . 0.0 111.56 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 m 56.84 60.84 2.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.615 1.166 . . . . 0.0 111.003 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -52.01 -36.65 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.583 1.153 . . . . 0.0 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.25 -46.8 88.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.368 0.667 . . . . 0.0 109.72 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -69.02 -35.7 76.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -56.5 -53.68 54.64 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -53.31 -47.42 69.27 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.08 79.88 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.91 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.05 -55.75 29.09 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.497 0.589 . . . . 0.0 109.607 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.59 -47.28 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.84 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.68 -56.44 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.672 0.272 . . . . 0.0 110.295 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -49.37 -62.77 1.36 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.914 1.286 . . . . 0.0 110.773 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -69.79 -22.55 63.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.84 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.21 -44.81 62.39 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.73 53.55 2.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.075 0.55 . . . . 0.0 109.802 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.593 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.17 -107.78 1.08 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.119 0.96 . . . . 0.0 111.37 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -71.85 -20.65 61.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 50' ' ' SER . 46.6 t -102.38 107.06 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.01 146.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 CA-C-N 119.315 0.962 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.84 22.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.317 1.847 . . . . 0.0 108.608 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.27 162.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -78.72 77.94 5.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -59.42 72.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 127.943 2.497 . . . . 0.0 115.45 -170.791 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -92.94 -66.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.121 1.369 . . . . 0.0 108.444 167.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.9 17.14 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.027 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.8 65.1 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.667 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -53.13 18.15 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 109.361 175.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.73 -48.52 68.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.828 0.451 . . . . 0.0 110.895 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.95 -60.92 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.598 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -57.09 -47.37 81.22 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.258 1.023 . . . . 0.0 109.689 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -49.66 -48.92 49.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.034 0.379 . . . . 0.0 110.61 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -63.63 1.08 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.638 0.375 . . . . 0.0 111.011 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.37 -25.87 67.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.822 -0.549 . . . . 0.0 111.951 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 -24.55 71.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.721 -1.044 . . . . 0.0 111.801 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 51.31 67.1 1.0 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.224 1.012 . . . . 0.0 109.752 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 46.12 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.395 1.878 . . . . 0.0 114.489 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -139.89 7.23 2.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.468 0.707 . . . . 0.0 112.803 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.03 129.3 61.87 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.14 122.86 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.608 1.538 . . . . 0.0 112.188 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.34 99.79 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.62 111.31 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.79 125.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.35 98.8 11.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.959 1.304 . . . . 0.0 109.463 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.77 96.83 9.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 t -127.21 -150.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -167.97 161.17 12.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 110.912 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -66.56 -59.67 3.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.749 1.22 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -51.01 -33.69 26.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.471 1.508 . . . . 0.0 114.594 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 p -78.37 57.81 2.0 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.605 1.093 . . . . 0.0 112.051 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.46 -87.65 0.0 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 129.129 3.252 . . . . 0.0 115.398 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -41.2 -37.16 2.77 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.717 3.611 . . . . 0.0 113.979 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -45.05 -45.87 11.11 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.405 1.482 . . . . 0.0 111.335 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -65.23 -21.97 66.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.865 0.866 . . . . 0.0 111.593 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.2 mtt -90.0 -37.51 14.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.999 1.32 . . . . 0.0 109.403 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mt -64.16 -42.52 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 109.382 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -47.98 -53.75 29.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.201 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 75.1 Cg_exo -46.57 -46.9 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.167 3.245 . . . . 0.0 114.186 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.08 -49.51 77.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.746 0.784 . . . . 0.0 108.891 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -58.53 -42.33 87.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.152 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.12 -40.63 96.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.026 0.83 . . . . 0.0 109.574 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -58.52 -49.98 75.41 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.75 -36.47 76.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.044 0.449 . . . . 0.0 109.995 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 41.9 m -60.17 -46.28 90.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.973 -0.454 . . . . 0.0 109.78 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -64.72 -43.8 92.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -47.55 -51.62 20.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.951 0.5 . . . . 0.0 111.675 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -101.54 33.7 2.86 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.377 0.535 . . . . 0.0 111.659 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.58 151.5 10.54 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.565 -0.709 . . . . 0.0 111.681 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 -62.99 3.2 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -55.66 -52.86 62.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.509 0.724 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 94.8 t -106.75 140.55 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 mm -96.31 131.77 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 93.8 m-85 -121.79 118.21 28.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.861 0.755 . . . . 0.0 110.778 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -112.44 148.66 33.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.612 1.565 . . . . 0.0 110.072 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -123.22 132.71 54.14 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.42 1.488 . . . . 0.0 107.849 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.23 130.46 39.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 119.171 0.896 . . . . 0.0 109.765 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.54 109.71 21.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.59 -27.38 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.958 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.03 -40.9 97.35 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.608 0.64 . . . . 0.0 109.476 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.51 -63.64 1.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.124 0.57 . . . . 0.0 110.073 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.57 58.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.666 0.746 . . . . 0.0 110.001 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.39 68.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.034 0.934 . . . . 0.0 110.963 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.5 -56.11 22.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.878 0.871 . . . . 0.0 112.16 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.16 -42.62 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.86 63.44 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.7 -38.64 80.43 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.454 -0.779 . . . . 0.0 110.189 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.82 -46.28 89.73 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.564 0.62 . . . . 0.0 109.943 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.92 73.06 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.453 0.701 . . . . 0.0 110.015 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 43.73 4.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.712 1.149 . . . . 0.0 111.208 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.8 mm -79.17 140.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -134.15 -80.35 0.46 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.376 1.07 . . . . 0.0 109.226 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.29 67.21 2.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.261 1.024 . . . . 0.0 111.033 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -63.77 144.77 97.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.168 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.45 148.22 64.43 Favored 'Cis proline' 0 N--CA 1.455 -0.745 0 CA-C-N 120.847 1.338 . . . . 0.0 112.783 -0.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -146.32 122.98 11.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.84 118.9 37.78 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.606 1.162 . . . . 0.0 109.395 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -109.52 150.12 28.62 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.77 107.75 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -99.77 114.31 27.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.648 0.779 . . . . 0.0 111.285 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.57 -170.5 2.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 166.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 89' ' ' VAL . 25.7 p-10 -67.61 -34.22 76.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.123 -0.985 . . . . 0.0 108.474 165.054 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 41.39 0.97 Allowed Glycine 0 CA--C 1.541 1.709 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.31 20.1 m 24.45 -139.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.64 1 C-N-CA 133.701 4.8 . . . . 0.0 113.458 -179.178 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -54.12 85.14 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.873 1.269 . . . . 0.0 109.616 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.87 40.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.491 0.716 . . . . 0.0 109.856 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.68 161.85 41.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.888 0.475 . . . . 0.0 110.345 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -140.58 165.48 27.34 Favored 'General case' 0 C--N 1.335 -0.048 0 C-N-CA 127.14 2.176 . . . . 0.0 107.731 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.1 tp -172.39 103.9 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.893 1.277 . . . . 0.0 109.785 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.82 162.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.548 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 170.42 27.77 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.423 1.011 . . . . 0.0 112.743 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.45 45.34 0.56 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.465 1.106 . . . . 0.0 110.312 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -77.99 60.11 2.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.051 1.34 . . . . 0.0 111.688 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.39 -46.37 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.56 1.544 . . . . 0.0 113.982 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.63 -48.31 75.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.283 -0.886 . . . . 0.0 110.372 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.6 -38.96 86.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.16 -57.43 13.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -45.38 -53.52 8.52 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.621 0.768 . . . . 0.0 110.213 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.55 -50.81 70.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.321 1.013 . . . . 0.0 111.511 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.98 -46.02 90.82 Favored 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.583 -0.698 . . . . 0.0 110.34 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.33 -46.34 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.9 -52.68 59.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.83 -61.0 2.57 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.104 0.962 . . . . 0.0 111.144 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -64.59 -31.79 73.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.885 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.58 42.67 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.946 0.898 . . . . 0.0 111.154 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.92 -23.0 66.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.347 0.659 . . . . 0.0 112.342 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.538 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.106 0 CA-C-O 119.074 -0.848 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.69 -71.98 0.86 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m -75.83 61.07 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.822 1.649 . . . . 0.0 110.583 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.26 31.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.83 2.052 . . . . 0.0 108.087 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 pt -131.79 -173.1 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.392 1.477 . . . . 0.0 110.677 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.95 115.45 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -155.64 99.54 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 122.343 1.068 . . . . 0.0 109.244 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -91.58 -42.49 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.866 1.266 . . . . 0.0 109.705 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 m -32.86 113.17 0.13 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 115.016 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -40.92 66.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 110.527 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -25.12 64.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.938 0.495 . . . . 0.0 111.885 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.44 -31.63 12.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.123 0.969 . . . . 0.0 110.898 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -45.94 -58.25 3.71 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.48 1.512 . . . . 0.0 112.147 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.95 -44.72 84.2 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.655 -0.653 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.77 -42.85 62.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -56.15 25.58 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.94 1.696 . . . . 0.0 109.085 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.6 mt -49.67 -45.79 49.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 110.481 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.85 -63.46 1.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.135 0.574 . . . . 0.0 111.589 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -57.4 -32.08 66.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.373 0.533 . . . . 0.0 111.082 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.97 55.31 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.113 -1.382 . . . . 0.0 113.031 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? 59.0 69.92 0.69 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -68.64 62.51 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.441 2.696 . . . . 0.0 112.767 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -116.92 -93.16 0.51 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.67 73.48 0.82 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.922 0.889 . . . . 0.0 109.052 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 27' ' ' ILE . 29.4 mmtm -140.29 150.31 60.9 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.13 86.39 0.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 N-CA-C 106.609 -2.112 . . . . 0.0 106.609 168.409 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 25' ' ' LYS . 3.4 mp -82.24 79.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.36 137.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 147.23 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -117.6 113.53 22.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.63 112.1 22.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -142.79 179.0 7.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.23 170.62 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.585 1.554 . . . . 0.0 110.812 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.9 p -96.8 -66.49 0.9 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.943 1.697 . . . . 0.0 110.708 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -43.07 -32.38 0.68 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.51 2.324 . . . . 0.0 113.164 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -58.46 -19.55 37.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.482 1.113 . . . . 0.0 113.093 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 -113.44 3.77 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.359 -1.245 . . . . 0.0 110.065 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.89 -42.84 6.78 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.282 3.321 . . . . 0.0 115.207 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -23.09 55.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -71.17 -31.67 67.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.428 -0.795 . . . . 0.0 110.364 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 mmt -61.22 -18.25 57.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.14 0.976 . . . . 0.0 112.467 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 43.6 mt -62.98 -33.43 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.6 6.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.114 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -57.11 -35.99 99.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.801 1.679 . . . . 0.0 112.019 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.34 -55.14 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.399 0.618 . . . . 0.0 109.733 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -56.5 -41.26 76.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.67 0.788 . . . . 0.0 109.522 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.68 -40.61 97.64 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.881 -0.512 . . . . 0.0 110.119 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -60.21 -48.84 80.03 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.51 -39.17 75.94 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.257 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -54.88 -54.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.05 -45.79 79.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.989 0.915 . . . . 0.0 110.771 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.24 -43.14 95.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.759 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -79.42 -45.41 19.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.97 -64.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.76 -119.47 0.01 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.575 2.512 . . . . 0.0 116.92 -170.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 55.37 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.091 -1.24 . . . . 0.0 111.12 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.89 149.46 25.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.042 1.337 . . . . 0.0 110.552 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.72 105.44 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.92 94.39 5.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.604 1.162 . . . . 0.0 108.434 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.9 92.45 5.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.911 1.284 . . . . 0.0 109.824 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -85.25 107.42 17.28 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.233 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.67 149.75 17.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 125.292 1.437 . . . . 0.0 110.255 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.99 115.77 30.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.0 0.92 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.66 -45.8 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 124.867 1.267 . . . . 0.0 110.991 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -58.45 -41.66 85.64 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.03 -70.91 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -87.88 63.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 O-C-N 121.332 -0.855 . . . . 0.0 110.955 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.93 48.3 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.48 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.5 69.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.008 0.923 . . . . 0.0 111.295 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.07 -44.96 97.83 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -55.59 29.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.648 0.379 . . . . 0.0 111.169 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.92 -41.71 97.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.707 0.685 . . . . 0.0 109.831 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.66 77.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.641 0.655 . . . . 0.0 110.528 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 7.76 12.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.12 0.968 . . . . 0.0 111.792 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.38 27.06 70.16 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.211 0.91 . . . . 0.0 113.093 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.88 81.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 122.558 1.171 . . . . 0.0 108.707 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -92.1 -72.58 0.58 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.842 2.057 . . . . 0.0 108.099 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.46 59.94 1.53 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.831 0.852 . . . . 0.0 111.389 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.86 152.18 96.89 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -60.17 147.96 44.01 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 121.016 1.398 . . . . 0.0 112.491 -2.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.8 m -147.35 141.79 26.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 51.8 m-85 -134.34 130.49 37.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.666 1.587 . . . . 0.0 107.917 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -125.3 158.49 34.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.551 1.14 . . . . 0.0 107.925 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.4 122.02 63.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 27' ' ' ILE . 40.6 m-85 -110.81 76.36 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.107 0.563 . . . . 0.0 111.966 -173.796 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -90.43 -168.08 2.01 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.349 -0.845 . . . . 0.0 110.285 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 89' ' ' VAL . 3.3 m-20 -51.23 -43.07 61.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.08 17.86 0.14 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.612 2.053 . . . . 0.0 112.507 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 90' ' ' LYS 0.277 40.5 t 67.18 -154.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.42 1.488 . . . . 0.0 107.34 170.592 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LYS . . . . . 0.67 ' H ' HG12 ' A' ' 89' ' ' VAL . 22.5 ttpp -64.29 79.53 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.29 -32.45 43.58 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.622 -166.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -147.19 151.07 36.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -142.97 166.27 25.1 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.081 1.352 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 98' ' ' SER . 1.7 tm? -161.83 140.98 9.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.762 1.225 . . . . 0.0 108.263 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 m -127.26 162.68 31.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.485 1.114 . . . . 0.0 110.793 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 179.16 36.76 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.841 -0.799 . . . . 0.0 111.09 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 94' ' ' LEU . 14.2 m -80.08 58.86 3.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -48.92 -46.57 43.27 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.374 . . . . 0.0 111.864 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.36 -48.51 74.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.103 0.561 . . . . 0.0 110.128 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' HD3' HD23 ' A' ' 94' ' ' LEU . 50.7 tttm -68.8 -35.62 77.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -58.69 -48.71 80.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 109.132 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.98 -47.76 80.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.93 77.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.23 -55.72 31.34 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.0 t -51.08 -53.34 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.24 -52.11 62.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.94 0.496 . . . . 0.0 111.562 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -68.28 0.23 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.471 0.653 . . . . 0.0 110.034 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -61.01 -24.04 65.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.091 -170.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.42 94.45 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.728 0.695 . . . . 0.0 109.696 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.26 -62.94 1.44 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.477 0.711 . . . . 0.0 109.47 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.591 1.556 . . . . 0.0 108.173 -179.845 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.25 80.3 0.5 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.351 0.575 . . . . 0.0 112.028 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -72.48 79.11 1.04 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.132 0.966 . . . . 0.0 109.139 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.71 32.41 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.481 1.512 . . . . 0.0 112.784 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -107.99 154.09 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.35 -0.844 . . . . 0.0 112.392 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.89 135.95 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -160.58 -41.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 122.7 1.238 . . . . 0.0 111.295 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.38 49.36 6.05 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 128.044 2.538 . . . . 0.0 112.241 168.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -131.82 134.73 46.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.578 1.151 . . . . 0.0 107.988 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -49.57 -46.81 49.35 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.754 0.822 . . . . 0.0 111.113 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.92 -11.34 37.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.871 1.268 . . . . 0.0 113.143 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 -33.28 6.91 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.499 1.12 . . . . 0.0 110.075 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -46.79 19.75 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.171 1.388 . . . . 0.0 110.274 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -69.47 -53.39 19.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.012 0.525 . . . . 0.0 109.954 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.68 27.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.608 1.163 . . . . 0.0 111.26 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -44.72 41.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.499 1.52 . . . . 0.0 111.286 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.54 -39.1 93.14 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.704 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.57 -54.13 15.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.039 0.536 . . . . 0.0 109.869 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.5 -28.63 69.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.43 -54.53 33.54 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.767 1.175 . . . . 0.0 111.312 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 103.64 81.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 1 C-N-CA 132.063 4.145 . . . . 0.0 107.665 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -72.83 60.89 0.53 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.641 1.977 . . . . 0.0 110.189 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -119.33 -60.1 1.77 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.947 1.299 . . . . 0.0 108.207 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -152.32 90.9 1.54 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -157.77 152.77 21.36 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -76.36 106.71 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.912 3.075 . . . . 0.0 108.793 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.24 81.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -84.18 120.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -120.62 118.42 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -88.72 96.75 10.79 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.567 1.147 . . . . 0.0 108.958 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -82.25 113.2 19.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 m -141.46 149.47 40.99 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 122.987 0.515 . . . . 0.0 110.041 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 133.21 34.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -50.83 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.63 100.74 5.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.2 133.13 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.479 -0.763 . . . . 0.0 109.003 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.48 150.97 40.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER 50.91 -29.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.445 3.43 . . . . 0.0 118.59 -170.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.2 m -50.73 -45.86 58.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 122.573 2.442 . . . . 0.0 108.354 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -56.06 -26.48 49.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.876 1.67 . . . . 0.0 112.438 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 60.6 mtt -91.15 -43.67 9.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.27 1.428 . . . . 0.0 110.371 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.65 -42.5 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.38 1.472 . . . . 0.0 110.31 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -55.32 -60.09 9.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.769 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 71.2 Cg_exo -47.14 -46.9 18.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.643 173.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.96 -55.44 34.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.429 0.633 . . . . 0.0 110.466 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -57.42 -37.91 73.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.023 0.529 . . . . 0.0 109.718 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.62 -38.35 89.2 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.704 -0.623 . . . . 0.0 110.146 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 m -60.9 -46.02 92.3 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.11 -40.49 93.94 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 p -58.7 -41.93 87.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.117 -0.99 . . . . 0.0 109.599 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -39.83 94.96 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.76 -47.91 81.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.773 0.429 . . . . 0.0 110.965 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -79.25 -47.74 15.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.874 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 18.77 73.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.585 2.754 . . . . 0.0 115.238 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.0 -96.76 0.11 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -76.46 46.29 0.42 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.09 1.356 . . . . 0.0 110.686 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.6 m -156.76 161.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.047 -1.033 . . . . 0.0 109.62 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.98 121.35 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 169.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.36 91.48 3.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.624 1.169 . . . . 0.0 107.92 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -84.96 127.24 34.09 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.273 1.029 . . . . 0.0 110.923 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.34 128.76 44.44 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.0 101.06 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 122.138 0.97 . . . . 0.0 111.388 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.07 104.07 0.84 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.22 -36.18 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.982 1.313 . . . . 0.0 110.018 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -63.16 -28.23 69.91 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.618 0.367 . . . . 0.0 111.104 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.46 -65.8 0.97 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.7 56.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 110.134 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.13 77.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.023 0.929 . . . . 0.0 111.529 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.32 -53.12 48.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.907 0.883 . . . . 0.0 111.657 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.41 -46.57 94.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.26 -57.25 11.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.722 0.237 . . . . 0.0 111.437 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.02 -41.3 97.94 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.415 -0.803 . . . . 0.0 110.703 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.35 98.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.384 0.538 . . . . 0.0 111.367 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.32 81.24 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 0.0 111.151 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.67 82.4 1.35 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.76 139.3 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 126.279 1.832 . . . . 0.0 106.401 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -131.92 -96.11 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.76 71.64 5.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.725 0.81 . . . . 0.0 109.446 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' MET . . . . . 0.409 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 1.7 pmm? -53.98 143.66 41.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.052 0.941 . . . . 0.0 109.855 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 79' ' ' MET . 99.9 Cg_exo -57.55 154.98 32.59 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-N 121.131 1.44 . . . . 0.0 113.642 -1.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.9 108.7 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.76 89.94 5.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.635 1.574 . . . . 0.0 110.104 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -80.26 146.15 31.81 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.42 104.58 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -92.68 52.83 1.94 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -50.69 132.14 25.92 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 74.85 -62.19 0.46 Allowed 'General case' 0 CA--C 1.526 0.043 0 C-N-CA 126.835 2.054 . . . . 0.0 108.726 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.71 39.06 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.912 1.244 . . . . 0.0 111.533 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.88 142.22 8.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -60.54 91.23 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 109.945 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.44 -31.56 29.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.224 1.41 . . . . 0.0 110.741 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -150.27 170.87 17.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.609 0.242 . . . . 0.0 111.163 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -150.12 165.07 33.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.448 1.899 . . . . 0.0 107.43 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.9 tp -172.39 108.08 0.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.264 1.426 . . . . 0.0 108.842 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.6 168.04 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.345 0.658 . . . . 0.0 110.446 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.12 -177.76 27.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.38 -65.77 0.63 Allowed 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m 45.45 43.91 9.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 113.046 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -48.59 -44.14 36.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 112.695 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -59.71 -52.32 65.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.21 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.85 -31.55 71.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.21 -59.22 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -53.54 -49.85 66.74 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.258 0.623 . . . . 0.0 110.464 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.84 71.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.067 0.147 . . . . 0.0 110.87 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.37 -46.27 84.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.454 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.77 -48.81 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.794 1.179 . . . . 0.0 108.916 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.72 47.7 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.75 0.42 . . . . 0.0 110.485 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -52.37 -63.23 1.21 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.057 0.943 . . . . 0.0 110.661 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.24 -19.1 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.351 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.29 9.12 37.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.277 0.944 . . . . 0.0 111.385 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.58 76.77 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.295 0.952 . . . . 0.0 111.703 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.502 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 CA-C-O 118.208 -1.329 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.44 -30.85 72.53 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.756 1.278 . . . . 0.0 110.591 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 58' ' ' ILE . 4.3 m -66.49 71.99 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.098 2.159 . . . . 0.0 113.192 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.8 m -142.57 31.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.048 2.139 . . . . 0.0 107.179 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.11 147.48 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 125.248 1.419 . . . . 0.0 111.672 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.1 71.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.352 1.061 . . . . 0.0 110.816 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.34 122.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -98.75 -25.15 14.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.336 2.254 . . . . 0.0 113.569 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -38.06 130.11 1.2 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.663 1.585 . . . . 0.0 111.627 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -49.89 -40.39 42.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.049 0.84 . . . . 0.0 112.537 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 -42.6 81.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.749 0.785 . . . . 0.0 110.034 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.18 -33.64 67.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.189 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -57.95 -52.23 66.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -56.2 -50.05 72.32 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.404 0.682 . . . . 0.0 109.939 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.1 61.97 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.869 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.6 -39.14 73.05 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.562 1.145 . . . . 0.0 111.058 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -62.34 -10.5 11.36 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.222 0.609 . . . . 0.0 111.454 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.69 -58.97 1.94 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.645 1.178 . . . . 0.0 109.908 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -9.57 23.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.522 -0.736 . . . . 0.0 112.184 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.53 -26.7 71.02 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt 55.07 51.73 12.93 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.738 1.215 . . . . 0.0 109.475 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -77.18 62.63 2.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.702 1.601 . . . . 0.0 110.218 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.95 -49.77 70.53 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 109.154 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.37 22.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.676 1.99 . . . . 0.0 108.865 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -87.56 160.71 47.14 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.498 1.119 . . . . 0.0 110.723 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.91 120.62 5.85 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.437 2.091 . . . . 0.0 112.255 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.36 92.88 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.64 111.29 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.64 128.96 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -99.84 102.74 14.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.591 2.356 . . . . 0.0 108.461 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.45 96.75 8.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 33' ' ' ALA . 72.9 m -136.75 -177.34 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 32' ' ' THR . . . -169.46 -177.83 2.91 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 120.878 1.672 . . . . 0.0 110.147 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 p -56.53 -50.17 72.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.931 1.693 . . . . 0.0 109.001 172.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -59.43 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.214 2.605 . . . . 0.0 113.704 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.0 p 170.72 -21.58 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.839 2.456 . . . . 0.0 110.491 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.95 -114.52 5.61 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.088 -1.396 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -41.04 -41.45 4.28 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.502 3.468 . . . . 0.0 115.853 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -27.23 58.02 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.473 0.579 . . . . 0.0 111.57 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -57.99 -23.7 55.07 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.544 -0.723 . . . . 0.0 111.125 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.8 mtm -60.83 -13.72 17.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.778 0.717 . . . . 0.0 111.965 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.84 -30.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.632 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.04 -56.48 25.37 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.629 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.24 -33.46 97.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 122.11 1.789 . . . . 0.0 111.962 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.99 -46.94 76.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.94 -42.72 97.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.579 0.752 . . . . 0.0 110.005 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.4 m -57.62 -47.07 83.22 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.64 -42.25 98.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -52.34 -50.25 62.68 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -41.76 95.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.952 0.501 . . . . 0.0 110.651 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.12 -49.8 75.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.728 0.811 . . . . 0.0 111.315 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.17 -48.18 14.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.176 0.19 . . . . 0.0 110.635 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.91 -73.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.313 1.845 . . . . 0.0 114.133 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.24 -68.7 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.388 0.994 . . . . 0.0 114.23 -172.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -69.88 19.43 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CE1' ' A' ' 59' ' ' PHE . 41.0 t -152.13 154.93 7.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 119.886 1.221 . . . . 0.0 109.43 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 3' ' ' SER . 4.2 mp -116.52 102.87 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE1' HG11 ' A' ' 57' ' ' VAL . 24.0 m-85 -94.25 98.03 10.65 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.086 0.954 . . . . 0.0 109.278 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.94 121.77 32.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.857 0.463 . . . . 0.0 109.787 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -99.52 115.77 30.12 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.81 119.45 58.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 118.484 0.584 . . . . 0.0 110.868 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.68 100.2 10.07 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 172.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -44.22 -58.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.854 1.662 . . . . 0.0 111.51 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.26 -42.59 86.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.9 0.88 . . . . 0.0 111.574 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.38 -67.9 0.42 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.124 0.42 . . . . 0.0 110.063 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -86.44 63.79 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.926 0.87 . . . . 0.0 109.869 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.2 -40.74 34.64 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.674 1.189 . . . . 0.0 110.615 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.39 77.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.692 0.797 . . . . 0.0 111.048 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.52 -45.07 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.12 35.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.552 0.341 . . . . 0.0 111.435 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.81 -41.12 96.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.26 0.482 . . . . 0.0 109.758 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.31 -41.82 76.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.741 0.7 . . . . 0.0 110.235 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.1 6.9 14.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.48 0.712 . . . . 0.0 112.295 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.94 97.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.023 0.821 . . . . 0.0 112.731 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.0 mm -94.3 153.65 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.5 m -153.64 -57.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.12 159.5 18.18 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.81 158.99 29.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.414 -1.279 . . . . 0.0 107.855 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.34 126.44 3.64 Favored 'Cis proline' 0 C--N 1.35 0.612 0 CA-C-N 121.338 1.514 . . . . 0.0 112.975 -1.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 m -126.87 122.07 33.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.44 129.01 56.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.146 . . . . 0.0 108.521 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -121.3 152.4 38.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.13 94.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -88.65 104.75 17.15 Favored 'General case' 0 C--O 1.227 -0.103 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -77.1 127.65 33.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.28 -64.78 0.32 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.792 2.037 . . . . 0.0 109.136 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 22.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.032 1.777 . . . . 0.0 112.242 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.34 125.63 43.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 119.324 1.562 . . . . 0.0 109.576 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -50.28 97.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.135 1.774 . . . . 0.0 110.782 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.97 -31.07 27.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.294 1.038 . . . . 0.0 110.101 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -160.35 172.89 16.49 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.737 0.815 . . . . 0.0 108.9 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.48 -179.28 7.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.115 0.966 . . . . 0.0 109.284 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -164.96 106.18 0.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 106.951 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.56 32.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.0 1.32 . . . . 0.0 113.075 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 168.73 37.19 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.187 -0.946 . . . . 0.0 112.661 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.92 38.55 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.298 1.439 . . . . 0.0 112.942 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.3 m -81.4 70.92 8.37 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 120.649 -1.282 . . . . 0.0 109.717 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -39.62 -52.06 2.23 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.826 1.651 . . . . 0.0 113.757 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.57 -44.19 93.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.81 -0.556 . . . . 0.0 110.959 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -65.32 -41.57 93.85 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -51.81 -58.01 7.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.938 1.295 . . . . 0.0 108.187 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.49 -52.68 58.78 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.92 0.888 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.25 71.24 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.8 mt -58.66 -51.37 70.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.18 -48.88 81.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.489 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.9 61.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.599 0.36 . . . . 0.0 110.864 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -56.21 -65.09 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.122 0.969 . . . . 0.0 110.417 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -64.42 -24.44 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.455 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.5 2.84 23.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.951 0.796 . . . . 0.0 112.033 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.95 48.72 0.73 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.031 1.287 . . . . 0.0 111.462 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 116.65 -1.643 . . . . 0.0 107.465 179.098 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.6 92.72 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 m -68.55 69.56 0.16 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.49 1.916 . . . . 0.0 112.429 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 50' ' ' SER . 11.3 t -131.66 92.38 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -136.96 176.06 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.247 0.546 . . . . 0.0 112.406 -171.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.08 22.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.516 1.526 . . . . 0.0 110.939 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -82.03 78.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.99 64.24 0.33 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.413 1.885 . . . . 0.0 109.631 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.6 m -153.12 167.82 27.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.19 1.396 . . . . 0.0 109.469 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -39.77 -42.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.695 1.998 . . . . 0.0 112.339 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.5 -41.12 9.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 112.037 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.01 62.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.578 -0.701 . . . . 0.0 109.944 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -53.96 -40.25 66.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.98 0.912 . . . . 0.0 112.198 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.06 -72.62 0.71 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.49 -55.68 23.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.257 0.623 . . . . 0.0 111.899 -173.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.96 -50.18 73.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -47.19 -50.13 21.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.891 0.476 . . . . 0.0 110.762 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.37 -58.35 8.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.118 0.567 . . . . 0.0 111.147 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.47 -19.4 63.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.561 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.18 49.2 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.751 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 57.56 65.76 1.28 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.026 1.413 . . . . 0.0 109.837 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 68.13 1.86 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 109.839 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.01 -51.79 35.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -163.48 22.59 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.38 1.872 . . . . 0.0 109.487 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -69.31 144.47 94.83 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 121.865 -0.522 . . . . 0.0 111.674 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.81 92.39 0.52 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.539 1.493 . . . . 0.0 108.844 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.5 111.65 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.52 123.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.3 104.22 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.832 0.853 . . . . 0.0 110.282 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.97 90.55 5.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.274 1.03 . . . . 0.0 109.395 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.11 113.35 18.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -139.55 146.89 40.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ALA . . . . . 0.602 ' HB1' ' CE2' ' A' ' 35' ' ' TRP . . . -77.58 107.48 10.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.8 m -58.44 -36.65 73.98 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.795 0.725 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TRP . . . . . 0.602 ' CE2' ' HB1' ' A' ' 33' ' ' ALA . 37.1 p-90 -60.91 -32.39 71.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.466 0.706 . . . . 0.0 110.572 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -78.89 77.08 5.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.58 -54.09 2.84 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.524 1.059 . . . . 0.0 112.184 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.49 -45.49 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.094 2.529 . . . . 0.0 112.75 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.16 -45.56 90.67 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -61.49 -13.01 17.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.753 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.92 -12.87 60.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 121.556 1.98 . . . . 0.0 111.128 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.79 -23.83 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 118.714 0.688 . . . . 0.0 109.306 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.55 -47.04 97.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.71 -1.244 . . . . 0.0 112.644 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.35 -35.43 73.07 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.347 1.874 . . . . 0.0 110.795 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.27 -46.26 89.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.75 -46.4 81.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.01 -41.97 88.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.567 0.747 . . . . 0.0 109.974 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -60.17 -44.83 94.72 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 49' ' ' LEU . 14.0 tp -62.51 -38.02 88.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.081 -0.387 . . . . 0.0 110.036 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.533 ' HB3' HG13 ' A' ' 4' ' ' VAL . 11.5 m -60.08 -48.67 80.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.401 0.68 . . . . 0.0 109.757 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -59.4 -45.19 92.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.944 0.497 . . . . 0.0 109.667 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.11 -56.77 17.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.734 0.414 . . . . 0.0 110.501 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -86.19 58.02 4.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.23 -20.73 66.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.649 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -149.44 0.05 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.591 1.567 . . . . 0.0 113.959 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 53.53 0.84 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 113.012 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.91 140.01 49.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.323 1.849 . . . . 0.0 106.183 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.1 mm -112.91 134.64 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -126.41 111.81 14.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.673 0.67 . . . . 0.0 110.04 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.59 147.21 37.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.307 1.443 . . . . 0.0 108.949 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -118.23 144.14 46.0 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.93 126.29 37.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -83.88 117.76 23.53 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.8 72.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 177.69 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.543 2.737 . . . . 0.0 105.759 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.02 65.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.457 0.303 . . . . 0.0 110.414 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.16 39.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.57 -49.59 26.12 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.224 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.21 -47.43 62.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.462 0.705 . . . . 0.0 112.252 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.49 -46.7 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.46 78.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.061 0.458 . . . . 0.0 110.271 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -57.46 -58.92 6.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.25 1.02 . . . . 0.0 109.519 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.9 73.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.814 0.446 . . . . 0.0 111.23 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.04 -17.89 63.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.707 0.803 . . . . 0.0 111.578 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 44.27 13.69 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.71 0.671 . . . . 0.0 111.436 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.0 mm -74.37 139.72 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.4 p -124.52 -85.08 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.509 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.67 86.3 6.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.434 1.094 . . . . 0.0 111.402 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -62.64 145.01 95.78 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.462 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.91 153.05 72.97 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.62 1.257 . . . . 0.0 111.634 -2.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -145.38 114.69 7.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.52 119.74 35.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.593 1.157 . . . . 0.0 109.382 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -111.2 134.9 52.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.99 109.44 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.76 97.64 7.44 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.658 0.383 . . . . 0.0 111.788 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -90.3 -165.22 1.3 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 89' ' ' VAL . 19.3 p-10 -69.63 -36.68 76.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 169.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.5 41.37 1.16 Allowed Glycine 0 CA--C 1.543 1.808 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 166.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.333 25.3 m 20.89 -134.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.448 1 C-N-CA 133.008 4.523 . . . . 0.0 113.482 -178.105 . . . . . . . . 4 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -58.18 79.06 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.338 1.455 . . . . 0.0 109.032 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -29.21 39.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.41 1.084 . . . . 0.0 111.589 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -158.34 157.4 32.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -147.05 158.87 44.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.0 tp -155.52 109.58 2.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 109.882 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.68 168.54 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 110.562 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.66 178.43 40.4 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.388 0.518 . . . . 0.0 112.208 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.74 -59.04 4.98 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 110.196 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 33.49 21.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.0 3.32 . . . . 0.0 119.237 171.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 4.0 pm0 -51.51 -40.59 59.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.279 1.4 . . . . 0.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.69 -36.42 69.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.848 -0.533 . . . . 0.0 111.203 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.66 -38.23 26.23 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.2 tp -45.81 -51.33 13.01 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.36 0.664 . . . . 0.0 109.508 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -41.5 -52.87 3.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 0.0 111.759 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.68 79.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.45 1.1 . . . . 0.0 110.725 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -49.12 79.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.6 t -57.83 -46.99 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.29 -53.26 46.4 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -54.98 -62.33 1.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.221 1.008 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -62.65 -22.21 66.28 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.72 -5.15 54.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.79 0.723 . . . . 0.0 112.126 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.91 49.56 0.93 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.831 1.196 . . . . 0.0 111.328 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.763 1.625 . . . . 0.0 107.426 179.566 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.0 -58.6 3.55 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 m -64.46 96.31 0.16 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.663 1.185 . . . . 0.0 110.983 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.7 26.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.335 1.854 . . . . 0.0 108.719 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 pp -97.94 175.31 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.66 122.69 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.24 2.216 . . . . 0.0 108.051 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 tt -160.63 151.32 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.772 0.714 . . . . 0.0 109.666 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -74.75 72.61 2.02 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -55.56 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 129.233 3.013 . . . . 0.0 115.556 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -93.78 -94.86 0.16 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.906 1.282 . . . . 0.0 109.596 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.73 77.06 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.453 -1.404 . . . . 0.0 109.314 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.9 69.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.14 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -50.29 71.83 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.48 1.037 . . . . 0.0 108.402 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -48.75 79.67 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.66 -49.39 75.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.386 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.57 64.68 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.554 0.742 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -49.42 -54.54 16.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 -62.36 1.74 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.924 0.489 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -59.61 -29.03 67.71 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.423 0.556 . . . . 0.0 111.103 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.41 67.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.091 -1.394 . . . . 0.0 112.916 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.33 55.01 10.13 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.995 1.398 . . . . 0.0 108.754 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -38.75 -31.57 0.06 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.56 3.144 . . . . 0.0 116.377 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -9.06 -74.09 0.0 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 129.464 3.106 . . . . 0.0 111.208 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -138.83 74.07 1.46 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -165.51 121.98 1.03 Allowed Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 133.98 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.057 1.838 . . . . 0.0 113.76 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.35 102.21 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 101.203 -3.628 . . . . 0.0 101.203 169.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 t -99.95 120.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -173.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.68 104.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 124.935 1.294 . . . . 0.0 110.636 -173.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -83.46 95.73 8.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.301 1.44 . . . . 0.0 107.925 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -80.19 122.81 27.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -146.51 168.24 21.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.66 114.85 23.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.895 0.77 . . . . 0.0 108.95 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -43.36 -57.0 3.24 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.193 1.397 . . . . 0.0 113.128 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -59.19 -30.67 68.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.076 0.551 . . . . 0.0 112.192 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.9 t -76.06 84.71 2.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.24 -59.73 0.76 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.95 1.262 . . . . 0.0 112.942 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.7 -40.6 79.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.163 2.575 . . . . 0.0 113.025 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -67.1 -43.95 81.23 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -62.77 -43.3 99.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.998 0.519 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.6 mmm -58.99 -17.49 25.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt -79.14 -24.45 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 119.193 0.906 . . . . 0.0 109.79 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.36 -55.05 41.4 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 117.453 -1.26 . . . . 0.0 112.272 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.73 94.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.205 1.937 . . . . 0.0 111.686 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.98 -52.9 63.76 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -60.54 -37.47 81.31 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.717 -0.615 . . . . 0.0 109.898 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.35 -35.52 75.85 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.297 -0.877 . . . . 0.0 109.861 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -61.23 -47.49 85.81 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.89 -39.63 90.02 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -55.89 -51.98 65.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.868 0.467 . . . . 0.0 109.857 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -39.9 94.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.159 0.584 . . . . 0.0 109.888 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.02 -46.54 85.12 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.031 0.532 . . . . 0.0 111.35 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -79.65 -53.17 7.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 -56.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.161 2.184 . . . . 0.0 115.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.49 -116.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.823 2.154 . . . . 0.0 115.688 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -40.4 -45.37 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.14 136.97 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 O-C-N 122.209 -0.307 . . . . 0.0 110.189 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.22 125.81 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 175.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -112.72 143.86 43.23 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.64 118.67 7.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.593 -167.794 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -106.28 118.2 36.02 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.85 134.4 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.389 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -85.39 106.66 16.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.424 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.41 -38.99 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 126.473 1.909 . . . . 0.0 109.791 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.96 -34.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.076 0.151 . . . . 0.0 111.29 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.65 -72.25 0.44 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.17 61.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 121.502 -0.749 . . . . 0.0 110.495 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.49 -41.25 53.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.501 0.72 . . . . 0.0 109.9 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.46 68.66 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.13 0.972 . . . . 0.0 111.112 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.11 -45.98 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -54.81 38.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.859 0.464 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.12 -40.09 82.61 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 110.646 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.07 89.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.521 0.601 . . . . 0.0 110.215 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.02 95.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.288 0.635 . . . . 0.0 109.833 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.01 47.09 0.73 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.58 1.086 . . . . 0.0 112.583 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.07 132.22 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.7 p -112.31 -76.79 0.59 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.31 149.39 22.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.512 1.125 . . . . 0.0 108.89 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.69 143.37 33.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -72.26 170.6 66.89 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 C-N-CA 125.144 -0.773 . . . . 0.0 112.588 -1.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 129.68 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -106.1 118.09 35.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.962 1.305 . . . . 0.0 110.58 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -112.38 144.21 42.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 118.824 0.738 . . . . 0.0 110.195 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.39 124.16 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.21 60.78 0.69 Allowed 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 124.763 1.289 . . . . 0.0 110.803 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -71.11 149.15 46.74 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.72 -52.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.248 1.819 . . . . 0.0 112.265 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.37 -57.93 0.22 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.76 164.04 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.106 0.563 . . . . 0.0 109.569 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -56.64 104.01 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.98 -39.65 29.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.097 0.959 . . . . 0.0 110.711 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -161.0 168.01 25.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.06 177.49 10.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.37 0.532 . . . . 0.0 109.914 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 tp -162.54 110.85 1.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.079 1.352 . . . . 0.0 109.404 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.1 161.61 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 0.0 110.989 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.6 -177.91 54.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.605 0.622 . . . . 0.0 112.601 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.18 34.99 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 109.307 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 m 30.82 46.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 115.124 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -59.15 -44.23 92.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 112.246 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -54.52 -53.6 52.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.45 0.7 . . . . 0.0 110.388 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.73 -37.1 76.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.1 tp -53.85 -51.96 61.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -52.39 -48.58 65.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.02 0.373 . . . . 0.0 110.18 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.24 86.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.232 0.213 . . . . 0.0 110.699 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.46 -50.49 67.27 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.66 -0.65 . . . . 0.0 110.37 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.57 -47.35 48.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.34 78.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.302 0.376 . . . . 0.0 111.207 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -49.14 -54.58 15.63 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.328 1.051 . . . . 0.0 110.77 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -75.93 -46.97 27.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.625 0.25 . . . . 0.0 111.454 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.31 -32.79 73.17 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.606 1.162 . . . . 0.0 113.179 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.88 45.76 14.8 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.877 1.271 . . . . 0.0 108.881 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.712 2.005 . . . . 0.0 106.449 -179.354 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 CA-C-O 119.228 -0.762 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.29 -56.21 0.61 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.282 1.42 . . . . 0.0 110.632 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -68.47 78.26 0.27 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.66 94.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 pt -152.75 169.12 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.874 0.845 . . . . 0.0 110.861 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.27 149.02 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -150.42 155.4 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 119.329 0.968 . . . . 0.0 110.471 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -137.7 36.3 2.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.958 1.303 . . . . 0.0 111.455 -175.39 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 m -157.28 127.01 6.14 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.164 -0.96 . . . . 0.0 111.162 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -51.85 -45.67 64.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.353 1.061 . . . . 0.0 110.428 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.15 59.6 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.212 0.53 . . . . 0.0 110.481 -178.105 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.32 90.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -52.19 65.73 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -64.49 -45.41 87.46 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.103 -178.567 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.47 65.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.969 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.87 -50.09 75.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.566 0.746 . . . . 0.0 110.256 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -46.94 -49.76 20.06 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.703 0.401 . . . . 0.0 109.927 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -65.97 0.61 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -58.77 -31.04 68.02 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.605 -0.685 . . . . 0.0 111.848 -174.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.5 -24.67 39.59 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.35 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 45.98 8.38 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.125 1.37 . . . . 0.0 109.911 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.64 40.0 0.36 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -174.354 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -15.2 -63.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.727 2.811 . . . . 0.0 113.399 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -142.74 23.14 1.94 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.885 1.674 . . . . 0.0 109.112 177.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.87 153.15 37.9 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.589 0.756 . . . . 0.0 111.192 -171.486 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -71.76 133.14 21.4 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.845 1.697 . . . . 0.0 114.124 -177.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.21 116.65 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 100.964 -3.717 . . . . 0.0 100.964 167.32 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.4 t -102.64 111.44 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -174.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.56 136.77 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.15 89.84 3.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 168.997 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.44 99.0 7.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.598 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 m -136.13 151.74 50.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.789 1.636 . . . . 0.0 107.1 178.861 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.44 -178.82 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.988 0.915 . . . . 0.0 111.114 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 p -77.2 -63.33 1.39 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.678 1.591 . . . . 0.0 106.84 174.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -61.28 147.47 44.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.744 174.342 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.7 t 136.24 -59.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 129.212 3.005 . . . . 0.0 107.766 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.28 -92.87 1.02 Allowed Glycine 0 CA--C 1.53 1.025 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.07 -40.73 15.83 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.971 3.114 . . . . 0.0 113.523 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -44.64 -43.52 8.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.577 1.151 . . . . 0.0 110.905 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -58.59 -33.75 70.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.596 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.35 -18.93 65.7 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -177.514 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.1 mp -76.99 -27.33 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.125 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.96 -57.04 13.72 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.474 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.37 -41.2 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.904 1.716 . . . . 0.0 112.016 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.4 -51.6 69.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.752 0.787 . . . . 0.0 109.493 178.313 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.6 -49.15 75.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.236 1.014 . . . . 0.0 109.835 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.79 -41.22 90.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.828 0.851 . . . . 0.0 110.792 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -57.41 -50.6 72.48 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.39 -44.77 89.11 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 121.051 0.453 . . . . 0.0 110.227 176.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -50.98 -46.23 61.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.231 0.612 . . . . 0.0 111.162 -177.394 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -54.14 -30.47 49.17 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.85 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.09 -52.34 36.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.77 0.714 . . . . 0.0 111.221 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -90.95 -13.37 33.58 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -19.37 -61.85 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 129.192 2.997 . . . . 0.0 115.69 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -50.51 -47.77 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.415 0.531 . . . . 0.0 111.831 -177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -86.16 -60.3 2.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.238 0.615 . . . . 0.0 110.498 -178.117 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -88.02 146.48 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.431 2.292 . . . . 0.0 112.825 -169.589 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.49 146.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -135.42 113.61 11.36 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.69 101.28 7.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.51 1.124 . . . . 0.0 111.189 -175.67 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -79.85 94.63 5.85 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.1 t -79.39 117.91 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -67.93 102.22 1.23 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.28 -34.23 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.499 1.12 . . . . 0.0 110.477 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.76 -28.0 69.68 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.337 0.255 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 -65.87 0.94 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.569 0.748 . . . . 0.0 110.856 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.01 60.71 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.879 0.847 . . . . 0.0 110.172 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.5 76.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.906 0.882 . . . . 0.0 110.526 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.64 -55.85 22.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 111.867 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -44.78 98.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.73 38.15 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.653 0.263 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.71 -41.17 88.39 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.217 -0.927 . . . . 0.0 110.491 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.49 92.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.548 0.613 . . . . 0.0 110.531 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.02 77.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.003 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.52 48.61 1.28 Allowed Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.661 1.124 . . . . 0.0 111.508 175.814 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.8 136.35 23.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.2 p -140.18 -76.65 0.33 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.0 0.92 . . . . 0.0 108.656 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.44 73.6 1.39 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.547 1.139 . . . . 0.0 110.577 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.08 138.75 96.29 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.337 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -64.78 130.52 10.66 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 CA-C-N 121.068 1.417 . . . . 0.0 112.731 -0.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.5 m -120.62 105.0 10.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.131 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.07 132.08 34.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.216 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -124.25 150.06 45.75 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.849 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.78 113.09 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.77 125.54 54.11 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.437 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.36 112.57 20.04 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 176.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 69.71 -64.03 0.36 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.984 2.514 . . . . 0.0 109.161 -173.4 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.95 7.21 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.975 1.75 . . . . 0.0 112.468 177.871 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.18 117.09 44.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-N 118.996 1.398 . . . . 0.0 107.526 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -56.48 111.2 0.93 Allowed 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.81 -32.21 10.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.341 1.057 . . . . 0.0 111.154 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.55 172.36 17.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.833 0.288 . . . . 0.0 110.53 -177.845 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -160.46 168.39 25.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.813 1.245 . . . . 0.0 108.856 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 tp -167.87 120.36 0.88 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.804 0.842 . . . . 0.0 109.603 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.4 163.28 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.239 0.616 . . . . 0.0 111.312 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.5 174.85 46.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.716 1.15 . . . . 0.0 111.951 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.32 43.35 0.37 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 110.72 178.555 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 m -79.35 54.12 1.64 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.926 1.69 . . . . 0.0 110.287 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -36.51 63.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.019 0.927 . . . . 0.0 112.445 -175.365 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -61.44 -51.58 68.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.533 0.733 . . . . 0.0 109.861 177.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -68.43 -32.97 73.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.09 -56.22 24.54 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.438 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -50.61 -50.61 53.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.111 0.564 . . . . 0.0 110.403 177.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.55 71.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.42 -48.17 82.42 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.787 -0.571 . . . . 0.0 110.378 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.7 t -54.92 -51.05 57.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.78 -51.19 61.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.436 0.295 . . . . 0.0 110.926 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -53.87 -66.66 0.36 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.041 0.924 . . . . 0.0 110.507 178.017 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -59.33 -31.71 69.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.409 -174.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.09 -2.64 28.46 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.81 52.4 1.03 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.965 1.257 . . . . 0.0 111.277 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.573 1.549 . . . . 0.0 107.765 179.611 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.632 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.17 57.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 118.642 1.221 . . . . 0.0 112.081 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 63.71 1.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.421 1.088 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 50' ' ' SER . 76.3 t -79.38 85.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.005 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -144.91 167.29 10.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.541 0.686 . . . . 0.0 111.287 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 7.8 p -111.85 134.7 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 174.05 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -153.61 162.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.913 0.863 . . . . 0.0 110.475 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -126.95 11.73 7.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.134 1.774 . . . . 0.0 112.648 -173.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -124.28 114.45 19.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.786 0.435 . . . . 0.0 111.65 -174.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -47.82 -40.59 21.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.006 1.322 . . . . 0.0 111.775 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.1 70.23 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.089 0.955 . . . . 0.0 111.058 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.31 74.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.936 -0.478 . . . . 0.0 109.802 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -50.86 68.09 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.413 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.09 -49.79 76.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.99 0.916 . . . . 0.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.41 -57.02 11.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.001 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -54.51 -44.8 73.04 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.539 0.736 . . . . 0.0 110.221 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -23.2 2.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.012 0.925 . . . . 0.0 112.046 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.47 -68.38 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 110.636 175.163 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -61.91 -23.0 66.05 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -171.487 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.57 -12.53 64.21 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.986 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 59.9 69.1 0.73 Allowed 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.53 2.13 23.27 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.176 -172.27 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -10.24 -65.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 129.742 3.217 . . . . 0.0 113.602 -176.115 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -146.39 57.27 1.18 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.833 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -118.48 136.61 24.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.021 . . . . 0.0 109.274 -177.083 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.25 114.87 4.14 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.146 1.898 . . . . 0.0 110.743 177.187 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.38 98.33 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 171.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.42 116.72 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.07 114.92 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 117.964 0.347 . . . . 0.0 110.296 -176.856 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 8.8 t0 -92.65 85.7 5.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 172.309 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.69 105.83 11.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -166.12 -159.79 0.4 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.754 0.706 . . . . 0.0 112.22 -171.562 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 64.1 -135.27 0.32 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 112.563 172.839 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p 54.61 -107.43 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.083 1.753 . . . . 0.0 109.537 -175.463 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -72.8 -26.63 61.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.919 0.487 . . . . 0.0 111.451 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.16 82.78 1.81 Allowed 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.53 -0.731 . . . . 0.0 111.056 -175.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 -56.63 8.27 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.976 0.798 . . . . 0.0 111.972 176.328 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.74 -37.07 64.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.977 2.451 . . . . 0.0 113.447 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.7 m -59.24 -26.0 64.52 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.609 0.364 . . . . 0.0 111.032 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -58.8 -20.63 51.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.498 0.59 . . . . 0.0 110.932 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.6 mmt -82.73 -31.3 28.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.812 0.733 . . . . 0.0 110.697 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.69 -33.5 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.83 -59.41 4.71 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.256 1.022 . . . . 0.0 113.168 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -59.76 -38.57 79.74 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.182 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.75 -54.16 45.65 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 30' ' ' ASP . 49.9 t80 -57.91 -41.12 81.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.132 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -57.19 -37.41 72.13 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.728 -0.653 . . . . 0.0 112.381 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -59.87 -51.92 67.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.447 1.476 . . . . 0.0 110.002 178.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -57.87 -41.42 82.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.69 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.461 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.6 m -52.72 -54.95 26.58 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -41.17 86.16 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.325 0.65 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.14 -53.92 52.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.128 0.571 . . . . 0.0 111.429 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -81.05 -21.42 40.11 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.096 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -21.45 110.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.504 2.322 . . . . 0.0 115.713 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.01 -71.08 0.39 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 174.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.35 24.84 2.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.945 0.898 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.42 161.12 4.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.801 1.64 . . . . 0.0 107.951 -174.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 93.79 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.99 94.97 10.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.257 0.623 . . . . 0.0 109.801 -178.884 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 111.93 23.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.009 1.323 . . . . 0.0 110.754 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.9 mtpp -91.65 109.34 20.65 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 174.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.62 122.49 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.08 81.13 3.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.848 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.8 m -39.92 -47.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 126.988 2.115 . . . . 0.0 114.176 -176.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.23 -40.57 67.82 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.039 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.57 -48.59 14.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 70' ' ' VAL . 95.1 t -80.95 51.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.241 1.02 . . . . 0.0 108.849 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.69 -58.13 9.4 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.841 1.656 . . . . 0.0 112.857 -173.299 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.12 -52.0 54.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -176.418 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 67' ' ' VAL . 84.0 t -62.91 -48.38 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.518 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.25 69.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.412 0.285 . . . . 0.0 110.283 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.63 -56.62 19.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.219 1.008 . . . . 0.0 110.007 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.8 -41.26 73.89 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.444 0.298 . . . . 0.0 111.118 -178.356 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 3.29 19.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.332 1.053 . . . . 0.0 111.905 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.1 41.8 94.8 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.011 -1.056 . . . . 0.0 113.412 176.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.7 137.62 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 p -148.9 -80.24 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.57 78.3 1.47 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.15 0.98 . . . . 0.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.73 139.43 88.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.73 132.38 22.06 Favored 'Cis proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.479 1.207 . . . . 0.0 110.595 -1.659 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 m -109.27 111.89 23.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.821 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -99.61 108.27 20.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.21 1.004 . . . . 0.0 109.197 -177.063 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -107.87 160.82 15.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.98 0.809 . . . . 0.0 109.891 177.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.02 110.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.42 108.4 19.72 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 175.776 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -83.97 109.56 17.72 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 71.4 -60.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.811 2.044 . . . . 0.0 110.807 -176.761 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.41 -41.0 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.219 1.39 . . . . 0.0 111.344 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.59 134.53 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.131 0.966 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -66.55 101.9 0.83 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.371 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.51 -32.43 25.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.111 0.964 . . . . 0.0 111.336 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.82 169.08 25.42 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -144.11 161.14 39.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.728 2.011 . . . . 0.0 107.285 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 tp -174.05 152.93 1.98 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.85 165.18 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 110.138 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 -179.08 39.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.184 0.897 . . . . 0.0 111.833 177.193 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.73 44.24 0.36 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.862 0.865 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m -81.22 61.37 4.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 109.688 -176.576 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.09 -42.73 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.922 0.889 . . . . 0.0 112.034 -175.619 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -57.82 -50.33 73.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.06 177.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -66.19 -40.32 90.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.27 -55.25 30.04 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.8 -51.28 61.42 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.442 0.297 . . . . 0.0 110.2 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.26 74.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.339 0.256 . . . . 0.0 111.298 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.82 -49.04 74.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.262 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.22 -54.33 18.26 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.504 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.6 -55.0 21.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.579 0.351 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.93 -64.78 0.71 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.463 0.705 . . . . 0.0 110.988 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -66.51 -19.98 65.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.086 0.954 . . . . 0.0 112.601 -173.62 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.02 -40.09 22.59 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.602 -0.686 . . . . 0.0 109.246 174.421 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.28 70.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.383 0.673 . . . . 0.0 112.147 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.456 -1.259 . . . . 0.0 109.52 -178.685 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.87 -7.2 88.71 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 174.994 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -51.69 105.81 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.76 2.424 . . . . 0.0 114.018 -178.035 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.32 29.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.777 2.031 . . . . 0.0 108.202 174.634 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.02 170.94 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -169.915 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.71 13.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.333 1.853 . . . . 0.0 111.404 178.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.06 73.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.69 -17.8 64.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.834 -174.464 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -38.13 117.59 0.62 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.413 1.485 . . . . 0.0 110.601 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 13' ' ' TRP . 20.3 ptmt -39.42 -44.04 1.3 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -51.07 71.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.467 0.651 . . . . 0.0 110.328 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.224 1.01 . . . . 0.0 109.697 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -48.16 -61.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.268 1.427 . . . . 0.0 108.483 175.291 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -55.82 -50.23 71.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.703 0.401 . . . . 0.0 110.286 -178.291 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.19 77.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.424 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -63.55 -47.34 81.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.294 1.038 . . . . 0.0 109.369 -177.774 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -56.96 -55.47 34.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.272 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.63 -58.82 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.989 0.516 . . . . 0.0 112.067 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -65.89 -14.2 61.06 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.646 -0.658 . . . . 0.0 111.457 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.52 -24.1 70.77 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.395 -1.225 . . . . 0.0 111.917 177.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 57.55 73.02 0.48 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.607 1.163 . . . . 0.0 109.319 -179.179 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.39 52.14 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.631 2.372 . . . . 0.0 113.35 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.57 -59.77 3.33 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.519 -0.738 . . . . 0.0 109.158 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.14 95.42 1.61 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -167.43 139.17 2.59 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.388 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 126.02 8.51 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.8 1.667 . . . . 0.0 111.525 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.4 mp -88.98 94.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 102.197 -3.261 . . . . 0.0 102.197 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.8 110.37 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -176.941 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.73 130.23 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.552 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -92.83 95.92 9.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.952 2.501 . . . . 0.0 106.985 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -88.86 100.53 13.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.943 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -127.47 -162.39 1.16 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.22 1.008 . . . . 0.0 108.369 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.24 117.71 2.87 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 120.155 1.343 . . . . 0.0 113.341 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -36.66 -46.79 0.61 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.498 1.519 . . . . 0.0 110.423 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -48.29 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.315 1.446 . . . . 0.0 113.685 177.68 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.24 35.34 1.62 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.221 0.464 . . . . 0.0 111.808 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 25.24 -88.35 0.01 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 128.411 2.91 . . . . 0.0 115.234 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -42.05 -40.77 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.869 3.046 . . . . 0.0 113.837 177.049 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.62 -36.97 79.93 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.711 0.404 . . . . 0.0 110.571 178.134 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -77.08 -31.16 55.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.845 0.858 . . . . 0.0 109.309 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -63.85 -4.1 2.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.061 0.544 . . . . 0.0 112.366 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.24 -23.87 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.222 0.919 . . . . 0.0 108.79 171.439 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.02 -53.84 43.89 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 120.89 -1.131 . . . . 0.0 112.339 177.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.15 -30.45 91.39 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.944 1.763 . . . . 0.0 111.982 176.627 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.58 -48.44 66.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.16 -35.07 69.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.404 1.081 . . . . 0.0 110.404 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -50.26 -34.01 21.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 110.418 176.894 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -57.67 -54.93 41.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 -41.61 99.18 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -49.14 -54.64 15.33 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -56.15 -57.72 10.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.734 0.814 . . . . 0.0 109.73 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -49.7 -44.21 47.96 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.267 1.027 . . . . 0.0 112.474 -174.623 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -95.39 -1.76 50.39 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.23 136.09 25.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.33 0.968 . . . . 0.0 111.461 -177.286 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.02 -67.01 0.53 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -81.43 -50.93 8.86 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 122.124 -0.633 . . . . 0.0 110.544 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.93 174.34 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.386 1.074 . . . . 0.0 112.75 -169.473 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 mm -129.92 94.7 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 174.225 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.94 138.87 31.1 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.93 126.24 23.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.74 0.816 . . . . 0.0 110.932 -174.131 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -100.65 119.93 39.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.74 134.98 64.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 123.014 0.526 . . . . 0.0 111.377 -176.993 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.23 95.61 7.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.117 1.367 . . . . 0.0 107.352 177.557 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -49.1 -41.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.978 2.511 . . . . 0.0 110.892 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.19 -22.34 66.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.8 0.84 . . . . 0.0 111.421 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.96 -72.4 0.65 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.936 0.894 . . . . 0.0 108.997 175.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 63.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.956 1.36 . . . . 0.0 109.392 -177.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.55 81.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.869 177.005 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.92 -43.38 18.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.568 1.547 . . . . 0.0 112.037 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.9 t -75.29 -57.39 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -43.66 -52.08 6.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.347 1.059 . . . . 0.0 113.293 -175.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.54 -35.01 69.76 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.783 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.81 20.93 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.81 -45.93 90.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.497 1.119 . . . . 0.0 111.741 -178.303 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.38 79.96 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.54 151.88 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.726 1.21 . . . . 0.0 108.37 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.9 p -119.89 -109.39 0.35 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 132.37 35.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.709 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -76.13 131.95 74.61 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -78.6 138.08 48.42 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.034 1.048 . . . . 0.0 112.789 -1.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.5 m -111.71 115.51 29.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 167.511 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 102' ' ' LEU . 55.2 m-85 -95.88 130.2 42.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 108.545 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -122.62 150.37 42.74 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.08 113.33 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.022 1.329 . . . . 0.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -107.39 137.46 45.39 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.434 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -90.82 -100.2 0.11 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.863 1.21 . . . . 0.0 110.279 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.25 -42.55 66.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.862 1.315 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.0 -27.33 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.07 2.271 . . . . 0.0 109.726 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.11 135.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.529 1.165 . . . . 0.0 110.893 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -52.18 112.43 0.8 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.225 1.81 . . . . 0.0 107.759 172.462 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.72 -41.02 7.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.135 1.374 . . . . 0.0 112.64 -174.966 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -151.14 161.29 42.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.572 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -150.77 169.01 22.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.175 0.99 . . . . 0.0 109.484 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -159.9 158.42 30.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 106.981 177.565 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.66 157.27 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.89 -164.69 51.85 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 -80.0 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.245 0.618 . . . . 0.0 110.717 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m 36.11 57.9 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.975 2.11 . . . . 0.0 113.59 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -46.86 -42.41 17.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.14 1.376 . . . . 0.0 111.862 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -57.91 -53.81 53.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.946 0.898 . . . . 0.0 110.44 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -64.09 -40.97 97.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 82' ' ' PHE . 1.6 tt -52.13 -53.97 36.32 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.262 1.025 . . . . 0.0 108.484 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.72 -50.14 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.583 0.353 . . . . 0.0 110.083 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.89 64.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.889 0.476 . . . . 0.0 110.666 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.31 -58.62 6.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.852 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.5 -51.67 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 123.215 0.606 . . . . 0.0 110.685 -177.19 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.71 -38.35 6.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.383 1.073 . . . . 0.0 112.424 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 109' ' ' HIS . 6.2 ptmt -64.3 -37.91 89.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.44 0.564 . . . . 0.0 111.358 -178.546 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 108' ' ' LYS . 80.7 m-70 -84.45 -49.15 8.92 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.95 0.9 . . . . 0.0 110.221 -178.809 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.07 96.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.454 2.301 . . . . 0.0 111.939 -177.121 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 64.66 49.35 2.33 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.733 1.613 . . . . 0.0 109.31 -175.119 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 C-N-CA 126.211 1.804 . . . . 0.0 106.865 179.728 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 m . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -78.6 35.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.114 1.765 . . . . 0.0 112.968 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.14 171.05 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.415 1.086 . . . . 0.0 112.017 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -94.96 143.69 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.101 1.36 . . . . 0.0 107.415 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -147.56 155.09 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 111.013 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -136.23 32.58 2.86 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.32 1.448 . . . . 0.0 112.0 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -152.57 139.04 18.59 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.961 0.886 . . . . 0.0 111.805 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -42.53 80.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 111.115 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.43 86.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.537 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.68 76.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.383 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -49.96 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.17 -50.14 74.84 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.782 0.801 . . . . 0.0 110.58 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.52 -56.65 13.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.801 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.16 -50.84 70.01 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.9 -47.85 11.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.502 0.721 . . . . 0.0 109.59 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.82 0.83 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -59.93 -21.94 61.79 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 111.786 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.96 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.179 . . . . 0.0 111.231 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm 62.41 50.72 3.59 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.323 1.449 . . . . 0.0 107.398 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -50.53 -31.91 16.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.192 2.197 . . . . 0.0 115.005 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -59.79 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 128.888 2.875 . . . . 0.0 114.061 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -136.85 84.22 2.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -178.16 155.84 1.01 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.952 0.901 . . . . 0.0 110.085 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.47 117.13 3.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.387 3.391 . . . . 0.0 114.179 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 27' ' ' ILE . 56.8 mt -88.7 96.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -93.1 104.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.88 131.73 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -104.66 98.76 8.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.3 98.14 8.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -124.66 174.92 7.54 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.835 1.254 . . . . 0.0 108.644 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.5 169.92 16.93 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.031 0.832 . . . . 0.0 109.696 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 p -71.25 -70.11 0.33 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -50.55 -30.17 12.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 115.358 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.6 p -76.04 61.58 1.55 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.902 1.228 . . . . 0.0 112.728 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 10.26 -84.6 0.0 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 128.83 3.11 . . . . 0.0 115.601 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -39.81 -39.44 2.15 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.875 3.716 . . . . 0.0 114.203 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -44.11 -44.22 7.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.92 1.688 . . . . 0.0 111.286 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -61.86 -26.17 67.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 112.11 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -91.02 -40.84 11.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.179 1.392 . . . . 0.0 109.756 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.52 -39.71 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.431 0.692 . . . . 0.0 109.617 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -61.54 6.13 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.832 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.62 -29.78 89.17 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.919 2.412 . . . . 0.0 112.284 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.83 -58.2 9.58 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.23 -32.36 66.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.93 0.892 . . . . 0.0 110.556 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.23 -33.86 63.47 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -59.02 -53.53 57.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.9 mt -59.6 -39.6 84.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 8.5 m -56.25 -51.49 67.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.477 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -56.06 -48.6 75.75 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.697 0.799 . . . . 0.0 110.269 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -64.1 -61.32 2.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.269 0.556 . . . . 0.0 111.295 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.24 57.49 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.647 1.179 . . . . 0.0 110.125 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.95 173.35 11.33 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.521 -0.737 . . . . 0.0 111.15 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -65.98 1.31 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.466 1.031 . . . . 0.0 114.686 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -82.63 -59.06 2.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.628 0.714 . . . . 0.0 111.04 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 59' ' ' PHE . 58.0 t -78.67 129.43 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -171.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.68 104.08 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 57' ' ' VAL . 33.8 m-85 -91.54 88.2 6.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.1 mt -83.91 99.67 10.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -81.82 94.0 6.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.19 124.31 43.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.04 0.536 . . . . 0.0 110.018 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -81.22 92.47 6.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.36 -36.51 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.683 1.993 . . . . 0.0 110.288 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -50.95 -37.84 46.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.372 0.669 . . . . 0.0 109.91 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.8 -62.31 1.41 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.2 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.99 58.28 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.496 -0.753 . . . . 0.0 111.069 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.67 87.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.308 0.643 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.59 -58.07 9.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.871 0.869 . . . . 0.0 111.894 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.6 -42.59 92.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.92 27.52 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -65.05 -39.56 93.48 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.063 -1.023 . . . . 0.0 110.315 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.04 93.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.412 0.551 . . . . 0.0 110.512 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.94 -32.09 73.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.096 0.958 . . . . 0.0 109.887 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.22 40.51 1.93 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.683 1.135 . . . . 0.0 111.952 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.32 137.98 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 p -136.0 -83.72 0.38 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.12 78.05 2.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.392 0.677 . . . . 0.0 109.802 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 143.14 93.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.99 143.81 76.69 Favored 'Cis proline' 0 N--CA 1.447 -1.258 0 CA-C-N 119.651 0.911 . . . . 0.0 110.453 -0.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.2 m -126.68 119.54 27.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -100.08 129.28 46.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.393 1.077 . . . . 0.0 109.433 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -124.09 147.23 48.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -114.69 91.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -84.43 64.73 8.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -61.03 138.52 58.19 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 72.98 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.807 2.043 . . . . 0.0 110.268 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.85 25.15 0.02 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.497 1.523 . . . . 0.0 111.686 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -156.12 138.57 6.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.236 1.518 . . . . 0.0 109.231 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -46.73 91.07 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.207 2.203 . . . . 0.0 110.88 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.35 21.5 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.95 164.22 39.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -147.29 164.02 34.55 Favored 'General case' 0 N--CA 1.46 0.05 0 C-N-CA 124.364 1.066 . . . . 0.0 109.243 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.6 tm? -162.11 114.83 1.75 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.198 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.56 157.43 3.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.804 0.811 . . . . 0.0 110.261 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.38 -174.65 53.47 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.897 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.29 -60.33 3.91 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.7 m 35.11 50.41 0.49 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.093 2.157 . . . . 0.0 112.874 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -47.01 -51.16 17.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.475 1.51 . . . . 0.0 113.353 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.87 -47.25 86.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.797 -0.565 . . . . 0.0 111.269 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.27 -41.23 97.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.2 tp -56.99 -54.84 42.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -50.93 -51.71 49.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.82 0.848 . . . . 0.0 109.945 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.905 0.482 . . . . 0.0 110.811 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.26 -48.04 81.71 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.307 0.503 . . . . 0.0 110.891 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.81 -52.66 33.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.42 27.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.477 0.311 . . . . 0.0 110.815 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -50.29 -57.44 7.87 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.543 1.137 . . . . 0.0 111.225 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -74.42 -25.26 59.34 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.13 40.02 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.796 0.726 . . . . 0.0 109.644 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.26 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.797 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m . . . . . 0 N--CA 1.44 -0.925 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.0 t -83.38 97.09 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.42 169.58 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.393 1.092 . . . . 0.0 112.699 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.33 138.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tp -151.11 152.14 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.918 0.781 . . . . 0.0 111.226 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -131.89 24.75 4.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.944 1.698 . . . . 0.0 112.415 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -149.33 142.45 24.96 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.158 0.89 . . . . 0.0 111.171 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -70.43 -36.55 74.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.563 1.545 . . . . 0.0 109.614 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.46 75.42 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.85 91.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.2 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.426 ' CZ3' HG11 ' A' ' 70' ' ' VAL . 20.6 t-105 -48.86 -58.16 5.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.32 -47.83 83.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.321 0.648 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.9 -47.32 71.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.614 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -64.11 -49.7 71.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp -46.1 -47.99 17.21 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.696 0.798 . . . . 0.0 110.285 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -64.74 0.82 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.492 0.317 . . . . 0.0 111.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -61.09 -24.74 66.46 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.719 -0.613 . . . . 0.0 112.634 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.76 -20.46 64.14 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.462 -1.188 . . . . 0.0 112.322 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 62.92 63.1 0.98 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.308 1.443 . . . . 0.0 108.751 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -75.25 62.32 1.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.892 1.277 . . . . 0.0 110.305 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.58 -55.44 13.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -154.16 19.23 0.5 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 109.554 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -78.59 133.81 62.48 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.16 119.28 6.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.576 1.517 . . . . 0.0 112.498 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mt -99.12 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.43 116.43 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.14 128.8 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.06 96.17 7.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.465 1.506 . . . . 0.0 107.224 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.15 94.01 9.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.8 m -131.69 117.42 18.62 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.06 58.83 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.895 0.316 . . . . 0.0 111.471 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.11 -49.15 52.66 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.112 0.965 . . . . 0.0 110.924 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -68.98 -6.56 28.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 113.29 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.53 64.81 4.51 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.55 -79.88 0.01 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.388 2.899 . . . . 0.0 115.748 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.33 -36.91 53.28 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.436 2.091 . . . . 0.0 111.188 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -38.06 70.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.644 0.778 . . . . 0.0 109.248 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -53.42 -26.64 20.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.634 0.773 . . . . 0.0 111.889 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.2 mtt -62.42 -16.21 53.65 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.11 0.868 . . . . 0.0 111.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.77 -26.18 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.371 0.668 . . . . 0.0 109.812 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.15 16.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.304 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -56.42 -38.92 94.37 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.024 1.816 . . . . 0.0 112.018 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.6 mt -56.6 -57.34 12.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.558 0.694 . . . . 0.0 109.602 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.96 -41.72 75.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.048 0.539 . . . . 0.0 110.067 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -62.61 -34.46 77.08 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.36 -0.838 . . . . 0.0 110.539 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.1 m -62.28 -47.46 84.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.58 -40.63 92.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 19.5 m -53.58 -52.39 59.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.63 -46.33 89.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.367 0.667 . . . . 0.0 110.429 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -51.16 -54.05 28.93 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.55 -55.52 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.739 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 36.05 -125.44 0.14 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.206 1.402 . . . . 0.0 110.391 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 45.05 -84.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.159 2.314 . . . . 0.0 115.188 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -91.19 -39.43 12.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.372 1.469 . . . . 0.0 112.916 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.63 132.14 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 113.235 -167.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.4 129.53 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 78.8 m-85 -122.14 113.47 19.54 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.15 101.58 10.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.844 1.258 . . . . 0.0 110.985 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.6 119.41 22.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.38 138.67 53.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.849 0.833 . . . . 0.0 111.88 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -97.88 104.92 16.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.949 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 m -55.65 -28.63 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.19 0.596 . . . . 0.0 110.985 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.01 -36.5 77.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.76 -66.38 0.9 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.936 0.495 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.07 53.88 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 121.497 -0.752 . . . . 0.0 111.267 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.62 -43.58 25.98 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.042 0.937 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.01 73.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.965 0.906 . . . . 0.0 111.138 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.426 HG11 ' CZ3' ' A' ' 13' ' ' TRP . 40.0 t -67.34 -43.49 87.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.45 27.48 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.667 0.387 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.16 -42.54 88.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.685 -0.634 . . . . 0.0 110.748 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.22 93.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.679 0.672 . . . . 0.0 110.886 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.54 91.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.767 1.227 . . . . 0.0 109.785 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 43.23 1.18 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.456 1.027 . . . . 0.0 112.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.45 131.08 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 p -113.51 -74.92 0.61 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.57 14.76 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.692 1.197 . . . . 0.0 108.899 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -137.96 139.87 27.48 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -62.73 155.63 67.04 Favored 'Cis proline' 0 N--CA 1.457 -0.667 0 CA-C-N 120.758 1.307 . . . . 0.0 114.899 -0.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -144.45 135.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.09 121.25 38.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -119.81 153.85 35.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.02 122.91 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.042 0.937 . . . . 0.0 108.698 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -113.59 118.85 35.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -90.69 -57.52 2.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.461 0.573 . . . . 0.0 112.107 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -93.16 -42.46 9.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.198 1.399 . . . . 0.0 110.545 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.02 -24.18 0.11 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.673 2.082 . . . . 0.0 110.138 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.84 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.16 1.384 . . . . 0.0 108.864 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.0 103.01 0.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.59 -33.66 41.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.835 0.854 . . . . 0.0 110.319 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -158.98 166.94 30.64 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.44 29.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.694 0.797 . . . . 0.0 111.569 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.3 tm? -160.3 149.34 17.25 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.067 1.747 . . . . 0.0 108.14 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.14 156.0 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.97 1.308 . . . . 0.0 110.631 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.33 177.43 46.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.816 0.722 . . . . 0.0 112.124 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.89 46.16 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.736 1.214 . . . . 0.0 111.138 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.658 ' HB2' HD11 ' A' ' 94' ' ' LEU . 8.4 m -80.04 67.08 5.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.33 -0.856 . . . . 0.0 109.985 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -49.53 -45.15 47.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.594 1.158 . . . . 0.0 111.963 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -56.76 -48.91 76.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.03 0.932 . . . . 0.0 110.147 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HG2' HD23 ' A' ' 94' ' ' LEU . 14.5 tppt? -67.65 -38.93 84.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -56.46 -55.43 33.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -51.58 -53.77 34.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.798 0.439 . . . . 0.0 110.462 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.91 -44.46 74.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.706 0.402 . . . . 0.0 111.209 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.9 mt -61.3 -49.76 75.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.955 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.26 -46.97 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.06 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.98 -52.26 58.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.143 0.177 . . . . 0.0 110.817 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -56.31 -62.7 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.897 0.879 . . . . 0.0 110.499 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -70.28 -14.95 62.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.16 16.78 25.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.035 0.834 . . . . 0.0 110.671 174.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 111.959 -179.636 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.667 ' HB2' HG23 ' A' ' 58' ' ' ILE . 15.0 m . . . . . 0 N--CA 1.445 -0.724 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' A' ' 50' ' ' SER . 77.0 t -105.88 101.65 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 108.734 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 pt -145.76 129.47 10.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 122.73 1.252 . . . . 0.0 111.397 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.14 57.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 8' ' ' ASP . 6.6 tp -89.03 -179.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.209 1.004 . . . . 0.0 111.152 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 7' ' ' ILE . 16.7 p-10 -134.32 -38.33 0.85 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -80.48 156.39 26.59 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -165.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.74 -46.2 91.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.837 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.72 -51.92 52.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.98 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.435 ' CB ' HG12 ' A' ' 7' ' ' ILE . . . -62.77 -47.8 81.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.169 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -46.85 -58.96 3.4 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.89 -54.68 43.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 111.646 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.39 -63.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.234 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -55.68 -47.42 76.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.581 -0.724 . . . . 0.0 110.901 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.61 -19.44 0.91 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.837 0.711 . . . . 0.0 112.016 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.32 -56.86 2.14 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.266 0.939 . . . . 0.0 111.092 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.42 63.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.96 -8.38 57.86 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 119.883 1.22 . . . . 0.0 112.569 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.42 56.28 0.78 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.795 2.038 . . . . 0.0 109.547 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -67.91 64.15 0.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.62 3.168 . . . . 0.0 111.202 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.36 93.71 4.03 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.766 2.026 . . . . 0.0 107.226 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 68.04 72.81 0.31 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 128.864 2.865 . . . . 0.0 110.217 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -172.53 155.27 3.24 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 122.731 0.412 . . . . 0.0 111.858 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.96 135.05 6.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.225 2.616 . . . . 0.0 113.883 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 5.3 mp -104.89 99.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -91.45 109.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.12 123.66 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.904 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -88.68 101.66 14.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.86 1.264 . . . . 0.0 110.232 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.42 115.53 20.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -140.85 162.03 36.42 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 108.212 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.62 163.81 15.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.0 1.32 . . . . 0.0 109.307 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.2 p -77.96 -57.92 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.505 0.722 . . . . 0.0 109.608 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -50.74 -31.59 17.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.648 1.579 . . . . 0.0 113.272 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -77.44 55.37 1.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.616 1.098 . . . . 0.0 110.778 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.86 -68.12 0.01 OUTLIER Glycine 0 CA--C 1.536 1.369 0 C-N-CA 127.938 2.685 . . . . 0.0 115.477 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -42.5 -39.22 6.61 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.577 3.518 . . . . 0.0 114.232 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.6 m -42.78 -44.06 4.24 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.474 1.51 . . . . 0.0 110.88 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.0 -29.16 59.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.03 0.932 . . . . 0.0 112.26 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.49 -19.87 64.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.902 0.774 . . . . 0.0 111.861 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.6 -28.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.51 27.3 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.993 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.2 -42.06 38.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.057 1.838 . . . . 0.0 111.736 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.78 -54.48 45.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.75 0.786 . . . . 0.0 109.565 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -55.86 -45.41 78.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.223 1.009 . . . . 0.0 109.311 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.68 -41.84 95.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.808 0.843 . . . . 0.0 110.836 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 m -58.36 -49.84 75.79 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.1 tp -60.43 -37.64 81.55 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.116 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.476 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 37.8 m -58.94 -44.71 91.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 122.073 -0.392 . . . . 0.0 110.549 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -58.85 -48.33 81.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -46.7 -52.89 12.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 112.736 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -103.99 36.26 2.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.623 0.647 . . . . 0.0 111.471 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.06 71.11 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.234 0.925 . . . . 0.0 112.038 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.37 -75.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.18 -49.2 17.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.45 124.61 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.382 -167.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 3' ' ' SER . 17.1 mm -90.99 114.53 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 96.8 m-85 -105.98 101.75 11.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.82 163.48 14.14 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.15 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -138.02 150.84 47.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.76 136.43 26.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -87.78 113.03 23.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.15 -30.48 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.274 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -62.34 -52.86 61.94 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.06 -60.81 2.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.198 0.599 . . . . 0.0 110.393 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.86 58.57 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.716 0.769 . . . . 0.0 110.338 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.07 -47.14 72.01 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.922 0.889 . . . . 0.0 111.04 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.1 -55.52 23.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.998 0.919 . . . . 0.0 111.978 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.25 -43.99 95.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.97 68.89 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.49 -42.39 74.84 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.83 -0.544 . . . . 0.0 109.761 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.65 78.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.679 0.672 . . . . 0.0 110.535 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 2.7 22.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.258 1.023 . . . . 0.0 111.757 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.75 42.86 94.64 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.569 1.08 . . . . 0.0 112.604 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.81 139.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 117.537 0.668 . . . . 0.0 109.632 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.1 p -139.84 -78.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 110.151 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.8 74.12 1.58 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.336 1.054 . . . . 0.0 111.311 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.31 138.67 91.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -63.7 135.25 19.54 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.443 1.551 . . . . 0.0 112.498 -1.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -125.52 107.37 10.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.86 121.1 33.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.943 0.897 . . . . 0.0 108.604 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.03 141.96 43.81 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.71 96.33 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.3 105.42 17.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -82.44 116.57 21.95 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.0 -59.81 0.37 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.784 2.834 . . . . 0.0 110.346 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.04 23.02 0.09 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.266 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.65 135.16 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.256 1.528 . . . . 0.0 108.406 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -62.96 98.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.393 0.677 . . . . 0.0 109.386 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -33.07 40.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.483 0.713 . . . . 0.0 110.182 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -161.91 174.67 12.78 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -160.61 172.24 17.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.16 1.384 . . . . 0.0 108.165 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.08 150.52 9.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.555 1.142 . . . . 0.0 108.666 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -126.95 158.56 37.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 175.04 46.23 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.573 1.082 . . . . 0.0 111.863 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.62 42.79 0.45 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.904 0.882 . . . . 0.0 110.548 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -78.71 55.4 1.68 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.081 1.752 . . . . 0.0 110.842 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.27 21.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.329 1.052 . . . . 0.0 113.104 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.49 -52.26 65.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.116 0.871 . . . . 0.0 110.245 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.77 -37.94 89.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.76 -57.94 9.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -53.47 -49.9 66.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.016 0.527 . . . . 0.0 110.754 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.93 76.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.14 0.176 . . . . 0.0 111.129 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.02 -47.09 81.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.935 -0.478 . . . . 0.0 110.466 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 65.6 t -56.42 -48.17 80.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.69 -56.6 15.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -47.11 -63.95 0.91 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.905 1.282 . . . . 0.0 111.065 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -70.39 -23.88 62.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.051 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.12 54.51 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.277 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 m . . . . . 0 N--CA 1.452 -0.327 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.93 26.65 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.121 1.368 . . . . 0.0 107.857 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 pt -145.67 177.27 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 126.424 1.89 . . . . 0.0 107.431 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.76 73.9 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 122.007 0.908 . . . . 0.0 110.496 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.26 127.9 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 107.952 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -105.12 -42.48 5.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.636 1.974 . . . . 0.0 110.675 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 m -14.13 110.81 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.301 3.041 . . . . 0.0 115.035 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -40.29 -47.1 2.44 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.477 1.511 . . . . 0.0 111.326 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.53 -49.54 74.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.932 0.493 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.19 85.63 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -58.59 5.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.588 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -59.54 -47.28 86.16 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.115 0.966 . . . . 0.0 110.346 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -48.47 64.61 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.954 0.902 . . . . 0.0 110.857 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -51.68 -25.92 8.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.866 0.866 . . . . 0.0 112.133 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.19 -60.23 1.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.195 0.907 . . . . 0.0 111.296 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -22.22 63.84 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.814 -0.554 . . . . 0.0 112.081 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.93 -29.71 71.35 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.896 -0.947 . . . . 0.0 110.95 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 45.89 55.04 7.37 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.866 1.266 . . . . 0.0 107.801 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 pm0 -73.55 43.36 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -47.83 -51.05 24.18 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 0.0 109.032 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -135.09 58.48 1.77 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.649 0.78 . . . . 0.0 108.905 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -138.32 126.76 14.16 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.91 105.23 1.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 120.823 1.015 . . . . 0.0 112.212 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.98 118.4 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -118.06 122.11 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.6 110.79 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 123.385 0.674 . . . . 0.0 109.877 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -88.44 93.1 9.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -79.5 94.54 5.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -116.14 -165.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.338 1.455 . . . . 0.0 108.832 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -154.23 147.17 24.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.73 -0.606 . . . . 0.0 110.572 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -64.33 -46.01 85.36 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 112.512 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -68.26 -47.69 67.07 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -77.94 64.43 3.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.065 0.848 . . . . 0.0 112.276 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 11.04 -83.29 0.0 OUTLIER Glycine 0 CA--C 1.536 1.377 0 C-N-CA 128.987 3.184 . . . . 0.0 115.398 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -40.45 -46.37 4.43 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.375 3.383 . . . . 0.0 113.251 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.3 m -46.11 -51.62 13.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.409 1.484 . . . . 0.0 109.695 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -72.46 -41.37 66.15 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 mmt -60.82 -25.39 66.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.532 0.605 . . . . 0.0 112.217 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mt -70.75 -27.11 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.688 -0.632 . . . . 0.0 110.001 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.05 -51.78 79.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 116.994 -1.479 . . . . 0.0 110.653 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.99 -44.23 23.29 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.441 2.76 . . . . 0.0 113.565 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -59.98 -54.93 40.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.47 -34.62 69.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.142 0.577 . . . . 0.0 110.362 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.7 -34.15 75.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.531 1.132 . . . . 0.0 109.926 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -62.66 -47.65 82.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.1 -39.5 86.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.857 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -53.63 -52.1 60.98 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.879 0.471 . . . . 0.0 109.87 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -55.18 -47.13 75.64 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.555 . . . . 0.0 110.344 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.64 -64.95 0.76 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.294 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -80.06 60.39 3.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.187 0.995 . . . . 0.0 108.923 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.19 69.03 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.43 -136.68 0.01 OUTLIER Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.171 1.843 . . . . 0.0 116.229 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -71.81 38.45 0.07 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.072 1.349 . . . . 0.0 114.462 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -121.85 137.32 55.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.25 108.22 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.39 110.0 22.64 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 105.46 14.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.655 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -88.26 90.44 8.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.24 103.57 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.184 0.516 . . . . 0.0 109.775 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -76.99 100.33 5.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.85 -33.11 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.544 0.738 . . . . 0.0 112.14 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.83 -27.92 67.04 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.541 0.61 . . . . 0.0 111.035 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.0 -61.42 1.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 70' ' ' VAL . 77.2 t -83.42 57.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 122.686 1.231 . . . . 0.0 109.314 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.69 40.06 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.864 1.266 . . . . 0.0 112.788 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.87 -50.84 32.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.724 0.81 . . . . 0.0 111.56 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 67' ' ' VAL . 67.5 t -63.81 -47.86 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.47 69.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.359 0.264 . . . . 0.0 111.704 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -66.16 -43.49 86.83 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.63 77.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 0.0 110.971 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.56 -9.21 58.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 111.882 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.73 36.03 38.56 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.197 0.904 . . . . 0.0 112.342 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -78.96 141.37 15.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.221 1.01 . . . . 0.0 109.025 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -136.75 -82.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.73 72.59 2.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.375 1.07 . . . . 0.0 111.1 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.65 146.27 86.15 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.793 0.437 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.49 159.83 96.96 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 119.684 0.923 . . . . 0.0 110.185 -1.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.4 m -147.8 118.41 7.49 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.13 120.75 34.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 109.593 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -114.68 153.39 30.31 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.33 124.82 67.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -110.64 105.59 14.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.927 0.891 . . . . 0.0 110.33 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -92.45 147.78 22.62 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.46 -64.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 129.096 2.959 . . . . 0.0 112.153 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.68 33.67 0.05 OUTLIER Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.955 2.217 . . . . 0.0 110.486 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.28 145.17 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 118.357 1.078 . . . . 0.0 109.901 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -57.51 106.08 0.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.291 1.436 . . . . 0.0 108.174 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.45 -37.56 12.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.477 1.111 . . . . 0.0 112.554 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -155.54 167.56 29.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -160.68 175.69 12.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.724 0.773 . . . . 0.0 111.939 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -156.87 110.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.513 2.325 . . . . 0.0 106.533 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.53 145.68 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.96 -158.79 29.63 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.37 122.4 44.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.762 1.225 . . . . 0.0 109.955 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -157.59 80.27 0.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -32.75 65.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.987 0.515 . . . . 0.0 111.704 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -60.93 -50.39 73.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.32 -37.43 87.23 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.49 -55.4 35.34 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.629 0.771 . . . . 0.0 109.812 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -51.97 -50.63 60.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.87 86.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.475 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.28 -51.97 67.29 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.816 0.846 . . . . 0.0 109.477 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.47 -50.36 73.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.35 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.55 -58.07 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.877 0.37 . . . . 0.0 110.582 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -45.91 -58.16 3.77 Favored 'General case' 0 C--O 1.228 -0.059 0 C-N-CA 125.57 1.548 . . . . 0.0 110.433 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -83.19 9.79 9.8 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.31 -46.27 5.08 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.34 0.177 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.793 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 CA-C-O 121.784 0.802 . . . . 0.0 109.281 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 59' ' ' PHE . 75.4 t -123.01 120.72 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.405 1.082 . . . . 0.0 109.904 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -144.38 171.81 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.172 0.987 . . . . 0.0 111.728 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.04 136.03 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -153.29 152.42 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 118.696 0.68 . . . . 0.0 110.787 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -115.81 -62.56 1.58 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.233 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 m -37.12 105.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.203 3.001 . . . . 0.0 113.483 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -44.53 -49.0 10.23 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.007 1.323 . . . . 0.0 110.346 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.78 -49.77 57.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.106 0.562 . . . . 0.0 111.074 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 -44.36 83.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.823 0.449 . . . . 0.0 109.966 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -61.34 2.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.876 0.87 . . . . 0.0 108.906 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -58.69 -48.66 80.35 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.463 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.24 -63.42 1.15 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.399 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -58.63 -48.2 81.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -46.49 -49.88 17.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 110.758 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -49.18 8.64 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -28.65 61.93 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.698 1.136 . . . . 0.0 111.261 -176.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.72 -37.57 61.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.061 -0.855 . . . . 0.0 111.824 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? 44.98 51.53 8.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.811 1.245 . . . . 0.0 109.281 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.44 56.72 1.81 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.679 1.191 . . . . 0.0 113.02 -171.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -22.57 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 128.321 2.648 . . . . 0.0 112.172 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -132.55 59.23 1.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -135.15 142.3 41.28 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.35 111.17 3.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.478 2.119 . . . . 0.0 114.52 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.79 97.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.51 114.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.6 t -106.42 115.79 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -100.13 103.65 15.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.46 90.39 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -114.94 139.7 49.61 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.749 1.219 . . . . 0.0 109.036 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.71 72.28 2.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.669 0.788 . . . . 0.0 110.037 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -25.67 -47.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.632 2.373 . . . . 0.0 113.428 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -38.74 65.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.4 p -77.18 66.54 2.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.487 1.04 . . . . 0.0 112.898 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.28 -88.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 128.849 3.119 . . . . 0.0 114.769 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.73 -45.05 4.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.872 3.048 . . . . 0.0 113.723 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.0 m -45.03 -39.13 5.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.042 1.737 . . . . 0.0 111.634 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -49.27 -33.29 12.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.939 0.896 . . . . 0.0 111.858 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -53.94 -24.75 17.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.9 -37.78 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.78 -57.33 26.31 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -58.51 -27.76 83.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 111.234 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mt -75.15 -44.67 45.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.502 0.592 . . . . 0.0 110.714 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -55.72 -39.09 70.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' HG11 ' A' ' 4' ' ' VAL . 32.6 mt-10 -70.21 -34.5 72.99 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.317 0.647 . . . . 0.0 111.456 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.7 m -55.35 -44.73 76.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.076 1.307 . . . . 0.0 107.875 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.4 -18.09 48.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.778 -0.629 . . . . 0.0 112.428 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.425 ' CB ' HG21 ' A' ' 4' ' ' VAL . 25.9 p -59.16 -38.03 78.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 120.293 1.406 . . . . 0.0 109.226 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -62.61 -49.16 76.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.373 1.046 . . . . 0.0 108.196 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.29 -59.82 4.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.923 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -88.05 65.18 8.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.784 0.802 . . . . 0.0 109.625 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.79 67.6 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.337 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.32 -166.12 19.45 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 121.417 0.454 . . . . 0.0 111.998 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.642 . . . . 0.0 110.892 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.69 131.66 69.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.32 96.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.673 1.124 . . . . 0.0 108.583 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.505 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 m-30 -91.61 115.04 27.72 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.87 98.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.072 1.349 . . . . 0.0 110.107 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.91 113.81 18.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -90.47 122.18 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -69.9 86.2 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.13 -50.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.629 1.971 . . . . 0.0 110.779 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -56.68 -31.31 64.32 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.482 1.113 . . . . 0.0 112.192 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.78 -70.8 0.55 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.31 61.56 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.906 0.86 . . . . 0.0 111.036 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.5 60.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.795 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.51 86.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.592 0.757 . . . . 0.0 111.71 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.19 -47.19 82.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.14 69.06 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.53 -55.81 25.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.137 0.975 . . . . 0.0 110.457 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.91 -41.8 75.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.047 0.539 . . . . 0.0 111.048 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -8.62 55.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.391 0.677 . . . . 0.0 111.761 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.43 30.19 31.01 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.231 0.919 . . . . 0.0 112.881 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.68 117.09 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 p -101.34 -71.41 0.71 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.23 156.14 18.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.707 1.203 . . . . 0.0 107.876 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -150.1 161.18 31.78 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.38 141.43 53.45 Favored 'Cis proline' 0 N--CA 1.453 -0.902 0 CA-C-N 120.726 1.295 . . . . 0.0 111.922 1.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.3 m -133.6 122.55 23.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.29 119.33 38.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.325 1.45 . . . . 0.0 108.419 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -107.86 153.52 22.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.67 117.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -107.08 126.64 52.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.978 0.911 . . . . 0.0 109.41 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -92.03 123.78 35.65 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 67.26 -63.12 0.3 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 128.617 2.767 . . . . 0.0 110.585 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.09 23.86 0.05 OUTLIER Glycine 0 CA--C 1.533 1.174 0 C-N-CA 127.151 2.31 . . . . 0.0 110.938 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.13 128.05 74.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.69 111.3 1.79 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.355 0.662 . . . . 0.0 109.881 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.08 -33.9 14.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.627 1.171 . . . . 0.0 110.938 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -155.4 166.01 34.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.768 0.258 . . . . 0.0 111.099 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -143.23 162.36 35.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.738 1.615 . . . . 0.0 109.759 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 tt -159.9 143.44 14.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.595 1.958 . . . . 0.0 106.424 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.25 152.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.07 -158.84 29.55 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.92 139.99 20.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 m -163.85 108.13 1.0 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -51.6 -49.2 62.62 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.912 1.285 . . . . 0.0 111.876 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -58.1 -43.87 87.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.889 0.476 . . . . 0.0 110.034 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -38.39 86.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.06 -46.86 85.49 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -54.6 -49.3 70.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -46.54 85.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.681 0.792 . . . . 0.0 111.005 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.35 -52.64 63.82 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.852 0.751 . . . . 0.0 109.523 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.44 -50.97 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.39 -54.98 28.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.708 0.403 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.58 -63.74 1.02 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 125.254 1.422 . . . . 0.0 110.198 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -68.04 -22.31 64.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.452 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -44.73 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 108.987 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.331 0 C-N-CA 123.867 0.867 . . . . 0.0 109.44 178.952 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p . . . . . 0 CA--C 1.535 0.379 0 N-CA-C 112.084 0.402 . . . . 0.0 112.084 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.72 108.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.91 149.89 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.079 0.942 . . . . 0.0 112.425 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -96.52 123.28 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 tp -148.61 146.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.312 0.96 . . . . 0.0 111.153 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -145.01 56.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.974 0.91 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -157.64 117.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -48.52 -38.85 21.4 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.458 1.103 . . . . 0.0 112.794 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.69 86.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.101 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.71 -35.89 65.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.72 0.408 . . . . 0.0 110.126 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -52.23 -53.01 48.93 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.56 -51.29 70.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.355 0.662 . . . . 0.0 110.68 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.14 -48.45 64.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.231 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.14 -51.19 70.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.3 tp -49.22 -50.02 40.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.97 0.508 . . . . 0.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.99 -61.16 2.64 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 111.236 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -63.57 -15.59 58.49 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.457 -0.777 . . . . 0.0 111.877 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.14 60.87 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.079 1.323 . . . . 0.0 111.986 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 mttm 66.08 73.75 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.752 1.263 . . . . 0.0 108.554 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.06 49.44 0.13 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.047 2.139 . . . . 0.0 113.797 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.6 -58.61 3.17 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -152.96 24.61 0.56 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.621 1.168 . . . . 0.0 110.313 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.34 148.88 35.35 Favored Pre-proline 0 C--O 1.234 0.239 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HG2' HG13 ' A' ' 57' ' ' VAL . 84.4 Cg_endo -79.62 129.98 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.294 3.329 . . . . 0.0 113.31 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.57 95.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.71 130.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.36 133.24 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -104.49 101.62 11.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.566 1.947 . . . . 0.0 106.599 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.4 95.99 8.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.6 m -122.49 162.81 21.04 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.845 1.258 . . . . 0.0 107.808 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.24 172.44 6.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.124 0.969 . . . . 0.0 110.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.6 p -83.05 -62.52 1.57 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.712 0.805 . . . . 0.0 109.382 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.4 -26.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.716 2.007 . . . . 0.0 113.742 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.7 p -76.69 9.87 2.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.447 1.021 . . . . 0.0 112.703 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 28.82 -89.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 128.635 3.017 . . . . 0.0 114.757 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.58 -37.82 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.089 3.193 . . . . 0.0 114.38 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 p -48.1 -35.1 10.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.024 0.93 . . . . 0.0 111.97 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -52.67 -28.44 21.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.396 1.078 . . . . 0.0 112.172 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.76 -19.8 52.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.158 0.89 . . . . 0.0 112.039 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 35.9 mt -71.83 -30.37 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.684 -0.635 . . . . 0.0 109.916 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.98 -58.23 12.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.558 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.78 -37.37 94.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.42 2.08 . . . . 0.0 112.452 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -54.54 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.56 -36.86 79.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.907 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.25 -37.46 83.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 0.0 109.764 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 m -59.17 -52.41 65.84 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.63 -41.11 76.54 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 m -56.12 -49.99 72.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.782 0.325 . . . . 0.0 110.276 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -41.42 95.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.107 0.563 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -63.61 -63.37 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.64 0.733 . . . . 0.0 109.806 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.05 57.32 4.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.24 1.416 . . . . 0.0 109.955 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.47 153.08 40.5 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.758 0.79 . . . . 0.0 112.332 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.24 -72.44 1.15 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.616 1.103 . . . . 0.0 114.978 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -71.95 -30.93 65.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.668 0.734 . . . . 0.0 112.818 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HG2' ' A' ' 26' ' ' PRO . 90.3 t -97.08 136.75 26.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -100.82 129.91 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 57' ' ' VAL . 47.4 m-85 -117.33 107.13 14.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.161 0.984 . . . . 0.0 108.541 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.4 mt -100.85 101.21 11.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.84 1.256 . . . . 0.0 110.272 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -86.4 120.88 28.22 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.5 141.12 47.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.949 0.899 . . . . 0.0 110.432 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -94.62 109.47 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.788 1.235 . . . . 0.0 107.668 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.0 t -53.2 -34.35 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.836 1.254 . . . . 0.0 110.732 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -68.43 -23.07 64.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.11 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.18 -75.32 0.47 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 0.0 110.9 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.28 63.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.324 0.966 . . . . 0.0 110.169 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.08 54.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.989 0.916 . . . . 0.0 109.739 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.49 -52.83 63.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.131 0.973 . . . . 0.0 111.228 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.35 -46.69 94.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.54 -53.57 52.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.068 0.547 . . . . 0.0 111.539 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.57 -39.81 80.83 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.268 -0.895 . . . . 0.0 110.4 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 86.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.485 0.584 . . . . 0.0 110.203 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' A' ' 76' ' ' ILE . . . -67.74 -33.75 75.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.392 0.677 . . . . 0.0 110.431 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.15 48.66 1.69 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.757 1.17 . . . . 0.0 111.767 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -85.87 98.54 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.3 p -93.21 -75.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.12 72.71 5.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.895 0.878 . . . . 0.0 111.012 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.51 142.71 97.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.73 134.35 34.28 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.306 1.145 . . . . 0.0 111.102 0.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.3 m -122.67 141.01 52.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.903 1.681 . . . . 0.0 108.506 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 84.1 m-85 -124.11 116.83 23.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 108.628 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -112.6 147.84 35.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.2 t -115.13 98.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -87.44 107.45 18.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.47 115.01 21.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 68.18 -58.92 0.45 Allowed 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 128.177 2.591 . . . . 0.0 111.448 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.68 19.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.355 0.979 . . . . 0.0 112.686 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.24 134.98 57.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.981 1.39 . . . . 0.0 108.336 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -60.87 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.484 1.114 . . . . 0.0 108.853 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.76 -28.08 40.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.871 0.869 . . . . 0.0 110.12 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -156.05 167.12 31.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.534 0.152 . . . . 0.0 111.026 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.61 -175.21 4.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.472 1.909 . . . . 0.0 108.306 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 98' ' ' SER . 13.5 tp 167.01 142.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.277 2.631 . . . . 0.0 107.595 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.15 149.21 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.088 1.355 . . . . 0.0 108.295 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.13 168.69 44.33 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.749 0.639 . . . . 0.0 111.89 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.48 43.61 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 113.38 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' HD11 ' A' ' 94' ' ' LEU . 8.3 t -80.03 72.63 6.82 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.16 -0.963 . . . . 0.0 108.655 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.67 -41.6 55.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.538 0.735 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.14 -50.44 72.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.251 0.62 . . . . 0.0 110.054 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -65.15 -38.93 92.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -52.93 58.2 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.94 -52.29 66.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.933 0.893 . . . . 0.0 110.171 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.82 76.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.706 0.402 . . . . 0.0 111.173 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.6 mt -57.6 -57.17 13.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.737 0.815 . . . . 0.0 109.379 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.09 -47.24 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.987 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.75 -50.52 72.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.416 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.12 -50.16 56.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.783 0.719 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -71.53 -13.5 61.82 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.21 -39.61 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.399 1.48 . . . . 0.0 112.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.302 0 C-N-CA 124.95 1.3 . . . . 0.0 108.894 -177.701 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 121.48 0.657 . . . . 0.0 109.447 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.7 t -83.49 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 126.059 1.744 . . . . 0.0 108.575 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -76.89 137.58 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 122.431 1.11 . . . . 0.0 109.651 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.43 64.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 61' ' ' LYS . 11.9 tt -160.06 167.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.129 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -162.61 -44.22 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.598 1.559 . . . . 0.0 108.268 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.6 m -112.92 157.21 21.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.148 1.379 . . . . 0.0 113.58 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -43.78 -37.97 2.99 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 127.814 2.446 . . . . 0.0 112.895 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.18 -28.67 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.78 3.22 15.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.274 0.943 . . . . 0.0 112.232 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.04 -57.11 13.52 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.91 1.284 . . . . 0.0 108.721 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -57.81 -47.04 83.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.078 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.34 -59.0 5.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.627 0.771 . . . . 0.0 110.856 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.3 -49.18 76.91 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.8 mt -52.04 -57.09 10.55 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.94 -59.55 4.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.104 0.962 . . . . 0.0 111.43 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -60.27 -26.85 66.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.14 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.66 -24.4 69.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.32 -1.267 . . . . 0.0 113.669 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.53 56.42 6.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.606 1.703 . . . . 0.0 108.897 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -31.76 -34.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 131.404 3.882 . . . . 0.0 117.564 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -12.65 -70.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 129.348 3.059 . . . . 0.0 113.147 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -139.16 53.16 1.75 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -117.59 131.1 24.25 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.13 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.7 91.6 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.538 1.492 . . . . 0.0 109.593 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mt -86.16 92.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.84 125.45 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 113.37 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.406 ' HB2' ' CE2' ' A' ' 46' ' ' PHE . 8.7 t0 -83.4 88.58 6.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.97 98.35 9.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -124.81 171.99 9.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.781 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.65 105.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.993 1.317 . . . . 0.0 108.231 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -43.28 -53.34 5.25 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.057 1.743 . . . . 0.0 112.807 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -58.92 -33.36 70.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.175 0.59 . . . . 0.0 111.867 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.2 t -75.82 85.42 2.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.93 -59.64 0.9 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.664 1.126 . . . . 0.0 112.638 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.22 -39.54 71.51 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.21 2.606 . . . . 0.0 113.214 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.5 m -71.16 -37.85 72.19 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.43 0.692 . . . . 0.0 109.179 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -67.26 -40.99 86.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.199 0.6 . . . . 0.0 110.442 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 83.3 mmm -53.61 -30.75 44.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.246 1.019 . . . . 0.0 112.672 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.64 -30.01 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.145 -0.347 . . . . 0.0 111.071 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.37 -55.4 37.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.704 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.1 -34.34 94.58 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 122.397 1.892 . . . . 0.0 112.067 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.24 -53.26 59.78 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 30' ' ' ASP . 93.0 t80 -53.9 -43.76 69.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.79 -44.39 90.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -58.99 -49.48 77.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.27 -33.56 74.85 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 121.93 -0.481 . . . . 0.0 110.516 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 7.0 m -57.02 -45.48 83.06 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.763 -0.585 . . . . 0.0 109.65 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -63.91 -48.28 77.24 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.38 -45.17 55.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.855 0.462 . . . . 0.0 111.257 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -102.69 44.68 1.0 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.184 0.994 . . . . 0.0 110.116 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.81 43.29 0.33 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.986 -1.071 . . . . 0.0 111.158 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.27 -135.22 8.21 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.848 1.69 . . . . 0.0 109.668 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -80.44 45.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.827 0.814 . . . . 0.0 110.007 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.46 148.77 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 107.801 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.82 130.69 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 26.0 m-85 -113.38 137.19 51.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.27 124.72 11.65 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.882 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 7' ' ' ILE . 39.4 ttpt -89.14 143.35 26.91 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.81 130.95 62.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.48 99.68 10.27 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -53.89 -43.37 57.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.38 1.072 . . . . 0.0 111.244 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.4 -49.63 73.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.718 0.407 . . . . 0.0 110.482 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 -59.17 2.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.506 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.08 54.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.635 -0.666 . . . . 0.0 110.716 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.95 70.75 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.768 0.827 . . . . 0.0 110.974 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.82 -56.32 20.64 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.917 0.887 . . . . 0.0 111.926 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.76 -43.58 98.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.8 -41.88 91.36 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.194 -0.941 . . . . 0.0 110.636 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.15 94.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.252 0.478 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.97 76.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.397 1.079 . . . . 0.0 110.312 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.0 70.95 0.47 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.87 145.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -136.39 -88.67 0.3 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 110.89 21.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -76.67 140.88 68.2 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -72.92 141.29 71.2 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 119.687 0.924 . . . . 0.0 111.02 -2.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -114.97 129.64 56.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' HD13 ' A' ' 102' ' ' LEU . 89.9 m-85 -111.17 122.05 46.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -116.8 144.55 44.35 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.62 103.84 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -95.36 93.72 7.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.199 0.454 . . . . 0.0 111.079 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -90.86 140.12 30.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.28 -58.87 0.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.156 2.583 . . . . 0.0 110.646 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.12 28.7 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 127.26 2.362 . . . . 0.0 110.095 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.72 136.27 39.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 96.7 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.23 40.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.736 0.415 . . . . 0.0 110.713 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -160.23 167.46 27.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.79 175.51 13.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.668 0.787 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.9 tp -164.68 158.75 18.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.893 1.677 . . . . 0.0 108.255 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.58 160.88 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 110.377 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.32 176.42 41.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.471 1.034 . . . . 0.0 111.554 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.42 41.77 0.26 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.145 0.978 . . . . 0.0 111.352 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -78.26 58.83 2.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.126 1.77 . . . . 0.0 110.047 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.71 -35.59 66.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 112.192 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -58.49 -53.15 61.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.262 0.625 . . . . 0.0 109.578 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -66.6 -34.9 78.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' A' ' 82' ' ' PHE . 23.7 tp -59.75 -50.48 73.67 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.165 0.586 . . . . 0.0 110.081 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -55.46 -44.78 76.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.13 95.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.508 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.2 mt -54.37 -55.88 24.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.74 -49.53 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.15 -52.71 50.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.36 0.264 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -56.63 -68.62 0.2 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.164 0.585 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -62.61 -22.69 66.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.841 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.76 80.66 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.134 0 C-N-CA 123.56 0.744 . . . . 0.0 110.878 -179.27 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 CA--C 1.532 0.264 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 50' ' ' SER . 8.5 p -130.27 31.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.169 1.787 . . . . 0.0 108.805 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.74 152.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 122.56 1.171 . . . . 0.0 113.085 -171.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.75 128.7 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.541 1.536 . . . . 0.0 110.566 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tt -160.82 -160.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -157.19 -56.9 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.616 0.766 . . . . 0.0 109.955 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -31.06 118.38 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.36 2.264 . . . . 0.0 113.018 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -40.51 -54.62 2.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.683 1.193 . . . . 0.0 112.869 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -43.24 67.41 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.475 -0.765 . . . . 0.0 111.029 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -35.74 73.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.399 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -55.13 38.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.67 -51.17 69.76 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.271 0.628 . . . . 0.0 110.069 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.22 79.45 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.64 -42.68 93.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -56.22 -58.41 8.08 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.572 1.078 . . . . 0.0 109.212 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 -57.83 9.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.233 0.613 . . . . 0.0 112.318 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.88 -10.11 35.39 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.001 -0.437 . . . . 0.0 111.44 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.43 91.6 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 58.76 76.63 0.34 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.026 1.331 . . . . 0.0 107.883 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 66.54 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.236 1.415 . . . . 0.0 109.591 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.27 -46.67 54.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -170.39 65.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.759 1.624 . . . . 0.0 107.724 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -139.99 132.67 14.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.416 1.486 . . . . 0.0 107.436 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.65 137.27 32.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.658 1.572 . . . . 0.0 109.096 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.61 120.3 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 t -120.81 126.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 125.353 1.461 . . . . 0.0 107.988 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.19 134.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 118.395 0.543 . . . . 0.0 110.327 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -101.41 96.49 7.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.098 1.359 . . . . 0.0 107.525 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -87.8 90.54 8.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -111.47 -178.48 3.46 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.664 1.186 . . . . 0.0 110.387 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.86 112.33 8.74 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.313 1.045 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -36.99 -57.18 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.568 1.947 . . . . 0.0 113.283 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -64.31 -28.33 69.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 t -76.9 91.41 3.57 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -26.8 -65.97 0.07 OUTLIER Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.151 1.834 . . . . 0.0 115.211 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.44 -37.71 47.21 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.153 1.902 . . . . 0.0 112.102 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.4 m -62.14 -40.36 95.68 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -62.43 -50.72 70.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.1 tpp -56.93 -32.55 66.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.775 0.83 . . . . 0.0 112.057 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -66.85 -27.43 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.471 -0.768 . . . . 0.0 110.746 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.25 45.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.98 -1.075 . . . . 0.0 113.601 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.1 -31.08 83.29 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.861 1.707 . . . . 0.0 111.435 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 -48.37 74.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -54.58 -45.7 73.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -58.02 -43.27 86.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.704 0.402 . . . . 0.0 110.394 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.3 m -58.8 -45.61 89.5 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.51 -39.65 94.18 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.257 0.48 . . . . 0.0 110.132 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 4' ' ' VAL . 10.3 m -51.53 -53.15 40.76 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -61.14 -48.72 80.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.013 0.525 . . . . 0.0 110.998 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -48.5 -56.38 8.46 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.045 1.338 . . . . 0.0 111.744 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -79.61 -33.26 41.66 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.78 -173.34 0.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.736 1.614 . . . . 0.0 112.082 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -41.43 -26.05 0.2 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.893 2.187 . . . . 0.0 117.142 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -66.2 -19.01 65.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.677 1.739 . . . . 0.0 111.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.98 139.29 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.76 121.42 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.09 124.23 41.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.321 -0.862 . . . . 0.0 109.127 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -115.68 107.55 15.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.535 1.134 . . . . 0.0 111.111 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -79.87 131.17 35.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . 0.473 ' CG1' HG21 ' A' ' 67' ' ' VAL . 57.7 t -139.65 134.32 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 119.203 0.911 . . . . 0.0 109.798 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.71 100.09 11.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.065 0.946 . . . . 0.0 109.046 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.7 t -44.56 -46.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 128.165 2.586 . . . . 0.0 110.708 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.64 -53.32 58.01 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.455 0.472 . . . . 0.0 110.491 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.55 -62.59 1.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.822 0.449 . . . . 0.0 111.098 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 62' ' ' VAL . 28.0 m -83.07 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.288 -0.883 . . . . 0.0 111.69 -175.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.48 30.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.133 0.973 . . . . 0.0 111.27 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -48.55 79.0 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.761 0.825 . . . . 0.0 111.13 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.82 -42.42 89.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.83 63.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.466 0.307 . . . . 0.0 111.216 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.77 -39.93 91.49 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.617 -0.677 . . . . 0.0 110.104 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.93 87.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.539 0.609 . . . . 0.0 110.662 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.45 77.85 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 0.0 110.325 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.12 46.56 2.81 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.888 1.232 . . . . 0.0 110.77 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -78.92 150.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.6 p -124.51 -84.94 0.64 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.14 177.71 6.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -138.44 152.26 70.84 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.52 141.96 57.98 Favored 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.216 -1.109 . . . . 0.0 109.216 -3.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 m -110.58 135.04 51.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -119.61 112.79 19.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 110.397 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -110.17 154.04 23.9 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.947 HG12 ' HB3' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -119.79 139.03 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -136.17 73.88 1.48 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.399 0.545 . . . . 0.0 112.453 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.67 152.66 43.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 69.18 -64.11 0.35 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 128.426 2.69 . . . . 0.0 109.116 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.04 34.88 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.664 2.078 . . . . 0.0 110.339 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.08 145.1 26.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.99 101.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.947 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -79.86 -41.75 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.347 1.459 . . . . 0.0 111.195 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -159.02 160.06 35.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -175.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -160.9 164.24 31.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 pp -166.27 158.17 13.81 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.137 2.175 . . . . 0.0 108.947 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.52 132.42 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.86 1.264 . . . . 0.0 107.948 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.83 160.56 10.18 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.67 38.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.822 1.249 . . . . 0.0 111.441 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 m -79.55 70.63 6.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.374 1.07 . . . . 0.0 110.63 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -48.81 -41.15 31.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.837 1.255 . . . . 0.0 111.936 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.5 -47.82 84.47 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.863 0.865 . . . . 0.0 110.152 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.96 -40.03 87.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.14 -58.76 5.92 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -49.16 -50.71 36.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.14 -40.42 77.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.603 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.0 -50.05 75.28 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.984 1.266 . . . . 0.0 108.682 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.8 -50.15 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.45 11.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.235 0.214 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -46.4 -62.16 1.48 Allowed 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.971 1.708 . . . . 0.0 111.117 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.28 -22.28 59.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.967 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.77 -47.78 61.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.362 0 C-N-CA 123.469 0.708 . . . . 0.0 109.837 177.949 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.535 0.377 0 CA-C-O 121.959 0.885 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.26 31.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 127.662 2.385 . . . . 0.0 107.57 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.12 -171.48 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 126.922 2.089 . . . . 0.0 108.785 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.42 73.43 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tp -79.08 145.8 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.755 1.222 . . . . 0.0 109.202 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -80.12 63.47 4.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.323 0.649 . . . . 0.0 112.492 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.1 t 29.73 -119.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.534 1.934 . . . . 0.0 113.532 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.2 -47.89 1.22 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.111 2.964 . . . . 0.0 115.304 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.99 79.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.928 0.491 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.55 -40.15 14.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.955 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -32.41 -64.75 0.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 128.566 2.746 . . . . 0.0 113.181 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.99 -55.91 29.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.858 0.837 . . . . 0.0 111.833 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.86 -52.45 49.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.653 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -53.75 54.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.799 1.24 . . . . 0.0 110.155 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.44 -49.21 18.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.976 1.311 . . . . 0.0 109.834 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.41 -61.84 1.88 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -56.81 -26.7 58.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.395 0.678 . . . . 0.0 111.665 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.89 63.18 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 117.56 -1.689 . . . . 0.0 112.103 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm 49.19 60.38 3.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.288 1.544 . . . . 0.0 108.054 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -63.39 24.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.392 2.677 . . . . 0.0 116.342 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -80.92 -59.74 2.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 120.867 -1.146 . . . . 0.0 108.378 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -112.45 36.36 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.544 1.137 . . . . 0.0 108.1 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -145.22 123.35 6.49 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.39 118.64 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.712 2.941 . . . . 0.0 110.454 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -107.08 112.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -119.84 148.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 107.085 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 83' ' ' HIS . 7.7 p -133.62 137.05 53.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -105.71 98.06 7.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.415 2.286 . . . . 0.0 106.217 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.74 93.85 8.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -113.36 -167.71 1.23 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.34 0.656 . . . . 0.0 109.654 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.64 11.3 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.288 1.435 . . . . 0.0 110.11 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -99.28 -65.06 0.98 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.442 1.497 . . . . 0.0 109.376 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -49.37 -24.62 2.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.317 1.847 . . . . 0.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.6 p -58.41 -16.64 15.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.134 0.574 . . . . 0.0 111.881 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.64 -112.64 5.1 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.128 -1.373 . . . . 0.0 110.552 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -38.62 -46.61 2.56 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.126 3.217 . . . . 0.0 115.026 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -32.28 39.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -56.13 -28.59 58.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.618 0.767 . . . . 0.0 110.559 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -54.35 -25.45 24.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.802 0.841 . . . . 0.0 112.501 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.86 -30.12 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 122.009 -0.432 . . . . 0.0 110.654 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.9 -59.07 10.72 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.258 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.5 -35.95 94.55 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.817 1.678 . . . . 0.0 112.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.67 -50.74 69.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -55.38 -44.12 75.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -61.15 -37.56 83.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 110.536 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.5 m -61.46 -47.29 86.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.39 -43.48 98.8 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.4 m -50.27 -51.01 48.46 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -35.98 81.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.881 0.872 . . . . 0.0 110.71 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.69 -47.91 82.92 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 123.107 0.563 . . . . 0.0 110.345 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -79.17 -50.95 10.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.7 -63.72 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.737 2.415 . . . . 0.0 116.048 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.89 -104.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.955 2.217 . . . . 0.0 115.755 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -76.61 48.7 0.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.143 0.977 . . . . 0.0 113.215 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.36 159.81 13.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 110.505 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -134.19 121.63 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -123.31 95.08 4.46 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.051 1.34 . . . . 0.0 107.746 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.79 102.62 10.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.468 1.107 . . . . 0.0 111.349 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -79.58 118.83 21.78 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.52 148.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.907 0.86 . . . . 0.0 111.173 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -111.43 112.89 24.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.443 1.497 . . . . 0.0 109.178 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.18 -31.2 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 122.527 0.331 . . . . 0.0 110.954 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.32 -34.39 76.53 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.55 -66.46 0.89 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -85.69 62.96 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 121.605 -0.684 . . . . 0.0 111.766 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.38 -43.19 44.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.351 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -56.31 23.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.215 1.006 . . . . 0.0 111.711 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.12 -43.35 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.13 35.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.867 0.467 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.2 -40.01 90.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.668 0.667 . . . . 0.0 110.08 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.03 82.28 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.639 0.654 . . . . 0.0 110.352 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.51 3.44 21.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.958 0.903 . . . . 0.0 111.715 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.45 32.74 85.19 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.013 0.816 . . . . 0.0 112.644 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.12 134.88 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 p -136.58 -70.11 0.47 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.872 1.269 . . . . 0.0 108.323 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.82 62.28 1.53 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.769 0.828 . . . . 0.0 111.376 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 143.27 98.2 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.46 136.56 44.19 Favored 'Cis proline' 0 N--CA 1.448 -1.151 0 CA-C-N 120.063 1.058 . . . . 0.0 110.606 0.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -126.56 129.57 48.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.44 1.096 . . . . 0.0 108.34 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.97 128.33 54.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.23 1.812 . . . . 0.0 106.902 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.2 m170 -127.94 150.98 49.65 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.699 1.199 . . . . 0.0 108.889 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.08 138.06 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.842 1.257 . . . . 0.0 107.639 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -129.75 50.81 2.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.851 0.75 . . . . 0.0 111.108 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.02 154.38 34.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 74.51 -58.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.626 1.97 . . . . 0.0 109.227 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.35 -48.6 0.3 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.54 157.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.93 0.492 . . . . 0.0 109.924 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -56.42 106.15 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.06 -42.5 17.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.103 0.961 . . . . 0.0 112.367 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -159.98 155.84 26.1 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -142.29 163.64 32.29 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 124.469 1.108 . . . . 0.0 110.076 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -157.52 115.86 3.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.146 1.378 . . . . 0.0 107.959 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.62 160.77 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.708 0.803 . . . . 0.0 112.274 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 177.17 40.42 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.196 0.903 . . . . 0.0 112.185 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.44 40.99 0.24 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.361 1.064 . . . . 0.0 111.298 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.1 m -80.73 58.98 3.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.31 1.444 . . . . 0.0 110.271 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -43.95 -51.97 7.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.59 1.556 . . . . 0.0 112.555 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -52.77 -51.03 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.419 0.687 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -69.48 -32.37 71.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.093 0.557 . . . . 0.0 109.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -57.76 11.08 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -55.78 -46.24 78.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.755 0.422 . . . . 0.0 109.869 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.76 -47.73 73.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.684 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mt -63.09 -45.64 91.15 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.661 0.664 . . . . 0.0 110.473 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.45 -50.9 70.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.16 74.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.618 0.367 . . . . 0.0 111.031 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -60.13 -58.64 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.006 0.922 . . . . 0.0 111.501 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -70.66 -53.13 16.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.14 57.58 4.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.712 0.805 . . . . 0.0 109.059 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.456 -0.154 0 C-N-CA 122.785 0.434 . . . . 0.0 109.951 178.265 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p . . . . . 0 N--CA 1.451 -0.395 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.08 20.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 124.894 1.278 . . . . 0.0 111.972 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -157.71 176.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 126.849 2.059 . . . . 0.0 106.908 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 61' ' ' LYS . 6.2 p -150.44 -158.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 6' ' ' VAL . 21.1 tt -156.39 164.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -68.85 -34.6 75.75 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.422 1.089 . . . . 0.0 112.652 -174.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.8 m -62.71 105.12 0.61 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.879 0.472 . . . . 0.0 109.976 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -39.62 -51.66 2.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.811 1.645 . . . . 0.0 113.158 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.7 45.72 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.465 0.65 . . . . 0.0 111.597 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.92 66.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.188 0.595 . . . . 0.0 111.246 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -49.41 76.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -59.98 -47.08 87.27 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.69 68.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -50.81 68.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.527 0.731 . . . . 0.0 109.525 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.81 -50.74 43.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.279 0.491 . . . . 0.0 109.804 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -55.7 27.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -64.27 -22.0 66.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.776 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.18 25.39 0.2 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.728 1.156 . . . . 0.0 115.399 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp 51.44 70.82 0.5 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.276 1.43 . . . . 0.0 111.461 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.9 70.84 0.51 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.496 1.918 . . . . 0.0 109.728 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -109.18 -66.38 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -161.4 17.85 0.11 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.08 1.752 . . . . 0.0 109.872 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -75.29 142.16 74.76 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.93 115.08 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.762 2.975 . . . . 0.0 110.931 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.7 mt -101.16 101.04 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.32 109.61 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.72 121.22 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 109.846 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -85.59 100.01 11.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.723 1.609 . . . . 0.0 106.958 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.02 99.22 11.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.2 m -131.71 153.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.43 158.43 17.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.316 0.579 . . . . 0.0 110.678 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -66.4 -29.52 69.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.365 1.066 . . . . 0.0 108.235 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -60.97 179.5 0.18 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.257 2.223 . . . . 0.0 112.996 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t 69.39 -62.25 0.41 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.518 2.327 . . . . 0.0 111.733 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.38 -83.05 0.36 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.665 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -47.32 -41.98 27.91 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.494 2.796 . . . . 0.0 112.276 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.0 m -46.47 -39.24 10.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.703 1.601 . . . . 0.0 111.285 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -80.79 -12.45 59.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.339 1.056 . . . . 0.0 113.067 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.3 mmm -58.63 -27.23 64.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.876 1.216 . . . . 0.0 111.362 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.63 -27.69 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.395 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.17 10.19 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.47 -35.62 89.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.153 1.902 . . . . 0.0 112.614 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.4 -53.11 60.89 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.8 -41.46 70.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 108.963 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -62.66 -35.51 79.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.608 1.163 . . . . 0.0 110.794 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -62.8 -50.92 69.1 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.92 -41.46 82.72 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -50.97 -55.76 15.71 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -58.64 -38.0 77.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.273 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -60.61 -48.13 83.14 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.589 0.631 . . . . 0.0 111.263 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -79.62 -29.98 41.24 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.794 -0.566 . . . . 0.0 112.033 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.11 -70.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 128.434 2.694 . . . . 0.0 114.342 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.72 -15.51 2.39 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.334 1.445 . . . . 0.0 112.654 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.49 -34.65 77.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.467 1.134 . . . . 0.0 110.388 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.73 139.44 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.0 mm -93.61 99.53 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -94.46 115.63 27.84 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.4 mt -109.9 140.59 43.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.517 1.127 . . . . 0.0 108.95 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.9 mtpm? -121.65 89.95 3.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.196 0.999 . . . . 0.0 110.448 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -97.19 120.23 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 102.42 5.59 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -44.84 -43.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.867 1.267 . . . . 0.0 111.446 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.93 -41.42 11.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.094 1.758 . . . . 0.0 111.611 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.37 -70.21 0.46 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.019 0.527 . . . . 0.0 111.354 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.64 59.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.743 -0.598 . . . . 0.0 111.191 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.41 -43.1 23.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.024 0.93 . . . . 0.0 111.137 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.12 -49.68 76.11 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.941 0.896 . . . . 0.0 111.307 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 -44.52 91.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.8 -55.14 33.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.893 0.477 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.21 -43.47 94.91 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.384 0.538 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.95 76.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.716 0.689 . . . . 0.0 110.844 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.58 6.28 18.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.607 1.163 . . . . 0.0 111.695 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.09 28.3 66.26 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.243 -0.91 . . . . 0.0 112.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.78 119.75 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -137.3 -70.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.883 1.273 . . . . 0.0 108.74 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.92 65.75 1.45 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.456 0.702 . . . . 0.0 110.996 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.25 142.0 89.31 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.05 133.4 10.84 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.253 1.483 . . . . 0.0 112.894 -2.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -127.05 109.87 12.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -96.62 123.49 40.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -115.74 139.99 49.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.596 1.159 . . . . 0.0 109.68 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.48 121.77 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.13 107.06 14.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.84 1.338 . . . . 0.0 107.418 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -86.63 130.5 34.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 t70 70.46 -68.69 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.847 2.059 . . . . 0.0 107.753 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.94 27.14 0.05 OUTLIER Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.148 2.309 . . . . 0.0 110.245 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.0 130.07 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -61.07 109.4 1.08 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.87 -40.84 9.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.197 0.599 . . . . 0.0 111.682 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -160.38 170.81 20.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.04 170.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.1 tm? -163.01 122.67 2.21 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.9 m -105.9 164.63 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.765 1.226 . . . . 0.0 112.289 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.48 179.23 49.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.676 1.132 . . . . 0.0 111.692 176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.34 39.18 0.25 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.819 0.848 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.3 m -80.87 57.94 3.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.63 1.572 . . . . 0.0 110.164 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -51.12 -48.93 61.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.401 1.08 . . . . 0.0 112.559 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.53 -47.13 80.03 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -61.54 -44.18 97.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.34 -54.49 44.84 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -54.81 -47.64 73.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.75 80.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.51 -46.15 91.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.572 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.99 -51.68 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 119.292 0.951 . . . . 0.0 108.683 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.19 69.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.472 0.309 . . . . 0.0 111.077 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -58.17 -58.69 7.34 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.394 1.078 . . . . 0.0 111.273 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -75.05 -15.68 60.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.746 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -37.48 -48.81 1.0 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.12 1.768 . . . . 0.0 112.67 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 0.0 109.739 -178.545 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.449 -0.489 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.72 128.32 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -145.01 143.64 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 124.476 1.111 . . . . 0.0 110.705 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.28 120.95 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 171.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.71 160.39 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 122.669 1.223 . . . . 0.0 111.639 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -133.69 35.36 3.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.076 2.15 . . . . 0.0 108.544 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 134.3 8.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.925 1.29 . . . . 0.0 108.232 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -51.69 -37.19 49.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.417 1.087 . . . . 0.0 112.46 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -34.01 -62.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.432 1.893 . . . . 0.0 112.573 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.13 77.16 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.935 -0.478 . . . . 0.0 111.363 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -51.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.57 -47.51 69.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.213 0.53 . . . . 0.0 110.297 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.84 60.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.02 -46.14 68.72 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.53 -52.2 6.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.932 0.787 . . . . 0.0 109.443 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.46 -70.0 0.21 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.228 0.611 . . . . 0.0 112.179 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -59.91 -28.42 67.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.895 0.77 . . . . 0.0 112.072 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.82 -24.28 69.79 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.542 1.544 . . . . 0.0 111.842 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 60.68 67.33 0.84 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.623 1.212 . . . . 0.0 110.485 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.02 -22.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.837 2.055 . . . . 0.0 113.459 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -34.14 -54.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.318 2.247 . . . . 0.0 110.572 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -130.66 -13.28 3.76 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -79.85 115.14 51.82 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HG2' HG22 ' A' ' 57' ' ' VAL . 57.1 Cg_endo -63.35 129.05 24.18 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.095 1.196 . . . . 0.0 109.734 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.4 mm -102.72 87.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.47 118.07 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.38 116.39 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 123.274 0.63 . . . . 0.0 109.468 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -92.47 89.19 6.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -79.71 94.49 5.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -115.84 -174.19 2.49 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.166 1.386 . . . . 0.0 108.38 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.72 139.56 40.22 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 123.191 0.596 . . . . 0.0 110.971 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -41.86 -58.91 1.87 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.293 1.437 . . . . 0.0 110.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -72.47 7.85 1.65 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.076 1.351 . . . . 0.0 113.94 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -74.43 -7.65 53.68 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.449 1.477 . . . . 0.0 111.747 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.11 -110.36 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.153 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.53 -41.6 10.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.0 3.133 . . . . 0.0 114.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -25.9 60.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.239 -0.288 . . . . 0.0 111.455 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -54.01 -27.92 34.85 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.8 -0.562 . . . . 0.0 111.135 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.0 mtm -57.71 -21.7 42.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.734 0.697 . . . . 0.0 112.457 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 97' ' ' ALA . 43.1 mt -69.04 -32.14 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.654 -0.654 . . . . 0.0 109.704 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.72 22.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.56 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -59.47 -34.72 97.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.26 1.974 . . . . 0.0 112.357 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.55 -54.41 43.48 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.71 -39.16 73.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.99 -42.33 99.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.339 1.056 . . . . 0.0 109.572 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.1 m -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 tp -59.61 -36.54 76.49 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.51 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 12.5 m -58.35 -48.83 79.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.477 0.711 . . . . 0.0 110.135 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.94 -54.04 51.14 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -54.33 -44.31 71.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.347 0.659 . . . . 0.0 111.844 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -105.83 32.39 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.968 0.907 . . . . 0.0 111.308 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.94 144.42 33.87 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.519 -0.738 . . . . 0.0 110.899 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 -60.7 3.53 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.12 -30.82 71.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' A' ' 26' ' ' PRO . 78.4 t -126.21 143.09 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 mm -100.48 118.02 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 63.2 m-85 -107.51 105.6 15.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.105 0.962 . . . . 0.0 108.827 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.81 89.36 2.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.607 1.163 . . . . 0.0 110.692 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -79.9 111.04 15.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.78 128.56 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.008 0.923 . . . . 0.0 109.952 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.25 106.31 14.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -62.37 -33.79 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.204 0.601 . . . . 0.0 111.059 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.42 -48.2 62.73 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.45 -59.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.663 0.785 . . . . 0.0 110.846 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.74 60.36 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.498 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.27 -43.96 79.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.021 0.928 . . . . 0.0 110.675 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.27 -57.11 11.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 111.907 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.66 -44.07 96.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.04 -52.83 57.23 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.19 -42.43 79.95 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.79 -0.569 . . . . 0.0 109.974 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.28 77.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.684 0.674 . . . . 0.0 110.813 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.21 3.38 27.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.782 1.233 . . . . 0.0 111.636 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.41 38.59 91.12 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.19 0.9 . . . . 0.0 112.632 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mm -76.26 134.66 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.7 p -136.25 -74.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.605 1.162 . . . . 0.0 108.749 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.23 68.41 1.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.503 1.121 . . . . 0.0 110.683 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.83 149.47 96.58 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.79 131.28 22.9 Favored 'Cis proline' 0 N--CA 1.448 -1.192 0 CA-C-N 119.948 1.017 . . . . 0.0 109.917 -1.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -115.42 128.84 56.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.747 1.219 . . . . 0.0 108.407 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -104.24 102.02 11.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.689 1.595 . . . . 0.0 109.913 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -98.94 156.11 17.07 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -127.5 103.73 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.7 66.36 4.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.368 0.531 . . . . 0.0 111.704 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -69.96 154.91 41.34 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 69.59 -63.62 0.37 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.829 2.452 . . . . 0.0 110.157 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.44 35.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.911 2.196 . . . . 0.0 110.419 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.0 152.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -60.01 94.7 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.175 0.59 . . . . 0.0 109.463 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.46 41.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.391 0.676 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -152.43 164.05 38.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.718 0.235 . . . . 0.0 110.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.36 -177.45 4.85 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.21 2.204 . . . . 0.0 107.237 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp 165.82 147.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 128.557 2.743 . . . . 0.0 106.828 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -132.53 150.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.473 1.109 . . . . 0.0 108.965 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.2 173.88 49.38 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 122.088 0.827 . . . . 0.0 113.4 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -76.1 35.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.416 1.487 . . . . 0.0 113.908 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m -78.1 67.15 3.88 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.479 -0.763 . . . . 0.0 110.216 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -49.43 -42.63 43.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.936 1.694 . . . . 0.0 111.504 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -56.58 -49.32 75.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.899 0.88 . . . . 0.0 110.003 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -70.26 -31.12 68.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -53.98 52.18 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.72 -47.3 80.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.92 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.77 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.0 mt -55.15 -55.36 32.07 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.263 0.625 . . . . 0.0 109.726 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.14 -54.11 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.22 -55.59 23.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.663 0.385 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -52.5 -58.62 6.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.288 1.435 . . . . 0.0 111.108 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -72.19 -26.52 62.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.764 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.53 -58.74 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 0.243 0 C-N-CA 126.124 1.769 . . . . 0.0 111.629 -179.134 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m . . . . . 0 CA--C 1.537 0.445 0 N-CA-C 110.129 -0.323 . . . . 0.0 110.129 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.2 29.55 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.231 1.412 . . . . 0.0 112.233 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.15 162.02 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.206 1.003 . . . . 0.0 113.211 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.32 135.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.616 1.966 . . . . 0.0 107.181 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 tt -160.04 169.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.949 0.881 . . . . 0.0 110.63 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -132.16 45.8 2.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 110.442 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -154.41 127.05 8.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.072 -1.018 . . . . 0.0 111.35 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -48.88 -50.07 36.69 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.528 1.131 . . . . 0.0 110.254 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.63 -48.35 19.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.721 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.95 81.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -52.2 48.57 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.69 -47.27 81.85 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.94 57.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.463 0.305 . . . . 0.0 110.275 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -51.47 69.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.085 0.954 . . . . 0.0 109.447 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tt -48.17 -50.07 30.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -62.24 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -63.47 -15.04 56.63 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.599 -0.688 . . . . 0.0 112.285 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.87 -16.74 57.28 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.112 -0.827 . . . . 0.0 111.455 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mttp 76.53 84.49 0.09 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.931 1.692 . . . . 0.0 108.296 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.49 66.16 0.31 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.622 1.969 . . . . 0.0 110.204 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.62 -61.25 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -168.1 8.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.9 153.03 57.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -170.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -65.91 116.1 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.308 2.672 . . . . 0.0 111.304 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.7 mt -97.64 91.96 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.03 109.69 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -111.61 126.24 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -95.72 105.66 17.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 107.615 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -86.25 97.39 10.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -117.6 142.51 47.12 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.1 56.58 1.22 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.9 p 6.89 -74.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.486 3.115 . . . . 0.0 114.645 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -43.64 -28.81 0.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.318 1.847 . . . . 0.0 115.094 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.41 69.18 1.15 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.9 1.682 . . . . 0.0 112.167 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 32.35 -95.99 0.01 OUTLIER Glycine 0 CA--C 1.532 1.151 0 C-N-CA 128.279 2.847 . . . . 0.0 113.576 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -39.59 -45.83 3.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.221 3.281 . . . . 0.0 112.555 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m -46.4 -37.85 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.821 1.648 . . . . 0.0 112.215 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -74.21 -62.15 1.61 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.2 ptp -58.88 -26.33 64.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 113.012 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.96 -29.76 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.653 -0.654 . . . . 0.0 110.047 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.73 -55.12 46.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.527 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -46.16 -43.84 20.3 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.757 2.971 . . . . 0.0 114.707 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.31 -55.13 35.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.07 -37.79 75.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.54 -34.35 74.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.504 1.121 . . . . 0.0 109.844 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 m -61.21 -53.66 54.11 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.6 -43.52 76.14 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 17.9 m -52.83 -56.46 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.577 0.751 . . . . 0.0 109.853 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.79 -50.61 60.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.703 0.401 . . . . 0.0 110.477 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.8 -60.17 4.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.887 1.367 . . . . 0.0 112.558 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -88.27 23.68 2.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.91 1.232 . . . . 0.0 111.754 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.17 151.92 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.868 -1.145 . . . . 0.0 111.769 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 -60.53 4.53 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.822 0.449 . . . . 0.0 109.969 175.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.26 138.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 107.373 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -98.53 131.14 46.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 97.1 m-85 -122.66 139.94 53.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.408 0.549 . . . . 0.0 110.68 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -132.89 125.43 29.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.338 1.055 . . . . 0.0 109.949 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -107.96 102.36 11.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.18 122.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.669 . . . . 0.0 110.82 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.47 104.54 5.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 t -56.62 -40.09 66.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.96 1.304 . . . . 0.0 110.781 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.81 -51.04 62.39 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.52 -60.05 2.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.256 0.622 . . . . 0.0 110.882 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.83 57.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.175 0.988 . . . . 0.0 109.576 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.16 98.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.811 0.844 . . . . 0.0 110.271 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.18 -57.22 10.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 111.993 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.07 -47.46 93.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.39 -47.14 63.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.634 0.254 . . . . 0.0 110.529 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.05 -58.35 8.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.882 0.873 . . . . 0.0 110.197 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -41.27 72.6 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.54 0.336 . . . . 0.0 111.78 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 -2.84 41.78 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.739 1.216 . . . . 0.0 111.754 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.36 47.49 78.89 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.028 -1.045 . . . . 0.0 113.019 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.38 117.85 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -98.37 -84.54 0.39 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.486 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.094 0.957 . . . . 0.0 110.245 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.52 141.47 79.88 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -71.24 140.36 64.18 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.246 1.123 . . . . 0.0 111.713 -1.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.3 m -121.01 109.42 15.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.31 131.09 34.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -126.58 135.51 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 107.979 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -113.15 91.31 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.925 0.784 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.21 69.22 9.88 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.7 133.46 55.36 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 70.84 -66.99 0.27 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 127.447 2.299 . . . . 0.0 107.061 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.86 26.86 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.427 1.965 . . . . 0.0 110.299 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.0 122.34 31.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 118.152 0.976 . . . . 0.0 108.542 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -45.61 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.593 1.957 . . . . 0.0 110.772 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.91 -33.68 19.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.039 0.936 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.89 159.11 37.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -143.79 166.0 26.12 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.807 1.243 . . . . 0.0 109.078 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.7 tp -162.52 115.46 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.862 0.865 . . . . 0.0 109.881 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.98 158.7 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.017 -0.427 . . . . 0.0 110.768 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 172.07 48.67 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.472 1.034 . . . . 0.0 112.662 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.85 74.0 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.083 0.953 . . . . 0.0 110.523 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.4 m 23.16 57.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.153 2.981 . . . . 0.0 115.055 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -57.97 -59.64 4.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 113.424 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.58 -45.84 73.62 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.894 0.854 . . . . 0.0 110.105 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.45 -43.86 96.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.03 0.932 . . . . 0.0 109.583 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -56.17 21.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.355 1.062 . . . . 0.0 108.185 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -53.36 -50.75 64.41 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.22 76.17 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.426 0.29 . . . . 0.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.64 -53.91 51.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 t -55.23 -47.43 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.406 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.73 -57.08 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.159 0.583 . . . . 0.0 111.746 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -64.7 -48.92 72.93 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.028 0.831 . . . . 0.0 112.098 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -64.44 -33.56 76.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.677 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.0 47.97 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.084 0.856 . . . . 0.0 110.837 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.273 0 C-N-CA 123.484 0.714 . . . . 0.0 111.824 179.592 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 CA--C 1.538 0.509 0 N-CA-C 113.831 1.048 . . . . 0.0 113.831 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 50' ' ' SER . 46.9 t -141.72 91.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.46 149.57 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.083 0.553 . . . . 0.0 109.865 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.89 55.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.253 1.421 . . . . 0.0 108.865 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.33 82.8 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 123.002 1.382 . . . . 0.0 110.179 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -76.09 70.0 2.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.64 1.576 . . . . 0.0 108.972 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -146.65 123.12 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.142 0.577 . . . . 0.0 110.302 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -49.32 -45.06 44.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.813 0.845 . . . . 0.0 110.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.71 78.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.303 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.23 74.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.876 0.47 . . . . 0.0 109.833 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -54.75 17.08 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.38 -57.21 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.666 0.786 . . . . 0.0 111.792 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -50.88 67.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.275 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.84 -49.08 74.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 109.351 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.66 -52.77 28.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.887 0.875 . . . . 0.0 109.636 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -60.28 4.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.456 0.702 . . . . 0.0 111.759 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -60.55 -24.16 65.18 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.668 -0.645 . . . . 0.0 111.428 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.09 -22.38 57.89 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.654 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mttp 54.8 60.3 3.57 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.05 1.425 . . . . 0.0 107.915 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -62.4 37.18 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 130.348 3.459 . . . . 0.0 116.221 -173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.1 -76.37 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -114.82 11.26 16.67 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 123.821 0.849 . . . . 0.0 110.883 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -76.55 139.83 67.65 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.66 94.7 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.644 2.229 . . . . 0.0 111.665 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.25 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.39 120.34 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.0 116.57 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.591 0.756 . . . . 0.0 110.834 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -91.03 104.28 16.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.488 1.115 . . . . 0.0 108.565 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -96.54 129.2 43.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 t -157.59 -172.74 4.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 120.4 16.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.989 0.813 . . . . 0.0 111.589 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -36.85 -63.8 0.39 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.056 2.142 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -54.81 -33.04 61.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 112.369 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.87 82.09 6.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.01 -62.68 0.56 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.004 1.288 . . . . 0.0 113.461 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.41 -30.96 93.99 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 119.828 1.814 . . . . 0.0 112.734 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.25 -29.43 67.34 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -81.32 -30.37 33.9 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.059 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.5 mmt -57.24 -22.06 38.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.04 0.836 . . . . 0.0 111.769 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -68.81 -30.44 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.759 . . . . 0.0 110.377 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.64 15.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 112.604 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -57.25 -39.72 87.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 CA-C-N 121.594 1.605 . . . . 0.0 111.495 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.74 -54.55 45.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -51.81 -48.65 63.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.916 1.286 . . . . 0.0 109.258 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.97 -30.36 70.91 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.688 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.4 m -56.56 -39.57 73.68 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 0.0 107.96 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.79 -25.82 63.47 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.099 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.608 ' HB2' HG11 ' A' ' 4' ' ' VAL . 22.9 t -50.65 -38.69 47.86 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.306 1.412 . . . . 0.0 110.294 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -55.94 -43.05 77.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.226 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.62 -53.4 9.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.67 0.788 . . . . 0.0 110.318 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.46 66.6 9.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.43 72.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.965 1.306 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.31 -166.14 3.73 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.466 1.031 . . . . 0.0 113.69 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.72 36.62 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.66 1.984 . . . . 0.0 114.805 -175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.5 122.84 39.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.64 104.47 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 4' ' ' VAL . 13.1 m-85 -92.59 90.22 7.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.72 145.09 31.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.98 121.2 41.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.31 72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.69 121.91 14.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.94 -29.14 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.897 0.879 . . . . 0.0 111.754 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.59 -29.86 70.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.6 -71.86 0.68 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.949 0.9 . . . . 0.0 110.342 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.04 61.8 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 122.649 1.214 . . . . 0.0 108.861 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.46 -42.15 77.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.006 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 -53.26 43.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.9 0.88 . . . . 0.0 111.613 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.61 -43.49 90.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -50.69 64.74 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.4 -43.98 76.07 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.733 -0.604 . . . . 0.0 109.711 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.84 -40.8 76.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.794 0.725 . . . . 0.0 111.169 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.25 45.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.143 1.377 . . . . 0.0 111.434 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.76 41.55 95.68 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 123.925 0.774 . . . . 0.0 112.405 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.7 mm -73.69 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.107 0.954 . . . . 0.0 108.874 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.8 p -131.03 -78.67 0.53 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.484 1.114 . . . . 0.0 108.86 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.57 63.21 1.5 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.626 1.171 . . . . 0.0 111.014 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 151.16 95.91 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.14 158.43 94.98 Favored 'Cis proline' 0 N--CA 1.448 -1.16 0 CA-C-N 119.721 0.936 . . . . 0.0 109.979 0.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 m -150.13 136.32 18.76 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.62 121.3 43.74 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.196 1.398 . . . . 0.0 108.211 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -115.95 150.36 37.27 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.051 0.94 . . . . 0.0 108.906 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.33 107.05 19.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -93.42 89.0 6.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.934 0.493 . . . . 0.0 111.884 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -90.47 156.46 18.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 69.67 -60.19 0.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.325 2.65 . . . . 0.0 109.485 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.31 28.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.058 2.742 . . . . 0.0 110.198 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.4 p -160.54 143.47 4.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.821 1.31 . . . . 0.0 109.902 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -39.83 97.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.749 2.019 . . . . 0.0 111.312 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.59 -37.55 21.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.404 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -139.15 163.16 33.15 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -160.39 169.45 23.05 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.649 0.78 . . . . 0.0 110.12 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -163.19 150.31 12.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.407 1.483 . . . . 0.0 107.921 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.95 162.87 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.495 1.118 . . . . 0.0 110.729 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.99 176.41 40.73 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.934 0.778 . . . . 0.0 112.565 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.72 40.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.354 1.062 . . . . 0.0 111.576 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -77.27 57.93 1.55 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.618 1.967 . . . . 0.0 110.729 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -50.51 -42.02 54.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.111 1.764 . . . . 0.0 112.217 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -57.66 -48.62 78.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 109.969 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -73.08 -26.8 61.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -54.5 45.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -53.33 -47.88 68.94 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.43 75.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.683 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -56.71 -54.61 44.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.612 0.642 . . . . 0.0 109.685 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.51 -46.36 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.771 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.24 -54.36 46.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.612 0.365 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -54.89 -56.04 23.93 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.519 1.128 . . . . 0.0 111.383 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -74.43 -27.93 60.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.156 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.83 41.86 0.82 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.597 1.09 . . . . 0.0 110.853 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.532 0.262 0 C-N-CA 123.121 0.568 . . . . 0.0 112.085 179.616 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m . . . . . 0 CA--C 1.537 0.48 0 CA-C-O 120.89 0.376 . . . . 0.0 110.418 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 50' ' ' SER . 78.5 t -154.23 90.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.63 2.372 . . . . 0.0 105.902 -175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 pt -145.08 149.56 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.315 0.646 . . . . 0.0 109.761 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.03 55.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.176 1.39 . . . . 0.0 109.022 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.19 -173.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.936 1.294 . . . . 0.0 110.475 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -165.34 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 125.653 1.581 . . . . 0.0 109.156 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -35.57 114.99 0.29 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.56 2.344 . . . . 0.0 113.753 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -42.74 -52.28 5.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.727 1.611 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.17 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.821 -0.549 . . . . 0.0 111.678 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.93 -32.73 67.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.829 -0.545 . . . . 0.0 109.95 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.94 79.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.89 -45.71 91.66 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.05 -53.92 46.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -50.54 38.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.488 1.115 . . . . 0.0 109.416 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.64 -14.38 3.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.897 1.279 . . . . 0.0 113.862 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.33 -63.12 1.39 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.761 1.224 . . . . 0.0 110.695 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -20.86 58.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.43 0.692 . . . . 0.0 112.46 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.09 -19.87 62.0 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.603 -1.109 . . . . 0.0 111.926 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? 67.81 64.88 0.38 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.594 1.558 . . . . 0.0 108.539 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -70.1 56.95 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.806 2.842 . . . . 0.0 111.762 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.65 -52.03 6.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.151 1.38 . . . . 0.0 108.064 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -160.53 75.25 0.56 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.245 1.418 . . . . 0.0 108.106 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -147.17 145.51 22.3 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 121.971 -0.456 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.81 126.7 7.41 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.999 2.466 . . . . 0.0 112.168 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mt -96.15 120.89 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 t -112.36 118.65 58.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.02 118.03 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 122.658 0.383 . . . . 0.0 111.79 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.78 87.08 7.26 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -84.76 93.94 8.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 t -117.89 -177.85 3.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.2 112.92 15.68 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.802 1.241 . . . . 0.0 109.08 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -43.56 -56.97 3.37 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.808 1.243 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -57.73 -31.19 66.19 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 112.496 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.6 t -77.39 85.81 3.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -36.23 -59.21 0.99 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.758 1.17 . . . . 0.0 113.07 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.19 -41.23 73.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.017 2.478 . . . . 0.0 112.986 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 m -68.74 -36.59 78.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.74 -47.58 77.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.284 0.634 . . . . 0.0 109.417 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.4 mtm -58.67 -20.3 46.96 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.4 mt -78.36 -24.85 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.88 -51.48 80.09 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.534 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.9 -36.63 89.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.283 1.851 . . . . 0.0 111.529 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.37 -50.81 72.13 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -56.32 -45.96 80.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.662 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.78 -43.4 90.43 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.445 1.02 . . . . 0.0 110.239 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.3 m -55.43 -48.66 74.09 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.65 -43.93 97.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.195 0.521 . . . . 0.0 109.972 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . 41.1 m -54.95 -47.23 74.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 111.537 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -67.53 -12.77 61.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.525 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -74.99 -64.53 1.03 Allowed 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.924 1.238 . . . . 0.0 108.773 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.11 38.31 0.47 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.339 -0.85 . . . . 0.0 110.61 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.914 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.6 -64.2 2.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -60.29 -49.05 79.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.854 0.827 . . . . 0.0 110.285 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 94.5 t -96.76 134.25 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.28 98.78 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 50' ' ' SER . 96.5 m-85 -91.21 143.19 26.92 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.544 -0.723 . . . . 0.0 110.621 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.42 109.69 5.89 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.257 -170.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -79.67 136.78 36.89 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.6 134.79 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -100.93 104.65 15.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.52 -30.16 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 122.607 0.363 . . . . 0.0 110.611 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.9 -36.4 76.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.506 0.323 . . . . 0.0 110.514 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.65 -69.5 0.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.91 58.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.432 -0.792 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.96 35.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.315 1.046 . . . . 0.0 110.678 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.4 72.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.806 0.842 . . . . 0.0 111.13 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.87 -45.41 91.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.98 -53.8 51.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.409 0.283 . . . . 0.0 111.501 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.46 -42.35 83.18 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.595 -0.691 . . . . 0.0 110.544 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.15 -46.2 90.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.539 0.609 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.64 90.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.938 0.895 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.84 52.44 0.75 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.325 0.964 . . . . 0.0 111.946 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.68 147.92 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.9 p -127.24 -81.42 0.6 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.22 177.89 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.819 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -140.55 139.23 19.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -63.36 153.67 70.99 Favored 'Cis proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.518 1.221 . . . . 0.0 113.987 -3.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.3 m -128.61 126.42 40.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.52 101.0 8.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.529 1.132 . . . . 0.0 109.447 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -97.35 145.39 26.18 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.36 111.53 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.17 104.3 14.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -75.98 105.28 6.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 70.58 -56.11 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.879 2.471 . . . . 0.0 110.673 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 89' ' ' VAL . . . -163.47 -13.11 0.03 OUTLIER Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.484 1.992 . . . . 0.0 111.77 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.416 ' H ' ' H ' ' A' ' 88' ' ' GLY . 24.6 t -85.67 122.63 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 118.8 1.3 . . . . 0.0 108.204 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.29 94.93 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.2 -35.84 35.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.645 1.178 . . . . 0.0 111.145 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.49 168.28 27.77 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -148.24 167.33 25.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.412 2.285 . . . . 0.0 107.509 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 tp -178.09 138.55 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.205 2.202 . . . . 0.0 106.125 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.13 144.91 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.3 63.69 0.98 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 49.62 -108.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.72 1.208 . . . . 0.0 111.56 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 m 56.84 60.84 2.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.615 1.166 . . . . 0.0 111.003 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -52.01 -36.65 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.583 1.153 . . . . 0.0 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.25 -46.8 88.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.368 0.667 . . . . 0.0 109.72 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -69.02 -35.7 76.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -56.5 -53.68 54.64 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -53.31 -47.42 69.27 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.08 79.88 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.91 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.05 -55.75 29.09 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.497 0.589 . . . . 0.0 109.607 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.59 -47.28 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.84 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.68 -56.44 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.672 0.272 . . . . 0.0 110.295 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -49.37 -62.77 1.36 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.914 1.286 . . . . 0.0 110.773 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -69.79 -22.55 63.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.84 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.21 -44.81 62.39 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.386 0 C-N-CA 123.075 0.55 . . . . 0.0 109.802 177.664 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p . . . . . 0 N--CA 1.453 -0.302 0 CA-C-O 119.56 -0.257 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 50' ' ' SER . 46.6 t -102.38 107.06 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.01 146.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 CA-C-N 119.315 0.962 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.84 22.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.317 1.847 . . . . 0.0 108.608 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.27 162.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -78.72 77.94 5.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -59.42 72.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 127.943 2.497 . . . . 0.0 115.45 -170.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -92.94 -66.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.121 1.369 . . . . 0.0 108.444 167.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.9 17.14 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.027 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.8 65.1 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.667 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -53.13 18.15 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 109.361 175.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.73 -48.52 68.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.828 0.451 . . . . 0.0 110.895 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.95 -60.92 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.598 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -57.09 -47.37 81.22 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.258 1.023 . . . . 0.0 109.689 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -49.66 -48.92 49.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.034 0.379 . . . . 0.0 110.61 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -63.63 1.08 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.638 0.375 . . . . 0.0 111.011 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.37 -25.87 67.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.822 -0.549 . . . . 0.0 111.951 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 -24.55 71.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.721 -1.044 . . . . 0.0 111.801 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 51.31 67.1 1.0 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.224 1.012 . . . . 0.0 109.752 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 46.12 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.395 1.878 . . . . 0.0 114.489 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -139.89 7.23 2.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.468 0.707 . . . . 0.0 112.803 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.03 129.3 61.87 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.14 122.86 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.608 1.538 . . . . 0.0 112.188 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.34 99.79 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.62 111.31 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.79 125.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.35 98.8 11.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.959 1.304 . . . . 0.0 109.463 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.77 96.83 9.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 t -127.21 -150.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -167.97 161.17 12.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 110.912 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -66.56 -59.67 3.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.749 1.22 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -51.01 -33.69 26.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.471 1.508 . . . . 0.0 114.594 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 p -78.37 57.81 2.0 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.605 1.093 . . . . 0.0 112.051 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.46 -87.65 0.0 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 129.129 3.252 . . . . 0.0 115.398 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -41.2 -37.16 2.77 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.717 3.611 . . . . 0.0 113.979 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -45.05 -45.87 11.11 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.405 1.482 . . . . 0.0 111.335 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -65.23 -21.97 66.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.865 0.866 . . . . 0.0 111.593 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.2 mtt -90.0 -37.51 14.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.999 1.32 . . . . 0.0 109.403 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mt -64.16 -42.52 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 109.382 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -47.98 -53.75 29.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.201 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 75.1 Cg_exo -46.57 -46.9 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.167 3.245 . . . . 0.0 114.186 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.08 -49.51 77.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.746 0.784 . . . . 0.0 108.891 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -58.53 -42.33 87.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.152 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.12 -40.63 96.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.026 0.83 . . . . 0.0 109.574 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -58.52 -49.98 75.41 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.75 -36.47 76.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.044 0.449 . . . . 0.0 109.995 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 41.9 m -60.17 -46.28 90.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.973 -0.454 . . . . 0.0 109.78 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -64.72 -43.8 92.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -47.55 -51.62 20.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.951 0.5 . . . . 0.0 111.675 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -101.54 33.7 2.86 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.377 0.535 . . . . 0.0 111.659 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.58 151.5 10.54 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.565 -0.709 . . . . 0.0 111.681 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 -62.99 3.2 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -55.66 -52.86 62.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.509 0.724 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 94.8 t -106.75 140.55 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 mm -96.31 131.77 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 93.8 m-85 -121.79 118.21 28.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.861 0.755 . . . . 0.0 110.778 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -112.44 148.66 33.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.612 1.565 . . . . 0.0 110.072 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -123.22 132.71 54.14 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.42 1.488 . . . . 0.0 107.849 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.23 130.46 39.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 119.171 0.896 . . . . 0.0 109.765 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.54 109.71 21.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.59 -27.38 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.958 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.03 -40.9 97.35 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.608 0.64 . . . . 0.0 109.476 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.51 -63.64 1.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.124 0.57 . . . . 0.0 110.073 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.57 58.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.666 0.746 . . . . 0.0 110.001 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.39 68.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.034 0.934 . . . . 0.0 110.963 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.5 -56.11 22.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.878 0.871 . . . . 0.0 112.16 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.16 -42.62 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.86 63.44 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.7 -38.64 80.43 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.454 -0.779 . . . . 0.0 110.189 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.82 -46.28 89.73 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.564 0.62 . . . . 0.0 109.943 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.92 73.06 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.453 0.701 . . . . 0.0 110.015 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 43.73 4.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.712 1.149 . . . . 0.0 111.208 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.8 mm -79.17 140.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -134.15 -80.35 0.46 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.376 1.07 . . . . 0.0 109.226 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.29 67.21 2.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.261 1.024 . . . . 0.0 111.033 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -63.77 144.77 97.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.168 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.45 148.22 64.43 Favored 'Cis proline' 0 N--CA 1.455 -0.745 0 CA-C-N 120.847 1.338 . . . . 0.0 112.783 -0.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -146.32 122.98 11.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.84 118.9 37.78 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.606 1.162 . . . . 0.0 109.395 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -109.52 150.12 28.62 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.77 107.75 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -99.77 114.31 27.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.648 0.779 . . . . 0.0 111.285 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.57 -170.5 2.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 166.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 89' ' ' VAL . 25.7 p-10 -67.61 -34.22 76.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.123 -0.985 . . . . 0.0 108.474 165.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 41.39 0.97 Allowed Glycine 0 CA--C 1.541 1.709 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.31 20.1 m 24.45 -139.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.64 1 C-N-CA 133.701 4.8 . . . . 0.0 113.458 -179.178 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -54.12 85.14 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.873 1.269 . . . . 0.0 109.616 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.87 40.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.491 0.716 . . . . 0.0 109.856 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.68 161.85 41.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.888 0.475 . . . . 0.0 110.345 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -140.58 165.48 27.34 Favored 'General case' 0 C--N 1.335 -0.048 0 C-N-CA 127.14 2.176 . . . . 0.0 107.731 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.1 tp -172.39 103.9 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.893 1.277 . . . . 0.0 109.785 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.82 162.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.548 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 170.42 27.77 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.423 1.011 . . . . 0.0 112.743 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.45 45.34 0.56 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.465 1.106 . . . . 0.0 110.312 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -77.99 60.11 2.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.051 1.34 . . . . 0.0 111.688 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.39 -46.37 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.56 1.544 . . . . 0.0 113.982 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.63 -48.31 75.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.283 -0.886 . . . . 0.0 110.372 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.6 -38.96 86.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.16 -57.43 13.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -45.38 -53.52 8.52 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.621 0.768 . . . . 0.0 110.213 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.55 -50.81 70.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.321 1.013 . . . . 0.0 111.511 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.98 -46.02 90.82 Favored 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.583 -0.698 . . . . 0.0 110.34 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.33 -46.34 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.9 -52.68 59.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.83 -61.0 2.57 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.104 0.962 . . . . 0.0 111.144 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -64.59 -31.79 73.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.885 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.58 42.67 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.946 0.898 . . . . 0.0 111.154 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.535 0.369 0 C-N-CA 123.347 0.659 . . . . 0.0 112.342 179.65 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m . . . . . 0 N--CA 1.448 -0.551 0 CA-C-O 120.917 0.389 . . . . 0.0 110.583 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.26 31.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.83 2.052 . . . . 0.0 108.087 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 pt -131.79 -173.1 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.392 1.477 . . . . 0.0 110.677 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.95 115.45 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -155.64 99.54 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 122.343 1.068 . . . . 0.0 109.244 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -91.58 -42.49 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.866 1.266 . . . . 0.0 109.705 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 m -32.86 113.17 0.13 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 115.016 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -40.92 66.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 110.527 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -25.12 64.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.938 0.495 . . . . 0.0 111.885 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.44 -31.63 12.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.123 0.969 . . . . 0.0 110.898 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -45.94 -58.25 3.71 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.48 1.512 . . . . 0.0 112.147 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.95 -44.72 84.2 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.655 -0.653 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.77 -42.85 62.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -56.15 25.58 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.94 1.696 . . . . 0.0 109.085 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.6 mt -49.67 -45.79 49.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 110.481 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.85 -63.46 1.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.135 0.574 . . . . 0.0 111.589 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -57.4 -32.08 66.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.373 0.533 . . . . 0.0 111.082 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.97 55.31 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.113 -1.382 . . . . 0.0 113.031 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? 59.0 69.92 0.69 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -68.64 62.51 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.441 2.696 . . . . 0.0 112.767 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -116.92 -93.16 0.51 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.67 73.48 0.82 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.922 0.889 . . . . 0.0 109.052 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 27' ' ' ILE . 29.4 mmtm -140.29 150.31 60.9 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.13 86.39 0.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 N-CA-C 106.609 -2.112 . . . . 0.0 106.609 168.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 25' ' ' LYS . 3.4 mp -82.24 79.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.36 137.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 147.23 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -117.6 113.53 22.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.63 112.1 22.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -142.79 179.0 7.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.23 170.62 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.585 1.554 . . . . 0.0 110.812 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.9 p -96.8 -66.49 0.9 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.943 1.697 . . . . 0.0 110.708 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -43.07 -32.38 0.68 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.51 2.324 . . . . 0.0 113.164 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -58.46 -19.55 37.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.482 1.113 . . . . 0.0 113.093 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 -113.44 3.77 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.359 -1.245 . . . . 0.0 110.065 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.89 -42.84 6.78 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.282 3.321 . . . . 0.0 115.207 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -23.09 55.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -71.17 -31.67 67.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.428 -0.795 . . . . 0.0 110.364 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 mmt -61.22 -18.25 57.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.14 0.976 . . . . 0.0 112.467 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.405 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 43.6 mt -62.98 -33.43 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.6 6.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.114 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -57.11 -35.99 99.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.801 1.679 . . . . 0.0 112.019 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.34 -55.14 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.399 0.618 . . . . 0.0 109.733 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -56.5 -41.26 76.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.67 0.788 . . . . 0.0 109.522 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.68 -40.61 97.64 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.881 -0.512 . . . . 0.0 110.119 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -60.21 -48.84 80.03 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.51 -39.17 75.94 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.257 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -54.88 -54.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.05 -45.79 79.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.989 0.915 . . . . 0.0 110.771 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.24 -43.14 95.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.759 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -79.42 -45.41 19.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.97 -64.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.76 -119.47 0.01 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.575 2.512 . . . . 0.0 116.92 -170.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 55.37 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.091 -1.24 . . . . 0.0 111.12 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.89 149.46 25.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.042 1.337 . . . . 0.0 110.552 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.72 105.44 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.92 94.39 5.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.604 1.162 . . . . 0.0 108.434 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.9 92.45 5.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.911 1.284 . . . . 0.0 109.824 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -85.25 107.42 17.28 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.233 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.67 149.75 17.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 125.292 1.437 . . . . 0.0 110.255 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.99 115.77 30.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.0 0.92 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.66 -45.8 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 124.867 1.267 . . . . 0.0 110.991 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -58.45 -41.66 85.64 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.03 -70.91 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -87.88 63.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 O-C-N 121.332 -0.855 . . . . 0.0 110.955 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.93 48.3 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.48 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.5 69.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.008 0.923 . . . . 0.0 111.295 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.07 -44.96 97.83 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -55.59 29.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.648 0.379 . . . . 0.0 111.169 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.92 -41.71 97.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.707 0.685 . . . . 0.0 109.831 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.66 77.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.641 0.655 . . . . 0.0 110.528 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 7.76 12.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.12 0.968 . . . . 0.0 111.792 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.38 27.06 70.16 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.211 0.91 . . . . 0.0 113.093 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.88 81.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 122.558 1.171 . . . . 0.0 108.707 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -92.1 -72.58 0.58 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.842 2.057 . . . . 0.0 108.099 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.46 59.94 1.53 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.831 0.852 . . . . 0.0 111.389 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.86 152.18 96.89 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -60.17 147.96 44.01 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 121.016 1.398 . . . . 0.0 112.491 -2.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.8 m -147.35 141.79 26.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 51.8 m-85 -134.34 130.49 37.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.666 1.587 . . . . 0.0 107.917 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -125.3 158.49 34.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.551 1.14 . . . . 0.0 107.925 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.4 122.02 63.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 27' ' ' ILE . 40.6 m-85 -110.81 76.36 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.107 0.563 . . . . 0.0 111.966 -173.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -90.43 -168.08 2.01 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.349 -0.845 . . . . 0.0 110.285 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 89' ' ' VAL . 3.3 m-20 -51.23 -43.07 61.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.08 17.86 0.14 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.612 2.053 . . . . 0.0 112.507 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 90' ' ' LYS 0.277 40.5 t 67.18 -154.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.42 1.488 . . . . 0.0 107.34 170.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . 0.67 ' H ' HG12 ' A' ' 89' ' ' VAL . 22.5 ttpp -64.29 79.53 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.29 -32.45 43.58 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.622 -166.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -147.19 151.07 36.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -142.97 166.27 25.1 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.081 1.352 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 98' ' ' SER . 1.7 tm? -161.83 140.98 9.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.762 1.225 . . . . 0.0 108.263 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 m -127.26 162.68 31.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.485 1.114 . . . . 0.0 110.793 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 179.16 36.76 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.841 -0.799 . . . . 0.0 111.09 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 94' ' ' LEU . 14.2 m -80.08 58.86 3.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -48.92 -46.57 43.27 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.374 . . . . 0.0 111.864 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.36 -48.51 74.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.103 0.561 . . . . 0.0 110.128 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.451 ' HD3' HD23 ' A' ' 94' ' ' LEU . 50.7 tttm -68.8 -35.62 77.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -58.69 -48.71 80.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 109.132 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.98 -47.76 80.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.93 77.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.23 -55.72 31.34 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.0 t -51.08 -53.34 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.24 -52.11 62.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.94 0.496 . . . . 0.0 111.562 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -68.28 0.23 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.471 0.653 . . . . 0.0 110.034 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -61.01 -24.04 65.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.091 -170.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.42 94.45 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.728 0.695 . . . . 0.0 109.696 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 123.477 0.711 . . . . 0.0 109.47 178.991 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.536 0.423 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.71 32.41 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.481 1.512 . . . . 0.0 112.784 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -107.99 154.09 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.35 -0.844 . . . . 0.0 112.392 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.89 135.95 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -160.58 -41.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 122.7 1.238 . . . . 0.0 111.295 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.38 49.36 6.05 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 128.044 2.538 . . . . 0.0 112.241 168.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -131.82 134.73 46.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.578 1.151 . . . . 0.0 107.988 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -49.57 -46.81 49.35 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.754 0.822 . . . . 0.0 111.113 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.92 -11.34 37.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.871 1.268 . . . . 0.0 113.143 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 -33.28 6.91 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.499 1.12 . . . . 0.0 110.075 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -46.79 19.75 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.171 1.388 . . . . 0.0 110.274 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -69.47 -53.39 19.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.012 0.525 . . . . 0.0 109.954 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.68 27.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.608 1.163 . . . . 0.0 111.26 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -44.72 41.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.499 1.52 . . . . 0.0 111.286 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.54 -39.1 93.14 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.704 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.57 -54.13 15.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.039 0.536 . . . . 0.0 109.869 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.5 -28.63 69.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.43 -54.53 33.54 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.767 1.175 . . . . 0.0 111.312 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 103.64 81.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 1 C-N-CA 132.063 4.145 . . . . 0.0 107.665 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -72.83 60.89 0.53 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.641 1.977 . . . . 0.0 110.189 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -119.33 -60.1 1.77 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.947 1.299 . . . . 0.0 108.207 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -152.32 90.9 1.54 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -157.77 152.77 21.36 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -76.36 106.71 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.912 3.075 . . . . 0.0 108.793 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.24 81.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -84.18 120.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -120.62 118.42 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -88.72 96.75 10.79 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.567 1.147 . . . . 0.0 108.958 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -82.25 113.2 19.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 m -141.46 149.47 40.99 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 122.987 0.515 . . . . 0.0 110.041 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 133.21 34.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -50.83 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.63 100.74 5.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.2 133.13 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.479 -0.763 . . . . 0.0 109.003 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.48 150.97 40.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER 50.91 -29.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.445 3.43 . . . . 0.0 118.59 -170.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.2 m -50.73 -45.86 58.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 122.573 2.442 . . . . 0.0 108.354 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -56.06 -26.48 49.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.876 1.67 . . . . 0.0 112.438 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 60.6 mtt -91.15 -43.67 9.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.27 1.428 . . . . 0.0 110.371 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.65 -42.5 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.38 1.472 . . . . 0.0 110.31 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -55.32 -60.09 9.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.769 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 71.2 Cg_exo -47.14 -46.9 18.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.643 173.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.96 -55.44 34.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.429 0.633 . . . . 0.0 110.466 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -57.42 -37.91 73.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.023 0.529 . . . . 0.0 109.718 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.62 -38.35 89.2 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.704 -0.623 . . . . 0.0 110.146 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 m -60.9 -46.02 92.3 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.11 -40.49 93.94 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 p -58.7 -41.93 87.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.117 -0.99 . . . . 0.0 109.599 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -39.83 94.96 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.76 -47.91 81.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.773 0.429 . . . . 0.0 110.965 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -79.25 -47.74 15.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.874 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 18.77 73.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.585 2.754 . . . . 0.0 115.238 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.0 -96.76 0.11 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -76.46 46.29 0.42 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.09 1.356 . . . . 0.0 110.686 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.6 m -156.76 161.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.047 -1.033 . . . . 0.0 109.62 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.98 121.35 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 169.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.36 91.48 3.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.624 1.169 . . . . 0.0 107.92 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -84.96 127.24 34.09 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.273 1.029 . . . . 0.0 110.923 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.34 128.76 44.44 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.0 101.06 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 122.138 0.97 . . . . 0.0 111.388 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.07 104.07 0.84 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.22 -36.18 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.982 1.313 . . . . 0.0 110.018 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -63.16 -28.23 69.91 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.618 0.367 . . . . 0.0 111.104 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.46 -65.8 0.97 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.7 56.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 110.134 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.13 77.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.023 0.929 . . . . 0.0 111.529 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.32 -53.12 48.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.907 0.883 . . . . 0.0 111.657 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.41 -46.57 94.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.26 -57.25 11.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.722 0.237 . . . . 0.0 111.437 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.02 -41.3 97.94 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.415 -0.803 . . . . 0.0 110.703 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.35 98.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.384 0.538 . . . . 0.0 111.367 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.32 81.24 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 0.0 111.151 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.67 82.4 1.35 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.76 139.3 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 126.279 1.832 . . . . 0.0 106.401 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -131.92 -96.11 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.76 71.64 5.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.725 0.81 . . . . 0.0 109.446 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . 0.409 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 1.7 pmm? -53.98 143.66 41.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.052 0.941 . . . . 0.0 109.855 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 79' ' ' MET . 99.9 Cg_exo -57.55 154.98 32.59 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-N 121.131 1.44 . . . . 0.0 113.642 -1.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.9 108.7 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.76 89.94 5.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.635 1.574 . . . . 0.0 110.104 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -80.26 146.15 31.81 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.42 104.58 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -92.68 52.83 1.94 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -50.69 132.14 25.92 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 74.85 -62.19 0.46 Allowed 'General case' 0 CA--C 1.526 0.043 0 C-N-CA 126.835 2.054 . . . . 0.0 108.726 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.71 39.06 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.912 1.244 . . . . 0.0 111.533 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.88 142.22 8.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -60.54 91.23 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 109.945 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.44 -31.56 29.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.224 1.41 . . . . 0.0 110.741 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -150.27 170.87 17.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.609 0.242 . . . . 0.0 111.163 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -150.12 165.07 33.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.448 1.899 . . . . 0.0 107.43 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.9 tp -172.39 108.08 0.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.264 1.426 . . . . 0.0 108.842 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.6 168.04 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.345 0.658 . . . . 0.0 110.446 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.12 -177.76 27.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.38 -65.77 0.63 Allowed 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m 45.45 43.91 9.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 113.046 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -48.59 -44.14 36.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 112.695 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -59.71 -52.32 65.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.21 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.85 -31.55 71.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.21 -59.22 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -53.54 -49.85 66.74 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.258 0.623 . . . . 0.0 110.464 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.84 71.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.067 0.147 . . . . 0.0 110.87 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.37 -46.27 84.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.454 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.77 -48.81 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.794 1.179 . . . . 0.0 108.916 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.72 47.7 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.75 0.42 . . . . 0.0 110.485 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -52.37 -63.23 1.21 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.057 0.943 . . . . 0.0 110.661 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.24 -19.1 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.351 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.29 9.12 37.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.277 0.944 . . . . 0.0 111.385 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.341 0.23 0 CA-C-N 119.295 0.952 . . . . 0.0 111.703 -179.079 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 58' ' ' ILE . 4.3 m . . . . . 0 N--CA 1.446 -0.663 0 N-CA-C 113.192 0.812 . . . . 0.0 113.192 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.8 m -142.57 31.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.048 2.139 . . . . 0.0 107.179 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.11 147.48 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 125.248 1.419 . . . . 0.0 111.672 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.1 71.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.352 1.061 . . . . 0.0 110.816 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.34 122.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -98.75 -25.15 14.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.336 2.254 . . . . 0.0 113.569 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -38.06 130.11 1.2 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.663 1.585 . . . . 0.0 111.627 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -49.89 -40.39 42.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.049 0.84 . . . . 0.0 112.537 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 -42.6 81.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.749 0.785 . . . . 0.0 110.034 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.18 -33.64 67.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.189 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -57.95 -52.23 66.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -56.2 -50.05 72.32 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.404 0.682 . . . . 0.0 109.939 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.1 61.97 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.869 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.6 -39.14 73.05 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.562 1.145 . . . . 0.0 111.058 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -62.34 -10.5 11.36 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.222 0.609 . . . . 0.0 111.454 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.69 -58.97 1.94 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.645 1.178 . . . . 0.0 109.908 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -9.57 23.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.522 -0.736 . . . . 0.0 112.184 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.53 -26.7 71.02 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt 55.07 51.73 12.93 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.738 1.215 . . . . 0.0 109.475 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -77.18 62.63 2.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.702 1.601 . . . . 0.0 110.218 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.95 -49.77 70.53 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 109.154 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.37 22.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.676 1.99 . . . . 0.0 108.865 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -87.56 160.71 47.14 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.498 1.119 . . . . 0.0 110.723 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.91 120.62 5.85 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.437 2.091 . . . . 0.0 112.255 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.36 92.88 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.64 111.29 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.64 128.96 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -99.84 102.74 14.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.591 2.356 . . . . 0.0 108.461 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.45 96.75 8.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 33' ' ' ALA . 72.9 m -136.75 -177.34 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 32' ' ' THR . . . -169.46 -177.83 2.91 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 120.878 1.672 . . . . 0.0 110.147 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 p -56.53 -50.17 72.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.931 1.693 . . . . 0.0 109.001 172.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -59.43 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.214 2.605 . . . . 0.0 113.704 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.0 p 170.72 -21.58 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.839 2.456 . . . . 0.0 110.491 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.95 -114.52 5.61 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.088 -1.396 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -41.04 -41.45 4.28 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.502 3.468 . . . . 0.0 115.853 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -27.23 58.02 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.473 0.579 . . . . 0.0 111.57 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -57.99 -23.7 55.07 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.544 -0.723 . . . . 0.0 111.125 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.8 mtm -60.83 -13.72 17.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.778 0.717 . . . . 0.0 111.965 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.84 -30.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.632 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.04 -56.48 25.37 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.629 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.24 -33.46 97.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 122.11 1.789 . . . . 0.0 111.962 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.99 -46.94 76.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.94 -42.72 97.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.579 0.752 . . . . 0.0 110.005 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.4 m -57.62 -47.07 83.22 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.64 -42.25 98.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -52.34 -50.25 62.68 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -41.76 95.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.952 0.501 . . . . 0.0 110.651 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.12 -49.8 75.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.728 0.811 . . . . 0.0 111.315 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.17 -48.18 14.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.176 0.19 . . . . 0.0 110.635 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.91 -73.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.313 1.845 . . . . 0.0 114.133 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.24 -68.7 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.388 0.994 . . . . 0.0 114.23 -172.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -69.88 19.43 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CE1' ' A' ' 59' ' ' PHE . 41.0 t -152.13 154.93 7.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 119.886 1.221 . . . . 0.0 109.43 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 3' ' ' SER . 4.2 mp -116.52 102.87 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE1' HG11 ' A' ' 57' ' ' VAL . 24.0 m-85 -94.25 98.03 10.65 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.086 0.954 . . . . 0.0 109.278 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.94 121.77 32.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.857 0.463 . . . . 0.0 109.787 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -99.52 115.77 30.12 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.81 119.45 58.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 118.484 0.584 . . . . 0.0 110.868 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.68 100.2 10.07 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 172.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -44.22 -58.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.854 1.662 . . . . 0.0 111.51 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.26 -42.59 86.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.9 0.88 . . . . 0.0 111.574 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.38 -67.9 0.42 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.124 0.42 . . . . 0.0 110.063 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -86.44 63.79 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.926 0.87 . . . . 0.0 109.869 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.2 -40.74 34.64 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.674 1.189 . . . . 0.0 110.615 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.39 77.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.692 0.797 . . . . 0.0 111.048 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.52 -45.07 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.12 35.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.552 0.341 . . . . 0.0 111.435 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.81 -41.12 96.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.26 0.482 . . . . 0.0 109.758 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.31 -41.82 76.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.741 0.7 . . . . 0.0 110.235 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.1 6.9 14.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.48 0.712 . . . . 0.0 112.295 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.94 97.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.023 0.821 . . . . 0.0 112.731 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.0 mm -94.3 153.65 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.5 m -153.64 -57.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.12 159.5 18.18 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.81 158.99 29.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.414 -1.279 . . . . 0.0 107.855 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.34 126.44 3.64 Favored 'Cis proline' 0 C--N 1.35 0.612 0 CA-C-N 121.338 1.514 . . . . 0.0 112.975 -1.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 m -126.87 122.07 33.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.44 129.01 56.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.146 . . . . 0.0 108.521 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -121.3 152.4 38.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.13 94.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -88.65 104.75 17.15 Favored 'General case' 0 C--O 1.227 -0.103 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -77.1 127.65 33.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.28 -64.78 0.32 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.792 2.037 . . . . 0.0 109.136 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 22.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.032 1.777 . . . . 0.0 112.242 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.34 125.63 43.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 119.324 1.562 . . . . 0.0 109.576 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -50.28 97.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.135 1.774 . . . . 0.0 110.782 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.97 -31.07 27.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.294 1.038 . . . . 0.0 110.101 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -160.35 172.89 16.49 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.737 0.815 . . . . 0.0 108.9 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.48 -179.28 7.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.115 0.966 . . . . 0.0 109.284 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -164.96 106.18 0.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 106.951 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.56 32.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.0 1.32 . . . . 0.0 113.075 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 168.73 37.19 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.187 -0.946 . . . . 0.0 112.661 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.92 38.55 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.298 1.439 . . . . 0.0 112.942 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.3 m -81.4 70.92 8.37 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 120.649 -1.282 . . . . 0.0 109.717 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -39.62 -52.06 2.23 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.826 1.651 . . . . 0.0 113.757 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.57 -44.19 93.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.81 -0.556 . . . . 0.0 110.959 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -65.32 -41.57 93.85 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -51.81 -58.01 7.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.938 1.295 . . . . 0.0 108.187 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.49 -52.68 58.78 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.92 0.888 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.25 71.24 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.8 mt -58.66 -51.37 70.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.18 -48.88 81.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.489 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.9 61.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.599 0.36 . . . . 0.0 110.864 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -56.21 -65.09 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.122 0.969 . . . . 0.0 110.417 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -64.42 -24.44 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.455 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.5 2.84 23.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.951 0.796 . . . . 0.0 112.033 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 0.531 0 CA-C-N 120.031 1.287 . . . . 0.0 111.462 179.441 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 m . . . . . 0 N--CA 1.448 -0.529 0 CA-C-O 121.404 0.621 . . . . 0.0 112.429 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 50' ' ' SER . 11.3 t -131.66 92.38 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -136.96 176.06 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.247 0.546 . . . . 0.0 112.406 -171.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.08 22.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.516 1.526 . . . . 0.0 110.939 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -82.03 78.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.99 64.24 0.33 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.413 1.885 . . . . 0.0 109.631 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.6 m -153.12 167.82 27.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.19 1.396 . . . . 0.0 109.469 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -39.77 -42.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.695 1.998 . . . . 0.0 112.339 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.5 -41.12 9.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 112.037 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.01 62.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.578 -0.701 . . . . 0.0 109.944 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -53.96 -40.25 66.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.98 0.912 . . . . 0.0 112.198 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.06 -72.62 0.71 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.49 -55.68 23.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.257 0.623 . . . . 0.0 111.899 -173.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.96 -50.18 73.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -47.19 -50.13 21.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.891 0.476 . . . . 0.0 110.762 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.37 -58.35 8.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.118 0.567 . . . . 0.0 111.147 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.47 -19.4 63.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.561 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.18 49.2 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.751 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 57.56 65.76 1.28 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.026 1.413 . . . . 0.0 109.837 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 68.13 1.86 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 109.839 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.01 -51.79 35.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -163.48 22.59 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.38 1.872 . . . . 0.0 109.487 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -69.31 144.47 94.83 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 121.865 -0.522 . . . . 0.0 111.674 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.81 92.39 0.52 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.539 1.493 . . . . 0.0 108.844 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.5 111.65 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.52 123.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.3 104.22 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.832 0.853 . . . . 0.0 110.282 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.97 90.55 5.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.274 1.03 . . . . 0.0 109.395 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.11 113.35 18.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -139.55 146.89 40.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . 0.602 ' HB1' ' CE2' ' A' ' 35' ' ' TRP . . . -77.58 107.48 10.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.8 m -58.44 -36.65 73.98 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.795 0.725 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . 0.602 ' CE2' ' HB1' ' A' ' 33' ' ' ALA . 37.1 p-90 -60.91 -32.39 71.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.466 0.706 . . . . 0.0 110.572 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -78.89 77.08 5.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.58 -54.09 2.84 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.524 1.059 . . . . 0.0 112.184 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.49 -45.49 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.094 2.529 . . . . 0.0 112.75 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.16 -45.56 90.67 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -61.49 -13.01 17.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.753 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.92 -12.87 60.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 121.556 1.98 . . . . 0.0 111.128 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.79 -23.83 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 118.714 0.688 . . . . 0.0 109.306 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.55 -47.04 97.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.71 -1.244 . . . . 0.0 112.644 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.35 -35.43 73.07 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.347 1.874 . . . . 0.0 110.795 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.27 -46.26 89.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.75 -46.4 81.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.01 -41.97 88.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.567 0.747 . . . . 0.0 109.974 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -60.17 -44.83 94.72 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 49' ' ' LEU . 14.0 tp -62.51 -38.02 88.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.081 -0.387 . . . . 0.0 110.036 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.533 ' HB3' HG13 ' A' ' 4' ' ' VAL . 11.5 m -60.08 -48.67 80.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.401 0.68 . . . . 0.0 109.757 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -59.4 -45.19 92.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.944 0.497 . . . . 0.0 109.667 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.11 -56.77 17.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.734 0.414 . . . . 0.0 110.501 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -86.19 58.02 4.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.23 -20.73 66.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.649 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -149.44 0.05 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.591 1.567 . . . . 0.0 113.959 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 53.53 0.84 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 113.012 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.91 140.01 49.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.323 1.849 . . . . 0.0 106.183 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.1 mm -112.91 134.64 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -126.41 111.81 14.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.673 0.67 . . . . 0.0 110.04 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.59 147.21 37.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.307 1.443 . . . . 0.0 108.949 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -118.23 144.14 46.0 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.93 126.29 37.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -83.88 117.76 23.53 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.8 72.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 177.69 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.543 2.737 . . . . 0.0 105.759 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.02 65.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.457 0.303 . . . . 0.0 110.414 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.16 39.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.57 -49.59 26.12 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.224 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.21 -47.43 62.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.462 0.705 . . . . 0.0 112.252 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.49 -46.7 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.46 78.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.061 0.458 . . . . 0.0 110.271 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -57.46 -58.92 6.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.25 1.02 . . . . 0.0 109.519 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.9 73.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.814 0.446 . . . . 0.0 111.23 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.04 -17.89 63.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.707 0.803 . . . . 0.0 111.578 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 44.27 13.69 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.71 0.671 . . . . 0.0 111.436 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.0 mm -74.37 139.72 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.4 p -124.52 -85.08 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.509 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.67 86.3 6.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.434 1.094 . . . . 0.0 111.402 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -62.64 145.01 95.78 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.462 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.91 153.05 72.97 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.62 1.257 . . . . 0.0 111.634 -2.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -145.38 114.69 7.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.52 119.74 35.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.593 1.157 . . . . 0.0 109.382 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -111.2 134.9 52.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.99 109.44 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.76 97.64 7.44 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.658 0.383 . . . . 0.0 111.788 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -90.3 -165.22 1.3 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 89' ' ' VAL . 19.3 p-10 -69.63 -36.68 76.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 169.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.5 41.37 1.16 Allowed Glycine 0 CA--C 1.543 1.808 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 166.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.333 25.3 m 20.89 -134.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.448 1 C-N-CA 133.008 4.523 . . . . 0.0 113.482 -178.105 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -58.18 79.06 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.338 1.455 . . . . 0.0 109.032 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -29.21 39.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.41 1.084 . . . . 0.0 111.589 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -158.34 157.4 32.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -147.05 158.87 44.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.0 tp -155.52 109.58 2.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 109.882 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.68 168.54 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 110.562 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.66 178.43 40.4 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.388 0.518 . . . . 0.0 112.208 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.74 -59.04 4.98 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 110.196 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 33.49 21.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.0 3.32 . . . . 0.0 119.237 171.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 4.0 pm0 -51.51 -40.59 59.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.279 1.4 . . . . 0.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.69 -36.42 69.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.848 -0.533 . . . . 0.0 111.203 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.66 -38.23 26.23 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.2 tp -45.81 -51.33 13.01 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.36 0.664 . . . . 0.0 109.508 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -41.5 -52.87 3.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 0.0 111.759 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.68 79.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.45 1.1 . . . . 0.0 110.725 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -49.12 79.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.6 t -57.83 -46.99 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.29 -53.26 46.4 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -54.98 -62.33 1.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.221 1.008 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -62.65 -22.21 66.28 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.72 -5.15 54.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.79 0.723 . . . . 0.0 112.126 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 0.466 0 CA-C-N 119.831 1.196 . . . . 0.0 111.328 179.457 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 m . . . . . 0 N--CA 1.444 -0.737 0 CA-C-O 120.3 0.095 . . . . 0.0 110.983 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.7 26.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.335 1.854 . . . . 0.0 108.719 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 pp -97.94 175.31 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.66 122.69 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.24 2.216 . . . . 0.0 108.051 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 tt -160.63 151.32 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.772 0.714 . . . . 0.0 109.666 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -74.75 72.61 2.02 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -55.56 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 129.233 3.013 . . . . 0.0 115.556 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -93.78 -94.86 0.16 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.906 1.282 . . . . 0.0 109.596 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.73 77.06 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.453 -1.404 . . . . 0.0 109.314 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.9 69.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.14 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -50.29 71.83 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.48 1.037 . . . . 0.0 108.402 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -48.75 79.67 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.66 -49.39 75.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.386 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.57 64.68 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.554 0.742 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -49.42 -54.54 16.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 -62.36 1.74 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.924 0.489 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -59.61 -29.03 67.71 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.423 0.556 . . . . 0.0 111.103 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.41 67.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.091 -1.394 . . . . 0.0 112.916 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.33 55.01 10.13 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.995 1.398 . . . . 0.0 108.754 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -38.75 -31.57 0.06 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.56 3.144 . . . . 0.0 116.377 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -9.06 -74.09 0.0 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 129.464 3.106 . . . . 0.0 111.208 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -138.83 74.07 1.46 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -165.51 121.98 1.03 Allowed Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 133.98 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.057 1.838 . . . . 0.0 113.76 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.35 102.21 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 101.203 -3.628 . . . . 0.0 101.203 169.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 t -99.95 120.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.68 104.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 124.935 1.294 . . . . 0.0 110.636 -173.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -83.46 95.73 8.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.301 1.44 . . . . 0.0 107.925 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -80.19 122.81 27.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -146.51 168.24 21.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.66 114.85 23.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.895 0.77 . . . . 0.0 108.95 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -43.36 -57.0 3.24 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.193 1.397 . . . . 0.0 113.128 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -59.19 -30.67 68.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.076 0.551 . . . . 0.0 112.192 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.9 t -76.06 84.71 2.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.24 -59.73 0.76 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.95 1.262 . . . . 0.0 112.942 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.7 -40.6 79.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.163 2.575 . . . . 0.0 113.025 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -67.1 -43.95 81.23 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -62.77 -43.3 99.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.998 0.519 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.6 mmm -58.99 -17.49 25.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt -79.14 -24.45 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 119.193 0.906 . . . . 0.0 109.79 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.36 -55.05 41.4 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 117.453 -1.26 . . . . 0.0 112.272 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.73 94.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.205 1.937 . . . . 0.0 111.686 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.98 -52.9 63.76 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -60.54 -37.47 81.31 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.717 -0.615 . . . . 0.0 109.898 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.35 -35.52 75.85 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.297 -0.877 . . . . 0.0 109.861 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -61.23 -47.49 85.81 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.89 -39.63 90.02 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -55.89 -51.98 65.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.868 0.467 . . . . 0.0 109.857 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -39.9 94.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.159 0.584 . . . . 0.0 109.888 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.02 -46.54 85.12 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.031 0.532 . . . . 0.0 111.35 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -79.65 -53.17 7.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 -56.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.161 2.184 . . . . 0.0 115.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.49 -116.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.823 2.154 . . . . 0.0 115.688 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -40.4 -45.37 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.14 136.97 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 O-C-N 122.209 -0.307 . . . . 0.0 110.189 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.22 125.81 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -112.72 143.86 43.23 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.64 118.67 7.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.593 -167.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -106.28 118.2 36.02 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.85 134.4 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.389 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -85.39 106.66 16.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.424 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.41 -38.99 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 126.473 1.909 . . . . 0.0 109.791 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.96 -34.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.076 0.151 . . . . 0.0 111.29 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.65 -72.25 0.44 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.17 61.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 121.502 -0.749 . . . . 0.0 110.495 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.49 -41.25 53.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.501 0.72 . . . . 0.0 109.9 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.46 68.66 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.13 0.972 . . . . 0.0 111.112 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.11 -45.98 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -54.81 38.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.859 0.464 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.12 -40.09 82.61 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 110.646 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.07 89.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.521 0.601 . . . . 0.0 110.215 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.02 95.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.288 0.635 . . . . 0.0 109.833 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.01 47.09 0.73 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.58 1.086 . . . . 0.0 112.583 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.07 132.22 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.7 p -112.31 -76.79 0.59 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.31 149.39 22.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.512 1.125 . . . . 0.0 108.89 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.69 143.37 33.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -72.26 170.6 66.89 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 C-N-CA 125.144 -0.773 . . . . 0.0 112.588 -1.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 129.68 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -106.1 118.09 35.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.962 1.305 . . . . 0.0 110.58 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -112.38 144.21 42.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 118.824 0.738 . . . . 0.0 110.195 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.39 124.16 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.21 60.78 0.69 Allowed 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 124.763 1.289 . . . . 0.0 110.803 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -71.11 149.15 46.74 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.72 -52.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.248 1.819 . . . . 0.0 112.265 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.37 -57.93 0.22 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.76 164.04 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.106 0.563 . . . . 0.0 109.569 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -56.64 104.01 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.98 -39.65 29.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.097 0.959 . . . . 0.0 110.711 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -161.0 168.01 25.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.06 177.49 10.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.37 0.532 . . . . 0.0 109.914 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 tp -162.54 110.85 1.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.079 1.352 . . . . 0.0 109.404 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.1 161.61 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 0.0 110.989 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.6 -177.91 54.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.605 0.622 . . . . 0.0 112.601 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.18 34.99 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 109.307 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 m 30.82 46.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 115.124 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -59.15 -44.23 92.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 112.246 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -54.52 -53.6 52.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.45 0.7 . . . . 0.0 110.388 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.73 -37.1 76.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.1 tp -53.85 -51.96 61.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -52.39 -48.58 65.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.02 0.373 . . . . 0.0 110.18 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.24 86.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.232 0.213 . . . . 0.0 110.699 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.46 -50.49 67.27 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.66 -0.65 . . . . 0.0 110.37 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.57 -47.35 48.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.34 78.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.302 0.376 . . . . 0.0 111.207 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -49.14 -54.58 15.63 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.328 1.051 . . . . 0.0 110.77 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -75.93 -46.97 27.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.625 0.25 . . . . 0.0 111.454 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.31 -32.79 73.17 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.606 1.162 . . . . 0.0 113.179 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.534 0.345 0 C-N-CA 124.877 1.271 . . . . 0.0 108.881 -173.935 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.66 94.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 pt -152.75 169.12 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.874 0.845 . . . . 0.0 110.861 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.27 149.02 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -150.42 155.4 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 119.329 0.968 . . . . 0.0 110.471 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -137.7 36.3 2.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.958 1.303 . . . . 0.0 111.455 -175.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 m -157.28 127.01 6.14 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.164 -0.96 . . . . 0.0 111.162 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -51.85 -45.67 64.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.353 1.061 . . . . 0.0 110.428 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.15 59.6 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.212 0.53 . . . . 0.0 110.481 -178.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.32 90.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -52.19 65.73 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -64.49 -45.41 87.46 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.103 -178.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.47 65.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.969 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.87 -50.09 75.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.566 0.746 . . . . 0.0 110.256 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -46.94 -49.76 20.06 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.703 0.401 . . . . 0.0 109.927 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -65.97 0.61 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -58.77 -31.04 68.02 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.605 -0.685 . . . . 0.0 111.848 -174.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.5 -24.67 39.59 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.35 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 45.98 8.38 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.125 1.37 . . . . 0.0 109.911 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.64 40.0 0.36 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -174.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -15.2 -63.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.727 2.811 . . . . 0.0 113.399 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -142.74 23.14 1.94 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.885 1.674 . . . . 0.0 109.112 177.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.87 153.15 37.9 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.589 0.756 . . . . 0.0 111.192 -171.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -71.76 133.14 21.4 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.845 1.697 . . . . 0.0 114.124 -177.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.21 116.65 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 100.964 -3.717 . . . . 0.0 100.964 167.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.4 t -102.64 111.44 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -174.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.56 136.77 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.15 89.84 3.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 168.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.44 99.0 7.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 m -136.13 151.74 50.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.789 1.636 . . . . 0.0 107.1 178.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.44 -178.82 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.988 0.915 . . . . 0.0 111.114 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 p -77.2 -63.33 1.39 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.678 1.591 . . . . 0.0 106.84 174.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -61.28 147.47 44.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.744 174.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.7 t 136.24 -59.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 129.212 3.005 . . . . 0.0 107.766 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.28 -92.87 1.02 Allowed Glycine 0 CA--C 1.53 1.025 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.07 -40.73 15.83 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.971 3.114 . . . . 0.0 113.523 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -44.64 -43.52 8.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.577 1.151 . . . . 0.0 110.905 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -58.59 -33.75 70.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.596 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.35 -18.93 65.7 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -177.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.1 mp -76.99 -27.33 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.96 -57.04 13.72 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.474 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.37 -41.2 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.904 1.716 . . . . 0.0 112.016 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.4 -51.6 69.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.752 0.787 . . . . 0.0 109.493 178.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.6 -49.15 75.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.236 1.014 . . . . 0.0 109.835 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.79 -41.22 90.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.828 0.851 . . . . 0.0 110.792 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -57.41 -50.6 72.48 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.39 -44.77 89.11 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 121.051 0.453 . . . . 0.0 110.227 176.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -50.98 -46.23 61.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.231 0.612 . . . . 0.0 111.162 -177.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -54.14 -30.47 49.17 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.85 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.09 -52.34 36.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.77 0.714 . . . . 0.0 111.221 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -90.95 -13.37 33.58 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -19.37 -61.85 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 129.192 2.997 . . . . 0.0 115.69 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -50.51 -47.77 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.415 0.531 . . . . 0.0 111.831 -177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -86.16 -60.3 2.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.238 0.615 . . . . 0.0 110.498 -178.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -88.02 146.48 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.431 2.292 . . . . 0.0 112.825 -169.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.49 146.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -135.42 113.61 11.36 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.69 101.28 7.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.51 1.124 . . . . 0.0 111.189 -175.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -79.85 94.63 5.85 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.1 t -79.39 117.91 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -67.93 102.22 1.23 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.28 -34.23 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.499 1.12 . . . . 0.0 110.477 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.76 -28.0 69.68 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.337 0.255 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 -65.87 0.94 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.569 0.748 . . . . 0.0 110.856 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.01 60.71 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.879 0.847 . . . . 0.0 110.172 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.5 76.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.906 0.882 . . . . 0.0 110.526 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.64 -55.85 22.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 111.867 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -44.78 98.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.73 38.15 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.653 0.263 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.71 -41.17 88.39 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.217 -0.927 . . . . 0.0 110.491 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.49 92.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.548 0.613 . . . . 0.0 110.531 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.02 77.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.003 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.52 48.61 1.28 Allowed Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.661 1.124 . . . . 0.0 111.508 175.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.8 136.35 23.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.2 p -140.18 -76.65 0.33 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.0 0.92 . . . . 0.0 108.656 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.44 73.6 1.39 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.547 1.139 . . . . 0.0 110.577 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.08 138.75 96.29 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -64.78 130.52 10.66 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 CA-C-N 121.068 1.417 . . . . 0.0 112.731 -0.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.5 m -120.62 105.0 10.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.07 132.08 34.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -124.25 150.06 45.75 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.78 113.09 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.77 125.54 54.11 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.36 112.57 20.04 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 176.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 69.71 -64.03 0.36 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.984 2.514 . . . . 0.0 109.161 -173.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.95 7.21 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.975 1.75 . . . . 0.0 112.468 177.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.18 117.09 44.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-N 118.996 1.398 . . . . 0.0 107.526 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -56.48 111.2 0.93 Allowed 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.81 -32.21 10.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.341 1.057 . . . . 0.0 111.154 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.55 172.36 17.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.833 0.288 . . . . 0.0 110.53 -177.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -160.46 168.39 25.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.813 1.245 . . . . 0.0 108.856 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 tp -167.87 120.36 0.88 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.804 0.842 . . . . 0.0 109.603 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.4 163.28 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.239 0.616 . . . . 0.0 111.312 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.5 174.85 46.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.716 1.15 . . . . 0.0 111.951 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.32 43.35 0.37 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 110.72 178.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 m -79.35 54.12 1.64 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.926 1.69 . . . . 0.0 110.287 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -36.51 63.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.019 0.927 . . . . 0.0 112.445 -175.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -61.44 -51.58 68.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.533 0.733 . . . . 0.0 109.861 177.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -68.43 -32.97 73.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.09 -56.22 24.54 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -50.61 -50.61 53.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.111 0.564 . . . . 0.0 110.403 177.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.55 71.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.42 -48.17 82.42 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.787 -0.571 . . . . 0.0 110.378 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.7 t -54.92 -51.05 57.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.78 -51.19 61.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.436 0.295 . . . . 0.0 110.926 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -53.87 -66.66 0.36 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.041 0.924 . . . . 0.0 110.507 178.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -59.33 -31.71 69.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.409 -174.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.09 -2.64 28.46 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.489 0 CA-C-N 119.965 1.257 . . . . 0.0 111.277 179.733 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.538 0.507 0 CA-C-O 121.609 0.719 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 50' ' ' SER . 76.3 t -79.38 85.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -144.91 167.29 10.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.541 0.686 . . . . 0.0 111.287 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 7.8 p -111.85 134.7 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 174.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -153.61 162.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.913 0.863 . . . . 0.0 110.475 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -126.95 11.73 7.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.134 1.774 . . . . 0.0 112.648 -173.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -124.28 114.45 19.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.786 0.435 . . . . 0.0 111.65 -174.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -47.82 -40.59 21.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.006 1.322 . . . . 0.0 111.775 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.1 70.23 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.089 0.955 . . . . 0.0 111.058 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.31 74.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.936 -0.478 . . . . 0.0 109.802 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -50.86 68.09 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.09 -49.79 76.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.99 0.916 . . . . 0.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.41 -57.02 11.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.001 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -54.51 -44.8 73.04 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.539 0.736 . . . . 0.0 110.221 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -23.2 2.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.012 0.925 . . . . 0.0 112.046 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.47 -68.38 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 110.636 175.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -61.91 -23.0 66.05 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -171.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.57 -12.53 64.21 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.986 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 59.9 69.1 0.73 Allowed 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.53 2.13 23.27 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.176 -172.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -10.24 -65.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 129.742 3.217 . . . . 0.0 113.602 -176.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -146.39 57.27 1.18 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -118.48 136.61 24.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.021 . . . . 0.0 109.274 -177.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.25 114.87 4.14 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.146 1.898 . . . . 0.0 110.743 177.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.38 98.33 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 171.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.42 116.72 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.07 114.92 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 117.964 0.347 . . . . 0.0 110.296 -176.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 8.8 t0 -92.65 85.7 5.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 172.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.69 105.83 11.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -166.12 -159.79 0.4 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.754 0.706 . . . . 0.0 112.22 -171.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 64.1 -135.27 0.32 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 112.563 172.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p 54.61 -107.43 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.083 1.753 . . . . 0.0 109.537 -175.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -72.8 -26.63 61.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.919 0.487 . . . . 0.0 111.451 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.16 82.78 1.81 Allowed 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.53 -0.731 . . . . 0.0 111.056 -175.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 -56.63 8.27 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.976 0.798 . . . . 0.0 111.972 176.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.74 -37.07 64.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.977 2.451 . . . . 0.0 113.447 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.7 m -59.24 -26.0 64.52 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.609 0.364 . . . . 0.0 111.032 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -58.8 -20.63 51.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.498 0.59 . . . . 0.0 110.932 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.6 mmt -82.73 -31.3 28.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.812 0.733 . . . . 0.0 110.697 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.69 -33.5 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.83 -59.41 4.71 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.256 1.022 . . . . 0.0 113.168 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -59.76 -38.57 79.74 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.182 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.75 -54.16 45.65 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 30' ' ' ASP . 49.9 t80 -57.91 -41.12 81.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.132 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -57.19 -37.41 72.13 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.728 -0.653 . . . . 0.0 112.381 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -59.87 -51.92 67.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.447 1.476 . . . . 0.0 110.002 178.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -57.87 -41.42 82.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.461 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.6 m -52.72 -54.95 26.58 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -41.17 86.16 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.325 0.65 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.14 -53.92 52.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.128 0.571 . . . . 0.0 111.429 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -81.05 -21.42 40.11 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -21.45 110.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.504 2.322 . . . . 0.0 115.713 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.01 -71.08 0.39 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 174.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.35 24.84 2.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.945 0.898 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.42 161.12 4.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.801 1.64 . . . . 0.0 107.951 -174.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 93.79 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.99 94.97 10.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.257 0.623 . . . . 0.0 109.801 -178.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 111.93 23.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.009 1.323 . . . . 0.0 110.754 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.9 mtpp -91.65 109.34 20.65 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 174.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.62 122.49 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.08 81.13 3.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.8 m -39.92 -47.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 126.988 2.115 . . . . 0.0 114.176 -176.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.23 -40.57 67.82 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.039 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.57 -48.59 14.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 70' ' ' VAL . 95.1 t -80.95 51.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.241 1.02 . . . . 0.0 108.849 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.69 -58.13 9.4 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.841 1.656 . . . . 0.0 112.857 -173.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.12 -52.0 54.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -176.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 67' ' ' VAL . 84.0 t -62.91 -48.38 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.25 69.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.412 0.285 . . . . 0.0 110.283 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.63 -56.62 19.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.219 1.008 . . . . 0.0 110.007 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.8 -41.26 73.89 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.444 0.298 . . . . 0.0 111.118 -178.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 3.29 19.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.332 1.053 . . . . 0.0 111.905 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.1 41.8 94.8 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.011 -1.056 . . . . 0.0 113.412 176.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.7 137.62 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 p -148.9 -80.24 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.57 78.3 1.47 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.15 0.98 . . . . 0.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.73 139.43 88.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.73 132.38 22.06 Favored 'Cis proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.479 1.207 . . . . 0.0 110.595 -1.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 m -109.27 111.89 23.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -99.61 108.27 20.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.21 1.004 . . . . 0.0 109.197 -177.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -107.87 160.82 15.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.98 0.809 . . . . 0.0 109.891 177.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.02 110.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.42 108.4 19.72 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 175.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -83.97 109.56 17.72 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 71.4 -60.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.811 2.044 . . . . 0.0 110.807 -176.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.41 -41.0 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.219 1.39 . . . . 0.0 111.344 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.59 134.53 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.131 0.966 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -66.55 101.9 0.83 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.51 -32.43 25.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.111 0.964 . . . . 0.0 111.336 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.82 169.08 25.42 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -144.11 161.14 39.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.728 2.011 . . . . 0.0 107.285 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 tp -174.05 152.93 1.98 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.85 165.18 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 110.138 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 -179.08 39.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.184 0.897 . . . . 0.0 111.833 177.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.73 44.24 0.36 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.862 0.865 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m -81.22 61.37 4.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 109.688 -176.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.09 -42.73 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.922 0.889 . . . . 0.0 112.034 -175.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -57.82 -50.33 73.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.06 177.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -66.19 -40.32 90.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.27 -55.25 30.04 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.8 -51.28 61.42 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.442 0.297 . . . . 0.0 110.2 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.26 74.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.339 0.256 . . . . 0.0 111.298 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.82 -49.04 74.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.262 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.22 -54.33 18.26 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.6 -55.0 21.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.579 0.351 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.93 -64.78 0.71 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.463 0.705 . . . . 0.0 110.988 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -66.51 -19.98 65.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.086 0.954 . . . . 0.0 112.601 -173.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.02 -40.09 22.59 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.602 -0.686 . . . . 0.0 109.246 174.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.217 0 C-N-CA 123.383 0.673 . . . . 0.0 112.147 -178.302 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.446 -0.636 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.32 29.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.777 2.031 . . . . 0.0 108.202 174.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.02 170.94 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -169.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.71 13.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.333 1.853 . . . . 0.0 111.404 178.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.06 73.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.69 -17.8 64.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.834 -174.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -38.13 117.59 0.62 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.413 1.485 . . . . 0.0 110.601 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 13' ' ' TRP . 20.3 ptmt -39.42 -44.04 1.3 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -51.07 71.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.467 0.651 . . . . 0.0 110.328 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.224 1.01 . . . . 0.0 109.697 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -48.16 -61.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.268 1.427 . . . . 0.0 108.483 175.291 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -55.82 -50.23 71.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.703 0.401 . . . . 0.0 110.286 -178.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.19 77.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.424 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -63.55 -47.34 81.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.294 1.038 . . . . 0.0 109.369 -177.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -56.96 -55.47 34.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.63 -58.82 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.989 0.516 . . . . 0.0 112.067 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -65.89 -14.2 61.06 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.646 -0.658 . . . . 0.0 111.457 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.52 -24.1 70.77 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.395 -1.225 . . . . 0.0 111.917 177.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 57.55 73.02 0.48 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.607 1.163 . . . . 0.0 109.319 -179.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.39 52.14 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.631 2.372 . . . . 0.0 113.35 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.57 -59.77 3.33 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.519 -0.738 . . . . 0.0 109.158 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.14 95.42 1.61 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -167.43 139.17 2.59 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 126.02 8.51 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.8 1.667 . . . . 0.0 111.525 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.4 mp -88.98 94.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 102.197 -3.261 . . . . 0.0 102.197 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.8 110.37 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -176.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.73 130.23 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.552 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -92.83 95.92 9.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.952 2.501 . . . . 0.0 106.985 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -88.86 100.53 13.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -127.47 -162.39 1.16 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.22 1.008 . . . . 0.0 108.369 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.24 117.71 2.87 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 120.155 1.343 . . . . 0.0 113.341 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -36.66 -46.79 0.61 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.498 1.519 . . . . 0.0 110.423 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -48.29 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.315 1.446 . . . . 0.0 113.685 177.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.24 35.34 1.62 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.221 0.464 . . . . 0.0 111.808 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 25.24 -88.35 0.01 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 128.411 2.91 . . . . 0.0 115.234 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -42.05 -40.77 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.869 3.046 . . . . 0.0 113.837 177.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.62 -36.97 79.93 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.711 0.404 . . . . 0.0 110.571 178.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -77.08 -31.16 55.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.845 0.858 . . . . 0.0 109.309 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -63.85 -4.1 2.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.061 0.544 . . . . 0.0 112.366 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.24 -23.87 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.222 0.919 . . . . 0.0 108.79 171.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.02 -53.84 43.89 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 120.89 -1.131 . . . . 0.0 112.339 177.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.15 -30.45 91.39 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.944 1.763 . . . . 0.0 111.982 176.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.58 -48.44 66.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.16 -35.07 69.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.404 1.081 . . . . 0.0 110.404 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -50.26 -34.01 21.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 110.418 176.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -57.67 -54.93 41.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 -41.61 99.18 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -49.14 -54.64 15.33 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -56.15 -57.72 10.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.734 0.814 . . . . 0.0 109.73 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -49.7 -44.21 47.96 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.267 1.027 . . . . 0.0 112.474 -174.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -95.39 -1.76 50.39 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.23 136.09 25.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.33 0.968 . . . . 0.0 111.461 -177.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.02 -67.01 0.53 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -81.43 -50.93 8.86 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 122.124 -0.633 . . . . 0.0 110.544 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.93 174.34 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.386 1.074 . . . . 0.0 112.75 -169.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 mm -129.92 94.7 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 174.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.94 138.87 31.1 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.93 126.24 23.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.74 0.816 . . . . 0.0 110.932 -174.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -100.65 119.93 39.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.74 134.98 64.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 123.014 0.526 . . . . 0.0 111.377 -176.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.23 95.61 7.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.117 1.367 . . . . 0.0 107.352 177.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -49.1 -41.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.978 2.511 . . . . 0.0 110.892 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.19 -22.34 66.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.8 0.84 . . . . 0.0 111.421 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.96 -72.4 0.65 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.936 0.894 . . . . 0.0 108.997 175.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 63.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.956 1.36 . . . . 0.0 109.392 -177.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.55 81.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.869 177.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.92 -43.38 18.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.568 1.547 . . . . 0.0 112.037 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.9 t -75.29 -57.39 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -43.66 -52.08 6.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.347 1.059 . . . . 0.0 113.293 -175.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.54 -35.01 69.76 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.81 20.93 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.81 -45.93 90.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.497 1.119 . . . . 0.0 111.741 -178.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.38 79.96 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.54 151.88 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.726 1.21 . . . . 0.0 108.37 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.9 p -119.89 -109.39 0.35 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 132.37 35.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -76.13 131.95 74.61 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -78.6 138.08 48.42 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.034 1.048 . . . . 0.0 112.789 -1.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.5 m -111.71 115.51 29.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 167.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 102' ' ' LEU . 55.2 m-85 -95.88 130.2 42.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 108.545 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -122.62 150.37 42.74 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.08 113.33 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.022 1.329 . . . . 0.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -107.39 137.46 45.39 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -90.82 -100.2 0.11 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.863 1.21 . . . . 0.0 110.279 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.25 -42.55 66.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.862 1.315 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.0 -27.33 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.07 2.271 . . . . 0.0 109.726 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.11 135.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.529 1.165 . . . . 0.0 110.893 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -52.18 112.43 0.8 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.225 1.81 . . . . 0.0 107.759 172.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.72 -41.02 7.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.135 1.374 . . . . 0.0 112.64 -174.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -151.14 161.29 42.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -150.77 169.01 22.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.175 0.99 . . . . 0.0 109.484 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -159.9 158.42 30.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 106.981 177.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.66 157.27 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.89 -164.69 51.85 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 -80.0 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.245 0.618 . . . . 0.0 110.717 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m 36.11 57.9 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.975 2.11 . . . . 0.0 113.59 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -46.86 -42.41 17.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.14 1.376 . . . . 0.0 111.862 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -57.91 -53.81 53.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.946 0.898 . . . . 0.0 110.44 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -64.09 -40.97 97.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 82' ' ' PHE . 1.6 tt -52.13 -53.97 36.32 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.262 1.025 . . . . 0.0 108.484 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.72 -50.14 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.583 0.353 . . . . 0.0 110.083 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.89 64.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.889 0.476 . . . . 0.0 110.666 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.31 -58.62 6.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.5 -51.67 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 123.215 0.606 . . . . 0.0 110.685 -177.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.71 -38.35 6.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.383 1.073 . . . . 0.0 112.424 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 109' ' ' HIS . 6.2 ptmt -64.3 -37.91 89.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.44 0.564 . . . . 0.0 111.358 -178.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 108' ' ' LYS . 80.7 m-70 -84.45 -49.15 8.92 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.95 0.9 . . . . 0.0 110.221 -178.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.07 96.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.454 2.301 . . . . 0.0 111.939 -177.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.533 0.307 0 C-N-CA 125.733 1.613 . . . . 0.0 109.31 -175.119 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.05 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.8 77.04 0.07 OUTLIER Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.699 1.142 . . . . 0.0 113.853 -176.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.9 m -71.96 72.99 0.86 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 117.987 0.894 . . . . 0.0 108.797 173.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 15.7 m -78.6 35.98 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 C-N-CA 126.114 1.765 . . . . 0.0 112.968 -174.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.0 pt -107.14 171.05 2.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 C-N-CA 124.415 1.086 . . . . 0.0 112.017 -176.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 p -94.96 143.69 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.45 0 C-N-CA 125.101 1.36 . . . . 0.0 107.415 175.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.428 HD12 ' HA ' ' A' ' 7' ' ' ILE . 8.9 tp -147.56 155.09 10.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 CA-C-O 121.195 0.521 . . . . 0.0 111.013 -177.444 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.1 p-10 -136.23 32.58 2.86 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.32 1.448 . . . . 0.0 112.0 -175.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 35.7 t -152.57 139.04 18.59 Favored 'General case' 0 C--N 1.339 0.135 0 CA-C-O 121.961 0.886 . . . . 0.0 111.805 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.03 -42.53 80.6 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 126.347 1.859 . . . . 0.0 111.115 176.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.67 -47.43 86.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.537 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.99 -35.68 76.98 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.383 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -56.45 -49.96 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.307 -0.998 . . . . 0.0 108.307 173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -60.17 -50.14 74.84 Favored 'General case' 0 C--O 1.231 0.111 0 CA-C-O 121.782 0.801 . . . . 0.0 110.58 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.52 -56.65 13.74 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.801 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -56.16 -50.84 70.01 Favored 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 123.383 0.673 . . . . 0.0 110.93 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 14.3 tp -44.9 -47.85 11.22 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.502 0.721 . . . . 0.0 109.59 175.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -70.94 -64.82 0.83 Allowed 'General case' 0 CA--C 1.537 0.445 0 N-CA-C 112.251 0.463 . . . . 0.0 112.251 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.0 pttt -59.93 -21.94 61.79 Favored 'General case' 0 N--CA 1.471 0.589 0 O-C-N 121.323 -0.861 . . . . 0.0 111.786 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.54 -25.96 44.02 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 124.777 1.179 . . . . 0.0 111.231 176.229 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm 62.41 50.72 3.59 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 125.323 1.449 . . . . 0.0 107.398 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -50.53 -31.91 16.93 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 127.192 2.197 . . . . 0.0 115.005 -172.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -15.05 -59.79 0.01 OUTLIER 'General case' 0 C--N 1.343 0.289 0 C-N-CA 128.888 2.875 . . . . 0.0 114.061 -175.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 13.5 t-160 -136.85 84.22 2.05 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 176.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -178.16 155.84 1.01 Allowed Pre-proline 0 CA--C 1.536 0.417 0 C-N-CA 123.952 0.901 . . . . 0.0 110.085 175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 75.1 Cg_endo -78.47 117.13 3.97 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 124.387 3.391 . . . . 0.0 114.179 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.402 HD13 HG21 ' A' ' 27' ' ' ILE . 56.8 mt -88.7 96.53 6.1 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 104.355 -2.461 . . . . 0.0 104.355 169.176 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 t -93.1 104.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.62 0 N-CA-C 105.946 -1.872 . . . . 0.0 105.946 -179.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.2 p -100.88 131.73 47.95 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.427 0 N-CA-C 108.337 -0.986 . . . . 0.0 108.337 178.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -104.66 98.76 8.47 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 173.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -82.3 98.14 8.65 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 175.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.5 t -124.66 174.92 7.54 Favored 'General case' 0 C--O 1.225 -0.223 0 C-N-CA 124.835 1.254 . . . . 0.0 108.644 -178.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -138.5 169.92 16.93 Favored 'General case' 0 C--N 1.333 -0.109 0 CA-C-N 119.031 0.832 . . . . 0.0 109.696 178.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.6 p -71.25 -70.11 0.33 Allowed 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 125.272 1.429 . . . . 0.0 110.371 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 5.4 p-90 -50.55 -30.17 12.44 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.298 2.239 . . . . 0.0 115.358 -174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.6 p -76.04 61.58 1.55 Allowed 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 119.902 1.228 . . . . 0.0 112.728 -176.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 10.26 -84.6 0.0 OUTLIER Glycine 0 CA--C 1.535 1.294 0 C-N-CA 128.83 3.11 . . . . 0.0 115.601 177.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -39.81 -39.44 2.15 Favored 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 124.875 3.716 . . . . 0.0 114.203 178.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 62.8 m -44.11 -44.22 7.46 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.92 1.688 . . . . 0.0 111.286 175.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -61.86 -26.17 67.98 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.176 0.99 . . . . 0.0 112.11 -179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -91.02 -40.84 11.43 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.179 1.392 . . . . 0.0 109.756 177.714 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 73.2 mt -59.52 -39.71 80.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 123.431 0.692 . . . . 0.0 109.617 179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.75 -61.54 6.13 Favored Pre-proline 0 CA--C 1.548 0.876 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.832 176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -60.62 -29.78 89.17 Favored 'Trans proline' 0 C--N 1.349 0.592 0 C-N-CA 122.919 2.412 . . . . 0.0 112.284 178.132 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.83 -58.2 9.58 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 174.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.0 t80 -57.23 -32.36 66.46 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 123.93 0.892 . . . . 0.0 110.556 177.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -55.23 -33.86 63.47 Favored 'General case' 0 CA--C 1.535 0.38 0 O-C-N 121.537 -0.727 . . . . 0.0 110.148 175.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.7 m -59.02 -53.53 57.34 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 178.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 34.9 mt -59.6 -39.6 84.74 Favored 'General case' 0 N--CA 1.456 -0.157 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 178.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.414 ' HA ' ' CD1' ' A' ' 59' ' ' PHE . 8.5 m -56.25 -51.49 67.96 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.714 0.406 . . . . 0.0 110.477 178.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -56.06 -48.6 75.75 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.697 0.799 . . . . 0.0 110.269 177.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 47.2 m-20 -64.1 -61.32 2.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.269 0.556 . . . . 0.0 111.295 -175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -81.24 57.49 3.22 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.647 1.179 . . . . 0.0 110.125 -177.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.95 173.35 11.33 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.521 -0.737 . . . . 0.0 111.15 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 72.41 -65.98 1.31 Allowed Glycine 0 CA--C 1.531 1.081 0 C-N-CA 124.466 1.031 . . . . 0.0 114.686 173.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 64.4 tttp -82.63 -59.06 2.64 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 117.628 0.714 . . . . 0.0 111.04 -176.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.422 HG12 ' CE1' ' A' ' 59' ' ' PHE . 58.0 t -78.67 129.43 37.56 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 -171.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -102.68 104.08 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.422 ' CE1' HG12 ' A' ' 57' ' ' VAL . 33.8 m-85 -91.54 88.2 6.68 Favored 'General case' 0 N--CA 1.463 0.218 0 C-N-CA 123.956 0.902 . . . . 0.0 110.485 -178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 73.1 mt -83.91 99.67 10.51 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -179.029 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.2 mtmm -81.82 94.0 6.96 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 174.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 25.1 t -91.19 124.31 43.68 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 123.04 0.536 . . . . 0.0 110.018 -176.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -81.22 92.47 6.33 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.794 176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 62.7 t -50.36 -36.51 13.5 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.206 0 C-N-CA 126.683 1.993 . . . . 0.0 110.288 176.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 36.0 t0 -50.95 -37.84 46.92 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.372 0.669 . . . . 0.0 109.91 178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.8 -62.31 1.41 Allowed 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.072 0.949 . . . . 0.0 110.2 178.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.4 t -82.99 58.28 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 O-C-N 121.496 -0.753 . . . . 0.0 111.069 -174.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -58.13 -43.67 87.38 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.308 0.643 . . . . 0.0 110.769 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.59 -58.07 9.32 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.871 0.869 . . . . 0.0 111.894 -178.349 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 50.1 t -60.6 -42.59 92.2 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.132 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 -179.245 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.35 -55.92 27.52 Favored 'General case' 0 CA--C 1.54 0.57 0 N-CA-C 111.366 0.136 . . . . 0.0 111.366 179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.1 pp20? -65.05 -39.56 93.48 Favored 'General case' 0 CA--C 1.532 0.263 0 O-C-N 121.063 -1.023 . . . . 0.0 110.315 -178.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.98 -45.04 93.98 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 118.412 0.551 . . . . 0.0 110.512 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.94 -32.09 73.65 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.096 0.958 . . . . 0.0 109.887 177.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.22 40.51 1.93 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.683 1.135 . . . . 0.0 111.952 175.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.32 137.98 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 23.0 p -136.0 -83.72 0.38 Allowed 'General case' 0 N--CA 1.454 -0.242 0 N-CA-C 108.153 -1.054 . . . . 0.0 108.153 179.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.12 78.05 2.28 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.392 0.677 . . . . 0.0 109.802 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.6 143.14 93.92 Favored Pre-proline 0 CA--C 1.546 0.796 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 176.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 70.5 Cg_endo -76.99 143.81 76.69 Favored 'Cis proline' 0 N--CA 1.447 -1.258 0 CA-C-N 119.651 0.911 . . . . 0.0 110.453 -0.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 21.2 m -126.68 119.54 27.23 Favored 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -100.08 129.28 46.11 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.393 1.077 . . . . 0.0 109.433 -178.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 40.7 m170 -124.09 147.23 48.06 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 175.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -114.69 91.72 1.87 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.272 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 178.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -84.43 64.73 8.55 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 177.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 63.7 tttm -61.03 138.52 58.19 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 39.4 m-20 72.98 -54.84 0.69 Allowed 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 126.807 2.043 . . . . 0.0 110.268 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.85 25.15 0.02 OUTLIER Glycine 0 CA--C 1.529 0.92 0 C-N-CA 125.497 1.523 . . . . 0.0 111.686 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -156.12 138.57 6.52 Favored 'Isoleucine or valine' 0 C--N 1.342 0.251 0 CA-C-N 119.236 1.518 . . . . 0.0 109.231 -179.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.3 ttpp -46.73 91.07 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.207 2.203 . . . . 0.0 110.88 177.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.86 -30.35 21.5 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.397 1.079 . . . . 0.0 111.632 -176.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 8.0 t0 -154.95 164.22 39.2 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 -177.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -147.29 164.02 34.55 Favored 'General case' 0 N--CA 1.46 0.05 0 C-N-CA 124.364 1.066 . . . . 0.0 109.243 -179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.6 tm? -162.11 114.83 1.75 Allowed 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 125.045 1.338 . . . . 0.0 108.198 -177.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 24.0 t -95.56 157.43 3.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 CA-C-O 121.804 0.811 . . . . 0.0 110.261 -179.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.38 -174.65 53.47 Favored Glycine 0 CA--C 1.526 0.732 0 CA-C-N 114.632 -1.167 . . . . 0.0 110.897 177.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.29 -60.33 3.91 Favored 'General case' 0 CA--C 1.529 0.15 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 177.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.7 m 35.11 50.41 0.49 Allowed 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 127.093 2.157 . . . . 0.0 112.874 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 28.3 mm100 -47.01 -51.16 17.91 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 125.475 1.51 . . . . 0.0 113.353 -173.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -59.87 -47.25 86.49 Favored 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.797 -0.565 . . . . 0.0 111.269 -177.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.6 tptp -64.27 -41.23 97.02 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 53.2 tp -56.99 -54.84 42.17 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 8.4 mtpm? -50.93 -51.71 49.43 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 123.82 0.848 . . . . 0.0 109.945 177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.86 -49.51 70.93 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 122.905 0.482 . . . . 0.0 110.811 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 14.5 mt -62.26 -48.04 81.71 Favored 'General case' 0 C--N 1.338 0.087 0 CA-C-N 118.307 0.503 . . . . 0.0 110.891 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 81.1 t -53.81 -52.66 33.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.27 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.42 27.72 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 122.477 0.311 . . . . 0.0 110.815 179.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -50.29 -57.44 7.87 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.543 1.137 . . . . 0.0 111.225 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -74.42 -25.26 59.34 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.216 0.451 . . . . 0.0 112.216 -174.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.88 -48.13 40.02 Favored 'General case' 0 N--CA 1.457 -0.081 0 CA-C-N 118.796 0.726 . . . . 0.0 109.644 176.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -80.75 56.64 2.74 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 178.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 C-N-CA 125.239 1.416 . . . . 0.0 107.279 -178.193 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.856 0 N-CA-C 107.535 -2.226 . . . . 0.0 107.535 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -70.12 50.93 0.75 Allowed Glycine 0 CA--C 1.526 0.741 0 C-N-CA 125.917 1.723 . . . . 0.0 113.6 -177.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 14.6 m -80.61 85.57 5.99 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 123.911 0.884 . . . . 0.0 109.431 -177.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 92.0 t -83.38 97.09 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 pt -140.42 169.58 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-O 122.393 1.092 . . . . 0.0 112.699 -177.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.5 p -119.33 138.17 50.88 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.243 -2.503 . . . . 0.0 104.243 172.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.8 tp -151.11 152.14 11.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 CA-C-N 118.918 0.781 . . . . 0.0 111.226 -176.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -131.89 24.75 4.65 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.944 1.698 . . . . 0.0 112.415 -174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 29.1 t -149.33 142.45 24.96 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 119.158 0.89 . . . . 0.0 111.171 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -70.43 -36.55 74.06 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 125.563 1.545 . . . . 0.0 109.614 177.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.86 -49.46 75.42 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 176.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.69 -39.85 91.69 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 115.152 -0.931 . . . . 0.0 110.2 177.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.426 ' CZ3' HG11 ' A' ' 70' ' ' VAL . 20.6 t-105 -48.86 -58.16 5.28 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 175.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -59.32 -47.83 83.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 123.321 0.648 . . . . 0.0 110.532 -178.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.9 -47.32 71.26 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.614 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 11.4 tp-100 -64.11 -49.7 71.17 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mp -46.1 -47.99 17.21 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 123.696 0.798 . . . . 0.0 110.285 177.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -63.45 -64.74 0.82 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.492 0.317 . . . . 0.0 111.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.2 ptpp? -61.09 -24.74 66.46 Favored 'General case' 0 N--CA 1.467 0.403 0 O-C-N 121.719 -0.613 . . . . 0.0 112.634 -175.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.76 -20.46 64.14 Favored Glycine 0 CA--C 1.532 1.101 0 CA-C-O 118.462 -1.188 . . . . 0.0 112.322 177.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt 62.92 63.1 0.98 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 125.308 1.443 . . . . 0.0 108.751 -178.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 66.6 tt0 -75.25 62.32 1.25 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.892 1.277 . . . . 0.0 110.305 -179.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -67.58 -55.44 13.38 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 106.329 -1.73 . . . . 0.0 106.329 173.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -154.16 19.23 0.5 Allowed 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.665 1.586 . . . . 0.0 109.554 175.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.7 mmtm -78.59 133.81 62.48 Favored Pre-proline 0 N--CA 1.454 -0.257 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 -173.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -65.16 119.28 6.27 Favored 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 121.576 1.517 . . . . 0.0 112.498 -178.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.6 mt -99.12 101.94 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 N-CA-C 104.486 -2.413 . . . . 0.0 104.486 170.01 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.2 t -96.43 116.43 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.52 0 N-CA-C 106.061 -1.829 . . . . 0.0 106.061 -178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -111.14 128.8 67.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.06 96.17 7.05 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 125.465 1.506 . . . . 0.0 107.224 177.064 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.1 m-85 -86.15 94.01 9.17 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 23.8 m -131.69 117.42 18.62 Favored 'General case' 0 N--CA 1.462 0.169 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 178.337 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -64.18 140.06 58.83 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 117.895 0.316 . . . . 0.0 111.471 -177.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -50.11 -49.15 52.66 Favored 'General case' 0 N--CA 1.461 0.113 0 C-N-CA 124.112 0.965 . . . . 0.0 110.924 177.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 31.2 p-90 -68.98 -6.56 28.5 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 123.911 0.884 . . . . 0.0 113.29 -178.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.5 t -79.53 64.81 4.51 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -24.55 -79.88 0.01 OUTLIER Glycine 0 CA--C 1.531 1.062 0 C-N-CA 128.388 2.899 . . . . 0.0 115.748 -174.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -63.33 -36.91 53.28 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 122.436 2.091 . . . . 0.0 111.188 -178.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.31 -38.06 70.77 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 123.644 0.778 . . . . 0.0 109.248 -179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 53.4 tttm -53.42 -26.64 20.69 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 123.634 0.773 . . . . 0.0 111.889 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 59.2 mtt -62.42 -16.21 53.65 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 119.11 0.868 . . . . 0.0 111.823 177.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 65.3 mt -72.77 -26.18 23.3 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.385 0 C-N-CA 123.371 0.668 . . . . 0.0 109.812 175.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.95 -58.15 16.01 Favored Pre-proline 0 CA--C 1.539 0.537 0 CA-C-O 117.509 -1.234 . . . . 0.0 111.304 -179.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -56.42 -38.92 94.37 Favored 'Trans proline' 0 C--N 1.35 0.649 0 C-N-CA 122.024 1.816 . . . . 0.0 112.018 178.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 49.6 mt -56.6 -57.34 12.78 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 121.558 0.694 . . . . 0.0 109.602 176.735 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -55.96 -41.72 75.15 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.048 0.539 . . . . 0.0 110.067 178.285 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.2 mt-10 -62.61 -34.46 77.08 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.36 -0.838 . . . . 0.0 110.539 177.094 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 34.1 m -62.28 -47.46 84.22 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -60.58 -40.63 92.4 Favored 'General case' 0 N--CA 1.463 0.218 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 175.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.48 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 19.5 m -53.58 -52.39 59.9 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.9 t30 -59.63 -46.33 89.3 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.367 0.667 . . . . 0.0 110.429 176.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -51.16 -54.05 28.93 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 123.74 0.816 . . . . 0.0 112.174 -178.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.2 m-85 -79.55 -55.52 4.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.817 -0.174 . . . . 0.0 110.739 -178.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 36.05 -125.44 0.14 Allowed 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.206 1.402 . . . . 0.0 110.391 -173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 45.05 -84.63 0.01 OUTLIER Glycine 0 CA--C 1.529 0.959 0 C-N-CA 127.159 2.314 . . . . 0.0 115.188 176.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 62.2 mtpt -91.19 -39.43 12.12 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.372 1.469 . . . . 0.0 112.916 -178.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 42.1 t -79.63 132.14 32.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 125.335 1.454 . . . . 0.0 113.235 -167.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.4 mp -91.4 129.53 41.98 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 N-CA-C 105.521 -2.029 . . . . 0.0 105.521 176.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.48 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 78.8 m-85 -122.14 113.47 19.54 Favored 'General case' 0 C--O 1.232 0.156 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 93.1 mt -108.15 101.58 10.79 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.844 1.258 . . . . 0.0 110.985 -177.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 tptp -79.6 119.41 22.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 105.045 -2.206 . . . . 0.0 105.045 170.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 76.6 t -126.38 138.67 53.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 CA-C-O 121.849 0.833 . . . . 0.0 111.88 -173.739 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.1 t0 -97.88 104.92 16.99 Favored 'General case' 0 N--CA 1.448 -0.536 0 CA-C-N 114.415 -1.266 . . . . 0.0 107.949 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.9 m -55.65 -28.63 23.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 123.19 0.596 . . . . 0.0 110.985 178.248 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.01 -36.5 77.36 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 178.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.76 -66.38 0.9 Allowed 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 122.936 0.495 . . . . 0.0 109.764 -179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 34.6 m -83.07 53.88 0.1 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 121.497 -0.752 . . . . 0.0 111.267 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.62 -43.58 25.98 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.042 0.937 . . . . 0.0 110.894 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.99 -50.01 73.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.965 0.906 . . . . 0.0 111.138 178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.426 HG11 ' CZ3' ' A' ' 13' ' ' TRP . 40.0 t -67.34 -43.49 87.84 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.288 0 N-CA-C 108.925 -0.769 . . . . 0.0 108.925 -179.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.09 -55.45 27.48 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 122.667 0.387 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -66.16 -42.54 88.83 Favored 'General case' 0 CA--C 1.534 0.346 0 O-C-N 121.685 -0.634 . . . . 0.0 110.748 -178.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.79 -45.22 93.0 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 118.679 0.672 . . . . 0.0 110.886 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.68 -38.54 91.51 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.767 1.227 . . . . 0.0 109.785 178.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.4 43.23 1.18 Allowed Glycine 0 CA--C 1.525 0.695 0 C-N-CA 124.456 1.027 . . . . 0.0 112.252 175.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -76.45 131.08 35.53 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.135 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 176.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.0 p -113.51 -74.92 0.61 Allowed 'General case' 0 N--CA 1.45 -0.459 0 N-CA-C 105.604 -1.998 . . . . 0.0 105.604 175.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.2 163.57 14.76 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.692 1.197 . . . . 0.0 108.899 174.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 pmm? -137.96 139.87 27.48 Favored Pre-proline 0 N--CA 1.451 -0.381 0 N-CA-C 106.071 -1.826 . . . . 0.0 106.071 177.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -62.73 155.63 67.04 Favored 'Cis proline' 0 N--CA 1.457 -0.667 0 CA-C-N 120.758 1.307 . . . . 0.0 114.899 -0.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.6 m -144.45 135.61 25.29 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 78.9 m-85 -120.09 121.25 38.44 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 -179.352 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -119.81 153.85 35.14 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -125.02 122.91 64.38 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 C-N-CA 124.042 0.937 . . . . 0.0 108.698 176.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -113.59 118.85 35.56 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 105.711 -1.959 . . . . 0.0 105.711 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 21.1 mmmt -90.69 -57.52 2.79 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 118.461 0.573 . . . . 0.0 112.107 -176.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.0 p-10 -93.16 -42.46 9.36 Favored 'General case' 0 C--O 1.226 -0.18 0 C-N-CA 125.198 1.399 . . . . 0.0 110.545 -178.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.02 -24.18 0.11 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 126.673 2.082 . . . . 0.0 110.138 -176.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 21.4 t -91.84 148.45 4.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 125.16 1.384 . . . . 0.0 108.864 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 24.1 ttpp -60.0 103.01 0.18 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.59 -33.66 41.42 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.835 0.854 . . . . 0.0 110.319 -178.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -158.98 166.94 30.64 Favored 'General case' 0 C--O 1.234 0.274 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -160.11 166.44 29.81 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.694 0.797 . . . . 0.0 111.569 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.658 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.3 tm? -160.3 149.34 17.25 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.067 1.747 . . . . 0.0 108.14 -175.522 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.7 m -121.14 156.0 24.79 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 124.97 1.308 . . . . 0.0 110.631 178.58 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.33 177.43 46.18 Favored Glycine 0 CA--C 1.527 0.817 0 C-N-CA 123.816 0.722 . . . . 0.0 112.124 177.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.89 46.16 0.46 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.736 1.214 . . . . 0.0 111.138 -179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.658 ' HB2' HD11 ' A' ' 94' ' ' LEU . 8.4 m -80.04 67.08 5.74 Favored 'General case' 0 N--CA 1.453 -0.28 0 O-C-N 121.33 -0.856 . . . . 0.0 109.985 -175.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.6 mm100 -49.53 -45.15 47.07 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.594 1.158 . . . . 0.0 111.963 -178.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.1 p-10 -56.76 -48.91 76.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.03 0.932 . . . . 0.0 110.147 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.403 ' HG2' HD23 ' A' ' 94' ' ' LEU . 14.5 tppt? -67.65 -38.93 84.52 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 -178.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -56.46 -55.43 33.78 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -51.58 -53.77 34.67 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 122.798 0.439 . . . . 0.0 110.462 178.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.91 -44.46 74.22 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.706 0.402 . . . . 0.0 111.209 179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.9 mt -61.3 -49.76 75.73 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-O 118.73 -0.652 . . . . 0.0 109.955 179.538 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 14.2 t -59.26 -46.97 91.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 C-N-CA 118.796 -1.162 . . . . 0.0 109.06 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.98 -52.26 58.85 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 122.143 0.177 . . . . 0.0 110.817 178.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 32.7 ttmt -56.31 -62.7 1.53 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.897 0.879 . . . . 0.0 110.499 178.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -70.28 -14.95 62.82 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 113.432 0.901 . . . . 0.0 113.432 -171.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -105.16 16.78 25.18 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 119.035 0.834 . . . . 0.0 110.671 174.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.57 -32.46 72.56 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 118.844 0.747 . . . . 0.0 111.959 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.221 0 N-CA-C 106.331 -1.729 . . . . 0.0 106.331 178.909 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 N-CA-C 107.751 -2.14 . . . . 0.0 107.751 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.26 50.37 2.75 Favored Glycine 0 CA--C 1.532 1.142 0 CA-C-N 119.927 1.864 . . . . 0.0 111.271 178.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.667 ' HB2' HG23 ' A' ' 58' ' ' ILE . 15.0 m -77.86 75.8 4.4 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.639 1.575 . . . . 0.0 109.217 -177.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.423 HG13 ' CB ' ' A' ' 50' ' ' SER . 77.0 t -105.88 101.65 12.73 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.375 0 C-N-CA 125.182 1.393 . . . . 0.0 108.734 179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.4 pt -145.76 129.47 10.9 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 CA-C-O 122.73 1.252 . . . . 0.0 111.397 178.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.9 t -84.14 57.7 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.46 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 175.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.446 HG13 ' H ' ' A' ' 8' ' ' ASP . 6.6 tp -89.03 -179.23 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 124.209 1.004 . . . . 0.0 111.152 -174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.446 ' H ' HG13 ' A' ' 7' ' ' ILE . 16.7 p-10 -134.32 -38.33 0.85 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.614 1.338 . . . . 0.0 114.614 -174.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 59.6 p -80.48 156.39 26.59 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 117.232 2.308 . . . . 0.0 117.232 -165.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -60.74 -46.2 91.36 Favored 'General case' 0 C--N 1.34 0.169 0 CA-C-N 113.936 -1.484 . . . . 0.0 108.837 173.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -51.72 -51.92 52.42 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 114.497 -1.229 . . . . 0.0 108.98 177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.435 ' CB ' HG12 ' A' ' 7' ' ' ILE . . . -62.77 -47.8 81.91 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 118.817 -0.611 . . . . 0.0 111.169 179.194 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -46.85 -58.96 3.4 Favored 'General case' 0 CA--C 1.532 0.254 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 177.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.89 -54.68 43.37 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.176 0.99 . . . . 0.0 111.646 -177.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -50.39 -63.23 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 CA-C-N 115.326 -0.852 . . . . 0.0 110.234 -178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -55.68 -47.42 76.79 Favored 'General case' 0 CA--C 1.52 -0.198 0 CA-C-O 118.581 -0.724 . . . . 0.0 110.901 -178.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 49.1 tp -50.61 -19.44 0.91 Allowed 'General case' 0 CA--C 1.542 0.655 0 O-C-N 123.837 0.711 . . . . 0.0 112.016 178.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -103.32 -56.86 2.14 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.266 0.939 . . . . 0.0 111.092 174.245 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.26 -16.42 63.58 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 -173.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.96 -8.38 57.86 Favored Glycine 0 CA--C 1.538 1.518 0 CA-C-N 119.883 1.22 . . . . 0.0 112.569 178.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.7 mmmt 66.42 56.28 0.78 Allowed 'General case' 0 C--N 1.344 0.337 0 C-N-CA 126.795 2.038 . . . . 0.0 109.547 179.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.3 mp0 -67.91 64.15 0.09 Allowed 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 129.62 3.168 . . . . 0.0 111.202 -178.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -123.36 93.71 4.03 Favored 'General case' 0 N--CA 1.442 -0.826 0 C-N-CA 126.766 2.026 . . . . 0.0 107.226 177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 4.1 t-160 68.04 72.81 0.31 Allowed 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 128.864 2.865 . . . . 0.0 110.217 -179.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.2 ptpt -172.53 155.27 3.24 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 122.731 0.412 . . . . 0.0 111.858 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -83.96 135.05 6.4 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.225 2.616 . . . . 0.0 113.883 -179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.401 ' HA ' ' HB ' ' A' ' 58' ' ' ILE . 5.3 mp -104.89 99.83 9.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 N-CA-C 104.705 -2.331 . . . . 0.0 104.705 171.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 42.5 t -91.45 109.78 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 -179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 13.8 p -115.12 123.66 70.98 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.98 0.419 . . . . 0.0 110.904 -177.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.8 t0 -88.68 101.66 14.21 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.86 1.264 . . . . 0.0 110.232 178.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.0 m-85 -81.42 115.53 20.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.55 -1.648 . . . . 0.0 106.55 171.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.3 m -140.85 162.03 36.42 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.493 1.117 . . . . 0.0 108.212 -177.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -115.62 163.81 15.25 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 125.0 1.32 . . . . 0.0 109.307 177.088 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 35.2 p -77.96 -57.92 3.54 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 123.505 0.722 . . . . 0.0 109.608 179.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.0 p-90 -50.74 -31.59 17.15 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.648 1.579 . . . . 0.0 113.272 -177.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 28.4 p -77.44 55.37 1.26 Allowed 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.616 1.098 . . . . 0.0 110.778 178.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -16.86 -68.12 0.01 OUTLIER Glycine 0 CA--C 1.536 1.369 0 C-N-CA 127.938 2.685 . . . . 0.0 115.477 -178.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_exo -42.5 -39.22 6.61 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 124.577 3.518 . . . . 0.0 114.232 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 69.6 m -42.78 -44.06 4.24 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.474 1.51 . . . . 0.0 110.88 176.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 36.1 ttmt -56.0 -29.16 59.9 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.03 0.932 . . . . 0.0 112.26 -176.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 86.1 mtp -68.49 -19.87 64.56 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 118.902 0.774 . . . . 0.0 111.861 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 4.2 mp -80.6 -28.38 11.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -48.91 -54.51 27.3 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.993 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -61.2 -42.06 38.24 Favored 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 122.057 1.838 . . . . 0.0 111.736 178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -56.78 -54.48 45.81 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.75 0.786 . . . . 0.0 109.565 177.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 61.6 t80 -55.86 -45.41 78.49 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.223 1.009 . . . . 0.0 109.311 177.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -60.68 -41.84 95.93 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.808 0.843 . . . . 0.0 110.836 178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 56.8 m -58.36 -49.84 75.79 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 177.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.1 tp -60.43 -37.64 81.55 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.916 0.389 . . . . 0.0 110.116 176.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.476 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 37.8 m -58.94 -44.71 91.43 Favored 'General case' 0 N--CA 1.448 -0.571 0 O-C-N 122.073 -0.392 . . . . 0.0 110.549 -179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -58.85 -48.33 81.73 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 109.43 -0.582 . . . . 0.0 109.43 177.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -46.7 -52.89 12.88 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 123.332 0.653 . . . . 0.0 112.736 -177.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -103.99 36.26 2.4 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.623 0.647 . . . . 0.0 111.471 -179.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.06 71.11 0.55 Allowed 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.234 0.925 . . . . 0.0 112.038 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -158.37 -75.9 0.02 OUTLIER Glycine 0 CA--C 1.526 0.769 0 N-CA-C 109.962 -1.255 . . . . 0.0 109.962 179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 53.1 mtpt -76.18 -49.2 17.9 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 175.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 40.7 t -77.45 124.61 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 C-N-CA 120.069 -0.652 . . . . 0.0 110.382 -167.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.667 HG23 ' HB2' ' A' ' 3' ' ' SER . 17.1 mm -90.99 114.53 28.5 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.311 0 N-CA-C 104.754 -2.313 . . . . 0.0 104.754 177.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.476 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 96.8 m-85 -105.98 101.75 11.22 Favored 'General case' 0 CA--C 1.516 -0.358 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -177.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 60.1 mt -111.82 163.48 14.14 Favored 'General case' 0 N--CA 1.445 -0.723 0 CA-C-N 114.622 -1.172 . . . . 0.0 110.15 -177.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -138.02 150.84 47.31 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 105.263 -2.125 . . . . 0.0 105.263 173.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.3 p -142.76 136.43 26.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.5 t0 -87.78 113.03 23.06 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.282 -1.007 . . . . 0.0 108.282 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 30.5 m -63.15 -30.48 49.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 CA-C-O 119.397 -0.335 . . . . 0.0 111.274 179.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 61.7 m-20 -62.34 -52.86 61.94 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 108.579 -0.896 . . . . 0.0 108.579 -177.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -69.06 -60.81 2.11 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.198 0.599 . . . . 0.0 110.393 177.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.8 t -83.86 58.57 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-O 121.716 0.769 . . . . 0.0 110.338 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.07 -47.14 72.01 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.922 0.889 . . . . 0.0 111.04 -179.521 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.1 -55.52 23.31 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.998 0.919 . . . . 0.0 111.978 -178.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 45.0 t -65.25 -43.99 95.14 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.141 0 N-CA-C 108.946 -0.761 . . . . 0.0 108.946 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.97 68.89 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -69.49 -42.39 74.84 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 121.83 -0.544 . . . . 0.0 109.761 -179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.98 -41.65 78.78 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.679 0.672 . . . . 0.0 110.535 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.07 2.7 22.89 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.258 1.023 . . . . 0.0 111.757 178.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 57.75 42.86 94.64 Favored Glycine 0 C--N 1.339 0.734 0 C-N-CA 124.569 1.08 . . . . 0.0 112.604 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.3 mm -74.81 139.22 19.52 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 117.537 0.668 . . . . 0.0 109.632 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.1 p -139.84 -78.95 0.31 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.058 0.943 . . . . 0.0 110.151 -179.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.8 74.12 1.58 Allowed 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 124.336 1.054 . . . . 0.0 111.311 -176.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -68.31 138.67 91.85 Favored Pre-proline 0 CA--C 1.541 0.614 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 176.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -63.7 135.25 19.54 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 121.443 1.551 . . . . 0.0 112.498 -1.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 84.9 m -125.52 107.37 10.55 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 178.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -91.86 121.1 33.15 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.943 0.897 . . . . 0.0 108.604 -179.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 15.7 m170 -111.03 141.96 43.81 Favored 'General case' 0 C--O 1.232 0.161 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 175.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 t -110.71 96.33 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -88.3 105.42 17.55 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 106.07 -1.826 . . . . 0.0 106.07 174.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -82.44 116.57 21.95 Favored 'General case' 0 CA--C 1.523 -0.064 0 N-CA-C 106.093 -1.817 . . . . 0.0 106.093 177.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 67.0 -59.81 0.37 Allowed 'General case' 0 N--CA 1.463 0.202 0 C-N-CA 128.784 2.834 . . . . 0.0 110.346 -176.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.04 23.02 0.09 OUTLIER Glycine 0 CA--C 1.531 1.032 0 CA-C-O 118.865 -0.964 . . . . 0.0 113.266 178.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 5.8 p -136.65 135.16 48.95 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 119.256 1.528 . . . . 0.0 108.406 177.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.0 ttpp -62.96 98.64 0.13 Allowed 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.393 0.677 . . . . 0.0 109.386 -178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.86 -33.07 40.4 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 123.483 0.713 . . . . 0.0 110.182 179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -161.91 174.67 12.78 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -177.308 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -160.61 172.24 17.51 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 125.16 1.384 . . . . 0.0 108.165 178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 23.6 tp -165.08 150.52 9.57 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.555 1.142 . . . . 0.0 108.666 -174.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.4 m -126.95 158.56 37.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.266 0 C-N-CA 124.981 1.312 . . . . 0.0 111.009 -179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.03 175.04 46.23 Favored Glycine 0 CA--C 1.525 0.682 0 C-N-CA 124.573 1.082 . . . . 0.0 111.863 176.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.62 42.79 0.45 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.904 0.882 . . . . 0.0 110.548 178.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -78.71 55.4 1.68 Allowed 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.081 1.752 . . . . 0.0 110.842 -174.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.91 -40.27 21.36 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.329 1.052 . . . . 0.0 113.104 -175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -60.49 -52.26 65.95 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 119.116 0.871 . . . . 0.0 110.245 178.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.9 tptm -63.77 -37.94 89.24 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.988 -0.745 . . . . 0.0 108.988 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -53.76 -57.94 9.05 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 176.761 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -53.47 -49.9 66.46 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.016 0.527 . . . . 0.0 110.754 178.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.3 -46.93 76.23 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 122.14 0.176 . . . . 0.0 111.129 179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 17.1 mt -64.02 -47.09 81.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 121.935 -0.478 . . . . 0.0 110.466 179.431 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 65.6 t -56.42 -48.17 80.42 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.135 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 178.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.69 -56.6 15.9 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 110.146 -0.316 . . . . 0.0 110.146 178.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -47.11 -63.95 0.91 Allowed 'General case' 0 C--O 1.228 -0.061 0 C-N-CA 124.905 1.282 . . . . 0.0 111.065 178.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -70.39 -23.88 62.85 Favored 'General case' 0 N--CA 1.452 -0.355 0 CA-C-N 115.169 -0.923 . . . . 0.0 113.051 -173.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.89 -46.12 54.51 Favored 'General case' 0 N--CA 1.457 -0.124 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 174.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.46 55.14 2.52 Favored 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 117.051 -1.452 . . . . 0.0 108.558 -179.354 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.917 0 CA-C-O 118.361 -1.244 . . . . 0.0 110.357 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 48.69 -125.82 15.2 Favored Glycine 0 CA--C 1.529 0.959 0 N-CA-C 110.208 -1.157 . . . . 0.0 110.208 -178.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 52.7 m -65.65 102.44 0.73 Allowed 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 107.756 -1.201 . . . . 0.0 107.756 174.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.0 p -137.93 26.65 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.121 1.368 . . . . 0.0 107.857 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 39.5 pt -145.67 177.27 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.261 0 C-N-CA 126.424 1.89 . . . . 0.0 107.431 -177.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.6 p -77.76 73.9 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 CA-C-O 122.007 0.908 . . . . 0.0 110.496 -176.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.8 tt -123.26 127.9 74.64 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.997 1.319 . . . . 0.0 107.952 174.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -105.12 -42.48 5.29 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 126.636 1.974 . . . . 0.0 110.675 -179.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 7.4 m -14.13 110.81 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.59 0 C-N-CA 129.301 3.041 . . . . 0.0 115.035 -176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -40.29 -47.1 2.44 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 125.477 1.511 . . . . 0.0 111.326 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.53 -49.54 74.48 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 122.932 0.493 . . . . 0.0 111.189 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.0 -46.19 85.63 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -50.67 -58.59 5.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.914 0.886 . . . . 0.0 109.588 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.8 m-20 -59.54 -47.28 86.16 Favored 'General case' 0 N--CA 1.456 -0.149 0 C-N-CA 124.115 0.966 . . . . 0.0 110.346 -177.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.61 -63.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -52.06 -48.47 64.61 Favored 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 123.954 0.902 . . . . 0.0 110.857 -178.325 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 45.3 tp -51.68 -25.92 8.18 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.866 0.866 . . . . 0.0 112.133 179.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -106.19 -60.23 1.68 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 119.195 0.907 . . . . 0.0 111.296 178.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.76 -22.22 63.84 Favored 'General case' 0 CA--C 1.529 0.167 0 O-C-N 121.814 -0.554 . . . . 0.0 112.081 -176.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.93 -29.71 71.35 Favored Glycine 0 CA--C 1.531 1.069 0 CA-C-O 118.896 -0.947 . . . . 0.0 110.95 174.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 68.0 mttm 45.89 55.04 7.37 Favored 'General case' 0 C--N 1.347 0.484 0 C-N-CA 124.866 1.266 . . . . 0.0 107.801 -177.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.0 pm0 -73.55 43.36 0.14 Allowed 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 115.643 1.719 . . . . 0.0 115.643 -167.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -47.83 -51.05 24.18 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 0.0 109.032 176.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 16.2 t-160 -135.09 58.48 1.77 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 123.649 0.78 . . . . 0.0 108.905 175.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.0 mttp -138.32 126.76 14.16 Favored Pre-proline 0 CA--C 1.528 0.124 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 176.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.91 105.23 1.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 120.823 1.015 . . . . 0.0 112.212 178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mt -85.98 118.4 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 102.619 -3.104 . . . . 0.0 102.619 165.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.7 t -118.06 122.11 68.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.713 -1.958 . . . . 0.0 105.713 -175.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.2 t -111.6 110.79 33.51 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 C-N-CA 123.385 0.674 . . . . 0.0 109.877 -175.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 32.1 t0 -88.44 93.1 9.42 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 171.095 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.2 m-85 -79.5 94.54 5.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 104.962 -2.236 . . . . 0.0 104.962 175.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -116.14 -165.11 1.01 Allowed 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 125.338 1.455 . . . . 0.0 108.832 -177.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -154.23 147.17 24.49 Favored 'General case' 0 N--CA 1.45 -0.431 0 O-C-N 121.73 -0.606 . . . . 0.0 110.572 178.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.3 m -64.33 -46.01 85.36 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.033 1.333 . . . . 0.0 112.512 -178.39 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 58.0 p-90 -68.26 -47.69 67.07 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 -170.457 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -77.94 64.43 3.15 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 119.065 0.848 . . . . 0.0 112.276 -174.187 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 11.04 -83.29 0.0 OUTLIER Glycine 0 CA--C 1.536 1.377 0 C-N-CA 128.987 3.184 . . . . 0.0 115.398 177.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_exo -40.45 -46.37 4.43 Favored 'Trans proline' 0 C--N 1.349 0.569 0 C-N-CA 124.375 3.383 . . . . 0.0 113.251 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 83.3 m -46.11 -51.62 13.61 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 125.409 1.484 . . . . 0.0 109.695 175.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.6 tptt -72.46 -41.37 66.15 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.921 -178.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 26.5 mmt -60.82 -25.39 66.57 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.532 0.605 . . . . 0.0 112.217 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 44.5 mt -70.75 -27.11 29.52 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 O-C-N 121.688 -0.632 . . . . 0.0 110.001 174.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.05 -51.78 79.05 Favored Pre-proline 0 CA--C 1.54 0.596 0 CA-C-O 116.994 -1.479 . . . . 0.0 110.653 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -46.99 -44.23 23.29 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 123.441 2.76 . . . . 0.0 113.565 172.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 63.2 mt -59.98 -54.93 40.22 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 48.5 t80 -57.47 -34.62 69.2 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.142 0.577 . . . . 0.0 110.362 178.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 -68.7 -34.15 75.17 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.531 1.132 . . . . 0.0 109.926 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 25.9 m -62.66 -47.65 82.77 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 174.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -60.1 -39.5 86.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 120.229 -0.588 . . . . 0.0 109.857 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 12.1 m -53.63 -52.1 60.98 Favored 'General case' 0 N--CA 1.465 0.313 0 C-N-CA 122.879 0.471 . . . . 0.0 109.87 175.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -55.18 -47.13 75.64 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.089 0.555 . . . . 0.0 110.344 177.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 42.2 m-20 -63.64 -64.95 0.76 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 121.109 0.481 . . . . 0.0 110.294 -176.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -80.06 60.39 3.58 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.187 0.995 . . . . 0.0 108.923 178.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -62.6 -27.19 69.03 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -61.43 -136.68 0.01 OUTLIER Glycine 0 CA--C 1.535 1.325 0 C-N-CA 126.171 1.843 . . . . 0.0 116.229 -174.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 19.8 pttt -71.81 38.45 0.07 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.072 1.349 . . . . 0.0 114.462 -173.196 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 23.8 t -121.85 137.32 55.85 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 26.9 mm -110.25 108.22 24.88 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 177.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -97.39 110.0 22.64 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 178.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -110.85 105.46 14.29 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 114.309 -1.314 . . . . 0.0 110.655 -171.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 14.3 mtmm -88.26 90.44 8.39 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.362 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 60.8 t -95.24 103.57 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.184 0.516 . . . . 0.0 109.775 -175.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -76.99 100.33 5.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 175.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.5 m -54.85 -33.11 27.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 C-N-CA 123.544 0.738 . . . . 0.0 112.14 -176.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -59.83 -27.92 67.04 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.541 0.61 . . . . 0.0 111.035 178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -96.0 -61.42 1.45 Allowed 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.519 HG12 ' HB ' ' A' ' 70' ' ' VAL . 77.2 t -83.42 57.29 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 CA-C-O 122.686 1.231 . . . . 0.0 109.314 -177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -61.46 -54.69 40.06 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 124.864 1.266 . . . . 0.0 112.788 -175.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -48.87 -50.84 32.93 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.724 0.81 . . . . 0.0 111.56 -177.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.519 ' HB ' HG12 ' A' ' 67' ' ' VAL . 67.5 t -63.81 -47.86 88.95 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.39 -50.47 69.64 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 122.359 0.264 . . . . 0.0 111.704 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -66.16 -43.49 86.83 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 109.444 -0.576 . . . . 0.0 109.444 179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.53 -41.63 77.11 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.714 0.688 . . . . 0.0 110.971 178.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -73.56 -9.21 58.44 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.971 0.908 . . . . 0.0 111.882 178.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 76.73 36.03 38.56 Favored Glycine 0 CA--C 1.526 0.777 0 C-N-CA 124.197 0.904 . . . . 0.0 112.342 178.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.9 mm -78.96 141.37 15.49 Favored 'Isoleucine or valine' 0 C--O 1.231 0.091 0 CA-C-N 118.221 1.01 . . . . 0.0 109.025 178.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 40.2 p -136.75 -82.25 0.37 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.226 1.01 . . . . 0.0 109.565 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.73 72.59 2.01 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.375 1.07 . . . . 0.0 111.1 -177.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -60.65 146.27 86.15 Favored Pre-proline 0 CA--C 1.547 0.835 0 C-N-CA 122.793 0.437 . . . . 0.0 109.863 177.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -75.49 159.83 96.96 Favored 'Cis proline' 0 N--CA 1.45 -1.035 0 CA-C-N 119.684 0.923 . . . . 0.0 110.185 -1.099 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.4 m -147.8 118.41 7.49 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 107.608 -1.256 . . . . 0.0 107.608 -177.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -94.13 120.75 34.82 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.396 1.078 . . . . 0.0 109.593 -178.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.1 m170 -114.68 153.39 30.31 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 175.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 17.0 t -125.33 124.82 67.96 Favored 'Isoleucine or valine' 0 C--O 1.232 0.137 0 N-CA-C 107.432 -1.322 . . . . 0.0 107.432 174.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 28.2 m-85 -110.64 105.59 14.54 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 123.927 0.891 . . . . 0.0 110.33 -179.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 12.2 mmmm -92.45 147.78 22.62 Favored 'General case' 0 C--O 1.232 0.138 0 N-CA-C 108.104 -1.072 . . . . 0.0 108.104 171.37 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 27.6 t70 62.46 -64.02 0.1 Allowed 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 129.096 2.959 . . . . 0.0 112.153 178.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 177.68 33.67 0.05 OUTLIER Glycine 0 CA--C 1.528 0.863 0 C-N-CA 126.955 2.217 . . . . 0.0 110.486 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.5 p -153.28 145.17 14.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 CA-C-N 118.357 1.078 . . . . 0.0 109.901 -178.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.7 ttmt -57.51 106.08 0.3 Allowed 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.291 1.436 . . . . 0.0 108.174 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.45 -37.56 12.48 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.477 1.111 . . . . 0.0 112.554 -175.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -155.54 167.56 29.98 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -176.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -160.68 175.69 12.36 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-O 121.724 0.773 . . . . 0.0 111.939 179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -156.87 110.55 2.64 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 127.513 2.325 . . . . 0.0 106.533 176.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 4.9 t -82.53 145.68 8.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 176.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 87.96 -158.79 29.63 Favored Glycine 0 CA--C 1.529 0.941 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -116.37 122.4 44.74 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.762 1.225 . . . . 0.0 109.955 -177.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 46.3 m -157.59 80.27 0.88 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.41 -32.75 65.14 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 122.987 0.515 . . . . 0.0 111.704 -177.482 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.8 p-10 -60.93 -50.39 73.59 Favored 'General case' 0 CA--C 1.535 0.379 0 O-C-N 121.437 -0.789 . . . . 0.0 109.2 175.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -63.32 -37.43 87.23 Favored 'General case' 0 C--O 1.222 -0.395 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.555 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 14.3 tp -57.49 -55.4 35.34 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.629 0.771 . . . . 0.0 109.812 178.511 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.8 mttm -51.97 -50.63 60.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 176.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.99 -42.87 86.03 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.475 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 27.1 mt -60.28 -51.97 67.29 Favored 'General case' 0 N--CA 1.458 -0.073 0 C-N-CA 123.816 0.846 . . . . 0.0 109.477 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 48.1 t -56.47 -50.36 73.07 Favored 'Isoleucine or valine' 0 C--N 1.339 0.12 0 C-N-CA 120.06 -0.656 . . . . 0.0 109.35 -179.185 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.55 -58.07 9.3 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.877 0.37 . . . . 0.0 110.582 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.5 ttmt -45.91 -58.16 3.77 Favored 'General case' 0 C--O 1.228 -0.059 0 C-N-CA 125.57 1.548 . . . . 0.0 110.433 179.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 98.7 m-70 -83.19 9.79 9.8 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 112.954 0.724 . . . . 0.0 112.954 -175.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -101.31 -46.27 5.08 Favored 'General case' 0 C--N 1.341 0.217 0 N-CA-C 106.612 -1.625 . . . . 0.0 106.612 171.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.35 -58.09 7.5 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 175.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.24 0 CA-C-O 116.495 -1.717 . . . . 0.0 107.15 172.34 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.987 0 N-CA-C 108.773 -1.731 . . . . 0.0 108.773 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -69.69 -176.35 16.07 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.732 1.266 . . . . 0.0 111.424 178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.06 78.47 0.23 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.761 1.224 . . . . 0.0 109.281 177.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.505 HG13 ' HB2' ' A' ' 59' ' ' PHE . 75.4 t -123.01 120.72 61.31 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 124.405 1.082 . . . . 0.0 109.904 -177.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 20.1 pt -144.38 171.81 6.48 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 CA-C-O 122.172 0.987 . . . . 0.0 111.728 179.193 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 43.1 t -110.04 136.03 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 172.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 11.1 tp -153.29 152.42 10.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 118.696 0.68 . . . . 0.0 110.787 -176.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 31.4 p-10 -115.81 -62.56 1.58 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.987 1.315 . . . . 0.0 108.233 176.015 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.9 m -37.12 105.71 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 129.203 3.001 . . . . 0.0 113.483 -176.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -44.53 -49.0 10.23 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 125.007 1.323 . . . . 0.0 110.346 178.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.78 -49.77 57.54 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.106 0.562 . . . . 0.0 111.074 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.35 -44.36 83.46 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 122.823 0.449 . . . . 0.0 109.966 -179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.2 OUTLIER -51.06 -61.34 2.29 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 123.876 0.87 . . . . 0.0 108.906 177.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -58.69 -48.66 80.35 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.393 1.077 . . . . 0.0 110.463 -178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.24 -63.42 1.15 Allowed 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.399 -178.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -58.63 -48.2 81.84 Favored 'General case' 0 CA--C 1.531 0.248 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 -176.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 44.8 tp -46.49 -49.88 17.8 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 110.758 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -84.83 -49.18 8.64 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 113.348 0.87 . . . . 0.0 113.348 -176.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.84 -28.65 61.93 Favored 'General case' 0 C--N 1.341 0.238 0 CA-C-N 119.698 1.136 . . . . 0.0 111.261 -176.157 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -54.72 -37.57 61.84 Favored Glycine 0 CA--C 1.534 1.275 0 CA-C-O 119.061 -0.855 . . . . 0.0 111.824 175.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 7.1 mtpm? 44.98 51.53 8.68 Favored 'General case' 0 C--N 1.345 0.411 0 C-N-CA 124.811 1.245 . . . . 0.0 109.281 -176.637 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -78.44 56.72 1.81 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.679 1.191 . . . . 0.0 113.02 -171.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -22.57 -66.63 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 128.321 2.648 . . . . 0.0 112.172 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 33.5 t60 -132.55 59.23 1.73 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.299 -1.741 . . . . 0.0 106.299 174.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -135.15 142.3 41.28 Favored Pre-proline 0 CA--C 1.532 0.283 0 N-CA-C 106.741 -1.578 . . . . 0.0 106.741 176.385 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -77.35 111.17 3.13 Favored 'Trans proline' 0 N--CA 1.449 -1.105 0 C-N-CA 122.478 2.119 . . . . 0.0 114.52 -172.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 40.1 mt -91.79 97.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 N-CA-C 103.277 -2.86 . . . . 0.0 103.277 167.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.6 t -90.51 114.33 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 -176.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 71.6 t -106.42 115.79 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 -175.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 11.5 t0 -100.13 103.65 15.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -91.46 90.39 7.64 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 173.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.2 m -114.94 139.7 49.61 Favored 'General case' 0 C--O 1.231 0.108 0 C-N-CA 124.749 1.219 . . . . 0.0 109.036 177.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -75.71 72.28 2.63 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.669 0.788 . . . . 0.0 110.037 178.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 94.8 m -25.67 -47.99 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.632 2.373 . . . . 0.0 113.428 174.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -53.93 -38.74 65.22 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 -176.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.4 p -77.18 66.54 2.99 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.487 1.04 . . . . 0.0 112.898 -172.209 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.28 -88.82 0.01 OUTLIER Glycine 0 CA--C 1.531 1.088 0 C-N-CA 128.849 3.119 . . . . 0.0 114.769 176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -40.73 -45.05 4.76 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 123.872 3.048 . . . . 0.0 113.723 178.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 81.0 m -45.03 -39.13 5.4 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.042 1.737 . . . . 0.0 111.634 178.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -49.27 -33.29 12.59 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.939 0.896 . . . . 0.0 111.858 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -53.94 -24.75 17.48 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.2 1.0 . . . . 0.0 112.961 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 70.5 mt -69.9 -37.78 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-O 120.944 0.402 . . . . 0.0 109.935 179.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -57.78 -57.33 26.31 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 -175.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo -58.51 -27.76 83.26 Favored 'Trans proline' 0 N--CA 1.454 -0.846 0 C-N-CA 121.922 1.748 . . . . 0.0 111.234 -179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.4 mt -75.15 -44.67 45.6 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 118.502 0.592 . . . . 0.0 110.714 178.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -55.72 -39.09 70.61 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.42 ' HA ' HG11 ' A' ' 4' ' ' VAL . 32.6 mt-10 -70.21 -34.5 72.99 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 123.317 0.647 . . . . 0.0 111.456 174.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.7 m -55.35 -44.73 76.23 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 120.076 1.307 . . . . 0.0 107.875 175.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 31.4 mt -60.4 -18.09 48.3 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 118.778 -0.629 . . . . 0.0 112.428 177.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.425 ' CB ' HG21 ' A' ' 4' ' ' VAL . 25.9 p -59.16 -38.03 78.76 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-N 120.293 1.406 . . . . 0.0 109.226 173.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 24.3 t30 -62.61 -49.16 76.31 Favored 'General case' 0 N--CA 1.438 -1.053 0 O-C-N 124.373 1.046 . . . . 0.0 108.196 -175.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -55.29 -59.82 4.26 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.108 0.963 . . . . 0.0 108.923 176.397 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -88.05 65.18 8.1 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.784 0.802 . . . . 0.0 109.625 -176.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.79 67.6 0.82 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.337 176.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -161.32 -166.12 19.45 Favored Glycine 0 CA--C 1.526 0.755 0 CA-C-O 121.417 0.454 . . . . 0.0 111.998 -178.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -77.77 64.52 3.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.806 1.642 . . . . 0.0 110.892 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 21.5 m -117.69 131.66 69.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 171.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 9.3 mm -105.32 96.49 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-N 119.673 1.124 . . . . 0.0 108.583 -175.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' HB2' HG13 ' A' ' 4' ' ' VAL . 3.8 m-30 -91.61 115.04 27.72 Favored 'General case' 0 N--CA 1.465 0.299 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.3 mt -114.87 98.96 7.13 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.072 1.349 . . . . 0.0 110.107 -178.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 44.2 tttp -79.91 113.81 18.35 Favored 'General case' 0 N--CA 1.462 0.144 0 N-CA-C 106.315 -1.735 . . . . 0.0 106.315 171.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 80.5 t -90.47 122.18 41.56 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 107.947 -1.131 . . . . 0.0 107.947 178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.0 m-20 -69.9 86.2 0.52 Allowed 'General case' 0 CA--C 1.533 0.296 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 176.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.2 t -42.13 -50.52 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 C-N-CA 126.629 1.971 . . . . 0.0 110.779 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -56.68 -31.31 64.32 Favored 'General case' 0 CA--C 1.528 0.112 0 C-N-CA 124.482 1.113 . . . . 0.0 112.192 -178.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -84.78 -70.8 0.55 Allowed 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.7 m -87.31 61.56 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.294 0 CA-C-O 121.906 0.86 . . . . 0.0 111.036 -177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.22 -39.5 60.31 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 114.973 -1.012 . . . . 0.0 109.795 177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.64 -41.51 86.16 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.592 0.757 . . . . 0.0 111.71 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 86.3 t -67.19 -47.19 82.36 Favored 'Isoleucine or valine' 0 C--N 1.339 0.133 0 N-CA-C 108.133 -1.062 . . . . 0.0 108.133 -179.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.83 -49.14 69.06 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -54.53 -55.81 25.32 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.137 0.975 . . . . 0.0 110.457 177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.91 -41.8 75.08 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.047 0.539 . . . . 0.0 111.048 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.99 -8.62 55.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.391 0.677 . . . . 0.0 111.761 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 83.43 30.19 31.01 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 124.231 0.919 . . . . 0.0 112.881 176.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.5 mp -80.68 117.09 26.04 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.13 0 N-CA-C 107.694 -1.225 . . . . 0.0 107.694 178.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 17.8 p -101.34 -71.41 0.71 Allowed 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 105.68 -1.97 . . . . 0.0 105.68 176.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.23 156.14 18.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.707 1.203 . . . . 0.0 107.876 172.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 pmm? -150.1 161.18 31.78 Favored Pre-proline 0 CA--C 1.543 0.684 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -66.38 141.43 53.45 Favored 'Cis proline' 0 N--CA 1.453 -0.902 0 CA-C-N 120.726 1.295 . . . . 0.0 111.922 1.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 19.3 m -133.6 122.55 23.68 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.646 -1.242 . . . . 0.0 107.646 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 76.5 m-85 -105.29 119.33 38.79 Favored 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 125.325 1.45 . . . . 0.0 108.419 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.4 m170 -107.86 153.52 22.9 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 175.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.8 t -124.67 117.06 49.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 173.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -107.08 126.64 52.62 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.978 0.911 . . . . 0.0 109.41 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -92.03 123.78 35.65 Favored 'General case' 0 C--O 1.231 0.095 0 N-CA-C 106.091 -1.818 . . . . 0.0 106.091 170.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.8 t70 67.26 -63.12 0.3 Allowed 'General case' 0 N--CA 1.462 0.145 0 C-N-CA 128.617 2.767 . . . . 0.0 110.585 -176.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -177.09 23.86 0.05 OUTLIER Glycine 0 CA--C 1.533 1.174 0 C-N-CA 127.151 2.31 . . . . 0.0 110.938 177.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 63.5 t -123.13 128.05 74.85 Favored 'Isoleucine or valine' 0 C--N 1.34 0.185 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 26.3 ttpp -61.69 111.3 1.79 Allowed 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.355 0.662 . . . . 0.0 109.881 -178.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -92.08 -33.9 14.59 Favored 'General case' 0 N--CA 1.452 -0.375 0 C-N-CA 124.627 1.171 . . . . 0.0 110.938 -179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -155.4 166.01 34.84 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 117.768 0.258 . . . . 0.0 111.099 -177.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -143.23 162.36 35.83 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 125.738 1.615 . . . . 0.0 109.759 -178.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 5.3 tt -159.9 143.44 14.2 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 126.595 1.958 . . . . 0.0 106.424 174.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.0 t -116.25 152.02 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 N-CA-C 105.95 -1.87 . . . . 0.0 105.95 175.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 88.07 -158.84 29.55 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 108.035 -2.026 . . . . 0.0 108.035 -176.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -151.92 139.99 20.18 Favored 'General case' 0 N--CA 1.453 -0.279 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 21.0 m -163.85 108.13 1.0 Allowed 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 22.3 mp0 -51.6 -49.2 62.62 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 124.912 1.285 . . . . 0.0 111.876 -175.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 13.6 p-10 -58.1 -43.87 87.35 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.889 0.476 . . . . 0.0 110.034 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.87 -38.39 86.25 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 109.773 -0.455 . . . . 0.0 109.773 -179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 48.1 mt -63.06 -46.86 85.49 Favored 'General case' 0 N--CA 1.457 -0.085 0 N-CA-C 109.027 -0.731 . . . . 0.0 109.027 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 52.1 tttm -54.6 -49.3 70.76 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.049 -0.723 . . . . 0.0 109.049 177.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.3 -46.54 85.92 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.681 0.792 . . . . 0.0 111.005 178.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 15.5 mt -56.35 -52.64 63.82 Favored 'General case' 0 CA--C 1.528 0.128 0 CA-C-N 118.852 0.751 . . . . 0.0 109.523 178.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.6 t -57.44 -50.97 75.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.39 -54.98 28.91 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 122.708 0.403 . . . . 0.0 110.595 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -49.58 -63.74 1.02 Allowed 'General case' 0 CA--C 1.52 -0.207 0 C-N-CA 125.254 1.422 . . . . 0.0 110.198 178.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 -68.04 -22.31 64.96 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.452 -174.525 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -71.69 -44.73 63.71 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.191 0.905 . . . . 0.0 108.987 172.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -91.31 -105.32 0.1 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.867 0.867 . . . . 0.0 109.44 178.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.418 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.456 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.898 0 N-CA-C 109.777 -1.329 . . . . 0.0 109.777 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.29 -115.4 6.57 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.316 -1.114 . . . . 0.0 110.316 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 56.2 p -75.04 -17.41 60.5 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.435 0.694 . . . . 0.0 112.084 -178.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 73.7 t -97.72 108.48 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.36 0 N-CA-C 107.225 -1.398 . . . . 0.0 107.225 179.023 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -151.91 149.89 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-O 122.079 0.942 . . . . 0.0 112.425 -174.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 60.7 t -96.52 123.28 48.72 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 N-CA-C 103.959 -2.608 . . . . 0.0 103.959 172.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.6 tp -148.61 146.82 17.35 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.276 0 CA-C-N 119.312 0.96 . . . . 0.0 111.153 -176.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -145.01 56.13 1.25 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.974 0.91 . . . . 0.0 109.079 179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.2 m -157.64 117.21 3.32 Favored 'General case' 0 N--CA 1.452 -0.336 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 175.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 59.1 pttt -48.52 -38.85 21.4 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.458 1.103 . . . . 0.0 112.794 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.49 -46.69 86.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.101 177.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.71 -35.89 65.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 122.72 0.408 . . . . 0.0 110.126 -179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 7.8 t-105 -52.23 -53.01 48.93 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 173.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -58.56 -51.29 70.52 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.355 0.662 . . . . 0.0 110.68 178.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.14 -48.45 64.88 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 115.947 -0.569 . . . . 0.0 111.231 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.4 tp-100 -61.14 -51.19 70.11 Favored 'General case' 0 N--CA 1.456 -0.147 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 27.3 tp -49.22 -50.02 40.31 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 122.97 0.508 . . . . 0.0 109.813 -179.627 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.99 -61.16 2.64 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.804 0.842 . . . . 0.0 111.236 178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.9 ptpp? -63.57 -15.59 58.49 Favored 'General case' 0 CA--C 1.535 0.402 0 O-C-N 121.457 -0.777 . . . . 0.0 111.877 -178.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -61.95 -21.14 60.87 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.079 1.323 . . . . 0.0 111.986 177.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 21.7 mttm 66.08 73.75 0.37 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-O 122.752 1.263 . . . . 0.0 108.554 178.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -71.06 49.44 0.13 Allowed 'General case' 0 CA--C 1.541 0.596 0 C-N-CA 127.047 2.139 . . . . 0.0 113.797 -175.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.9 mp0 -77.6 -58.61 3.17 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 176.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 47.6 p-80 -152.96 24.61 0.56 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.621 1.168 . . . . 0.0 110.313 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -95.34 148.88 35.35 Favored Pre-proline 0 C--O 1.234 0.239 0 N-CA-C 113.579 0.955 . . . . 0.0 113.579 -169.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.443 ' HG2' HG13 ' A' ' 57' ' ' VAL . 84.4 Cg_endo -79.62 129.98 8.59 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 124.294 3.329 . . . . 0.0 113.31 174.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.57 95.83 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 104.866 -2.272 . . . . 0.0 104.866 170.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 6.9 p -89.71 130.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.0 p -120.36 133.24 67.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.5 t0 -104.49 101.62 11.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 126.566 1.947 . . . . 0.0 106.599 177.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 87.1 m-85 -97.4 95.99 8.05 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 24.6 m -122.49 162.81 21.04 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 124.845 1.258 . . . . 0.0 107.808 179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -113.24 172.44 6.95 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.124 0.969 . . . . 0.0 110.251 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 44.6 p -83.05 -62.52 1.57 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.712 0.805 . . . . 0.0 109.382 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.6 p-90 -47.4 -26.37 1.3 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.716 2.007 . . . . 0.0 113.742 -177.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 25.7 p -76.69 9.87 2.53 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-N 119.447 1.021 . . . . 0.0 112.703 177.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 28.82 -89.84 0.01 OUTLIER Glycine 0 C--N 1.344 0.983 0 C-N-CA 128.635 3.017 . . . . 0.0 114.757 174.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -39.58 -37.82 1.45 Allowed 'Trans proline' 0 C--N 1.348 0.531 0 C-N-CA 124.089 3.193 . . . . 0.0 114.38 177.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 p -48.1 -35.1 10.75 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 124.024 0.93 . . . . 0.0 111.97 176.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -52.67 -28.44 21.68 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 124.396 1.078 . . . . 0.0 112.172 178.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.0 mmm -59.76 -19.8 52.64 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 119.158 0.89 . . . . 0.0 112.039 -179.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.443 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 35.9 mt -71.83 -30.37 37.25 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 O-C-N 121.684 -0.635 . . . . 0.0 109.916 176.541 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.98 -58.23 12.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 CA-C-O 116.948 -1.501 . . . . 0.0 112.558 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -58.78 -37.37 94.27 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.42 2.08 . . . . 0.0 112.452 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 13.2 mt -58.93 -54.54 45.95 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -60.56 -36.86 79.5 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.907 177.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -61.25 -37.46 83.18 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 124.252 1.021 . . . . 0.0 109.764 177.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.8 m -59.17 -52.41 65.84 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 177.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 43.8 mt -56.63 -41.11 76.54 Favored 'General case' 0 C--O 1.225 -0.188 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 176.467 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 10.9 m -56.12 -49.99 72.34 Favored 'General case' 0 N--CA 1.455 -0.198 0 CA-C-O 120.782 0.325 . . . . 0.0 110.276 178.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -60.86 -41.42 95.85 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.107 0.563 . . . . 0.0 109.84 179.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -63.61 -63.37 1.19 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.64 0.733 . . . . 0.0 109.806 -179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -84.05 57.32 4.12 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 125.24 1.416 . . . . 0.0 109.955 -177.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.47 153.08 40.5 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.758 0.79 . . . . 0.0 112.332 -177.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.24 -72.44 1.15 Allowed Glycine 0 CA--C 1.527 0.789 0 C-N-CA 124.616 1.103 . . . . 0.0 114.978 171.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 54.6 pttt -71.95 -30.93 65.8 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 117.668 0.734 . . . . 0.0 112.818 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.443 HG13 ' HG2' ' A' ' 26' ' ' PRO . 90.3 t -97.08 136.75 26.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.354 0 N-CA-C 105.842 -1.91 . . . . 0.0 105.842 175.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.459 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -100.82 129.91 50.99 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -178.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.403 ' CE1' HG12 ' A' ' 57' ' ' VAL . 47.4 m-85 -117.33 107.13 14.01 Favored 'General case' 0 C--O 1.232 0.151 0 C-N-CA 124.161 0.984 . . . . 0.0 108.541 179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 47.4 mt -100.85 101.21 11.99 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 124.84 1.256 . . . . 0.0 110.272 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -86.4 120.88 28.22 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 172.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 58.8 t -127.5 141.12 47.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 C-N-CA 123.949 0.899 . . . . 0.0 110.432 -175.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -94.62 109.47 21.38 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.788 1.235 . . . . 0.0 107.668 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 65.0 t -53.2 -34.35 21.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 C-N-CA 124.836 1.254 . . . . 0.0 110.732 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 60.6 m-20 -68.43 -23.07 64.58 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 119.371 -0.347 . . . . 0.0 111.11 -178.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -91.18 -75.32 0.47 Allowed 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 123.276 0.63 . . . . 0.0 110.9 -177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.9 m -81.28 63.99 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.434 0 CA-C-N 119.324 0.966 . . . . 0.0 110.169 -178.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.64 -41.08 54.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.989 0.916 . . . . 0.0 109.739 177.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.49 -52.83 63.26 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.131 0.973 . . . . 0.0 111.228 178.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 60.8 t -63.35 -46.69 94.82 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.123 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.54 -53.57 52.75 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.068 0.547 . . . . 0.0 111.539 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -68.57 -39.81 80.83 Favored 'General case' 0 CA--C 1.531 0.23 0 O-C-N 121.268 -0.895 . . . . 0.0 110.4 -178.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.11 -47.0 86.87 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 118.485 0.584 . . . . 0.0 110.203 178.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' HB3' HD13 ' A' ' 76' ' ' ILE . . . -67.74 -33.75 75.49 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.392 0.677 . . . . 0.0 110.431 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 99.15 48.66 1.69 Allowed Glycine 0 CA--C 1.526 0.754 0 C-N-CA 124.757 1.17 . . . . 0.0 111.767 175.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . 0.415 HD13 ' HB3' ' A' ' 74' ' ' ALA . 1.0 OUTLIER -85.87 98.54 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.14 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -179.615 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 21.3 p -93.21 -75.98 0.48 Allowed 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.164 -1.051 . . . . 0.0 108.164 177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.12 72.71 5.68 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.895 0.878 . . . . 0.0 111.012 -178.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -66.51 142.71 97.82 Favored Pre-proline 0 CA--C 1.543 0.687 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 172.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.73 134.35 34.28 Favored 'Cis proline' 0 N--CA 1.45 -1.085 0 CA-C-N 120.306 1.145 . . . . 0.0 111.102 0.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 87.3 m -122.67 141.01 52.22 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.903 1.681 . . . . 0.0 108.506 -177.567 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.443 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 84.1 m-85 -124.11 116.83 23.4 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.63 1.172 . . . . 0.0 108.628 -178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -112.6 147.84 35.84 Favored 'General case' 0 CA--C 1.518 -0.271 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 177.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.2 t -115.13 98.58 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 175.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -87.44 107.45 18.56 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.578 -1.638 . . . . 0.0 106.578 176.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 10.3 ttmt -83.47 115.01 21.87 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 105.262 -2.125 . . . . 0.0 105.262 175.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 68.18 -58.92 0.45 Allowed 'General case' 0 C--O 1.225 -0.191 0 C-N-CA 128.177 2.591 . . . . 0.0 111.448 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -170.68 19.4 0.07 OUTLIER Glycine 0 CA--C 1.528 0.901 0 C-N-CA 124.355 0.979 . . . . 0.0 112.686 178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 3.9 p -133.24 134.98 57.1 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 CA-C-N 118.981 1.39 . . . . 0.0 108.336 178.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -60.87 95.29 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 124.484 1.114 . . . . 0.0 108.853 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.76 -28.08 40.42 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.871 0.869 . . . . 0.0 110.12 179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -156.05 167.12 31.42 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 117.534 0.152 . . . . 0.0 111.026 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -137.61 -175.21 4.0 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 126.472 1.909 . . . . 0.0 108.306 -178.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.41 HD11 ' HB3' ' A' ' 98' ' ' SER . 13.5 tp 167.01 142.82 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 128.277 2.631 . . . . 0.0 107.595 179.433 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 14.9 m -132.15 149.21 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.415 0 C-N-CA 125.088 1.355 . . . . 0.0 108.295 176.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.13 168.69 44.33 Favored Glycine 0 CA--C 1.529 0.939 0 CA-C-O 121.749 0.639 . . . . 0.0 111.89 179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.48 43.61 0.24 Allowed 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 124.644 1.178 . . . . 0.0 113.38 -176.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' HD11 ' A' ' 94' ' ' LEU . 8.3 t -80.03 72.63 6.82 Favored 'General case' 0 CA--C 1.531 0.217 0 O-C-N 121.16 -0.963 . . . . 0.0 108.655 179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -50.67 -41.6 55.75 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.538 0.735 . . . . 0.0 111.155 -179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -57.14 -50.44 72.8 Favored 'General case' 0 CA--C 1.529 0.17 0 C-N-CA 123.251 0.62 . . . . 0.0 110.054 177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 15.3 tppt? -65.15 -38.93 92.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -53.59 -52.93 58.2 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 177.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -58.94 -52.29 66.39 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 123.933 0.893 . . . . 0.0 110.171 178.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.34 -46.82 76.36 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 122.706 0.402 . . . . 0.0 111.173 -179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 51.6 mt -57.6 -57.17 13.87 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 123.737 0.815 . . . . 0.0 109.379 179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 2.2 t -54.09 -47.24 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.281 0 C-N-CA 119.886 -0.726 . . . . 0.0 109.987 178.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.75 -50.52 72.02 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-O 119.417 -0.325 . . . . 0.0 111.416 -175.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.0 ptpt -68.12 -50.16 56.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 118.783 0.719 . . . . 0.0 111.243 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.2 m-70 -71.53 -13.5 61.82 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.97 0.729 . . . . 0.0 112.97 -175.72 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -44.21 -39.61 4.52 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 125.399 1.48 . . . . 0.0 112.425 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 63.15 -126.47 0.57 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.95 1.3 . . . . 0.0 108.894 -177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 N-CA-C 106.54 -1.652 . . . . 0.0 106.54 179.807 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.807 0 N-CA-C 109.9 -1.28 . . . . 0.0 109.9 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -76.88 50.66 3.02 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-N 118.471 1.136 . . . . 0.0 111.78 -179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.5 m -80.03 58.86 3.07 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.627 1.171 . . . . 0.0 109.447 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 62.7 t -83.49 176.59 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.425 0 C-N-CA 126.059 1.744 . . . . 0.0 108.575 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 9.7 pt -76.89 137.58 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-O 122.431 1.11 . . . . 0.0 109.651 -178.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 4.9 p -161.43 64.51 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.81 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 168.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.577 HG23 ' O ' ' A' ' 61' ' ' LYS . 11.9 tt -160.06 167.0 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 CA-C-N 113.812 -1.54 . . . . 0.0 108.129 -170.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -162.61 -44.22 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.598 1.559 . . . . 0.0 108.268 -179.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 73.6 m -112.92 157.21 21.74 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 125.148 1.379 . . . . 0.0 113.58 -175.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 34.2 ttmt -43.78 -37.97 2.99 Favored 'General case' 0 C--O 1.225 -0.23 0 C-N-CA 127.814 2.446 . . . . 0.0 112.895 -179.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.18 -28.67 1.31 Allowed 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 114.436 1.273 . . . . 0.0 114.436 -177.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -113.78 3.22 15.44 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 119.274 0.943 . . . . 0.0 112.232 177.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 68.1 t-105 -56.04 -57.11 13.52 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 124.91 1.284 . . . . 0.0 108.721 178.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -57.81 -47.04 83.75 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 114.477 -1.238 . . . . 0.0 110.078 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.34 -59.0 5.26 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.627 0.771 . . . . 0.0 110.856 -179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -57.3 -49.18 76.91 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 36.8 mt -52.04 -57.09 10.55 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 109.996 -0.372 . . . . 0.0 109.996 178.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.94 -59.55 4.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 124.104 0.962 . . . . 0.0 111.43 -178.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 pttm -60.27 -26.85 66.8 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 119.971 -0.691 . . . . 0.0 111.14 -177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.66 -24.4 69.61 Favored Glycine 0 CA--C 1.53 0.999 0 CA-C-O 118.32 -1.267 . . . . 0.0 113.669 178.24 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.4 mmtt 55.53 56.42 6.28 Favored 'General case' 0 N--CA 1.467 0.388 0 CA-C-N 119.606 1.703 . . . . 0.0 108.897 -176.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -31.76 -34.5 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 131.404 3.882 . . . . 0.0 117.564 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -12.65 -70.75 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 129.348 3.059 . . . . 0.0 113.147 -173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -139.16 53.16 1.75 Allowed 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -117.59 131.1 24.25 Favored Pre-proline 0 N--CA 1.455 -0.199 0 CA-C-O 118.813 -0.613 . . . . 0.0 110.13 -178.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -67.7 91.6 0.36 Allowed 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.538 1.492 . . . . 0.0 109.593 173.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 2.3 mt -86.16 92.22 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 N-CA-C 104.505 -2.405 . . . . 0.0 104.505 172.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.1 p -87.84 125.45 41.38 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 -177.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 21.8 t -106.33 113.37 42.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.23 -175.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.406 ' HB2' ' CE2' ' A' ' 46' ' ' PHE . 8.7 t0 -83.4 88.58 6.97 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 175.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -83.97 98.35 9.76 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 106.541 -1.652 . . . . 0.0 106.541 175.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.3 t -124.81 171.99 9.7 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.199 0.6 . . . . 0.0 109.781 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -118.65 105.57 11.73 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.993 1.317 . . . . 0.0 108.231 -178.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.4 p -43.28 -53.34 5.25 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 126.057 1.743 . . . . 0.0 112.807 -178.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.4 p-90 -58.92 -33.36 70.48 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 123.175 0.59 . . . . 0.0 111.867 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 11.2 t -75.82 85.42 2.79 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 177.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.93 -59.64 0.9 Allowed Glycine 0 CA--C 1.536 1.375 0 C-N-CA 124.664 1.126 . . . . 0.0 112.638 178.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -52.22 -39.54 71.51 Favored 'Trans proline' 0 N--CA 1.456 -0.68 0 C-N-CA 123.21 2.606 . . . . 0.0 113.214 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 36.5 m -71.16 -37.85 72.19 Favored 'General case' 0 C--O 1.232 0.17 0 C-N-CA 123.43 0.692 . . . . 0.0 109.179 179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 25.7 ttpp -67.26 -40.99 86.28 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 123.199 0.6 . . . . 0.0 110.442 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 83.3 mmm -53.61 -30.75 44.11 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 124.246 1.019 . . . . 0.0 112.672 -179.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 24.4 mm -66.64 -30.01 48.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 O-C-N 122.145 -0.347 . . . . 0.0 111.071 177.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.37 -55.4 37.67 Favored Pre-proline 0 CA--C 1.542 0.65 0 CA-C-O 117.72 -1.133 . . . . 0.0 112.704 -178.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -60.1 -34.34 94.58 Favored 'Trans proline' 0 C--N 1.349 0.577 0 CA-C-N 122.397 1.892 . . . . 0.0 112.067 178.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 66.5 mt -60.24 -53.26 59.78 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 175.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.406 ' CE2' ' HB2' ' A' ' 30' ' ' ASP . 93.0 t80 -53.9 -43.76 69.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 123.325 0.65 . . . . 0.0 109.925 177.618 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.7 tm-20 -58.79 -44.39 90.71 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 124.747 1.219 . . . . 0.0 110.078 177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.4 m -58.99 -49.48 77.72 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -62.27 -33.56 74.85 Favored 'General case' 0 C--O 1.225 -0.213 0 O-C-N 121.93 -0.481 . . . . 0.0 110.516 177.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.47 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 7.0 m -57.02 -45.48 83.06 Favored 'General case' 0 C--N 1.329 -0.294 0 O-C-N 121.763 -0.585 . . . . 0.0 109.65 176.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -63.91 -48.28 77.24 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 177.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -50.38 -45.17 55.16 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.855 0.462 . . . . 0.0 111.257 178.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.3 m-85 -102.69 44.68 1.0 Allowed 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 124.184 0.994 . . . . 0.0 110.116 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -76.81 43.29 0.33 Allowed 'General case' 0 CA--C 1.544 0.719 0 O-C-N 120.986 -1.071 . . . . 0.0 111.158 178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -105.27 -135.22 8.21 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.848 1.69 . . . . 0.0 109.668 -178.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 12.8 ptmt -80.44 45.07 0.74 Allowed 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 117.827 0.814 . . . . 0.0 110.007 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -131.46 148.77 32.66 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 107.801 -175.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.82 130.69 68.67 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.198 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 177.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.47 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 26.0 m-85 -113.38 137.19 51.88 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 177.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -147.27 124.72 11.65 Favored 'General case' 0 N--CA 1.457 -0.082 0 C-N-CA 120.582 -0.447 . . . . 0.0 109.882 -177.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.577 ' O ' HG23 ' A' ' 7' ' ' ILE . 39.4 ttpt -89.14 143.35 26.91 Favored 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 178.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 46.7 t -131.81 130.95 62.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.31 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 176.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -83.48 99.68 10.27 Favored 'General case' 0 N--CA 1.454 -0.274 0 N-CA-C 106.719 -1.585 . . . . 0.0 106.719 175.355 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -53.89 -43.37 57.04 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 124.38 1.072 . . . . 0.0 111.244 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -56.4 -49.63 73.92 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 122.718 0.407 . . . . 0.0 110.482 -177.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.57 -59.17 2.85 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.506 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.2 t -83.08 54.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 O-C-N 121.635 -0.666 . . . . 0.0 110.716 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -53.75 -45.95 70.75 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.768 0.827 . . . . 0.0 110.974 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.82 -56.32 20.64 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.917 0.887 . . . . 0.0 111.926 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.4 t -63.76 -43.58 98.01 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.28 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.52 -55.51 31.06 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -65.8 -41.88 91.36 Favored 'General case' 0 CA--C 1.533 0.303 0 O-C-N 121.194 -0.941 . . . . 0.0 110.636 -178.194 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.04 -45.15 94.85 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 118.252 0.478 . . . . 0.0 110.961 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.49 -47.97 76.97 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.397 1.079 . . . . 0.0 110.312 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 116.0 70.95 0.47 Allowed Glycine 0 CA--C 1.526 0.764 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 179.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -99.87 145.8 10.04 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.102 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 176.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 32.2 p -136.39 -88.67 0.3 Allowed 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 110.89 21.89 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 4.7 mpp? -76.67 140.88 68.2 Favored Pre-proline 0 CA--C 1.538 0.515 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 177.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 25.6 Cg_exo -72.92 141.29 71.2 Favored 'Cis proline' 0 N--CA 1.452 -0.938 0 CA-C-N 119.687 0.924 . . . . 0.0 111.02 -2.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.9 m -114.97 129.64 56.76 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.538 -1.653 . . . . 0.0 106.538 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.41 ' CG ' HD13 ' A' ' 102' ' ' LEU . 89.9 m-85 -111.17 122.05 46.87 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 108.944 -0.761 . . . . 0.0 108.944 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 30.6 m170 -116.8 144.55 44.35 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 176.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.62 103.84 15.98 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 178.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -95.36 93.72 7.41 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 118.199 0.454 . . . . 0.0 111.079 -178.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.7 mtmt -90.86 140.12 30.11 Favored 'General case' 0 C--O 1.233 0.207 0 N-CA-C 107.393 -1.336 . . . . 0.0 107.393 174.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 28.8 t70 68.28 -58.87 0.45 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 128.156 2.583 . . . . 0.0 110.646 -177.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 170.12 28.7 0.02 OUTLIER Glycine 0 CA--C 1.527 0.802 0 C-N-CA 127.26 2.362 . . . . 0.0 110.095 176.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 44.4 t -139.72 136.27 39.4 Favored 'Isoleucine or valine' 0 C--N 1.343 0.283 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 -176.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 27.9 ttpp -60.68 96.7 0.05 OUTLIER 'General case' 0 CA--C 1.529 0.168 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -28.23 40.84 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 122.736 0.415 . . . . 0.0 110.713 -177.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 47.4 t0 -160.23 167.46 27.55 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 107.877 -1.157 . . . . 0.0 107.877 -178.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -159.79 175.51 13.03 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 123.668 0.787 . . . . 0.0 110.558 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.9 tp -164.68 158.75 18.13 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.893 1.677 . . . . 0.0 108.255 -174.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.1 m -136.58 160.88 37.34 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 110.377 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.32 176.42 41.74 Favored Glycine 0 CA--C 1.527 0.807 0 C-N-CA 124.471 1.034 . . . . 0.0 111.554 178.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.42 41.77 0.26 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.145 0.978 . . . . 0.0 111.352 179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 11.4 m -78.26 58.83 2.16 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.126 1.77 . . . . 0.0 110.047 -176.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -55.71 -35.59 66.28 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.26 0.624 . . . . 0.0 112.192 -175.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.3 p-10 -58.49 -53.15 61.6 Favored 'General case' 0 CA--C 1.533 0.326 0 C-N-CA 123.262 0.625 . . . . 0.0 109.578 177.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -66.6 -34.9 78.92 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.41 HD13 ' CG ' ' A' ' 82' ' ' PHE . 23.7 tp -59.75 -50.48 73.67 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.165 0.586 . . . . 0.0 110.081 178.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -55.46 -44.78 76.71 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 176.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.32 -40.13 95.34 Favored 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.508 178.7 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 70.2 mt -54.37 -55.88 24.13 Favored 'General case' 0 C--N 1.343 0.287 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 177.041 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 47.7 t -56.74 -49.53 77.99 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 -177.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.15 -52.71 50.11 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.36 0.264 . . . . 0.0 111.124 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 65.3 tttt -56.63 -68.62 0.2 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 123.164 0.585 . . . . 0.0 109.773 178.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -62.61 -22.69 66.58 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 115.144 -0.934 . . . . 0.0 112.841 -169.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -67.0 -35.76 80.66 Favored 'General case' 0 CA--C 1.532 0.27 0 O-C-N 121.242 -0.911 . . . . 0.0 109.905 173.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -87.06 -51.05 6.23 Favored 'General case' 0 N--CA 1.456 -0.134 0 C-N-CA 123.56 0.744 . . . . 0.0 110.878 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.145 0 C-N-CA 125.168 1.387 . . . . 0.0 108.351 -179.105 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.981 0 CA-C-O 118.879 -0.956 . . . . 0.0 110.846 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.47 62.42 1.13 Allowed Glycine 0 CA--C 1.53 1.006 0 C-N-CA 124.4 1.0 . . . . 0.0 114.212 -175.538 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 19.6 m -80.95 65.48 6.11 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 175.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.437 HG22 ' HB3' ' A' ' 50' ' ' SER . 8.5 p -130.27 31.79 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.169 1.787 . . . . 0.0 108.805 -175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.6 pt -119.74 152.55 22.39 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 CA-C-O 122.56 1.171 . . . . 0.0 113.085 -171.292 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -79.75 128.7 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 C-N-CA 125.541 1.536 . . . . 0.0 110.566 -177.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.4 tt -160.82 -160.63 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 174.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -157.19 -56.9 0.08 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.616 0.766 . . . . 0.0 109.955 177.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.9 m -31.06 118.38 0.19 Allowed 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 127.36 2.264 . . . . 0.0 113.018 -176.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -40.51 -54.62 2.47 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.683 1.193 . . . . 0.0 112.869 -177.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -53.31 -43.24 67.41 Favored 'General case' 0 CA--C 1.534 0.361 0 O-C-N 121.475 -0.765 . . . . 0.0 111.029 179.085 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -35.74 73.63 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 118.818 -0.61 . . . . 0.0 110.399 178.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -58.54 -55.13 38.98 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 175.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 62.9 m-20 -56.67 -51.17 69.76 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 123.271 0.628 . . . . 0.0 110.069 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.4 -47.22 79.45 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.521 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -59.64 -42.68 93.29 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 108.844 -0.799 . . . . 0.0 108.844 -179.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 9.2 mt -56.22 -58.41 8.08 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 119.572 1.078 . . . . 0.0 109.212 175.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 -57.83 9.51 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.233 0.613 . . . . 0.0 112.318 -175.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -65.88 -10.11 35.39 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 122.001 -0.437 . . . . 0.0 111.44 -177.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.29 -35.43 91.6 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 109.402 -1.479 . . . . 0.0 109.402 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 13.6 mmmm 58.76 76.63 0.34 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.026 1.331 . . . . 0.0 107.883 -176.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.96 66.54 1.18 Allowed 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.236 1.415 . . . . 0.0 109.591 -178.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -72.27 -46.67 54.91 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 176.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 17.9 t-160 -170.39 65.64 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.759 1.624 . . . . 0.0 107.724 178.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 34.3 mmtm -139.99 132.67 14.95 Favored Pre-proline 0 CA--C 1.536 0.414 0 C-N-CA 125.416 1.486 . . . . 0.0 107.436 -178.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -70.65 137.27 32.51 Favored 'Trans proline' 0 N--CA 1.455 -0.772 0 C-N-CA 121.658 1.572 . . . . 0.0 109.096 177.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -113.61 120.3 63.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 N-CA-C 106.136 -1.801 . . . . 0.0 106.136 176.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.7 t -120.81 126.98 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 125.353 1.461 . . . . 0.0 107.988 -174.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.3 p -114.19 134.88 55.71 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 CA-C-N 118.395 0.543 . . . . 0.0 110.327 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -101.41 96.49 7.19 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.098 1.359 . . . . 0.0 107.525 175.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 72.9 m-85 -87.8 90.54 8.42 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.652 -1.61 . . . . 0.0 106.652 176.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 7.7 t -111.47 -178.48 3.46 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 124.664 1.186 . . . . 0.0 110.387 -178.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.86 112.33 8.74 Favored 'General case' 0 CA--C 1.527 0.082 0 C-N-CA 124.313 1.045 . . . . 0.0 109.712 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.5 p -36.99 -57.18 0.84 Allowed 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.568 1.947 . . . . 0.0 113.283 179.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 55.5 p-90 -64.31 -28.33 69.64 Favored 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.4 t -76.9 91.41 3.57 Favored 'General case' 0 C--O 1.224 -0.276 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -179.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -26.8 -65.97 0.07 OUTLIER Glycine 0 CA--C 1.538 1.531 0 C-N-CA 126.151 1.834 . . . . 0.0 115.211 178.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -63.44 -37.71 47.21 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 122.153 1.902 . . . . 0.0 112.102 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.4 m -62.14 -40.36 95.68 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -62.43 -50.72 70.36 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 177.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 48.1 tpp -56.93 -32.55 66.09 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.775 0.83 . . . . 0.0 112.057 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 6.0 mm -66.85 -27.43 39.77 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 O-C-N 121.471 -0.768 . . . . 0.0 110.746 176.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.97 -55.25 45.88 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 120.98 -1.075 . . . . 0.0 113.601 -177.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.9 Cg_endo -62.1 -31.08 83.29 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.861 1.707 . . . . 0.0 111.435 177.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -64.98 -48.37 74.25 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 176.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 90.5 t80 -54.58 -45.7 73.62 Favored 'General case' 0 CA--C 1.532 0.261 0 N-CA-C 109.168 -0.679 . . . . 0.0 109.168 175.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -58.02 -43.27 86.62 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 122.704 0.402 . . . . 0.0 110.394 177.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 51.3 m -58.8 -45.61 89.5 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 178.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.4 mp -64.51 -39.65 94.18 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 118.257 0.48 . . . . 0.0 110.132 177.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.437 ' HB3' HG22 ' A' ' 4' ' ' VAL . 10.3 m -51.53 -53.15 40.76 Favored 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 107.899 -1.149 . . . . 0.0 107.899 176.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -61.14 -48.72 80.31 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.013 0.525 . . . . 0.0 110.998 178.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -48.5 -56.38 8.46 Favored 'General case' 0 N--CA 1.462 0.128 0 C-N-CA 125.045 1.338 . . . . 0.0 111.744 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -79.61 -33.26 41.66 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.934 -178.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 70.78 -173.34 0.17 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.736 1.614 . . . . 0.0 112.082 178.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -41.43 -26.05 0.2 Allowed Glycine 0 CA--C 1.532 1.099 0 C-N-CA 126.893 2.187 . . . . 0.0 117.142 -174.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.2 ptpp? -66.2 -19.01 65.7 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 119.677 1.739 . . . . 0.0 111.814 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 32.6 m -114.98 139.29 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.147 0 N-CA-C 106.884 -1.525 . . . . 0.0 106.884 172.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 8.4 mm -92.76 121.42 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.484 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 3.5 m-85 -125.09 124.23 41.45 Favored 'General case' 0 CA--C 1.517 -0.313 0 O-C-N 121.321 -0.862 . . . . 0.0 109.127 -178.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -115.68 107.55 15.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.535 1.134 . . . . 0.0 111.111 -173.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 2.6 tppp? -79.87 131.17 35.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 173.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . 0.473 ' CG1' HG21 ' A' ' 67' ' ' VAL . 57.7 t -139.65 134.32 38.43 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.427 0 CA-C-N 119.203 0.911 . . . . 0.0 109.798 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -98.71 100.09 11.27 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.065 0.946 . . . . 0.0 109.046 177.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.7 t -44.56 -46.14 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 C-N-CA 128.165 2.586 . . . . 0.0 110.708 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -55.64 -53.32 58.01 Favored 'General case' 0 CA--C 1.533 0.292 0 O-C-N 123.455 0.472 . . . . 0.0 110.491 -178.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -68.55 -62.59 1.33 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 122.822 0.449 . . . . 0.0 111.098 179.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG21 ' CG1' ' A' ' 62' ' ' VAL . 28.0 m -83.07 57.25 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 O-C-N 121.288 -0.883 . . . . 0.0 111.69 -175.485 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.26 -42.48 30.67 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.133 0.973 . . . . 0.0 111.27 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -48.55 79.0 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.761 0.825 . . . . 0.0 111.13 178.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 46.5 t -66.82 -42.42 89.17 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.171 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.15 -52.83 63.74 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 122.466 0.307 . . . . 0.0 111.216 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -65.77 -39.93 91.49 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 121.617 -0.677 . . . . 0.0 110.104 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.56 -46.93 87.45 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.539 0.609 . . . . 0.0 110.662 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.45 77.85 Favored 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 123.822 0.849 . . . . 0.0 110.325 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 95.12 46.56 2.81 Favored Glycine 0 CA--C 1.525 0.669 0 C-N-CA 124.888 1.232 . . . . 0.0 110.77 178.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 35.8 mm -78.92 150.22 5.31 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.6 p -124.51 -84.94 0.64 Allowed 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.14 177.71 6.37 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 174.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 2.4 mpp? -138.44 152.26 70.84 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -80.52 141.96 57.98 Favored 'Cis proline' 0 N--CA 1.452 -0.962 0 N-CA-C 109.216 -1.109 . . . . 0.0 109.216 -3.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 7.2 m -110.58 135.04 51.83 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.334 -1.358 . . . . 0.0 107.334 178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -119.61 112.79 19.76 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.275 1.03 . . . . 0.0 110.397 -176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -110.17 154.04 23.9 Favored 'General case' 0 C--O 1.234 0.27 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 175.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.947 HG12 ' HB3' ' A' ' 91' ' ' ALA . 0.8 OUTLIER -119.79 139.03 48.46 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -136.17 73.88 1.48 Allowed 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 118.399 0.545 . . . . 0.0 112.453 -179.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 33.8 mtpt -70.67 152.66 43.62 Favored 'General case' 0 CA--C 1.534 0.35 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.0 t70 69.18 -64.11 0.35 Allowed 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 128.426 2.69 . . . . 0.0 109.116 -175.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 157.04 34.88 0.02 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.664 2.078 . . . . 0.0 110.339 178.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 58.6 t -140.08 145.1 26.81 Favored 'Isoleucine or valine' 0 C--N 1.339 0.121 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 -179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 34.9 ttmt -55.99 101.87 0.06 Allowed 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 108.393 -0.966 . . . . 0.0 108.393 179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.947 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -79.86 -41.75 25.64 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 125.347 1.459 . . . . 0.0 111.195 -175.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -159.02 160.06 35.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.23 -1.767 . . . . 0.0 106.23 -175.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 29.6 t0 -160.9 164.24 31.37 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 -179.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.3 pp -166.27 158.17 13.81 Favored 'General case' 0 C--N 1.326 -0.447 0 C-N-CA 127.137 2.175 . . . . 0.0 108.947 173.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 60.8 t -124.52 132.42 71.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.86 1.264 . . . . 0.0 107.948 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 129.83 160.56 10.18 Favored Glycine 0 CA--C 1.526 0.77 0 N-CA-C 111.305 -0.718 . . . . 0.0 111.305 176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.67 38.37 0.19 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 124.822 1.249 . . . . 0.0 111.441 179.184 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.0 m -79.55 70.63 6.06 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.374 1.07 . . . . 0.0 110.63 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.8 tp-100 -48.81 -41.15 31.84 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.837 1.255 . . . . 0.0 111.936 -179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.0 p-10 -60.5 -47.82 84.47 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.863 0.865 . . . . 0.0 110.152 177.058 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -66.96 -40.03 87.39 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -178.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 19.7 tp -53.14 -58.76 5.92 Favored 'General case' 0 N--CA 1.461 0.104 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 174.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 7.0 tmtm? -49.16 -50.71 36.42 Favored 'General case' 0 CA--C 1.537 0.45 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.14 -40.42 77.17 Favored 'General case' 0 CA--C 1.535 0.4 0 CA-C-O 118.447 -0.787 . . . . 0.0 111.603 178.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 56.0 mt -60.0 -50.05 75.28 Favored 'General case' 0 C--N 1.342 0.261 0 CA-C-N 119.984 1.266 . . . . 0.0 108.682 177.121 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.8 t -56.8 -50.15 75.97 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 -178.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -55.12 -57.45 11.68 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 122.235 0.214 . . . . 0.0 110.657 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -46.4 -62.16 1.48 Allowed 'General case' 0 C--O 1.227 -0.117 0 C-N-CA 125.971 1.708 . . . . 0.0 111.117 178.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -74.28 -22.28 59.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.967 -172.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -69.77 -47.78 61.67 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 171.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -81.13 56.64 2.89 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.469 0.708 . . . . 0.0 109.837 177.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.128 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 -179.798 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.925 0 CA-C-O 119.682 -0.51 . . . . 0.0 112.128 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 76.43 -60.08 3.24 Favored Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.016 -0.833 . . . . 0.0 111.016 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.5 p -74.79 65.41 1.36 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.684 1.594 . . . . 0.0 110.891 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 m -138.26 31.27 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 C-N-CA 127.662 2.385 . . . . 0.0 107.57 176.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 34.2 pt -138.12 -171.48 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 126.922 2.089 . . . . 0.0 108.785 -176.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 38.6 t -78.42 73.43 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 N-CA-C 106.028 -1.841 . . . . 0.0 106.028 176.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tp -79.08 145.8 8.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.369 0 C-N-CA 124.755 1.222 . . . . 0.0 109.202 -176.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.5 t0 -80.12 63.47 4.64 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.323 0.649 . . . . 0.0 112.492 -174.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 32.1 t 29.73 -119.15 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.268 0 C-N-CA 126.534 1.934 . . . . 0.0 113.532 170.531 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -38.2 -47.89 1.22 Allowed 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 129.111 2.964 . . . . 0.0 115.304 -175.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.99 79.31 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 122.928 0.491 . . . . 0.0 110.934 -179.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -87.55 -40.15 14.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.379 0.672 . . . . 0.0 110.955 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.6 t-105 -32.41 -64.75 0.17 Allowed 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 128.566 2.746 . . . . 0.0 113.181 -176.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -58.99 -55.91 29.12 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 121.858 0.837 . . . . 0.0 111.833 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.86 -52.45 49.39 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.653 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.92 -53.75 54.4 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.799 1.24 . . . . 0.0 110.155 -179.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -46.44 -49.21 18.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.976 1.311 . . . . 0.0 109.834 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -79.41 -61.84 1.88 Allowed 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 111.816 0.302 . . . . 0.0 111.816 -176.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -56.81 -26.7 58.64 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.395 0.678 . . . . 0.0 111.665 -175.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -58.59 -28.89 63.18 Favored Glycine 0 N--CA 1.443 -0.878 0 CA-C-O 117.56 -1.689 . . . . 0.0 112.103 178.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 38.1 mtmm 49.19 60.38 3.79 Favored 'General case' 0 N--CA 1.467 0.397 0 CA-C-N 119.288 1.544 . . . . 0.0 108.054 -177.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.9 pm0 -63.39 24.6 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 128.392 2.677 . . . . 0.0 116.342 -171.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.8 mp0 -80.92 -59.74 2.56 Favored 'General case' 0 N--CA 1.453 -0.284 0 O-C-N 120.867 -1.146 . . . . 0.0 108.378 -178.65 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -112.45 36.36 3.44 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.544 1.137 . . . . 0.0 108.1 176.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -145.22 123.35 6.49 Favored Pre-proline 0 CA--C 1.534 0.346 0 N-CA-C 107.409 -1.33 . . . . 0.0 107.409 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -78.39 118.64 4.33 Favored 'Trans proline' 0 N--CA 1.45 -1.087 0 C-N-CA 123.712 2.941 . . . . 0.0 110.454 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 pt -107.08 112.4 39.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 N-CA-C 103.225 -2.879 . . . . 0.0 103.225 171.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 38.8 t -119.84 148.44 22.89 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.461 0 C-N-CA 125.892 1.677 . . . . 0.0 107.085 -174.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 83' ' ' HIS . 7.7 p -133.62 137.05 53.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 175.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -105.71 98.06 7.8 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 127.415 2.286 . . . . 0.0 106.217 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.9 m-85 -92.74 93.85 8.68 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.7 t -113.36 -167.71 1.23 Allowed 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 123.34 0.656 . . . . 0.0 109.654 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -140.39 173.64 11.3 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.288 1.435 . . . . 0.0 110.11 -177.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.7 p -99.28 -65.06 0.98 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 125.442 1.497 . . . . 0.0 109.376 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 67.4 p-90 -49.37 -24.62 2.01 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 126.317 1.847 . . . . 0.0 112.808 -179.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 13.6 p -58.41 -16.64 15.65 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 123.134 0.574 . . . . 0.0 111.881 176.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 62.64 -112.64 5.1 Favored Glycine 0 CA--C 1.528 0.871 0 CA-C-O 118.128 -1.373 . . . . 0.0 110.552 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -38.62 -46.61 2.56 Favored 'Trans proline' 0 N--CA 1.455 -0.738 0 C-N-CA 124.126 3.217 . . . . 0.0 115.026 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -52.55 -32.28 39.95 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.35 0.5 . . . . 0.0 112.35 -177.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.8 tmtt? -56.13 -28.59 58.5 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 123.618 0.767 . . . . 0.0 110.559 -179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 4.8 ppp? -54.35 -25.45 24.24 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.802 0.841 . . . . 0.0 112.501 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 59.0 mt -68.86 -30.12 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 O-C-N 122.009 -0.432 . . . . 0.0 110.654 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.9 -59.07 10.72 Favored Pre-proline 0 CA--C 1.54 0.568 0 CA-C-O 117.875 -1.06 . . . . 0.0 112.258 -178.138 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -59.5 -35.95 94.55 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 121.817 1.678 . . . . 0.0 112.427 179.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 92.5 mt -62.67 -50.74 69.97 Favored 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 178.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 82.9 t80 -55.38 -44.12 75.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 175.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -61.15 -37.56 83.3 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.429 0.692 . . . . 0.0 110.536 177.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 48.5 m -61.46 -47.29 86.35 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 177.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.2 mp -61.39 -43.48 98.8 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.688 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.4 m -50.27 -51.01 48.46 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 177.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -66.91 -35.98 81.22 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.881 0.872 . . . . 0.0 110.71 179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -58.69 -47.91 82.92 Favored 'General case' 0 N--CA 1.458 -0.051 0 C-N-CA 123.107 0.563 . . . . 0.0 110.345 179.822 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 49.0 m-85 -79.17 -50.95 10.17 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 109.962 -0.384 . . . . 0.0 109.962 -179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 61.7 -63.72 0.08 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 127.737 2.415 . . . . 0.0 116.048 175.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.89 -104.66 0.01 OUTLIER Glycine 0 CA--C 1.53 1.012 0 C-N-CA 126.955 2.217 . . . . 0.0 115.755 -171.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -76.61 48.7 0.57 Allowed 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.143 0.977 . . . . 0.0 113.215 -172.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.9 m -145.36 159.81 13.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 C-N-CA 124.957 1.303 . . . . 0.0 110.505 -178.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.2 mp -134.19 121.63 38.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 107.003 -1.48 . . . . 0.0 107.003 173.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.7 m-85 -123.31 95.08 4.46 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 125.051 1.34 . . . . 0.0 107.746 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 84.1 mt -81.79 102.62 10.91 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 124.468 1.107 . . . . 0.0 111.349 -178.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 30.4 tptt -79.58 118.83 21.78 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 68.8 t -136.52 148.18 27.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-O 121.907 0.86 . . . . 0.0 111.173 -176.429 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.6 t0 -111.43 112.89 24.95 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 125.443 1.497 . . . . 0.0 109.178 -179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.6 m -60.18 -31.2 47.57 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.121 0 C-N-CA 122.527 0.331 . . . . 0.0 110.954 179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -62.32 -34.39 76.53 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 109.279 -0.638 . . . . 0.0 109.279 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -82.55 -66.46 0.89 Allowed 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 25.7 m -85.69 62.96 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.149 0 O-C-N 121.605 -0.684 . . . . 0.0 111.766 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.38 -43.19 44.03 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.351 177.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.3 -56.31 23.69 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.215 1.006 . . . . 0.0 111.711 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 39.6 t -62.12 -43.35 97.66 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.106 0 N-CA-C 108.751 -0.833 . . . . 0.0 108.751 -178.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.65 -55.13 35.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 122.867 0.467 . . . . 0.0 110.997 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.0 pp20? -66.2 -40.01 90.08 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 118.668 0.667 . . . . 0.0 110.08 -179.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.57 -42.03 82.28 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-N 118.639 0.654 . . . . 0.0 110.352 178.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.51 3.44 21.6 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 123.958 0.903 . . . . 0.0 111.715 177.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.45 32.74 85.19 Favored Glycine 0 CA--C 1.526 0.78 0 C-N-CA 124.013 0.816 . . . . 0.0 112.644 178.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.5 mm -72.12 134.88 29.02 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 12.1 p -136.58 -70.11 0.47 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.872 1.269 . . . . 0.0 108.323 -178.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.82 62.28 1.53 Allowed 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.769 0.828 . . . . 0.0 111.376 -179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.35 143.27 98.2 Favored Pre-proline 0 CA--C 1.546 0.807 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 176.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 96.0 Cg_endo -72.46 136.56 44.19 Favored 'Cis proline' 0 N--CA 1.448 -1.151 0 CA-C-N 120.063 1.058 . . . . 0.0 110.606 0.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.0 m -126.56 129.57 48.83 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.44 1.096 . . . . 0.0 108.34 -179.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -106.97 128.33 54.24 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 126.23 1.812 . . . . 0.0 106.902 -179.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . 0.421 ' HB2' HG13 ' A' ' 29' ' ' VAL . 5.2 m170 -127.94 150.98 49.65 Favored 'General case' 0 C--N 1.332 -0.19 0 C-N-CA 124.699 1.199 . . . . 0.0 108.889 -177.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.9 t -129.08 138.06 55.51 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 124.842 1.257 . . . . 0.0 107.639 176.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -129.75 50.81 2.13 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 118.851 0.75 . . . . 0.0 111.108 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.3 mtpp -64.02 154.38 34.44 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 173.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 24.4 t70 74.51 -58.28 0.59 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.626 1.97 . . . . 0.0 109.227 -174.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 164.35 -48.6 0.3 Allowed Glycine 0 CA--C 1.52 0.383 0 N-CA-C 109.304 -1.519 . . . . 0.0 109.304 177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 12.6 p -70.54 157.25 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 C-N-CA 122.93 0.492 . . . . 0.0 109.924 178.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.6 ttpp -56.42 106.15 0.26 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 175.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.06 -42.5 17.38 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.103 0.961 . . . . 0.0 112.367 -172.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 49.6 t0 -159.98 155.84 26.1 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -142.29 163.64 32.29 Favored 'General case' 0 C--N 1.337 0.059 0 C-N-CA 124.469 1.108 . . . . 0.0 110.076 -177.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.6 tm? -157.52 115.86 3.17 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.146 1.378 . . . . 0.0 107.959 -179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.7 m -99.62 160.77 3.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 C-N-CA 123.708 0.803 . . . . 0.0 112.274 -177.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 177.17 40.42 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 124.196 0.903 . . . . 0.0 112.185 175.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.44 40.99 0.24 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.361 1.064 . . . . 0.0 111.298 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 6.1 m -80.73 58.98 3.48 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 125.31 1.444 . . . . 0.0 110.271 -175.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 10.5 tp-100 -43.95 -51.97 7.28 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 125.59 1.556 . . . . 0.0 112.555 -176.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -52.77 -51.03 62.28 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 123.419 0.687 . . . . 0.0 110.671 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 1.1 ttmp? -69.48 -32.37 71.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.093 0.557 . . . . 0.0 109.838 -178.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.81 -57.76 11.08 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 175.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 48.5 mttm -55.78 -46.24 78.0 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 122.755 0.422 . . . . 0.0 109.869 179.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -54.76 -47.73 73.52 Favored 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 119.653 -0.213 . . . . 0.0 110.684 178.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 4.4 mt -63.09 -45.64 91.15 Favored 'General case' 0 N--CA 1.457 -0.106 0 CA-C-N 118.661 0.664 . . . . 0.0 110.473 178.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 93.2 t -56.45 -50.9 70.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.329 0 N-CA-C 108.69 -0.855 . . . . 0.0 108.69 178.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.86 -46.16 74.64 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 122.618 0.367 . . . . 0.0 111.031 178.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.2 ttmt -60.13 -58.64 7.67 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 124.006 0.922 . . . . 0.0 111.501 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -70.66 -53.13 16.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 N-CA-C 109.792 -0.447 . . . . 0.0 109.792 -175.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.14 57.58 4.01 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.712 0.805 . . . . 0.0 109.059 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -74.33 -46.8 38.51 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 122.785 0.434 . . . . 0.0 109.951 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 C-N-CA 127.458 2.303 . . . . 0.0 105.588 179.978 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.034 0 CA-C-O 117.354 -1.803 . . . . 0.0 108.679 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.19 -158.32 14.36 Favored Glycine 0 CA--C 1.527 0.792 0 N-CA-C 109.199 -1.56 . . . . 0.0 109.199 -179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.5 p -82.42 67.55 8.5 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.0 m -120.08 20.65 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 C-N-CA 124.894 1.278 . . . . 0.0 111.972 -174.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -157.71 176.08 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.772 0 C-N-CA 126.849 2.059 . . . . 0.0 106.908 -177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.44 HG12 ' H ' ' A' ' 61' ' ' LYS . 6.2 p -150.44 -158.72 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.615 0 N-CA-C 102.325 -3.213 . . . . 0.0 102.325 172.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . 0.402 ' H ' HG22 ' A' ' 6' ' ' VAL . 21.1 tt -156.39 164.26 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 N-CA-C 106.773 -1.566 . . . . 0.0 106.773 -178.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -68.85 -34.6 75.75 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.422 1.089 . . . . 0.0 112.652 -174.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 49.8 m -62.71 105.12 0.61 Allowed 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 122.879 0.472 . . . . 0.0 109.976 -177.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -39.62 -51.66 2.25 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.811 1.645 . . . . 0.0 113.158 -176.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -50.25 -39.7 45.72 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-O 121.465 0.65 . . . . 0.0 111.597 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.11 -27.92 66.88 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.188 0.595 . . . . 0.0 111.246 179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -61.98 -49.41 76.2 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 106.715 -1.587 . . . . 0.0 106.715 175.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 55.1 m-20 -59.98 -47.08 87.27 Favored 'General case' 0 C--N 1.34 0.156 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.51 -48.69 68.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.877 177.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.49 -50.81 68.93 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.527 0.731 . . . . 0.0 109.525 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.2 mt -49.81 -50.74 43.97 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 118.279 0.491 . . . . 0.0 109.804 176.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.69 -55.7 27.59 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -177.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.8 ptmm? -64.27 -22.0 66.79 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 120.119 -0.632 . . . . 0.0 110.776 -179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -67.18 25.39 0.2 Allowed Glycine 0 CA--C 1.536 1.382 0 C-N-CA 124.728 1.156 . . . . 0.0 115.399 -179.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 36.0 mmtp 51.44 70.82 0.5 Allowed 'General case' 0 CA--C 1.528 0.106 0 C-N-CA 125.276 1.43 . . . . 0.0 111.461 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -70.9 70.84 0.51 Allowed 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.496 1.918 . . . . 0.0 109.728 178.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -109.18 -66.38 1.06 Allowed 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 174.614 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 52.3 p-80 -161.4 17.85 0.11 Allowed 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 126.08 1.752 . . . . 0.0 109.872 178.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 38.8 mmtm -75.29 142.16 74.76 Favored Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.989 -172.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -73.93 115.08 4.2 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 123.762 2.975 . . . . 0.0 110.931 177.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 49.7 mt -101.16 101.04 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.168 -2.16 . . . . 0.0 105.168 174.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.9 t -97.32 109.61 23.63 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -178.021 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 12.1 p -107.72 121.22 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-O 121.517 0.675 . . . . 0.0 109.846 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 6.7 t0 -85.59 100.01 11.66 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 125.723 1.609 . . . . 0.0 106.958 174.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -94.02 99.22 11.57 Favored 'General case' 0 N--CA 1.451 -0.383 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 173.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 37.2 m -131.71 153.54 49.92 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -90.43 158.43 17.08 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-O 121.316 0.579 . . . . 0.0 110.678 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 4.8 m -66.4 -29.52 69.69 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.365 1.066 . . . . 0.0 108.235 171.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 6.0 m95 -60.97 179.5 0.18 Allowed 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 127.257 2.223 . . . . 0.0 112.996 177.481 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 5.9 t 69.39 -62.25 0.41 Allowed 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.518 2.327 . . . . 0.0 111.733 176.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 105.38 -83.05 0.36 Allowed Glycine 0 CA--C 1.53 1.015 0 CA-C-O 118.04 -1.422 . . . . 0.0 110.665 178.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 99.4 Cg_exo -47.32 -41.98 27.91 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 123.494 2.796 . . . . 0.0 112.276 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.0 m -46.47 -39.24 10.37 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.703 1.601 . . . . 0.0 111.285 177.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.2 tttp -80.79 -12.45 59.44 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.339 1.056 . . . . 0.0 113.067 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 92.3 mmm -58.63 -27.23 64.53 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.876 1.216 . . . . 0.0 111.362 178.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 89.5 mt -64.63 -27.69 43.12 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-O 119.331 -0.366 . . . . 0.0 110.395 176.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.62 -59.17 10.19 Favored Pre-proline 0 CA--C 1.54 0.592 0 CA-C-O 117.547 -1.216 . . . . 0.0 112.502 -178.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -60.47 -35.62 89.84 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 122.153 1.902 . . . . 0.0 112.614 178.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 83.5 mt -61.4 -53.11 60.89 Favored 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 177.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -54.8 -41.46 70.62 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.375 1.07 . . . . 0.0 108.963 175.72 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 -62.66 -35.51 79.89 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.608 1.163 . . . . 0.0 110.794 178.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -62.8 -50.92 69.1 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 176.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 9.9 mp -57.92 -41.46 82.72 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 176.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.6 m -50.97 -55.76 15.71 Favored 'General case' 0 N--CA 1.456 -0.139 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 37.7 m-80 -58.64 -38.0 77.15 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 118.81 -0.614 . . . . 0.0 111.273 178.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -60.61 -48.13 83.14 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 118.589 0.631 . . . . 0.0 111.263 179.175 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -79.62 -29.98 41.24 Favored 'General case' 0 CA--C 1.539 0.523 0 O-C-N 121.794 -0.566 . . . . 0.0 112.033 -178.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.11 -70.16 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 128.434 2.694 . . . . 0.0 114.342 176.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -127.72 -15.51 2.39 Favored Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.334 1.445 . . . . 0.0 112.654 -177.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.7 mmpt? -62.49 -34.65 77.28 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 118.467 1.134 . . . . 0.0 110.388 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -129.73 139.44 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 -179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 24.0 mm -93.61 99.53 9.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -94.46 115.63 27.84 Favored 'General case' 0 N--CA 1.461 0.107 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 -179.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.4 mt -109.9 140.59 43.7 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.517 1.127 . . . . 0.0 108.95 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.44 ' H ' HG12 ' A' ' 6' ' ' VAL . 8.9 mtpm? -121.65 89.95 3.22 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.196 0.999 . . . . 0.0 110.448 -177.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 69.5 t -97.19 120.23 46.26 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.323 0 N-CA-C 112.351 0.5 . . . . 0.0 112.351 -174.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 102.42 5.59 Favored 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 106.984 -1.488 . . . . 0.0 106.984 171.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.5 t -44.84 -43.11 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 C-N-CA 124.867 1.267 . . . . 0.0 111.446 -179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.93 -41.42 11.53 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 126.094 1.758 . . . . 0.0 111.611 178.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -76.37 -70.21 0.46 Allowed 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.019 0.527 . . . . 0.0 111.354 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 24.5 m -83.64 59.38 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 O-C-N 121.743 -0.598 . . . . 0.0 111.191 -174.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.41 -43.1 23.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.024 0.93 . . . . 0.0 111.137 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.12 -49.68 76.11 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.941 0.896 . . . . 0.0 111.307 179.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 43.6 t -66.07 -44.52 91.91 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.148 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.8 -55.14 33.39 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 122.893 0.477 . . . . 0.0 110.91 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -64.21 -43.47 94.91 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.384 0.538 . . . . 0.0 109.938 -179.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.65 -40.95 76.35 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.716 0.689 . . . . 0.0 110.844 178.44 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.58 6.28 18.17 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.607 1.163 . . . . 0.0 111.695 179.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 60.09 28.3 66.26 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.243 -0.91 . . . . 0.0 112.751 178.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 50.2 mm -66.78 119.75 12.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.38 0 N-CA-C 107.219 -1.4 . . . . 0.0 107.219 -179.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 1.7 p -137.3 -70.72 0.44 Allowed 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 124.883 1.273 . . . . 0.0 108.74 -174.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.92 65.75 1.45 Allowed 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.456 0.702 . . . . 0.0 110.996 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.25 142.0 89.31 Favored Pre-proline 0 CA--C 1.543 0.679 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 82.0 Cg_exo -61.05 133.4 10.84 Favored 'Cis proline' 0 N--CA 1.46 -0.492 0 CA-C-N 121.253 1.483 . . . . 0.0 112.894 -2.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 54.5 m -127.05 109.87 12.34 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -96.62 123.49 40.31 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.269 -1.382 . . . . 0.0 107.269 178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 3.0 m170 -115.74 139.99 49.63 Favored 'General case' 0 CA--C 1.506 -0.723 0 C-N-CA 124.596 1.159 . . . . 0.0 109.68 -178.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 39.4 t -114.48 121.77 67.24 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.115 0 N-CA-C 108.763 -0.828 . . . . 0.0 108.763 177.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -116.13 107.06 14.43 Favored 'General case' 0 N--CA 1.437 -1.079 0 O-C-N 124.84 1.338 . . . . 0.0 107.418 172.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -86.63 130.5 34.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 105.917 -1.882 . . . . 0.0 105.917 176.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.9 t70 70.46 -68.69 0.2 Allowed 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 126.847 2.059 . . . . 0.0 107.753 -174.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -178.94 27.14 0.05 OUTLIER Glycine 0 CA--C 1.532 1.095 0 C-N-CA 127.148 2.309 . . . . 0.0 110.245 177.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 59.5 t -125.0 130.07 73.28 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 -178.716 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -61.07 109.4 1.08 Allowed 'General case' 0 CA--C 1.531 0.22 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 -179.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -93.87 -40.84 9.94 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 123.197 0.599 . . . . 0.0 111.682 -175.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -160.38 170.81 20.26 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 -174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 25.1 m-20 -157.04 170.71 21.9 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.437 HD11 ' HB2' ' A' ' 98' ' ' SER . 1.1 tm? -163.01 122.67 2.21 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 -178.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 28.9 m -105.9 164.63 4.2 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 124.765 1.226 . . . . 0.0 112.289 -177.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.48 179.23 49.09 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 124.676 1.132 . . . . 0.0 111.692 176.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.34 39.18 0.25 Allowed 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.819 0.848 . . . . 0.0 111.161 179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.437 ' HB2' HD11 ' A' ' 94' ' ' LEU . 6.3 m -80.87 57.94 3.21 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 125.63 1.572 . . . . 0.0 110.164 -175.426 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -51.12 -48.93 61.63 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.401 1.08 . . . . 0.0 112.559 -174.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -56.53 -47.13 80.03 Favored 'General case' 0 C--O 1.232 0.181 0 O-C-N 121.562 -0.711 . . . . 0.0 110.113 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -61.54 -44.18 97.51 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 179.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 54.6 tp -56.34 -54.49 44.84 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 177.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -54.81 -47.64 73.8 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.39 -45.75 80.45 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 110.339 -0.245 . . . . 0.0 110.339 177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 6.3 mt -61.51 -46.15 91.2 Favored 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.572 178.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 84.9 t -54.99 -51.68 51.32 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.099 0 CA-C-N 119.292 0.951 . . . . 0.0 108.683 178.33 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.49 -48.19 69.16 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 122.472 0.309 . . . . 0.0 111.077 179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 11.3 tppt? -58.17 -58.69 7.34 Favored 'General case' 0 CA--C 1.529 0.166 0 C-N-CA 124.394 1.078 . . . . 0.0 111.273 178.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.8 m-70 -75.05 -15.68 60.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 CA-C-O 118.326 -0.845 . . . . 0.0 112.746 -173.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -37.48 -48.81 1.0 Allowed 'General case' 0 C--N 1.342 0.259 0 C-N-CA 126.12 1.768 . . . . 0.0 112.67 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.1 -119.56 1.53 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 123.666 0.786 . . . . 0.0 109.739 -178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.282 0 N-CA-C 106.166 -1.79 . . . . 0.0 106.166 178.895 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.861 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 60.55 -120.39 22.62 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 109.496 -1.442 . . . . 0.0 109.496 -178.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.0 p -74.12 -24.46 59.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 117.735 0.767 . . . . 0.0 112.424 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 1.8 m -99.72 128.32 51.66 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -145.01 143.64 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 C-N-CA 124.476 1.111 . . . . 0.0 110.705 -171.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 33.2 m -125.28 120.95 59.46 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.753 0 N-CA-C 102.601 -3.111 . . . . 0.0 102.601 171.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 2.1 tp -151.71 160.39 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 CA-C-O 122.669 1.223 . . . . 0.0 111.639 -173.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -133.69 35.36 3.38 Favored 'General case' 0 N--CA 1.446 -0.638 0 C-N-CA 127.076 2.15 . . . . 0.0 108.544 178.186 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.5 m -158.69 134.3 8.78 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.925 1.29 . . . . 0.0 108.232 179.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -51.69 -37.19 49.64 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.417 1.087 . . . . 0.0 112.46 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -34.01 -62.28 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.432 1.893 . . . . 0.0 112.573 -178.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -66.74 -34.13 77.16 Favored 'General case' 0 N--CA 1.456 -0.163 0 O-C-N 121.935 -0.478 . . . . 0.0 111.363 -177.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.16 -51.68 68.57 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -67.57 -47.51 69.57 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 121.213 0.53 . . . . 0.0 110.297 -178.42 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.1 -50.84 60.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.722 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -69.02 -46.14 68.72 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-O 118.04 -0.981 . . . . 0.0 110.951 179.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 mt -43.53 -52.2 6.32 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 118.932 0.787 . . . . 0.0 109.443 176.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -61.46 -70.0 0.21 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.228 0.611 . . . . 0.0 112.179 -179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 10.4 ptpp? -59.91 -28.42 67.58 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 118.895 0.77 . . . . 0.0 112.072 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.82 -24.28 69.79 Favored Glycine 0 CA--C 1.53 1.018 0 C-N-CA 125.542 1.544 . . . . 0.0 111.842 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt 60.68 67.33 0.84 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.623 1.212 . . . . 0.0 110.485 -179.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -47.02 -22.33 0.32 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.837 2.055 . . . . 0.0 113.459 178.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -34.14 -54.74 0.5 Allowed 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 127.318 2.247 . . . . 0.0 110.572 176.094 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -130.66 -13.28 3.76 Favored 'General case' 0 C--N 1.341 0.231 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 176.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -79.85 115.14 51.82 Favored Pre-proline 0 C--N 1.319 -0.72 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HG2' HG22 ' A' ' 57' ' ' VAL . 57.1 Cg_endo -63.35 129.05 24.18 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 121.095 1.196 . . . . 0.0 109.734 178.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.4 mm -102.72 87.78 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.187 -1.783 . . . . 0.0 106.187 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.9 p -83.47 118.07 30.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.8 t -108.38 116.39 51.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.266 0 C-N-CA 123.274 0.63 . . . . 0.0 109.468 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 49.3 t0 -92.47 89.19 6.66 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.053 -1.832 . . . . 0.0 106.053 174.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -79.71 94.49 5.74 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 106.738 -1.579 . . . . 0.0 106.738 176.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -115.84 -174.19 2.49 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.166 1.386 . . . . 0.0 108.38 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.72 139.56 40.22 Favored 'General case' 0 CA--C 1.527 0.075 0 C-N-CA 123.191 0.596 . . . . 0.0 110.971 -178.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.7 p -41.86 -58.91 1.87 Allowed 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 125.293 1.437 . . . . 0.0 110.182 173.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 30.4 p-90 -72.47 7.85 1.65 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 125.076 1.351 . . . . 0.0 113.94 -177.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.4 p -74.43 -7.65 53.68 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 120.449 1.477 . . . . 0.0 111.747 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 48.11 -110.36 0.64 Allowed Glycine 0 CA--C 1.531 1.058 0 CA-C-O 118.228 -1.318 . . . . 0.0 112.153 176.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -43.53 -41.6 10.87 Favored 'Trans proline' 0 N--CA 1.458 -0.597 0 C-N-CA 124.0 3.133 . . . . 0.0 114.728 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.43 -25.9 60.33 Favored 'General case' 0 CA--C 1.534 0.354 0 O-C-N 122.239 -0.288 . . . . 0.0 111.455 -178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.1 tppp? -54.01 -27.92 34.85 Favored 'General case' 0 CA--C 1.534 0.347 0 O-C-N 121.8 -0.562 . . . . 0.0 111.135 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 75.0 mtm -57.71 -21.7 42.18 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 118.734 0.697 . . . . 0.0 112.457 177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.434 HD11 ' HB2' ' A' ' 97' ' ' ALA . 43.1 mt -69.04 -32.14 53.12 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 O-C-N 121.654 -0.654 . . . . 0.0 109.704 176.547 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.97 -56.72 22.7 Favored Pre-proline 0 CA--C 1.537 0.479 0 CA-C-O 117.133 -1.413 . . . . 0.0 112.56 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -59.47 -34.72 97.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.26 1.974 . . . . 0.0 112.357 179.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -61.55 -54.41 43.48 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 176.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -56.71 -39.16 73.37 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -61.99 -42.33 99.02 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.339 1.056 . . . . 0.0 109.572 177.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.1 m -58.41 -48.24 81.31 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 107.818 -1.178 . . . . 0.0 107.818 177.219 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 14.2 tp -59.61 -36.54 76.49 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 176.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.51 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 12.5 m -58.35 -48.83 79.32 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.477 0.711 . . . . 0.0 110.135 177.343 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -56.94 -54.04 51.14 Favored 'General case' 0 CA--C 1.529 0.164 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 175.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 43.8 m-20 -54.33 -44.31 71.96 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 123.347 0.659 . . . . 0.0 111.844 -174.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -105.83 32.39 4.39 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.968 0.907 . . . . 0.0 111.308 179.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.94 144.42 33.87 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.519 -0.738 . . . . 0.0 110.899 -179.008 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 77.23 -60.7 3.53 Favored Glycine 0 CA--C 1.529 0.908 0 N-CA-C 111.549 -0.621 . . . . 0.0 111.549 179.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 40.8 mtpt -62.12 -30.82 71.29 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.03 0.752 . . . . 0.0 113.03 -176.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.419 HG22 ' HG2' ' A' ' 26' ' ' PRO . 78.4 t -126.21 143.09 40.88 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 7.8 mm -100.48 118.02 46.54 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.208 0 N-CA-C 106.6 -1.63 . . . . 0.0 106.6 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.51 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 63.2 m-85 -107.51 105.6 15.58 Favored 'General case' 0 CA--C 1.518 -0.285 0 C-N-CA 124.105 0.962 . . . . 0.0 108.827 -177.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -106.81 89.36 2.99 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 124.607 1.163 . . . . 0.0 110.692 -177.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 1.2 ttpp -79.9 111.04 15.84 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.5 t -110.78 128.56 67.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 C-N-CA 124.008 0.923 . . . . 0.0 109.952 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -83.25 106.31 14.92 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 173.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 25.6 m -62.37 -33.79 61.01 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.115 0 C-N-CA 123.204 0.601 . . . . 0.0 111.059 179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -51.42 -48.2 62.73 Favored 'General case' 0 CA--C 1.53 0.205 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.45 -59.98 2.56 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.663 0.785 . . . . 0.0 110.846 176.299 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.5 t -81.74 60.36 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 CA-C-O 121.765 0.793 . . . . 0.0 110.498 -175.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.27 -43.96 79.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.021 0.928 . . . . 0.0 110.675 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.27 -57.11 11.65 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.085 0.954 . . . . 0.0 111.907 -178.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 44.3 t -64.66 -44.07 96.64 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.157 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.04 -52.83 57.23 Favored 'General case' 0 CA--C 1.534 0.329 0 N-CA-C 111.651 0.241 . . . . 0.0 111.651 -179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -68.19 -42.43 79.95 Favored 'General case' 0 CA--C 1.532 0.271 0 O-C-N 121.79 -0.569 . . . . 0.0 109.974 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.72 -41.28 77.17 Favored 'General case' 0 CA--C 1.536 0.409 0 CA-C-N 118.684 0.674 . . . . 0.0 110.813 178.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.21 3.38 27.55 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.782 1.233 . . . . 0.0 111.636 178.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.41 38.59 91.12 Favored Glycine 0 CA--C 1.528 0.861 0 C-N-CA 124.19 0.9 . . . . 0.0 112.632 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 44.8 mm -76.26 134.66 28.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 34.7 p -136.25 -74.03 0.44 Allowed 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 124.605 1.162 . . . . 0.0 108.749 -179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -74.23 68.41 1.47 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.503 1.121 . . . . 0.0 110.683 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.83 149.47 96.58 Favored Pre-proline 0 CA--C 1.543 0.702 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 175.351 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.79 131.28 22.9 Favored 'Cis proline' 0 N--CA 1.448 -1.192 0 CA-C-N 119.948 1.017 . . . . 0.0 109.917 -1.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 32.7 m -115.42 128.84 56.32 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.747 1.219 . . . . 0.0 108.407 -177.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 56.7 m-85 -104.24 102.02 11.73 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.689 1.595 . . . . 0.0 109.913 -177.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -98.94 156.11 17.07 Favored 'General case' 0 CA--C 1.519 -0.238 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.591 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 16.7 t -127.5 103.73 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -92.7 66.36 4.41 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 118.368 0.531 . . . . 0.0 111.704 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -69.96 154.91 41.34 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 108.523 -0.918 . . . . 0.0 108.523 172.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.1 t70 69.59 -63.62 0.37 Allowed 'General case' 0 N--CA 1.463 0.198 0 C-N-CA 127.829 2.452 . . . . 0.0 110.157 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.44 35.84 0.02 OUTLIER Glycine 0 CA--C 1.527 0.83 0 C-N-CA 126.911 2.196 . . . . 0.0 110.419 178.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.6 p -159.0 152.14 6.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 -179.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 10.0 ttpp -60.01 94.7 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.175 0.59 . . . . 0.0 109.463 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.65 -26.46 41.08 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 123.391 0.676 . . . . 0.0 110.734 -178.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -152.43 164.05 38.31 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 117.718 0.235 . . . . 0.0 110.496 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -138.36 -177.45 4.85 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 127.21 2.204 . . . . 0.0 107.237 -178.435 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 22.9 tp 165.82 147.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 128.557 2.743 . . . . 0.0 106.828 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 15.1 m -132.53 150.43 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.473 1.109 . . . . 0.0 108.965 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 86.2 173.88 49.38 Favored Glycine 0 CA--C 1.53 0.969 0 CA-C-O 122.088 0.827 . . . . 0.0 113.4 175.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . 0.434 ' HB2' HD11 ' A' ' 42' ' ' ILE . . . -76.1 35.92 0.14 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.416 1.487 . . . . 0.0 113.908 -175.323 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.9 m -78.1 67.15 3.88 Favored 'General case' 0 CA--C 1.53 0.205 0 O-C-N 121.479 -0.763 . . . . 0.0 110.216 -178.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 11.1 mt-30 -49.43 -42.63 43.36 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 125.936 1.694 . . . . 0.0 111.504 -178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.8 p-10 -56.58 -49.32 75.22 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.899 0.88 . . . . 0.0 110.003 176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 22.3 ttmt -70.26 -31.12 68.36 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 -179.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -58.36 -53.98 52.18 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 174.575 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -56.72 -47.3 80.3 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 109.665 -0.495 . . . . 0.0 109.665 177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.19 -48.92 73.12 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 119.351 -0.357 . . . . 0.0 110.77 178.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 47.0 mt -55.15 -55.36 32.07 Favored 'General case' 0 C--N 1.339 0.147 0 C-N-CA 123.263 0.625 . . . . 0.0 109.726 178.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 80.1 t -55.14 -54.11 27.72 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 -177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.22 -55.59 23.17 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.663 0.385 . . . . 0.0 110.883 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.4 ttmt -52.5 -58.62 6.17 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.288 1.435 . . . . 0.0 111.108 -179.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 -72.19 -26.52 62.09 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-O 119.172 -0.442 . . . . 0.0 111.764 -175.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -65.53 -58.74 5.06 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 174.334 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 70.14 -59.31 0.52 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 126.124 1.769 . . . . 0.0 111.629 -179.134 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 C-N-CA 126.065 1.746 . . . . 0.0 107.571 179.052 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.212 0 CA-C-O 118.101 -1.388 . . . . 0.0 110.559 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 156.56 -130.68 2.76 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.832 -2.107 . . . . 0.0 107.832 -178.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 5.5 m -72.21 73.8 0.95 Allowed 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 118.312 1.056 . . . . 0.0 110.129 177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.1 m -134.2 29.55 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 125.231 1.412 . . . . 0.0 112.233 -175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 pp -79.15 162.02 4.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-O 122.206 1.003 . . . . 0.0 113.211 -172.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 p -116.32 135.46 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 126.616 1.966 . . . . 0.0 107.181 176.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.6 tt -160.04 169.22 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.431 0 CA-C-O 121.949 0.881 . . . . 0.0 110.63 -178.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 23.2 p-10 -132.16 45.8 2.72 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 126.692 1.997 . . . . 0.0 110.442 -174.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 38.2 m -154.41 127.05 8.06 Favored 'General case' 0 CA--C 1.531 0.229 0 O-C-N 121.072 -1.018 . . . . 0.0 111.35 -179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 50.9 tttp -48.88 -50.07 36.69 Favored 'General case' 0 C--O 1.225 -0.199 0 C-N-CA 124.528 1.131 . . . . 0.0 110.254 177.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -46.63 -48.35 19.88 Favored 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.721 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.37 -40.95 81.25 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.186 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -51.48 -52.2 48.57 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 175.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -63.69 -47.27 81.85 Favored 'General case' 0 C--O 1.23 0.077 0 C-N-CA 122.826 0.45 . . . . 0.0 110.189 -178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.55 -51.94 57.3 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 122.463 0.305 . . . . 0.0 110.275 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -57.5 -51.47 69.32 Favored 'General case' 0 CA--C 1.53 0.175 0 C-N-CA 124.085 0.954 . . . . 0.0 109.447 177.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.8 tt -48.17 -50.07 30.31 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.361 0.665 . . . . 0.0 109.747 179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.79 -62.24 1.54 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 19.9 ptmt -63.47 -15.04 56.63 Favored 'General case' 0 CA--C 1.532 0.272 0 O-C-N 121.599 -0.688 . . . . 0.0 112.285 -175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.87 -16.74 57.28 Favored Glycine 0 CA--C 1.529 0.959 0 CA-C-O 119.112 -0.827 . . . . 0.0 111.455 175.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 55.4 mttp 76.53 84.49 0.09 Allowed 'General case' 0 C--N 1.342 0.269 0 C-N-CA 125.931 1.692 . . . . 0.0 108.296 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -70.49 66.16 0.31 Allowed 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.622 1.969 . . . . 0.0 110.204 178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -94.62 -61.25 1.54 Allowed 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 177.021 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 55.8 p-80 -168.1 8.04 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.249 0 N-CA-C 113.428 0.899 . . . . 0.0 113.428 -178.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -85.9 153.03 57.3 Favored Pre-proline 0 C--N 1.327 -0.371 0 N-CA-C 112.51 0.559 . . . . 0.0 112.51 -170.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -65.91 116.1 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.826 0 C-N-CA 123.308 2.672 . . . . 0.0 111.304 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.7 mt -97.64 91.96 2.74 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 N-CA-C 104.536 -2.394 . . . . 0.0 104.536 172.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.3 t -88.03 109.69 20.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.457 HG23 ' HB3' ' A' ' 60' ' ' LEU . 6.9 p -111.61 126.24 68.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.324 0 CA-C-O 120.97 0.414 . . . . 0.0 110.491 178.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -95.72 105.66 17.68 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 125.292 1.437 . . . . 0.0 107.615 175.188 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -86.25 97.39 10.35 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 105.812 -1.921 . . . . 0.0 105.812 173.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 12.4 t -117.6 142.51 47.12 Favored 'General case' 0 CA--C 1.527 0.087 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 -179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.1 56.58 1.22 Allowed 'General case' 0 C--N 1.333 -0.129 0 N-CA-C 108.091 -1.078 . . . . 0.0 108.091 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 24.9 p 6.89 -74.38 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 129.486 3.115 . . . . 0.0 114.645 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 48.6 p-90 -43.64 -28.81 0.43 Allowed 'General case' 0 CA--C 1.538 0.505 0 C-N-CA 126.318 1.847 . . . . 0.0 115.094 -177.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.9 p -73.41 69.18 1.15 Allowed 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 120.9 1.682 . . . . 0.0 112.167 -179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 32.35 -95.99 0.01 OUTLIER Glycine 0 CA--C 1.532 1.151 0 C-N-CA 128.279 2.847 . . . . 0.0 113.576 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -39.59 -45.83 3.41 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 124.221 3.281 . . . . 0.0 112.555 175.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 93.7 m -46.4 -37.85 8.17 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 125.821 1.648 . . . . 0.0 112.215 179.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.0 tmtm? -74.21 -62.15 1.61 Allowed 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 22.2 ptp -58.88 -26.33 64.16 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.81 0.844 . . . . 0.0 113.012 -175.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 51.0 mt -64.96 -29.76 48.36 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 O-C-N 121.653 -0.654 . . . . 0.0 110.047 176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.73 -55.12 46.57 Favored Pre-proline 0 CA--C 1.539 0.554 0 CA-C-O 116.839 -1.553 . . . . 0.0 110.527 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_exo -46.16 -43.84 20.3 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 123.757 2.971 . . . . 0.0 114.707 173.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 60.9 mt -61.31 -55.13 35.24 Favored 'General case' 0 CA--C 1.521 -0.141 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -179.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -58.07 -37.79 75.12 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.467 177.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -60.54 -34.35 74.01 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.504 1.121 . . . . 0.0 109.844 178.405 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.2 m -61.21 -53.66 54.11 Favored 'General case' 0 CA--C 1.539 0.537 0 N-CA-C 107.996 -1.112 . . . . 0.0 107.996 177.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 10.0 mp -55.6 -43.52 76.14 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.465 ' HA ' ' CE1' ' A' ' 59' ' ' PHE . 17.9 m -52.83 -56.46 15.57 Favored 'General case' 0 N--CA 1.45 -0.457 0 C-N-CA 123.577 0.751 . . . . 0.0 109.853 -179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.5 t30 -51.79 -50.61 60.4 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 122.703 0.401 . . . . 0.0 110.477 178.343 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -59.8 -60.17 4.26 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 124.887 1.367 . . . . 0.0 112.558 -172.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -88.27 23.68 2.09 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-N 119.91 1.232 . . . . 0.0 111.754 -178.413 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -56.17 151.92 11.63 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 120.868 -1.145 . . . . 0.0 111.769 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 80.45 -60.53 4.53 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.08 -42.7 98.99 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 122.822 0.449 . . . . 0.0 109.969 175.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 92.8 t -119.26 138.99 48.14 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 C-N-CA 125.298 1.439 . . . . 0.0 107.373 179.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 ' N ' HD12 ' A' ' 58' ' ' ILE . 1.3 mp -98.53 131.14 46.26 Favored 'Isoleucine or valine' 0 C--O 1.231 0.079 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.465 ' CE1' ' HA ' ' A' ' 50' ' ' SER . 97.1 m-85 -122.66 139.94 53.39 Favored 'General case' 0 N--CA 1.455 -0.192 0 CA-C-N 118.408 0.549 . . . . 0.0 110.68 -177.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.457 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -132.89 125.43 29.91 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.338 1.055 . . . . 0.0 109.949 -177.133 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 22.5 mtmm -107.96 102.36 11.55 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 174.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 39.2 t -105.18 122.42 58.4 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 123.371 0.669 . . . . 0.0 110.82 -174.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -74.47 104.54 5.23 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 173.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 35.2 t -56.62 -40.09 66.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 C-N-CA 124.96 1.304 . . . . 0.0 110.781 178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -52.81 -51.04 62.39 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -72.52 -60.05 2.42 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 123.256 0.622 . . . . 0.0 110.882 177.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.6 t -82.83 57.97 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 122.175 0.988 . . . . 0.0 109.576 -176.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.85 -43.16 98.71 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 123.811 0.844 . . . . 0.0 110.271 -179.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.18 -57.22 10.31 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.64 0.776 . . . . 0.0 111.993 -178.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 42.7 t -62.07 -47.46 93.08 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -179.33 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -51.39 -47.14 63.0 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 120.634 0.254 . . . . 0.0 110.529 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -60.05 -58.35 8.93 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.882 0.873 . . . . 0.0 110.197 177.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.43 -41.27 72.6 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 122.54 0.336 . . . . 0.0 111.78 -176.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -78.89 -2.84 41.78 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.739 1.216 . . . . 0.0 111.754 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.36 47.49 78.89 Favored Glycine 0 CA--C 1.527 0.813 0 O-C-N 121.028 -1.045 . . . . 0.0 113.019 176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.1 mp -77.38 117.85 23.13 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 178.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.5 p -98.37 -84.54 0.39 Allowed 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 123.976 0.91 . . . . 0.0 110.486 -178.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.17 101.45 14.17 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 124.094 0.957 . . . . 0.0 110.245 -177.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -73.52 141.47 79.88 Favored Pre-proline 0 CA--C 1.54 0.584 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -71.24 140.36 64.18 Favored 'Cis proline' 0 N--CA 1.455 -0.777 0 CA-C-N 120.246 1.123 . . . . 0.0 111.713 -1.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 18.3 m -121.01 109.42 15.04 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.105 -1.072 . . . . 0.0 108.105 178.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -85.31 131.09 34.46 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -126.58 135.51 51.34 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 125.967 1.707 . . . . 0.0 107.979 -178.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 13.4 t -113.15 91.31 1.71 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.225 0 CA-C-N 118.925 0.784 . . . . 0.0 109.391 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 77.9 m-85 -83.21 69.22 9.88 Favored 'General case' 0 C--N 1.337 0.051 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 6.3 ttpm? -57.7 133.46 55.36 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 26.3 t0 70.84 -66.99 0.27 Allowed 'General case' 0 C--N 1.34 0.165 0 C-N-CA 127.447 2.299 . . . . 0.0 107.061 -172.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.86 26.86 0.05 OUTLIER Glycine 0 CA--C 1.529 0.952 0 C-N-CA 126.427 1.965 . . . . 0.0 110.299 175.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 43.4 t -136.0 122.34 31.44 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 CA-C-N 118.152 0.976 . . . . 0.0 108.542 -176.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.7 ttpp -45.61 90.98 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 126.593 1.957 . . . . 0.0 110.772 176.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -86.91 -33.68 19.64 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.039 0.936 . . . . 0.0 111.715 -175.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -156.89 159.11 37.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 -177.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 49.6 m-20 -143.79 166.0 26.12 Favored 'General case' 0 N--CA 1.457 -0.078 0 C-N-CA 124.807 1.243 . . . . 0.0 109.078 -177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 25.7 tp -162.52 115.46 1.69 Allowed 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 123.862 0.865 . . . . 0.0 109.881 -178.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -88.98 158.7 2.96 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 O-C-N 122.017 -0.427 . . . . 0.0 110.768 177.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 84.48 172.07 48.67 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 124.472 1.034 . . . . 0.0 112.662 176.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -55.6 -41.85 74.0 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 124.083 0.953 . . . . 0.0 110.523 179.275 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.4 m 23.16 57.83 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 129.153 2.981 . . . . 0.0 115.055 170.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 63.0 mm-40 -57.97 -59.64 4.95 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 113.424 -174.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -54.58 -45.84 73.62 Favored 'General case' 0 N--CA 1.463 0.175 0 CA-C-O 121.894 0.854 . . . . 0.0 110.105 -178.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.6 mttp -60.45 -43.86 96.42 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.03 0.932 . . . . 0.0 109.583 177.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.33 -56.17 21.19 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.355 1.062 . . . . 0.0 108.185 177.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 63.0 mttp -53.36 -50.75 64.41 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.422 0.689 . . . . 0.0 110.025 179.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.28 -46.22 76.17 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 122.426 0.29 . . . . 0.0 110.865 179.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 5.9 mt -60.64 -53.91 51.72 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 178.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.8 t -55.23 -47.43 77.64 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 C-N-CA 119.723 -0.791 . . . . 0.0 109.406 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.73 -57.08 11.27 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.159 0.583 . . . . 0.0 111.746 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.3 ptpt -64.7 -48.92 72.93 Favored 'General case' 0 C--N 1.339 0.15 0 CA-C-N 119.028 0.831 . . . . 0.0 112.098 -177.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -64.44 -33.56 76.16 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.677 -176.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.0 47.97 0.81 Allowed 'General case' 0 CA--C 1.537 0.449 0 CA-C-N 119.084 0.856 . . . . 0.0 110.837 176.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.87 -30.48 71.56 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.484 0.714 . . . . 0.0 111.824 179.592 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.329 0 C-N-CA 126.766 2.027 . . . . 0.0 105.634 179.3 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.853 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -58.29 -43.86 95.35 Favored Glycine 0 CA--C 1.53 0.983 0 CA-C-N 118.21 1.005 . . . . 0.0 111.234 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.9 m -71.62 48.56 0.15 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.59 1.556 . . . . 0.0 113.831 -177.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.608 HG11 ' HB2' ' A' ' 50' ' ' SER . 46.9 t -141.72 91.89 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.617 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 176.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.5 pt -144.46 149.57 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.083 0.553 . . . . 0.0 109.865 -178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.5 t -79.89 55.61 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 125.253 1.421 . . . . 0.0 108.865 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 17.7 tt -95.33 82.8 1.42 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 CA-C-O 123.002 1.382 . . . . 0.0 110.179 -176.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -76.09 70.0 2.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 125.64 1.576 . . . . 0.0 108.972 179.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 25.3 m -146.65 123.12 11.04 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 123.142 0.577 . . . . 0.0 110.302 178.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 65.1 tttm -49.32 -45.06 44.94 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 123.813 0.845 . . . . 0.0 110.622 179.404 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -56.04 -43.71 78.11 Favored 'General case' 0 N--CA 1.455 -0.211 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.303 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -68.03 -45.23 74.57 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 122.876 0.47 . . . . 0.0 109.833 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -54.75 17.08 Favored 'General case' 0 CA--C 1.529 0.157 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 176.24 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -61.38 -57.21 13.18 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 123.666 0.786 . . . . 0.0 111.792 -177.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.64 -50.88 67.07 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.275 -177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -63.84 -49.08 74.21 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 123.702 0.801 . . . . 0.0 109.351 -178.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 24.5 tp -49.66 -52.77 28.52 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.887 0.875 . . . . 0.0 109.636 176.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.48 -60.28 4.06 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 123.456 0.702 . . . . 0.0 111.759 -179.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.3 ptpp? -60.55 -24.16 65.18 Favored 'General case' 0 N--CA 1.466 0.354 0 O-C-N 121.668 -0.645 . . . . 0.0 111.428 -177.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.09 -22.38 57.89 Favored Glycine 0 CA--C 1.532 1.099 0 CA-C-O 118.485 -1.175 . . . . 0.0 112.654 176.549 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 49.6 mttp 54.8 60.3 3.57 Favored 'General case' 0 C--N 1.346 0.414 0 CA-C-N 119.05 1.425 . . . . 0.0 107.915 -178.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 pm0 -62.4 37.18 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 130.348 3.459 . . . . 0.0 116.221 -173.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -60.1 -76.37 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 178.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 43.0 p-80 -114.82 11.26 16.67 Favored 'General case' 0 C--O 1.227 -0.111 0 C-N-CA 123.821 0.849 . . . . 0.0 110.883 176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -76.55 139.83 67.65 Favored Pre-proline 0 N--CA 1.45 -0.446 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_endo -72.66 94.7 0.78 Allowed 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.644 2.229 . . . . 0.0 111.665 174.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.6 mp -88.25 93.44 4.25 Favored 'Isoleucine or valine' 0 C--N 1.34 0.187 0 N-CA-C 103.266 -2.864 . . . . 0.0 103.266 169.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.5 t -89.39 120.34 37.96 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.71 -1.589 . . . . 0.0 106.71 -178.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -109.0 116.57 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 C-N-CA 123.591 0.756 . . . . 0.0 110.834 -175.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 54.6 t0 -91.03 104.28 16.89 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 124.488 1.115 . . . . 0.0 108.565 175.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 91.6 m-85 -96.54 129.2 43.97 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.877 -1.897 . . . . 0.0 105.877 172.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.6 t -157.59 -172.74 4.08 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -137.16 120.4 16.8 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.989 0.813 . . . . 0.0 111.589 -176.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 17.8 p -36.85 -63.8 0.39 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 127.056 2.142 . . . . 0.0 112.256 -179.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.4 p-90 -54.81 -33.04 61.05 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.285 1.434 . . . . 0.0 112.369 -178.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 44.2 t -79.87 82.09 6.02 Favored 'General case' 0 N--CA 1.454 -0.253 0 O-C-N 121.268 -0.895 . . . . 0.0 109.439 179.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.01 -62.68 0.56 Allowed Glycine 0 CA--C 1.539 1.583 0 C-N-CA 125.004 1.288 . . . . 0.0 113.461 176.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -59.41 -30.96 93.99 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 119.828 1.814 . . . . 0.0 112.734 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 56.8 m -69.25 -29.43 67.34 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 177.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -81.32 -30.37 33.9 Favored 'General case' 0 C--O 1.227 -0.113 0 CA-C-O 118.783 -0.627 . . . . 0.0 111.059 177.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.5 mmt -57.24 -22.06 38.4 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-N 119.04 0.836 . . . . 0.0 111.769 178.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 48.4 mt -68.81 -30.44 46.99 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 O-C-N 121.485 -0.759 . . . . 0.0 110.377 176.164 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.26 -57.64 15.88 Favored Pre-proline 0 CA--C 1.541 0.625 0 CA-C-O 117.908 -1.044 . . . . 0.0 112.604 -177.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 29.9 Cg_endo -57.25 -39.72 87.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 CA-C-N 121.594 1.605 . . . . 0.0 111.495 178.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -57.74 -54.55 45.63 Favored 'General case' 0 CA--C 1.534 0.36 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.033 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -51.81 -48.65 63.79 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.916 1.286 . . . . 0.0 109.258 177.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -65.97 -30.36 70.91 Favored 'General case' 0 C--O 1.228 -0.064 0 CA-C-O 118.288 -0.863 . . . . 0.0 112.688 177.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 80.4 m -56.56 -39.57 73.68 Favored 'General case' 0 CA--C 1.53 0.2 0 CA-C-N 120.046 1.294 . . . . 0.0 107.96 176.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 40.0 mt -58.79 -25.82 63.47 Favored 'General case' 0 C--O 1.223 -0.314 0 CA-C-O 118.304 -0.855 . . . . 0.0 111.099 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.608 ' HB2' HG11 ' A' ' 4' ' ' VAL . 22.9 t -50.65 -38.69 47.86 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-N 120.306 1.412 . . . . 0.0 110.294 175.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -55.94 -43.05 77.08 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.226 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -74.62 -53.4 9.43 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.67 0.788 . . . . 0.0 110.318 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -85.46 66.6 9.76 Favored 'General case' 0 N--CA 1.447 -0.586 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -175.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -61.2 -32.43 72.19 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.965 1.306 . . . . 0.0 111.32 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -68.31 -166.14 3.73 Favored Glycine 0 CA--C 1.532 1.131 0 C-N-CA 124.466 1.031 . . . . 0.0 113.69 -178.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.72 36.62 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 126.66 1.984 . . . . 0.0 114.805 -175.468 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.0 t -86.5 122.84 39.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 N-CA-C 106.406 -1.701 . . . . 0.0 106.406 177.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.1 mp -101.64 104.47 16.4 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.142 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 -173.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.459 ' HB2' HG13 ' A' ' 4' ' ' VAL . 13.1 m-85 -92.59 90.22 7.03 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 58.5 mt -80.72 145.09 31.73 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 177.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.98 121.2 41.55 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 174.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.31 72.02 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -176.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -61.69 121.91 14.0 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 4.2 m -60.94 -29.14 44.93 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.193 0 C-N-CA 123.897 0.879 . . . . 0.0 111.754 -176.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -65.59 -29.86 70.51 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 110.035 -0.357 . . . . 0.0 110.035 178.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -99.6 -71.86 0.68 Allowed 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.949 0.9 . . . . 0.0 110.342 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.2 t -85.04 61.8 0.31 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 CA-C-O 122.649 1.214 . . . . 0.0 108.861 -176.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.46 -42.15 77.7 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 114.78 -1.1 . . . . 0.0 111.006 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.0 -53.26 43.85 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.9 0.88 . . . . 0.0 111.613 -179.045 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 52.0 t -66.61 -43.49 90.42 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.207 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -50.69 64.74 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 111.839 0.311 . . . . 0.0 111.839 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.4 -43.98 76.07 Favored 'General case' 0 CA--C 1.533 0.298 0 O-C-N 121.733 -0.604 . . . . 0.0 109.711 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.84 -40.8 76.75 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.794 0.725 . . . . 0.0 111.169 179.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -77.82 -4.25 45.63 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 125.143 1.377 . . . . 0.0 111.434 178.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 65.76 41.55 95.68 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 123.925 0.774 . . . . 0.0 112.405 178.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 39.7 mm -73.69 134.69 29.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.107 0.954 . . . . 0.0 108.874 178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 33.8 p -131.03 -78.67 0.53 Allowed 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 124.484 1.114 . . . . 0.0 108.86 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.57 63.21 1.5 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.626 1.171 . . . . 0.0 111.014 -178.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.08 151.16 95.91 Favored Pre-proline 0 CA--C 1.546 0.822 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -71.14 158.43 94.98 Favored 'Cis proline' 0 N--CA 1.448 -1.16 0 CA-C-N 119.721 0.936 . . . . 0.0 109.979 0.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 15.7 m -150.13 136.32 18.76 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 -173.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 85.1 m-85 -113.62 121.3 43.74 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 125.196 1.398 . . . . 0.0 108.211 -177.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 37.8 m170 -115.95 150.36 37.27 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 124.051 0.94 . . . . 0.0 108.906 178.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -120.33 107.05 19.91 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.1 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 175.387 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 10.9 m-85 -93.42 89.0 6.15 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 122.934 0.493 . . . . 0.0 111.884 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.1 mttp -90.47 156.46 18.18 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 171.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 69.67 -60.19 0.48 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.325 2.65 . . . . 0.0 109.485 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 166.31 28.24 0.02 OUTLIER Glycine 0 CA--C 1.528 0.875 0 C-N-CA 128.058 2.742 . . . . 0.0 110.198 176.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 8.4 p -160.54 143.47 4.64 Favored 'Isoleucine or valine' 0 C--N 1.342 0.27 0 CA-C-N 118.821 1.31 . . . . 0.0 109.902 -177.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -39.83 97.34 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 126.749 2.019 . . . . 0.0 111.312 173.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -84.59 -37.55 21.01 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.52 1.528 . . . . 0.0 110.404 179.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 31.2 t0 -139.15 163.16 33.15 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -160.39 169.45 23.05 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.649 0.78 . . . . 0.0 110.12 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 17.8 tp -163.19 150.31 12.8 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 125.407 1.483 . . . . 0.0 107.921 -174.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.1 m -124.95 162.87 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 C-N-CA 124.495 1.118 . . . . 0.0 110.729 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.99 176.41 40.73 Favored Glycine 0 CA--C 1.527 0.786 0 C-N-CA 123.934 0.778 . . . . 0.0 112.565 176.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.72 40.85 0.32 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.354 1.062 . . . . 0.0 111.576 -179.297 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -77.27 57.93 1.55 Allowed 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.618 1.967 . . . . 0.0 110.729 -175.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 15.2 mt-30 -50.51 -42.02 54.35 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.111 1.764 . . . . 0.0 112.217 -176.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -57.66 -48.62 78.97 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.648 0.737 . . . . 0.0 109.969 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 13.2 ttmm -73.08 -26.8 61.4 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 109.438 -0.579 . . . . 0.0 109.438 -179.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.79 -54.5 45.55 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 173.52 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.2 mttp -53.33 -47.88 68.94 Favored 'General case' 0 CA--C 1.53 0.185 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 177.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.16 -46.43 75.72 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-O 119.121 -0.466 . . . . 0.0 110.683 178.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 41.8 mt -56.71 -54.61 44.26 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-N 118.612 0.642 . . . . 0.0 109.685 177.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.51 -46.36 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 119.4 -0.92 . . . . 0.0 109.771 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -56.24 -54.36 46.26 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 122.612 0.365 . . . . 0.0 110.751 179.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 31.5 ttmt -54.89 -56.04 23.93 Favored 'General case' 0 N--CA 1.457 -0.116 0 C-N-CA 124.519 1.128 . . . . 0.0 111.383 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -74.43 -27.93 60.83 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-O 118.939 -0.553 . . . . 0.0 112.156 -172.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -83.83 41.86 0.82 Allowed 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.597 1.09 . . . . 0.0 110.853 175.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -64.57 -33.05 75.0 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.121 0.568 . . . . 0.0 112.085 179.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.172 0 C-N-CA 126.456 1.902 . . . . 0.0 106.186 -179.737 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 CA-C-O 118.209 -1.328 . . . . 0.0 110.044 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -74.39 -86.77 0.25 Allowed Glycine 0 CA--C 1.528 0.848 0 N-CA-C 108.34 -1.904 . . . . 0.0 108.34 176.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 6.1 m -78.48 46.39 0.63 Allowed 'General case' 0 CA--C 1.537 0.48 0 O-C-N 121.715 -0.874 . . . . 0.0 110.418 176.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 50' ' ' SER . 78.5 t -154.23 90.28 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.72 0 C-N-CA 127.63 2.372 . . . . 0.0 105.902 -175.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.6 pt -145.08 149.56 16.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.18 0 C-N-CA 123.315 0.646 . . . . 0.0 109.761 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.7 p -80.03 55.45 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.559 0 C-N-CA 125.176 1.39 . . . . 0.0 109.022 179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 4.7 tp -84.19 -173.84 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 C-N-CA 124.936 1.294 . . . . 0.0 110.475 -177.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -165.34 -49.6 0.03 OUTLIER 'General case' 0 C--O 1.226 -0.134 0 C-N-CA 125.653 1.581 . . . . 0.0 109.156 175.604 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.7 m -35.57 114.99 0.29 Allowed 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 127.56 2.344 . . . . 0.0 113.753 -177.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 9.6 tmtt? -42.74 -52.28 5.02 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.727 1.611 . . . . 0.0 111.028 -179.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -55.24 -42.17 73.08 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.821 -0.549 . . . . 0.0 111.678 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.93 -32.73 67.63 Favored 'General case' 0 N--CA 1.455 -0.197 0 O-C-N 121.829 -0.545 . . . . 0.0 109.95 179.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -60.13 -48.94 79.63 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 173.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 -59.89 -45.71 91.66 Favored 'General case' 0 C--N 1.338 0.101 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 178.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.05 -53.92 46.47 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 178.02 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.31 -50.54 38.92 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 124.488 1.115 . . . . 0.0 109.416 177.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.6 mp -56.64 -14.38 3.18 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.897 1.279 . . . . 0.0 113.862 179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -109.33 -63.12 1.39 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.761 1.224 . . . . 0.0 110.695 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -20.86 58.49 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.43 0.692 . . . . 0.0 112.46 -177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -63.09 -19.87 62.0 Favored Glycine 0 CA--C 1.535 1.29 0 CA-C-O 118.603 -1.109 . . . . 0.0 111.926 176.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 6.6 mtmp? 67.81 64.88 0.38 Allowed 'General case' 0 C--N 1.343 0.323 0 C-N-CA 125.594 1.558 . . . . 0.0 108.539 -178.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -70.1 56.95 0.15 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 128.806 2.842 . . . . 0.0 111.762 -177.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -83.65 -52.03 6.78 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 125.151 1.38 . . . . 0.0 108.064 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 18.0 t-160 -160.53 75.25 0.56 Allowed 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 125.245 1.418 . . . . 0.0 108.106 177.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 32.0 mtpt -147.17 145.51 22.3 Favored Pre-proline 0 CA--C 1.536 0.424 0 O-C-N 121.971 -0.456 . . . . 0.0 111.474 -178.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -78.81 126.7 7.41 Favored 'Trans proline' 0 N--CA 1.453 -0.855 0 C-N-CA 122.999 2.466 . . . . 0.0 112.168 175.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 46.9 mt -96.15 120.89 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 104.489 -2.411 . . . . 0.0 104.489 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 35.9 t -112.36 118.65 58.32 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -176.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.9 t -107.02 118.03 54.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 122.658 0.383 . . . . 0.0 111.79 -175.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.78 87.08 7.26 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -84.76 93.94 8.57 Favored 'General case' 0 N--CA 1.45 -0.44 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 175.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.5 t -117.89 -177.85 3.35 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -127.2 112.92 15.68 Favored 'General case' 0 C--N 1.334 -0.108 0 C-N-CA 124.802 1.241 . . . . 0.0 109.08 -178.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 p -43.56 -56.97 3.37 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.808 1.243 . . . . 0.0 112.357 -179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 39.5 p-90 -57.73 -31.19 66.19 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.107 0.563 . . . . 0.0 112.496 -178.559 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 16.6 t -77.39 85.81 3.79 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -36.23 -59.21 0.99 Allowed Glycine 0 CA--C 1.538 1.493 0 C-N-CA 124.758 1.17 . . . . 0.0 113.07 178.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_exo -53.19 -41.23 73.78 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 123.017 2.478 . . . . 0.0 112.986 177.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 30.6 m -68.74 -36.59 78.58 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -64.74 -47.58 77.71 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.284 0.634 . . . . 0.0 109.417 178.345 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 73.4 mtm -58.67 -20.3 46.96 Favored 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.438 0.903 . . . . 0.0 113.438 -178.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 72.4 mt -78.36 -24.85 13.72 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 O-C-N 121.756 -0.59 . . . . 0.0 110.004 175.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -55.88 -51.48 80.09 Favored Pre-proline 0 CA--C 1.542 0.656 0 CA-C-O 117.746 -1.121 . . . . 0.0 112.534 178.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -59.9 -36.63 89.86 Favored 'Trans proline' 0 C--N 1.35 0.613 0 CA-C-N 122.283 1.851 . . . . 0.0 111.529 177.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.6 mt -60.37 -50.81 72.13 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 176.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -56.32 -45.96 80.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.662 177.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -58.78 -43.4 90.43 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 119.445 1.02 . . . . 0.0 110.239 177.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 32.3 m -55.43 -48.66 74.09 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 178.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 26.6 tp -60.65 -43.93 97.01 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.195 0.521 . . . . 0.0 109.972 176.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.468 ' HA ' ' CZ ' ' A' ' 59' ' ' PHE . 41.1 m -54.95 -47.23 74.77 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 123.73 0.812 . . . . 0.0 111.537 -176.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -67.53 -12.77 61.14 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 118.251 -0.88 . . . . 0.0 111.525 -178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -74.99 -64.53 1.03 Allowed 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.924 1.238 . . . . 0.0 108.773 175.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 46.4 m-85 -81.11 38.31 0.47 Allowed 'General case' 0 CA--C 1.538 0.51 0 O-C-N 121.339 -0.85 . . . . 0.0 110.61 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.51 150.87 30.05 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.312 0.577 . . . . 0.0 110.914 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.6 -64.2 2.96 Favored Glycine 0 CA--C 1.527 0.828 0 N-CA-C 111.31 -0.716 . . . . 0.0 111.31 178.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -60.29 -49.05 79.15 Favored 'General case' 0 CA--C 1.528 0.115 0 CA-C-N 117.854 0.827 . . . . 0.0 110.285 -178.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.417 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 94.5 t -96.76 134.25 35.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.215 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 178.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.4 mm -94.28 98.78 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' CZ ' ' HA ' ' A' ' 50' ' ' SER . 96.5 m-85 -91.21 143.19 26.92 Favored 'General case' 0 CA--C 1.509 -0.623 0 O-C-N 121.544 -0.723 . . . . 0.0 110.621 -177.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -141.42 109.69 5.89 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 114.53 -1.214 . . . . 0.0 111.257 -170.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -79.67 136.78 36.89 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 174.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 43.4 t -143.6 134.79 22.6 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.308 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 177.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -100.93 104.65 15.84 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 174.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 19.9 m -56.52 -30.16 30.78 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 122.607 0.363 . . . . 0.0 110.611 -178.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.9 -36.4 76.87 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 122.506 0.323 . . . . 0.0 110.514 178.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.65 -69.5 0.63 Allowed 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 123.238 0.615 . . . . 0.0 109.739 -179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 27.8 m -83.91 58.89 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 O-C-N 121.432 -0.792 . . . . 0.0 110.961 -176.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.89 -41.96 35.24 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.315 1.046 . . . . 0.0 110.678 178.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -55.51 -49.4 72.68 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.806 0.842 . . . . 0.0 111.13 178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 41.4 t -65.87 -45.41 91.39 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.187 0 N-CA-C 108.358 -0.979 . . . . 0.0 108.358 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.98 -53.8 51.05 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 122.409 0.283 . . . . 0.0 111.501 -179.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -67.46 -42.35 83.18 Favored 'General case' 0 CA--C 1.532 0.284 0 O-C-N 121.595 -0.691 . . . . 0.0 110.544 -178.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.15 -46.2 90.48 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 118.539 0.609 . . . . 0.0 110.794 179.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.08 -39.64 90.18 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.938 0.895 . . . . 0.0 110.395 179.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 106.84 52.44 0.75 Allowed Glycine 0 CA--C 1.525 0.713 0 C-N-CA 124.325 0.964 . . . . 0.0 111.946 176.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -75.68 147.92 7.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 176.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 38.9 p -127.24 -81.42 0.6 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.992 -1.484 . . . . 0.0 106.992 177.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.22 177.89 6.3 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 124.481 1.112 . . . . 0.0 108.819 175.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -140.55 139.23 19.86 Favored Pre-proline 0 CA--C 1.533 0.315 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 178.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_exo -63.36 153.67 70.99 Favored 'Cis proline' 0 N--CA 1.455 -0.743 0 CA-C-N 120.518 1.221 . . . . 0.0 113.987 -3.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.3 m -128.61 126.42 40.21 Favored 'General case' 0 N--CA 1.449 -0.501 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 172.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -113.52 101.0 8.93 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.529 1.132 . . . . 0.0 109.447 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 19.5 m170 -97.35 145.39 26.18 Favored 'General case' 0 CA--C 1.516 -0.338 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 178.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.0 t -121.36 111.53 31.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 175.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -105.17 104.3 14.01 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 175.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -75.98 105.28 6.93 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 177.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 70.58 -56.11 0.61 Allowed 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 127.879 2.471 . . . . 0.0 110.673 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.416 ' H ' ' H ' ' A' ' 89' ' ' VAL . . . -163.47 -13.11 0.03 OUTLIER Glycine 0 CA--C 1.534 1.275 0 C-N-CA 126.484 1.992 . . . . 0.0 111.77 177.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.416 ' H ' ' H ' ' A' ' 88' ' ' GLY . 24.6 t -85.67 122.63 38.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 CA-C-N 118.8 1.3 . . . . 0.0 108.204 -177.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -62.29 94.93 0.06 Allowed 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.937 -1.134 . . . . 0.0 107.937 177.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -80.2 -35.84 35.72 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 124.645 1.178 . . . . 0.0 111.145 -176.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -157.49 168.28 27.77 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 111.986 0.365 . . . . 0.0 111.986 -177.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 10.2 t0 -148.24 167.33 25.39 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 127.412 2.285 . . . . 0.0 107.509 -179.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 19.4 tp -178.09 138.55 0.2 Allowed 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 127.205 2.202 . . . . 0.0 106.125 -178.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 5.0 m -136.13 144.91 31.9 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 177.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 95.3 63.69 0.98 Allowed Glycine 0 CA--C 1.525 0.659 0 N-CA-C 112.045 -0.422 . . . . 0.0 112.045 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 49.62 -108.57 0.31 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.72 1.208 . . . . 0.0 111.56 174.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.8 m 56.84 60.84 2.85 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.615 1.166 . . . . 0.0 111.003 179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.1 mp0 -52.01 -36.65 50.67 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.583 1.153 . . . . 0.0 111.651 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 -60.25 -46.8 88.53 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.368 0.667 . . . . 0.0 109.72 176.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.5 ttmt -69.02 -35.7 76.94 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 -179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 13.6 tp -56.5 -53.68 54.64 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 173.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 60.6 mttp -53.31 -47.42 69.27 Favored 'General case' 0 CA--C 1.533 0.29 0 O-C-N 121.902 -0.499 . . . . 0.0 109.821 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.45 -47.08 79.88 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 119.328 -0.368 . . . . 0.0 110.91 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 65.6 mt -56.05 -55.75 29.09 Favored 'General case' 0 C--N 1.34 0.194 0 CA-C-N 118.497 0.589 . . . . 0.0 109.607 178.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 25.6 t -57.59 -47.28 85.69 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.196 0 C-N-CA 120.256 -0.578 . . . . 0.0 109.84 -176.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.68 -56.44 19.08 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-O 120.672 0.272 . . . . 0.0 110.295 178.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -49.37 -62.77 1.36 Allowed 'General case' 0 CA--C 1.522 -0.119 0 C-N-CA 124.914 1.286 . . . . 0.0 110.773 178.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.8 m-70 -69.79 -22.55 63.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 115.235 -0.893 . . . . 0.0 112.84 -173.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -72.21 -44.81 62.39 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 172.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.73 53.55 2.74 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 123.075 0.55 . . . . 0.0 109.802 177.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.089 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -179.593 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.929 0 N-CA-C 109.919 -1.272 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 57.17 -107.78 1.08 Allowed Glycine 0 CA--C 1.528 0.877 0 CA-C-N 118.119 0.96 . . . . 0.0 111.37 178.533 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 p -71.85 -20.65 61.79 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 124.216 1.006 . . . . 0.0 111.652 179.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.425 HG13 ' HB3' ' A' ' 50' ' ' SER . 46.6 t -102.38 107.06 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 178.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.1 pt -136.01 146.35 29.51 Favored 'Isoleucine or valine' 0 C--N 1.339 0.15 0 CA-C-N 119.315 0.962 . . . . 0.0 110.899 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.2 t -113.84 22.97 5.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 C-N-CA 126.317 1.847 . . . . 0.0 108.608 178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 15.3 tt -81.27 162.02 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -78.72 77.94 5.19 Favored 'General case' 0 N--CA 1.457 -0.104 0 N-CA-C 105.779 -1.934 . . . . 0.0 105.779 177.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 6.8 m -59.42 72.86 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 127.943 2.497 . . . . 0.0 115.45 -170.791 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 22.5 tptp -92.94 -66.91 0.89 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 125.121 1.369 . . . . 0.0 108.444 167.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -75.6 -49.9 17.14 Favored 'General case' 0 C--N 1.333 -0.13 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.027 179.517 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -54.26 -37.8 65.1 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.667 178.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -48.23 -53.13 18.15 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 123.802 0.841 . . . . 0.0 109.361 175.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -66.73 -48.52 68.9 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 122.828 0.451 . . . . 0.0 110.895 -178.102 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.95 -60.92 2.68 Favored 'General case' 0 CA--C 1.532 0.282 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.598 -179.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.4 mp0 -57.09 -47.37 81.22 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 124.258 1.023 . . . . 0.0 109.689 178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 7.6 tt -49.66 -48.92 49.14 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 118.034 0.379 . . . . 0.0 110.61 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -64.55 -63.63 1.08 Allowed 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 122.638 0.375 . . . . 0.0 111.011 -179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -61.37 -25.87 67.46 Favored 'General case' 0 N--CA 1.466 0.345 0 O-C-N 121.822 -0.549 . . . . 0.0 111.951 -176.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.74 -24.55 71.34 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-O 118.721 -1.044 . . . . 0.0 111.801 177.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 37.4 mtmm 51.31 67.1 1.0 Allowed 'General case' 0 C--N 1.345 0.38 0 CA-C-N 118.224 1.012 . . . . 0.0 109.752 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.4 46.12 0.06 Allowed 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.395 1.878 . . . . 0.0 114.489 -177.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.23 -45.86 89.65 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 107.772 -1.195 . . . . 0.0 107.772 175.099 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 26.9 p-80 -139.89 7.23 2.26 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.468 0.707 . . . . 0.0 112.803 173.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -83.03 129.3 61.87 Favored Pre-proline 0 CA--C 1.531 0.236 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -75.14 122.86 7.4 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.608 1.538 . . . . 0.0 112.188 179.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 76.2 mt -96.34 99.79 9.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 105.277 -2.12 . . . . 0.0 105.277 170.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 47.4 t -89.62 111.31 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.586 0 N-CA-C 106.549 -1.649 . . . . 0.0 106.549 -177.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 9.0 p -110.79 125.68 68.11 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.143 0 CA-C-O 120.501 0.191 . . . . 0.0 110.533 -179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -93.35 98.8 11.47 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.959 1.304 . . . . 0.0 109.463 177.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -84.77 96.83 9.39 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 173.316 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.6 t -127.21 -150.97 0.46 Allowed 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -167.97 161.17 12.68 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 118.729 0.695 . . . . 0.0 110.912 174.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.7 p -66.56 -59.67 3.42 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.749 1.22 . . . . 0.0 110.698 178.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 66.6 p-90 -51.01 -33.69 26.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 125.471 1.508 . . . . 0.0 114.594 -174.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 7.4 p -78.37 57.81 2.0 Allowed 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 119.605 1.093 . . . . 0.0 112.051 -176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 15.46 -87.65 0.0 OUTLIER Glycine 0 CA--C 1.535 1.316 0 C-N-CA 129.129 3.252 . . . . 0.0 115.398 178.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_exo -41.2 -37.16 2.77 Favored 'Trans proline' 0 C--N 1.35 0.627 0 C-N-CA 124.717 3.611 . . . . 0.0 113.979 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 61.7 m -45.05 -45.87 11.11 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 125.405 1.482 . . . . 0.0 111.335 175.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 83.7 tttt -65.23 -21.97 66.82 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 123.865 0.866 . . . . 0.0 111.593 -178.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 52.2 mtt -90.0 -37.51 14.27 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.999 1.32 . . . . 0.0 109.403 177.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 41.3 mt -64.16 -42.52 95.82 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.773 0.829 . . . . 0.0 109.382 177.342 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -47.98 -53.75 29.88 Favored Pre-proline 0 CA--C 1.547 0.841 0 CA-C-O 117.973 -1.013 . . . . 0.0 111.201 179.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.417 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 75.1 Cg_exo -46.57 -46.9 16.68 Favored 'Trans proline' 0 N--CA 1.459 -0.521 0 C-N-CA 124.167 3.245 . . . . 0.0 114.186 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 44.4 mt -60.08 -49.51 77.39 Favored 'General case' 0 C--O 1.231 0.125 0 CA-C-O 121.746 0.784 . . . . 0.0 108.891 179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 41.2 t80 -58.53 -42.33 87.54 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.351 -0.841 . . . . 0.0 110.152 178.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 41.0 tp10 -62.12 -40.63 96.55 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 119.026 0.83 . . . . 0.0 109.574 177.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 26.1 m -58.52 -49.98 75.41 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 24.0 tp -59.75 -36.47 76.68 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 121.044 0.449 . . . . 0.0 109.995 176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.477 ' HA ' ' CE2' ' A' ' 59' ' ' PHE . 41.9 m -60.17 -46.28 90.22 Favored 'General case' 0 N--CA 1.447 -0.617 0 O-C-N 121.973 -0.454 . . . . 0.0 109.78 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 23.2 m-80 -64.72 -43.8 92.24 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -47.55 -51.62 20.25 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 122.951 0.5 . . . . 0.0 111.675 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -101.54 33.7 2.86 Favored 'General case' 0 CA--C 1.539 0.544 0 CA-C-N 118.377 0.535 . . . . 0.0 111.659 178.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -55.58 151.5 10.54 Favored 'General case' 0 CA--C 1.532 0.269 0 O-C-N 121.565 -0.709 . . . . 0.0 111.681 -178.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 76.85 -62.99 3.2 Favored Glycine 0 CA--C 1.526 0.76 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -55.66 -52.86 62.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.509 0.724 . . . . 0.0 110.428 178.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 59' ' ' PHE . 94.8 t -106.75 140.55 24.51 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 -176.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 14.5 mm -96.31 131.77 42.26 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 105.393 -2.077 . . . . 0.0 105.393 177.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.477 ' CE2' ' HA ' ' A' ' 50' ' ' SER . 93.8 m-85 -121.79 118.21 28.46 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 118.861 0.755 . . . . 0.0 110.778 -176.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.0 mt -112.44 148.66 33.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 125.612 1.565 . . . . 0.0 110.072 -178.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -123.22 132.71 54.14 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 125.42 1.488 . . . . 0.0 107.849 179.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 94.3 t -138.23 130.46 39.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 119.171 0.896 . . . . 0.0 109.765 179.662 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.6 t0 -92.54 109.71 21.12 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.072 -1.825 . . . . 0.0 106.072 172.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 33.7 m -58.59 -27.38 33.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 119.32 -0.371 . . . . 0.0 111.958 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -64.03 -40.9 97.35 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 118.608 0.64 . . . . 0.0 109.476 178.058 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.51 -63.64 1.35 Allowed 'General case' 0 N--CA 1.449 -0.502 0 C-N-CA 123.124 0.57 . . . . 0.0 110.073 -178.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -84.57 58.45 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 CA-C-O 121.666 0.746 . . . . 0.0 110.001 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -52.99 -46.39 68.29 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.034 0.934 . . . . 0.0 110.963 -179.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.5 -56.11 22.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 123.878 0.871 . . . . 0.0 112.16 -178.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 40.7 t -65.16 -42.62 94.7 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.068 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.86 -52.86 63.44 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 111.627 0.232 . . . . 0.0 111.627 179.262 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -68.7 -38.64 80.43 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 121.454 -0.779 . . . . 0.0 110.189 -178.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.82 -46.28 89.73 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 118.564 0.62 . . . . 0.0 109.943 177.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.13 -31.92 73.06 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.453 0.701 . . . . 0.0 110.015 177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 92.49 43.73 4.19 Favored Glycine 0 CA--C 1.523 0.533 0 C-N-CA 124.712 1.149 . . . . 0.0 111.208 176.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 41.8 mm -79.17 140.86 16.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.177 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 39.2 p -134.15 -80.35 0.46 Allowed 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.376 1.07 . . . . 0.0 109.226 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.29 67.21 2.51 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 124.261 1.024 . . . . 0.0 111.033 -177.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 1.8 pmm? -63.77 144.77 97.91 Favored Pre-proline 0 CA--C 1.545 0.778 0 CA-C-O 118.529 -0.748 . . . . 0.0 109.168 177.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -63.45 148.22 64.43 Favored 'Cis proline' 0 N--CA 1.455 -0.745 0 CA-C-N 120.847 1.338 . . . . 0.0 112.783 -0.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 96.2 m -146.32 122.98 11.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.47 -1.307 . . . . 0.0 107.47 178.402 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -103.84 118.9 37.78 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.606 1.162 . . . . 0.0 109.395 -176.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 29.0 m170 -109.52 150.12 28.62 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 177.17 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.4 t -115.77 107.75 23.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.23 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 65.9 m-85 -99.77 114.31 27.37 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.648 0.779 . . . . 0.0 111.285 -179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -92.57 -170.5 2.49 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 106.539 -1.652 . . . . 0.0 106.539 166.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.543 ' C ' ' H ' ' A' ' 89' ' ' VAL . 25.7 p-10 -67.61 -34.22 76.55 Favored 'General case' 0 CA--C 1.507 -0.705 0 O-C-N 121.123 -0.985 . . . . 0.0 108.474 165.054 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -73.48 41.39 0.97 Allowed Glycine 0 CA--C 1.541 1.709 0 N-CA-C 108.823 -1.711 . . . . 0.0 108.823 166.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.543 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.31 20.1 m 24.45 -139.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.64 1 C-N-CA 133.701 4.8 . . . . 0.0 113.458 -179.178 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 30.6 ttmt -54.12 85.14 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 124.873 1.269 . . . . 0.0 109.616 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.84 -29.87 40.22 Favored 'General case' 0 N--CA 1.446 -0.632 0 C-N-CA 123.491 0.716 . . . . 0.0 109.856 -177.132 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.68 161.85 41.82 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 122.888 0.475 . . . . 0.0 110.345 -179.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -140.58 165.48 27.34 Favored 'General case' 0 C--N 1.335 -0.048 0 C-N-CA 127.14 2.176 . . . . 0.0 107.731 -178.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 48.1 tp -172.39 103.9 0.16 Allowed 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.893 1.277 . . . . 0.0 109.785 -177.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.6 m -80.82 162.32 3.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.436 0 CA-C-O 121.155 0.502 . . . . 0.0 110.548 177.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 75.4 170.42 27.77 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 124.423 1.011 . . . . 0.0 112.743 176.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.45 45.34 0.56 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 124.465 1.106 . . . . 0.0 110.312 178.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -77.99 60.11 2.29 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.051 1.34 . . . . 0.0 111.688 -172.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -46.39 -46.37 18.45 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.56 1.544 . . . . 0.0 113.982 -176.499 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -64.63 -48.31 75.33 Favored 'General case' 0 CA--C 1.532 0.273 0 O-C-N 121.283 -0.886 . . . . 0.0 110.372 -179.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 28.3 tptp -60.6 -38.96 86.4 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 179.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.2 tp -59.16 -57.43 13.09 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 66.2 tttm -45.38 -53.52 8.52 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 123.621 0.768 . . . . 0.0 110.213 178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.55 -50.81 70.81 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 124.321 1.013 . . . . 0.0 111.511 179.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 22.2 mt -59.98 -46.02 90.82 Favored 'General case' 0 C--N 1.338 0.079 0 O-C-N 121.583 -0.698 . . . . 0.0 110.34 179.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 57.5 t -58.33 -46.34 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.415 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.9 -52.68 59.78 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 178.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.83 -61.0 2.57 Favored 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.104 0.962 . . . . 0.0 111.144 178.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.0 m-70 -64.59 -31.79 73.17 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.279 -0.873 . . . . 0.0 111.885 -175.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.58 42.67 0.78 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.946 0.898 . . . . 0.0 111.154 178.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -61.92 -23.0 66.07 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 123.347 0.659 . . . . 0.0 112.342 179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.17 0 N-CA-C 105.896 -1.89 . . . . 0.0 105.896 179.538 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.106 0 CA-C-O 119.074 -0.848 . . . . 0.0 111.35 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 71.69 -71.98 0.86 Allowed Glycine 0 CA--C 1.526 0.736 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 -175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 9.0 m -75.83 61.07 1.4 Allowed 'General case' 0 N--CA 1.448 -0.551 0 C-N-CA 125.822 1.649 . . . . 0.0 110.583 177.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.8 m -136.26 31.03 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 126.83 2.052 . . . . 0.0 108.087 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 41.3 pt -131.79 -173.1 0.98 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 C-N-CA 125.392 1.477 . . . . 0.0 110.677 -174.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.1 t -78.95 115.45 21.22 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 178.44 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 5.2 tp -155.64 99.54 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 CA-C-O 122.343 1.068 . . . . 0.0 109.244 176.693 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 19.3 p-10 -91.58 -42.49 10.19 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 124.866 1.266 . . . . 0.0 109.705 178.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.1 m -32.86 113.17 0.13 Allowed 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 127.667 2.387 . . . . 0.0 115.016 -176.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.4 tmtp? -53.65 -40.92 66.27 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.015 0.926 . . . . 0.0 110.527 177.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -59.98 -25.12 64.98 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 122.938 0.495 . . . . 0.0 111.885 178.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -96.44 -31.63 12.73 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.123 0.969 . . . . 0.0 110.898 179.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 18.8 t-105 -45.94 -58.25 3.71 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.48 1.512 . . . . 0.0 112.147 -179.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -65.95 -44.72 84.2 Favored 'General case' 0 C--O 1.227 -0.122 0 O-C-N 121.655 -0.653 . . . . 0.0 110.853 -177.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.77 -42.85 62.69 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 176.366 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -59.47 -56.15 25.58 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.94 1.696 . . . . 0.0 109.085 176.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 39.6 mt -49.67 -45.79 49.09 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 123.441 0.697 . . . . 0.0 110.481 177.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -65.85 -63.46 1.08 Allowed 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 123.135 0.574 . . . . 0.0 111.589 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 21.4 ptmt -57.4 -32.08 66.47 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-N 118.373 0.533 . . . . 0.0 111.082 -176.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.6 -19.97 55.31 Favored Glycine 0 CA--C 1.528 0.878 0 CA-C-O 118.113 -1.382 . . . . 0.0 113.031 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 5.3 mtmp? 59.0 69.92 0.69 Allowed 'General case' 0 C--N 1.344 0.329 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.8 tt0 -68.64 62.51 0.1 Allowed 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 128.441 2.696 . . . . 0.0 112.767 -173.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -116.92 -93.16 0.51 Allowed 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 175.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 3.8 t-160 -113.67 73.48 0.82 Allowed 'General case' 0 CA--C 1.521 -0.139 0 C-N-CA 123.922 0.889 . . . . 0.0 109.052 -176.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.547 ' O ' HD12 ' A' ' 27' ' ' ILE . 29.4 mmtm -140.29 150.31 60.9 Favored Pre-proline 0 N--CA 1.451 -0.408 0 N-CA-C 104.708 -2.33 . . . . 0.0 104.708 172.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.13 86.39 0.95 Allowed 'Trans proline' 0 N--CA 1.443 -1.47 0 N-CA-C 106.609 -2.112 . . . . 0.0 106.609 168.409 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 25' ' ' LYS . 3.4 mp -82.24 79.47 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 N-CA-C 102.54 -3.133 . . . . 0.0 102.54 173.182 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.4 p -96.36 137.67 23.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 N-CA-C 107.397 -1.334 . . . . 0.0 107.397 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 7.5 p -112.6 147.23 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 175.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -117.6 113.53 22.08 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 172.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -114.63 112.1 22.36 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 13.3 t -142.79 179.0 7.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 177.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -120.23 170.62 9.16 Favored 'General case' 0 CA--C 1.529 0.139 0 C-N-CA 125.585 1.554 . . . . 0.0 110.812 -176.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 45.9 p -96.8 -66.49 0.9 Allowed 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 125.943 1.697 . . . . 0.0 110.708 -177.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.9 p-90 -43.07 -32.38 0.68 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 127.51 2.324 . . . . 0.0 113.164 -178.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 21.7 p -58.46 -19.55 37.65 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.482 1.113 . . . . 0.0 113.093 178.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 77.07 -113.44 3.77 Favored Glycine 0 CA--C 1.531 1.078 0 CA-C-O 118.359 -1.245 . . . . 0.0 110.065 179.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -41.89 -42.84 6.78 Favored 'Trans proline' 0 N--CA 1.459 -0.502 0 C-N-CA 124.282 3.321 . . . . 0.0 115.207 -178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -23.09 55.6 Favored 'General case' 0 CA--C 1.541 0.62 0 N-CA-C 112.256 0.465 . . . . 0.0 112.256 -177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -71.17 -31.67 67.96 Favored 'General case' 0 CA--C 1.531 0.234 0 O-C-N 121.428 -0.795 . . . . 0.0 110.364 177.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 24.7 mmt -61.22 -18.25 57.32 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.14 0.976 . . . . 0.0 112.467 -173.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.405 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 43.6 mt -62.98 -33.43 60.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 175.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -56.9 -61.6 6.68 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-O 117.858 -1.067 . . . . 0.0 112.114 -178.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -57.11 -35.99 99.07 Favored 'Trans proline' 0 N--CA 1.459 -0.549 0 CA-C-N 121.801 1.679 . . . . 0.0 112.019 178.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.4 mt -59.34 -55.14 38.51 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 121.399 0.618 . . . . 0.0 109.733 176.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -56.5 -41.26 76.37 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.67 0.788 . . . . 0.0 109.522 177.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -62.68 -40.61 97.64 Favored 'General case' 0 CA--C 1.534 0.365 0 O-C-N 121.881 -0.512 . . . . 0.0 110.119 177.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 40.0 m -60.21 -48.84 80.03 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 13.6 mt -57.51 -39.17 75.94 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.775 -0.578 . . . . 0.0 110.257 176.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 7.1 m -54.88 -54.38 43.3 Favored 'General case' 0 CA--C 1.53 0.176 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 176.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -56.05 -45.79 79.12 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 123.989 0.915 . . . . 0.0 110.771 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -64.24 -43.14 95.85 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 123.566 0.746 . . . . 0.0 111.759 -175.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -79.42 -45.41 19.53 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 -177.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 60.97 -64.64 0.06 Allowed 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 116.74 2.126 . . . . 0.0 116.74 173.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -52.76 -119.47 0.01 OUTLIER Glycine 0 CA--C 1.535 1.304 0 C-N-CA 127.575 2.512 . . . . 0.0 116.92 -170.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.14 55.37 1.48 Allowed 'General case' 0 CA--C 1.532 0.285 0 O-C-N 121.091 -1.24 . . . . 0.0 111.12 -175.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 m -137.89 149.46 25.03 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 C-N-CA 125.042 1.337 . . . . 0.0 110.552 -177.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.9 mp -133.72 105.44 7.45 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.34 0 N-CA-C 107.505 -1.295 . . . . 0.0 107.505 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -104.92 94.39 5.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 124.604 1.162 . . . . 0.0 108.434 -178.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 81.2 mt -79.9 92.45 5.52 Favored 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 124.911 1.284 . . . . 0.0 109.824 -178.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 17.8 ttpt -85.25 107.42 17.28 Favored 'General case' 0 CA--C 1.535 0.381 0 O-C-N 121.515 -0.741 . . . . 0.0 109.233 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.67 149.75 17.81 Favored 'Isoleucine or valine' 0 C--N 1.342 0.282 0 C-N-CA 125.292 1.437 . . . . 0.0 110.255 -176.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -109.99 115.77 30.39 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.0 0.92 . . . . 0.0 108.553 177.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 53.6 t -58.66 -45.8 90.64 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.064 0 C-N-CA 124.867 1.267 . . . . 0.0 110.991 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -58.45 -41.66 85.64 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -177.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -71.03 -70.91 0.28 Allowed 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 179.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 m -87.88 63.34 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 O-C-N 121.332 -0.855 . . . . 0.0 110.955 -176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.02 -41.93 48.3 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.48 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.72 -51.5 69.3 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.008 0.923 . . . . 0.0 111.295 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 61.0 t -64.07 -44.96 97.83 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.096 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.1 -55.59 29.41 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 122.648 0.379 . . . . 0.0 111.169 179.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -63.92 -41.71 97.59 Favored 'General case' 0 CA--C 1.533 0.324 0 CA-C-N 118.707 0.685 . . . . 0.0 109.831 -179.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.66 -41.66 77.65 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 118.641 0.655 . . . . 0.0 110.528 177.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.27 7.76 12.97 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 124.12 0.968 . . . . 0.0 111.792 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.38 27.06 70.16 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 124.211 0.91 . . . . 0.0 113.093 177.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 43.3 mm -74.88 81.28 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 CA-C-O 122.558 1.171 . . . . 0.0 108.707 -178.695 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 3.3 p -92.1 -72.58 0.58 Allowed 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 126.842 2.057 . . . . 0.0 108.099 179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -76.46 59.94 1.53 Allowed 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 123.831 0.852 . . . . 0.0 111.389 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.86 152.18 96.89 Favored Pre-proline 0 CA--C 1.542 0.645 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 177.802 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_exo -60.17 147.96 44.01 Favored 'Cis proline' 0 N--CA 1.457 -0.648 0 CA-C-N 121.016 1.398 . . . . 0.0 112.491 -2.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 99.8 m -147.35 141.79 26.42 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.405 ' CZ ' HG21 ' A' ' 42' ' ' ILE . 51.8 m-85 -134.34 130.49 37.04 Favored 'General case' 0 N--CA 1.445 -0.683 0 C-N-CA 125.666 1.587 . . . . 0.0 107.917 -176.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 44.5 m170 -125.3 158.49 34.05 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.551 1.14 . . . . 0.0 107.925 178.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.1 t -124.4 122.02 63.03 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.316 0 N-CA-C 108.142 -1.059 . . . . 0.0 108.142 175.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.508 ' O ' HD13 ' A' ' 27' ' ' ILE . 40.6 m-85 -110.81 76.36 0.97 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.107 0.563 . . . . 0.0 111.966 -173.796 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 39.8 mtpt -90.43 -168.08 2.01 Favored 'General case' 0 N--CA 1.471 0.613 0 O-C-N 121.349 -0.845 . . . . 0.0 110.285 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' A' ' 89' ' ' VAL . 3.3 m-20 -51.23 -43.07 61.39 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 172.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -65.08 17.86 0.14 Allowed Glycine 0 CA--C 1.53 0.981 0 C-N-CA 126.612 2.053 . . . . 0.0 112.507 176.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.67 HG12 ' H ' ' A' ' 90' ' ' LYS 0.277 40.5 t 67.18 -154.83 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 C-N-CA 125.42 1.488 . . . . 0.0 107.34 170.592 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . 0.67 ' H ' HG12 ' A' ' 89' ' ' VAL . 22.5 ttpp -64.29 79.53 0.04 OUTLIER 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 104.954 -2.239 . . . . 0.0 104.954 170.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.29 -32.45 43.58 Favored 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 114.968 -1.015 . . . . 0.0 111.622 -166.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -147.19 151.07 36.12 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 -176.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -142.97 166.27 25.1 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 125.081 1.352 . . . . 0.0 109.48 -177.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.587 HD21 ' HB2' ' A' ' 98' ' ' SER . 1.7 tm? -161.83 140.98 9.73 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.762 1.225 . . . . 0.0 108.263 -177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 25.0 m -127.26 162.68 31.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 124.485 1.114 . . . . 0.0 110.793 -179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 179.16 36.76 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 111.723 -0.551 . . . . 0.0 111.723 178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.01 44.84 0.58 Allowed 'General case' 0 CA--C 1.535 0.371 0 O-C-N 121.841 -0.799 . . . . 0.0 111.09 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.587 ' HB2' HD21 ' A' ' 94' ' ' LEU . 14.2 m -80.08 58.86 3.1 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.76 1.224 . . . . 0.0 110.302 -176.718 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 12.4 tp-100 -48.92 -46.57 43.27 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.134 1.374 . . . . 0.0 111.864 -176.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -55.36 -48.51 74.13 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.103 0.561 . . . . 0.0 110.128 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.451 ' HD3' HD23 ' A' ' 94' ' ' LEU . 50.7 tttm -68.8 -35.62 77.25 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 31.3 tp -58.69 -48.71 80.16 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 118.923 0.783 . . . . 0.0 109.132 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 58.7 mttp -56.98 -47.76 80.03 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.82 -43.93 77.39 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 119.453 -0.308 . . . . 0.0 110.841 178.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 39.3 mt -58.23 -55.72 31.34 Favored 'General case' 0 C--N 1.34 0.162 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 77.0 t -51.08 -53.34 14.87 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.111 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -179.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -54.24 -52.11 62.35 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 122.94 0.496 . . . . 0.0 111.562 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -56.35 -68.28 0.23 Allowed 'General case' 0 N--CA 1.456 -0.133 0 CA-C-O 121.471 0.653 . . . . 0.0 110.034 178.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -61.01 -24.04 65.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.724 -1.125 . . . . 0.0 112.091 -170.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -61.47 -40.42 94.45 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 118.728 0.695 . . . . 0.0 109.696 172.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -84.26 -62.94 1.44 Allowed 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 123.477 0.711 . . . . 0.0 109.47 178.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.252 1.199 0 C-N-CA 125.591 1.556 . . . . 0.0 108.173 -179.845 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.077 0 N-CA-C 111.425 -0.67 . . . . 0.0 111.425 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -71.25 80.3 0.5 Allowed Glycine 0 CA--C 1.527 0.822 0 CA-C-N 117.351 0.575 . . . . 0.0 112.028 -178.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 15.0 m -72.48 79.11 1.04 Allowed 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 118.132 0.966 . . . . 0.0 109.139 176.164 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 33.2 m -116.71 32.41 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.481 1.512 . . . . 0.0 112.784 -175.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 43.3 pt -107.99 154.09 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 O-C-N 121.35 -0.844 . . . . 0.0 112.392 -173.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 11.6 p -83.89 135.95 23.78 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 106.456 -1.683 . . . . 0.0 106.456 174.266 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 8.8 tp -160.58 -41.31 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.362 0 CA-C-O 122.7 1.238 . . . . 0.0 111.295 -178.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 43.38 49.36 6.05 Favored 'General case' 0 C--N 1.32 -0.705 0 C-N-CA 128.044 2.538 . . . . 0.0 112.241 168.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.3 m -131.82 134.73 46.11 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.578 1.151 . . . . 0.0 107.988 -179.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 37.3 ttpt -49.57 -46.81 49.35 Favored 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.754 0.822 . . . . 0.0 111.113 -179.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.92 -11.34 37.0 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.871 1.268 . . . . 0.0 113.143 -178.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -109.23 -33.28 6.91 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 124.499 1.12 . . . . 0.0 110.075 177.65 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -46.58 -46.79 19.75 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.171 1.388 . . . . 0.0 110.274 178.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 18.5 p-10 -69.47 -53.39 19.43 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 123.012 0.525 . . . . 0.0 109.954 179.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -47.62 -45.68 27.88 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.608 1.163 . . . . 0.0 111.26 -178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.04 -44.72 41.83 Favored 'General case' 0 C--O 1.232 0.161 0 C-N-CA 125.499 1.52 . . . . 0.0 111.286 178.214 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 43.5 mt -64.54 -39.1 93.14 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.704 0.802 . . . . 0.0 110.704 178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -69.57 -54.13 15.56 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.039 0.536 . . . . 0.0 109.869 -177.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -64.5 -28.63 69.79 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 176.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -62.43 -54.53 33.54 Favored Glycine 0 N--CA 1.442 -0.919 0 C-N-CA 124.767 1.175 . . . . 0.0 111.312 178.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? 103.64 81.25 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.239 1 C-N-CA 132.063 4.145 . . . . 0.0 107.665 -177.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.4 tt0 -72.83 60.89 0.53 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 126.641 1.977 . . . . 0.0 110.189 177.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -119.33 -60.1 1.77 Allowed 'General case' 0 CA--C 1.529 0.167 0 C-N-CA 124.947 1.299 . . . . 0.0 108.207 175.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 7.5 t60 -152.32 90.9 1.54 Allowed 'General case' 0 N--CA 1.456 -0.136 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 177.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.2 mtpt -157.77 152.77 21.36 Favored Pre-proline 0 CA--C 1.533 0.29 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -76.36 106.71 2.31 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.912 3.075 . . . . 0.0 108.793 172.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 7.3 mt -95.24 81.31 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 14.3 t -84.18 120.43 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -179.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.41 HG23 ' HB3' ' A' ' 60' ' ' LEU . 4.0 p -120.62 118.42 56.45 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 177.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 50.8 t0 -88.72 96.75 10.79 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 124.567 1.147 . . . . 0.0 108.958 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.5 m-85 -82.25 113.2 19.9 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 172.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.6 m -141.46 149.47 40.99 Favored 'General case' 0 C--N 1.333 -0.134 0 C-N-CA 122.987 0.515 . . . . 0.0 110.041 -177.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -84.93 133.21 34.29 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.127 -1.434 . . . . 0.0 107.127 174.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -65.94 -50.83 63.01 Favored 'General case' 0 C--N 1.331 -0.213 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 61.3 p-90 -76.63 100.74 5.46 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.241 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER 176.2 133.13 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 O-C-N 121.479 -0.763 . . . . 0.0 109.003 178.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.48 150.97 40.71 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.002 -1.639 . . . . 0.0 109.002 177.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . 0.315 0.1 OUTLIER 50.91 -29.51 0.0 OUTLIER 'Trans proline' 0 CA--C 1.541 0.86 0 C-N-CA 124.445 3.43 . . . . 0.0 118.59 -170.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 65.2 m -50.73 -45.86 58.83 Favored 'General case' 0 N--CA 1.471 0.578 0 CA-C-N 122.573 2.442 . . . . 0.0 108.354 172.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 13.7 tptm -56.06 -26.48 49.42 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.876 1.67 . . . . 0.0 112.438 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 60.6 mtt -91.15 -43.67 9.73 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.27 1.428 . . . . 0.0 110.371 177.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 56.6 mt -56.65 -42.5 76.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 125.38 1.472 . . . . 0.0 110.31 -178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.482 ' HB3' ' HD3' ' A' ' 44' ' ' PRO . . . -55.32 -60.09 9.27 Favored Pre-proline 0 CA--C 1.548 0.885 0 CA-C-O 118.29 -0.862 . . . . 0.0 109.769 175.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.482 ' HD3' ' HB3' ' A' ' 43' ' ' ALA . 71.2 Cg_exo -47.14 -46.9 18.2 Favored 'Trans proline' 0 C--N 1.349 0.581 0 C-N-CA 123.869 3.046 . . . . 0.0 113.643 173.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 47.2 mt -56.96 -55.44 34.65 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-O 121.429 0.633 . . . . 0.0 110.466 179.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -57.42 -37.91 73.52 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.023 0.529 . . . . 0.0 109.718 178.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -65.62 -38.35 89.2 Favored 'General case' 0 CA--C 1.536 0.429 0 O-C-N 121.704 -0.623 . . . . 0.0 110.146 176.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 30.9 m -60.9 -46.02 92.3 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 18.4 tp -61.11 -40.49 93.94 Favored 'General case' 0 CA--C 1.537 0.475 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 176.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.8 p -58.7 -41.93 87.41 Favored 'General case' 0 CA--C 1.53 0.204 0 O-C-N 121.117 -0.99 . . . . 0.0 109.599 178.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.04 -39.83 94.96 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -57.76 -47.91 81.15 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 122.773 0.429 . . . . 0.0 110.965 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -79.25 -47.74 15.39 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 119.382 -0.342 . . . . 0.0 111.874 -176.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 18.77 73.89 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 128.585 2.754 . . . . 0.0 115.238 178.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 173.0 -96.76 0.11 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 111.457 -0.657 . . . . 0.0 111.457 178.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 17.2 tptm -76.46 46.29 0.42 Allowed 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 125.09 1.356 . . . . 0.0 110.686 -178.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 26.6 m -156.76 161.46 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 O-C-N 121.047 -1.033 . . . . 0.0 109.62 -178.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.7 mt -125.98 121.35 59.34 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 N-CA-C 104.168 -2.531 . . . . 0.0 104.168 169.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 8.8 m-85 -119.36 91.48 3.56 Favored 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 124.624 1.169 . . . . 0.0 107.92 179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.41 ' HB3' HG23 ' A' ' 29' ' ' VAL . 0.6 OUTLIER -84.96 127.24 34.09 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.273 1.029 . . . . 0.0 110.923 -178.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 12.5 mptt -97.34 128.76 44.44 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 106.368 -1.716 . . . . 0.0 106.368 171.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 98.1 t -136.0 101.06 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.286 0 CA-C-O 122.138 0.97 . . . . 0.0 111.388 -178.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -65.07 104.07 0.84 Allowed 'General case' 0 N--CA 1.447 -0.581 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 172.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.4 t -53.22 -36.18 25.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 C-N-CA 124.982 1.313 . . . . 0.0 110.018 178.96 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.3 m-20 -63.16 -28.23 69.91 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 122.618 0.367 . . . . 0.0 111.104 -179.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -92.46 -65.8 0.97 Allowed 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 177.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -85.7 56.19 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-O 121.835 0.826 . . . . 0.0 110.134 -175.465 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.31 -48.13 77.31 Favored 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 124.023 0.929 . . . . 0.0 111.529 -178.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.32 -53.12 48.44 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 123.907 0.883 . . . . 0.0 111.657 -178.515 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 59.4 t -63.41 -46.57 94.98 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.282 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 -179.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.26 -57.25 11.9 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 117.722 0.237 . . . . 0.0 111.437 -179.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -62.02 -41.3 97.94 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.415 -0.803 . . . . 0.0 110.703 -177.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.39 -42.35 98.81 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 118.384 0.538 . . . . 0.0 111.367 179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.19 -45.32 81.24 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.428 1.091 . . . . 0.0 111.151 -178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 109.67 82.4 1.35 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 110.433 -1.067 . . . . 0.0 110.433 179.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.2 mp -111.76 139.3 36.76 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.102 0 C-N-CA 126.279 1.832 . . . . 0.0 106.401 178.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 55.8 p -131.92 -96.11 0.33 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.76 71.64 5.24 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 123.725 0.81 . . . . 0.0 109.446 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . 0.409 ' HA ' ' C ' ' A' ' 80' ' ' PRO . 1.7 pmm? -53.98 143.66 41.09 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 124.052 0.941 . . . . 0.0 109.855 178.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 79' ' ' MET . 99.9 Cg_exo -57.55 154.98 32.59 Favored 'Cis proline' 0 C--N 1.348 0.51 0 CA-C-N 121.131 1.44 . . . . 0.0 113.642 -1.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.9 m -145.9 108.7 4.53 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 -178.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -95.76 89.94 5.48 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.635 1.574 . . . . 0.0 110.104 -177.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 33.4 m170 -80.26 146.15 31.81 Favored 'General case' 0 C--O 1.231 0.099 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 18.9 t -117.42 104.58 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 175.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 69.1 m-85 -92.68 52.83 1.94 Allowed 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 57.0 tttp -50.69 132.14 25.92 Favored 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 -176.203 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 74.85 -62.19 0.46 Allowed 'General case' 0 CA--C 1.526 0.043 0 C-N-CA 126.835 2.054 . . . . 0.0 108.726 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 168.71 39.06 0.02 OUTLIER Glycine 0 CA--C 1.529 0.918 0 C-N-CA 124.912 1.244 . . . . 0.0 111.533 177.69 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 7.2 p -156.88 142.22 8.97 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.2 ttpt -60.54 91.23 0.02 OUTLIER 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.672 0.789 . . . . 0.0 109.945 -177.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.44 -31.56 29.41 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 125.224 1.41 . . . . 0.0 110.741 -178.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -150.27 170.87 17.97 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-O 120.609 0.242 . . . . 0.0 111.163 -178.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -150.12 165.07 33.94 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 126.448 1.899 . . . . 0.0 107.43 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 46.9 tp -172.39 108.08 0.2 Allowed 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 125.264 1.426 . . . . 0.0 108.842 -179.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.6 168.04 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 C-N-CA 123.345 0.658 . . . . 0.0 110.446 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.12 -177.76 27.77 Favored Glycine 0 CA--C 1.529 0.922 0 N-CA-C 111.413 -0.675 . . . . 0.0 111.413 -179.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.38 -65.77 0.63 Allowed 'General case' 0 CA--C 1.528 0.122 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 178.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.4 m 45.45 43.91 9.16 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.379 1.472 . . . . 0.0 113.046 173.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 23.8 mm100 -48.59 -44.14 36.68 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.988 1.315 . . . . 0.0 112.695 -175.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 20.4 p-10 -59.71 -52.32 65.99 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.582 0.753 . . . . 0.0 110.21 179.566 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 52.1 tttp -67.85 -31.55 71.46 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 -179.669 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -55.21 -59.22 5.08 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 106.976 -1.491 . . . . 0.0 106.976 175.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 62.4 mttp -53.54 -49.85 66.74 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.258 0.623 . . . . 0.0 110.464 178.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.98 -46.84 71.8 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.067 0.147 . . . . 0.0 110.87 179.352 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 23.1 mt -64.37 -46.27 84.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 118.405 -0.807 . . . . 0.0 110.454 179.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 13.5 t -57.77 -48.81 82.74 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 CA-C-N 119.794 1.179 . . . . 0.0 108.916 179.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.6 -53.72 47.7 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 122.75 0.42 . . . . 0.0 110.485 178.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -52.37 -63.23 1.21 Allowed 'General case' 0 N--CA 1.457 -0.102 0 C-N-CA 124.057 0.943 . . . . 0.0 110.661 178.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -66.24 -19.1 65.73 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.351 -175.294 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -93.29 9.12 37.56 Favored 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.277 0.944 . . . . 0.0 111.385 174.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -56.47 -41.58 76.77 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 119.295 0.952 . . . . 0.0 111.703 -179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 178.502 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.957 0 CA-C-O 118.208 -1.329 . . . . 0.0 110.05 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -60.44 -30.85 72.53 Favored Glycine 0 CA--C 1.532 1.095 0 CA-C-N 118.756 1.278 . . . . 0.0 110.591 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . 0.45 ' HB2' HG23 ' A' ' 58' ' ' ILE . 4.3 m -66.49 71.99 0.08 Allowed 'General case' 0 N--CA 1.446 -0.663 0 C-N-CA 127.098 2.159 . . . . 0.0 113.192 179.55 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.8 m -142.57 31.64 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 C-N-CA 127.048 2.139 . . . . 0.0 107.179 174.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 24.9 pt -116.11 147.48 19.47 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 C-N-CA 125.248 1.419 . . . . 0.0 111.672 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.4 p -83.1 71.62 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 C-N-CA 124.352 1.061 . . . . 0.0 110.816 -177.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 14.8 tt -149.34 122.98 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.315 0 N-CA-C 108.506 -0.924 . . . . 0.0 108.506 174.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 18.0 p-10 -98.75 -25.15 14.76 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 127.336 2.254 . . . . 0.0 113.569 -175.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 m -38.06 130.11 1.2 Allowed 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.663 1.585 . . . . 0.0 111.627 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -49.89 -40.39 42.73 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.049 0.84 . . . . 0.0 112.537 -175.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.17 -42.6 81.43 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-O 121.749 0.785 . . . . 0.0 110.034 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.18 -33.64 67.83 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.475 -0.774 . . . . 0.0 110.189 178.114 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -57.95 -52.23 66.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 106.978 -1.489 . . . . 0.0 106.978 174.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 73.7 m-20 -56.2 -50.05 72.32 Favored 'General case' 0 C--N 1.338 0.09 0 C-N-CA 123.404 0.682 . . . . 0.0 109.939 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -53.1 61.97 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.147 0.498 . . . . 0.0 110.869 179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -56.6 -39.14 73.05 Favored 'General case' 0 C--O 1.231 0.123 0 C-N-CA 124.562 1.145 . . . . 0.0 111.058 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 25.3 tp -62.34 -10.5 11.36 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.222 0.609 . . . . 0.0 111.454 177.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -108.69 -58.97 1.94 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.645 1.178 . . . . 0.0 109.908 175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -65.13 -9.57 23.96 Favored 'General case' 0 N--CA 1.472 0.652 0 O-C-N 121.522 -0.736 . . . . 0.0 112.184 -177.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.53 -26.7 71.02 Favored Glycine 0 CA--C 1.535 1.303 0 N-CA-C 111.03 -0.828 . . . . 0.0 111.03 172.413 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 43.3 mtpt 55.07 51.73 12.93 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 124.738 1.215 . . . . 0.0 109.475 -176.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -77.18 62.63 2.29 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.702 1.601 . . . . 0.0 110.218 -179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -54.95 -49.77 70.53 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.002 0.921 . . . . 0.0 109.154 176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 24.4 p-80 -163.37 22.81 0.08 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 126.676 1.99 . . . . 0.0 108.865 178.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 46.6 mmtm -87.56 160.71 47.14 Favored Pre-proline 0 C--O 1.236 0.392 0 C-N-CA 124.498 1.119 . . . . 0.0 110.723 -174.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -75.91 120.62 5.85 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 122.437 2.091 . . . . 0.0 112.255 178.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.4 mt -89.36 92.88 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.512 0 N-CA-C 104.553 -2.388 . . . . 0.0 104.553 170.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.4 t -85.64 111.29 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 N-CA-C 104.168 -2.53 . . . . 0.0 104.168 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 6.3 p -109.64 128.96 65.3 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 -179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -99.84 102.74 14.25 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 127.591 2.356 . . . . 0.0 108.461 179.053 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 96.2 m-85 -97.45 96.75 8.55 Favored 'General case' 0 N--CA 1.448 -0.536 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 33' ' ' ALA . 72.9 m -136.75 -177.34 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 177.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.427 ' H ' HG22 ' A' ' 32' ' ' THR . . . -169.46 -177.83 2.91 Favored 'General case' 0 N--CA 1.457 -0.122 0 CA-C-N 120.878 1.672 . . . . 0.0 110.147 178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 12.9 p -56.53 -50.17 72.64 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.931 1.693 . . . . 0.0 109.001 172.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 4.3 m95 -59.43 74.7 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 128.214 2.605 . . . . 0.0 113.704 -175.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 19.0 p 170.72 -21.58 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 127.839 2.456 . . . . 0.0 110.491 176.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 69.95 -114.52 5.61 Favored Glycine 0 CA--C 1.532 1.12 0 CA-C-O 118.088 -1.396 . . . . 0.0 110.084 179.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -41.04 -41.45 4.28 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 124.502 3.468 . . . . 0.0 115.853 -178.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -56.64 -27.23 58.02 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.473 0.579 . . . . 0.0 111.57 -178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 41.0 tttp -57.99 -23.7 55.07 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 121.544 -0.723 . . . . 0.0 111.125 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.8 mtm -60.83 -13.72 17.29 Favored 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 118.778 0.717 . . . . 0.0 111.965 177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 71.0 mt -67.84 -30.58 48.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 O-C-N 121.482 -0.761 . . . . 0.0 109.632 173.803 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.04 -56.48 25.37 Favored Pre-proline 0 CA--C 1.541 0.607 0 CA-C-O 117.754 -1.117 . . . . 0.0 112.629 -177.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_endo -58.24 -33.46 97.62 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 CA-C-N 122.11 1.789 . . . . 0.0 111.962 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.99 -46.94 76.18 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 177.046 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -58.6 -38.4 77.88 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 175.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -63.94 -42.72 97.26 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.579 0.752 . . . . 0.0 110.005 176.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 61.4 m -57.62 -47.07 83.22 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 177.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 11.3 mt -61.64 -42.25 98.63 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 176.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 14.9 m -52.34 -50.25 62.68 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 176.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -64.86 -41.76 95.42 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 122.952 0.501 . . . . 0.0 110.651 179.013 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.12 -49.8 75.7 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.728 0.811 . . . . 0.0 111.315 -178.691 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 -79.17 -48.18 14.72 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 122.176 0.19 . . . . 0.0 110.635 -177.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 59.91 -73.37 0.03 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.313 1.845 . . . . 0.0 114.133 177.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -81.24 -68.7 1.44 Allowed Glycine 0 CA--C 1.527 0.806 0 C-N-CA 124.388 0.994 . . . . 0.0 114.23 -172.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 22.4 tttp -69.88 19.43 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.696 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -169.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.428 HG11 ' CE1' ' A' ' 59' ' ' PHE . 41.0 t -152.13 154.93 7.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-N 119.886 1.221 . . . . 0.0 109.43 -178.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.45 HG23 ' HB2' ' A' ' 3' ' ' SER . 4.2 mp -116.52 102.87 14.24 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 N-CA-C 105.638 -1.986 . . . . 0.0 105.638 175.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.428 ' CE1' HG11 ' A' ' 57' ' ' VAL . 24.0 m-85 -94.25 98.03 10.65 Favored 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 124.086 0.954 . . . . 0.0 109.278 -179.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 54.6 mt -89.94 121.77 32.35 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 122.857 0.463 . . . . 0.0 109.787 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.7 mttm -99.52 115.77 30.12 Favored 'General case' 0 C--N 1.334 -0.079 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 176.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 24.7 t -121.81 119.45 58.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.141 0 CA-C-N 118.484 0.584 . . . . 0.0 110.868 -177.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -82.68 100.2 10.07 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 105.652 -1.981 . . . . 0.0 105.652 172.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 43.4 t -44.22 -58.77 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.196 0 C-N-CA 125.854 1.662 . . . . 0.0 111.51 -177.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -58.26 -42.59 86.77 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.9 0.88 . . . . 0.0 111.574 -177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -67.38 -67.9 0.42 Allowed 'General case' 0 N--CA 1.454 -0.247 0 CA-C-N 118.124 0.42 . . . . 0.0 110.063 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.7 m -86.44 63.79 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.2 0 CA-C-O 121.926 0.87 . . . . 0.0 109.869 -179.167 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.2 -40.74 34.64 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.674 1.189 . . . . 0.0 110.615 177.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.73 -48.39 77.89 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.692 0.797 . . . . 0.0 111.048 178.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.52 -45.07 89.8 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.132 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -179.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.12 35.69 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 122.552 0.341 . . . . 0.0 111.435 179.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -64.81 -41.12 96.05 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 118.26 0.482 . . . . 0.0 109.758 -179.113 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.31 -41.82 76.61 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.741 0.7 . . . . 0.0 110.235 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -82.1 6.9 14.88 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 123.48 0.712 . . . . 0.0 112.295 178.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 63.23 38.94 97.28 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.023 0.821 . . . . 0.0 112.731 177.312 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 42.0 mm -94.3 153.65 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 31.5 m -153.64 -57.53 0.12 Allowed 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 176.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.12 159.5 18.18 Favored 'General case' 0 C--O 1.234 0.248 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 175.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -158.81 158.99 29.64 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-O 117.414 -1.279 . . . . 0.0 107.855 178.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -61.34 126.44 3.64 Favored 'Cis proline' 0 C--N 1.35 0.612 0 CA-C-N 121.338 1.514 . . . . 0.0 112.975 -1.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 42.5 m -126.87 122.07 33.62 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -111.44 129.01 56.16 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.566 1.146 . . . . 0.0 108.521 179.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 46.7 m170 -121.3 152.4 38.96 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 107.516 -1.29 . . . . 0.0 107.516 174.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 11.8 t -120.13 94.16 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 177.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 46.7 m-85 -88.65 104.75 17.15 Favored 'General case' 0 C--O 1.227 -0.103 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 176.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 19.5 ttmm -77.1 127.65 33.04 Favored 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 176.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 13.0 t70 69.28 -64.78 0.32 Allowed 'General case' 0 N--CA 1.467 0.419 0 C-N-CA 126.792 2.037 . . . . 0.0 109.136 -176.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -173.31 22.2 0.07 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.032 1.777 . . . . 0.0 112.242 177.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 4.8 p -135.34 125.63 43.72 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 CA-C-N 119.324 1.562 . . . . 0.0 109.576 179.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 23.3 ttpp -50.28 97.46 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.135 1.774 . . . . 0.0 110.782 178.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -82.97 -31.07 27.79 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.294 1.038 . . . . 0.0 110.101 178.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -160.35 172.89 16.49 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 123.737 0.815 . . . . 0.0 108.9 -176.623 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -161.48 -179.28 7.21 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 124.115 0.966 . . . . 0.0 109.284 179.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.5 tp -164.96 106.18 0.81 Allowed 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 126.052 1.741 . . . . 0.0 106.951 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 32.0 m -85.56 32.07 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 125.0 1.32 . . . . 0.0 113.075 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -162.03 168.73 37.19 Favored Glycine 0 CA--C 1.526 0.741 0 O-C-N 121.187 -0.946 . . . . 0.0 112.661 179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.92 38.55 0.13 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.298 1.439 . . . . 0.0 112.942 -177.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 40.3 m -81.4 70.92 8.37 Favored 'General case' 0 C--O 1.225 -0.202 0 O-C-N 120.649 -1.282 . . . . 0.0 109.717 -177.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 26.4 mm100 -39.62 -52.06 2.23 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.826 1.651 . . . . 0.0 113.757 -176.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -59.57 -44.19 93.37 Favored 'General case' 0 CA--C 1.534 0.344 0 O-C-N 121.81 -0.556 . . . . 0.0 110.959 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -65.32 -41.57 93.85 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 1.1 tt -51.81 -58.01 7.67 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.938 1.295 . . . . 0.0 108.187 175.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -53.49 -52.68 58.78 Favored 'General case' 0 C--O 1.232 0.16 0 C-N-CA 123.92 0.888 . . . . 0.0 110.392 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -53.95 -45.25 71.24 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 123.593 0.757 . . . . 0.0 110.899 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 48.8 mt -58.66 -51.37 70.21 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 177.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 18.3 t -57.18 -48.88 81.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.238 0 C-N-CA 119.032 -1.067 . . . . 0.0 109.489 -179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -53.77 -51.9 61.94 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 122.599 0.36 . . . . 0.0 110.864 -179.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -56.21 -65.09 0.66 Allowed 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.122 0.969 . . . . 0.0 110.417 179.05 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 86.3 m-70 -64.42 -24.44 67.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.29 -0.868 . . . . 0.0 112.455 -173.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -80.5 2.84 23.65 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.951 0.796 . . . . 0.0 112.033 177.605 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.95 48.72 0.73 Allowed 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 120.031 1.287 . . . . 0.0 111.462 179.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.094 0 CA-C-O 116.65 -1.643 . . . . 0.0 107.465 179.098 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.625 0 N-CA-C 108.207 -1.957 . . . . 0.0 108.207 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.8 -37.6 92.72 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 109.008 -1.637 . . . . 0.0 109.008 175.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 8.8 m -68.55 69.56 0.16 Allowed 'General case' 0 N--CA 1.448 -0.529 0 C-N-CA 126.49 1.916 . . . . 0.0 112.429 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.533 HG13 ' HB3' ' A' ' 50' ' ' SER . 11.3 t -131.66 92.38 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.569 0 N-CA-C 102.022 -3.325 . . . . 0.0 102.022 174.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.3 pp -136.96 176.06 8.68 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.169 0 CA-C-O 121.247 0.546 . . . . 0.0 112.406 -171.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 34.0 m -127.08 22.26 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 C-N-CA 125.516 1.526 . . . . 0.0 110.939 178.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 21.1 tt -82.03 78.49 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 178.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -70.99 64.24 0.33 Allowed 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 126.413 1.885 . . . . 0.0 109.631 179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 48.6 m -153.12 167.82 27.99 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 125.19 1.396 . . . . 0.0 109.469 179.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 58.8 tttp -39.77 -42.74 1.31 Allowed 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 126.695 1.998 . . . . 0.0 112.339 179.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -45.5 -41.12 9.28 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.655 1.182 . . . . 0.0 112.037 178.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.78 -51.01 62.63 Favored 'General case' 0 N--CA 1.453 -0.325 0 O-C-N 121.578 -0.701 . . . . 0.0 109.944 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 63.7 t-105 -53.96 -40.25 66.67 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 123.98 0.912 . . . . 0.0 112.198 -176.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -106.06 -72.62 0.71 Allowed 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.985 0.735 . . . . 0.0 112.985 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.49 -55.68 23.33 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 123.257 0.623 . . . . 0.0 111.899 -173.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 10.2 tp-100 -61.96 -50.18 73.16 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 -178.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 51.7 tp -47.19 -50.13 21.35 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.891 0.476 . . . . 0.0 110.762 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.37 -58.35 8.88 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.118 0.567 . . . . 0.0 111.147 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 22.0 ptmt -62.47 -19.4 63.5 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 120.091 -0.644 . . . . 0.0 111.561 -178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -64.22 -12.18 49.2 Favored Glycine 0 CA--C 1.538 1.486 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.751 174.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 98.0 mttt 57.56 65.76 1.28 Allowed 'General case' 0 C--N 1.344 0.328 0 CA-C-N 119.026 1.413 . . . . 0.0 109.837 179.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -75.12 68.13 1.86 Allowed 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.201 1.4 . . . . 0.0 109.839 -178.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -69.01 -51.79 35.49 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 106.792 -1.559 . . . . 0.0 106.792 172.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -163.48 22.59 0.08 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.38 1.872 . . . . 0.0 109.487 177.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -69.31 144.47 94.83 Favored Pre-proline 0 N--CA 1.454 -0.258 0 O-C-N 121.865 -0.522 . . . . 0.0 111.674 -171.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.81 92.39 0.52 Allowed 'Trans proline' 0 N--CA 1.448 -1.15 0 C-N-CA 121.539 1.493 . . . . 0.0 108.844 171.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -93.5 111.65 25.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 105.454 -2.054 . . . . 0.0 105.454 174.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -96.52 123.4 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.785 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 58.0 t -111.3 104.22 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.832 0.853 . . . . 0.0 110.282 -177.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -79.97 90.55 5.37 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.274 1.03 . . . . 0.0 109.395 176.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 74.8 m-85 -80.11 113.35 18.21 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 106.599 -1.63 . . . . 0.0 106.599 172.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 17.0 m -139.55 146.89 40.46 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . 0.602 ' HB1' ' CE2' ' A' ' 35' ' ' TRP . . . -77.58 107.48 10.07 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.983 -1.117 . . . . 0.0 107.983 175.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 92.8 m -58.44 -36.65 73.98 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 118.795 0.725 . . . . 0.0 110.333 179.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . 0.602 ' CE2' ' HB1' ' A' ' 33' ' ' ALA . 37.1 p-90 -60.91 -32.39 71.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 123.466 0.706 . . . . 0.0 110.572 175.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 43.5 t -78.89 77.08 5.37 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 177.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -39.58 -54.09 2.84 Favored Glycine 0 CA--C 1.537 1.417 0 C-N-CA 124.524 1.059 . . . . 0.0 112.184 177.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -53.49 -45.49 40.7 Favored 'Trans proline' 0 N--CA 1.455 -0.781 0 C-N-CA 123.094 2.529 . . . . 0.0 112.75 177.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 67.3 m -59.16 -45.56 90.67 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -61.49 -13.01 17.39 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-O 117.516 -1.23 . . . . 0.0 112.753 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 64.2 mtt -66.92 -12.87 60.88 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 121.556 1.98 . . . . 0.0 111.128 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.79 -23.83 7.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 118.714 0.688 . . . . 0.0 109.306 172.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -53.55 -47.04 97.8 Favored Pre-proline 0 CA--C 1.544 0.714 0 O-C-N 120.71 -1.244 . . . . 0.0 112.644 178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -62.35 -35.43 73.07 Favored 'Trans proline' 0 N--CA 1.456 -0.681 0 CA-C-N 122.347 1.874 . . . . 0.0 110.795 176.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -62.27 -46.26 89.58 Favored 'General case' 0 CA--C 1.536 0.442 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 175.454 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 62.2 t80 -56.75 -46.4 81.43 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 176.699 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.7 tp10 -59.01 -41.97 88.99 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 123.567 0.747 . . . . 0.0 109.974 177.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 36.9 m -60.17 -44.83 94.72 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 177.234 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.438 HD12 ' HA ' ' A' ' 49' ' ' LEU . 14.0 tp -62.51 -38.02 88.3 Favored 'General case' 0 CA--C 1.533 0.325 0 O-C-N 122.081 -0.387 . . . . 0.0 110.036 177.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.533 ' HB3' HG13 ' A' ' 4' ' ' VAL . 11.5 m -60.08 -48.67 80.74 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.401 0.68 . . . . 0.0 109.757 176.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 5.5 t30 -59.4 -45.19 92.2 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 122.944 0.497 . . . . 0.0 109.667 177.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -58.11 -56.77 17.75 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 122.734 0.414 . . . . 0.0 110.501 178.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -86.19 58.02 4.82 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 -179.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -65.23 -20.73 66.57 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.668 -0.697 . . . . 0.0 110.649 179.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -64.24 -149.44 0.05 OUTLIER Glycine 0 CA--C 1.537 1.455 0 C-N-CA 125.591 1.567 . . . . 0.0 113.959 -179.628 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.33 53.53 0.84 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 124.872 1.269 . . . . 0.0 113.012 -174.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 47.2 t -130.91 140.01 49.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 C-N-CA 126.323 1.849 . . . . 0.0 106.183 177.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 50.1 mm -112.91 134.64 54.89 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.382 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 -176.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -126.41 111.81 14.9 Favored 'General case' 0 N--CA 1.463 0.204 0 CA-C-N 118.673 0.67 . . . . 0.0 110.04 -178.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 45.0 mt -112.59 147.21 37.15 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 125.307 1.443 . . . . 0.0 108.949 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.4 mttp -118.23 144.14 46.0 Favored 'General case' 0 N--CA 1.456 -0.153 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 172.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 92.0 t -136.93 126.29 37.18 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 N-CA-C 108.757 -0.831 . . . . 0.0 108.757 -179.13 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -83.88 117.76 23.53 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 179.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -75.8 72.62 0.41 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 176.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 4.6 t70 177.69 -71.65 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 128.543 2.737 . . . . 0.0 105.759 177.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.5 -40.02 65.05 Favored 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 122.457 0.303 . . . . 0.0 110.414 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.9 t -115.16 39.63 0.61 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 176.929 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -47.57 -49.59 26.12 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.008 0.923 . . . . 0.0 112.224 -178.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -51.21 -47.43 62.3 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.462 0.705 . . . . 0.0 112.252 -177.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 96.3 t -65.49 -46.7 89.12 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.075 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -178.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.3 -43.46 78.94 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.061 0.458 . . . . 0.0 110.271 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -57.46 -58.92 6.16 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.25 1.02 . . . . 0.0 109.519 176.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.57 -41.9 73.97 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 122.814 0.446 . . . . 0.0 111.23 -178.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.04 -17.89 63.95 Favored 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 123.707 0.803 . . . . 0.0 111.578 178.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 77.38 44.27 13.69 Favored Glycine 0 CA--C 1.526 0.742 0 C-N-CA 123.71 0.671 . . . . 0.0 111.436 178.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 48.0 mm -74.37 139.72 18.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 178.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 37.4 p -124.52 -85.08 0.64 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.226 1.01 . . . . 0.0 111.509 -176.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.67 86.3 6.33 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.434 1.094 . . . . 0.0 111.402 -176.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.4 mpp? -62.64 145.01 95.78 Favored Pre-proline 0 CA--C 1.541 0.634 0 CA-C-O 118.429 -0.796 . . . . 0.0 109.462 177.17 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -63.91 153.05 72.97 Favored 'Cis proline' 0 N--CA 1.458 -0.564 0 CA-C-N 120.62 1.257 . . . . 0.0 111.634 -2.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 52.5 m -145.38 114.69 7.1 Favored 'General case' 0 N--CA 1.45 -0.426 0 N-CA-C 108.358 -0.978 . . . . 0.0 108.358 178.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 62.1 m-85 -96.52 119.74 35.56 Favored 'General case' 0 N--CA 1.447 -0.619 0 C-N-CA 124.593 1.157 . . . . 0.0 109.382 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -111.2 134.9 52.44 Favored 'General case' 0 N--CA 1.466 0.349 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 175.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 9.9 t -102.99 109.44 26.82 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -105.76 97.64 7.44 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 122.658 0.383 . . . . 0.0 111.788 -177.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 51.6 mttm -90.3 -165.22 1.3 Allowed 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.047 -1.094 . . . . 0.0 108.047 173.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.507 ' C ' ' H ' ' A' ' 89' ' ' VAL . 19.3 p-10 -69.63 -36.68 76.34 Favored 'General case' 0 CA--C 1.508 -0.657 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 169.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.5 41.37 1.16 Allowed Glycine 0 CA--C 1.543 1.808 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 166.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . 0.507 ' H ' ' C ' ' A' ' 87' ' ' ASP 0.333 25.3 m 20.89 -134.66 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.448 1 C-N-CA 133.008 4.523 . . . . 0.0 113.482 -178.105 . . . . . . . . 4 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -58.18 79.06 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.338 1.455 . . . . 0.0 109.032 -179.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.96 -29.21 39.57 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.41 1.084 . . . . 0.0 111.589 -173.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -158.34 157.4 32.32 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 -178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 24.8 m-20 -147.05 158.87 44.07 Favored 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.504 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 52.0 tp -155.52 109.58 2.85 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.349 0.66 . . . . 0.0 109.882 -179.283 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 27.4 m -84.68 168.54 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.38 0 C-N-CA 124.04 0.936 . . . . 0.0 110.562 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 74.66 178.43 40.4 Favored Glycine 0 CA--C 1.527 0.823 0 C-N-CA 123.388 0.518 . . . . 0.0 112.208 178.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -52.74 -59.04 4.98 Favored 'General case' 0 C--O 1.225 -0.186 0 C-N-CA 123.915 0.886 . . . . 0.0 110.196 -179.475 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 4.9 m 33.49 21.34 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 130.0 3.32 . . . . 0.0 119.237 171.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . 0.4 ' H ' ' CD ' ' A' ' 99' ' ' GLN . 4.0 pm0 -51.51 -40.59 59.89 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 120.279 1.4 . . . . 0.0 111.846 -179.008 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -56.69 -36.42 69.61 Favored 'General case' 0 CA--C 1.531 0.225 0 O-C-N 121.848 -0.533 . . . . 0.0 111.203 179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -81.66 -38.23 26.23 Favored 'General case' 0 CA--C 1.533 0.313 0 N-CA-C 109.054 -0.721 . . . . 0.0 109.054 178.001 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 23.2 tp -45.81 -51.33 13.01 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 123.36 0.664 . . . . 0.0 109.508 177.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 27.9 mtpp -41.5 -52.87 3.58 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 124.334 1.054 . . . . 0.0 111.759 177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -68.19 -42.68 79.57 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.45 1.1 . . . . 0.0 110.725 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 34.1 mt -58.95 -49.12 79.05 Favored 'General case' 0 CA--C 1.529 0.139 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 177.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 50.6 t -57.83 -46.99 87.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.134 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 178.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.29 -53.26 46.4 Favored 'General case' 0 CA--C 1.533 0.298 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 179.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -54.98 -62.33 1.73 Allowed 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 124.221 1.008 . . . . 0.0 109.979 178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 77.4 m-70 -62.65 -22.21 66.28 Favored 'General case' 0 CA--C 1.533 0.317 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 -174.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -79.72 -5.15 54.64 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 118.79 0.723 . . . . 0.0 112.126 177.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -78.91 49.56 0.93 Allowed 'General case' 0 CA--C 1.537 0.466 0 CA-C-N 119.831 1.196 . . . . 0.0 111.328 179.457 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.16 0 C-N-CA 125.763 1.625 . . . . 0.0 107.426 179.566 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.944 0 N-CA-C 110.038 -1.225 . . . . 0.0 110.038 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.0 -58.6 3.55 Favored Glycine 0 CA--C 1.53 0.976 0 N-CA-C 108.558 -1.817 . . . . 0.0 108.558 -174.497 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 13.0 m -64.46 96.31 0.16 Allowed 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 124.663 1.185 . . . . 0.0 110.983 176.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 18.8 m -137.7 26.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 C-N-CA 126.335 1.854 . . . . 0.0 108.719 171.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.5 pp -97.94 175.31 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -171.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 24.1 t -108.66 122.69 63.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 127.24 2.216 . . . . 0.0 108.051 178.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 19.4 tt -160.63 151.32 5.22 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.097 0 CA-C-N 118.772 0.714 . . . . 0.0 109.666 177.271 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -74.75 72.61 2.02 Favored 'General case' 0 CA--C 1.53 0.187 0 N-CA-C 105.96 -1.867 . . . . 0.0 105.96 174.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 18.6 m -55.56 71.98 0.0 OUTLIER 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 129.233 3.013 . . . . 0.0 115.556 -171.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 63.5 tttp -93.78 -94.86 0.16 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.906 1.282 . . . . 0.0 109.596 168.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -57.48 -39.73 77.06 Favored 'General case' 0 CA--C 1.534 0.334 0 O-C-N 120.453 -1.404 . . . . 0.0 109.314 176.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -60.22 -30.9 69.69 Favored 'General case' 0 N--CA 1.449 -0.514 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.14 177.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -50.29 71.83 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 119.48 1.037 . . . . 0.0 108.402 177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 50.6 m-20 -58.43 -48.75 79.67 Favored 'General case' 0 C--O 1.232 0.146 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 178.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.66 -49.39 75.2 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.386 -179.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.34 -52.57 64.68 Favored 'General case' 0 C--O 1.228 -0.052 0 C-N-CA 123.554 0.742 . . . . 0.0 109.553 -179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 23.9 mt -49.42 -54.54 16.97 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 177.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.59 -62.36 1.74 Allowed 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 122.924 0.489 . . . . 0.0 111.831 -179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 8.0 ptpp? -59.61 -29.03 67.71 Favored 'General case' 0 CA--C 1.532 0.267 0 CA-C-N 118.423 0.556 . . . . 0.0 111.103 -177.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -60.35 -28.41 67.08 Favored Glycine 0 CA--C 1.526 0.742 0 CA-C-O 118.091 -1.394 . . . . 0.0 112.916 179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 50.33 55.01 10.13 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 118.995 1.398 . . . . 0.0 108.754 -177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.9 mp0 -38.75 -31.57 0.06 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 129.56 3.144 . . . . 0.0 116.377 -174.401 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 45.4 tt0 -9.06 -74.09 0.0 OUTLIER 'General case' 0 C--N 1.346 0.419 0 C-N-CA 129.464 3.106 . . . . 0.0 111.208 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 41.3 t60 -138.83 74.07 1.46 Allowed 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 170.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.2 ptpp? -165.51 121.98 1.03 Allowed Pre-proline 0 N--CA 1.453 -0.316 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 172.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -70.12 133.98 26.17 Favored 'Trans proline' 0 N--CA 1.449 -1.095 0 C-N-CA 122.057 1.838 . . . . 0.0 113.76 -173.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.7 mp -101.35 102.21 13.16 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 N-CA-C 101.203 -3.628 . . . . 0.0 101.203 169.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 3.9 t -99.95 120.47 49.41 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 -173.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 57.1 t -114.68 104.5 17.02 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 C-N-CA 124.935 1.294 . . . . 0.0 110.636 -173.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 60.0 t0 -83.46 95.73 8.35 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 125.301 1.44 . . . . 0.0 107.925 175.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.7 m-85 -80.19 122.81 27.3 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 172.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 9.9 t -146.51 168.24 21.71 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 179.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -117.66 114.85 23.98 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-N 118.895 0.77 . . . . 0.0 108.95 -179.058 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.6 p -43.36 -57.0 3.24 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.193 1.397 . . . . 0.0 113.128 -178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 53.2 p-90 -59.19 -30.67 68.38 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.076 0.551 . . . . 0.0 112.192 -178.393 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 12.9 t -76.06 84.71 2.93 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 177.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -35.24 -59.73 0.76 Allowed Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.95 1.262 . . . . 0.0 112.942 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_exo -53.7 -40.6 79.14 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.163 2.575 . . . . 0.0 113.025 178.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 53.0 m -67.1 -43.95 81.23 Favored 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 179.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 24.6 ttpp -62.77 -43.3 99.16 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 122.998 0.519 . . . . 0.0 110.224 -179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 79.6 mmm -58.99 -17.49 25.37 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 52.0 mt -79.14 -24.45 12.75 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-N 119.193 0.906 . . . . 0.0 109.79 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -54.36 -55.05 41.4 Favored Pre-proline 0 CA--C 1.539 0.528 0 CA-C-O 117.453 -1.26 . . . . 0.0 112.272 178.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -59.27 -36.73 94.23 Favored 'Trans proline' 0 C--N 1.35 0.644 0 C-N-CA 122.205 1.937 . . . . 0.0 111.686 178.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -58.98 -52.9 63.76 Favored 'General case' 0 CA--C 1.53 0.189 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 176.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -60.54 -37.47 81.31 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 121.717 -0.615 . . . . 0.0 109.898 176.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 29.3 tt0 -60.35 -35.52 75.85 Favored 'General case' 0 CA--C 1.534 0.333 0 O-C-N 121.297 -0.877 . . . . 0.0 109.861 176.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 27.0 m -61.23 -47.49 85.81 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 21.8 tp -60.89 -39.63 90.02 Favored 'General case' 0 CA--C 1.535 0.377 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.184 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 11.0 m -55.89 -51.98 65.69 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 122.868 0.467 . . . . 0.0 109.857 177.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -62.41 -39.9 94.78 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 123.159 0.584 . . . . 0.0 109.888 178.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -58.02 -46.54 85.12 Favored 'General case' 0 CA--C 1.528 0.121 0 C-N-CA 123.031 0.532 . . . . 0.0 111.35 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 13.3 m-85 -79.65 -53.17 7.09 Favored 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 -177.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . 64.91 -56.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 127.161 2.184 . . . . 0.0 115.33 178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -74.49 -116.5 0.09 OUTLIER Glycine 0 CA--C 1.533 1.16 0 C-N-CA 126.823 2.154 . . . . 0.0 115.688 -173.071 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm -40.4 -45.37 2.17 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 114.994 1.479 . . . . 0.0 114.994 -171.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 95.1 t -78.14 136.97 22.98 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 O-C-N 122.209 -0.307 . . . . 0.0 110.189 -173.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 1.7 mp -100.22 125.81 53.89 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 N-CA-C 105.045 -2.205 . . . . 0.0 105.045 175.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 62.6 m-85 -112.72 143.86 43.23 Favored 'General case' 0 CA--C 1.511 -0.549 0 N-CA-C 107.764 -1.198 . . . . 0.0 107.764 178.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -147.64 118.67 7.69 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.593 -167.794 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 23.2 mtmm -106.28 118.2 36.02 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 7.1 p -120.85 134.4 64.39 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 123.572 0.749 . . . . 0.0 110.389 -177.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.2 t0 -85.39 106.66 16.92 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.424 178.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 52.4 t -49.41 -38.99 13.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 C-N-CA 126.473 1.909 . . . . 0.0 109.791 175.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -61.96 -34.77 76.74 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 122.076 0.151 . . . . 0.0 111.29 -179.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -81.65 -72.25 0.44 Allowed 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.738 -0.467 . . . . 0.0 109.738 -178.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 15.5 m -85.17 61.59 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.198 0 O-C-N 121.502 -0.749 . . . . 0.0 110.495 -177.204 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.49 -41.25 53.07 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.501 0.72 . . . . 0.0 109.9 177.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.67 -51.46 68.66 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.13 0.972 . . . . 0.0 111.112 178.321 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.11 -45.98 94.96 Favored 'Isoleucine or valine' 0 N--CA 1.458 -0.061 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 -179.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -54.81 38.64 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 122.859 0.464 . . . . 0.0 111.313 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -68.12 -40.09 82.61 Favored 'General case' 0 CA--C 1.532 0.276 0 O-C-N 121.507 -0.746 . . . . 0.0 110.646 -178.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.52 -46.07 89.91 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 118.521 0.601 . . . . 0.0 110.215 178.433 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.02 95.53 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 123.288 0.635 . . . . 0.0 109.833 177.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 112.01 47.09 0.73 Allowed Glycine 0 CA--C 1.524 0.656 0 C-N-CA 124.58 1.086 . . . . 0.0 112.583 174.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -85.07 132.22 32.23 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.092 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 177.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 22.7 p -112.31 -76.79 0.59 Allowed 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 106.604 -1.628 . . . . 0.0 106.604 176.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.31 149.39 22.35 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.512 1.125 . . . . 0.0 108.89 175.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -118.69 143.37 33.38 Favored Pre-proline 0 CA--C 1.537 0.452 0 C-N-CA 124.396 1.078 . . . . 0.0 108.185 177.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -72.26 170.6 66.89 Favored 'Cis proline' 0 N--CA 1.453 -0.88 0 C-N-CA 125.144 -0.773 . . . . 0.0 112.588 -1.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.4 m -156.34 129.68 8.15 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.104 -1.443 . . . . 0.0 107.104 176.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 93.5 m-85 -106.1 118.09 35.71 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 124.962 1.305 . . . . 0.0 110.58 -175.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 25.3 m170 -112.38 144.21 42.2 Favored 'General case' 0 CA--C 1.51 -0.576 0 CA-C-N 118.824 0.738 . . . . 0.0 110.195 176.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 56.1 t -113.39 124.16 69.76 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.987 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -115.21 60.78 0.69 Allowed 'General case' 0 N--CA 1.444 -0.765 0 O-C-N 124.763 1.289 . . . . 0.0 110.803 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 18.0 ttpp -71.11 149.15 46.74 Favored 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 106.065 -1.828 . . . . 0.0 106.065 172.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 t70 72.72 -52.88 0.7 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 126.248 1.819 . . . . 0.0 112.265 -177.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 167.37 -57.93 0.22 Allowed Glycine 0 CA--C 1.521 0.434 0 N-CA-C 110.545 -1.022 . . . . 0.0 110.545 176.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 10.6 p -74.76 164.04 3.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.106 0.563 . . . . 0.0 109.569 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt -56.64 104.01 0.13 Allowed 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 174.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -79.98 -39.65 29.66 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.097 0.959 . . . . 0.0 110.711 -177.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 36.8 t0 -161.0 168.01 25.36 Favored 'General case' 0 N--CA 1.449 -0.475 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 -175.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -161.06 177.49 10.26 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 118.37 0.532 . . . . 0.0 109.914 175.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 20.2 tp -162.54 110.85 1.35 Allowed 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 125.079 1.352 . . . . 0.0 109.404 -177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 35.4 m -76.1 161.61 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-O 121.045 0.45 . . . . 0.0 110.989 178.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.6 -177.91 54.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 123.605 0.622 . . . . 0.0 112.601 175.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -61.24 -55.18 34.99 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.888 0.875 . . . . 0.0 109.307 178.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.0 m 30.82 46.77 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 128.601 2.76 . . . . 0.0 115.124 172.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 18.1 mp0 -59.15 -44.23 92.09 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.653 0.781 . . . . 0.0 112.246 -174.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 19.7 p-10 -54.52 -53.6 52.3 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.45 0.7 . . . . 0.0 110.388 -179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.73 -37.1 76.38 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.31 -0.626 . . . . 0.0 109.31 -179.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 56.1 tp -53.85 -51.96 61.93 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -52.39 -48.58 65.55 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 118.02 0.373 . . . . 0.0 110.18 177.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.92 -43.24 86.13 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.232 0.213 . . . . 0.0 110.699 178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 38.2 mt -64.46 -50.49 67.27 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.66 -0.65 . . . . 0.0 110.37 178.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 62.7 t -52.57 -47.35 48.95 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 178.545 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -57.17 -48.34 78.97 Favored 'General case' 0 CA--C 1.537 0.459 0 O-C-N 123.302 0.376 . . . . 0.0 111.207 177.648 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.2 ttmt -49.14 -54.58 15.63 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.328 1.051 . . . . 0.0 110.77 177.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -75.93 -46.97 27.08 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-O 120.625 0.25 . . . . 0.0 111.454 -174.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -68.31 -32.79 73.17 Favored 'General case' 0 C--N 1.332 -0.161 0 C-N-CA 124.606 1.162 . . . . 0.0 113.179 -176.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 58.88 45.76 14.8 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.877 1.271 . . . . 0.0 108.881 -173.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.316 0 C-N-CA 126.712 2.005 . . . . 0.0 106.449 -179.354 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.796 0 CA-C-O 119.228 -0.762 . . . . 0.0 112.926 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 120.29 -56.21 0.61 Allowed Glycine 0 CA--C 1.529 0.912 0 C-N-CA 125.282 1.42 . . . . 0.0 110.632 -179.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -68.47 78.26 0.27 Allowed 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 113.447 0.906 . . . . 0.0 113.447 -175.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.2 t -93.66 94.23 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.235 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 174.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 37.1 pt -152.75 169.12 1.16 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.209 0 CA-C-O 121.874 0.845 . . . . 0.0 110.861 179.754 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 7.9 m -88.27 149.02 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.565 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 169.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 9.9 tp -150.42 155.4 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 CA-C-N 119.329 0.968 . . . . 0.0 110.471 -177.548 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 25.0 p-10 -137.7 36.3 2.42 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.958 1.303 . . . . 0.0 111.455 -175.39 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 36.9 m -157.28 127.01 6.14 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 121.164 -0.96 . . . . 0.0 111.162 179.049 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -51.85 -45.67 64.1 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 124.353 1.061 . . . . 0.0 110.428 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -52.1 -51.15 59.6 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-O 121.212 0.53 . . . . 0.0 110.481 -178.105 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -65.02 -38.32 90.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.344 179.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -52.19 65.73 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 176.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 61.1 m-20 -64.49 -45.41 87.46 Favored 'General case' 0 C--O 1.232 0.147 0 O-C-N 122.008 -0.432 . . . . 0.0 110.103 -178.567 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -53.44 -50.47 65.19 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.969 178.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 32.5 mt-30 -58.87 -50.09 75.3 Favored 'General case' 0 N--CA 1.457 -0.105 0 C-N-CA 123.566 0.746 . . . . 0.0 110.256 178.159 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.2 mp -46.94 -49.76 20.06 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.703 0.401 . . . . 0.0 109.927 176.557 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -66.72 -65.97 0.61 Allowed 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -179.166 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 18.3 ptpt -58.77 -31.04 68.02 Favored 'General case' 0 N--CA 1.464 0.234 0 O-C-N 121.605 -0.685 . . . . 0.0 111.848 -174.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -55.5 -24.67 39.59 Favored Glycine 0 CA--C 1.532 1.131 0 CA-C-O 118.959 -0.912 . . . . 0.0 112.35 179.06 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.22 45.98 8.38 Favored 'General case' 0 C--N 1.343 0.301 0 C-N-CA 125.125 1.37 . . . . 0.0 109.911 179.129 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 23.2 mm-40 -78.64 40.0 0.36 Allowed 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 -174.354 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -15.2 -63.08 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 C-N-CA 128.727 2.811 . . . . 0.0 113.399 -178.621 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 48.9 p-80 -142.74 23.14 1.94 Allowed 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.885 1.674 . . . . 0.0 109.112 177.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -100.87 153.15 37.9 Favored Pre-proline 0 C--O 1.234 0.279 0 C-N-CA 123.589 0.756 . . . . 0.0 111.192 -171.486 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -71.76 133.14 21.4 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 121.845 1.697 . . . . 0.0 114.124 -177.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -107.21 116.65 51.33 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 100.964 -3.717 . . . . 0.0 100.964 167.32 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 10.4 t -102.64 111.44 32.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.765 0 N-CA-C 106.555 -1.646 . . . . 0.0 106.555 -174.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.5 t -94.56 136.77 24.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.649 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 35.3 t0 -112.15 89.84 3.18 Favored 'General case' 0 N--CA 1.455 -0.184 0 N-CA-C 104.943 -2.243 . . . . 0.0 104.943 168.997 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -79.44 99.0 7.01 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 178.598 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 11.1 m -136.13 151.74 50.1 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 125.789 1.636 . . . . 0.0 107.1 178.861 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -98.44 -178.82 4.14 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.988 0.915 . . . . 0.0 111.114 -178.586 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.6 p -77.2 -63.33 1.39 Allowed 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.678 1.591 . . . . 0.0 106.84 174.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 36.0 p-90 -61.28 147.47 44.4 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 114.332 -1.304 . . . . 0.0 108.744 174.342 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 9.7 t 136.24 -59.72 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 129.212 3.005 . . . . 0.0 107.766 -179.315 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 102.28 -92.87 1.02 Allowed Glycine 0 CA--C 1.53 1.025 0 CA-C-O 117.869 -1.517 . . . . 0.0 109.99 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 83.6 Cg_exo -45.07 -40.73 15.83 Favored 'Trans proline' 0 C--N 1.348 0.539 0 C-N-CA 123.971 3.114 . . . . 0.0 113.523 -178.809 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 74.9 m -44.64 -43.52 8.3 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.577 1.151 . . . . 0.0 110.905 178.115 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.2 tppt? -58.59 -33.75 70.32 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.643 0.777 . . . . 0.0 111.596 -176.99 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 58.8 mtt -65.35 -18.93 65.7 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.608 0.763 . . . . 0.0 112.285 -177.514 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . 0.425 ' N ' HD12 ' A' ' 42' ' ' ILE . 2.1 mp -76.99 -27.33 16.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 108.658 -0.868 . . . . 0.0 108.658 177.125 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -49.96 -57.04 13.72 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 117.512 -1.232 . . . . 0.0 112.474 -179.321 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -57.37 -41.2 75.2 Favored 'Trans proline' 0 N--CA 1.457 -0.656 0 CA-C-N 121.904 1.716 . . . . 0.0 112.016 179.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 85.2 mt -58.4 -51.6 69.15 Favored 'General case' 0 CA--C 1.533 0.326 0 CA-C-O 121.752 0.787 . . . . 0.0 109.493 178.313 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 87.8 t80 -56.6 -49.15 75.77 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 124.236 1.014 . . . . 0.0 109.835 178.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -59.79 -41.22 90.7 Favored 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.828 0.851 . . . . 0.0 110.792 178.868 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 63.8 m -57.41 -50.6 72.48 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 108.42 -0.955 . . . . 0.0 108.42 177.326 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 23.4 tp -58.39 -44.77 89.11 Favored 'General case' 0 C--N 1.339 0.111 0 CA-C-O 121.051 0.453 . . . . 0.0 110.227 176.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 23.3 m -50.98 -46.23 61.24 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 123.231 0.612 . . . . 0.0 111.162 -177.394 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -54.14 -30.47 49.17 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 119.122 -0.466 . . . . 0.0 111.85 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -68.09 -52.34 36.19 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 118.77 0.714 . . . . 0.0 111.221 -177.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 69.4 m-85 -90.95 -13.37 33.58 Favored 'General case' 0 CA--C 1.537 0.469 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -174.956 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -19.37 -61.85 0.02 OUTLIER 'General case' 0 C--N 1.34 0.188 0 C-N-CA 129.192 2.997 . . . . 0.0 115.69 -179.196 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -50.51 -47.77 43.81 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 123.415 0.531 . . . . 0.0 111.831 -177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 9.0 mtpm? -86.16 -60.3 2.05 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 123.238 0.615 . . . . 0.0 110.498 -178.117 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 86.3 t -88.02 146.48 6.19 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 C-N-CA 127.431 2.292 . . . . 0.0 112.825 -169.589 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mm -99.49 146.73 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 177.408 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 86.7 m-85 -135.42 113.61 11.36 Favored 'General case' 0 C--N 1.34 0.193 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 178.457 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 62.7 mt -120.69 101.28 7.63 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.51 1.124 . . . . 0.0 111.189 -175.67 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 50.0 tttm -79.85 94.63 5.85 Favored 'General case' 0 CA--C 1.528 0.098 0 N-CA-C 105.771 -1.937 . . . . 0.0 105.771 171.447 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 51.1 t -79.39 117.91 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -67.93 102.22 1.23 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.963 -0.754 . . . . 0.0 108.963 177.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.2 t -55.28 -34.23 32.9 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.175 0 C-N-CA 124.499 1.12 . . . . 0.0 110.477 178.242 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -62.76 -28.0 69.68 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 122.337 0.255 . . . . 0.0 110.748 179.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.76 -65.87 0.94 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 123.569 0.748 . . . . 0.0 110.856 -179.214 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.1 t -84.01 60.71 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.879 0.847 . . . . 0.0 110.172 -175.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -55.71 -43.5 76.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.906 0.882 . . . . 0.0 110.526 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.64 -55.85 22.34 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.046 0.938 . . . . 0.0 111.867 -178.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 63.0 t -63.6 -44.78 98.7 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.239 0 N-CA-C 108.82 -0.807 . . . . 0.0 108.82 -179.286 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.73 -54.73 38.15 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.653 0.263 . . . . 0.0 111.544 179.74 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.71 -41.17 88.39 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 121.217 -0.927 . . . . 0.0 110.491 -178.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.02 -45.49 92.62 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 118.548 0.613 . . . . 0.0 110.531 178.665 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.47 -34.02 77.24 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.216 1.006 . . . . 0.0 110.003 178.015 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 102.52 48.61 1.28 Allowed Glycine 0 CA--C 1.524 0.646 0 C-N-CA 124.661 1.124 . . . . 0.0 111.508 175.814 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -87.8 136.35 23.35 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.151 0 N-CA-C 108.524 -0.917 . . . . 0.0 108.524 179.884 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 35.2 p -140.18 -76.65 0.33 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 124.0 0.92 . . . . 0.0 108.656 179.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.44 73.6 1.39 Allowed 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.547 1.139 . . . . 0.0 110.577 -178.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -66.08 138.75 96.29 Favored Pre-proline 0 CA--C 1.543 0.703 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 176.337 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_exo -64.78 130.52 10.66 Favored 'Cis proline' 0 N--CA 1.456 -0.692 0 CA-C-N 121.068 1.417 . . . . 0.0 112.731 -0.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 30.5 m -120.62 105.0 10.38 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.131 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -88.07 132.08 34.43 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 108.72 -0.844 . . . . 0.0 108.72 178.216 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 16.5 m170 -124.25 150.06 45.75 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 175.849 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.6 t -123.78 113.09 35.64 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 N-CA-C 106.78 -1.563 . . . . 0.0 106.78 175.808 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -111.77 125.54 54.11 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 106.82 -1.548 . . . . 0.0 106.82 174.437 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 56.4 mtpt -83.36 112.57 20.04 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 105.457 -2.053 . . . . 0.0 105.457 176.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 29.6 t70 69.71 -64.03 0.36 Allowed 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 127.984 2.514 . . . . 0.0 109.161 -173.4 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -164.95 7.21 0.07 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 125.975 1.75 . . . . 0.0 112.468 177.871 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 47.1 t -100.18 117.09 44.86 Favored 'Isoleucine or valine' 0 C--N 1.34 0.169 0 CA-C-N 118.996 1.398 . . . . 0.0 107.526 -179.88 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -56.48 111.2 0.93 Allowed 'General case' 0 C--N 1.342 0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -179.712 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -100.81 -32.21 10.8 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.341 1.057 . . . . 0.0 111.154 -178.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -159.55 172.36 17.98 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 117.833 0.288 . . . . 0.0 110.53 -177.845 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -160.46 168.39 25.22 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.813 1.245 . . . . 0.0 108.856 176.171 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 28.4 tp -167.87 120.36 0.88 Allowed 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.804 0.842 . . . . 0.0 109.603 -173.901 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 29.9 m -96.4 163.28 2.4 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 123.239 0.616 . . . . 0.0 111.312 179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 79.5 174.85 46.75 Favored Glycine 0 CA--C 1.525 0.667 0 C-N-CA 124.716 1.15 . . . . 0.0 111.951 176.468 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -77.32 43.35 0.37 Allowed 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.103 0.961 . . . . 0.0 110.72 178.555 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 7.8 m -79.35 54.12 1.64 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 125.926 1.69 . . . . 0.0 110.287 -175.917 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.29 -36.51 63.74 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.019 0.927 . . . . 0.0 112.445 -175.365 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -61.44 -51.58 68.12 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.533 0.733 . . . . 0.0 109.861 177.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -68.43 -32.97 73.37 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -179.974 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 2.4 tm? -57.09 -56.22 24.54 Favored 'General case' 0 C--N 1.338 0.089 0 N-CA-C 107.413 -1.329 . . . . 0.0 107.413 176.438 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 65.1 mttm -50.61 -50.61 53.65 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.111 0.564 . . . . 0.0 110.403 177.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -56.32 -50.55 71.14 Favored 'General case' 0 CA--C 1.536 0.429 0 N-CA-C 111.634 0.235 . . . . 0.0 111.634 179.539 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 42.0 mt -61.42 -48.17 82.42 Favored 'General case' 0 CA--C 1.529 0.14 0 O-C-N 121.787 -0.571 . . . . 0.0 110.378 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 76.7 t -54.92 -51.05 57.03 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.176 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 178.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -52.78 -51.19 61.68 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.436 0.295 . . . . 0.0 110.926 178.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 38.8 ttmt -53.87 -66.66 0.36 Allowed 'General case' 0 CA--C 1.529 0.147 0 CA-C-O 122.041 0.924 . . . . 0.0 110.507 178.017 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 82.3 m-70 -59.33 -31.71 69.42 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 115.199 -0.909 . . . . 0.0 112.409 -174.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -75.09 -2.64 28.46 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -179.66 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -77.81 52.4 1.03 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.965 1.257 . . . . 0.0 111.277 179.733 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.113 0 C-N-CA 125.573 1.549 . . . . 0.0 107.765 179.611 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.632 0 N-CA-C 107.89 -2.084 . . . . 0.0 107.89 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 98.42 4.17 57.34 Favored Glycine 0 CA--C 1.525 0.684 0 CA-C-N 118.642 1.221 . . . . 0.0 112.081 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.67 63.71 1.16 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.421 1.088 . . . . 0.0 110.628 -179.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.461 HG13 ' HB3' ' A' ' 50' ' ' SER . 76.3 t -79.38 85.99 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 178.005 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 13.2 pt -144.91 167.29 10.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 CA-C-O 121.541 0.686 . . . . 0.0 111.287 -177.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.4 ' HA ' ' HB2' ' A' ' 61' ' ' LYS . 7.8 p -111.85 134.7 53.44 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 174.05 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 1.9 tt -153.61 162.73 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.464 0 CA-C-O 121.913 0.863 . . . . 0.0 110.475 -177.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 30.6 p-10 -126.95 11.73 7.15 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 126.134 1.774 . . . . 0.0 112.648 -173.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 44.7 m -124.28 114.45 19.59 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 122.786 0.435 . . . . 0.0 111.65 -174.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 21.5 ptmt -47.82 -40.59 21.54 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.006 1.322 . . . . 0.0 111.775 176.768 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -54.46 -42.1 70.23 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.089 0.955 . . . . 0.0 111.058 178.183 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -70.4 -39.31 74.56 Favored 'General case' 0 N--CA 1.455 -0.221 0 O-C-N 121.936 -0.478 . . . . 0.0 109.802 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -55.08 -50.86 68.09 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.413 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -60.09 -49.79 76.26 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 123.99 0.916 . . . . 0.0 110.675 -179.605 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -52.41 -57.02 11.16 Favored 'General case' 0 N--CA 1.454 -0.27 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.001 179.359 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -54.51 -44.8 73.04 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 123.539 0.736 . . . . 0.0 110.221 178.896 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.78 -23.2 2.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.012 0.925 . . . . 0.0 112.046 176.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -102.47 -68.38 0.83 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.614 0.766 . . . . 0.0 110.636 175.163 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.6 ptmm? -61.91 -23.0 66.05 Favored 'General case' 0 CA--C 1.53 0.203 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -171.487 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -68.57 -12.53 64.21 Favored Glycine 0 CA--C 1.535 1.32 0 CA-C-O 118.565 -1.131 . . . . 0.0 112.986 -179.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 61.0 mttp 59.9 69.1 0.73 Allowed 'General case' 0 C--N 1.345 0.378 0 N-CA-C 107.789 -1.189 . . . . 0.0 107.789 -178.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -79.53 2.13 23.27 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 114.254 -1.339 . . . . 0.0 114.176 -172.27 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 22.0 tp10 -10.24 -65.8 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 129.742 3.217 . . . . 0.0 113.602 -176.115 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 65.8 t60 -146.39 57.27 1.18 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 174.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 29.5 mmtp -118.48 136.61 24.14 Favored Pre-proline 0 C--O 1.235 0.321 0 C-N-CA 124.254 1.021 . . . . 0.0 109.274 -177.083 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -74.25 114.87 4.14 Favored 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 122.146 1.898 . . . . 0.0 110.743 177.187 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 48.9 mt -86.38 98.33 6.83 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 N-CA-C 103.44 -2.8 . . . . 0.0 103.44 171.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -88.42 116.72 30.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.483 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.6 t -107.07 114.92 47.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 CA-C-N 117.964 0.347 . . . . 0.0 110.296 -176.856 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.421 ' HB2' ' CZ ' ' A' ' 46' ' ' PHE . 8.8 t0 -92.65 85.7 5.34 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 105.641 -1.985 . . . . 0.0 105.641 172.309 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 80.0 m-85 -79.69 105.83 11.27 Favored 'General case' 0 N--CA 1.453 -0.314 0 N-CA-C 105.551 -2.018 . . . . 0.0 105.551 177.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 6.3 t -166.12 -159.79 0.4 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 118.754 0.706 . . . . 0.0 112.22 -171.562 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . 64.1 -135.27 0.32 Allowed 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 127.831 2.452 . . . . 0.0 112.563 172.839 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.3 p 54.61 -107.43 0.38 Allowed 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 126.083 1.753 . . . . 0.0 109.537 -175.463 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 62.5 p-90 -72.8 -26.63 61.58 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 122.919 0.487 . . . . 0.0 111.451 179.849 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 52.2 t -74.16 82.78 1.81 Allowed 'General case' 0 CA--C 1.529 0.144 0 O-C-N 121.53 -0.731 . . . . 0.0 111.056 -175.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -47.65 -56.63 8.27 Favored Glycine 0 CA--C 1.536 1.393 0 C-N-CA 123.976 0.798 . . . . 0.0 111.972 176.328 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -51.74 -37.07 64.27 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.977 2.451 . . . . 0.0 113.447 179.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 95.7 m -59.24 -26.0 64.52 Favored 'General case' 0 C--O 1.232 0.146 0 C-N-CA 122.609 0.364 . . . . 0.0 111.032 -178.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -58.8 -20.63 51.86 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 118.498 0.59 . . . . 0.0 110.932 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 33.6 mmt -82.73 -31.3 28.52 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 118.812 0.733 . . . . 0.0 110.697 176.281 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 64.0 mt -78.69 -33.5 16.75 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 179.886 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -45.83 -59.41 4.71 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 124.256 1.022 . . . . 0.0 113.168 178.089 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -59.76 -38.57 79.74 Favored 'Trans proline' 0 N--CA 1.457 -0.654 0 C-N-CA 122.629 2.219 . . . . 0.0 111.182 179.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mp -54.75 -54.16 45.65 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 177.845 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.421 ' CZ ' ' HB2' ' A' ' 30' ' ' ASP . 49.9 t80 -57.91 -41.12 81.97 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.132 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -57.19 -37.41 72.13 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 118.728 -0.653 . . . . 0.0 112.381 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.9 p -59.87 -51.92 67.65 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 120.447 1.476 . . . . 0.0 110.002 178.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -57.87 -41.42 82.41 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.69 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.461 ' HB3' HG13 ' A' ' 4' ' ' VAL . 10.6 m -52.72 -54.95 26.58 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 109.687 -0.486 . . . . 0.0 109.687 176.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -58.81 -41.17 86.16 Favored 'General case' 0 CA--C 1.529 0.137 0 C-N-CA 123.325 0.65 . . . . 0.0 110.401 179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -59.14 -53.92 52.82 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.128 0.571 . . . . 0.0 111.429 -179.002 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 52.9 m-85 -81.05 -21.42 40.11 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 113.429 0.9 . . . . 0.0 113.429 -176.096 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -21.45 110.48 0.03 OUTLIER 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.504 2.322 . . . . 0.0 115.713 -179.072 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.01 -71.08 0.39 Allowed Glycine 0 C--N 1.341 0.81 0 N-CA-C 110.701 -0.96 . . . . 0.0 110.701 174.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -90.35 24.84 2.42 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 123.945 0.898 . . . . 0.0 110.91 -179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.3 m -149.42 161.12 4.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 125.801 1.64 . . . . 0.0 107.951 -174.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.1 mp -134.25 93.79 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 177.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -88.99 94.97 10.13 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.257 0.623 . . . . 0.0 109.801 -178.884 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 80.8 mt -91.82 111.93 23.66 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 125.009 1.323 . . . . 0.0 110.754 -178.635 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.4 ' HB2' ' HA ' ' A' ' 6' ' ' VAL . 21.9 mtpp -91.65 109.34 20.65 Favored 'General case' 0 CA--C 1.531 0.228 0 N-CA-C 105.605 -1.998 . . . . 0.0 105.605 174.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 40.0 t -105.62 122.49 59.13 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -171.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -77.08 81.13 3.6 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.848 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 18.8 m -39.92 -47.49 0.56 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 126.988 2.115 . . . . 0.0 114.176 -176.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -54.23 -40.57 67.82 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 122.87 0.468 . . . . 0.0 111.039 -178.277 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -78.57 -48.59 14.9 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.18 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.535 HG12 ' HB ' ' A' ' 70' ' ' VAL . 95.1 t -80.95 51.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 CA-C-O 122.241 1.02 . . . . 0.0 108.849 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.69 -58.13 9.4 Favored 'General case' 0 C--O 1.223 -0.298 0 C-N-CA 125.841 1.656 . . . . 0.0 112.857 -173.299 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.12 -52.0 54.28 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-O 121.107 0.48 . . . . 0.0 111.722 -176.418 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.535 ' HB ' HG12 ' A' ' 67' ' ' VAL . 84.0 t -62.91 -48.38 88.34 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 -179.518 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.45 -45.25 69.43 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 122.412 0.285 . . . . 0.0 110.283 178.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.63 -56.62 19.77 Favored 'General case' 0 N--CA 1.451 -0.402 0 C-N-CA 124.219 1.008 . . . . 0.0 110.007 176.826 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.8 -41.26 73.89 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.444 0.298 . . . . 0.0 111.118 -178.356 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.57 3.29 19.32 Favored 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 124.332 1.053 . . . . 0.0 111.905 179.132 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 58.1 41.8 94.8 Favored Glycine 0 CA--C 1.529 0.917 0 O-C-N 121.011 -1.056 . . . . 0.0 113.412 176.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.3 mp -64.7 137.62 24.6 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.123 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 178.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 13.1 p -148.9 -80.24 0.13 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.953 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.57 78.3 1.47 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.15 0.98 . . . . 0.0 110.539 -178.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 34.0 mtp -69.73 139.43 88.61 Favored Pre-proline 0 CA--C 1.542 0.641 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 175.724 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_exo -69.73 132.38 22.06 Favored 'Cis proline' 0 N--CA 1.452 -0.924 0 CA-C-N 120.479 1.207 . . . . 0.0 110.595 -1.659 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 22.1 m -109.27 111.89 23.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.821 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 64.2 m-85 -99.61 108.27 20.62 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.21 1.004 . . . . 0.0 109.197 -177.063 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 26.1 m170 -107.87 160.82 15.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 118.98 0.809 . . . . 0.0 109.891 177.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 15.2 t -131.02 110.9 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 176.573 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -107.42 108.4 19.72 Favored 'General case' 0 CA--C 1.529 0.151 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 175.776 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 58.8 mtpt -83.97 109.56 17.72 Favored 'General case' 0 CA--C 1.521 -0.135 0 N-CA-C 106.846 -1.538 . . . . 0.0 106.846 179.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 37.2 t70 71.4 -60.02 0.53 Allowed 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 126.811 2.044 . . . . 0.0 110.807 -176.761 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -155.41 -41.0 0.02 OUTLIER Glycine 0 CA--C 1.528 0.868 0 C-N-CA 125.219 1.39 . . . . 0.0 111.344 179.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 11.5 p -70.59 134.53 29.88 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-N 118.131 0.966 . . . . 0.0 110.793 -177.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 22.0 ttpp -66.55 101.9 0.83 Allowed 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 177.371 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -83.51 -32.43 25.93 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 124.111 0.964 . . . . 0.0 111.336 -177.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -157.82 169.08 25.42 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 112.512 0.56 . . . . 0.0 112.512 -179.43 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -144.11 161.14 39.59 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 126.728 2.011 . . . . 0.0 107.285 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 51.1 tp -174.05 152.93 1.98 Allowed 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 -178.58 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.5 m -141.85 165.18 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 C-N-CA 123.924 0.89 . . . . 0.0 110.138 -178.523 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.19 -179.08 39.93 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 124.184 0.897 . . . . 0.0 111.833 177.193 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.73 44.24 0.36 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.862 0.865 . . . . 0.0 111.039 179.986 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.1 m -81.22 61.37 4.71 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.257 1.023 . . . . 0.0 109.688 -176.576 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -56.09 -42.73 77.22 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.922 0.889 . . . . 0.0 112.034 -175.619 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 18.6 p-10 -57.82 -50.33 73.63 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 123.302 0.641 . . . . 0.0 110.06 177.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 14.1 tppt? -66.19 -40.32 90.35 Favored 'General case' 0 N--CA 1.449 -0.49 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 -178.951 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . . . . . . . . . 21.4 tp -54.27 -55.25 30.04 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 176.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 56.8 mttp -52.8 -51.28 61.42 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 122.442 0.297 . . . . 0.0 110.2 178.897 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -55.45 -48.26 74.76 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 122.339 0.256 . . . . 0.0 111.298 179.97 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 33.1 mt -63.82 -49.04 74.41 Favored 'General case' 0 N--CA 1.455 -0.184 0 CA-C-O 119.202 -0.428 . . . . 0.0 110.262 -179.536 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 67.1 t -53.22 -54.33 18.26 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.128 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.504 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -51.6 -55.0 21.75 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 122.579 0.351 . . . . 0.0 110.526 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 40.0 ttmt -52.93 -64.78 0.71 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 123.463 0.705 . . . . 0.0 110.988 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -66.51 -19.98 65.92 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.086 0.954 . . . . 0.0 112.601 -173.62 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -82.02 -40.09 22.59 Favored 'General case' 0 CA--C 1.531 0.219 0 O-C-N 121.602 -0.686 . . . . 0.0 109.246 174.421 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -71.17 -41.28 70.57 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 123.383 0.673 . . . . 0.0 112.147 -178.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.111 0 CA-C-O 117.456 -1.259 . . . . 0.0 109.52 -178.685 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.53 0.976 0 N-CA-C 110.469 -1.052 . . . . 0.0 110.469 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.87 -7.2 88.71 Favored Glycine 0 CA--C 1.534 1.246 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 174.994 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.4 m -51.69 105.81 0.12 Allowed 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 127.76 2.424 . . . . 0.0 114.018 -178.035 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.0 m -137.32 29.38 0.66 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.777 2.031 . . . . 0.0 108.202 174.634 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 1.4 pp -84.02 170.94 1.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 N-CA-C 114.963 1.468 . . . . 0.0 114.963 -169.915 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -123.71 13.76 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 126.333 1.853 . . . . 0.0 111.404 178.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ILE . . . . . . . . . . . . . 10.1 tt -80.06 73.88 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 N-CA-C 105.556 -2.016 . . . . 0.0 105.556 174.737 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -67.69 -17.8 64.7 Favored 'General case' 0 N--CA 1.448 -0.547 0 CA-C-N 114.524 -1.216 . . . . 0.0 113.834 -174.464 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.4 m -38.13 117.59 0.62 Allowed 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 125.413 1.485 . . . . 0.0 110.601 -179.582 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.43 ' HA ' ' HB3' ' A' ' 13' ' ' TRP . 20.3 ptmt -39.42 -44.04 1.3 Allowed 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 114.666 1.358 . . . . 0.0 114.666 -173.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -58.78 -51.07 71.53 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 121.467 0.651 . . . . 0.0 110.328 177.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -64.6 -43.34 94.1 Favored 'General case' 0 N--CA 1.451 -0.375 0 C-N-CA 124.224 1.01 . . . . 0.0 109.697 178.824 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' TRP . . . . . 0.43 ' HB3' ' HA ' ' A' ' 10' ' ' LYS . 0.9 OUTLIER -48.16 -61.45 1.98 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.268 1.427 . . . . 0.0 108.483 175.291 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -55.82 -50.23 71.12 Favored 'General case' 0 C--O 1.232 0.18 0 C-N-CA 122.703 0.401 . . . . 0.0 110.286 -178.291 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -55.73 -44.19 77.3 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.424 -179.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 9.8 tp-100 -63.55 -47.34 81.97 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.294 1.038 . . . . 0.0 109.369 -177.774 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 46.0 mt -56.96 -55.47 34.22 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 177.272 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.63 -58.82 5.57 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 122.989 0.516 . . . . 0.0 112.067 -178.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.6 ptmm? -65.89 -14.2 61.06 Favored 'General case' 0 CA--C 1.533 0.291 0 O-C-N 121.646 -0.658 . . . . 0.0 111.457 -178.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' GLY . . . . . . . . . . . . . . . -65.52 -24.1 70.77 Favored Glycine 0 CA--C 1.528 0.903 0 CA-C-O 118.395 -1.225 . . . . 0.0 111.917 177.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 97.8 mttt 57.55 73.02 0.48 Allowed 'General case' 0 C--N 1.344 0.349 0 C-N-CA 124.607 1.163 . . . . 0.0 109.319 -179.179 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -70.39 52.14 0.13 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 127.631 2.372 . . . . 0.0 113.35 -175.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -66.57 -59.77 3.33 Favored 'General case' 0 CA--C 1.536 0.411 0 O-C-N 121.519 -0.738 . . . . 0.0 109.158 179.52 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' HIS . . . . . . . . . . . . . 6.3 t-160 -156.14 95.42 1.61 Allowed 'General case' 0 CA--C 1.519 -0.234 0 N-CA-C 105.664 -1.976 . . . . 0.0 105.664 173.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 14.7 ptpt -167.43 139.17 2.59 Favored Pre-proline 0 N--CA 1.445 -0.689 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 179.388 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.82 126.02 8.51 Favored 'Trans proline' 0 N--CA 1.444 -1.428 0 C-N-CA 121.8 1.667 . . . . 0.0 111.525 -179.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 1.4 mp -88.98 94.71 4.94 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.718 0 N-CA-C 102.197 -3.261 . . . . 0.0 102.197 171.237 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 13.0 t -95.8 110.37 24.23 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 -176.941 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . . . . . . . . . 2.0 p -116.73 130.23 71.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 120.057 -0.657 . . . . 0.0 110.552 178.631 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -92.83 95.92 9.82 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.952 2.501 . . . . 0.0 106.985 176.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -88.86 100.53 13.25 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 107.34 -1.355 . . . . 0.0 107.34 176.943 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 8.8 t -127.47 -162.39 1.16 Allowed 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.22 1.008 . . . . 0.0 108.369 178.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ALA . . . . . . . . . . . . . . . -159.24 117.71 2.87 Favored 'General case' 0 C--O 1.227 -0.103 0 CA-C-N 120.155 1.343 . . . . 0.0 113.341 -177.364 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 15.6 m -36.66 -46.79 0.61 Allowed 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.498 1.519 . . . . 0.0 110.423 172.548 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -39.9 -48.29 2.31 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 125.315 1.446 . . . . 0.0 113.685 177.68 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.1 p -97.24 35.34 1.62 Allowed 'General case' 0 CA--C 1.536 0.41 0 CA-C-N 118.221 0.464 . . . . 0.0 111.808 -177.347 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 25.24 -88.35 0.01 OUTLIER Glycine 0 CA--C 1.534 1.226 0 C-N-CA 128.411 2.91 . . . . 0.0 115.234 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -42.05 -40.77 6.49 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 123.869 3.046 . . . . 0.0 113.837 177.049 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 11.7 p -60.62 -36.97 79.93 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.711 0.404 . . . . 0.0 110.571 178.134 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 5.1 tmmm? -77.08 -31.16 55.81 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 123.845 0.858 . . . . 0.0 109.309 179.18 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' MET . . . . . . . . . . . . . 65.6 mtt -63.85 -4.1 2.97 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 123.061 0.544 . . . . 0.0 112.366 177.93 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ILE . . . . . . . . . . . . . 63.8 mt -78.24 -23.87 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 CA-C-N 119.222 0.919 . . . . 0.0 108.79 171.439 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -51.02 -53.84 43.89 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 120.89 -1.131 . . . . 0.0 112.339 177.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -60.15 -30.45 91.39 Favored 'Trans proline' 0 C--N 1.348 0.526 0 C-N-CA 121.944 1.763 . . . . 0.0 111.982 176.627 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -67.58 -48.44 66.88 Favored 'General case' 0 CA--C 1.535 0.395 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.16 -35.07 69.11 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.404 1.081 . . . . 0.0 110.404 176.902 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -50.26 -34.01 21.78 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.603 0.761 . . . . 0.0 110.418 176.894 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 4.3 m -57.67 -54.93 41.35 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.517 -0.549 . . . . 0.0 109.517 178.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.2 -41.61 99.18 Favored 'General case' 0 CA--C 1.53 0.197 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 -179.723 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 4.6 m -49.14 -54.64 15.33 Favored 'General case' 0 CA--C 1.531 0.222 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 176.59 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -56.15 -57.72 10.99 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.734 0.814 . . . . 0.0 109.73 176.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -49.7 -44.21 47.96 Favored 'General case' 0 C--N 1.334 -0.07 0 C-N-CA 124.267 1.027 . . . . 0.0 112.474 -174.623 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' TYR . . . . . . . . . . . . . 51.1 m-85 -95.39 -1.76 50.39 Favored 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 113.544 0.942 . . . . 0.0 113.544 -176.763 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -51.23 136.09 25.06 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 119.33 0.968 . . . . 0.0 111.461 -177.286 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.02 -67.01 0.53 Allowed Glycine 0 C--N 1.338 0.681 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -81.43 -50.93 8.86 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 122.124 -0.633 . . . . 0.0 110.544 -179.488 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 13.6 m -76.93 174.34 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 C-N-CA 124.386 1.074 . . . . 0.0 112.75 -169.473 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.6 mm -129.92 94.7 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 174.225 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -92.94 138.87 31.1 Favored 'General case' 0 N--CA 1.457 -0.094 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 179.12 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -137.93 126.24 23.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 123.74 0.816 . . . . 0.0 110.932 -174.131 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 20.8 mtmm -100.65 119.93 39.3 Favored 'General case' 0 CA--C 1.529 0.135 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 173.777 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' VAL . . . . . . . . . . . . . 86.2 t -122.74 134.98 64.31 Favored 'Isoleucine or valine' 0 C--N 1.342 0.261 0 C-N-CA 123.014 0.526 . . . . 0.0 111.377 -176.993 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.23 95.61 7.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.117 1.367 . . . . 0.0 107.352 177.557 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 54.0 t -49.1 -41.72 14.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 C-N-CA 127.978 2.511 . . . . 0.0 110.892 178.658 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 19.2 p-10 -63.19 -22.34 66.81 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.8 0.84 . . . . 0.0 111.421 178.593 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -97.96 -72.4 0.65 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 123.936 0.894 . . . . 0.0 108.997 175.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 45.2 t -85.24 63.05 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 122.956 1.36 . . . . 0.0 109.392 -177.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.55 -37.55 81.62 Favored 'General case' 0 CA--C 1.53 0.192 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.869 177.005 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -46.92 -43.38 18.94 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.568 1.547 . . . . 0.0 112.037 179.648 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 77.9 t -75.29 -57.39 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 177.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -43.66 -52.08 6.65 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.347 1.059 . . . . 0.0 113.293 -175.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -57.54 -35.01 69.76 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.783 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.62 -41.81 20.93 Favored 'General case' 0 CA--C 1.53 0.178 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -59.81 -45.93 90.82 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.497 1.119 . . . . 0.0 111.741 -178.303 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . 100.38 79.96 1.48 Allowed Glycine 0 CA--C 1.529 0.918 0 N-CA-C 110.817 -0.913 . . . . 0.0 110.817 179.749 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' ILE . . . . . . . . . . . . . 1.4 mp -94.54 151.88 3.71 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 C-N-CA 124.726 1.21 . . . . 0.0 108.37 179.156 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 60.9 p -119.89 -109.39 0.35 Allowed 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 107.395 -1.335 . . . . 0.0 107.395 177.797 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -90.12 132.37 35.47 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 174.709 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' MET . . . . . . . . . . . . . 5.5 mpp? -76.13 131.95 74.61 Favored Pre-proline 0 CA--C 1.537 0.473 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 178.614 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_exo -78.6 138.08 48.42 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 CA-C-N 120.034 1.048 . . . . 0.0 112.789 -1.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 55.5 m -111.71 115.51 29.21 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 103.94 -2.615 . . . . 0.0 103.94 167.511 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.426 ' CE1' HD11 ' A' ' 102' ' ' LEU . 55.2 m-85 -95.88 130.2 42.91 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.545 1.138 . . . . 0.0 108.545 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' HIS . . . . . . . . . . . . . 63.3 m170 -122.62 150.37 42.74 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 175.785 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 t -127.08 113.33 32.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 C-N-CA 125.022 1.329 . . . . 0.0 107.475 176.352 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -107.39 137.46 45.39 Favored 'General case' 0 CA--C 1.53 0.18 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.434 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 8.3 mtmp? -90.82 -100.2 0.11 Allowed 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 119.863 1.21 . . . . 0.0 110.279 179.882 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 15.5 p-10 -53.25 -42.55 66.58 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-O 122.862 1.315 . . . . 0.0 110.761 179.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 179.0 -27.33 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 127.07 2.271 . . . . 0.0 109.726 -178.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.11 135.42 24.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 CA-C-N 118.529 1.165 . . . . 0.0 110.893 -178.959 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' LYS . . . . . . . . . . . . . 18.6 ttpp -52.18 112.43 0.8 Allowed 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 126.225 1.81 . . . . 0.0 107.759 172.462 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -98.72 -41.02 7.87 Favored 'General case' 0 N--CA 1.45 -0.471 0 C-N-CA 125.135 1.374 . . . . 0.0 112.64 -174.966 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -151.14 161.29 42.99 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 -173.572 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' ASP . . . . . . . . . . . . . 50.2 m-20 -150.77 169.01 22.68 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.175 0.99 . . . . 0.0 109.484 -175.597 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 6.8 tt -159.9 158.42 30.81 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 126.21 1.804 . . . . 0.0 106.981 177.565 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 21.6 m -130.66 157.27 43.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.241 0 N-CA-C 107.704 -1.221 . . . . 0.0 107.704 178.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 77.89 -164.69 51.85 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.497 -1.041 . . . . 0.0 110.497 -179.244 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -82.98 -80.0 0.18 Allowed 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.245 0.618 . . . . 0.0 110.717 -178.323 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 19.2 m 36.11 57.9 0.99 Allowed 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.975 2.11 . . . . 0.0 113.59 179.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' GLN . . . . . . . . . . . . . 5.5 mm100 -46.86 -42.41 17.33 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 125.14 1.376 . . . . 0.0 111.862 179.476 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' ASP . . . . . . . . . . . . . 21.1 p-10 -57.91 -53.81 53.99 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.946 0.898 . . . . 0.0 110.44 178.532 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -64.09 -40.97 97.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' LEU . . . . . 0.426 HD11 ' CE1' ' A' ' 82' ' ' PHE . 1.6 tt -52.13 -53.97 36.32 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 124.262 1.025 . . . . 0.0 108.484 177.216 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 43.6 tttm -59.72 -50.14 75.0 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 122.583 0.353 . . . . 0.0 110.083 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -51.9 -45.89 64.37 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 122.889 0.476 . . . . 0.0 110.666 -179.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' LEU . . . . . . . . . . . . . 71.9 mt -63.31 -58.62 6.53 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 176.852 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -44.5 -51.67 1.76 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.403 0 C-N-CA 123.215 0.606 . . . . 0.0 110.685 -177.19 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -45.71 -38.35 6.8 Favored 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 124.383 1.073 . . . . 0.0 112.424 -178.445 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . 0.542 ' HG2' ' CD2' ' A' ' 109' ' ' HIS . 6.2 ptmt -64.3 -37.91 89.17 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 118.44 0.564 . . . . 0.0 111.358 -178.546 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.542 ' CD2' ' HG2' ' A' ' 108' ' ' LYS . 80.7 m-70 -84.45 -49.15 8.92 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 123.95 0.9 . . . . 0.0 110.221 -178.809 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' ALA . . . . . . . . . . . . . . . -63.46 -40.07 96.14 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 127.454 2.301 . . . . 0.0 111.939 -177.121 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 64.66 49.35 2.33 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.733 1.613 . . . . 0.0 109.31 -175.119 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 C-N-CA 126.211 1.804 . . . . 0.0 106.865 179.728 . . . . . . . . 0 0 . 1 stop_ save_